data_1rdu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rdu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.91 141.01 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.05 155.06 18.99 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.56 122.17 13.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.45 102.62 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.618 4.212 . . . . 0.0 109.129 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -100.26 175.41 5.73 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.34 1.456 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.06 37.03 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.694 0.798 . . . . 0.0 109.968 166.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.94 -173.86 46.34 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 120.46 -1.4 . . . . 0.0 111.783 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -125.61 39.55 3.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.45 1.125 . . . . 0.0 111.602 -165.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.18 153.03 51.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.963 1.305 . . . . 0.0 107.626 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -7.21 53.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.349 1.46 . . . . 0.0 113.02 -170.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -115.59 38.15 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.434 -1.416 . . . . 0.0 109.667 164.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.9 m -79.5 166.91 21.47 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.61 140.45 39.65 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.714 -1.242 . . . . 0.0 108.344 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.4 t -77.47 137.28 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -83.06 146.31 28.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.45 1.5 . . . . 0.0 108.203 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.67 38.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.786 -0.571 . . . . 0.0 110.293 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 179.77 108.91 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 119.923 -1.736 . . . . 0.0 108.889 -161.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.95 -65.6 0.54 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.247 0.619 . . . . 0.0 111.392 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.96 12.19 3.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.711 -171.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -131.23 37.43 3.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.815 0.734 . . . . 0.0 109.481 164.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.81 -176.01 5.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -122.74 -14.27 7.74 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -144.72 154.69 43.01 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -133.09 116.37 16.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.4 mm -95.42 118.03 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.31 97.77 6.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -83.96 111.05 18.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.784 1.234 . . . . 0.0 108.637 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 101.36 7.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.813 2.845 . . . . 0.0 111.322 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 p -75.78 43.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.96 -1.088 . . . . 0.0 112.732 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.7 -37.72 1.17 Allowed 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 116.996 -1.478 . . . . 0.0 112.197 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -133.86 36.79 3.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 124.94 1.4 . . . . 0.0 111.972 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.89 1.3 Allowed Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.988 1.756 . . . . 0.0 113.003 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.01 150.85 21.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.3 149.12 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 122.218 1.008 . . . . 0.0 109.063 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.09 134.44 52.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.32 108.63 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.24 152.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.34 103.25 7.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 CA-C-O 118.599 -0.667 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 0.4 OUTLIER 59.93 -62.06 0.06 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 127.038 2.135 . . . . 0.0 112.333 -168.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -52.5 -62.55 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -52.73 52.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-O 116.129 -1.891 . . . . 0.0 109.692 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -46.21 -48.42 17.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.96 1.254 . . . . 0.0 111.481 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 t -61.96 -62.65 1.64 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.388 0.675 . . . . 0.0 111.139 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.9 mt -53.75 -46.83 71.02 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.925 1.69 . . . . 0.0 111.281 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 t -56.75 -45.55 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.846 1.658 . . . . 0.0 110.232 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.8 m -71.95 8.07 1.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.013 0.925 . . . . 0.0 112.217 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.68 37.62 4.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 166.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.91 5.32 2.85 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 129.102 3.239 . . . . 0.0 117.344 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.7 t -53.46 108.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 121.107 2.453 . . . . 0.0 112.681 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -105.82 35.65 2.82 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.948 0.88 . . . . 0.0 111.711 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -176.91 168.36 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.008 -2.308 . . . . 0.0 108.384 -172.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 tp -166.55 152.19 8.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -119.94 94.9 3.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.43 108.82 3.96 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.069 0.948 . . . . 0.0 111.202 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 p -48.74 -28.21 3.46 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.908 2.483 . . . . 0.0 115.565 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.75 178.52 4.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.662 1.985 . . . . 0.0 106.039 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.19 155.09 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.848 -1.158 . . . . 0.0 108.356 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -48.51 -58.93 6.94 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 167.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 151.6 -177.7 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 1 C-N-CA 133.82 4.848 . . . . 0.0 105.357 -166.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 25.62 58.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 129.426 3.091 . . . . 0.0 116.153 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.28 -29.3 0.12 Allowed 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.595 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 46.4 t80 -61.2 -33.8 74.05 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.632 0.651 . . . . 0.0 112.462 -169.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.89 -33.88 71.03 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.625 0.37 . . . . 0.0 110.833 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -16.54 41.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.307 0.643 . . . . 0.0 110.088 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.8 mt -64.28 -66.69 0.51 Allowed 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.595 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -60.73 -27.0 67.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.47 -31.08 33.11 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.294 0.638 . . . . 0.0 112.368 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.25 37.42 2.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.279 1.032 . . . . 0.0 110.631 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.82 27.03 8.85 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.773 1.654 . . . . 0.0 116.653 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.64 114.02 19.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 118.639 1.219 . . . . 0.0 109.187 -168.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -79.59 103.32 9.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.07 109.88 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.988 1.715 . . . . 0.0 108.695 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -79.72 162.25 25.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.015 1.326 . . . . 0.0 111.465 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -79.56 152.61 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.479 1.912 . . . . 0.0 106.567 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -131.92 163.93 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 155.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.33 92.72 1.72 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.658 1.572 . . . . 0.0 109.274 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.56 86.48 0.91 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.697 1.142 . . . . 0.0 115.695 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.63 159.95 28.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 121.387 -1.067 . . . . 0.0 112.302 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.7 p -82.8 172.51 12.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.347 0.659 . . . . 0.0 109.505 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.6 t -46.26 -42.55 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.298 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -35.24 76.93 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.548 1.522 . . . . 0.0 114.499 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.86 -45.64 85.19 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 125.106 1.362 . . . . 0.0 108.138 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.06 -29.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -89.58 -60.91 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 C-N-CA 125.141 1.376 . . . . 0.0 107.448 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -48.98 -41.23 33.59 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 127.51 2.324 . . . . 0.0 109.404 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.64 -54.99 15.1 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.731 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -58.09 -47.44 83.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.932 1.293 . . . . 0.0 111.971 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.8 p -68.43 -33.44 74.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.086 1.754 . . . . 0.0 110.413 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.75 37.82 2.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.87 44.66 24.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.906 2.194 . . . . 0.0 115.115 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -118.28 38.25 3.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.49 1.145 . . . . 0.0 110.468 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.4 mt -133.04 170.37 15.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.386 0.994 . . . . 0.0 108.686 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -112.74 147.29 37.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -79.94 121.97 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.234 0.241 0 C-N-CA 124.213 1.005 . . . . 0.0 109.903 -172.049 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.32 134.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.478 -2.415 . . . . 0.0 104.478 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.43 146.19 27.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.25 123.41 20.62 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.73 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 1 C-N-CA 126.404 4.736 . . . . 0.0 109.392 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.2 t -83.48 169.34 15.6 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.307 1.043 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.1 m -120.56 38.77 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.701 1.2 . . . . 0.0 110.582 163.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 170.63 42.18 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 164.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -93.48 46.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.952 1.701 . . . . 0.0 110.27 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -138.41 153.43 48.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.041 0.936 . . . . 0.0 108.74 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.72 -15.49 59.76 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.246 1.418 . . . . 0.0 109.256 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.55 39.46 3.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.587 -1.321 . . . . 0.0 110.638 165.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -88.41 166.71 14.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 159.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.15 146.46 35.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.919 0.887 . . . . 0.0 109.887 -173.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.408 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 3.2 t -93.0 147.31 5.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 122.349 1.071 . . . . 0.0 109.859 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -105.8 132.74 51.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.222 1.809 . . . . 0.0 108.193 -165.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -79.45 38.44 0.37 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.767 0.794 . . . . 0.0 110.024 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -172.61 93.99 0.12 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 119.209 -2.182 . . . . 0.0 108.752 -160.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -49.97 -61.42 2.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 112.047 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.5 -0.8 16.12 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -168.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -133.69 58.92 1.75 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.753 2.421 . . . . 0.0 107.066 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.98 179.71 4.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 163.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.91 -19.99 7.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.488 0.586 . . . . 0.0 112.145 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.41 144.23 33.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -126.29 99.7 5.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.1 mm -80.79 121.53 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -108.82 117.11 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -103.11 131.31 50.21 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.093 1.357 . . . . 0.0 109.014 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.12 122.78 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.849 1.66 . . . . 0.0 111.005 173.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 p -88.16 42.15 1.04 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 164.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.33 -96.85 0.36 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.72 37.92 1.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.919 -162.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.22 2.79 0.03 OUTLIER Glycine 0 CA--C 1.536 1.37 0 C-N-CA 128.708 3.052 . . . . 0.0 116.387 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -72.84 140.88 47.9 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.957 1.303 . . . . 0.0 109.745 -165.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.937 0.895 . . . . 0.0 109.745 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -141.92 128.76 20.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.646 1.578 . . . . 0.0 107.435 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.76 117.85 33.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.69 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 152.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.57 142.93 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.133 1.773 . . . . 0.0 106.382 158.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 O-C-N 121.025 -1.047 . . . . 0.0 109.929 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.45 -1.057 0 CA-C-O 118.268 -0.805 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 63.51 -63.56 0.13 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.403 1.481 . . . . 0.0 111.249 -166.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -65.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -49.05 -53.02 8.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 126.324 1.85 . . . . 0.0 108.97 175.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -53.57 7.06 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.378 1.049 . . . . 0.0 111.466 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -70.05 -46.79 64.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.19 -40.54 90.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.783 -1.198 . . . . 0.0 110.069 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.8 t -57.0 -41.95 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.998 1.719 . . . . 0.0 110.291 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -55.74 -29.85 60.23 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.597 0.635 . . . . 0.0 111.666 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -101.82 38.57 1.61 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.442 1.019 . . . . 0.0 109.045 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.47 18.35 29.56 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 126.324 1.916 . . . . 0.0 116.443 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.82 114.12 4.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -124.15 35.63 4.78 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.626 0.648 . . . . 0.0 111.443 167.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -158.75 162.7 37.13 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.17 150.8 8.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.736 -1.853 . . . . 0.0 107.099 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.0 mt -121.79 99.66 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.91 113.18 3.75 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.308 1.043 . . . . 0.0 109.21 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -52.52 -30.45 30.46 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.433 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -160.53 169.81 22.2 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.541 1.937 . . . . 0.0 106.911 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.04 153.67 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.29 50.95 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.61 -160.82 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.834 3.254 . . . . 0.0 106.553 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -28.93 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 129.404 3.081 . . . . 0.0 112.766 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -175.98 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.38 1.872 . . . . 0.0 110.084 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.435 ' CD2' ' HE3' ' A' ' 80' ' ' LYS . 45.8 t80 -57.56 -38.97 75.67 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.195 1.398 . . . . 0.0 111.61 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.45 -24.89 63.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.457 0.571 . . . . 0.0 111.226 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.8 m -84.41 -18.2 36.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.964 -1.085 . . . . 0.0 112.065 170.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -66.85 -61.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.341 0.973 . . . . 0.0 108.696 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -55.95 -32.67 64.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 171.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.28 67.66 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.388 0.994 . . . . 0.0 110.674 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.38 36.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.386 0.994 . . . . 0.0 111.914 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.16 28.68 3.18 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.453 1.502 . . . . 0.0 116.047 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 t -86.61 123.63 39.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 118.772 1.286 . . . . 0.0 108.344 -170.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 159.65 28.3 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.14 148.0 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.642 1.577 . . . . 0.0 108.011 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -118.33 155.87 29.89 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.346 1.858 . . . . 0.0 109.994 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.78 146.45 33.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 164.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.408 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -122.85 166.91 14.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 154.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -154.31 60.11 0.7 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.816 1.189 . . . . 0.0 109.411 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.24 121.02 3.05 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.564 1.078 . . . . 0.0 111.89 168.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.97 167.58 18.32 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.359 1.079 . . . . 0.0 114.993 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.1 p -87.88 174.79 8.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.231 1.012 . . . . 0.0 110.694 162.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.6 t -48.85 -38.29 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.002 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -65.99 -33.61 76.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 121.076 1.762 . . . . 0.0 113.928 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -69.58 -41.6 75.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.768 1.627 . . . . 0.0 108.801 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -42.88 -42.08 3.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.141 0.882 . . . . 0.0 111.902 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.19 -48.66 14.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.791 1.237 . . . . 0.0 108.227 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.13 -24.97 63.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.274 1.829 . . . . 0.0 110.153 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.67 -57.33 3.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.14 -44.7 83.65 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.211 1.004 . . . . 0.0 113.015 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.0 p -61.97 -50.76 70.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.084 1.354 . . . . 0.0 108.765 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.92 35.62 0.64 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.857 . . . . 0.0 109.134 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.05 24.51 2.09 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.02 1.771 . . . . 0.0 114.978 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -98.34 37.76 1.42 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.076 1.438 . . . . 0.0 109.984 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.7 mt -134.36 165.24 25.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -109.03 138.52 45.25 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.7 100.47 7.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.689 1.131 . . . . 0.0 108.59 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 CA--C 1.536 0.437 0 C-N-CA 123.751 0.821 . . . . 0.0 110.65 -166.41 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 9.8 p -82.88 156.02 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.96 146.4 39.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 163.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.78 129.08 24.13 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.83 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.203 1 C-N-CA 125.307 4.005 . . . . 0.0 108.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 t -111.3 171.08 7.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.567 1.147 . . . . 0.0 109.876 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -129.82 39.39 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.73 2.012 . . . . 0.0 108.227 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.1 173.1 42.34 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -110.29 50.0 0.82 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.016 1.326 . . . . 0.0 108.268 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.71 157.13 45.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.983 1.313 . . . . 0.0 108.016 171.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 0.8 25.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.313 1.445 . . . . 0.0 110.339 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -127.25 37.63 4.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.021 -1.674 . . . . 0.0 108.755 168.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -81.07 165.07 21.98 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.419 -0.801 . . . . 0.0 109.381 163.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.41 135.35 37.41 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.664 1.12 . . . . 0.0 109.047 -175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.501 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 93.0 t -75.34 137.53 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.67 131.12 42.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 107.361 -172.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.67 38.59 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.634 1.207 . . . . 0.0 110.862 -173.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.46 93.5 0.76 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 118.401 -2.687 . . . . 0.0 107.132 -166.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -55.12 -52.58 62.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.632 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.79 13.59 1.0 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.04 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.28 38.29 1.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.286 1.403 . . . . 0.0 110.082 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.91 127.85 51.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -172.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.43 -20.15 64.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.62 151.98 42.02 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -131.3 119.61 22.0 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.31 112.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.76 112.47 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.42 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 16.7 t80 -104.28 125.83 50.87 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.859 1.264 . . . . 0.0 110.582 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.84 112.11 19.82 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 108.676 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -77.43 54.57 1.16 Allowed 'General case' 0 C--O 1.239 0.518 0 O-C-N 120.832 -1.167 . . . . 0.0 108.838 163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -151.58 -34.67 0.14 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.46 38.03 0.43 Allowed 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 117.524 -1.67 . . . . 0.0 111.873 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.1 9.48 2.0 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.011 1.291 . . . . 0.0 115.01 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -61.91 146.36 50.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.893 1.346 . . . . 0.0 107.687 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.44 142.42 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.25 132.23 53.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.275 1.83 . . . . 0.0 106.629 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.27 110.53 25.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.22 150.57 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 158.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -124.02 106.76 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo . . . . . 0 N--CA 1.448 -1.158 0 N-CA-C 110.758 -0.516 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 58.61 -66.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.397 1.879 . . . . 0.0 111.094 -161.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -48.91 -63.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.427 1.491 . . . . 0.0 111.174 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.36 -49.66 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 116.028 -1.939 . . . . 0.0 109.266 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -49.69 -49.81 46.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.827 1.194 . . . . 0.0 110.652 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 t -61.83 -55.11 33.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.406 1.082 . . . . 0.0 112.073 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.21 -43.15 92.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.28 0.632 . . . . 0.0 109.843 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -60.66 -45.17 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.528 1.931 . . . . 0.0 110.861 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -58.02 -26.07 61.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.532 1.06 . . . . 0.0 111.808 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -104.0 36.78 2.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.053 0.941 . . . . 0.0 109.08 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.12 11.69 55.93 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 127.012 2.244 . . . . 0.0 117.162 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.57 105.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.96 1.38 . . . . 0.0 110.791 -170.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -104.88 36.43 2.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.338 1.055 . . . . 0.0 110.847 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -171.62 173.05 4.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 119.804 -1.81 . . . . 0.0 109.888 -172.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.4 tp -166.81 157.64 12.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.941 1.296 . . . . 0.0 108.716 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.37 106.12 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.41 130.99 10.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 p -63.68 -26.04 68.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -170.02 -177.89 2.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -166.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.17 154.09 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.603 -1.311 . . . . 0.0 108.037 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.05 -51.37 25.31 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 164.52 -86.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 130.942 3.697 . . . . 0.0 104.937 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.73 119.88 15.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.7 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 130.572 3.549 . . . . 0.0 109.831 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.525 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 33.6 t80 -53.02 -43.92 66.92 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.163 1.385 . . . . 0.0 111.658 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.43 -31.2 72.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.339 1.455 . . . . 0.0 109.856 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -21.78 38.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.817 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.86 -59.11 3.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.273 0.942 . . . . 0.0 108.653 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -58.9 -31.35 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.568 1.147 . . . . 0.0 112.999 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.13 -8.19 7.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.47 36.5 4.55 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.81 1.641 . . . . 0.0 110.211 165.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.79 19.46 3.39 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.681 2.086 . . . . 0.0 116.619 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.2 129.73 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.131 -1.217 . . . . 0.0 108.184 -163.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -78.56 165.18 24.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.6 t -151.71 114.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -89.03 157.51 18.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.768 0.827 . . . . 0.0 110.181 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.81 156.17 27.53 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.697 1.599 . . . . 0.0 107.101 162.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.501 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.04 175.73 9.33 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 158.182 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.45 38.72 0.71 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 122.191 2.269 . . . . 0.0 114.759 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.04 123.17 2.82 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 172.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.41 163.37 13.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -166.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 p -81.97 172.31 13.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.305 0.553 . . . . 0.0 110.272 168.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -41.26 -47.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.698 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -35.22 77.89 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -67.88 -45.19 75.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 125.363 1.465 . . . . 0.0 108.573 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.25 -30.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.71 -52.6 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 116.359 -1.781 . . . . 0.0 108.684 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -33.69 69.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 124.38 1.05 . . . . 0.0 108.964 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -54.0 14.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -45.53 82.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.515 1.126 . . . . 0.0 111.899 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.7 p -64.46 -42.15 96.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.526 1.13 . . . . 0.0 108.104 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.64 35.65 1.22 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.937 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.08 7.52 3.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.517 1.532 . . . . 0.0 116.39 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -85.66 36.82 0.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 120.067 1.933 . . . . 0.0 112.064 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.5 mt -131.22 170.24 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 120.081 1.309 . . . . 0.0 108.614 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -111.69 142.07 44.49 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -81.34 106.68 13.5 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.905 1.23 . . . . 0.0 107.943 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.332 1.453 . . . . 0.0 109.48 178.589 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 9.3 p -129.35 125.79 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.878 1.271 . . . . 0.0 109.463 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.2 29.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.8 118.63 24.19 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.55 99.58 0.95 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 1 C-N-CA 125.43 4.086 . . . . 0.0 107.551 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 t -94.3 175.47 6.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.911 1.285 . . . . 0.0 108.77 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.54 39.42 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.282 1.033 . . . . 0.0 109.891 161.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.17 172.13 45.2 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.774 -1.204 . . . . 0.0 111.441 167.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 29.4 mtmt -94.6 39.9 1.09 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.141 2.177 . . . . 0.0 108.871 -172.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.95 148.27 38.35 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -12.46 61.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.142 2.577 . . . . 0.0 110.81 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -116.02 38.8 3.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.607 -1.308 . . . . 0.0 109.014 170.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -89.88 168.03 12.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.182 -0.949 . . . . 0.0 109.026 163.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 142.39 38.32 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.283 -0.885 . . . . 0.0 109.007 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.444 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 59.2 t -81.83 150.81 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -109.03 138.46 45.33 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.805 1.642 . . . . 0.0 110.548 -167.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -83.45 37.31 0.56 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.422 1.106 . . . . 0.0 112.034 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -172.75 85.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 119.956 -1.715 . . . . 0.0 109.334 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -50.39 -50.77 50.71 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -0.03 30.72 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.396 -0.815 . . . . 0.0 112.071 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.02 38.61 3.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.876 1.271 . . . . 0.0 109.839 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.59 142.25 47.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -91.79 -20.64 21.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -158.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 96.5 m-85 -146.47 124.95 12.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.38 107.85 18.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.8 mm -81.88 114.96 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.6 mt -110.61 106.89 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 5.1 t80 -88.1 116.6 26.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.47 101.25 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.779 2.032 . . . . 0.0 108.079 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 p -86.6 22.51 1.88 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.559 1.171 . . . . 0.0 111.227 -171.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.47 -89.84 0.4 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 167.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.95 37.4 0.84 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.063 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.36 24.04 9.91 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.754 2.121 . . . . 0.0 114.437 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -82.66 154.3 24.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -138.92 136.88 42.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.8 pt-20 -122.96 163.2 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.312 1.045 . . . . 0.0 110.446 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.94 104.31 15.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.173 1.389 . . . . 0.0 108.209 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 t -79.25 151.75 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -120.17 123.56 43.61 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 129.597 3.159 . . . . 0.0 104.427 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 CA--C 1.513 -0.458 0 CA-C-N 118.991 0.814 . . . . 0.0 109.289 -177.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 CA-C-O 117.935 -0.944 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 63.66 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 126.597 1.959 . . . . 0.0 109.217 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -56.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 126.028 1.731 . . . . 0.0 111.675 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.11 -34.98 72.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.107 -171.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -16.38 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.535 1.516 . . . . 0.0 113.727 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -98.11 -46.2 5.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 120.283 1.401 . . . . 0.0 109.971 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.88 -37.93 79.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.967 0.507 . . . . 0.0 112.012 -173.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.48 -50.52 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 123.85 0.86 . . . . 0.0 108.845 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.3 m -74.89 13.13 0.7 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.434 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 4.9 mttt -127.66 37.56 4.19 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.356 1.463 . . . . 0.0 108.707 163.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 38.57 39.3 0.79 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.831 1.682 . . . . 0.0 114.523 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 77.5 t -81.69 87.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.484 1.513 . . . . 0.0 108.402 -172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -91.09 35.62 0.91 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.555 1.071 . . . . 0.0 111.851 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -164.63 162.45 21.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.797 -1.815 . . . . 0.0 108.595 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tp -160.15 153.22 21.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.81 98.59 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.263 1.425 . . . . 0.0 107.707 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.62 133.33 16.84 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 120.205 1.366 . . . . 0.0 111.412 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.4 p -74.39 -18.4 60.67 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.42 -169.86 0.87 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.063 1.745 . . . . 0.0 108.292 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.66 140.37 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 120.376 -1.453 . . . . 0.0 108.764 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -46.29 -54.89 8.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.459 1.504 . . . . 0.0 110.526 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 172.12 152.92 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.541 2.736 . . . . 0.0 106.464 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 -144.91 0.5 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.378 1.871 . . . . 0.0 109.923 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.42 -30.9 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 129.565 3.146 . . . . 0.0 116.117 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.681 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 59.0 t80 -57.92 -40.94 81.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.245 2.218 . . . . 0.0 111.653 -169.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.75 -41.11 83.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.599 1.159 . . . . 0.0 110.099 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -69.06 -19.59 64.09 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.252 -0.905 . . . . 0.0 110.575 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.4 -61.33 1.84 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.351 0.978 . . . . 0.0 109.411 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.681 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -58.33 -35.89 72.57 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.769 -1.207 . . . . 0.0 112.473 176.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.12 -7.54 9.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.69 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.61 36.5 4.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 121.211 1.823 . . . . 0.0 110.733 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.16 5.91 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.111 1.815 . . . . 0.0 115.48 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.24 116.31 27.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 118.486 1.143 . . . . 0.0 109.626 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -79.8 94.62 5.82 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.12 128.78 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -103.78 160.65 14.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.415 1.886 . . . . 0.0 108.895 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -79.0 161.23 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 164.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.28 165.12 27.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 155.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -150.24 39.47 0.75 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 121.008 1.731 . . . . 0.0 113.189 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.25 102.69 1.71 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 121.231 -0.918 . . . . 0.0 112.207 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.07 163.14 26.99 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 111.68 -168.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.4 p -84.41 173.64 10.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.118 0.567 . . . . 0.0 109.95 165.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -48.61 -40.21 11.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.321 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -63.07 -33.53 75.64 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -71.77 -37.57 70.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.556 1.542 . . . . 0.0 109.897 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.03 -43.55 19.76 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.092 0.86 . . . . 0.0 110.548 168.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -81.14 -55.6 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 C-N-CA 125.329 1.452 . . . . 0.0 108.356 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.28 -31.23 65.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.109 1.764 . . . . 0.0 108.603 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.04 -52.54 7.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.939 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -51.77 -45.1 63.63 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.168 0.895 . . . . 0.0 111.14 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -65.95 -44.78 84.01 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.013 0.925 . . . . 0.0 110.16 -168.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.94 37.18 1.33 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.584 0.707 . . . . 0.0 109.18 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 41.89 44.16 4.46 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 127.93 2.681 . . . . 0.0 113.096 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -106.14 37.26 2.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.085 0.954 . . . . 0.0 110.485 169.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.2 mt -138.75 172.73 12.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.198 0.908 . . . . 0.0 109.454 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.38 146.95 37.42 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.002 1.321 . . . . 0.0 108.498 -168.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -81.26 99.1 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.424 1.107 . . . . 0.0 108.474 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.5 -0.975 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.413 HG22 ' HB3' ' A' ' 65' ' ' TYR . 2.3 p -97.62 151.03 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.606 1.191 . . . . 0.0 108.235 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.67 136.79 52.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 166.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.95 118.32 28.23 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.0 115.35 4.23 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 124.507 3.471 . . . . 0.0 107.573 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -118.16 151.87 36.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.233 1.413 . . . . 0.0 107.467 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.49 41.55 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.32 176.96 48.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -119.83 57.73 0.91 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.123 1.769 . . . . 0.0 108.202 -169.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.15 154.17 39.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.223 1.809 . . . . 0.0 106.431 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.717 1.207 . . . . 0.0 110.253 172.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -123.48 37.36 4.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 119.983 -1.698 . . . . 0.0 110.753 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.9 m -82.17 172.25 13.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.387 160.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.06 136.59 37.21 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.201 -0.937 . . . . 0.0 109.559 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.471 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 43.3 t -72.32 159.09 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -115.7 149.91 37.64 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.919 0.888 . . . . 0.0 111.447 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.3 37.81 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.453 1.101 . . . . 0.0 111.065 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.71 101.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.564 -1.335 . . . . 0.0 108.988 -162.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -53.39 -62.29 1.75 Allowed 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 123.36 0.412 . . . . 0.0 111.068 170.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 -3.5 29.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -118.78 38.94 3.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 109.495 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.38 115.31 28.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.188 -164.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -69.85 -23.8 63.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -166.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.08 156.9 47.31 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 106.855 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -132.19 112.72 12.52 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 124.107 0.963 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.4 mm -79.78 120.19 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 169.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.38 117.08 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -103.0 126.0 49.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.151 1.38 . . . . 0.0 110.182 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 115.03 27.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.842 2.057 . . . . 0.0 110.173 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -76.0 23.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.86 -6.02 2.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.25 36.46 0.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 158.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 34.88 34.54 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 C-N-CA 127.092 2.282 . . . . 0.0 113.327 -170.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -88.29 154.64 20.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -168.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.51 137.34 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 123.412 0.685 . . . . 0.0 110.872 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -109.86 154.28 23.25 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.174 2.19 . . . . 0.0 108.371 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.37 112.04 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 158.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.05 137.48 21.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 157.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.98 135.73 33.9 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 161.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.521 -0.143 0 CA-C-N 119.002 0.819 . . . . 0.0 110.159 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 CA-C-O 117.396 -1.168 . . . . 0.0 112.757 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.1 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.851 2.06 . . . . 0.0 111.231 -167.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.59 -54.44 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.928 1.691 . . . . 0.0 110.055 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.45 -52.83 42.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 116.521 -1.704 . . . . 0.0 109.624 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -53.47 -33.35 53.91 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.351 1.432 . . . . 0.0 111.418 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -68.04 -67.43 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 120.93 -1.106 . . . . 0.0 112.594 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.35 -38.58 80.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.794 0.838 . . . . 0.0 111.08 -166.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.8 t -54.77 -36.52 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.729 1.611 . . . . 0.0 111.518 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 t -67.66 -13.43 62.08 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.649 -1.282 . . . . 0.0 112.91 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.03 37.09 2.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.832 1.196 . . . . 0.0 109.957 172.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.8 26.76 41.35 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.964 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.7 t -73.05 97.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 118.256 1.028 . . . . 0.0 109.014 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -104.61 35.27 2.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.033 0.921 . . . . 0.0 111.597 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB3' HG22 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -174.74 151.5 1.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.447 -1.408 . . . . 0.0 108.363 -162.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 tp -159.29 154.64 25.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.717 1.207 . . . . 0.0 108.706 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.3 mt -127.02 104.06 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.25 105.81 1.01 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.957 0.903 . . . . 0.0 109.203 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -13.46 25.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -156.34 -177.72 6.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 119.683 1.129 . . . . 0.0 108.806 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.256 4.1 p -133.16 166.14 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.18 60.2 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 168.37 -88.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 130.799 3.64 . . . . 0.0 106.52 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.75 139.32 58.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 153.31 -30.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 130.688 3.595 . . . . 0.0 109.838 160.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 60.7 t80 -52.74 -42.5 64.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.433 1.893 . . . . 0.0 111.434 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -69.45 -35.68 75.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.403 1.481 . . . . 0.0 109.408 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -22.36 58.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 110.276 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.1 mt -68.85 -64.14 0.92 Allowed 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.59 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.95 -39.87 20.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.43 1.092 . . . . 0.0 111.892 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.64 37.16 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.979 0.912 . . . . 0.0 111.247 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.14 30.37 1.83 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.037 1.78 . . . . 0.0 116.742 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.49 126.53 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.68 1.24 . . . . 0.0 108.123 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.23 159.91 27.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.37 133.52 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -116.73 162.89 16.97 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.033 1.733 . . . . 0.0 110.14 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -79.74 153.42 29.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.264 2.226 . . . . 0.0 108.051 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.9 129.66 15.16 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.861 2.064 . . . . 0.0 106.303 164.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.68 39.38 3.94 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 123.472 2.851 . . . . 0.0 111.615 -165.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.74 131.91 4.03 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.322 1.915 . . . . 0.0 110.415 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.6 163.48 11.85 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.075 0.937 . . . . 0.0 113.035 -164.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.4 p -87.89 170.02 11.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.489 1.516 . . . . 0.0 110.39 166.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -44.0 -47.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-N 119.338 0.972 . . . . 0.0 110.022 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -56.73 -38.01 71.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.47 -46.39 76.54 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.707 1.603 . . . . 0.0 108.722 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.76 -30.13 13.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.449 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.4 mm -93.5 -51.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 C-N-CA 124.596 1.158 . . . . 0.0 107.912 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.64 -42.46 78.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.32 -49.03 63.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.623 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.55 78.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 111.563 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.3 p -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.56 1.144 . . . . 0.0 109.499 -170.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.6 36.59 2.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.402 1.081 . . . . 0.0 108.617 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.72 11.92 0.19 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.642 2.068 . . . . 0.0 116.666 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -85.35 36.05 0.62 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.177 1.988 . . . . 0.0 111.061 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.8 mt -139.72 175.53 9.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -114.61 159.84 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -78.91 137.46 37.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 161.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 N--CA 1.453 -0.277 0 C-N-CA 125.013 1.325 . . . . 0.0 108.16 173.654 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm105 . . . . . 0 CA--C 1.507 -0.708 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.71 136.27 30.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.18 95.68 5.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 0.947 . . . . 0.0 108.81 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.96 132.07 49.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -170.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.63 136.5 23.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 1 C-N-CA 125.586 4.191 . . . . 0.0 109.676 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.0 t -138.05 166.08 25.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.261 1.424 . . . . 0.0 108.077 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.63 39.15 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.127 0.971 . . . . 0.0 109.532 163.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.14 167.17 40.31 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 164.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 8.7 mtmp? -92.95 42.42 1.1 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.543 1.537 . . . . 0.0 109.106 -175.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.83 149.94 32.17 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.522 0.729 . . . . 0.0 109.399 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.0 -12.0 60.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.216 1.807 . . . . 0.0 112.058 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -114.12 35.8 3.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.828 -1.17 . . . . 0.0 111.625 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 m -86.26 169.63 12.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 171.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.48 134.22 37.35 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.48 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 65.5 t -78.86 130.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 122.452 1.12 . . . . 0.0 108.589 172.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -79.94 153.9 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.159 1.783 . . . . 0.0 109.499 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.94 37.14 1.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.645 1.112 . . . . 0.0 110.775 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -167.53 99.38 0.49 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 119.168 -2.208 . . . . 0.0 110.23 -166.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -49.27 -64.69 0.73 Allowed 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.253 0.933 . . . . 0.0 111.34 -175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.84 24.31 1.29 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.77 -170.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 39.42 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 167.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.71 132.8 56.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.29 -26.22 46.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -162.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 97.9 m-85 -135.36 148.21 49.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -125.92 125.37 42.66 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 mm -112.59 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -92.84 97.9 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -81.77 117.95 22.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.89 118.35 22.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.711 2.004 . . . . 0.0 109.892 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.7 p -90.26 28.16 1.5 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.761 1.164 . . . . 0.0 111.802 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -99.67 -87.05 0.37 Allowed 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 155.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -94.78 35.42 1.25 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.339 -156.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 28.09 38.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.192 1.377 . . . . 0.0 113.933 -163.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -68.79 155.51 40.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.2 170.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.66 140.7 17.36 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.6 t -112.63 107.98 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.83 145.57 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -109.41 133.9 52.5 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 128.599 2.759 . . . . 0.0 104.446 166.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.462 0.153 0 C-N-CA 123.88 0.872 . . . . 0.0 109.009 -177.485 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.503 -1.044 0 CA-C-O 117.29 -1.213 . . . . 0.0 113.852 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 66.15 -68.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -61.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.161 1.385 . . . . 0.0 108.566 170.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -57.54 -45.51 86.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-O 116.006 -1.949 . . . . 0.0 109.131 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -45.2 -53.56 8.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.247 1.385 . . . . 0.0 111.662 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -67.05 -44.85 79.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.78 -41.46 87.62 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.22 -0.925 . . . . 0.0 110.148 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.07 -34.03 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.84 1.656 . . . . 0.0 110.361 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -66.8 -16.24 64.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.371 0.987 . . . . 0.0 113.536 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -104.35 37.44 2.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.558 1.072 . . . . 0.0 109.634 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.13 34.12 3.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.006 1.289 . . . . 0.0 114.074 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.1 106.42 5.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 118.936 1.368 . . . . 0.0 107.525 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -108.27 35.23 3.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -168.58 151.83 5.45 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.326 -1.484 . . . . 0.0 108.406 -163.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.3 tp -166.26 145.0 5.72 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.245 -1.534 . . . . 0.0 109.064 -169.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 mt -125.23 100.06 6.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.54 94.52 0.97 Allowed 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.315 0.961 . . . . 0.0 110.835 -167.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.5 p -29.6 -32.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.733 3.213 . . . . 0.0 119.462 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -162.63 -174.73 4.11 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.845 2.058 . . . . 0.0 105.816 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.38 156.62 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 120.735 -1.228 . . . . 0.0 109.304 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.02 66.15 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.697 1.142 . . . . 0.0 113.253 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 144.0 -105.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 1 C-N-CA 135.865 5.666 . . . . 0.0 107.019 169.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -57.13 119.01 5.61 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.881 -1.137 . . . . 0.0 109.846 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.88 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 130.89 3.676 . . . . 0.0 110.907 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.513 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 28.4 t80 -54.65 -36.1 64.22 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.231 0.923 . . . . 0.0 111.558 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.55 -30.74 71.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.61 1.964 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -92.96 -14.78 27.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.583 1.553 . . . . 0.0 111.002 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt -66.93 -68.05 0.4 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 167.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -52.25 -30.67 28.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.32 -30.62 12.46 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.05 36.9 3.15 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.927 1.291 . . . . 0.0 111.059 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.64 15.85 54.57 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.098 1.199 . . . . 0.0 116.098 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.93 123.35 36.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 118.314 1.057 . . . . 0.0 110.782 -158.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -78.9 156.79 28.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.5 t -149.29 138.31 15.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -169.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -122.25 155.45 35.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.76 0.824 . . . . 0.0 111.544 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -79.22 149.24 31.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 162.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.48 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.73 167.97 16.5 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -142.73 116.35 9.18 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.915 -1.115 . . . . 0.0 110.187 160.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.03 90.3 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 125.577 1.56 . . . . 0.0 113.654 162.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 165.72 37.98 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.2 p -81.81 178.39 8.34 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.977 -0.719 . . . . 0.0 110.698 167.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.03 -44.93 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.121 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -60.76 -37.27 81.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 120.972 1.715 . . . . 0.0 114.626 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.86 -40.7 83.61 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.592 1.557 . . . . 0.0 108.264 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.74 -35.53 14.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.397 0.544 . . . . 0.0 111.983 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.7 -53.25 9.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 125.131 1.372 . . . . 0.0 109.376 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -28.21 68.87 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.801 2.04 . . . . 0.0 108.69 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.68 -58.01 3.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -54.74 -50.74 67.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.569 0.747 . . . . 0.0 112.451 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 p -63.1 -44.72 94.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.896 0.879 . . . . 0.0 108.904 -168.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.63 37.4 0.91 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.875 0.845 . . . . 0.0 109.014 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.98 17.05 8.78 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 128.073 2.749 . . . . 0.0 116.501 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -89.65 36.62 0.85 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.72 2.26 . . . . 0.0 112.769 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.1 mt -137.32 166.8 22.93 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.985 1.721 . . . . 0.0 110.339 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.21 147.7 24.34 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -93.24 82.4 4.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.986 0.898 . . . . 0.0 109.558 -169.588 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.29 124.81 72.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -169.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.9 137.97 39.48 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.25 116.66 28.38 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.57 112.53 2.65 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 125.074 3.849 . . . . 0.0 106.877 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -113.99 167.52 10.59 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.561 1.944 . . . . 0.0 107.447 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.13 38.36 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.569 -0.707 . . . . 0.0 109.654 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 166.94 39.84 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 120.99 -1.069 . . . . 0.0 110.958 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -89.22 39.44 0.94 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 122.151 -0.617 . . . . 0.0 110.712 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.02 153.42 50.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.609 1.164 . . . . 0.0 109.277 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.74 -15.89 55.3 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.486 1.914 . . . . 0.0 109.745 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 38.9 2.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.285 1.434 . . . . 0.0 108.229 170.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -83.88 173.17 11.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 119.822 -1.799 . . . . 0.0 107.991 164.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.39 140.65 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.582 -1.324 . . . . 0.0 109.553 166.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.45 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.7 t -73.37 149.93 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 167.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -102.57 136.52 42.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.82 1.648 . . . . 0.0 108.59 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -81.5 37.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.409 1.1 . . . . 0.0 111.082 -172.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 110.28 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -162.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -64.17 -56.45 14.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.677 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.34 0.02 9.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -134.93 76.61 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.487 1.915 . . . . 0.0 107.192 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.48 166.56 14.58 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 160.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 14.6 mt-10 -106.68 -16.89 14.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -144.76 153.86 42.12 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -131.53 98.4 4.5 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.145 1.778 . . . . 0.0 107.51 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 mm -79.43 103.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -89.27 103.87 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -85.06 146.17 27.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.51 114.42 21.74 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 127.172 2.189 . . . . 0.0 111.09 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.9 p -78.86 13.82 1.58 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -99.89 -32.94 10.75 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.348 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.93 36.49 1.41 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.033 160.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.57 33.62 26.17 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.257 0.932 . . . . 0.0 111.784 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -81.88 157.79 24.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.128 1.771 . . . . 0.0 107.091 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.48 150.33 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.867 0.842 . . . . 0.0 110.052 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.97 141.73 51.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.011 1.325 . . . . 0.0 108.845 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.87 110.26 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 163.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.37 150.31 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 160.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.88 117.01 27.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.213 -0.817 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -168.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.448 -1.153 0 CA-C-O 118.102 -0.874 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 -66.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.791 2.437 . . . . 0.0 114.99 -170.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -57.65 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.456 1.502 . . . . 0.0 107.99 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -41.93 79.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 115.747 -2.073 . . . . 0.0 110.922 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -40.56 61.76 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.879 1.672 . . . . 0.0 111.499 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -75.61 -50.78 14.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.084 1.354 . . . . 0.0 109.787 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.5 -43.62 89.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.928 0.891 . . . . 0.0 110.102 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.74 -51.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.897 1.679 . . . . 0.0 110.756 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.3 t -62.15 -25.91 68.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -92.15 37.59 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.44 -1.412 . . . . 0.0 110.331 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.11 6.32 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 127.518 2.485 . . . . 0.0 115.779 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.68 137.81 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.189 1.495 . . . . 0.0 109.272 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.38 35.01 2.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 110.955 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 179.89 164.5 1.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 119.634 -1.916 . . . . 0.0 107.209 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.0 tp -171.2 147.42 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.9 mt -123.85 101.14 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.31 115.48 3.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.418 1.008 . . . . 0.0 110.639 -166.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.8 p -59.43 -23.89 63.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -171.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.01 174.09 9.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -170.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -120.06 157.66 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.492 -1.38 . . . . 0.0 108.428 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.7 67.62 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 169.75 -154.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 131.409 3.884 . . . . 0.0 105.657 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -24.75 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.18 2.992 . . . . 0.0 114.355 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -170.99 -29.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.412 1.485 . . . . 0.0 113.97 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.627 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 82.3 t80 -58.68 -36.08 73.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.49 1.116 . . . . 0.0 112.51 -169.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.16 -41.03 74.34 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -23.77 67.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.84 -0.537 . . . . 0.0 111.039 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.34 -68.16 0.41 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.857 0.863 . . . . 0.0 108.968 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.627 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -58.33 -31.38 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.82 24.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.096 0.558 . . . . 0.0 110.445 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.7 36.86 1.83 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.386 0.674 . . . . 0.0 111.828 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.25 8.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.416 1.484 . . . . 0.0 116.333 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.86 120.26 33.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.191 1.495 . . . . 0.0 108.98 -170.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -78.43 160.79 27.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.8 t -143.42 137.34 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.57 158.19 25.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.022 1.729 . . . . 0.0 110.112 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -78.95 148.24 32.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.45 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.12 161.12 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 156.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -148.94 85.38 1.48 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 120.268 1.395 . . . . 0.0 111.154 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.9 112.47 0.59 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.454 1.026 . . . . 0.0 111.063 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.92 158.3 10.76 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -83.08 171.76 13.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 110.397 170.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.15 -40.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-O 116.747 -1.597 . . . . 0.0 113.138 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -35.26 76.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 121.012 1.733 . . . . 0.0 113.626 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.83 -46.25 69.04 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.75 2.02 . . . . 0.0 108.355 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.41 -40.45 17.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 118.699 0.681 . . . . 0.0 111.144 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.65 -51.04 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.39 1.876 . . . . 0.0 108.886 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -40.05 85.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.382 1.473 . . . . 0.0 108.237 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.66 -49.48 25.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.79 0.836 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.78 -50.45 73.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.477 1.035 . . . . 0.0 111.787 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -64.18 -39.05 93.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.384 1.074 . . . . 0.0 110.163 -168.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -101.42 37.34 1.81 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.975 0.91 . . . . 0.0 109.435 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 40.22 46.06 3.3 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 127.497 2.475 . . . . 0.0 114.113 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -112.49 37.35 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.901 0.88 . . . . 0.0 109.854 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.3 mt -143.39 170.09 16.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.994 -1.067 . . . . 0.0 108.547 165.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -119.11 147.64 43.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.641 1.576 . . . . 0.0 108.075 -165.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -78.99 116.84 19.55 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 C--O 1.232 0.147 0 C-N-CA 126.727 2.011 . . . . 0.0 108.362 -178.527 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 . . . . . 0 CA--C 1.51 -0.583 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.96 124.64 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.284 -172.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.45 111.38 23.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.98 124.55 51.68 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.55 112.0 3.25 Favored 'Trans proline' 0 N--CA 1.443 -1.448 1 C-N-CA 125.464 4.109 . . . . 0.0 108.528 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 t -108.66 174.8 5.71 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.192 1.397 . . . . 0.0 108.498 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.82 38.49 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 109.655 167.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.78 -170.14 32.18 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -129.48 64.8 1.48 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.593 1.696 . . . . 0.0 110.195 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.62 153.99 29.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.082 1.753 . . . . 0.0 107.949 169.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -12.07 52.14 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.737 1.215 . . . . 0.0 110.521 174.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -110.58 36.44 3.1 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.589 -1.319 . . . . 0.0 111.435 172.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 166.73 11.77 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.053 -1.03 . . . . 0.0 109.771 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 135.14 37.35 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.302 -1.499 . . . . 0.0 109.81 -172.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.444 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 45.7 t -78.02 131.11 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 t -81.07 144.16 31.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.614 1.566 . . . . 0.0 109.76 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -86.41 36.71 0.7 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.444 1.593 . . . . 0.0 110.739 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.61 121.54 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -166.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.65 -61.25 1.84 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.41 -23.6 66.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.832 -168.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -105.04 75.56 1.19 Allowed 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 127.673 2.389 . . . . 0.0 107.753 166.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.19 160.26 37.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 157.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -105.96 -12.63 15.75 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -168.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -146.22 145.86 30.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.35 108.25 9.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mp -89.62 117.71 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -171.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -105.24 97.29 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -91.25 109.08 20.34 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.77 110.22 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.463 1.505 . . . . 0.0 108.962 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -78.02 55.03 1.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.558 -0.714 . . . . 0.0 110.016 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -134.21 -39.86 0.83 Allowed 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 124.814 1.246 . . . . 0.0 111.374 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -144.37 37.33 1.23 Allowed 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.601 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 16.29 2.24 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.609 1.576 . . . . 0.0 115.294 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -82.22 134.03 35.28 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.305 1.053 . . . . 0.0 108.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.64 160.51 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 125.261 1.424 . . . . 0.0 108.817 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.17 132.86 27.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.87 110.55 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.12 152.07 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 160.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -124.44 96.04 4.76 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.96 2.504 . . . . 0.0 105.935 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.457 -0.635 0 CA-C-O 119.007 -0.497 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.46 -77.38 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.513 2.325 . . . . 0.0 110.87 -165.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -49.66 -60.52 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 C-N-CA 126.317 1.847 . . . . 0.0 109.334 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -60.04 -51.2 75.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 115.743 -2.075 . . . . 0.0 109.708 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.82 -51.31 9.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.914 1.688 . . . . 0.0 110.949 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -62.41 -56.05 21.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.67 -41.9 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.301 0.64 . . . . 0.0 110.262 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -57.44 -46.62 85.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -58.37 -27.64 64.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.146 0.884 . . . . 0.0 112.415 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -99.74 37.4 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.665 1.186 . . . . 0.0 109.471 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.11 23.42 7.75 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.292 2.377 . . . . 0.0 116.69 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.64 125.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.535 1.168 . . . . 0.0 108.053 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.19 36.59 4.61 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 164.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.74 157.46 14.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.485 -1.385 . . . . 0.0 109.112 -168.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.1 tp -164.08 148.34 10.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.2 mt -124.58 106.77 17.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.77 134.44 10.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.999 2.182 . . . . 0.0 111.184 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -64.08 -21.16 66.41 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.602 -1.311 . . . . 0.0 113.641 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -163.21 177.45 9.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.07 1.748 . . . . 0.0 106.432 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.251 1.0 OUTLIER -107.35 161.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.055 -1.028 . . . . 0.0 108.561 174.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.29 24.77 3.42 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.683 1.135 . . . . 0.0 111.63 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 68.05 -71.09 0.11 Allowed 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 129.684 3.194 . . . . 0.0 113.257 -172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.29 56.37 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.448 2.299 . . . . 0.0 113.833 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -161.62 -28.64 0.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 113.95 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.631 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 56.6 t80 -69.39 -32.59 71.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.897 1.68 . . . . 0.0 111.986 -169.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.21 -38.13 85.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 110.073 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -14.83 58.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.928 2.891 . . . . 0.0 109.366 -174.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.9 mt -80.86 -58.13 3.23 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 108.221 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.631 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -62.6 -28.37 69.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.299 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.0 54.82 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.034 0.834 . . . . 0.0 111.876 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.9 37.31 4.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.617 1.099 . . . . 0.0 110.765 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.39 30.53 0.3 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.686 2.088 . . . . 0.0 117.041 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.78 125.2 38.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 118.87 1.335 . . . . 0.0 109.048 -169.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -78.96 155.99 28.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -145.69 129.47 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.24 170.6 7.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 110.655 171.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -107.58 152.02 24.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 126.898 2.079 . . . . 0.0 109.586 162.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.18 167.9 21.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.199 2.2 . . . . 0.0 106.425 176.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.93 129.17 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 167.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.04 90.5 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 128.04 2.733 . . . . 0.0 115.784 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.96 163.77 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -89.86 173.83 8.03 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.979 -0.719 . . . . 0.0 109.894 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.74 -42.83 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 117.731 -1.128 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -61.55 -36.9 81.9 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.55 -40.64 73.27 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.961 1.304 . . . . 0.0 109.08 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.75 -39.76 26.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.457 170.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -78.91 -60.43 2.27 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.91 -21.39 43.32 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 127.955 2.502 . . . . 0.0 110.919 -172.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.32 -52.69 6.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -59.51 -50.14 75.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.688 0.795 . . . . 0.0 112.732 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -64.07 -41.87 97.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 109.32 -168.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.38 36.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.293 1.037 . . . . 0.0 109.27 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.06 20.36 6.47 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 128.621 3.01 . . . . 0.0 117.244 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -97.1 37.41 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.538 1.669 . . . . 0.0 111.335 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.0 mt -134.97 169.7 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.569 1.077 . . . . 0.0 109.062 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -108.64 138.74 44.46 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.354 1.462 . . . . 0.0 108.138 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.7 108.26 13.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--O 1.238 0.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -178.005 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 . . . . . 0 CA--C 1.503 -0.861 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.64 167.83 19.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 128.499 2.72 . . . . 0.0 103.756 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.42 149.45 52.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.52 120.01 19.59 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.57 123.67 11.07 Favored 'Trans proline' 0 N--CA 1.443 -1.492 1 C-N-CA 126.097 4.531 . . . . 0.0 107.135 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.3 t -127.44 169.16 13.93 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.825 1.65 . . . . 0.0 108.356 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.09 37.77 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 110.298 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.79 -177.85 41.03 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.224 -1.548 . . . . 0.0 111.008 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.4 mtpt -114.53 39.89 2.69 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.262 -1.14 . . . . 0.0 109.943 -172.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.33 148.44 36.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.919 1.288 . . . . 0.0 108.065 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.81 -10.5 5.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 112.574 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -112.69 36.6 3.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.277 -0.89 . . . . 0.0 111.396 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -90.2 167.97 12.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.041 -1.037 . . . . 0.0 108.967 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 139.8 39.16 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 120.865 1.666 . . . . 0.0 108.668 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 99.0 t -72.67 135.97 26.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -87.71 135.71 33.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.58 38.13 0.37 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.098 0.952 . . . . 0.0 110.903 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.93 99.05 0.07 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 119.86 -1.775 . . . . 0.0 110.174 -165.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -53.49 -51.65 62.07 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.785 1.175 . . . . 0.0 112.957 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -3.66 33.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.002 -1.062 . . . . 0.0 112.401 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 38.79 3.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.549 0.74 . . . . 0.0 109.886 -171.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.77 108.94 16.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -165.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -52.64 -24.45 8.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.254 1.822 . . . . 0.0 115.272 -168.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 96.2 m-85 -139.19 151.26 46.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -129.61 112.79 14.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.1 mm -91.82 118.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.2 mt -111.97 100.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -172.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -82.77 141.7 32.15 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -117.87 110.82 18.23 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 127.197 2.199 . . . . 0.0 109.692 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.282 1.3 p -85.08 43.04 0.97 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.947 0.88 . . . . 0.0 110.699 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.94 -29.45 2.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 126.019 1.728 . . . . 0.0 112.604 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -147.58 35.25 0.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 117.728 -1.589 . . . . 0.0 111.069 157.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.2 24.12 14.59 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.804 -1.185 . . . . 0.0 112.31 -176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -64.75 156.24 31.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.74 162.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.533 1.158 . . . . 0.0 108.842 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -141.77 128.01 19.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.22 105.01 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.56 143.13 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 159.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.95 121.41 43.84 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 122.984 1.373 . . . . 0.0 110.221 -172.105 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.45 -1.034 0 CA-C-O 118.938 -0.526 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? 65.17 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.351 1.46 . . . . 0.0 108.674 -166.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -67.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 127.135 2.174 . . . . 0.0 108.985 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -55.81 -49.96 71.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 115.669 -2.11 . . . . 0.0 109.651 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.46 -50.37 23.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.306 1.412 . . . . 0.0 111.117 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -42.16 68.52 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.107 -0.996 . . . . 0.0 113.342 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.5 -44.32 82.88 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.751 0.705 . . . . 0.0 109.888 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.31 -32.17 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.407 1.483 . . . . 0.0 110.118 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.6 m -75.89 1.98 13.66 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.802 -1.186 . . . . 0.0 113.879 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -119.42 38.46 3.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.452 1.901 . . . . 0.0 108.289 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.89 19.98 12.24 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.64 1.114 . . . . 0.0 115.845 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.0 96.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.131 1.373 . . . . 0.0 107.864 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.47 36.31 2.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.324 1.05 . . . . 0.0 110.568 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 179.83 165.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.608 1.563 . . . . 0.0 107.024 -165.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 tp -166.14 152.65 9.31 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.271 1.429 . . . . 0.0 107.449 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 57.3 mt -123.06 103.04 12.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.95 130.03 13.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.698 1.136 . . . . 0.0 110.342 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.7 p -62.72 -28.19 69.79 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -169.14 -171.07 1.22 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.399 1.479 . . . . 0.0 107.15 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 p -136.24 136.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.45 96.54 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.85 177.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 129.486 3.114 . . . . 0.0 107.561 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.98 50.38 3.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 127.581 2.352 . . . . 0.0 115.616 154.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.4 -26.35 0.1 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 171.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.602 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 33.9 t80 -62.35 -35.62 79.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.377 0.989 . . . . 0.0 112.539 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.91 -34.59 73.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.7 m -73.09 -20.05 61.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.624 0.77 . . . . 0.0 111.072 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.46 -57.61 5.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.602 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -65.2 -29.74 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.94 -1.71 1.58 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.01 37.23 2.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.87 1.668 . . . . 0.0 110.181 162.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.6 30.99 1.58 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.868 . . . . 0.0 116.804 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.37 117.58 25.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 118.937 1.368 . . . . 0.0 108.524 -168.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -79.14 99.01 6.78 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.537 0.684 . . . . 0.0 109.959 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.5 117.75 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.81 155.29 18.34 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.662 1.185 . . . . 0.0 109.558 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 157.56 26.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 164.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 163.15 30.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 160.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.52 68.21 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.801 1.182 . . . . 0.0 110.508 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.62 136.23 8.58 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.05 154.1 6.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.879 0.339 . . . . 0.0 112.519 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -80.05 171.08 15.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.07 0.548 . . . . 0.0 109.653 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -43.82 -42.15 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.769 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.37 -38.74 81.23 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -42.35 83.29 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 127.144 2.178 . . . . 0.0 108.849 -174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.81 -38.98 11.01 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.819 0.736 . . . . 0.0 111.167 171.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -86.0 -53.79 9.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 125.275 1.43 . . . . 0.0 109.121 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -26.69 65.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.044 1.738 . . . . 0.0 109.375 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.11 -62.6 1.41 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -48.84 63.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.59 1.556 . . . . 0.0 112.626 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -77.88 -13.27 59.94 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.664 2.786 . . . . 0.0 113.482 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -114.37 37.78 3.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.245 1.384 . . . . 0.0 109.836 159.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.51 12.73 4.91 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 127.626 2.536 . . . . 0.0 117.345 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -89.31 37.39 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.254 1.527 . . . . 0.0 111.413 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 mt -136.29 167.33 21.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.013 1.279 . . . . 0.0 110.821 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -108.44 142.86 38.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.44 110.88 17.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 125.96 1.704 . . . . 0.0 108.608 -176.484 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.07 142.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.96 153.98 18.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 160.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.01 125.64 19.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.27 106.63 2.27 Favored 'Trans proline' 0 N--CA 1.445 -1.35 1 C-N-CA 126.131 4.554 . . . . 0.0 109.576 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -104.12 172.07 7.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.364 1.466 . . . . 0.0 109.408 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.29 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 108.623 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.22 -169.36 42.36 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.794 -1.191 . . . . 0.0 111.259 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 7.5 mtmp? -129.96 52.71 1.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 111.842 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.64 167.48 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.917 1.687 . . . . 0.0 107.205 166.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.71 -6.31 58.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.501 -1.375 . . . . 0.0 111.0 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -116.26 39.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.579 -1.325 . . . . 0.0 108.922 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 m -78.66 169.39 18.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.25 -1.38 . . . . 0.0 107.303 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 145.08 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 69.5 t -86.05 137.77 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.404 1.097 . . . . 0.0 108.746 170.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -90.84 137.44 32.36 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.847 2.059 . . . . 0.0 108.74 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -81.25 36.16 0.41 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 122.895 1.331 . . . . 0.0 111.035 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 101.38 0.12 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -157.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -55.04 -59.41 4.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.493 0.588 . . . . 0.0 110.571 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.08 -3.74 31.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.667 -170.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.71 74.1 1.24 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.312 1.415 . . . . 0.0 107.357 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.99 120.65 18.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.38 -22.13 66.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.259 1.424 . . . . 0.0 113.535 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 98.4 m-85 -137.25 148.67 46.61 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.01 1.724 . . . . 0.0 107.455 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -130.59 112.82 13.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.36 120.87 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.9 mt -109.77 101.49 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -89.63 110.89 21.73 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.86 108.88 13.78 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.076 2.15 . . . . 0.0 108.313 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -83.31 57.96 4.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -129.57 -48.51 1.16 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 124.649 1.18 . . . . 0.0 109.128 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 38.19 3.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.736 162.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.4 22.35 10.55 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.2 0.905 . . . . 0.0 113.68 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.86 148.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.14 148.88 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.1 0.96 . . . . 0.0 109.921 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -132.52 139.32 47.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.587 2.355 . . . . 0.0 105.793 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.9 t -108.9 103.57 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.48 151.71 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 167.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.54 129.96 56.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 CA--C 1.514 -0.414 0 O-C-N 120.697 -1.252 . . . . 0.0 110.124 -174.369 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 CA-C-O 117.932 -0.945 . . . . 0.0 112.968 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.322 1.7 ptpt 54.19 -65.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.821 2.448 . . . . 0.0 114.339 -164.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -65.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 127.156 2.182 . . . . 0.0 108.069 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.92 -48.09 78.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-O 116.863 -1.542 . . . . 0.0 109.151 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -46.95 21.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.171 0.896 . . . . 0.0 111.678 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -69.5 -56.22 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.305 0.642 . . . . 0.0 111.082 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -57.4 -46.01 83.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.418 0.554 . . . . 0.0 109.578 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 t -56.71 -36.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.373 1.869 . . . . 0.0 111.54 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -61.18 -38.93 88.26 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.575 1.079 . . . . 0.0 110.575 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.06 38.49 0.85 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.694 1.134 . . . . 0.0 110.029 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.17 26.4 42.76 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.019 1.771 . . . . 0.0 115.578 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.1 t -71.85 101.25 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.123 1.461 . . . . 0.0 109.231 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.28 34.88 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.618 0.645 . . . . 0.0 109.995 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.07 157.55 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 119.989 -1.694 . . . . 0.0 108.796 -169.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.9 tp -166.36 145.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 120.232 -1.542 . . . . 0.0 108.671 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 mt -111.18 107.02 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 126.404 1.882 . . . . 0.0 106.222 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.97 106.15 1.8 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 120.998 1.726 . . . . 0.0 110.623 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.7 p -34.46 -48.8 0.37 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.153 1.781 . . . . 0.0 113.195 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.39 -178.4 6.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -114.64 160.1 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.79 -23.54 38.6 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.392 -166.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -169.43 -132.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.363 3.465 . . . . 0.0 103.437 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -164.3 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.872 1.214 . . . . 0.0 110.872 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 97.58 -26.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.208 1 C-N-CA 133.427 4.691 . . . . 0.0 112.633 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 60.6 t80 -60.85 -36.5 79.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.501 1.5 . . . . 0.0 112.247 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.75 -38.25 79.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.405 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -74.0 -24.44 59.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.914 0.886 . . . . 0.0 110.018 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.69 -72.01 0.17 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -57.05 -32.73 66.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.13 17.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.688 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.39 36.6 0.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.101 0.864 . . . . 0.0 112.071 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.26 33.89 0.56 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.232 1.872 . . . . 0.0 116.238 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 t -81.06 119.39 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 152.95 31.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.5 t -150.2 112.34 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.51 172.97 9.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.229 1.411 . . . . 0.0 111.311 166.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -112.02 148.46 33.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.452 2.701 . . . . 0.0 108.767 164.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -127.31 166.34 17.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.047 2.539 . . . . 0.0 105.086 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -148.4 56.68 1.05 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.122 1.328 . . . . 0.0 110.168 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.63 110.88 3.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 123.444 0.545 . . . . 0.0 112.395 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.56 166.49 31.94 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.6 p -87.39 173.68 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.748 0.819 . . . . 0.0 110.492 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.51 -38.42 12.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 CA-C-O 117.028 -1.463 . . . . 0.0 110.959 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.05 -45.33 93.19 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 120.45 1.477 . . . . 0.0 114.002 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -42.3 97.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.192 1.797 . . . . 0.0 109.283 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.75 -36.1 10.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -87.4 -57.13 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.71 -49.08 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.546 2.339 . . . . 0.0 106.53 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.81 76.7 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.354 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -62.34 -47.66 83.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.55 -0.719 . . . . 0.0 110.78 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.4 p -70.36 -29.97 66.78 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.059 1.344 . . . . 0.0 109.688 -166.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -99.96 35.98 1.93 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.238 1.015 . . . . 0.0 110.732 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.44 53.62 2.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.45 1.5 . . . . 0.0 113.289 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -127.27 38.28 4.1 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 126.641 1.977 . . . . 0.0 109.189 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.7 mt -132.93 167.07 20.92 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 120.899 1.681 . . . . 0.0 111.071 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.68 134.96 40.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.914 1.686 . . . . 0.0 107.863 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -91.03 101.9 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.237 0.44 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -170.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.66 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.03 164.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 161.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 154.49 47.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 163.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.7 120.11 13.17 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.45 108.57 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.75 3.634 . . . . 0.0 106.887 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 t -105.59 168.87 8.81 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.544 1.537 . . . . 0.0 108.16 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.03 37.47 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.531 -0.73 . . . . 0.0 110.317 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.57 165.93 39.26 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.5 39.64 1.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.051 1.34 . . . . 0.0 110.351 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.78 148.79 36.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -14.71 62.56 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.355 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 t -122.59 37.52 4.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -104.45 170.99 7.58 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.522 -0.736 . . . . 0.0 109.82 163.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.9 mmm -77.5 137.29 38.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.983 -1.073 . . . . 0.0 111.078 -166.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 41.6 t -71.51 131.17 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.623 167.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 t -79.51 144.67 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.46 1.904 . . . . 0.0 108.599 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -85.07 36.44 0.62 Allowed 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.29 116.23 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -156.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -63.32 -69.33 0.28 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.575 0.75 . . . . 0.0 110.706 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.88 10.83 1.63 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -169.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -132.98 71.34 1.47 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 159.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.68 179.62 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 156.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -120.68 -16.89 8.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -140.01 155.2 47.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -133.39 108.7 8.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -86.9 127.8 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.0 mt -125.22 97.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -165.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -92.53 125.64 37.26 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.758 1.223 . . . . 0.0 109.153 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 125.79 30.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.043 1.737 . . . . 0.0 111.933 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.281 3.2 p -91.58 31.86 1.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.775 0.798 . . . . 0.0 109.967 174.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.88 -90.18 0.56 Allowed 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 154.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.55 35.59 1.21 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.359 -157.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 45.63 15.15 0.09 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.127 2.298 . . . . 0.0 115.617 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -69.35 154.58 41.81 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.34 144.09 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.679 1.228 . . . . 0.0 109.581 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.99 130.5 52.68 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.19 107.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.67 146.5 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 157.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.37 150.15 27.06 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.076 1.75 . . . . 0.0 106.533 161.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 109.879 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.326 0.7 OUTLIER 54.27 -67.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.895 2.078 . . . . 0.0 111.624 -158.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -50.59 -61.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.708 1.603 . . . . 0.0 109.876 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.41 -53.9 38.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-O 115.155 -2.355 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -49.03 -47.33 44.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 121.146 1.794 . . . . 0.0 110.194 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -50.35 60.03 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.185 1.394 . . . . 0.0 112.816 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.69 -39.06 90.87 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.096 0.862 . . . . 0.0 110.088 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.73 -41.47 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.965 1.306 . . . . 0.0 109.791 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.39 1.41 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -126.43 37.46 4.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.367 1.467 . . . . 0.0 107.622 171.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.76 17.16 41.31 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.709 2.1 . . . . 0.0 116.503 166.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.05 102.43 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.777 1.288 . . . . 0.0 110.873 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.12 36.43 2.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.212 1.805 . . . . 0.0 111.658 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 177.11 173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.745 -1.847 . . . . 0.0 106.81 -168.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 tp -174.62 146.17 0.98 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.69 103.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.85 101.89 1.64 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.983 1.313 . . . . 0.0 109.412 -168.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 5.8 t -60.81 -17.55 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.664 1.585 . . . . 0.0 113.792 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.89 178.33 7.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.411 -1.431 . . . . 0.0 108.806 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 p -126.47 156.51 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 120.313 -1.492 . . . . 0.0 110.216 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.4 20.5 0.13 Allowed Glycine 0 CA--C 1.546 2.009 0 C-N-CA 127.096 2.284 . . . . 0.0 114.219 166.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.7 0.76 0.7 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.874 2.469 . . . . 0.0 116.518 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -137.83 101.02 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 162.31 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.502 1.521 . . . . 0.0 113.675 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.61 -44.73 81.45 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.806 1.185 . . . . 0.0 109.769 -160.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.73 -40.38 95.23 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.927 1.291 . . . . 0.0 110.384 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -67.1 -19.54 65.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.054 0.542 . . . . 0.0 111.271 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.71 -47.19 32.8 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HE3' ' N ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -62.77 -35.23 79.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.195 0.998 . . . . 0.0 111.489 176.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.94 86.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.127 0.571 . . . . 0.0 110.073 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.18 36.27 1.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.361 0.528 . . . . 0.0 111.196 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.34 31.72 0.21 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 127.607 2.527 . . . . 0.0 117.083 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.42 125.16 38.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.016 1.326 . . . . 0.0 108.31 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -78.5 160.2 27.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.3 t -143.83 131.68 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -107.62 157.81 17.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.048 1.739 . . . . 0.0 109.762 172.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -80.0 160.73 25.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 160.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -132.77 159.08 40.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.512 1.525 . . . . 0.0 108.826 162.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 9.1 pt-20 -129.34 74.7 1.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.818 2.099 . . . . 0.0 111.632 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.47 159.86 3.01 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.942 1.258 . . . . 0.0 111.148 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.39 161.66 9.19 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.845 -0.797 . . . . 0.0 112.833 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -96.8 164.74 12.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.91 1.284 . . . . 0.0 107.555 167.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.87 -37.3 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 117.014 -1.469 . . . . 0.0 114.277 -166.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.54 -32.79 74.58 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 121.007 1.731 . . . . 0.0 114.184 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -66.53 -43.0 86.36 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.612 1.965 . . . . 0.0 108.898 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.81 -28.84 16.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.291 0.496 . . . . 0.0 112.166 174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mm -95.04 -53.37 8.37 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -25.3 68.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 110.125 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -57.16 4.1 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -59.96 -44.29 94.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.499 1.52 . . . . 0.0 113.451 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -67.71 -13.15 61.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.637 1.575 . . . . 0.0 111.498 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.37 35.15 4.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.261 1.024 . . . . 0.0 108.761 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.31 2.93 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.09 1.805 . . . . 0.0 117.016 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -81.12 39.69 0.52 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.747 2.274 . . . . 0.0 111.176 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 mt -128.55 -166.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -128.24 154.75 45.52 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -78.48 132.2 37.17 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 164.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 108.833 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.38 153.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.07 147.58 39.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.17 119.96 21.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.54 95.13 0.78 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 1 C-N-CA 125.956 4.437 . . . . 0.0 107.308 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 t -89.57 172.58 8.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.3 1.04 . . . . 0.0 109.058 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.97 37.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.537 1.135 . . . . 0.0 111.107 166.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.23 173.16 45.19 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 167.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -107.78 38.12 2.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.393 0.596 . . . . 0.0 110.189 -166.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.93 151.69 47.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -5.3 39.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 111.649 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t -124.27 37.86 4.32 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.388 -1.445 . . . . 0.0 109.355 165.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.3 m -79.75 175.09 10.94 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 159.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.3 mmm -77.88 144.68 36.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 119.879 -1.763 . . . . 0.0 110.577 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 61.4 t -78.43 161.5 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 163.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -118.54 133.45 55.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 110.625 -167.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.19 39.03 0.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.392 1.477 . . . . 0.0 110.342 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -178.46 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.347 -1.471 . . . . 0.0 109.25 -164.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -50.98 -56.32 13.04 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.404 -0.81 . . . . 0.0 112.589 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.2 4.43 1.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -138.67 38.77 2.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.686 1.995 . . . . 0.0 108.166 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.31 179.59 5.85 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.7 -17.94 7.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -146.31 147.74 31.67 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -128.94 96.09 4.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 mp -79.9 113.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -100.37 107.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -93.72 133.81 36.7 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.87 0.868 . . . . 0.0 108.783 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -97.76 115.15 27.43 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.034 1.734 . . . . 0.0 111.123 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.5 p -86.26 29.82 0.73 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.693 0.758 . . . . 0.0 110.758 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -113.35 -86.53 0.57 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 159.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -93.16 35.45 1.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 115.584 -2.446 . . . . 0.0 110.439 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.8 18.73 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.771 1.653 . . . . 0.0 113.827 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -69.92 160.77 31.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.548 1.139 . . . . 0.0 108.973 -175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.69 152.0 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.701 0.763 . . . . 0.0 109.081 172.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -131.97 123.92 28.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 173.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -88.91 104.89 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.96 141.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -98.07 141.4 31.06 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.842 1.657 . . . . 0.0 106.656 164.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.04 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.455 -0.744 0 CA-C-O 119.329 -0.363 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.341 2.1 ptpt 49.72 -73.59 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 129.142 2.977 . . . . 0.0 112.445 -163.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -54.35 -56.76 8.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 125.285 1.434 . . . . 0.0 109.182 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.6 t -57.03 -56.71 13.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.495 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -41.91 -54.59 3.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.972 0.909 . . . . 0.0 111.527 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.7 m -65.13 -53.6 42.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 113.598 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.1 -43.41 98.56 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.071 0.948 . . . . 0.0 109.755 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.24 -41.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.318 1.447 . . . . 0.0 110.346 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -68.59 0.89 3.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -110.02 38.39 2.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 109.972 165.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.55 32.41 16.07 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.069 1.318 . . . . 0.0 114.69 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.84 92.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 3.4 mm-40 -95.18 33.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.192 1.397 . . . . 0.0 111.109 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 171.65 160.13 0.09 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 119.184 -2.198 . . . . 0.0 107.748 -158.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 tp -168.8 147.01 3.99 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.301 1.04 . . . . 0.0 108.512 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.5 mt -118.25 105.97 18.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 125.6 1.56 . . . . 0.0 107.278 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.56 112.64 3.0 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.069 1.304 . . . . 0.0 111.85 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -25.13 32.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.63 178.01 9.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.786 3.235 . . . . 0.0 104.562 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.09 165.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 151.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.02 -12.23 68.59 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.394 -1.225 . . . . 0.0 113.905 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 148.76 174.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 1 C-N-CA 132.942 4.497 . . . . 0.0 108.732 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 24.61 74.41 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 130.878 3.671 . . . . 0.0 113.21 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.06 -24.27 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.621 1.568 . . . . 0.0 112.484 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.84 -45.05 93.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.893 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -66.94 -34.11 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -15.69 62.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.739 1.216 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.9 mt -79.63 -54.55 5.77 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.31 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.815 0.846 . . . . 0.0 112.303 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.82 -35.75 61.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.73 0.812 . . . . 0.0 112.2 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.79 37.07 2.89 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.962 0.801 . . . . 0.0 110.792 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.06 30.4 2.54 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.992 1.758 . . . . 0.0 115.865 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.34 97.24 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 118.529 1.165 . . . . 0.0 108.078 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -79.19 112.36 16.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.762 0.792 . . . . 0.0 108.978 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.11 131.12 40.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.745 1.618 . . . . 0.0 107.982 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.71 161.99 13.28 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 126.026 1.73 . . . . 0.0 109.979 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 160.51 26.83 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 163.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.18 151.94 49.35 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 127.701 2.4 . . . . 0.0 104.634 163.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -141.23 66.02 1.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 121.715 2.052 . . . . 0.0 111.191 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.8 128.08 1.75 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.67 160.03 8.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -161.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.8 p -89.77 174.51 7.67 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.583 1.153 . . . . 0.0 110.19 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 83.4 t -48.63 -40.23 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.761 -1.212 . . . . 0.0 112.17 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -64.32 -34.85 79.08 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.044 1.293 . . . . 0.0 113.483 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.72 -41.52 78.94 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 125.773 1.629 . . . . 0.0 109.15 -176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.63 -40.75 13.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.09 0.859 . . . . 0.0 111.301 170.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -84.89 -49.23 15.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 O-C-N 121.267 -0.896 . . . . 0.0 108.812 -171.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.05 -18.22 63.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 128.442 2.697 . . . . 0.0 109.618 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 -63.83 1.25 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 108.687 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -54.08 -51.28 64.65 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.95 0.795 . . . . 0.0 112.5 -175.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -66.69 -41.52 87.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.5 36.8 0.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.42 0.629 . . . . 0.0 110.133 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.28 9.25 2.05 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 127.635 2.54 . . . . 0.0 117.101 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.89 36.75 0.73 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.851 1.825 . . . . 0.0 111.824 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -131.94 172.18 12.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.551 1.069 . . . . 0.0 110.066 173.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -107.36 149.73 27.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -82.97 127.34 33.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 162.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 C--O 1.24 0.562 0 C-N-CA 124.561 1.145 . . . . 0.0 109.677 -170.753 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 CA--C 1.504 -0.816 0 CA-C-O 121.97 0.89 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 2.2 p -79.46 153.58 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.57 149.32 42.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 163.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.17 118.17 18.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.1 126.27 14.2 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 125.075 3.85 . . . . 0.0 108.227 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -125.16 173.98 8.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.113 2.165 . . . . 0.0 105.986 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.05 37.26 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 128.149 2.58 . . . . 0.0 107.626 170.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.72 177.38 46.49 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.474 1.988 . . . . 0.0 109.555 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -121.47 40.37 3.61 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.459 -157.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.77 155.27 48.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -15.77 63.11 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.129 2.172 . . . . 0.0 110.983 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 p -112.07 38.58 2.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.915 -1.115 . . . . 0.0 112.212 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -97.24 168.47 10.4 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 166.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.6 132.99 38.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.827 1.651 . . . . 0.0 111.11 -171.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 88.5 t -71.29 139.18 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.2 t -86.87 137.35 32.46 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -0.99 . . . . 0.0 109.355 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.31 37.43 0.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.59 1.186 . . . . 0.0 111.861 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 178.42 97.02 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.188 0 O-C-N 119.736 -1.853 . . . . 0.0 109.247 -156.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -54.32 -50.38 67.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 119.424 1.011 . . . . 0.0 112.778 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.3 13.57 18.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.671 0.669 . . . . 0.0 111.173 -171.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.39 39.29 3.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.427 1.891 . . . . 0.0 106.856 168.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.28 139.51 51.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -89.82 -74.35 0.49 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.847 1.308 . . . . 0.0 108.792 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.48 156.63 22.77 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -135.52 124.56 24.3 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.5 mm -93.04 113.01 27.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -98.43 113.74 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -91.7 153.82 19.4 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.344 1.028 . . . . 0.0 108.643 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -124.45 106.17 9.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.54 1.936 . . . . 0.0 110.807 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.7 p -81.63 36.52 0.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.071 1.305 . . . . 0.0 112.228 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -105.54 -64.31 1.16 Allowed 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 124.743 1.217 . . . . 0.0 109.206 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -124.44 38.05 4.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 125.06 1.475 . . . . 0.0 110.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.79 15.24 18.62 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 126.08 1.8 . . . . 0.0 113.792 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.13 160.33 31.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.874 0.87 . . . . 0.0 109.032 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.29 147.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.689 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -130.36 140.34 50.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.208 1.803 . . . . 0.0 106.643 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.91 109.29 23.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 165.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.4 144.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.64 107.22 14.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.451 -1.001 0 CA-C-O 117.525 -1.115 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 11.3 ttpt 60.67 -71.25 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.981 1.312 . . . . 0.0 110.701 -169.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.62 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.95 1.7 . . . . 0.0 110.049 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -54.79 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.349 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.32 -47.37 18.46 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.215 0.916 . . . . 0.0 111.42 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -67.29 0.42 Allowed 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 121.47 -0.769 . . . . 0.0 111.946 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 mt -51.79 -41.5 61.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.466 1.106 . . . . 0.0 110.744 -173.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.4 -41.52 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 126.486 1.914 . . . . 0.0 111.465 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.2 m -66.23 -3.8 6.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.848 -1.157 . . . . 0.0 111.716 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 37.26 4.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.445 1.021 . . . . 0.0 108.812 171.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.03 21.14 69.52 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.578 2.037 . . . . 0.0 116.115 161.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.95 122.81 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.23 1.012 . . . . 0.0 109.877 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -123.75 35.86 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.974 2.11 . . . . 0.0 109.923 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 5.9 m-85 -179.76 176.59 0.76 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.972 1.709 . . . . 0.0 107.358 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -176.63 151.04 0.89 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.339 1.856 . . . . 0.0 107.885 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.07 105.61 16.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 126.444 1.898 . . . . 0.0 107.601 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.21 136.03 16.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.684 1.584 . . . . 0.0 110.339 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.5 p -64.4 -27.21 68.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.863 -1.148 . . . . 0.0 112.999 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -168.4 -175.29 2.49 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.921 1.688 . . . . 0.0 108.132 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.46 153.21 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.989 0.916 . . . . 0.0 109.953 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.77 28.92 2.1 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 126.682 2.087 . . . . 0.0 111.811 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 51.05 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.524 1.93 . . . . 0.0 111.488 -159.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 25.82 75.17 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.153 2.981 . . . . 0.0 112.07 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 179.89 -40.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.844 1.658 . . . . 0.0 112.301 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.4 -35.76 68.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.096 0.862 . . . . 0.0 112.095 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.9 -40.63 68.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.331 0.652 . . . . 0.0 110.012 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -15.46 63.53 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.542 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -75.78 -47.69 24.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -67.04 -26.14 66.61 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 120.944 -1.097 . . . . 0.0 113.114 174.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.99 -40.42 63.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.238 0.927 . . . . 0.0 110.699 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.74 36.5 2.62 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.958 0.503 . . . . 0.0 111.329 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.51 16.02 4.81 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 117.424 1.73 . . . . 0.0 117.424 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.19 126.76 39.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.97 1.885 . . . . 0.0 109.813 -159.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -79.83 132.16 36.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.5 t -113.1 141.55 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -111.69 160.4 17.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.84 1.656 . . . . 0.0 109.509 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -79.16 159.68 27.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 160.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -141.12 161.39 37.98 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 154.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -150.0 95.53 2.31 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.404 1.456 . . . . 0.0 111.992 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.1 109.27 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 125.69 1.614 . . . . 0.0 111.003 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 162.84 158.44 9.7 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 117.86 0.83 . . . . 0.0 113.682 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -85.29 168.5 14.64 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.148 0.579 . . . . 0.0 109.644 166.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -39.25 -44.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.394 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.97 -39.57 82.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.14 1.791 . . . . 0.0 114.729 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -64.91 -41.66 95.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.312 1.845 . . . . 0.0 108.76 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.69 -38.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.616 0.644 . . . . 0.0 111.53 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mm -82.42 -61.12 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 -33.01 43.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.22 1.808 . . . . 0.0 110.498 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.61 -50.57 20.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -61.89 -50.51 71.93 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.408 1.083 . . . . 0.0 112.027 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.5 p -64.51 -45.52 86.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.864 2.065 . . . . 0.0 108.656 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -91.84 36.45 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.06 45.54 14.82 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.926 2.203 . . . . 0.0 115.078 166.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -120.84 36.51 4.56 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 111.058 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.4 mt -124.7 -175.74 3.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.791 1.178 . . . . 0.0 109.446 173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.49 138.42 53.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -79.72 111.08 15.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--O 1.239 0.551 0 C-N-CA 125.412 1.485 . . . . 0.0 109.762 -172.525 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 10.0 p -115.2 134.28 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.774 1.63 . . . . 0.0 107.42 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.06 143.96 40.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.72 120.91 20.8 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.03 111.57 3.31 Favored 'Trans proline' 0 N--CA 1.446 -1.302 1 C-N-CA 125.687 4.258 . . . . 0.0 108.631 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -112.93 171.04 7.77 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.831 1.653 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.85 39.39 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.173 1.389 . . . . 0.0 109.899 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.69 -174.5 47.07 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.64 1.591 . . . . 0.0 109.984 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.2 mtmt -115.33 38.91 3.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.152 1.381 . . . . 0.0 109.457 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -124.48 149.37 46.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 2.23 3.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 122.309 1.052 . . . . 0.0 110.778 168.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 38.4 3.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.027 -1.671 . . . . 0.0 108.448 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.7 m -80.17 170.56 16.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 159.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 139.72 38.87 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.896 -1.128 . . . . 0.0 108.904 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 92.9 t -76.87 147.67 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -109.9 133.84 52.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -169.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.87 38.1 0.44 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.352 0.596 . . . . 0.0 110.833 -172.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -167.34 86.92 0.26 Allowed 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.427 -1.421 . . . . 0.0 107.839 -163.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -48.23 -53.13 18.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.009 0.822 . . . . 0.0 112.787 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.72 -6.77 50.69 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -129.19 64.59 1.47 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.18 25.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.26 -16.77 61.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.36 1.064 . . . . 0.0 113.249 -163.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.478 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 92.1 m-85 -141.0 154.7 46.14 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -139.02 107.27 5.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.607 1.163 . . . . 0.0 107.885 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.74 116.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.85 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.456 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 18.3 t80 -88.84 116.51 27.16 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.99 1.716 . . . . 0.0 107.536 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.62 100.0 6.8 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.899 1.679 . . . . 0.0 108.501 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 p -74.04 70.3 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.445 1.117 . . . . 0.0 108.586 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -155.76 -53.01 0.09 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.91 2.484 . . . . 0.0 110.458 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 m -136.22 36.71 2.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.481 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.01 11.74 1.07 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.495 1.998 . . . . 0.0 114.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -71.59 141.97 50.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.676 1.238 . . . . 0.0 107.688 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.37 160.62 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.747 1.619 . . . . 0.0 107.066 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -137.42 141.91 41.65 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.8 116.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.79 132.52 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 160.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -85.85 136.6 33.24 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 155.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 CA--C 1.524 -0.046 0 CA-C-N 119.451 1.023 . . . . 0.0 111.288 167.487 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.457 -0.652 0 CA-C-O 118.382 -0.758 . . . . 0.0 112.992 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER 58.15 -64.65 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.041 1.291 . . . . 0.0 112.249 -157.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.13 -61.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.308 1.443 . . . . 0.0 108.582 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -53.28 -47.62 56.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 126.101 1.76 . . . . 0.0 109.257 175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -45.22 -52.47 9.44 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.365 1.439 . . . . 0.0 111.649 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 t -66.41 -51.95 51.61 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.374 0.669 . . . . 0.0 112.258 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.5 -41.33 97.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.632 -1.292 . . . . 0.0 110.113 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 t -59.99 -35.37 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.466 1.506 . . . . 0.0 111.241 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -65.45 -33.72 76.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.565 1.075 . . . . 0.0 109.489 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.33 38.07 0.65 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.766 1.226 . . . . 0.0 109.603 170.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.32 22.74 2.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.023 1.773 . . . . 0.0 116.092 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.66 118.86 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 119.831 1.816 . . . . 0.0 109.108 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.36 35.61 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.412 0.685 . . . . 0.0 110.982 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -174.91 160.7 2.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -173.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.2 tp -164.26 148.35 9.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -119.43 97.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.69 103.67 2.81 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.281 0.632 . . . . 0.0 109.527 -171.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.5 p -45.92 -28.87 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.966 1.706 . . . . 0.0 115.58 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 -171.19 2.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -128.67 155.03 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.32 -41.65 30.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -171.52 -148.3 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.248 2.219 . . . . 0.0 107.761 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -52.49 104.58 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 111.561 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.79 -29.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.956 2.102 . . . . 0.0 109.141 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.601 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 28.2 t80 -51.9 -39.49 59.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.088 1.755 . . . . 0.0 112.442 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.43 -37.35 86.66 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.618 0.767 . . . . 0.0 109.535 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.6 m -80.13 -13.84 58.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.726 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.8 mt -71.14 -58.2 3.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.907 -1.12 . . . . 0.0 109.093 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.601 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -63.21 -29.27 70.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.27 37.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.22 171.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.94 35.88 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.069 0.849 . . . . 0.0 111.621 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.03 34.29 4.1 Favored Glycine 0 CA--C 1.538 1.521 0 O-C-N 120.387 -1.446 . . . . 0.0 115.696 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.79 127.92 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 119.258 1.529 . . . . 0.0 110.036 -166.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -79.35 112.54 16.69 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.651 -0.656 . . . . 0.0 110.748 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -97.61 121.04 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.05 157.89 15.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 109.954 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.46 151.5 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.6 172.79 10.86 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 156.07 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.38 52.21 0.53 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 121.288 1.858 . . . . 0.0 112.787 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.51 101.95 2.67 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.386 -0.822 . . . . 0.0 112.488 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.82 166.36 34.76 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -162.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 p -88.39 174.11 8.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.373 1.069 . . . . 0.0 110.488 167.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.2 t -45.1 -42.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.588 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.15 -34.12 76.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 120.305 1.411 . . . . 0.0 114.369 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.36 -45.07 85.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.608 1.563 . . . . 0.0 107.209 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.69 -45.59 19.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.356 0.662 . . . . 0.0 111.254 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.38 -52.05 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.16 -33.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.758 2.023 . . . . 0.0 109.405 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -61.5 1.79 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -54.64 -41.17 69.75 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.452 -174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.1 p -69.41 -50.45 45.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.202 1.401 . . . . 0.0 108.119 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -86.12 36.63 0.69 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.597 0.713 . . . . 0.0 109.689 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.71 12.89 2.76 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.287 1.899 . . . . 0.0 116.658 172.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.6 mtp180 -85.74 35.91 0.64 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 121.027 2.413 . . . . 0.0 112.314 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -134.44 -178.89 5.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.586 -1.321 . . . . 0.0 109.414 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -127.81 153.34 46.71 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 125.769 1.628 . . . . 0.0 108.886 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.92 91.57 6.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.509 1.524 . . . . 0.0 107.065 -176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 124.521 1.128 . . . . 0.0 110.691 -175.646 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.37 151.14 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 127.706 2.403 . . . . 0.0 105.394 165.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.63 143.73 48.52 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.6 121.71 15.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.78 110.28 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.338 4.025 . . . . 0.0 108.363 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 t -111.23 169.18 8.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.189 1.795 . . . . 0.0 108.13 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.86 37.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.361 0.664 . . . . 0.0 111.051 165.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.62 177.04 42.19 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.472 1.51 . . . . 0.0 109.832 168.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -115.18 38.63 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.735 -166.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -139.29 159.26 42.58 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.471 1.908 . . . . 0.0 108.306 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.02 -5.05 39.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.612 1.965 . . . . 0.0 111.07 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -122.82 37.97 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.669 -1.269 . . . . 0.0 110.916 167.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 m -83.24 173.29 11.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.14 164.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.91 142.88 36.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.89 1.223 . . . . 0.0 109.766 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 87.8 t -71.57 165.07 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.047 0.927 . . . . 0.0 108.508 166.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 t -119.98 127.87 53.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.396 1.478 . . . . 0.0 109.26 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.22 37.11 0.37 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 122.13 0.967 . . . . 0.0 110.826 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.85 108.82 0.48 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 -166.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -63.65 -58.19 7.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.639 1.109 . . . . 0.0 110.622 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.76 -13.66 59.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.737 -170.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -123.82 77.39 1.52 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.201 1.8 . . . . 0.0 106.81 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.58 116.3 13.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.86 -16.34 11.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -173.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -142.97 157.76 44.24 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -135.19 107.52 7.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -79.88 126.79 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.6 mt -119.93 101.33 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -89.8 133.61 34.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.513 1.125 . . . . 0.0 108.191 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.64 121.65 27.95 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.338 1.455 . . . . 0.0 107.497 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 p -84.83 53.17 2.62 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.029 1.286 . . . . 0.0 108.454 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.08 -82.78 0.22 Allowed 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 p -104.88 36.97 2.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 117.99 -1.484 . . . . 0.0 110.347 -160.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.77 4.32 0.15 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.08 1.8 . . . . 0.0 116.489 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -75.26 158.32 33.09 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.221 1.008 . . . . 0.0 110.514 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.9 162.97 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.383 0.673 . . . . 0.0 109.349 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -131.69 138.2 48.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 168.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.73 110.05 22.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 155.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.08 135.79 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.454 -2.425 . . . . 0.0 104.454 156.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.25 128.67 47.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 CA--C 1.513 -0.456 0 CA-C-N 119.357 0.98 . . . . 0.0 111.766 -179.54 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.447 -1.234 0 CA-C-O 116.34 -1.608 . . . . 0.0 113.62 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 61.47 -72.82 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.544 1.152 . . . . 0.0 110.646 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.82 -56.53 12.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 119.702 1.137 . . . . 0.0 110.383 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.79 -51.25 61.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 C-N-CA 125.235 1.414 . . . . 0.0 107.893 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -12.91 1.08 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.504 1.521 . . . . 0.0 114.615 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.52 -48.72 3.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.377 1.471 . . . . 0.0 109.526 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.08 -45.29 87.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.523 1.129 . . . . 0.0 110.504 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.27 -41.3 91.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.208 1.403 . . . . 0.0 109.652 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -67.1 3.33 1.17 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.299 -0.876 . . . . 0.0 113.223 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -124.61 38.84 4.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.488 2.315 . . . . 0.0 108.317 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.08 35.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 126.1 1.81 . . . . 0.0 116.745 165.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.99 120.59 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 118.456 1.128 . . . . 0.0 110.394 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -124.54 36.17 4.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.688 0.756 . . . . 0.0 110.984 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 170.74 170.8 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.317 1.847 . . . . 0.0 107.675 -168.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 tp -172.51 146.34 1.72 Allowed 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.413 -1.429 . . . . 0.0 107.263 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.9 mt -114.91 103.25 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.07 102.36 2.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.538 1.063 . . . . 0.0 111.32 -171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.453 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 22.7 t -59.74 -4.89 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.69 -179.43 3.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 123.612 2.915 . . . . 0.0 108.85 167.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.25 146.32 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 O-C-N 121.626 -0.671 . . . . 0.0 110.056 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.08 2.49 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.033 1.778 . . . . 0.0 110.461 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' C ' ' H ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -171.54 173.61 4.66 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.066 2.546 . . . . 0.0 106.338 173.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -71.63 29.23 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.404 1.097 . . . . 0.0 112.373 162.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 73' ' ' ARG . . . -76.1 -27.64 57.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.209 -1.557 . . . . 0.0 111.677 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.633 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 16.2 t80 -61.54 -36.12 79.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.473 1.033 . . . . 0.0 110.951 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.97 -28.65 65.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.854 0.861 . . . . 0.0 110.639 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 m -78.16 -20.79 51.3 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.862 -0.523 . . . . 0.0 110.432 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.1 mt -71.87 -54.83 8.85 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.633 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -56.2 -32.27 64.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 171.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.82 -2.58 7.46 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.68 37.33 4.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.643 1.177 . . . . 0.0 110.472 163.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.34 31.33 8.84 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.821 1.489 . . . . 0.0 116.821 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.42 115.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -78.73 107.77 11.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.83 114.69 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.9 163.24 19.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.983 1.713 . . . . 0.0 111.008 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -90.59 157.14 17.66 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.137 0.975 . . . . 0.0 108.54 161.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.46 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -121.42 171.36 8.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.264 2.626 . . . . 0.0 109.362 165.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.06 96.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.08 -1.637 . . . . 0.0 110.141 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.47 139.28 0.72 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.13 158.58 8.39 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.8 p -85.93 169.65 13.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.105 0.962 . . . . 0.0 108.73 160.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.5 t -42.17 -47.37 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.879 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -60.7 -32.65 71.88 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -64.32 -46.46 83.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.324 1.45 . . . . 0.0 109.274 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.84 -36.32 11.74 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 118.471 0.578 . . . . 0.0 111.582 174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.68 -55.07 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 108.143 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -37.97 70.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 108.641 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.87 11.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -58.54 -44.15 89.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.756 0.822 . . . . 0.0 112.272 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -69.51 -42.51 74.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 109.156 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -92.07 37.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.37 -1.54 0.1 OUTLIER Glycine 0 CA--C 1.526 0.77 0 C-N-CA 130.37 3.843 . . . . 0.0 118.277 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.6 mtt-85 -82.63 37.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.638 1.719 . . . . 0.0 111.692 -170.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.7 mt -127.89 -171.24 2.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.588 -1.32 . . . . 0.0 108.532 169.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.79 145.15 37.84 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.337 1.455 . . . . 0.0 108.276 -169.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.7 108.46 13.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 109.501 -176.42 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 p -84.71 153.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.66 145.85 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.42 124.3 23.54 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 103.65 1.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 1 C-N-CA 125.768 4.312 . . . . 0.0 108.963 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -101.38 173.0 6.64 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.093 1.357 . . . . 0.0 109.249 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.27 38.58 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 109.172 169.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.14 177.84 48.45 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.734 1.635 . . . . 0.0 109.552 171.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 3.5 mttm -108.79 40.05 1.88 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.115 1.766 . . . . 0.0 109.698 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -128.27 154.89 45.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -14.77 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.703 1.201 . . . . 0.0 110.044 170.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -110.74 38.35 2.52 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.64 -1.287 . . . . 0.0 108.758 166.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -86.99 167.42 14.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.589 -1.319 . . . . 0.0 108.056 162.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.58 146.1 34.4 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.467 -1.396 . . . . 0.0 110.417 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 78.8 t -87.77 132.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.523 1.154 . . . . 0.0 108.521 170.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -91.81 135.65 33.75 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.354 2.262 . . . . 0.0 108.674 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.17 38.27 0.47 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.884 0.849 . . . . 0.0 112.147 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.25 96.44 0.69 Allowed 'General case' 0 C--O 1.224 -0.266 0 O-C-N 119.905 -1.747 . . . . 0.0 107.996 -160.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -65.18 -32.62 74.4 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 119.979 -1.7 . . . . 0.0 113.927 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.69 -3.68 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.197 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -135.37 79.3 1.78 Allowed 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 119.449 1.022 . . . . 0.0 109.885 164.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.27 127.52 33.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -72.19 -17.73 61.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.466 1.106 . . . . 0.0 112.744 -167.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.431 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.1 m-85 -143.98 154.88 43.74 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.804 1.241 . . . . 0.0 107.733 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -137.76 107.67 6.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.461 1.504 . . . . 0.0 107.633 -175.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.77 123.53 43.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -175.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.25 96.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.145 0.884 . . . . 0.0 108.679 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -85.42 117.68 24.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.815 1.246 . . . . 0.0 107.869 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.77 119.91 28.57 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.263 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -89.91 60.05 4.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.862 1.21 . . . . 0.0 110.697 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -136.73 -43.29 0.59 Allowed 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 117.243 -1.361 . . . . 0.0 113.085 164.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.2 m -137.04 36.87 2.57 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 117.6 -1.64 . . . . 0.0 113.128 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.26 13.83 4.08 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.477 1.513 . . . . 0.0 114.192 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -82.24 135.08 35.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.785 1.634 . . . . 0.0 108.133 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.43 170.18 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 125.178 1.391 . . . . 0.0 107.938 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.04 145.03 39.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -106.69 109.08 26.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.9 129.37 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 159.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.89 133.87 33.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 127.145 2.178 . . . . 0.0 106.295 159.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 119.977 1.262 . . . . 0.0 111.159 178.288 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 N--CA 1.449 -1.137 0 CA-C-O 118.231 -0.82 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 58.82 -78.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.989 2.116 . . . . 0.0 111.395 -169.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -57.3 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 126.942 2.097 . . . . 0.0 109.963 -176.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -42.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 CA-C-O 115.167 -2.349 . . . . 0.0 109.578 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -52.31 -44.43 65.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 121.074 1.761 . . . . 0.0 111.497 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -68.12 -51.9 40.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 111.191 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.17 -43.62 92.12 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.305 -0.872 . . . . 0.0 110.525 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.97 -34.65 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.604 1.962 . . . . 0.0 110.628 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -36.4 79.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.504 1.047 . . . . 0.0 109.973 175.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -81.39 38.3 0.48 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.383 0.992 . . . . 0.0 110.29 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.12 27.38 1.58 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.674 2.559 . . . . 0.0 116.279 171.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.66 120.58 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.839 1.319 . . . . 0.0 108.129 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -121.78 36.78 4.53 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.757 1.623 . . . . 0.0 109.953 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -179.6 169.45 1.36 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 120.06 -1.65 . . . . 0.0 108.044 -171.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.6 tp -169.33 151.89 4.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.515 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.1 mt -126.63 102.88 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.44 111.02 2.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.78 0.832 . . . . 0.0 109.944 -171.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -46.54 -31.09 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.247 1.819 . . . . 0.0 114.998 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -165.55 -170.12 1.75 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 119.058 0.844 . . . . 0.0 109.102 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.83 133.54 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.347 -0.696 . . . . 0.0 111.388 -169.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -166.25 152.45 8.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.807 2.443 . . . . 0.0 105.44 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 45.36 -143.67 0.21 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.672 1.589 . . . . 0.0 109.228 168.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 72.77 -34.57 0.3 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 129.275 3.03 . . . . 0.0 114.767 162.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.628 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 56.5 t80 -56.39 -40.71 75.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.302 1.441 . . . . 0.0 110.109 174.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.19 -40.76 98.43 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.517 0.727 . . . . 0.0 110.612 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -27.27 66.83 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.266 -0.896 . . . . 0.0 110.764 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.3 mt -69.12 -61.13 1.92 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.628 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -61.63 -27.55 68.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 176.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.05 67.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.224 0.92 . . . . 0.0 110.613 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.85 35.98 1.91 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.541 1.064 . . . . 0.0 111.484 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.88 19.28 1.34 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.238 1.875 . . . . 0.0 117.422 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.43 120.04 29.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 118.987 1.393 . . . . 0.0 108.769 -160.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HE3' ' CD ' ' A' ' 108' ' ' GLU . 44.1 tttt -80.42 116.39 20.46 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.929 0.892 . . . . 0.0 110.208 -171.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -99.3 129.23 50.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.26 158.13 16.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 0.0 110.306 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -79.6 163.66 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.586 1.555 . . . . 0.0 106.891 162.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.36 169.92 16.89 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 157.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -153.41 67.41 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 121.931 2.15 . . . . 0.0 113.008 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.34 95.67 2.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.459 1.028 . . . . 0.0 111.783 159.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.8 168.84 40.55 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -165.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.0 p -87.4 176.57 7.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.761 0.824 . . . . 0.0 110.559 167.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -46.33 -43.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.759 1.223 . . . . 0.0 109.887 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -32.43 73.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -72.57 -40.92 66.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.623 1.169 . . . . 0.0 109.072 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.58 11.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 123.83 0.707 . . . . 0.0 111.083 168.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -81.69 -51.34 15.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 124.487 1.115 . . . . 0.0 108.313 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -21.0 65.49 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.95 1.3 . . . . 0.0 110.527 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.6 -62.31 1.71 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -56.03 -44.13 78.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.624 1.17 . . . . 0.0 112.657 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.7 p -63.61 -51.84 63.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.579 1.152 . . . . 0.0 108.451 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.37 36.36 0.69 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.593 0.711 . . . . 0.0 109.31 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.44 11.05 4.75 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.695 2.093 . . . . 0.0 116.747 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -85.03 35.34 0.57 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 121.508 2.654 . . . . 0.0 112.478 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.9 mt -135.45 167.44 21.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 121.151 1.796 . . . . 0.0 110.033 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -110.27 139.95 44.92 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.624 1.57 . . . . 0.0 107.416 -167.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.426 ' CD ' ' HE3' ' A' ' 85' ' ' LYS . 73.5 tt0 -85.41 96.04 9.45 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.833 1.197 . . . . 0.0 107.883 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 111.676 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -97.65 129.22 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.51 133.1 46.69 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.64 121.29 37.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.7 93.23 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 1 C-N-CA 126.043 4.495 . . . . 0.0 109.509 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.2 t -87.71 171.02 10.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.753 2.821 . . . . 0.0 110.338 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 m -124.72 37.86 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.96 1.304 . . . . 0.0 109.487 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.93 -174.81 45.45 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.532 -1.355 . . . . 0.0 112.645 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 22.9 mtmt -111.06 39.6 2.23 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.05 1.34 . . . . 0.0 111.859 -162.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -143.35 157.58 44.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 108.784 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -13.79 59.59 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.444 -0.785 . . . . 0.0 111.053 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -104.91 37.39 2.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.375 -1.453 . . . . 0.0 111.072 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 97.0 p -82.76 170.7 14.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.277 174.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.56 134.18 37.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.791 1.632 . . . . 0.0 109.133 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.479 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 47.8 t -78.14 132.42 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -79.7 152.23 30.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.402 2.681 . . . . 0.0 108.42 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -88.71 36.46 0.8 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.234 -0.916 . . . . 0.0 112.613 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.37 107.01 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.433 -1.417 . . . . 0.0 110.024 -153.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -58.0 -60.44 3.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.848 1.204 . . . . 0.0 112.058 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.06 1.19 28.75 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -167.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.8 63.91 1.29 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 162.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.95 169.05 12.0 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 164.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -117.64 -30.48 5.46 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 119.034 0.834 . . . . 0.0 112.657 -165.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 95.7 m-85 -126.4 145.71 50.36 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -133.04 89.12 2.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 126.89 2.076 . . . . 0.0 106.009 -170.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mm -79.12 107.19 11.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.1 mt -94.23 107.88 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.408 ' HB3' HG13 ' A' ' 4' ' ' VAL . 41.2 t80 -89.96 131.59 35.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -100.81 109.35 21.33 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.745 2.018 . . . . 0.0 111.211 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.2 p -82.14 53.86 2.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.372 0.987 . . . . 0.0 110.225 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -140.86 -20.53 0.81 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.563 1.545 . . . . 0.0 112.712 166.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.2 p -150.63 34.92 0.62 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.597 162.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.88 10.0 2.1 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.976 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.87 152.97 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.683 1.593 . . . . 0.0 107.2 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.43 160.72 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.175 172.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -149.9 136.88 19.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.226 -0.892 . . . . 0.0 109.232 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.07 114.69 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.521 0.728 . . . . 0.0 109.508 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.73 158.12 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.692 1.197 . . . . 0.0 108.66 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -120.11 122.19 40.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 163.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 109.383 -1.045 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -152.64 -52.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.197 1.399 . . . . 0.0 107.486 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.56 -39.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.965 1.706 . . . . 0.0 110.473 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -52.04 66.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 116.368 -1.777 . . . . 0.0 109.986 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -44.06 -49.86 8.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.849 1.204 . . . . 0.0 110.949 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -58.55 -64.59 0.87 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 112.657 173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.49 -39.39 87.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.337 -167.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.37 -33.87 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.643 1.977 . . . . 0.0 110.904 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -59.9 -30.87 69.32 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.66 37.86 1.63 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.163 0.985 . . . . 0.0 110.303 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.72 25.52 29.46 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.954 -0.914 . . . . 0.0 115.003 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 72.6 t -74.24 96.93 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -105.85 36.84 2.41 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -164.95 155.95 14.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.2 tp -164.56 146.06 8.24 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.26 -1.525 . . . . 0.0 107.15 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.3 mt -120.73 104.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.02 134.51 17.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.453 1.024 . . . . 0.0 111.831 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.3 p -68.43 -23.79 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.558 -0.714 . . . . 0.0 112.669 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -177.81 -176.19 0.56 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 107.433 -162.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.07 141.16 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 119.75 -1.844 . . . . 0.0 112.872 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.87 11.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.911 2.672 . . . . 0.0 116.265 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.274 22.8 mtm180 143.27 -103.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 1 C-N-CA 131.716 4.006 . . . . 0.0 107.062 167.768 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -64.97 137.41 57.72 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.38 -35.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 130.354 3.462 . . . . 0.0 110.637 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.506 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 69.6 t80 -58.27 -41.86 85.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.718 0.807 . . . . 0.0 111.851 -162.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -62.34 -39.49 93.28 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.062 1.345 . . . . 0.0 109.357 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -74.69 -23.96 58.7 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.247 1.019 . . . . 0.0 110.652 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.67 -51.18 29.44 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 121.377 -0.827 . . . . 0.0 108.933 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.37 -30.44 70.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 117.125 -1.417 . . . . 0.0 113.575 175.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.31 -60.57 3.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.316 1.01 . . . . 0.0 108.961 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.53 36.83 0.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.693 0.679 . . . . 0.0 112.058 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.68 27.71 3.27 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.562 2.029 . . . . 0.0 115.636 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.36 121.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.197 0.999 . . . . 0.0 108.54 -166.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' HZ1' ' CD ' ' A' ' 108' ' ' GLU . 6.4 tppt? -77.65 153.51 33.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -144.16 116.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -172.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -95.37 157.99 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.526 0.731 . . . . 0.0 109.313 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 153.81 29.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 163.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.479 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -134.26 167.27 21.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 162.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.75 77.39 1.58 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.36 1.076 . . . . 0.0 112.266 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.53 88.33 0.11 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.832 1.206 . . . . 0.0 114.568 159.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.43 164.59 35.12 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.818 2.628 . . . . 0.0 109.781 -163.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.6 p -79.59 169.67 17.68 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.519 164.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -50.28 -41.78 19.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-N 121.135 1.788 . . . . 0.0 111.907 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -52.92 -39.5 62.85 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -65.69 -46.64 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.803 1.641 . . . . 0.0 108.575 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.28 -34.54 10.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.479 0.581 . . . . 0.0 112.464 171.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.96 -58.36 3.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.83 -29.06 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.992 2.517 . . . . 0.0 110.155 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 -60.55 2.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -56.01 -48.67 75.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.857 1.263 . . . . 0.0 113.217 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.1 p -72.25 -30.89 65.31 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.683 1.193 . . . . 0.0 109.992 -170.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -104.52 35.99 2.55 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 122.561 1.172 . . . . 0.0 108.494 170.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.46 -2.74 1.54 Allowed Glycine 0 CA--C 1.531 1.05 1 C-N-CA 131.334 4.302 . . . . 0.0 120.135 165.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -80.1 38.43 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.956 2.878 . . . . 0.0 113.59 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.86 -166.6 1.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.129 -0.982 . . . . 0.0 108.684 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.21 148.23 46.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.233 1.413 . . . . 0.0 108.498 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.408 ' CD ' ' HZ1' ' A' ' 85' ' ' LYS . 5.2 tt0 -80.96 101.03 9.24 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.569 1.548 . . . . 0.0 107.856 175.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 N--CA 1.443 -0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 107.525 -177.47 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -99.4 149.6 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.03 147.56 44.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.152 1.342 . . . . 0.0 108.657 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 120.64 19.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.03 101.31 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 127.147 5.231 . . . . 0.0 107.568 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -100.1 164.37 12.01 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.77 1.228 . . . . 0.0 109.207 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.75 38.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 165.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 -178.68 41.83 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.594 1.092 . . . . 0.0 110.485 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 37.3 mtmt -108.91 39.95 1.92 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 109.536 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -143.02 148.66 37.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.376 1.07 . . . . 0.0 109.907 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 1.91 3.41 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.041 2.136 . . . . 0.0 112.957 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -130.74 38.18 3.73 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.25 -1.531 . . . . 0.0 107.98 167.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 p -81.76 165.2 21.15 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.466 167.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.13 131.77 37.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.324 1.42 . . . . 0.0 109.881 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 84.8 t -74.29 144.21 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.251 1.021 . . . . 0.0 108.763 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -94.92 132.22 39.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.286 2.234 . . . . 0.0 109.52 -169.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -81.3 39.01 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.054 0.93 . . . . 0.0 111.026 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.73 97.82 0.07 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.312 -1.492 . . . . 0.0 108.313 -162.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -60.49 -51.04 71.16 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.755 1.161 . . . . 0.0 112.478 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.04 3.36 15.06 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -134.56 69.72 1.45 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 165.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.67 -177.96 3.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 160.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.48 -21.42 9.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.894 0.378 . . . . 0.0 110.115 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.2 m-85 -145.42 156.34 43.7 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.567 2.347 . . . . 0.0 105.681 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -132.92 110.77 10.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -86.35 129.58 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.9 mt -124.43 105.79 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -91.29 117.36 29.58 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.023 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.32 98.88 11.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.12 2.568 . . . . 0.0 112.055 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -78.13 58.11 1.95 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.652 -1.905 . . . . 0.0 109.3 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.88 -21.83 0.36 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.286 2.234 . . . . 0.0 112.105 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.78 35.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.072 1.305 . . . . 0.0 113.548 158.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.91 6.88 5.72 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.572 -1.33 . . . . 0.0 114.593 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.68 158.04 34.99 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.177 0.989 . . . . 0.0 109.254 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.35 173.54 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 125.736 1.614 . . . . 0.0 107.945 171.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.77 139.91 28.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.58 104.37 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.58 145.45 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 162.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -105.42 144.09 32.68 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 O-C-N 120.74 -1.225 . . . . 0.0 110.491 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.453 -0.873 0 CA-C-O 119.102 -0.458 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 60.31 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.907 2.083 . . . . 0.0 111.16 -169.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.274 1.43 . . . . 0.0 110.627 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -45.46 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.822 0 CA-C-O 115.859 -2.02 . . . . 0.0 109.072 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -51.97 -42.73 63.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.054 1.752 . . . . 0.0 112.138 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -68.46 -55.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.361 0.664 . . . . 0.0 110.111 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -45.61 80.45 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.015 -1.053 . . . . 0.0 110.923 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 t -56.67 -33.87 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.412 1.885 . . . . 0.0 111.484 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 m -66.75 -39.24 87.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.336 0.971 . . . . 0.0 109.806 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.74 37.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.027 0.931 . . . . 0.0 110.21 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.27 30.25 0.77 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.812 2.149 . . . . 0.0 116.353 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.64 119.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.74 1.27 . . . . 0.0 108.211 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -120.0 36.06 4.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.943 0.897 . . . . 0.0 111.089 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -177.39 168.52 2.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.093 -2.255 . . . . 0.0 107.286 -167.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.6 tp -169.85 153.84 5.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.953 0.901 . . . . 0.0 108.614 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.0 mt -127.21 106.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.183 1.793 . . . . 0.0 106.594 171.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.98 125.49 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.585 0.754 . . . . 0.0 109.823 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.8 p -60.49 -27.97 67.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -165.38 -179.61 5.63 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 126.424 1.89 . . . . 0.0 105.989 -168.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.43 166.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -10.3 84.33 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 116.114 -2.492 . . . . 0.0 113.545 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.408 0.2 OUTLIER 143.99 -59.36 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 131.782 4.033 . . . . 0.0 112.614 161.334 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -76.51 -159.07 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.665 1.186 . . . . 0.0 109.139 165.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 77.42 -35.99 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.317 2.647 . . . . 0.0 113.244 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.502 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 60.9 t80 -55.35 -43.43 75.03 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.776 1.23 . . . . 0.0 111.544 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -66.43 -32.14 73.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.127 0.971 . . . . 0.0 110.445 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -18.47 54.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.926 1.29 . . . . 0.0 110.756 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.57 -62.85 1.49 Allowed 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.406 -0.809 . . . . 0.0 108.944 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.502 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -55.97 -35.45 66.74 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 120.973 -1.08 . . . . 0.0 113.74 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.31 69.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.14 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.74 36.35 0.54 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.245 0.929 . . . . 0.0 111.651 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.48 33.22 3.07 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.309 1.433 . . . . 0.0 115.259 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.97 111.38 23.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 118.858 1.329 . . . . 0.0 108.581 -169.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -80.33 113.23 18.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.101 -0.999 . . . . 0.0 110.355 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.25 133.73 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -172.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -105.15 155.56 18.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.355 1.062 . . . . 0.0 110.073 165.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 162.59 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 163.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.494 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -140.39 172.6 12.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 160.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.68 75.06 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.995 1.725 . . . . 0.0 112.46 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.76 124.82 2.38 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.748 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.84 162.72 12.88 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.4 p -82.31 174.29 11.28 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.751 167.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.3 t -42.29 -47.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-O 117.429 -1.272 . . . . 0.0 110.597 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -60.82 -36.23 78.55 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.817 1.19 . . . . 0.0 113.85 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -66.08 -44.02 85.67 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.995 1.318 . . . . 0.0 108.632 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.7 -36.81 11.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.61 0.641 . . . . 0.0 111.298 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.5 mm -87.16 -52.06 12.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 108.849 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.47 -13.73 43.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.508 2.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -62.31 1.52 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 167.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -55.73 -43.78 76.91 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.449 -1.407 . . . . 0.0 113.163 -175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 p -60.16 -51.24 70.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.098 1.359 . . . . 0.0 108.794 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.49 37.87 0.71 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.169 0.988 . . . . 0.0 109.753 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 44.17 33.9 3.04 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.672 2.558 . . . . 0.0 114.549 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -106.63 36.58 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.422 1.111 . . . . 0.0 110.684 -168.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 mt -137.82 172.05 13.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.3 -0.875 . . . . 0.0 108.922 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -111.33 139.13 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -170.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.23 91.89 6.82 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 124.745 1.218 . . . . 0.0 110.214 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 p -114.68 166.96 7.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.31 154.41 41.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 163.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.06 129.87 16.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.65 1.98 . . . . 0.0 106.947 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.79 99.19 0.81 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 1 C-N-CA 127.97 5.78 . . . . 0.0 108.765 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -96.04 170.32 9.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.842 1.257 . . . . 0.0 109.455 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.8 m -121.06 38.27 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.506 1.123 . . . . 0.0 110.739 163.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.23 171.62 44.69 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 120.807 -1.183 . . . . 0.0 112.623 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -90.57 38.19 0.94 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.891 0.876 . . . . 0.0 111.212 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.48 160.57 41.93 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 120.939 -1.101 . . . . 0.0 111.301 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -12.53 59.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.427 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 t -121.05 37.22 4.38 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 120.575 -1.328 . . . . 0.0 108.499 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 m -80.0 168.91 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 159.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mtp -79.26 145.62 33.45 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.572 -1.33 . . . . 0.0 110.099 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 57.3 t -80.2 158.68 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.99 149.49 49.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.206 . . . . 0.0 111.32 -166.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER -86.21 33.02 0.61 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.436 1.016 . . . . 0.0 113.297 -166.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -165.13 120.93 1.38 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 118.717 -2.489 . . . . 0.0 106.657 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -58.68 -72.37 0.1 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 124.582 1.176 . . . . 0.0 111.903 167.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.82 2.03 7.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.657 -160.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 44.45 2.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.115 1.766 . . . . 0.0 109.068 173.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.5 -174.85 4.5 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 170.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -120.07 -25.78 5.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.27 0.941 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -142.2 139.91 32.17 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -123.44 100.87 7.03 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -80.98 120.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mt -110.55 112.16 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -99.41 123.29 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -87.55 114.29 24.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.281 2.232 . . . . 0.0 109.601 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -75.59 7.15 3.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.049 1.295 . . . . 0.0 113.643 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -96.31 -41.26 8.73 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 119.123 0.874 . . . . 0.0 113.208 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -130.03 37.1 3.95 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.185 160.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.7 29.4 7.81 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.884 1.23 . . . . 0.0 113.185 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -91.87 161.22 14.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.692 1.197 . . . . 0.0 107.914 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.57 155.83 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.236 0.541 . . . . 0.0 109.605 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -136.06 155.96 49.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 166.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.18 107.52 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.27 141.79 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 159.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -111.08 111.56 22.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 127.517 2.327 . . . . 0.0 105.269 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 . . . . . 0 CA--C 1.519 -0.232 0 CA-C-N 119.237 0.926 . . . . 0.0 109.123 -167.159 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 CA-C-O 118.213 -0.828 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt 58.23 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.418 2.287 . . . . 0.0 110.787 -170.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -63.09 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 108.992 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.17 -53.08 38.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 115.612 -2.137 . . . . 0.0 109.184 -173.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -51.61 -46.14 63.49 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 120.658 1.572 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -38.89 85.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.5 mt -77.68 -38.21 48.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.965 0.802 . . . . 0.0 110.168 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -58.25 -32.42 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.372 1.869 . . . . 0.0 110.304 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -13.42 8.57 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 112.934 173.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -114.17 37.7 3.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.331 1.052 . . . . 0.0 110.091 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.58 25.2 8.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.579 1.085 . . . . 0.0 114.401 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.04 114.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.11 37.87 3.37 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.299 1.523 . . . . 0.0 110.48 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -176.48 172.07 2.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -165.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tp -177.6 130.41 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 108.459 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.32 104.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.98 6.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.622 0.646 . . . . 0.0 109.379 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 p -47.2 -33.46 5.36 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.692 1.197 . . . . 0.0 112.209 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.25 -176.44 5.88 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.296 1.5 p -104.78 176.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 165.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -104.82 25.84 24.26 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' A' ' 74' ' ' ASN . 6.2 ttt180 69.25 -169.53 0.18 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 128.659 2.784 . . . . 0.0 110.165 -164.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.41 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 22.0 t30 28.09 60.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.833 3.253 . . . . 0.0 114.77 170.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -174.73 -33.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.374 1.07 . . . . 0.0 113.328 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 48.1 t80 -54.13 -37.66 64.61 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.268 1.027 . . . . 0.0 112.178 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.5 -34.88 70.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.517 0.727 . . . . 0.0 110.189 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.8 -14.61 59.17 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.444 -0.785 . . . . 0.0 111.184 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.7 mt -70.25 -57.29 5.06 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.262 -0.899 . . . . 0.0 109.19 171.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.59 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -60.74 -28.89 69.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.352 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -53.28 51.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.062 0.846 . . . . 0.0 109.986 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.58 35.72 0.68 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.193 0.452 . . . . 0.0 111.556 176.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 36.19 0.4 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.214 2.34 . . . . 0.0 115.901 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 t -86.99 136.92 21.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.406 1.603 . . . . 0.0 109.925 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -79.23 162.33 25.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 172.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.39 139.02 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.74 155.88 26.99 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.307 1.843 . . . . 0.0 109.345 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -78.39 139.64 38.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 167.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.15 161.45 21.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 156.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -144.77 80.1 1.62 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.307 1.051 . . . . 0.0 110.686 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.75 139.65 1.31 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.52 166.24 13.07 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 121.784 0.658 . . . . 0.0 111.906 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.5 p -86.09 172.03 10.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.88 -0.66 . . . . 0.0 109.619 164.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -45.43 -40.9 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.199 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.13 -35.51 81.35 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.878 1.217 . . . . 0.0 114.277 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.37 -42.43 83.45 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.932 1.693 . . . . 0.0 108.617 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.46 -39.16 15.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.212 0.915 . . . . 0.0 111.916 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.33 -53.07 11.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -60.05 -27.23 66.77 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.829 2.051 . . . . 0.0 110.31 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -59.48 2.71 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -55.54 -49.77 71.78 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.204 0.911 . . . . 0.0 113.159 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.2 p -66.79 -25.88 66.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 110.414 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.19 37.23 3.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.278 1.431 . . . . 0.0 107.745 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.18 6.4 0.88 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.281 2.848 . . . . 0.0 116.715 168.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.449 ' HB3' HH11 ' A' ' 105' ' ' ARG . 0.0 OUTLIER -79.95 36.47 0.34 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 121.05 2.425 . . . . 0.0 111.445 -178.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.6 mt -141.84 173.49 11.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.381 -1.449 . . . . 0.0 108.863 173.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -127.6 148.54 50.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.444 1.898 . . . . 0.0 107.557 -166.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.36 99.0 11.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 120.374 1.443 . . . . 0.0 108.062 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 tp . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.974 1.309 . . . . 0.0 109.976 -178.294 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.43 158.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.95 145.52 50.24 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.67 118.29 21.23 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.86 102.54 0.77 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 1 C-N-CA 126.18 4.587 . . . . 0.0 107.995 176.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.0 t -96.31 173.45 7.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.185 1.394 . . . . 0.0 107.406 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.07 38.38 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 109.038 164.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.35 175.46 44.62 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 121.025 -1.047 . . . . 0.0 111.96 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 19.9 mtmt -97.15 39.34 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.974 1.31 . . . . 0.0 110.296 -164.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.56 152.18 49.16 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.04 -0.43 31.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.169 1.788 . . . . 0.0 110.236 174.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -133.51 37.34 3.32 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 119.96 -1.712 . . . . 0.0 109.607 166.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.6 m -82.76 173.36 11.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.321 156.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.97 139.03 39.15 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.812 -1.18 . . . . 0.0 109.216 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.502 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 62.1 t -69.57 153.65 8.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 164.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -118.64 153.64 33.99 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.56 1.144 . . . . 0.0 110.253 -169.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.29 35.79 2.46 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.687 0.756 . . . . 0.0 111.256 -164.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -162.03 106.65 1.22 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.549 -1.344 . . . . 0.0 108.332 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 79' ' ' LEU . 14.4 t80 -53.96 -56.23 19.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.96 -6.23 49.96 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 121.013 1.733 . . . . 0.0 112.48 -174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.47 39.0 4.07 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.254 1.021 . . . . 0.0 109.843 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.32 178.99 5.55 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.46 -18.04 7.98 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 89.8 m-85 -146.3 156.17 43.16 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -132.76 105.51 7.2 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.1 mm -80.05 119.34 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.63 109.44 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -98.45 108.87 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 102.28 8.39 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.924 1.69 . . . . 0.0 109.757 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -68.48 15.9 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -120.69 -18.85 7.6 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.572 0.749 . . . . 0.0 112.663 -165.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.82 38.77 0.53 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 123.502 0.501 . . . . 0.0 110.098 158.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.42 16.33 0.92 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 128.572 2.987 . . . . 0.0 116.005 173.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -76.63 144.46 39.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.744 1.272 . . . . 0.0 109.584 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.29 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.616 1.166 . . . . 0.0 109.288 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.51 149.33 36.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.314 1.845 . . . . 0.0 108.043 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.14 111.04 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 162.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.87 128.64 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 153.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -84.14 140.87 31.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 160.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.436 -1.862 0 N-CA-C 109.639 -0.947 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 63.34 -64.59 0.11 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 126.426 1.89 . . . . 0.0 111.266 -171.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -63.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.314 1.446 . . . . 0.0 108.752 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.46 -49.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 126.291 1.836 . . . . 0.0 108.894 177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.49 -37.96 12.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.017 1.281 . . . . 0.0 111.902 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -75.74 -58.74 3.1 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.792 0.837 . . . . 0.0 110.403 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.74 -44.33 85.97 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.26 1.024 . . . . 0.0 110.84 -171.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.76 -45.03 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.137 1.775 . . . . 0.0 110.108 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.4 m -77.18 7.42 5.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.622 1.169 . . . . 0.0 113.901 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.73 38.98 3.75 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.461 -1.399 . . . . 0.0 108.741 155.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.58 18.14 29.54 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.636 2.065 . . . . 0.0 116.759 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.74 89.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.511 1.924 . . . . 0.0 110.219 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -91.58 35.7 0.95 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.954 1.302 . . . . 0.0 111.066 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 177.89 166.56 0.71 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 120.03 -1.668 . . . . 0.0 107.317 -170.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 tp -165.96 150.51 8.22 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.1 mt -120.84 103.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.13 120.87 8.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.607 1.094 . . . . 0.0 108.16 -176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.4 p -54.35 -34.57 61.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.896 0.379 . . . . 0.0 111.981 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.26 170.33 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.37 147.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.15 33.72 2.67 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ttm105 61.14 -161.35 0.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.316 1.846 . . . . 0.0 108.64 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t30 25.28 69.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.842 2.857 . . . . 0.0 112.802 174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -177.89 -28.54 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.546 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 57.3 t80 -70.27 -36.92 74.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 121.317 1.871 . . . . 0.0 110.928 -158.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.24 -32.43 72.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.523 0.729 . . . . 0.0 109.598 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -13.85 59.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.627 1.171 . . . . 0.0 109.842 -177.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 21' ' ' PHE . 28.8 mt -80.81 -62.47 1.66 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.546 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -59.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.387 -0.815 . . . . 0.0 112.265 177.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -16.04 27.75 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.217 -0.897 . . . . 0.0 113.366 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.62 36.71 4.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.674 1.125 . . . . 0.0 111.071 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.03 31.01 1.14 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.121 2.296 . . . . 0.0 116.824 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.49 112.62 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.071 1.435 . . . . 0.0 109.841 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HZ3' ' CD ' ' A' ' 108' ' ' GLU . 12.0 mttt -79.31 102.75 8.8 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.05 126.05 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -96.69 157.1 16.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.17 1.788 . . . . 0.0 109.726 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.49 154.16 30.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.77 2.028 . . . . 0.0 105.794 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.43 168.52 19.48 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 152.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.56 38.75 1.38 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.035 1.289 . . . . 0.0 112.288 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 112.82 3.74 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.358 -1.463 . . . . 0.0 112.908 170.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.37 164.71 30.36 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.598 2.047 . . . . 0.0 109.697 -161.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -87.63 169.85 11.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.226 1.013 . . . . 0.0 109.211 166.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -43.1 -47.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.538 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -63.11 -30.32 71.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -69.6 -40.67 76.52 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 120.483 1.492 . . . . 0.0 110.119 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.88 -28.27 15.56 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -92.94 -56.78 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 C-N-CA 125.689 1.596 . . . . 0.0 107.351 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.93 -41.31 64.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.247 0.967 . . . . 0.0 108.68 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.39 -50.66 58.71 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -43.37 68.67 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 111.479 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.9 p -67.41 -35.65 79.7 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.175 1.79 . . . . 0.0 110.464 -171.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.64 36.76 2.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.031 0.932 . . . . 0.0 108.74 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.96 20.93 0.79 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.813 2.149 . . . . 0.0 115.953 172.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -93.63 38.92 1.06 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.58 1.69 . . . . 0.0 110.206 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.3 mt -140.37 169.67 17.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 109.02 165.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -121.61 143.18 49.46 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.609 -163.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.403 ' CD ' ' HZ3' ' A' ' 85' ' ' LYS . 23.2 tt0 -79.48 100.8 7.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 125.079 1.352 . . . . 0.0 108.517 174.055 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 -173.85 3.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.531 1.132 . . . . 0.0 112.029 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.23 116.74 27.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 128.371 2.669 . . . . 0.0 107.636 165.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.91 141.01 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.05 155.06 18.99 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.56 122.17 13.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.45 102.62 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.618 4.212 . . . . 0.0 109.129 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -100.26 175.41 5.73 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.34 1.456 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.06 37.03 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.694 0.798 . . . . 0.0 109.968 166.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.94 -173.86 46.34 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 120.46 -1.4 . . . . 0.0 111.783 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -125.61 39.55 3.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.45 1.125 . . . . 0.0 111.602 -165.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.18 153.03 51.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.963 1.305 . . . . 0.0 107.626 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -7.21 53.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.349 1.46 . . . . 0.0 113.02 -170.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -115.59 38.15 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.434 -1.416 . . . . 0.0 109.667 164.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.9 m -79.5 166.91 21.47 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.61 140.45 39.65 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.714 -1.242 . . . . 0.0 108.344 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.4 t -77.47 137.28 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -83.06 146.31 28.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.45 1.5 . . . . 0.0 108.203 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.67 38.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.786 -0.571 . . . . 0.0 110.293 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 179.77 108.91 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 119.923 -1.736 . . . . 0.0 108.889 -161.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.95 -65.6 0.54 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.247 0.619 . . . . 0.0 111.392 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.96 12.19 3.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.711 -171.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -131.23 37.43 3.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.815 0.734 . . . . 0.0 109.481 164.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.81 -176.01 5.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -122.74 -14.27 7.74 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -144.72 154.69 43.01 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -133.09 116.37 16.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.4 mm -95.42 118.03 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.31 97.77 6.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -83.96 111.05 18.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.784 1.234 . . . . 0.0 108.637 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 101.36 7.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.813 2.845 . . . . 0.0 111.322 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 p -75.78 43.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.96 -1.088 . . . . 0.0 112.732 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.7 -37.72 1.17 Allowed 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 116.996 -1.478 . . . . 0.0 112.197 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -133.86 36.79 3.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 124.94 1.4 . . . . 0.0 111.972 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.89 1.3 Allowed Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.988 1.756 . . . . 0.0 113.003 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.01 150.85 21.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.3 149.12 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 122.218 1.008 . . . . 0.0 109.063 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.09 134.44 52.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.32 108.63 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.24 152.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.34 103.25 7.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.95 111.96 14.72 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -168.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.3 p -96.75 71.13 2.56 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -166.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.513 ' CG2' ' HE3' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -112.34 96.83 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 126.608 1.963 . . . . 0.0 108.4 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.75 50.3 2.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.033 0.933 . . . . 0.0 109.303 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -160.61 -171.46 3.14 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.278 -0.889 . . . . 0.0 108.823 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.94 176.11 7.85 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.21 1.804 . . . . 0.0 110.126 170.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 61.59 -174.72 0.13 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.271 2.228 . . . . 0.0 112.167 -164.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.06 179.34 18.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.307 1.432 . . . . 0.0 110.061 -166.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.7 t -135.06 134.07 39.97 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.682 1.193 . . . . 0.0 108.325 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.34 157.36 24.0 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.011 1.291 . . . . 0.0 110.356 -171.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.11 -55.12 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.303 2.002 . . . . 0.0 111.523 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' HE3' ' CG2' ' A' ' 44' ' ' ILE . 0.4 OUTLIER 59.93 -62.06 0.06 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 127.038 2.135 . . . . 0.0 112.333 -168.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -52.5 -62.55 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -52.73 52.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-O 116.129 -1.891 . . . . 0.0 109.692 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -46.21 -48.42 17.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.96 1.254 . . . . 0.0 111.481 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 t -61.96 -62.65 1.64 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.388 0.675 . . . . 0.0 111.139 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.9 mt -53.75 -46.83 71.02 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.925 1.69 . . . . 0.0 111.281 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 t -56.75 -45.55 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.846 1.658 . . . . 0.0 110.232 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.8 m -71.95 8.07 1.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.013 0.925 . . . . 0.0 112.217 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.68 37.62 4.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 166.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.91 5.32 2.85 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 129.102 3.239 . . . . 0.0 117.344 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.7 t -53.46 108.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 121.107 2.453 . . . . 0.0 112.681 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -105.82 35.65 2.82 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.948 0.88 . . . . 0.0 111.711 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -176.91 168.36 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.008 -2.308 . . . . 0.0 108.384 -172.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 tp -166.55 152.19 8.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -119.94 94.9 3.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.43 108.82 3.96 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.069 0.948 . . . . 0.0 111.202 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 p -48.74 -28.21 3.46 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.908 2.483 . . . . 0.0 115.565 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.75 178.52 4.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.662 1.985 . . . . 0.0 106.039 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.19 155.09 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.848 -1.158 . . . . 0.0 108.356 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -48.51 -58.93 6.94 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 167.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 151.6 -177.7 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 1 C-N-CA 133.82 4.848 . . . . 0.0 105.357 -166.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 25.62 58.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 129.426 3.091 . . . . 0.0 116.153 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.28 -29.3 0.12 Allowed 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.595 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 46.4 t80 -61.2 -33.8 74.05 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.632 0.651 . . . . 0.0 112.462 -169.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.89 -33.88 71.03 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.625 0.37 . . . . 0.0 110.833 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -16.54 41.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.307 0.643 . . . . 0.0 110.088 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.8 mt -64.28 -66.69 0.51 Allowed 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.595 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -60.73 -27.0 67.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.47 -31.08 33.11 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.294 0.638 . . . . 0.0 112.368 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.25 37.42 2.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.279 1.032 . . . . 0.0 110.631 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.82 27.03 8.85 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.773 1.654 . . . . 0.0 116.653 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.64 114.02 19.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 118.639 1.219 . . . . 0.0 109.187 -168.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -79.59 103.32 9.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.07 109.88 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.988 1.715 . . . . 0.0 108.695 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -79.72 162.25 25.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.015 1.326 . . . . 0.0 111.465 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -79.56 152.61 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.479 1.912 . . . . 0.0 106.567 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -131.92 163.93 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 155.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.33 92.72 1.72 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.658 1.572 . . . . 0.0 109.274 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.56 86.48 0.91 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.697 1.142 . . . . 0.0 115.695 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.63 159.95 28.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 121.387 -1.067 . . . . 0.0 112.302 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.7 p -82.8 172.51 12.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.347 0.659 . . . . 0.0 109.505 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.6 t -46.26 -42.55 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.298 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -35.24 76.93 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.548 1.522 . . . . 0.0 114.499 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.86 -45.64 85.19 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 125.106 1.362 . . . . 0.0 108.138 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.06 -29.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -89.58 -60.91 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 C-N-CA 125.141 1.376 . . . . 0.0 107.448 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -48.98 -41.23 33.59 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 127.51 2.324 . . . . 0.0 109.404 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.64 -54.99 15.1 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.731 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -58.09 -47.44 83.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.932 1.293 . . . . 0.0 111.971 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.8 p -68.43 -33.44 74.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.086 1.754 . . . . 0.0 110.413 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.75 37.82 2.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.87 44.66 24.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.906 2.194 . . . . 0.0 115.115 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -118.28 38.25 3.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.49 1.145 . . . . 0.0 110.468 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.4 mt -133.04 170.37 15.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.386 0.994 . . . . 0.0 108.686 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -112.74 147.29 37.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -79.94 121.97 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.51 66.93 0.89 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.213 1.005 . . . . 0.0 109.903 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -96.03 37.7 1.22 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.295 1.038 . . . . 0.0 111.913 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.1 t 157.93 164.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 1 C-N-CA 133.112 4.565 . . . . 0.0 104.929 172.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.77 169.21 17.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.8 1.64 . . . . 0.0 107.567 173.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -94.76 161.94 13.97 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.242 1.017 . . . . 0.0 109.348 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -164.17 107.82 0.95 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.99 38.38 0.65 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 117.01 -1.994 . . . . 0.0 109.072 -178.269 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 178.86 158.4 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.533 2.733 . . . . 0.0 107.879 162.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -79.35 140.7 37.42 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.32 134.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.478 -2.415 . . . . 0.0 104.478 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.43 146.19 27.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.25 123.41 20.62 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.73 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 1 C-N-CA 126.404 4.736 . . . . 0.0 109.392 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.2 t -83.48 169.34 15.6 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.307 1.043 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.1 m -120.56 38.77 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.701 1.2 . . . . 0.0 110.582 163.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 170.63 42.18 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 164.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -93.48 46.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.952 1.701 . . . . 0.0 110.27 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -138.41 153.43 48.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.041 0.936 . . . . 0.0 108.74 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.72 -15.49 59.76 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.246 1.418 . . . . 0.0 109.256 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.55 39.46 3.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.587 -1.321 . . . . 0.0 110.638 165.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -88.41 166.71 14.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 159.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.15 146.46 35.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.919 0.887 . . . . 0.0 109.887 -173.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.408 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 3.2 t -93.0 147.31 5.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 122.349 1.071 . . . . 0.0 109.859 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -105.8 132.74 51.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.222 1.809 . . . . 0.0 108.193 -165.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -79.45 38.44 0.37 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.767 0.794 . . . . 0.0 110.024 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -172.61 93.99 0.12 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 119.209 -2.182 . . . . 0.0 108.752 -160.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -49.97 -61.42 2.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 112.047 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.5 -0.8 16.12 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -168.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -133.69 58.92 1.75 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.753 2.421 . . . . 0.0 107.066 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.98 179.71 4.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 163.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.91 -19.99 7.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.488 0.586 . . . . 0.0 112.145 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.41 144.23 33.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -126.29 99.7 5.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.1 mm -80.79 121.53 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -108.82 117.11 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -103.11 131.31 50.21 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.093 1.357 . . . . 0.0 109.014 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.12 122.78 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.849 1.66 . . . . 0.0 111.005 173.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 p -88.16 42.15 1.04 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 164.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.33 -96.85 0.36 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.72 37.92 1.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.919 -162.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.22 2.79 0.03 OUTLIER Glycine 0 CA--C 1.536 1.37 0 C-N-CA 128.708 3.052 . . . . 0.0 116.387 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -72.84 140.88 47.9 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.957 1.303 . . . . 0.0 109.745 -165.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.937 0.895 . . . . 0.0 109.745 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -141.92 128.76 20.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.646 1.578 . . . . 0.0 107.435 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.76 117.85 33.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.69 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 152.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.57 142.93 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.133 1.773 . . . . 0.0 106.382 158.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.2 114.33 4.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.025 -1.047 . . . . 0.0 109.929 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.2 p -101.65 52.1 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.308 0.643 . . . . 0.0 110.116 -155.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 107.35 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.829 0.824 . . . . 0.0 110.361 -172.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.66 60.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.761 2.025 . . . . 0.0 107.298 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -147.79 152.55 37.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.241 1.816 . . . . 0.0 106.252 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.01 39.67 1.48 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.292 1.037 . . . . 0.0 110.768 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -4.87 56.0 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.1 15.8 80.92 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.953 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.7 m -102.52 102.78 13.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.381 1.591 . . . . 0.0 109.923 -170.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.31 171.56 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.423 1.487 . . . . 0.0 114.867 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.23 -59.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.833 1.688 . . . . 0.0 111.008 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 63.51 -63.56 0.13 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.403 1.481 . . . . 0.0 111.249 -166.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -65.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -49.05 -53.02 8.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 126.324 1.85 . . . . 0.0 108.97 175.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -53.57 7.06 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.378 1.049 . . . . 0.0 111.466 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -70.05 -46.79 64.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.19 -40.54 90.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.783 -1.198 . . . . 0.0 110.069 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.8 t -57.0 -41.95 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.998 1.719 . . . . 0.0 110.291 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -55.74 -29.85 60.23 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.597 0.635 . . . . 0.0 111.666 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -101.82 38.57 1.61 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.442 1.019 . . . . 0.0 109.045 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.47 18.35 29.56 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 126.324 1.916 . . . . 0.0 116.443 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.82 114.12 4.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -124.15 35.63 4.78 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.626 0.648 . . . . 0.0 111.443 167.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -158.75 162.7 37.13 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.17 150.8 8.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.736 -1.853 . . . . 0.0 107.099 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.0 mt -121.79 99.66 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.91 113.18 3.75 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.308 1.043 . . . . 0.0 109.21 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -52.52 -30.45 30.46 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.433 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -160.53 169.81 22.2 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.541 1.937 . . . . 0.0 106.911 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.04 153.67 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.29 50.95 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.61 -160.82 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.834 3.254 . . . . 0.0 106.553 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -28.93 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 129.404 3.081 . . . . 0.0 112.766 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -175.98 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.38 1.872 . . . . 0.0 110.084 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.435 ' CD2' ' HE3' ' A' ' 80' ' ' LYS . 45.8 t80 -57.56 -38.97 75.67 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.195 1.398 . . . . 0.0 111.61 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.45 -24.89 63.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.457 0.571 . . . . 0.0 111.226 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.8 m -84.41 -18.2 36.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.964 -1.085 . . . . 0.0 112.065 170.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -66.85 -61.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.341 0.973 . . . . 0.0 108.696 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -55.95 -32.67 64.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 171.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.28 67.66 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.388 0.994 . . . . 0.0 110.674 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.38 36.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.386 0.994 . . . . 0.0 111.914 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.16 28.68 3.18 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.453 1.502 . . . . 0.0 116.047 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 t -86.61 123.63 39.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 118.772 1.286 . . . . 0.0 108.344 -170.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 159.65 28.3 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.14 148.0 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.642 1.577 . . . . 0.0 108.011 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -118.33 155.87 29.89 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.346 1.858 . . . . 0.0 109.994 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.78 146.45 33.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 164.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.408 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -122.85 166.91 14.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 154.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -154.31 60.11 0.7 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.816 1.189 . . . . 0.0 109.411 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.24 121.02 3.05 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.564 1.078 . . . . 0.0 111.89 168.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.97 167.58 18.32 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.359 1.079 . . . . 0.0 114.993 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.1 p -87.88 174.79 8.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.231 1.012 . . . . 0.0 110.694 162.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.6 t -48.85 -38.29 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.002 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -65.99 -33.61 76.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 121.076 1.762 . . . . 0.0 113.928 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -69.58 -41.6 75.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.768 1.627 . . . . 0.0 108.801 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -42.88 -42.08 3.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.141 0.882 . . . . 0.0 111.902 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.19 -48.66 14.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.791 1.237 . . . . 0.0 108.227 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.13 -24.97 63.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.274 1.829 . . . . 0.0 110.153 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.67 -57.33 3.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.14 -44.7 83.65 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.211 1.004 . . . . 0.0 113.015 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.0 p -61.97 -50.76 70.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.084 1.354 . . . . 0.0 108.765 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.92 35.62 0.64 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.857 . . . . 0.0 109.134 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.05 24.51 2.09 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.02 1.771 . . . . 0.0 114.978 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -98.34 37.76 1.42 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.076 1.438 . . . . 0.0 109.984 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.7 mt -134.36 165.24 25.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -109.03 138.52 45.25 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.7 100.47 7.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.689 1.131 . . . . 0.0 108.59 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -84.61 71.72 10.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.751 0.821 . . . . 0.0 110.65 -166.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 p -91.25 35.29 0.93 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.955 -1.09 . . . . 0.0 112.306 -170.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.7 t 158.82 164.63 0.01 OUTLIER 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.328 2.251 . . . . 0.0 106.495 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -167.82 -169.65 1.21 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.979 2.511 . . . . 0.0 106.097 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.1 m -128.44 145.85 50.97 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -162.67 91.47 0.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -85.82 59.13 5.44 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 -170.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 126.227 1.87 . . . . 0.0 110.331 176.512 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptp . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.04 128.99 9.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 161.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -98.18 103.59 15.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.112 1.365 . . . . 0.0 109.719 164.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 9.8 p -82.88 156.02 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.96 146.4 39.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 163.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.78 129.08 24.13 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.83 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.203 1 C-N-CA 125.307 4.005 . . . . 0.0 108.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 t -111.3 171.08 7.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.567 1.147 . . . . 0.0 109.876 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -129.82 39.39 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.73 2.012 . . . . 0.0 108.227 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.1 173.1 42.34 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -110.29 50.0 0.82 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.016 1.326 . . . . 0.0 108.268 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.71 157.13 45.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.983 1.313 . . . . 0.0 108.016 171.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 0.8 25.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.313 1.445 . . . . 0.0 110.339 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -127.25 37.63 4.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.021 -1.674 . . . . 0.0 108.755 168.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -81.07 165.07 21.98 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.419 -0.801 . . . . 0.0 109.381 163.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.41 135.35 37.41 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.664 1.12 . . . . 0.0 109.047 -175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.501 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 93.0 t -75.34 137.53 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.67 131.12 42.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 107.361 -172.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.67 38.59 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.634 1.207 . . . . 0.0 110.862 -173.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.46 93.5 0.76 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 118.401 -2.687 . . . . 0.0 107.132 -166.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -55.12 -52.58 62.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.632 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.79 13.59 1.0 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.04 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.28 38.29 1.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.286 1.403 . . . . 0.0 110.082 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.91 127.85 51.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -172.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.43 -20.15 64.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.62 151.98 42.02 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -131.3 119.61 22.0 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.31 112.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.76 112.47 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.42 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 16.7 t80 -104.28 125.83 50.87 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.859 1.264 . . . . 0.0 110.582 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.84 112.11 19.82 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 108.676 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -77.43 54.57 1.16 Allowed 'General case' 0 C--O 1.239 0.518 0 O-C-N 120.832 -1.167 . . . . 0.0 108.838 163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -151.58 -34.67 0.14 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.46 38.03 0.43 Allowed 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 117.524 -1.67 . . . . 0.0 111.873 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.1 9.48 2.0 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.011 1.291 . . . . 0.0 115.01 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -61.91 146.36 50.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.893 1.346 . . . . 0.0 107.687 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.44 142.42 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.25 132.23 53.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.275 1.83 . . . . 0.0 106.629 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.27 110.53 25.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.22 150.57 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 158.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -124.02 106.76 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -122.89 124.56 43.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.1 p -110.02 62.22 0.6 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -165.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.39 76.74 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.092 -1.005 . . . . 0.0 110.485 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -105.5 37.69 2.15 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.885 -0.509 . . . . 0.0 111.337 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -144.7 159.62 42.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 110.006 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.6 103.55 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -145.72 -47.28 0.21 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.314 -168.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.24 174.37 18.53 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.496 1.044 . . . . 0.0 113.84 163.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m 52.1 87.76 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.804 2.041 . . . . 0.0 111.1 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.8 126.24 2.56 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 117.91 -1.495 . . . . 0.0 110.61 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -74.94 -51.22 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.029 1.819 . . . . 0.0 110.758 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 58.61 -66.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.397 1.879 . . . . 0.0 111.094 -161.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -48.91 -63.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.427 1.491 . . . . 0.0 111.174 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.36 -49.66 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 116.028 -1.939 . . . . 0.0 109.266 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -49.69 -49.81 46.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.827 1.194 . . . . 0.0 110.652 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 t -61.83 -55.11 33.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.406 1.082 . . . . 0.0 112.073 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.21 -43.15 92.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.28 0.632 . . . . 0.0 109.843 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -60.66 -45.17 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.528 1.931 . . . . 0.0 110.861 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -58.02 -26.07 61.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.532 1.06 . . . . 0.0 111.808 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -104.0 36.78 2.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.053 0.941 . . . . 0.0 109.08 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.12 11.69 55.93 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 127.012 2.244 . . . . 0.0 117.162 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.57 105.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.96 1.38 . . . . 0.0 110.791 -170.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -104.88 36.43 2.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.338 1.055 . . . . 0.0 110.847 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -171.62 173.05 4.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 119.804 -1.81 . . . . 0.0 109.888 -172.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.4 tp -166.81 157.64 12.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.941 1.296 . . . . 0.0 108.716 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.37 106.12 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.41 130.99 10.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 p -63.68 -26.04 68.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -170.02 -177.89 2.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -166.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.17 154.09 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.603 -1.311 . . . . 0.0 108.037 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.05 -51.37 25.31 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 164.52 -86.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 130.942 3.697 . . . . 0.0 104.937 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.73 119.88 15.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.7 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 130.572 3.549 . . . . 0.0 109.831 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.525 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 33.6 t80 -53.02 -43.92 66.92 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.163 1.385 . . . . 0.0 111.658 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.43 -31.2 72.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.339 1.455 . . . . 0.0 109.856 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -21.78 38.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.817 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.86 -59.11 3.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.273 0.942 . . . . 0.0 108.653 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -58.9 -31.35 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.568 1.147 . . . . 0.0 112.999 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.13 -8.19 7.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.47 36.5 4.55 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.81 1.641 . . . . 0.0 110.211 165.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.79 19.46 3.39 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.681 2.086 . . . . 0.0 116.619 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.2 129.73 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.131 -1.217 . . . . 0.0 108.184 -163.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -78.56 165.18 24.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.6 t -151.71 114.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -89.03 157.51 18.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.768 0.827 . . . . 0.0 110.181 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.81 156.17 27.53 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.697 1.599 . . . . 0.0 107.101 162.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.501 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.04 175.73 9.33 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 158.182 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.45 38.72 0.71 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 122.191 2.269 . . . . 0.0 114.759 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.04 123.17 2.82 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 172.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.41 163.37 13.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -166.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 p -81.97 172.31 13.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.305 0.553 . . . . 0.0 110.272 168.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -41.26 -47.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.698 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -35.22 77.89 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -67.88 -45.19 75.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 125.363 1.465 . . . . 0.0 108.573 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.25 -30.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.71 -52.6 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 116.359 -1.781 . . . . 0.0 108.684 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -33.69 69.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 124.38 1.05 . . . . 0.0 108.964 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -54.0 14.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -45.53 82.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.515 1.126 . . . . 0.0 111.899 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.7 p -64.46 -42.15 96.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.526 1.13 . . . . 0.0 108.104 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.64 35.65 1.22 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.937 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.08 7.52 3.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.517 1.532 . . . . 0.0 116.39 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -85.66 36.82 0.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 120.067 1.933 . . . . 0.0 112.064 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.5 mt -131.22 170.24 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 120.081 1.309 . . . . 0.0 108.614 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -111.69 142.07 44.49 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -81.34 106.68 13.5 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.905 1.23 . . . . 0.0 107.943 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -85.08 54.74 3.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.332 1.453 . . . . 0.0 109.48 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.286 8.2 t -88.48 35.88 0.78 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.446 -1.409 . . . . 0.0 111.555 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t 169.61 84.75 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.35 -1.469 . . . . 0.0 107.847 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -156.9 170.32 22.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 107.302 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.65 168.67 26.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.726 1.61 . . . . 0.0 107.675 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -146.17 171.89 14.25 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 161.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.37 47.34 0.59 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.575 -0.703 . . . . 0.0 110.807 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 157.087 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.47 -173.65 4.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.725 1.21 . . . . 0.0 110.906 -173.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -110.27 147.97 32.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.179 150.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 9.3 p -129.35 125.79 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.878 1.271 . . . . 0.0 109.463 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.2 29.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.8 118.63 24.19 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.55 99.58 0.95 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 1 C-N-CA 125.43 4.086 . . . . 0.0 107.551 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 t -94.3 175.47 6.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.911 1.285 . . . . 0.0 108.77 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.54 39.42 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.282 1.033 . . . . 0.0 109.891 161.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.17 172.13 45.2 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.774 -1.204 . . . . 0.0 111.441 167.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 29.4 mtmt -94.6 39.9 1.09 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.141 2.177 . . . . 0.0 108.871 -172.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.95 148.27 38.35 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -12.46 61.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.142 2.577 . . . . 0.0 110.81 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -116.02 38.8 3.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.607 -1.308 . . . . 0.0 109.014 170.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -89.88 168.03 12.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.182 -0.949 . . . . 0.0 109.026 163.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 142.39 38.32 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.283 -0.885 . . . . 0.0 109.007 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.444 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 59.2 t -81.83 150.81 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -109.03 138.46 45.33 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.805 1.642 . . . . 0.0 110.548 -167.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -83.45 37.31 0.56 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.422 1.106 . . . . 0.0 112.034 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -172.75 85.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 119.956 -1.715 . . . . 0.0 109.334 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -50.39 -50.77 50.71 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -0.03 30.72 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.396 -0.815 . . . . 0.0 112.071 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.02 38.61 3.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.876 1.271 . . . . 0.0 109.839 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.59 142.25 47.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -91.79 -20.64 21.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -158.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 96.5 m-85 -146.47 124.95 12.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.38 107.85 18.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.8 mm -81.88 114.96 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.6 mt -110.61 106.89 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 5.1 t80 -88.1 116.6 26.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.47 101.25 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.779 2.032 . . . . 0.0 108.079 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 p -86.6 22.51 1.88 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.559 1.171 . . . . 0.0 111.227 -171.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.47 -89.84 0.4 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 167.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.95 37.4 0.84 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.063 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.36 24.04 9.91 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.754 2.121 . . . . 0.0 114.437 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -82.66 154.3 24.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -138.92 136.88 42.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.8 pt-20 -122.96 163.2 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.312 1.045 . . . . 0.0 110.446 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.94 104.31 15.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.173 1.389 . . . . 0.0 108.209 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 t -79.25 151.75 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -120.17 123.56 43.61 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 129.597 3.159 . . . . 0.0 104.427 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -144.96 113.04 6.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.991 0.814 . . . . 0.0 109.289 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.3 p -94.79 65.17 3.0 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -161.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.69 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 122.987 1.375 . . . . 0.0 112.198 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.22 -139.27 0.09 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.733 1.613 . . . . 0.0 109.15 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.57 38.84 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.499 1.52 . . . . 0.0 109.465 -165.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.76 -175.36 3.55 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.926 1.691 . . . . 0.0 109.833 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 157.13 8.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 169.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.07 -62.25 6.51 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.266 8.7 p 64.85 -137.18 0.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.366 1.466 . . . . 0.0 109.203 -173.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.18 170.51 20.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.93 -27.35 84.72 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 63.66 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 126.597 1.959 . . . . 0.0 109.217 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -56.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 126.028 1.731 . . . . 0.0 111.675 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.11 -34.98 72.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.107 -171.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -16.38 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.535 1.516 . . . . 0.0 113.727 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -98.11 -46.2 5.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 120.283 1.401 . . . . 0.0 109.971 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.88 -37.93 79.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.967 0.507 . . . . 0.0 112.012 -173.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.48 -50.52 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 123.85 0.86 . . . . 0.0 108.845 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.3 m -74.89 13.13 0.7 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.434 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 4.9 mttt -127.66 37.56 4.19 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.356 1.463 . . . . 0.0 108.707 163.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 38.57 39.3 0.79 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.831 1.682 . . . . 0.0 114.523 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 77.5 t -81.69 87.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.484 1.513 . . . . 0.0 108.402 -172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -91.09 35.62 0.91 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.555 1.071 . . . . 0.0 111.851 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -164.63 162.45 21.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.797 -1.815 . . . . 0.0 108.595 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tp -160.15 153.22 21.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.81 98.59 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.263 1.425 . . . . 0.0 107.707 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.62 133.33 16.84 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 120.205 1.366 . . . . 0.0 111.412 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.4 p -74.39 -18.4 60.67 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.42 -169.86 0.87 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.063 1.745 . . . . 0.0 108.292 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.66 140.37 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 120.376 -1.453 . . . . 0.0 108.764 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -46.29 -54.89 8.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.459 1.504 . . . . 0.0 110.526 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 172.12 152.92 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.541 2.736 . . . . 0.0 106.464 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 -144.91 0.5 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.378 1.871 . . . . 0.0 109.923 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.42 -30.9 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 129.565 3.146 . . . . 0.0 116.117 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.681 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 59.0 t80 -57.92 -40.94 81.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.245 2.218 . . . . 0.0 111.653 -169.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.75 -41.11 83.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.599 1.159 . . . . 0.0 110.099 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -69.06 -19.59 64.09 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.252 -0.905 . . . . 0.0 110.575 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.4 -61.33 1.84 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.351 0.978 . . . . 0.0 109.411 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.681 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -58.33 -35.89 72.57 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.769 -1.207 . . . . 0.0 112.473 176.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.12 -7.54 9.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.69 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.61 36.5 4.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 121.211 1.823 . . . . 0.0 110.733 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.16 5.91 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.111 1.815 . . . . 0.0 115.48 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.24 116.31 27.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 118.486 1.143 . . . . 0.0 109.626 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -79.8 94.62 5.82 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.12 128.78 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -103.78 160.65 14.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.415 1.886 . . . . 0.0 108.895 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -79.0 161.23 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 164.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.28 165.12 27.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 155.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -150.24 39.47 0.75 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 121.008 1.731 . . . . 0.0 113.189 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.25 102.69 1.71 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 121.231 -0.918 . . . . 0.0 112.207 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.07 163.14 26.99 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 111.68 -168.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.4 p -84.41 173.64 10.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.118 0.567 . . . . 0.0 109.95 165.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -48.61 -40.21 11.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.321 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -63.07 -33.53 75.64 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -71.77 -37.57 70.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.556 1.542 . . . . 0.0 109.897 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.03 -43.55 19.76 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.092 0.86 . . . . 0.0 110.548 168.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -81.14 -55.6 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 C-N-CA 125.329 1.452 . . . . 0.0 108.356 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.28 -31.23 65.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.109 1.764 . . . . 0.0 108.603 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.04 -52.54 7.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.939 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -51.77 -45.1 63.63 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.168 0.895 . . . . 0.0 111.14 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -65.95 -44.78 84.01 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.013 0.925 . . . . 0.0 110.16 -168.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.94 37.18 1.33 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.584 0.707 . . . . 0.0 109.18 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 41.89 44.16 4.46 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 127.93 2.681 . . . . 0.0 113.096 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -106.14 37.26 2.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.085 0.954 . . . . 0.0 110.485 169.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.2 mt -138.75 172.73 12.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.198 0.908 . . . . 0.0 109.454 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.38 146.95 37.42 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.002 1.321 . . . . 0.0 108.498 -168.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -81.26 99.1 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.424 1.107 . . . . 0.0 108.474 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp -87.83 87.41 7.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.3 p -122.46 35.81 4.79 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.696 1.589 . . . . 0.0 110.662 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -159.63 38.38 0.19 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.269 -163.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -125.24 128.32 48.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.822 -1.174 . . . . 0.0 108.299 -167.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.85 143.64 33.47 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -154.19 140.84 18.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -148.37 78.59 1.43 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 103.775 -3.73 . . . . 0.0 103.775 158.549 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.51 -172.41 1.92 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.698 1.599 . . . . 0.0 109.845 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.75 125.66 42.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.471 156.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.413 HG22 ' HB3' ' A' ' 65' ' ' TYR . 2.3 p -97.62 151.03 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.606 1.191 . . . . 0.0 108.235 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.67 136.79 52.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 166.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.95 118.32 28.23 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.0 115.35 4.23 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 124.507 3.471 . . . . 0.0 107.573 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -118.16 151.87 36.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.233 1.413 . . . . 0.0 107.467 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.49 41.55 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.32 176.96 48.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -119.83 57.73 0.91 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.123 1.769 . . . . 0.0 108.202 -169.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.15 154.17 39.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.223 1.809 . . . . 0.0 106.431 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.717 1.207 . . . . 0.0 110.253 172.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -123.48 37.36 4.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 119.983 -1.698 . . . . 0.0 110.753 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.9 m -82.17 172.25 13.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.387 160.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.06 136.59 37.21 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.201 -0.937 . . . . 0.0 109.559 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.471 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 43.3 t -72.32 159.09 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -115.7 149.91 37.64 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.919 0.888 . . . . 0.0 111.447 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.3 37.81 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.453 1.101 . . . . 0.0 111.065 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.71 101.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.564 -1.335 . . . . 0.0 108.988 -162.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -53.39 -62.29 1.75 Allowed 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 123.36 0.412 . . . . 0.0 111.068 170.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 -3.5 29.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -118.78 38.94 3.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 109.495 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.38 115.31 28.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.188 -164.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -69.85 -23.8 63.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -166.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.08 156.9 47.31 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 106.855 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -132.19 112.72 12.52 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 124.107 0.963 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.4 mm -79.78 120.19 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 169.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.38 117.08 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -103.0 126.0 49.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.151 1.38 . . . . 0.0 110.182 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 115.03 27.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.842 2.057 . . . . 0.0 110.173 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -76.0 23.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.86 -6.02 2.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.25 36.46 0.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 158.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 34.88 34.54 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 C-N-CA 127.092 2.282 . . . . 0.0 113.327 -170.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -88.29 154.64 20.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -168.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.51 137.34 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 123.412 0.685 . . . . 0.0 110.872 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -109.86 154.28 23.25 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.174 2.19 . . . . 0.0 108.371 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.37 112.04 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 158.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.05 137.48 21.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 157.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.98 135.73 33.9 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 161.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.05 95.04 3.13 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.002 0.819 . . . . 0.0 110.159 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.1 p -93.3 76.91 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.41 163.29 3.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 162.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -131.84 133.26 44.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 153.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -79.07 77.35 5.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.04 114.85 1.51 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.905 2.082 . . . . 0.0 107.658 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.4 m170 67.57 -64.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.762 2.425 . . . . 0.0 111.688 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.44 83.09 0.07 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.86 1.219 . . . . 0.0 112.219 168.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -69.35 -10.21 56.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -172.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -169.76 -173.31 37.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.373 1.94 . . . . 0.0 108.812 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.59 -33.86 3.74 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 120.383 2.092 . . . . 0.0 112.757 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.1 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.851 2.06 . . . . 0.0 111.231 -167.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.59 -54.44 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.928 1.691 . . . . 0.0 110.055 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.45 -52.83 42.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 116.521 -1.704 . . . . 0.0 109.624 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -53.47 -33.35 53.91 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.351 1.432 . . . . 0.0 111.418 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -68.04 -67.43 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 120.93 -1.106 . . . . 0.0 112.594 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.35 -38.58 80.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.794 0.838 . . . . 0.0 111.08 -166.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.8 t -54.77 -36.52 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.729 1.611 . . . . 0.0 111.518 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 t -67.66 -13.43 62.08 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.649 -1.282 . . . . 0.0 112.91 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.03 37.09 2.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.832 1.196 . . . . 0.0 109.957 172.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.8 26.76 41.35 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.964 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.7 t -73.05 97.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 118.256 1.028 . . . . 0.0 109.014 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -104.61 35.27 2.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.033 0.921 . . . . 0.0 111.597 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB3' HG22 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -174.74 151.5 1.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.447 -1.408 . . . . 0.0 108.363 -162.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 tp -159.29 154.64 25.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.717 1.207 . . . . 0.0 108.706 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.3 mt -127.02 104.06 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.25 105.81 1.01 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.957 0.903 . . . . 0.0 109.203 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -13.46 25.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -156.34 -177.72 6.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 119.683 1.129 . . . . 0.0 108.806 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.256 4.1 p -133.16 166.14 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.18 60.2 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 168.37 -88.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 130.799 3.64 . . . . 0.0 106.52 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.75 139.32 58.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 153.31 -30.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 130.688 3.595 . . . . 0.0 109.838 160.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 60.7 t80 -52.74 -42.5 64.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.433 1.893 . . . . 0.0 111.434 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -69.45 -35.68 75.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.403 1.481 . . . . 0.0 109.408 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -22.36 58.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 110.276 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.1 mt -68.85 -64.14 0.92 Allowed 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.59 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.95 -39.87 20.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.43 1.092 . . . . 0.0 111.892 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.64 37.16 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.979 0.912 . . . . 0.0 111.247 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.14 30.37 1.83 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.037 1.78 . . . . 0.0 116.742 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.49 126.53 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.68 1.24 . . . . 0.0 108.123 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.23 159.91 27.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.37 133.52 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -116.73 162.89 16.97 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.033 1.733 . . . . 0.0 110.14 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -79.74 153.42 29.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.264 2.226 . . . . 0.0 108.051 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.9 129.66 15.16 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.861 2.064 . . . . 0.0 106.303 164.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.68 39.38 3.94 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 123.472 2.851 . . . . 0.0 111.615 -165.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.74 131.91 4.03 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.322 1.915 . . . . 0.0 110.415 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.6 163.48 11.85 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.075 0.937 . . . . 0.0 113.035 -164.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.4 p -87.89 170.02 11.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.489 1.516 . . . . 0.0 110.39 166.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -44.0 -47.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-N 119.338 0.972 . . . . 0.0 110.022 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -56.73 -38.01 71.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.47 -46.39 76.54 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.707 1.603 . . . . 0.0 108.722 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.76 -30.13 13.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.449 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.4 mm -93.5 -51.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 C-N-CA 124.596 1.158 . . . . 0.0 107.912 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.64 -42.46 78.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.32 -49.03 63.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.623 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.55 78.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 111.563 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.3 p -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.56 1.144 . . . . 0.0 109.499 -170.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.6 36.59 2.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.402 1.081 . . . . 0.0 108.617 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.72 11.92 0.19 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.642 2.068 . . . . 0.0 116.666 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -85.35 36.05 0.62 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.177 1.988 . . . . 0.0 111.061 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.8 mt -139.72 175.53 9.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -114.61 159.84 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -78.91 137.46 37.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 161.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp -120.64 59.05 0.92 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.013 1.325 . . . . 0.0 108.16 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.345 7.2 t -104.33 36.58 2.34 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.557 1.17 . . . . 0.0 109.611 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.43 89.02 0.11 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -171.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -79.12 158.84 27.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.24 45.74 2.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.198 1.799 . . . . 0.0 107.959 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -114.0 97.66 6.51 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 125.789 1.636 . . . . 0.0 108.525 -171.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.72 94.85 5.81 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.416 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -177.532 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.07 93.53 2.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.596 1.089 . . . . 0.0 113.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm105 -78.62 114.44 17.54 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.923 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.71 136.27 30.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.18 95.68 5.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 0.947 . . . . 0.0 108.81 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.96 132.07 49.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -170.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.63 136.5 23.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 1 C-N-CA 125.586 4.191 . . . . 0.0 109.676 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.0 t -138.05 166.08 25.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.261 1.424 . . . . 0.0 108.077 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.63 39.15 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.127 0.971 . . . . 0.0 109.532 163.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.14 167.17 40.31 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 164.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 8.7 mtmp? -92.95 42.42 1.1 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.543 1.537 . . . . 0.0 109.106 -175.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.83 149.94 32.17 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.522 0.729 . . . . 0.0 109.399 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.0 -12.0 60.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.216 1.807 . . . . 0.0 112.058 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -114.12 35.8 3.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.828 -1.17 . . . . 0.0 111.625 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 m -86.26 169.63 12.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 171.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.48 134.22 37.35 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.48 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 65.5 t -78.86 130.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 122.452 1.12 . . . . 0.0 108.589 172.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -79.94 153.9 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.159 1.783 . . . . 0.0 109.499 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.94 37.14 1.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.645 1.112 . . . . 0.0 110.775 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -167.53 99.38 0.49 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 119.168 -2.208 . . . . 0.0 110.23 -166.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -49.27 -64.69 0.73 Allowed 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.253 0.933 . . . . 0.0 111.34 -175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.84 24.31 1.29 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.77 -170.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 39.42 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 167.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.71 132.8 56.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.29 -26.22 46.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -162.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 97.9 m-85 -135.36 148.21 49.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -125.92 125.37 42.66 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 mm -112.59 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -92.84 97.9 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -81.77 117.95 22.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.89 118.35 22.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.711 2.004 . . . . 0.0 109.892 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.7 p -90.26 28.16 1.5 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.761 1.164 . . . . 0.0 111.802 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -99.67 -87.05 0.37 Allowed 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 155.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -94.78 35.42 1.25 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.339 -156.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 28.09 38.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.192 1.377 . . . . 0.0 113.933 -163.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -68.79 155.51 40.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.2 170.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.66 140.7 17.36 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.6 t -112.63 107.98 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.83 145.57 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -109.41 133.9 52.5 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 128.599 2.759 . . . . 0.0 104.446 166.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -153.89 112.29 3.61 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.88 0.872 . . . . 0.0 109.009 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.0 p -117.05 55.58 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.68 0.752 . . . . 0.0 110.255 -155.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.81 99.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.1 0.96 . . . . 0.0 111.037 -170.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.91 39.65 3.9 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.946 -1.096 . . . . 0.0 111.786 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.96 146.78 16.18 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.242 1.417 . . . . 0.0 108.278 -175.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.08 38.22 2.35 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.544 0.738 . . . . 0.0 112.835 -166.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -130.96 77.84 1.81 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -126.89 103.43 0.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.363 1.935 . . . . 0.0 110.988 -170.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -80.42 -11.34 59.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.966 1.306 . . . . 0.0 112.423 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.54 168.06 27.4 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.5 -35.69 4.57 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 C-N-CA 123.014 2.476 . . . . 0.0 113.852 -161.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 66.15 -68.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -61.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.161 1.385 . . . . 0.0 108.566 170.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -57.54 -45.51 86.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-O 116.006 -1.949 . . . . 0.0 109.131 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -45.2 -53.56 8.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.247 1.385 . . . . 0.0 111.662 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -67.05 -44.85 79.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.78 -41.46 87.62 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.22 -0.925 . . . . 0.0 110.148 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.07 -34.03 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.84 1.656 . . . . 0.0 110.361 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -66.8 -16.24 64.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.371 0.987 . . . . 0.0 113.536 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -104.35 37.44 2.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.558 1.072 . . . . 0.0 109.634 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.13 34.12 3.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.006 1.289 . . . . 0.0 114.074 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.1 106.42 5.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 118.936 1.368 . . . . 0.0 107.525 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -108.27 35.23 3.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -168.58 151.83 5.45 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.326 -1.484 . . . . 0.0 108.406 -163.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.3 tp -166.26 145.0 5.72 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.245 -1.534 . . . . 0.0 109.064 -169.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 mt -125.23 100.06 6.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.54 94.52 0.97 Allowed 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.315 0.961 . . . . 0.0 110.835 -167.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.5 p -29.6 -32.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.733 3.213 . . . . 0.0 119.462 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -162.63 -174.73 4.11 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.845 2.058 . . . . 0.0 105.816 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.38 156.62 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 120.735 -1.228 . . . . 0.0 109.304 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.02 66.15 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.697 1.142 . . . . 0.0 113.253 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 144.0 -105.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 1 C-N-CA 135.865 5.666 . . . . 0.0 107.019 169.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -57.13 119.01 5.61 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.881 -1.137 . . . . 0.0 109.846 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.88 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 130.89 3.676 . . . . 0.0 110.907 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.513 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 28.4 t80 -54.65 -36.1 64.22 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.231 0.923 . . . . 0.0 111.558 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.55 -30.74 71.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.61 1.964 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -92.96 -14.78 27.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.583 1.553 . . . . 0.0 111.002 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt -66.93 -68.05 0.4 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 167.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -52.25 -30.67 28.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.32 -30.62 12.46 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.05 36.9 3.15 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.927 1.291 . . . . 0.0 111.059 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.64 15.85 54.57 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.098 1.199 . . . . 0.0 116.098 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.93 123.35 36.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 118.314 1.057 . . . . 0.0 110.782 -158.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -78.9 156.79 28.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.5 t -149.29 138.31 15.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -169.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -122.25 155.45 35.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.76 0.824 . . . . 0.0 111.544 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -79.22 149.24 31.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 162.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.48 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.73 167.97 16.5 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -142.73 116.35 9.18 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.915 -1.115 . . . . 0.0 110.187 160.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.03 90.3 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 125.577 1.56 . . . . 0.0 113.654 162.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 165.72 37.98 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.2 p -81.81 178.39 8.34 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.977 -0.719 . . . . 0.0 110.698 167.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.03 -44.93 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.121 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -60.76 -37.27 81.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 120.972 1.715 . . . . 0.0 114.626 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.86 -40.7 83.61 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.592 1.557 . . . . 0.0 108.264 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.74 -35.53 14.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.397 0.544 . . . . 0.0 111.983 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.7 -53.25 9.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 125.131 1.372 . . . . 0.0 109.376 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -28.21 68.87 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.801 2.04 . . . . 0.0 108.69 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.68 -58.01 3.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -54.74 -50.74 67.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.569 0.747 . . . . 0.0 112.451 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 p -63.1 -44.72 94.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.896 0.879 . . . . 0.0 108.904 -168.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.63 37.4 0.91 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.875 0.845 . . . . 0.0 109.014 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.98 17.05 8.78 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 128.073 2.749 . . . . 0.0 116.501 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -89.65 36.62 0.85 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.72 2.26 . . . . 0.0 112.769 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.1 mt -137.32 166.8 22.93 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.985 1.721 . . . . 0.0 110.339 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.21 147.7 24.34 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -93.24 82.4 4.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 tp -79.53 74.01 6.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.986 0.898 . . . . 0.0 109.558 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p -115.43 37.42 3.57 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 120.442 -1.411 . . . . 0.0 110.125 -167.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t 168.7 90.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.705 2.002 . . . . 0.0 105.596 -166.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.75 165.97 33.06 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.1 m -143.26 -155.01 0.56 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.963 2.105 . . . . 0.0 105.662 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -141.59 141.57 33.48 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.54 36.5 2.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.511 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -177.162 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 9.9 ttt . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 119.94 -0.076 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 161.93 140.67 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 128.137 2.575 . . . . 0.0 109.083 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 -116.8 131.62 56.9 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 124.003 0.814 . . . . 0.0 110.111 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.29 124.81 72.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -169.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.9 137.97 39.48 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.25 116.66 28.38 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.57 112.53 2.65 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 125.074 3.849 . . . . 0.0 106.877 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -113.99 167.52 10.59 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.561 1.944 . . . . 0.0 107.447 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.13 38.36 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.569 -0.707 . . . . 0.0 109.654 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 166.94 39.84 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 120.99 -1.069 . . . . 0.0 110.958 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -89.22 39.44 0.94 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 122.151 -0.617 . . . . 0.0 110.712 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.02 153.42 50.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.609 1.164 . . . . 0.0 109.277 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.74 -15.89 55.3 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.486 1.914 . . . . 0.0 109.745 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 38.9 2.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.285 1.434 . . . . 0.0 108.229 170.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -83.88 173.17 11.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 119.822 -1.799 . . . . 0.0 107.991 164.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.39 140.65 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.582 -1.324 . . . . 0.0 109.553 166.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.7 t -73.37 149.93 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 167.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -102.57 136.52 42.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.82 1.648 . . . . 0.0 108.59 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -81.5 37.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.409 1.1 . . . . 0.0 111.082 -172.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 110.28 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -162.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -64.17 -56.45 14.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.677 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.34 0.02 9.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -134.93 76.61 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.487 1.915 . . . . 0.0 107.192 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.48 166.56 14.58 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 160.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 14.6 mt-10 -106.68 -16.89 14.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -144.76 153.86 42.12 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -131.53 98.4 4.5 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.145 1.778 . . . . 0.0 107.51 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 mm -79.43 103.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -89.27 103.87 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -85.06 146.17 27.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.51 114.42 21.74 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 127.172 2.189 . . . . 0.0 111.09 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.9 p -78.86 13.82 1.58 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 1' ' ' MET . 17.5 mm-40 -99.89 -32.94 10.75 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.348 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.93 36.49 1.41 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.033 160.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.57 33.62 26.17 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.257 0.932 . . . . 0.0 111.784 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -81.88 157.79 24.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.128 1.771 . . . . 0.0 107.091 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.48 150.33 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.867 0.842 . . . . 0.0 110.052 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.97 141.73 51.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.011 1.325 . . . . 0.0 108.845 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.87 110.26 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 163.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.37 150.31 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 160.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.88 117.01 27.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -134.65 87.75 2.38 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -168.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.1 p -79.63 60.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 -174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mm -91.23 152.65 3.32 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.18 172.22 13.15 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.205 1.002 . . . . 0.0 110.533 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.43 76.07 6.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.801 1.64 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.11 163.71 23.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.966 1.706 . . . . 0.0 106.805 168.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.497 ' CE1' HH21 ' A' ' 73' ' ' ARG . 31.2 m-70 -56.95 -56.38 22.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.94 74.55 0.5 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 166.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.9 p -60.03 146.56 42.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.566 0.746 . . . . 0.0 112.663 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.42 171.57 41.6 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -168.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.53 -33.77 2.25 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.17 1.247 . . . . 0.0 113.149 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 -66.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.791 2.437 . . . . 0.0 114.99 -170.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -57.65 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.456 1.502 . . . . 0.0 107.99 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -41.93 79.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 115.747 -2.073 . . . . 0.0 110.922 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -40.56 61.76 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.879 1.672 . . . . 0.0 111.499 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -75.61 -50.78 14.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.084 1.354 . . . . 0.0 109.787 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.5 -43.62 89.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.928 0.891 . . . . 0.0 110.102 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.74 -51.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.897 1.679 . . . . 0.0 110.756 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.3 t -62.15 -25.91 68.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -92.15 37.59 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.44 -1.412 . . . . 0.0 110.331 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.11 6.32 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 127.518 2.485 . . . . 0.0 115.779 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.68 137.81 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.189 1.495 . . . . 0.0 109.272 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.38 35.01 2.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 110.955 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 179.89 164.5 1.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 119.634 -1.916 . . . . 0.0 107.209 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.0 tp -171.2 147.42 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.9 mt -123.85 101.14 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.31 115.48 3.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.418 1.008 . . . . 0.0 110.639 -166.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.8 p -59.43 -23.89 63.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -171.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.01 174.09 9.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -170.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -120.06 157.66 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.492 -1.38 . . . . 0.0 108.428 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.7 67.62 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.497 HH21 ' CE1' ' A' ' 48' ' ' HIS . 9.6 ttp-105 169.75 -154.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 131.409 3.884 . . . . 0.0 105.657 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -24.75 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.18 2.992 . . . . 0.0 114.355 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -170.99 -29.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.412 1.485 . . . . 0.0 113.97 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.627 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 82.3 t80 -58.68 -36.08 73.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.49 1.116 . . . . 0.0 112.51 -169.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.16 -41.03 74.34 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -23.77 67.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.84 -0.537 . . . . 0.0 111.039 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.34 -68.16 0.41 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.857 0.863 . . . . 0.0 108.968 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.627 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -58.33 -31.38 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.82 24.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.096 0.558 . . . . 0.0 110.445 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.7 36.86 1.83 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.386 0.674 . . . . 0.0 111.828 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.25 8.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.416 1.484 . . . . 0.0 116.333 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.86 120.26 33.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.191 1.495 . . . . 0.0 108.98 -170.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -78.43 160.79 27.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.8 t -143.42 137.34 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.57 158.19 25.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.022 1.729 . . . . 0.0 110.112 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -78.95 148.24 32.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.45 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.12 161.12 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 156.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -148.94 85.38 1.48 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 120.268 1.395 . . . . 0.0 111.154 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.9 112.47 0.59 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.454 1.026 . . . . 0.0 111.063 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.92 158.3 10.76 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -83.08 171.76 13.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 110.397 170.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.15 -40.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-O 116.747 -1.597 . . . . 0.0 113.138 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -35.26 76.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 121.012 1.733 . . . . 0.0 113.626 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.83 -46.25 69.04 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.75 2.02 . . . . 0.0 108.355 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.41 -40.45 17.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 118.699 0.681 . . . . 0.0 111.144 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.65 -51.04 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.39 1.876 . . . . 0.0 108.886 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -40.05 85.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.382 1.473 . . . . 0.0 108.237 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.66 -49.48 25.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.79 0.836 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.78 -50.45 73.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.477 1.035 . . . . 0.0 111.787 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -64.18 -39.05 93.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.384 1.074 . . . . 0.0 110.163 -168.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -101.42 37.34 1.81 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.975 0.91 . . . . 0.0 109.435 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 40.22 46.06 3.3 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 127.497 2.475 . . . . 0.0 114.113 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -112.49 37.35 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.901 0.88 . . . . 0.0 109.854 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.3 mt -143.39 170.09 16.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.994 -1.067 . . . . 0.0 108.547 165.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -119.11 147.64 43.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.641 1.576 . . . . 0.0 108.075 -165.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -78.99 116.84 19.55 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.1 59.63 2.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.727 2.011 . . . . 0.0 108.362 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 p -88.97 38.95 0.91 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.456 1.102 . . . . 0.0 111.396 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t 159.57 159.96 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 131.222 3.809 . . . . 0.0 104.645 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -165.0 163.05 20.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.4 m -108.49 142.55 38.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -146.89 125.54 12.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.48 96.27 5.36 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 175.822 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 153.94 22.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.235 1.414 . . . . 0.0 108.566 170.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -78.52 119.57 22.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.96 124.64 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.284 -172.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.45 111.38 23.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.98 124.55 51.68 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.55 112.0 3.25 Favored 'Trans proline' 0 N--CA 1.443 -1.448 1 C-N-CA 125.464 4.109 . . . . 0.0 108.528 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 t -108.66 174.8 5.71 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.192 1.397 . . . . 0.0 108.498 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.82 38.49 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 109.655 167.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.78 -170.14 32.18 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -129.48 64.8 1.48 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.593 1.696 . . . . 0.0 110.195 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.62 153.99 29.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.082 1.753 . . . . 0.0 107.949 169.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -12.07 52.14 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.737 1.215 . . . . 0.0 110.521 174.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -110.58 36.44 3.1 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.589 -1.319 . . . . 0.0 111.435 172.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 166.73 11.77 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.053 -1.03 . . . . 0.0 109.771 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 135.14 37.35 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.302 -1.499 . . . . 0.0 109.81 -172.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.444 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 45.7 t -78.02 131.11 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 t -81.07 144.16 31.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.614 1.566 . . . . 0.0 109.76 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -86.41 36.71 0.7 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.444 1.593 . . . . 0.0 110.739 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.61 121.54 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -166.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.65 -61.25 1.84 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.41 -23.6 66.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.832 -168.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -105.04 75.56 1.19 Allowed 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 127.673 2.389 . . . . 0.0 107.753 166.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.19 160.26 37.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 157.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -105.96 -12.63 15.75 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -168.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -146.22 145.86 30.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.35 108.25 9.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mp -89.62 117.71 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -171.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -105.24 97.29 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -91.25 109.08 20.34 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.77 110.22 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.463 1.505 . . . . 0.0 108.962 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -78.02 55.03 1.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.558 -0.714 . . . . 0.0 110.016 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -134.21 -39.86 0.83 Allowed 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 124.814 1.246 . . . . 0.0 111.374 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -144.37 37.33 1.23 Allowed 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.601 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 16.29 2.24 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.609 1.576 . . . . 0.0 115.294 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -82.22 134.03 35.28 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.305 1.053 . . . . 0.0 108.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.64 160.51 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 125.261 1.424 . . . . 0.0 108.817 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.17 132.86 27.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.87 110.55 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.12 152.07 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 160.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -124.44 96.04 4.76 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.96 2.504 . . . . 0.0 105.935 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.46 106.7 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -170.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.8 p -84.27 62.09 6.95 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.268 -0.895 . . . . 0.0 110.642 -167.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -82.3 156.38 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.216 -0.927 . . . . 0.0 109.171 -166.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.07 178.61 10.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.167 1.787 . . . . 0.0 110.046 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.94 40.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.149 2.18 . . . . 0.0 114.665 -156.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.82 -179.32 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 120.545 -1.347 . . . . 0.0 110.194 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -175.22 5.02 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.512 1.525 . . . . 0.0 109.013 161.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.92 56.26 0.01 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p 50.34 29.56 3.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.95 2.1 . . . . 0.0 115.729 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.49 129.02 7.37 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 161.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 -30.35 50.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 CA-C-N 121.106 2.453 . . . . 0.0 112.033 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.46 -77.38 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.513 2.325 . . . . 0.0 110.87 -165.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -49.66 -60.52 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 C-N-CA 126.317 1.847 . . . . 0.0 109.334 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -60.04 -51.2 75.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 115.743 -2.075 . . . . 0.0 109.708 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.82 -51.31 9.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.914 1.688 . . . . 0.0 110.949 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -62.41 -56.05 21.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.67 -41.9 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.301 0.64 . . . . 0.0 110.262 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -57.44 -46.62 85.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -58.37 -27.64 64.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.146 0.884 . . . . 0.0 112.415 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -99.74 37.4 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.665 1.186 . . . . 0.0 109.471 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.11 23.42 7.75 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.292 2.377 . . . . 0.0 116.69 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.64 125.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.535 1.168 . . . . 0.0 108.053 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.19 36.59 4.61 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 164.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.74 157.46 14.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.485 -1.385 . . . . 0.0 109.112 -168.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.1 tp -164.08 148.34 10.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.2 mt -124.58 106.77 17.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.77 134.44 10.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.999 2.182 . . . . 0.0 111.184 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -64.08 -21.16 66.41 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.602 -1.311 . . . . 0.0 113.641 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -163.21 177.45 9.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.07 1.748 . . . . 0.0 106.432 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.251 1.0 OUTLIER -107.35 161.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.055 -1.028 . . . . 0.0 108.561 174.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.29 24.77 3.42 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.683 1.135 . . . . 0.0 111.63 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 68.05 -71.09 0.11 Allowed 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 129.684 3.194 . . . . 0.0 113.257 -172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.29 56.37 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.448 2.299 . . . . 0.0 113.833 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -161.62 -28.64 0.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 113.95 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.631 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 56.6 t80 -69.39 -32.59 71.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.897 1.68 . . . . 0.0 111.986 -169.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.21 -38.13 85.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 110.073 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -14.83 58.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.928 2.891 . . . . 0.0 109.366 -174.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.9 mt -80.86 -58.13 3.23 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 108.221 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.631 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -62.6 -28.37 69.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.299 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.0 54.82 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.034 0.834 . . . . 0.0 111.876 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.9 37.31 4.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.617 1.099 . . . . 0.0 110.765 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.39 30.53 0.3 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.686 2.088 . . . . 0.0 117.041 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.78 125.2 38.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 118.87 1.335 . . . . 0.0 109.048 -169.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -78.96 155.99 28.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -145.69 129.47 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.24 170.6 7.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 110.655 171.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -107.58 152.02 24.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 126.898 2.079 . . . . 0.0 109.586 162.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.18 167.9 21.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.199 2.2 . . . . 0.0 106.425 176.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.93 129.17 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 167.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.04 90.5 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 128.04 2.733 . . . . 0.0 115.784 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.96 163.77 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -89.86 173.83 8.03 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.979 -0.719 . . . . 0.0 109.894 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.74 -42.83 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 117.731 -1.128 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -61.55 -36.9 81.9 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.55 -40.64 73.27 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.961 1.304 . . . . 0.0 109.08 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.75 -39.76 26.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.457 170.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -78.91 -60.43 2.27 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.91 -21.39 43.32 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 127.955 2.502 . . . . 0.0 110.919 -172.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.32 -52.69 6.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -59.51 -50.14 75.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.688 0.795 . . . . 0.0 112.732 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -64.07 -41.87 97.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 109.32 -168.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.38 36.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.293 1.037 . . . . 0.0 109.27 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.06 20.36 6.47 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 128.621 3.01 . . . . 0.0 117.244 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -97.1 37.41 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.538 1.669 . . . . 0.0 111.335 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.0 mt -134.97 169.7 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.569 1.077 . . . . 0.0 109.062 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -108.64 138.74 44.46 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.354 1.462 . . . . 0.0 108.138 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.7 108.26 13.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp -95.62 50.41 1.22 Allowed 'General case' 0 C--O 1.238 0.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.4 p -86.52 37.36 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 120.732 -1.23 . . . . 0.0 110.24 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 t 159.8 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.7 2.8 . . . . 0.0 103.714 -161.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.11 161.74 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.643 1.977 . . . . 0.0 106.064 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.3 m -83.95 133.06 34.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -154.82 102.86 2.39 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.498 1.044 . . . . 0.0 109.996 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -78.14 105.12 9.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 147.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttm . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.77 165.71 26.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 119.558 1.072 . . . . 0.0 110.95 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -103.02 152.8 20.92 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.596 155.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.64 167.83 19.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 128.499 2.72 . . . . 0.0 103.756 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.42 149.45 52.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.52 120.01 19.59 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.57 123.67 11.07 Favored 'Trans proline' 0 N--CA 1.443 -1.492 1 C-N-CA 126.097 4.531 . . . . 0.0 107.135 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.3 t -127.44 169.16 13.93 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.825 1.65 . . . . 0.0 108.356 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.09 37.77 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 110.298 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.79 -177.85 41.03 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.224 -1.548 . . . . 0.0 111.008 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.4 mtpt -114.53 39.89 2.69 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.262 -1.14 . . . . 0.0 109.943 -172.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.33 148.44 36.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.919 1.288 . . . . 0.0 108.065 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.81 -10.5 5.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 112.574 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -112.69 36.6 3.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.277 -0.89 . . . . 0.0 111.396 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -90.2 167.97 12.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.041 -1.037 . . . . 0.0 108.967 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 139.8 39.16 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 120.865 1.666 . . . . 0.0 108.668 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 99.0 t -72.67 135.97 26.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -87.71 135.71 33.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.58 38.13 0.37 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.098 0.952 . . . . 0.0 110.903 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.93 99.05 0.07 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 119.86 -1.775 . . . . 0.0 110.174 -165.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -53.49 -51.65 62.07 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.785 1.175 . . . . 0.0 112.957 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -3.66 33.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.002 -1.062 . . . . 0.0 112.401 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 38.79 3.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.549 0.74 . . . . 0.0 109.886 -171.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.77 108.94 16.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -165.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -52.64 -24.45 8.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.254 1.822 . . . . 0.0 115.272 -168.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 96.2 m-85 -139.19 151.26 46.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -129.61 112.79 14.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.1 mm -91.82 118.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.2 mt -111.97 100.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -172.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -82.77 141.7 32.15 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -117.87 110.82 18.23 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 127.197 2.199 . . . . 0.0 109.692 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.282 1.3 p -85.08 43.04 0.97 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.947 0.88 . . . . 0.0 110.699 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.94 -29.45 2.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 126.019 1.728 . . . . 0.0 112.604 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -147.58 35.25 0.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 117.728 -1.589 . . . . 0.0 111.069 157.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.2 24.12 14.59 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.804 -1.185 . . . . 0.0 112.31 -176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -64.75 156.24 31.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.74 162.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.533 1.158 . . . . 0.0 108.842 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -141.77 128.01 19.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.22 105.01 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.56 143.13 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 159.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.95 121.41 43.84 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -138.72 116.77 11.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.984 1.373 . . . . 0.0 110.221 -172.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.9 p -92.3 51.99 1.86 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.925 1.69 . . . . 0.0 110.67 -164.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.73 38.89 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.815 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.44 39.18 1.02 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.057 1.343 . . . . 0.0 110.61 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -147.54 168.18 22.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.01 173.84 12.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.994 1.718 . . . . 0.0 109.837 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 55.43 -174.18 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.45 1.5 . . . . 0.0 112.645 175.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.9 153.5 5.92 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 120.812 -1.18 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -88.96 -12.85 40.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.197 0.999 . . . . 0.0 112.539 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.38 -152.86 22.85 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -64.38 -43.67 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.289 1.992 . . . . 0.0 111.127 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? 65.17 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.351 1.46 . . . . 0.0 108.674 -166.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -67.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 127.135 2.174 . . . . 0.0 108.985 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -55.81 -49.96 71.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 115.669 -2.11 . . . . 0.0 109.651 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.46 -50.37 23.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.306 1.412 . . . . 0.0 111.117 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -42.16 68.52 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.107 -0.996 . . . . 0.0 113.342 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.5 -44.32 82.88 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.751 0.705 . . . . 0.0 109.888 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.31 -32.17 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.407 1.483 . . . . 0.0 110.118 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.6 m -75.89 1.98 13.66 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.802 -1.186 . . . . 0.0 113.879 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -119.42 38.46 3.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.452 1.901 . . . . 0.0 108.289 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.89 19.98 12.24 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.64 1.114 . . . . 0.0 115.845 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.0 96.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.131 1.373 . . . . 0.0 107.864 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.47 36.31 2.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.324 1.05 . . . . 0.0 110.568 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 179.83 165.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.608 1.563 . . . . 0.0 107.024 -165.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 tp -166.14 152.65 9.31 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.271 1.429 . . . . 0.0 107.449 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 57.3 mt -123.06 103.04 12.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.95 130.03 13.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.698 1.136 . . . . 0.0 110.342 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.7 p -62.72 -28.19 69.79 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -169.14 -171.07 1.22 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.399 1.479 . . . . 0.0 107.15 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 p -136.24 136.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.45 96.54 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.85 177.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 129.486 3.114 . . . . 0.0 107.561 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.98 50.38 3.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 127.581 2.352 . . . . 0.0 115.616 154.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.4 -26.35 0.1 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 171.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.602 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 33.9 t80 -62.35 -35.62 79.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.377 0.989 . . . . 0.0 112.539 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.91 -34.59 73.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.7 m -73.09 -20.05 61.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.624 0.77 . . . . 0.0 111.072 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.46 -57.61 5.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.602 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -65.2 -29.74 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.94 -1.71 1.58 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.01 37.23 2.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.87 1.668 . . . . 0.0 110.181 162.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.6 30.99 1.58 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.868 . . . . 0.0 116.804 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.37 117.58 25.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 118.937 1.368 . . . . 0.0 108.524 -168.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -79.14 99.01 6.78 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.537 0.684 . . . . 0.0 109.959 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.5 117.75 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.81 155.29 18.34 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.662 1.185 . . . . 0.0 109.558 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 157.56 26.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 164.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 163.15 30.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 160.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.52 68.21 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.801 1.182 . . . . 0.0 110.508 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.62 136.23 8.58 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.05 154.1 6.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.879 0.339 . . . . 0.0 112.519 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -80.05 171.08 15.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.07 0.548 . . . . 0.0 109.653 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -43.82 -42.15 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.769 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.37 -38.74 81.23 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -42.35 83.29 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 127.144 2.178 . . . . 0.0 108.849 -174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.81 -38.98 11.01 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.819 0.736 . . . . 0.0 111.167 171.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -86.0 -53.79 9.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 125.275 1.43 . . . . 0.0 109.121 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -26.69 65.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.044 1.738 . . . . 0.0 109.375 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.11 -62.6 1.41 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -48.84 63.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.59 1.556 . . . . 0.0 112.626 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -77.88 -13.27 59.94 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.664 2.786 . . . . 0.0 113.482 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -114.37 37.78 3.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.245 1.384 . . . . 0.0 109.836 159.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.51 12.73 4.91 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 127.626 2.536 . . . . 0.0 117.345 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -89.31 37.39 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.254 1.527 . . . . 0.0 111.413 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 mt -136.29 167.33 21.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.013 1.279 . . . . 0.0 110.821 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -108.44 142.86 38.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.44 110.88 17.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.2 tp -99.48 58.04 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.96 1.704 . . . . 0.0 108.608 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.9 p -101.7 35.91 2.2 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.154 -1.591 . . . . 0.0 110.181 -169.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.3 t -175.45 37.59 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.086 -1.009 . . . . 0.0 112.137 -173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -88.96 174.36 7.96 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.532 -1.355 . . . . 0.0 110.257 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.8 p -106.12 172.42 6.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.345 0.52 . . . . 0.0 110.255 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -142.72 122.15 13.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -152.36 88.18 1.35 Allowed 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 124.157 0.91 . . . . 0.0 109.241 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 176.247 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.25 153.9 14.12 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.451 1.9 . . . . 0.0 108.777 156.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -80.76 117.97 21.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.795 -0.566 . . . . 0.0 109.595 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.07 142.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.96 153.98 18.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 160.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.01 125.64 19.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.27 106.63 2.27 Favored 'Trans proline' 0 N--CA 1.445 -1.35 1 C-N-CA 126.131 4.554 . . . . 0.0 109.576 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -104.12 172.07 7.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.364 1.466 . . . . 0.0 109.408 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.29 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 108.623 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.22 -169.36 42.36 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.794 -1.191 . . . . 0.0 111.259 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 7.5 mtmp? -129.96 52.71 1.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 111.842 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.64 167.48 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.917 1.687 . . . . 0.0 107.205 166.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.71 -6.31 58.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.501 -1.375 . . . . 0.0 111.0 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -116.26 39.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.579 -1.325 . . . . 0.0 108.922 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 m -78.66 169.39 18.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.25 -1.38 . . . . 0.0 107.303 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 145.08 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 69.5 t -86.05 137.77 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.404 1.097 . . . . 0.0 108.746 170.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -90.84 137.44 32.36 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.847 2.059 . . . . 0.0 108.74 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -81.25 36.16 0.41 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 122.895 1.331 . . . . 0.0 111.035 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 101.38 0.12 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -157.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -55.04 -59.41 4.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.493 0.588 . . . . 0.0 110.571 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.08 -3.74 31.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.667 -170.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.71 74.1 1.24 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.312 1.415 . . . . 0.0 107.357 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.99 120.65 18.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.38 -22.13 66.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.259 1.424 . . . . 0.0 113.535 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 98.4 m-85 -137.25 148.67 46.61 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.01 1.724 . . . . 0.0 107.455 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -130.59 112.82 13.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.36 120.87 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.9 mt -109.77 101.49 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -89.63 110.89 21.73 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.86 108.88 13.78 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.076 2.15 . . . . 0.0 108.313 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -83.31 57.96 4.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -129.57 -48.51 1.16 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 124.649 1.18 . . . . 0.0 109.128 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 38.19 3.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.736 162.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.4 22.35 10.55 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.2 0.905 . . . . 0.0 113.68 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.86 148.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.14 148.88 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.1 0.96 . . . . 0.0 109.921 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -132.52 139.32 47.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.587 2.355 . . . . 0.0 105.793 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.9 t -108.9 103.57 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.48 151.71 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 167.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.54 129.96 56.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.78 132.31 23.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 120.697 -1.252 . . . . 0.0 110.124 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.2 p -115.3 57.24 0.73 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.314 1.054 . . . . 0.0 110.31 -152.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.51 40.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 128.178 2.591 . . . . 0.0 112.317 -174.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.55 38.42 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.294 -1.503 . . . . 0.0 112.243 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 160.26 25.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.066 2.147 . . . . 0.0 108.426 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.93 -152.31 0.07 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.371 2.268 . . . . 0.0 113.728 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -77.76 131.68 37.74 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.351 1.46 . . . . 0.0 112.958 -162.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.71 -175.77 45.7 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.767 1.651 . . . . 0.0 109.567 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.314 1.5 t 48.82 -153.21 0.11 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.193 1.797 . . . . 0.0 110.862 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.13 -163.69 38.41 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.307 -1.496 . . . . 0.0 109.749 165.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.5 -27.43 54.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.153 1.902 . . . . 0.0 112.968 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.322 1.7 ptpt 54.19 -65.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.821 2.448 . . . . 0.0 114.339 -164.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -65.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 127.156 2.182 . . . . 0.0 108.069 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.92 -48.09 78.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-O 116.863 -1.542 . . . . 0.0 109.151 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -46.95 21.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.171 0.896 . . . . 0.0 111.678 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -69.5 -56.22 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.305 0.642 . . . . 0.0 111.082 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -57.4 -46.01 83.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.418 0.554 . . . . 0.0 109.578 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 t -56.71 -36.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.373 1.869 . . . . 0.0 111.54 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -61.18 -38.93 88.26 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.575 1.079 . . . . 0.0 110.575 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.06 38.49 0.85 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.694 1.134 . . . . 0.0 110.029 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.17 26.4 42.76 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.019 1.771 . . . . 0.0 115.578 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.1 t -71.85 101.25 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.123 1.461 . . . . 0.0 109.231 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.28 34.88 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.618 0.645 . . . . 0.0 109.995 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.07 157.55 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 119.989 -1.694 . . . . 0.0 108.796 -169.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.9 tp -166.36 145.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 120.232 -1.542 . . . . 0.0 108.671 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 mt -111.18 107.02 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 126.404 1.882 . . . . 0.0 106.222 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.97 106.15 1.8 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 120.998 1.726 . . . . 0.0 110.623 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.7 p -34.46 -48.8 0.37 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.153 1.781 . . . . 0.0 113.195 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.39 -178.4 6.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -114.64 160.1 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.79 -23.54 38.6 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.392 -166.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -169.43 -132.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.363 3.465 . . . . 0.0 103.437 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -164.3 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.872 1.214 . . . . 0.0 110.872 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 97.58 -26.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.208 1 C-N-CA 133.427 4.691 . . . . 0.0 112.633 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 60.6 t80 -60.85 -36.5 79.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.501 1.5 . . . . 0.0 112.247 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.75 -38.25 79.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.405 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -74.0 -24.44 59.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.914 0.886 . . . . 0.0 110.018 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.69 -72.01 0.17 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -57.05 -32.73 66.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.13 17.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.688 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.39 36.6 0.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.101 0.864 . . . . 0.0 112.071 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.26 33.89 0.56 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.232 1.872 . . . . 0.0 116.238 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 t -81.06 119.39 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 152.95 31.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.5 t -150.2 112.34 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.51 172.97 9.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.229 1.411 . . . . 0.0 111.311 166.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -112.02 148.46 33.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.452 2.701 . . . . 0.0 108.767 164.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -127.31 166.34 17.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.047 2.539 . . . . 0.0 105.086 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -148.4 56.68 1.05 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.122 1.328 . . . . 0.0 110.168 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.63 110.88 3.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 123.444 0.545 . . . . 0.0 112.395 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.56 166.49 31.94 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.6 p -87.39 173.68 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.748 0.819 . . . . 0.0 110.492 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.51 -38.42 12.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 CA-C-O 117.028 -1.463 . . . . 0.0 110.959 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.05 -45.33 93.19 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 120.45 1.477 . . . . 0.0 114.002 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -42.3 97.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.192 1.797 . . . . 0.0 109.283 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.75 -36.1 10.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -87.4 -57.13 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.71 -49.08 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.546 2.339 . . . . 0.0 106.53 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.81 76.7 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.354 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -62.34 -47.66 83.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.55 -0.719 . . . . 0.0 110.78 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.4 p -70.36 -29.97 66.78 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.059 1.344 . . . . 0.0 109.688 -166.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -99.96 35.98 1.93 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.238 1.015 . . . . 0.0 110.732 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.44 53.62 2.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.45 1.5 . . . . 0.0 113.289 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -127.27 38.28 4.1 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 126.641 1.977 . . . . 0.0 109.189 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.7 mt -132.93 167.07 20.92 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 120.899 1.681 . . . . 0.0 111.071 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.68 134.96 40.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.914 1.686 . . . . 0.0 107.863 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -91.03 101.9 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.4 tp -82.3 72.91 9.36 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -170.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -91.44 37.67 0.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.904 -1.122 . . . . 0.0 110.323 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -177.4 168.25 2.27 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.855 -1.153 . . . . 0.0 109.039 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -136.48 177.85 7.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.703 2.401 . . . . 0.0 112.293 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.25 168.88 8.92 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 124.768 1.293 . . . . 0.0 107.559 158.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -130.72 125.53 34.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.998 1.719 . . . . 0.0 109.396 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -95.88 90.11 5.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 115.407 -2.885 . . . . 0.0 113.601 171.246 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.71 155.87 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.153 -0.967 . . . . 0.0 108.68 168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.76 140.76 29.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 151.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.03 164.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 161.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 154.49 47.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 163.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.7 120.11 13.17 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.45 108.57 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.75 3.634 . . . . 0.0 106.887 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 t -105.59 168.87 8.81 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.544 1.537 . . . . 0.0 108.16 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.03 37.47 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.531 -0.73 . . . . 0.0 110.317 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.57 165.93 39.26 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.5 39.64 1.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.051 1.34 . . . . 0.0 110.351 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.78 148.79 36.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -14.71 62.56 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.355 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 t -122.59 37.52 4.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -104.45 170.99 7.58 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.522 -0.736 . . . . 0.0 109.82 163.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.9 mmm -77.5 137.29 38.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.983 -1.073 . . . . 0.0 111.078 -166.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 41.6 t -71.51 131.17 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.623 167.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 t -79.51 144.67 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.46 1.904 . . . . 0.0 108.599 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -85.07 36.44 0.62 Allowed 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.29 116.23 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -156.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -63.32 -69.33 0.28 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.575 0.75 . . . . 0.0 110.706 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.88 10.83 1.63 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -169.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -132.98 71.34 1.47 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 159.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.68 179.62 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 156.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -120.68 -16.89 8.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -140.01 155.2 47.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -133.39 108.7 8.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -86.9 127.8 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.0 mt -125.22 97.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -165.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -92.53 125.64 37.26 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.758 1.223 . . . . 0.0 109.153 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 125.79 30.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.043 1.737 . . . . 0.0 111.933 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.281 3.2 p -91.58 31.86 1.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.775 0.798 . . . . 0.0 109.967 174.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.88 -90.18 0.56 Allowed 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 154.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.55 35.59 1.21 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.359 -157.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 45.63 15.15 0.09 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.127 2.298 . . . . 0.0 115.617 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -69.35 154.58 41.81 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.34 144.09 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.679 1.228 . . . . 0.0 109.581 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.99 130.5 52.68 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.19 107.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.67 146.5 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 157.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.37 150.15 27.06 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.076 1.75 . . . . 0.0 106.533 161.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.58 133.69 7.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 109.879 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 p -119.58 61.42 0.83 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 123.628 1.68 . . . . 0.0 109.789 -163.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 75.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.656 1.982 . . . . 0.0 111.265 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.1 38.37 2.22 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.248 1.419 . . . . 0.0 112.497 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.92 -177.12 5.37 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.408 -1.432 . . . . 0.0 110.516 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.34 39.0 2.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.202 1.801 . . . . 0.0 111.975 -168.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -56.99 150.02 17.72 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.777 0.831 . . . . 0.0 111.218 -174.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.51 -30.75 6.07 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.556 -1.135 . . . . 0.0 112.269 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -146.25 165.33 29.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.023 1.912 . . . . 0.0 109.936 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.15 99.31 0.18 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -166.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -62.9 -38.13 49.81 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 CA-C-N 120.383 2.091 . . . . 0.0 110.687 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.326 0.7 OUTLIER 54.27 -67.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.895 2.078 . . . . 0.0 111.624 -158.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -50.59 -61.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.708 1.603 . . . . 0.0 109.876 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.41 -53.9 38.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-O 115.155 -2.355 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -49.03 -47.33 44.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 121.146 1.794 . . . . 0.0 110.194 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -50.35 60.03 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.185 1.394 . . . . 0.0 112.816 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.69 -39.06 90.87 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.096 0.862 . . . . 0.0 110.088 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.73 -41.47 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.965 1.306 . . . . 0.0 109.791 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.39 1.41 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -126.43 37.46 4.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.367 1.467 . . . . 0.0 107.622 171.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.76 17.16 41.31 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.709 2.1 . . . . 0.0 116.503 166.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.05 102.43 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.777 1.288 . . . . 0.0 110.873 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.12 36.43 2.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.212 1.805 . . . . 0.0 111.658 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 177.11 173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.745 -1.847 . . . . 0.0 106.81 -168.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 tp -174.62 146.17 0.98 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.69 103.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.85 101.89 1.64 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.983 1.313 . . . . 0.0 109.412 -168.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 5.8 t -60.81 -17.55 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.664 1.585 . . . . 0.0 113.792 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.89 178.33 7.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.411 -1.431 . . . . 0.0 108.806 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 p -126.47 156.51 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 120.313 -1.492 . . . . 0.0 110.216 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.4 20.5 0.13 Allowed Glycine 0 CA--C 1.546 2.009 0 C-N-CA 127.096 2.284 . . . . 0.0 114.219 166.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.7 0.76 0.7 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.874 2.469 . . . . 0.0 116.518 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -137.83 101.02 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 162.31 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.502 1.521 . . . . 0.0 113.675 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.61 -44.73 81.45 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.806 1.185 . . . . 0.0 109.769 -160.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.73 -40.38 95.23 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.927 1.291 . . . . 0.0 110.384 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -67.1 -19.54 65.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.054 0.542 . . . . 0.0 111.271 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.71 -47.19 32.8 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HE3' ' N ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -62.77 -35.23 79.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.195 0.998 . . . . 0.0 111.489 176.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.94 86.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.127 0.571 . . . . 0.0 110.073 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.18 36.27 1.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.361 0.528 . . . . 0.0 111.196 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.34 31.72 0.21 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 127.607 2.527 . . . . 0.0 117.083 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.42 125.16 38.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.016 1.326 . . . . 0.0 108.31 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -78.5 160.2 27.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.3 t -143.83 131.68 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -107.62 157.81 17.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.048 1.739 . . . . 0.0 109.762 172.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -80.0 160.73 25.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 160.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -132.77 159.08 40.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.512 1.525 . . . . 0.0 108.826 162.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 9.1 pt-20 -129.34 74.7 1.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.818 2.099 . . . . 0.0 111.632 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.47 159.86 3.01 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.942 1.258 . . . . 0.0 111.148 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.39 161.66 9.19 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.845 -0.797 . . . . 0.0 112.833 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -96.8 164.74 12.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.91 1.284 . . . . 0.0 107.555 167.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.87 -37.3 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 117.014 -1.469 . . . . 0.0 114.277 -166.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.54 -32.79 74.58 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 121.007 1.731 . . . . 0.0 114.184 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -66.53 -43.0 86.36 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.612 1.965 . . . . 0.0 108.898 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.81 -28.84 16.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.291 0.496 . . . . 0.0 112.166 174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mm -95.04 -53.37 8.37 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -25.3 68.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 110.125 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -57.16 4.1 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -59.96 -44.29 94.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.499 1.52 . . . . 0.0 113.451 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -67.71 -13.15 61.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.637 1.575 . . . . 0.0 111.498 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.37 35.15 4.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.261 1.024 . . . . 0.0 108.761 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.31 2.93 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.09 1.805 . . . . 0.0 117.016 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -81.12 39.69 0.52 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.747 2.274 . . . . 0.0 111.176 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 mt -128.55 -166.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -128.24 154.75 45.52 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -78.48 132.2 37.17 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 164.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp -117.22 71.49 0.8 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 108.833 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.2 p -112.5 37.37 3.07 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.925 -1.11 . . . . 0.0 110.453 -167.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 t 173.88 106.35 0.01 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 128.43 2.692 . . . . 0.0 103.854 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -161.46 166.24 27.51 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.981 1.712 . . . . 0.0 106.463 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 p -145.77 173.12 12.38 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.126 1.371 . . . . 0.0 107.805 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -145.74 131.47 18.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 164.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.94 88.94 2.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 176.542 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 159.13 148.36 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 130.617 3.567 . . . . 0.0 107.31 166.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -105.35 131.74 52.42 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 165.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.38 153.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.07 147.58 39.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.17 119.96 21.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.54 95.13 0.78 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 1 C-N-CA 125.956 4.437 . . . . 0.0 107.308 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 t -89.57 172.58 8.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.3 1.04 . . . . 0.0 109.058 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.97 37.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.537 1.135 . . . . 0.0 111.107 166.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.23 173.16 45.19 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 167.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -107.78 38.12 2.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.393 0.596 . . . . 0.0 110.189 -166.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.93 151.69 47.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -5.3 39.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 111.649 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t -124.27 37.86 4.32 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.388 -1.445 . . . . 0.0 109.355 165.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.3 m -79.75 175.09 10.94 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 159.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.3 mmm -77.88 144.68 36.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 119.879 -1.763 . . . . 0.0 110.577 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 61.4 t -78.43 161.5 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 163.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -118.54 133.45 55.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 110.625 -167.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.19 39.03 0.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.392 1.477 . . . . 0.0 110.342 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -178.46 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.347 -1.471 . . . . 0.0 109.25 -164.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -50.98 -56.32 13.04 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.404 -0.81 . . . . 0.0 112.589 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.2 4.43 1.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -138.67 38.77 2.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.686 1.995 . . . . 0.0 108.166 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.31 179.59 5.85 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.7 -17.94 7.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -146.31 147.74 31.67 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -128.94 96.09 4.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 mp -79.9 113.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -100.37 107.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -93.72 133.81 36.7 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.87 0.868 . . . . 0.0 108.783 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -97.76 115.15 27.43 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.034 1.734 . . . . 0.0 111.123 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.5 p -86.26 29.82 0.73 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.693 0.758 . . . . 0.0 110.758 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -113.35 -86.53 0.57 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 159.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -93.16 35.45 1.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 115.584 -2.446 . . . . 0.0 110.439 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.8 18.73 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.771 1.653 . . . . 0.0 113.827 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -69.92 160.77 31.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.548 1.139 . . . . 0.0 108.973 -175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.69 152.0 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.701 0.763 . . . . 0.0 109.081 172.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -131.97 123.92 28.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 173.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -88.91 104.89 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.96 141.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -98.07 141.4 31.06 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.842 1.657 . . . . 0.0 106.656 164.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -146.42 146.95 30.78 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 p -129.02 44.38 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.14 -0.975 . . . . 0.0 110.122 -163.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.94 93.94 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 122.514 1.149 . . . . 0.0 111.235 -165.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.57 38.99 2.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.632 1.973 . . . . 0.0 108.866 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -158.05 179.81 8.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.375 2.27 . . . . 0.0 108.902 -164.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 159.78 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.796 3.239 . . . . 0.0 108.996 166.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -83.63 46.68 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.329 1.052 . . . . 0.0 110.5 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.14 82.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.579 1.085 . . . . 0.0 114.404 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 p -86.52 178.39 7.1 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.105 1.362 . . . . 0.0 113.893 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.22 -179.7 8.1 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.908 2.194 . . . . 0.0 112.775 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.51 -32.73 58.9 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.851 1.701 . . . . 0.0 112.615 -165.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.341 2.1 ptpt 49.72 -73.59 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 129.142 2.977 . . . . 0.0 112.445 -163.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -54.35 -56.76 8.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 125.285 1.434 . . . . 0.0 109.182 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.6 t -57.03 -56.71 13.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.495 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -41.91 -54.59 3.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.972 0.909 . . . . 0.0 111.527 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.7 m -65.13 -53.6 42.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 113.598 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.1 -43.41 98.56 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.071 0.948 . . . . 0.0 109.755 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.24 -41.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.318 1.447 . . . . 0.0 110.346 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -68.59 0.89 3.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -110.02 38.39 2.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 109.972 165.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.55 32.41 16.07 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.069 1.318 . . . . 0.0 114.69 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.84 92.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 3.4 mm-40 -95.18 33.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.192 1.397 . . . . 0.0 111.109 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 171.65 160.13 0.09 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 119.184 -2.198 . . . . 0.0 107.748 -158.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 tp -168.8 147.01 3.99 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.301 1.04 . . . . 0.0 108.512 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.5 mt -118.25 105.97 18.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 125.6 1.56 . . . . 0.0 107.278 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.56 112.64 3.0 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.069 1.304 . . . . 0.0 111.85 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -25.13 32.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.63 178.01 9.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.786 3.235 . . . . 0.0 104.562 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.09 165.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 151.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.02 -12.23 68.59 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.394 -1.225 . . . . 0.0 113.905 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 148.76 174.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 1 C-N-CA 132.942 4.497 . . . . 0.0 108.732 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 24.61 74.41 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 130.878 3.671 . . . . 0.0 113.21 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.06 -24.27 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.621 1.568 . . . . 0.0 112.484 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.84 -45.05 93.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.893 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -66.94 -34.11 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -15.69 62.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.739 1.216 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.9 mt -79.63 -54.55 5.77 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.31 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.815 0.846 . . . . 0.0 112.303 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.82 -35.75 61.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.73 0.812 . . . . 0.0 112.2 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.79 37.07 2.89 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.962 0.801 . . . . 0.0 110.792 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.06 30.4 2.54 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.992 1.758 . . . . 0.0 115.865 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.34 97.24 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 118.529 1.165 . . . . 0.0 108.078 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -79.19 112.36 16.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.762 0.792 . . . . 0.0 108.978 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.11 131.12 40.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.745 1.618 . . . . 0.0 107.982 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.71 161.99 13.28 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 126.026 1.73 . . . . 0.0 109.979 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 160.51 26.83 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 163.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.18 151.94 49.35 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 127.701 2.4 . . . . 0.0 104.634 163.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -141.23 66.02 1.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 121.715 2.052 . . . . 0.0 111.191 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.8 128.08 1.75 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.67 160.03 8.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -161.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.8 p -89.77 174.51 7.67 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.583 1.153 . . . . 0.0 110.19 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 83.4 t -48.63 -40.23 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.761 -1.212 . . . . 0.0 112.17 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -64.32 -34.85 79.08 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.044 1.293 . . . . 0.0 113.483 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.72 -41.52 78.94 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 125.773 1.629 . . . . 0.0 109.15 -176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.63 -40.75 13.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.09 0.859 . . . . 0.0 111.301 170.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -84.89 -49.23 15.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 O-C-N 121.267 -0.896 . . . . 0.0 108.812 -171.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.05 -18.22 63.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 128.442 2.697 . . . . 0.0 109.618 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 -63.83 1.25 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 108.687 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -54.08 -51.28 64.65 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.95 0.795 . . . . 0.0 112.5 -175.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -66.69 -41.52 87.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.5 36.8 0.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.42 0.629 . . . . 0.0 110.133 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.28 9.25 2.05 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 127.635 2.54 . . . . 0.0 117.101 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.89 36.75 0.73 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.851 1.825 . . . . 0.0 111.824 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -131.94 172.18 12.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.551 1.069 . . . . 0.0 110.066 173.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -107.36 149.73 27.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -82.97 127.34 33.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 162.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp -112.83 64.46 0.64 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.561 1.145 . . . . 0.0 109.677 -170.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.3 p -107.85 37.98 2.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -164.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t 165.44 57.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.255 1.422 . . . . 0.0 109.311 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -79.99 164.79 23.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.597 -1.315 . . . . 0.0 108.909 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.2 p -111.35 165.16 12.19 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.379 1.071 . . . . 0.0 109.628 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -153.04 142.24 21.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.319 -0.863 . . . . 0.0 110.644 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -155.45 88.56 1.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 117.96 -1.467 . . . . 0.0 112.144 -171.62 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 161.84 165.77 0.02 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 131.082 3.753 . . . . 0.0 108.083 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -112.85 112.24 23.58 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.97 0.89 . . . . 0.0 109.92 167.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 2.2 p -79.46 153.58 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.57 149.32 42.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 163.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.17 118.17 18.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.1 126.27 14.2 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 125.075 3.85 . . . . 0.0 108.227 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -125.16 173.98 8.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.113 2.165 . . . . 0.0 105.986 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.05 37.26 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 128.149 2.58 . . . . 0.0 107.626 170.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.72 177.38 46.49 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.474 1.988 . . . . 0.0 109.555 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -121.47 40.37 3.61 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.459 -157.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.77 155.27 48.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -15.77 63.11 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.129 2.172 . . . . 0.0 110.983 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 p -112.07 38.58 2.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.915 -1.115 . . . . 0.0 112.212 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -97.24 168.47 10.4 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 166.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.6 132.99 38.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.827 1.651 . . . . 0.0 111.11 -171.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 88.5 t -71.29 139.18 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.2 t -86.87 137.35 32.46 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -0.99 . . . . 0.0 109.355 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.31 37.43 0.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.59 1.186 . . . . 0.0 111.861 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 178.42 97.02 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.188 0 O-C-N 119.736 -1.853 . . . . 0.0 109.247 -156.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -54.32 -50.38 67.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 119.424 1.011 . . . . 0.0 112.778 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.3 13.57 18.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.671 0.669 . . . . 0.0 111.173 -171.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.39 39.29 3.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.427 1.891 . . . . 0.0 106.856 168.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.28 139.51 51.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -89.82 -74.35 0.49 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.847 1.308 . . . . 0.0 108.792 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.48 156.63 22.77 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -135.52 124.56 24.3 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.5 mm -93.04 113.01 27.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -98.43 113.74 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -91.7 153.82 19.4 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.344 1.028 . . . . 0.0 108.643 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -124.45 106.17 9.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.54 1.936 . . . . 0.0 110.807 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.7 p -81.63 36.52 0.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.071 1.305 . . . . 0.0 112.228 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -105.54 -64.31 1.16 Allowed 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 124.743 1.217 . . . . 0.0 109.206 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -124.44 38.05 4.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 125.06 1.475 . . . . 0.0 110.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.79 15.24 18.62 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 126.08 1.8 . . . . 0.0 113.792 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.13 160.33 31.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.874 0.87 . . . . 0.0 109.032 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.29 147.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.689 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -130.36 140.34 50.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.208 1.803 . . . . 0.0 106.643 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.91 109.29 23.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 165.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.4 144.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.64 107.22 14.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.09 109.38 16.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.9 p -82.01 71.93 9.06 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.076 -1.64 . . . . 0.0 109.409 -172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mm -106.0 110.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 122.409 1.1 . . . . 0.0 109.527 -166.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.34 165.74 12.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.938 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 69.02 6.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 123.006 1.384 . . . . 0.0 109.401 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.74 142.63 34.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 150.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -74.58 163.0 28.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.306 0.957 . . . . 0.0 108.424 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.02 -164.75 24.24 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.214 0.911 . . . . 0.0 111.059 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.91 156.98 41.75 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.881 1.672 . . . . 0.0 107.467 168.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.42 159.65 6.78 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.562 1.553 . . . . 0.0 111.304 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.62 -45.88 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.353 2.035 . . . . 0.0 113.366 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 11.3 ttpt 60.67 -71.25 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.981 1.312 . . . . 0.0 110.701 -169.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.62 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.95 1.7 . . . . 0.0 110.049 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -54.79 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.349 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.32 -47.37 18.46 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.215 0.916 . . . . 0.0 111.42 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -67.29 0.42 Allowed 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 121.47 -0.769 . . . . 0.0 111.946 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 mt -51.79 -41.5 61.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.466 1.106 . . . . 0.0 110.744 -173.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.4 -41.52 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 126.486 1.914 . . . . 0.0 111.465 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.2 m -66.23 -3.8 6.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.848 -1.157 . . . . 0.0 111.716 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 37.26 4.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.445 1.021 . . . . 0.0 108.812 171.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.03 21.14 69.52 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.578 2.037 . . . . 0.0 116.115 161.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.95 122.81 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.23 1.012 . . . . 0.0 109.877 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -123.75 35.86 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.974 2.11 . . . . 0.0 109.923 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 5.9 m-85 -179.76 176.59 0.76 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.972 1.709 . . . . 0.0 107.358 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -176.63 151.04 0.89 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.339 1.856 . . . . 0.0 107.885 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.07 105.61 16.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 126.444 1.898 . . . . 0.0 107.601 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.21 136.03 16.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.684 1.584 . . . . 0.0 110.339 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.5 p -64.4 -27.21 68.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.863 -1.148 . . . . 0.0 112.999 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -168.4 -175.29 2.49 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.921 1.688 . . . . 0.0 108.132 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.46 153.21 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.989 0.916 . . . . 0.0 109.953 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.77 28.92 2.1 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 126.682 2.087 . . . . 0.0 111.811 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 51.05 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.524 1.93 . . . . 0.0 111.488 -159.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 25.82 75.17 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.153 2.981 . . . . 0.0 112.07 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 179.89 -40.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.844 1.658 . . . . 0.0 112.301 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.4 -35.76 68.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.096 0.862 . . . . 0.0 112.095 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.9 -40.63 68.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.331 0.652 . . . . 0.0 110.012 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -15.46 63.53 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.542 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -75.78 -47.69 24.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -67.04 -26.14 66.61 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 120.944 -1.097 . . . . 0.0 113.114 174.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.99 -40.42 63.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.238 0.927 . . . . 0.0 110.699 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.74 36.5 2.62 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.958 0.503 . . . . 0.0 111.329 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.51 16.02 4.81 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 117.424 1.73 . . . . 0.0 117.424 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.19 126.76 39.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.97 1.885 . . . . 0.0 109.813 -159.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -79.83 132.16 36.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.5 t -113.1 141.55 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -111.69 160.4 17.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.84 1.656 . . . . 0.0 109.509 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -79.16 159.68 27.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 160.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -141.12 161.39 37.98 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 154.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -150.0 95.53 2.31 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.404 1.456 . . . . 0.0 111.992 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.1 109.27 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 125.69 1.614 . . . . 0.0 111.003 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 162.84 158.44 9.7 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 117.86 0.83 . . . . 0.0 113.682 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -85.29 168.5 14.64 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.148 0.579 . . . . 0.0 109.644 166.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -39.25 -44.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.394 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.97 -39.57 82.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.14 1.791 . . . . 0.0 114.729 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -64.91 -41.66 95.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.312 1.845 . . . . 0.0 108.76 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.69 -38.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.616 0.644 . . . . 0.0 111.53 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mm -82.42 -61.12 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 -33.01 43.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.22 1.808 . . . . 0.0 110.498 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.61 -50.57 20.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -61.89 -50.51 71.93 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.408 1.083 . . . . 0.0 112.027 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.5 p -64.51 -45.52 86.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.864 2.065 . . . . 0.0 108.656 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -91.84 36.45 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.06 45.54 14.82 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.926 2.203 . . . . 0.0 115.078 166.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -120.84 36.51 4.56 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 111.058 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.4 mt -124.7 -175.74 3.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.791 1.178 . . . . 0.0 109.446 173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.49 138.42 53.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -79.72 111.08 15.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.27 61.62 2.86 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.412 1.485 . . . . 0.0 109.762 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.8 p -95.93 35.03 1.45 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.921 -1.112 . . . . 0.0 112.759 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.1 t 167.91 93.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.3 -1.5 . . . . 0.0 107.864 -169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -82.5 158.14 23.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.8 p -140.38 68.19 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.632 1.206 . . . . 0.0 109.472 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -147.27 102.22 3.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.68 109.04 13.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 147.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 115.336 -2.925 . . . . 0.0 113.634 162.298 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.83 177.33 11.47 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 140.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -114.32 130.18 56.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 156.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 10.0 p -115.2 134.28 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.774 1.63 . . . . 0.0 107.42 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.06 143.96 40.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.72 120.91 20.8 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.03 111.57 3.31 Favored 'Trans proline' 0 N--CA 1.446 -1.302 1 C-N-CA 125.687 4.258 . . . . 0.0 108.631 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -112.93 171.04 7.77 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.831 1.653 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.85 39.39 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.173 1.389 . . . . 0.0 109.899 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.69 -174.5 47.07 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.64 1.591 . . . . 0.0 109.984 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.2 mtmt -115.33 38.91 3.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.152 1.381 . . . . 0.0 109.457 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -124.48 149.37 46.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 2.23 3.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 122.309 1.052 . . . . 0.0 110.778 168.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 38.4 3.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.027 -1.671 . . . . 0.0 108.448 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.7 m -80.17 170.56 16.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 159.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 139.72 38.87 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.896 -1.128 . . . . 0.0 108.904 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 92.9 t -76.87 147.67 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -109.9 133.84 52.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -169.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.87 38.1 0.44 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.352 0.596 . . . . 0.0 110.833 -172.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -167.34 86.92 0.26 Allowed 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.427 -1.421 . . . . 0.0 107.839 -163.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -48.23 -53.13 18.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.009 0.822 . . . . 0.0 112.787 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.72 -6.77 50.69 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -129.19 64.59 1.47 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.18 25.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.26 -16.77 61.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.36 1.064 . . . . 0.0 113.249 -163.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.478 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 92.1 m-85 -141.0 154.7 46.14 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -139.02 107.27 5.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.607 1.163 . . . . 0.0 107.885 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.74 116.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.85 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.456 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 18.3 t80 -88.84 116.51 27.16 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.99 1.716 . . . . 0.0 107.536 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.62 100.0 6.8 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.899 1.679 . . . . 0.0 108.501 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 p -74.04 70.3 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.445 1.117 . . . . 0.0 108.586 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -155.76 -53.01 0.09 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.91 2.484 . . . . 0.0 110.458 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 m -136.22 36.71 2.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.481 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.01 11.74 1.07 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.495 1.998 . . . . 0.0 114.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -71.59 141.97 50.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.676 1.238 . . . . 0.0 107.688 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.37 160.62 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.747 1.619 . . . . 0.0 107.066 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -137.42 141.91 41.65 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.8 116.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.79 132.52 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 160.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -85.85 136.6 33.24 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 155.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.73 132.11 20.77 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-N 119.451 1.023 . . . . 0.0 111.288 167.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -103.22 50.2 0.81 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.382 0.673 . . . . 0.0 111.516 -159.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.42 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 120.445 -1.409 . . . . 0.0 111.74 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.66 39.67 0.75 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.662 1.585 . . . . 0.0 111.241 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.94 179.43 9.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.976 2.11 . . . . 0.0 107.046 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 76.06 1.57 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.223 1.809 . . . . 0.0 110.232 -172.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -159.12 176.85 11.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.088 0.955 . . . . 0.0 110.816 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.51 104.12 1.66 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.9 p -74.21 -16.44 60.97 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.921 0.86 . . . . 0.0 111.53 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.6 178.46 16.48 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 126.523 2.011 . . . . 0.0 108.877 165.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.32 -48.09 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.352 2.702 . . . . 0.0 112.992 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER 58.15 -64.65 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.041 1.291 . . . . 0.0 112.249 -157.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.13 -61.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.308 1.443 . . . . 0.0 108.582 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -53.28 -47.62 56.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 126.101 1.76 . . . . 0.0 109.257 175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -45.22 -52.47 9.44 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.365 1.439 . . . . 0.0 111.649 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 t -66.41 -51.95 51.61 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.374 0.669 . . . . 0.0 112.258 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.5 -41.33 97.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.632 -1.292 . . . . 0.0 110.113 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 t -59.99 -35.37 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.466 1.506 . . . . 0.0 111.241 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -65.45 -33.72 76.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.565 1.075 . . . . 0.0 109.489 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.33 38.07 0.65 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.766 1.226 . . . . 0.0 109.603 170.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.32 22.74 2.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.023 1.773 . . . . 0.0 116.092 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.66 118.86 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 119.831 1.816 . . . . 0.0 109.108 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.36 35.61 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.412 0.685 . . . . 0.0 110.982 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -174.91 160.7 2.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -173.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.2 tp -164.26 148.35 9.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -119.43 97.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.69 103.67 2.81 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.281 0.632 . . . . 0.0 109.527 -171.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.5 p -45.92 -28.87 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.966 1.706 . . . . 0.0 115.58 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 -171.19 2.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -128.67 155.03 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.32 -41.65 30.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -171.52 -148.3 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.248 2.219 . . . . 0.0 107.761 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -52.49 104.58 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 111.561 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.79 -29.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.956 2.102 . . . . 0.0 109.141 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.601 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 28.2 t80 -51.9 -39.49 59.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.088 1.755 . . . . 0.0 112.442 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.43 -37.35 86.66 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.618 0.767 . . . . 0.0 109.535 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.6 m -80.13 -13.84 58.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.726 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.8 mt -71.14 -58.2 3.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.907 -1.12 . . . . 0.0 109.093 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.601 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -63.21 -29.27 70.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.27 37.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.22 171.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.94 35.88 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.069 0.849 . . . . 0.0 111.621 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.03 34.29 4.1 Favored Glycine 0 CA--C 1.538 1.521 0 O-C-N 120.387 -1.446 . . . . 0.0 115.696 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.79 127.92 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 119.258 1.529 . . . . 0.0 110.036 -166.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -79.35 112.54 16.69 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.651 -0.656 . . . . 0.0 110.748 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -97.61 121.04 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.05 157.89 15.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 109.954 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.46 151.5 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.6 172.79 10.86 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 156.07 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.38 52.21 0.53 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 121.288 1.858 . . . . 0.0 112.787 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.51 101.95 2.67 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.386 -0.822 . . . . 0.0 112.488 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.82 166.36 34.76 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -162.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 p -88.39 174.11 8.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.373 1.069 . . . . 0.0 110.488 167.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.2 t -45.1 -42.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.588 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.15 -34.12 76.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 120.305 1.411 . . . . 0.0 114.369 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.36 -45.07 85.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.608 1.563 . . . . 0.0 107.209 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.69 -45.59 19.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.356 0.662 . . . . 0.0 111.254 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.38 -52.05 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.16 -33.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.758 2.023 . . . . 0.0 109.405 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -61.5 1.79 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -54.64 -41.17 69.75 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.452 -174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.1 p -69.41 -50.45 45.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.202 1.401 . . . . 0.0 108.119 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -86.12 36.63 0.69 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.597 0.713 . . . . 0.0 109.689 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.71 12.89 2.76 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.287 1.899 . . . . 0.0 116.658 172.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.6 mtp180 -85.74 35.91 0.64 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 121.027 2.413 . . . . 0.0 112.314 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -134.44 -178.89 5.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.586 -1.321 . . . . 0.0 109.414 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -127.81 153.34 46.71 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 125.769 1.628 . . . . 0.0 108.886 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.92 91.57 6.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.509 1.524 . . . . 0.0 107.065 -176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -85.33 49.04 1.67 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.521 1.128 . . . . 0.0 110.691 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.0 p -85.73 36.54 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 119.904 -1.747 . . . . 0.0 110.351 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t 169.78 106.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -160.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -170.09 168.18 8.52 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.035 2.934 . . . . 0.0 106.165 170.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.6 p -142.12 164.71 29.43 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.291 0.637 . . . . 0.0 110.043 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -165.83 140.79 4.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 124.939 1.296 . . . . 0.0 110.871 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.33 105.67 3.22 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.561 165.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 153.374 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.47 159.0 24.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.697 1.599 . . . . 0.0 108.377 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -79.68 149.42 31.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.007 157.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.37 151.14 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 127.706 2.403 . . . . 0.0 105.394 165.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.63 143.73 48.52 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.6 121.71 15.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.78 110.28 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.338 4.025 . . . . 0.0 108.363 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 t -111.23 169.18 8.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.189 1.795 . . . . 0.0 108.13 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.86 37.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.361 0.664 . . . . 0.0 111.051 165.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.62 177.04 42.19 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.472 1.51 . . . . 0.0 109.832 168.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -115.18 38.63 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.735 -166.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -139.29 159.26 42.58 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.471 1.908 . . . . 0.0 108.306 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.02 -5.05 39.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.612 1.965 . . . . 0.0 111.07 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -122.82 37.97 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.669 -1.269 . . . . 0.0 110.916 167.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 m -83.24 173.29 11.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.14 164.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.91 142.88 36.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.89 1.223 . . . . 0.0 109.766 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 87.8 t -71.57 165.07 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.047 0.927 . . . . 0.0 108.508 166.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 t -119.98 127.87 53.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.396 1.478 . . . . 0.0 109.26 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.22 37.11 0.37 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 122.13 0.967 . . . . 0.0 110.826 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.85 108.82 0.48 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 -166.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -63.65 -58.19 7.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.639 1.109 . . . . 0.0 110.622 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.76 -13.66 59.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.737 -170.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -123.82 77.39 1.52 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.201 1.8 . . . . 0.0 106.81 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.58 116.3 13.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.86 -16.34 11.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -173.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -142.97 157.76 44.24 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -135.19 107.52 7.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -79.88 126.79 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.6 mt -119.93 101.33 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -89.8 133.61 34.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.513 1.125 . . . . 0.0 108.191 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.64 121.65 27.95 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.338 1.455 . . . . 0.0 107.497 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 p -84.83 53.17 2.62 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.029 1.286 . . . . 0.0 108.454 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.08 -82.78 0.22 Allowed 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 p -104.88 36.97 2.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 117.99 -1.484 . . . . 0.0 110.347 -160.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.77 4.32 0.15 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.08 1.8 . . . . 0.0 116.489 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -75.26 158.32 33.09 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.221 1.008 . . . . 0.0 110.514 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.9 162.97 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.383 0.673 . . . . 0.0 109.349 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -131.69 138.2 48.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 168.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.73 110.05 22.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 155.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.08 135.79 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.454 -2.425 . . . . 0.0 104.454 156.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.25 128.67 47.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -140.12 132.51 28.44 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.357 0.98 . . . . 0.0 111.766 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -110.58 54.32 0.67 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.61 1.195 . . . . 0.0 108.303 -155.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.47 89.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.914 1.286 . . . . 0.0 109.263 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.3 60.23 1.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.439 1.896 . . . . 0.0 107.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.1 p30 -162.79 170.32 18.49 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.727 0.811 . . . . 0.0 111.846 -165.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.15 38.31 0.97 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.532 1.933 . . . . 0.0 109.93 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 178.84 3.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 109.695 167.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.14 -114.94 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.535 1.064 . . . . 0.0 112.451 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.265 53.8 m 52.05 -171.54 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.956 0.903 . . . . 0.0 109.497 -164.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.42 -119.53 4.41 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.0 -43.54 1.58 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 119.552 1.676 . . . . 0.0 113.62 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 61.47 -72.82 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.544 1.152 . . . . 0.0 110.646 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.82 -56.53 12.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 119.702 1.137 . . . . 0.0 110.383 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.79 -51.25 61.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 C-N-CA 125.235 1.414 . . . . 0.0 107.893 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -12.91 1.08 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.504 1.521 . . . . 0.0 114.615 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.52 -48.72 3.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.377 1.471 . . . . 0.0 109.526 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.08 -45.29 87.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.523 1.129 . . . . 0.0 110.504 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.27 -41.3 91.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.208 1.403 . . . . 0.0 109.652 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -67.1 3.33 1.17 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.299 -0.876 . . . . 0.0 113.223 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -124.61 38.84 4.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.488 2.315 . . . . 0.0 108.317 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.08 35.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 126.1 1.81 . . . . 0.0 116.745 165.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.99 120.59 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 118.456 1.128 . . . . 0.0 110.394 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -124.54 36.17 4.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.688 0.756 . . . . 0.0 110.984 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 170.74 170.8 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.317 1.847 . . . . 0.0 107.675 -168.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 tp -172.51 146.34 1.72 Allowed 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.413 -1.429 . . . . 0.0 107.263 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.9 mt -114.91 103.25 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.07 102.36 2.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.538 1.063 . . . . 0.0 111.32 -171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.453 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 22.7 t -59.74 -4.89 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.69 -179.43 3.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 123.612 2.915 . . . . 0.0 108.85 167.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.25 146.32 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 O-C-N 121.626 -0.671 . . . . 0.0 110.056 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.08 2.49 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.033 1.778 . . . . 0.0 110.461 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' C ' ' H ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -171.54 173.61 4.66 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.066 2.546 . . . . 0.0 106.338 173.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -71.63 29.23 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.404 1.097 . . . . 0.0 112.373 162.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 73' ' ' ARG . . . -76.1 -27.64 57.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.209 -1.557 . . . . 0.0 111.677 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.633 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 16.2 t80 -61.54 -36.12 79.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.473 1.033 . . . . 0.0 110.951 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.97 -28.65 65.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.854 0.861 . . . . 0.0 110.639 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 m -78.16 -20.79 51.3 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.862 -0.523 . . . . 0.0 110.432 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.1 mt -71.87 -54.83 8.85 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.633 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -56.2 -32.27 64.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 171.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.82 -2.58 7.46 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.68 37.33 4.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.643 1.177 . . . . 0.0 110.472 163.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.34 31.33 8.84 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.821 1.489 . . . . 0.0 116.821 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.42 115.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -78.73 107.77 11.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.83 114.69 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.9 163.24 19.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.983 1.713 . . . . 0.0 111.008 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -90.59 157.14 17.66 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.137 0.975 . . . . 0.0 108.54 161.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.46 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -121.42 171.36 8.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.264 2.626 . . . . 0.0 109.362 165.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.06 96.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.08 -1.637 . . . . 0.0 110.141 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.47 139.28 0.72 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.13 158.58 8.39 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.8 p -85.93 169.65 13.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.105 0.962 . . . . 0.0 108.73 160.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.5 t -42.17 -47.37 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.879 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -60.7 -32.65 71.88 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -64.32 -46.46 83.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.324 1.45 . . . . 0.0 109.274 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.84 -36.32 11.74 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 118.471 0.578 . . . . 0.0 111.582 174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.68 -55.07 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 108.143 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -37.97 70.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 108.641 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.87 11.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -58.54 -44.15 89.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.756 0.822 . . . . 0.0 112.272 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -69.51 -42.51 74.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 109.156 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -92.07 37.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.37 -1.54 0.1 OUTLIER Glycine 0 CA--C 1.526 0.77 0 C-N-CA 130.37 3.843 . . . . 0.0 118.277 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.6 mtt-85 -82.63 37.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.638 1.719 . . . . 0.0 111.692 -170.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.7 mt -127.89 -171.24 2.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.588 -1.32 . . . . 0.0 108.532 169.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.79 145.15 37.84 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.337 1.455 . . . . 0.0 108.276 -169.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.7 108.46 13.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -87.91 44.22 1.18 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 109.501 -176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 p -89.55 36.58 0.84 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 119.332 -2.105 . . . . 0.0 112.034 -163.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.1 t -172.56 38.48 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.536 -1.352 . . . . 0.0 111.84 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -137.53 124.29 21.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.165 -1.585 . . . . 0.0 110.087 -171.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.99 37.78 0.5 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.431 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -110.63 103.26 11.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -100.34 84.78 2.86 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.835 2.054 . . . . 0.0 106.704 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 CA-C-O 115.685 -2.73 . . . . 0.0 114.11 174.171 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.03 112.03 7.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.313 0.96 . . . . 0.0 112.129 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -80.91 107.74 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 p -84.71 153.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.66 145.85 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.42 124.3 23.54 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 103.65 1.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 1 C-N-CA 125.768 4.312 . . . . 0.0 108.963 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -101.38 173.0 6.64 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.093 1.357 . . . . 0.0 109.249 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.27 38.58 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 109.172 169.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.14 177.84 48.45 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.734 1.635 . . . . 0.0 109.552 171.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 3.5 mttm -108.79 40.05 1.88 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.115 1.766 . . . . 0.0 109.698 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -128.27 154.89 45.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -14.77 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.703 1.201 . . . . 0.0 110.044 170.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -110.74 38.35 2.52 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.64 -1.287 . . . . 0.0 108.758 166.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -86.99 167.42 14.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.589 -1.319 . . . . 0.0 108.056 162.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.58 146.1 34.4 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.467 -1.396 . . . . 0.0 110.417 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 78.8 t -87.77 132.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.523 1.154 . . . . 0.0 108.521 170.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -91.81 135.65 33.75 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.354 2.262 . . . . 0.0 108.674 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.17 38.27 0.47 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.884 0.849 . . . . 0.0 112.147 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.25 96.44 0.69 Allowed 'General case' 0 C--O 1.224 -0.266 0 O-C-N 119.905 -1.747 . . . . 0.0 107.996 -160.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -65.18 -32.62 74.4 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 119.979 -1.7 . . . . 0.0 113.927 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.69 -3.68 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.197 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -135.37 79.3 1.78 Allowed 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 119.449 1.022 . . . . 0.0 109.885 164.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.27 127.52 33.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -72.19 -17.73 61.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.466 1.106 . . . . 0.0 112.744 -167.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.431 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.1 m-85 -143.98 154.88 43.74 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.804 1.241 . . . . 0.0 107.733 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -137.76 107.67 6.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.461 1.504 . . . . 0.0 107.633 -175.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.77 123.53 43.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -175.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.25 96.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.145 0.884 . . . . 0.0 108.679 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -85.42 117.68 24.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.815 1.246 . . . . 0.0 107.869 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.77 119.91 28.57 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.263 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -89.91 60.05 4.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.862 1.21 . . . . 0.0 110.697 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -136.73 -43.29 0.59 Allowed 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 117.243 -1.361 . . . . 0.0 113.085 164.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.2 m -137.04 36.87 2.57 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 117.6 -1.64 . . . . 0.0 113.128 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.26 13.83 4.08 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.477 1.513 . . . . 0.0 114.192 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -82.24 135.08 35.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.785 1.634 . . . . 0.0 108.133 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.43 170.18 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 125.178 1.391 . . . . 0.0 107.938 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.04 145.03 39.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -106.69 109.08 26.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.9 129.37 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 159.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.89 133.87 33.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 127.145 2.178 . . . . 0.0 106.295 159.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -145.57 122.51 11.33 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.977 1.262 . . . . 0.0 111.159 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.4 p -103.73 46.31 0.92 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.429 0.692 . . . . 0.0 111.944 -155.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.84 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 120.252 -1.53 . . . . 0.0 110.653 -165.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.09 83.9 1.33 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.214 1.406 . . . . 0.0 108.435 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -157.37 163.53 38.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.034 1.334 . . . . 0.0 108.339 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 39.05 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.778 -1.202 . . . . 0.0 111.144 167.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -72.64 -74.18 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 108.972 161.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.81 94.47 0.89 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.5 m -140.65 61.36 1.51 Allowed 'General case' 0 C--O 1.238 0.473 0 O-C-N 120.39 -1.653 . . . . 0.0 109.944 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.54 -174.94 26.92 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.91 -31.76 19.25 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.032 1.821 . . . . 0.0 113.162 -171.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 58.82 -78.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.989 2.116 . . . . 0.0 111.395 -169.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -57.3 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 126.942 2.097 . . . . 0.0 109.963 -176.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -42.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 CA-C-O 115.167 -2.349 . . . . 0.0 109.578 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -52.31 -44.43 65.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 121.074 1.761 . . . . 0.0 111.497 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -68.12 -51.9 40.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 111.191 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.17 -43.62 92.12 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.305 -0.872 . . . . 0.0 110.525 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.97 -34.65 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.604 1.962 . . . . 0.0 110.628 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -36.4 79.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.504 1.047 . . . . 0.0 109.973 175.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -81.39 38.3 0.48 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.383 0.992 . . . . 0.0 110.29 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.12 27.38 1.58 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.674 2.559 . . . . 0.0 116.279 171.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.66 120.58 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.839 1.319 . . . . 0.0 108.129 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -121.78 36.78 4.53 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.757 1.623 . . . . 0.0 109.953 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -179.6 169.45 1.36 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 120.06 -1.65 . . . . 0.0 108.044 -171.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.6 tp -169.33 151.89 4.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.515 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.1 mt -126.63 102.88 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.44 111.02 2.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.78 0.832 . . . . 0.0 109.944 -171.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -46.54 -31.09 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.247 1.819 . . . . 0.0 114.998 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -165.55 -170.12 1.75 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 119.058 0.844 . . . . 0.0 109.102 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.83 133.54 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.347 -0.696 . . . . 0.0 111.388 -169.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -166.25 152.45 8.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.807 2.443 . . . . 0.0 105.44 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 45.36 -143.67 0.21 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.672 1.589 . . . . 0.0 109.228 168.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 72.77 -34.57 0.3 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 129.275 3.03 . . . . 0.0 114.767 162.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.628 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 56.5 t80 -56.39 -40.71 75.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.302 1.441 . . . . 0.0 110.109 174.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.19 -40.76 98.43 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.517 0.727 . . . . 0.0 110.612 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -27.27 66.83 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.266 -0.896 . . . . 0.0 110.764 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.3 mt -69.12 -61.13 1.92 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.628 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -61.63 -27.55 68.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 176.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.05 67.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.224 0.92 . . . . 0.0 110.613 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.85 35.98 1.91 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.541 1.064 . . . . 0.0 111.484 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.88 19.28 1.34 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.238 1.875 . . . . 0.0 117.422 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.43 120.04 29.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 118.987 1.393 . . . . 0.0 108.769 -160.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HE3' ' CD ' ' A' ' 108' ' ' GLU . 44.1 tttt -80.42 116.39 20.46 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.929 0.892 . . . . 0.0 110.208 -171.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -99.3 129.23 50.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.26 158.13 16.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 0.0 110.306 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -79.6 163.66 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.586 1.555 . . . . 0.0 106.891 162.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.36 169.92 16.89 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 157.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -153.41 67.41 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 121.931 2.15 . . . . 0.0 113.008 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.34 95.67 2.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.459 1.028 . . . . 0.0 111.783 159.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.8 168.84 40.55 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -165.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.0 p -87.4 176.57 7.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.761 0.824 . . . . 0.0 110.559 167.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -46.33 -43.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.759 1.223 . . . . 0.0 109.887 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -32.43 73.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -72.57 -40.92 66.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.623 1.169 . . . . 0.0 109.072 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.58 11.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 123.83 0.707 . . . . 0.0 111.083 168.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -81.69 -51.34 15.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 124.487 1.115 . . . . 0.0 108.313 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -21.0 65.49 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.95 1.3 . . . . 0.0 110.527 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.6 -62.31 1.71 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -56.03 -44.13 78.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.624 1.17 . . . . 0.0 112.657 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.7 p -63.61 -51.84 63.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.579 1.152 . . . . 0.0 108.451 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.37 36.36 0.69 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.593 0.711 . . . . 0.0 109.31 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.44 11.05 4.75 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.695 2.093 . . . . 0.0 116.747 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -85.03 35.34 0.57 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 121.508 2.654 . . . . 0.0 112.478 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.9 mt -135.45 167.44 21.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 121.151 1.796 . . . . 0.0 110.033 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -110.27 139.95 44.92 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.624 1.57 . . . . 0.0 107.416 -167.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.426 ' CD ' ' HE3' ' A' ' 85' ' ' LYS . 73.5 tt0 -85.41 96.04 9.45 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.833 1.197 . . . . 0.0 107.883 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.81 38.76 0.46 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 111.676 -169.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 p -91.88 37.51 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 118.656 -2.527 . . . . 0.0 109.505 -167.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 t -176.1 40.87 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -159.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -136.76 143.1 43.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.323 -1.485 . . . . 0.0 108.129 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 12.6 p -155.81 94.51 1.56 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.897 1.279 . . . . 0.0 108.626 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -155.16 114.5 3.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.62 -1.3 . . . . 0.0 109.718 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -79.76 90.55 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.696 0 C-N-CA 125.778 1.656 . . . . 0.0 110.805 -175.377 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.41 133.62 34.06 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 120.933 1.697 . . . . 0.0 113.308 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -104.74 111.76 24.6 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 170.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -97.65 129.22 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.51 133.1 46.69 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.64 121.29 37.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.7 93.23 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 1 C-N-CA 126.043 4.495 . . . . 0.0 109.509 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.2 t -87.71 171.02 10.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.753 2.821 . . . . 0.0 110.338 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 m -124.72 37.86 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.96 1.304 . . . . 0.0 109.487 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.93 -174.81 45.45 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.532 -1.355 . . . . 0.0 112.645 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 22.9 mtmt -111.06 39.6 2.23 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.05 1.34 . . . . 0.0 111.859 -162.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -143.35 157.58 44.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 108.784 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -13.79 59.59 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.444 -0.785 . . . . 0.0 111.053 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -104.91 37.39 2.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.375 -1.453 . . . . 0.0 111.072 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 97.0 p -82.76 170.7 14.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.277 174.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.56 134.18 37.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.791 1.632 . . . . 0.0 109.133 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.479 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 47.8 t -78.14 132.42 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -79.7 152.23 30.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.402 2.681 . . . . 0.0 108.42 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -88.71 36.46 0.8 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.234 -0.916 . . . . 0.0 112.613 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.37 107.01 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.433 -1.417 . . . . 0.0 110.024 -153.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -58.0 -60.44 3.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.848 1.204 . . . . 0.0 112.058 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.06 1.19 28.75 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -167.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.8 63.91 1.29 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 162.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.95 169.05 12.0 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 164.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -117.64 -30.48 5.46 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 119.034 0.834 . . . . 0.0 112.657 -165.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 95.7 m-85 -126.4 145.71 50.36 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -133.04 89.12 2.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 126.89 2.076 . . . . 0.0 106.009 -170.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mm -79.12 107.19 11.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.1 mt -94.23 107.88 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.408 ' HB3' HG13 ' A' ' 4' ' ' VAL . 41.2 t80 -89.96 131.59 35.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -100.81 109.35 21.33 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.745 2.018 . . . . 0.0 111.211 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.2 p -82.14 53.86 2.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.372 0.987 . . . . 0.0 110.225 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -140.86 -20.53 0.81 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.563 1.545 . . . . 0.0 112.712 166.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.2 p -150.63 34.92 0.62 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.597 162.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.88 10.0 2.1 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.976 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.87 152.97 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.683 1.593 . . . . 0.0 107.2 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.43 160.72 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.175 172.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -149.9 136.88 19.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.226 -0.892 . . . . 0.0 109.232 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.07 114.69 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.521 0.728 . . . . 0.0 109.508 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.73 158.12 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.692 1.197 . . . . 0.0 108.66 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -120.11 122.19 40.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 163.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.87 111.7 10.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -174.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 p -83.58 74.97 10.07 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mm -98.33 113.03 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 C-N-CA 123.9 0.88 . . . . 0.0 109.933 -170.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.5 -165.79 1.09 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.664 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -78.68 108.39 12.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.23 2.212 . . . . 0.0 106.52 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 157.23 28.81 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.784 2.034 . . . . 0.0 108.282 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -73.07 -48.99 31.19 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.762 -0.586 . . . . 0.0 110.039 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.68 -134.26 3.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m 62.73 99.66 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.039 1.736 . . . . 0.0 110.72 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.57 -173.63 33.25 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.456 0.55 . . . . 0.0 111.914 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.53 -167.08 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.406 2.737 . . . . 0.0 109.383 163.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -152.64 -52.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.197 1.399 . . . . 0.0 107.486 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.56 -39.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.965 1.706 . . . . 0.0 110.473 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -52.04 66.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 116.368 -1.777 . . . . 0.0 109.986 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -44.06 -49.86 8.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.849 1.204 . . . . 0.0 110.949 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -58.55 -64.59 0.87 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 112.657 173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.49 -39.39 87.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.337 -167.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.37 -33.87 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.643 1.977 . . . . 0.0 110.904 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -59.9 -30.87 69.32 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.66 37.86 1.63 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.163 0.985 . . . . 0.0 110.303 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.72 25.52 29.46 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.954 -0.914 . . . . 0.0 115.003 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 72.6 t -74.24 96.93 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -105.85 36.84 2.41 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -164.95 155.95 14.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.2 tp -164.56 146.06 8.24 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.26 -1.525 . . . . 0.0 107.15 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.3 mt -120.73 104.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.02 134.51 17.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.453 1.024 . . . . 0.0 111.831 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.3 p -68.43 -23.79 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.558 -0.714 . . . . 0.0 112.669 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -177.81 -176.19 0.56 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 107.433 -162.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.07 141.16 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 119.75 -1.844 . . . . 0.0 112.872 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.87 11.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.911 2.672 . . . . 0.0 116.265 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.274 22.8 mtm180 143.27 -103.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 1 C-N-CA 131.716 4.006 . . . . 0.0 107.062 167.768 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -64.97 137.41 57.72 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.38 -35.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 130.354 3.462 . . . . 0.0 110.637 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.506 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 69.6 t80 -58.27 -41.86 85.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.718 0.807 . . . . 0.0 111.851 -162.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -62.34 -39.49 93.28 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.062 1.345 . . . . 0.0 109.357 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -74.69 -23.96 58.7 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.247 1.019 . . . . 0.0 110.652 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.67 -51.18 29.44 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 121.377 -0.827 . . . . 0.0 108.933 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.37 -30.44 70.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 117.125 -1.417 . . . . 0.0 113.575 175.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.31 -60.57 3.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.316 1.01 . . . . 0.0 108.961 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.53 36.83 0.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.693 0.679 . . . . 0.0 112.058 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.68 27.71 3.27 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.562 2.029 . . . . 0.0 115.636 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.36 121.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.197 0.999 . . . . 0.0 108.54 -166.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' HZ1' ' CD ' ' A' ' 108' ' ' GLU . 6.4 tppt? -77.65 153.51 33.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -144.16 116.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -172.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -95.37 157.99 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.526 0.731 . . . . 0.0 109.313 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 153.81 29.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 163.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.479 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -134.26 167.27 21.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 162.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.75 77.39 1.58 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.36 1.076 . . . . 0.0 112.266 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.53 88.33 0.11 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.832 1.206 . . . . 0.0 114.568 159.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.43 164.59 35.12 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.818 2.628 . . . . 0.0 109.781 -163.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.6 p -79.59 169.67 17.68 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.519 164.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -50.28 -41.78 19.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-N 121.135 1.788 . . . . 0.0 111.907 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -52.92 -39.5 62.85 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -65.69 -46.64 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.803 1.641 . . . . 0.0 108.575 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.28 -34.54 10.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.479 0.581 . . . . 0.0 112.464 171.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.96 -58.36 3.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.83 -29.06 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.992 2.517 . . . . 0.0 110.155 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 -60.55 2.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -56.01 -48.67 75.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.857 1.263 . . . . 0.0 113.217 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.1 p -72.25 -30.89 65.31 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.683 1.193 . . . . 0.0 109.992 -170.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -104.52 35.99 2.55 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 122.561 1.172 . . . . 0.0 108.494 170.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.46 -2.74 1.54 Allowed Glycine 0 CA--C 1.531 1.05 1 C-N-CA 131.334 4.302 . . . . 0.0 120.135 165.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -80.1 38.43 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.956 2.878 . . . . 0.0 113.59 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.86 -166.6 1.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.129 -0.982 . . . . 0.0 108.684 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.21 148.23 46.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.233 1.413 . . . . 0.0 108.498 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.408 ' CD ' ' HZ1' ' A' ' 85' ' ' LYS . 5.2 tt0 -80.96 101.03 9.24 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.569 1.548 . . . . 0.0 107.856 175.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.42 67.49 1.81 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 107.525 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.8 p -105.72 36.78 2.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.298 1.408 . . . . 0.0 110.08 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -168.17 37.96 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.336 1.065 . . . . 0.0 110.537 -148.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -125.23 167.72 14.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 125.664 1.586 . . . . 0.0 107.83 -169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.69 -169.27 3.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 123.006 1.384 . . . . 0.0 108.467 -171.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.99 155.72 37.73 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 156.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -113.35 86.84 2.47 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.191 1.853 . . . . 0.0 108.918 -174.538 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' THR . 3.4 ptt? . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 159.35 148.68 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 130.526 3.53 . . . . 0.0 108.753 164.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 -109.83 126.27 53.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 165.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -99.4 149.6 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.03 147.56 44.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.152 1.342 . . . . 0.0 108.657 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 120.64 19.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.03 101.31 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 127.147 5.231 . . . . 0.0 107.568 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -100.1 164.37 12.01 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.77 1.228 . . . . 0.0 109.207 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.75 38.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 165.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 -178.68 41.83 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.594 1.092 . . . . 0.0 110.485 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 37.3 mtmt -108.91 39.95 1.92 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 109.536 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -143.02 148.66 37.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.376 1.07 . . . . 0.0 109.907 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 1.91 3.41 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.041 2.136 . . . . 0.0 112.957 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -130.74 38.18 3.73 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.25 -1.531 . . . . 0.0 107.98 167.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 p -81.76 165.2 21.15 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.466 167.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.13 131.77 37.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.324 1.42 . . . . 0.0 109.881 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 84.8 t -74.29 144.21 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.251 1.021 . . . . 0.0 108.763 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -94.92 132.22 39.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.286 2.234 . . . . 0.0 109.52 -169.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -81.3 39.01 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.054 0.93 . . . . 0.0 111.026 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.73 97.82 0.07 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.312 -1.492 . . . . 0.0 108.313 -162.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -60.49 -51.04 71.16 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.755 1.161 . . . . 0.0 112.478 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.04 3.36 15.06 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -134.56 69.72 1.45 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 165.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.67 -177.96 3.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 160.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.48 -21.42 9.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.894 0.378 . . . . 0.0 110.115 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.2 m-85 -145.42 156.34 43.7 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.567 2.347 . . . . 0.0 105.681 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -132.92 110.77 10.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -86.35 129.58 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.9 mt -124.43 105.79 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -91.29 117.36 29.58 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.023 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.32 98.88 11.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.12 2.568 . . . . 0.0 112.055 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 1' ' ' MET . 76.1 p -78.13 58.11 1.95 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.652 -1.905 . . . . 0.0 109.3 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.88 -21.83 0.36 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.286 2.234 . . . . 0.0 112.105 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.78 35.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.072 1.305 . . . . 0.0 113.548 158.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.91 6.88 5.72 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.572 -1.33 . . . . 0.0 114.593 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.68 158.04 34.99 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.177 0.989 . . . . 0.0 109.254 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.35 173.54 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 125.736 1.614 . . . . 0.0 107.945 171.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.77 139.91 28.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.58 104.37 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.58 145.45 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 162.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -105.42 144.09 32.68 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.04 129.63 9.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 120.74 -1.225 . . . . 0.0 110.491 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.2 p -116.02 43.75 2.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.441 0.296 . . . . 0.0 110.685 -158.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.33 48.53 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 120.91 -1.119 . . . . 0.0 113.477 -163.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 98.47 6.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 152.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.14 -175.53 4.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.006 2.122 . . . . 0.0 106.867 163.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.5 67.72 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.563 1.529 . . . . 0.0 111.154 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -131.92 100.8 5.19 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 108.145 171.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.8 45.24 1.88 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.731 1.158 . . . . 0.0 111.434 169.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -116.96 68.3 0.74 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.856 1.262 . . . . 0.0 107.638 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.6 142.28 9.52 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.908 1.718 . . . . 0.0 109.313 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.84 -33.21 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.629 2.886 . . . . 0.0 112.4 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 60.31 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.907 2.083 . . . . 0.0 111.16 -169.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.274 1.43 . . . . 0.0 110.627 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -45.46 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.822 0 CA-C-O 115.859 -2.02 . . . . 0.0 109.072 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -51.97 -42.73 63.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.054 1.752 . . . . 0.0 112.138 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -68.46 -55.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.361 0.664 . . . . 0.0 110.111 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -45.61 80.45 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.015 -1.053 . . . . 0.0 110.923 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 t -56.67 -33.87 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.412 1.885 . . . . 0.0 111.484 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 m -66.75 -39.24 87.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.336 0.971 . . . . 0.0 109.806 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.74 37.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.027 0.931 . . . . 0.0 110.21 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.27 30.25 0.77 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.812 2.149 . . . . 0.0 116.353 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.64 119.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.74 1.27 . . . . 0.0 108.211 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -120.0 36.06 4.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.943 0.897 . . . . 0.0 111.089 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -177.39 168.52 2.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.093 -2.255 . . . . 0.0 107.286 -167.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.6 tp -169.85 153.84 5.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.953 0.901 . . . . 0.0 108.614 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.0 mt -127.21 106.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.183 1.793 . . . . 0.0 106.594 171.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.98 125.49 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.585 0.754 . . . . 0.0 109.823 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.8 p -60.49 -27.97 67.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -165.38 -179.61 5.63 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 126.424 1.89 . . . . 0.0 105.989 -168.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.43 166.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -10.3 84.33 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 116.114 -2.492 . . . . 0.0 113.545 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.408 0.2 OUTLIER 143.99 -59.36 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 131.782 4.033 . . . . 0.0 112.614 161.334 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -76.51 -159.07 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.665 1.186 . . . . 0.0 109.139 165.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 77.42 -35.99 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.317 2.647 . . . . 0.0 113.244 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.502 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 60.9 t80 -55.35 -43.43 75.03 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.776 1.23 . . . . 0.0 111.544 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -66.43 -32.14 73.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.127 0.971 . . . . 0.0 110.445 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -18.47 54.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.926 1.29 . . . . 0.0 110.756 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.57 -62.85 1.49 Allowed 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.406 -0.809 . . . . 0.0 108.944 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.502 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -55.97 -35.45 66.74 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 120.973 -1.08 . . . . 0.0 113.74 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.31 69.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.14 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.74 36.35 0.54 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.245 0.929 . . . . 0.0 111.651 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.48 33.22 3.07 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.309 1.433 . . . . 0.0 115.259 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.97 111.38 23.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 118.858 1.329 . . . . 0.0 108.581 -169.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -80.33 113.23 18.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.101 -0.999 . . . . 0.0 110.355 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.25 133.73 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -172.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -105.15 155.56 18.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.355 1.062 . . . . 0.0 110.073 165.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 162.59 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 163.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.494 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -140.39 172.6 12.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 160.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.68 75.06 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.995 1.725 . . . . 0.0 112.46 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.76 124.82 2.38 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.748 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.84 162.72 12.88 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.4 p -82.31 174.29 11.28 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.751 167.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.3 t -42.29 -47.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-O 117.429 -1.272 . . . . 0.0 110.597 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -60.82 -36.23 78.55 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.817 1.19 . . . . 0.0 113.85 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -66.08 -44.02 85.67 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.995 1.318 . . . . 0.0 108.632 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.7 -36.81 11.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.61 0.641 . . . . 0.0 111.298 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.5 mm -87.16 -52.06 12.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 108.849 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.47 -13.73 43.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.508 2.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -62.31 1.52 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 167.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -55.73 -43.78 76.91 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.449 -1.407 . . . . 0.0 113.163 -175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 p -60.16 -51.24 70.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.098 1.359 . . . . 0.0 108.794 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.49 37.87 0.71 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.169 0.988 . . . . 0.0 109.753 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 44.17 33.9 3.04 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.672 2.558 . . . . 0.0 114.549 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -106.63 36.58 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.422 1.111 . . . . 0.0 110.684 -168.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 mt -137.82 172.05 13.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.3 -0.875 . . . . 0.0 108.922 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -111.33 139.13 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -170.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.23 91.89 6.82 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 38.47 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.745 1.218 . . . . 0.0 110.214 -176.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.323 5.7 t -93.7 36.03 1.11 Allowed 'General case' 0 CA--C 1.542 0.654 0 O-C-N 119.36 -2.087 . . . . 0.0 110.262 -167.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.3 t 171.57 56.89 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.547 -1.346 . . . . 0.0 107.539 -163.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.35 138.42 34.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 120.629 -1.294 . . . . 0.0 108.058 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -145.86 110.62 5.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 171.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -147.1 147.43 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.08 39.64 3.35 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 O-C-N 120.463 -1.398 . . . . 0.0 110.851 177.511 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.9 172.58 7.59 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.721 1.209 . . . . 0.0 111.279 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -89.01 148.43 23.76 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 159.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 p -114.68 166.96 7.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.31 154.41 41.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 163.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.06 129.87 16.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.65 1.98 . . . . 0.0 106.947 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.79 99.19 0.81 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 1 C-N-CA 127.97 5.78 . . . . 0.0 108.765 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -96.04 170.32 9.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.842 1.257 . . . . 0.0 109.455 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.8 m -121.06 38.27 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.506 1.123 . . . . 0.0 110.739 163.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.23 171.62 44.69 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 120.807 -1.183 . . . . 0.0 112.623 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -90.57 38.19 0.94 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.891 0.876 . . . . 0.0 111.212 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.48 160.57 41.93 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 120.939 -1.101 . . . . 0.0 111.301 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -12.53 59.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.427 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 t -121.05 37.22 4.38 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 120.575 -1.328 . . . . 0.0 108.499 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 m -80.0 168.91 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 159.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mtp -79.26 145.62 33.45 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.572 -1.33 . . . . 0.0 110.099 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 57.3 t -80.2 158.68 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.99 149.49 49.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.206 . . . . 0.0 111.32 -166.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER -86.21 33.02 0.61 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.436 1.016 . . . . 0.0 113.297 -166.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -165.13 120.93 1.38 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 118.717 -2.489 . . . . 0.0 106.657 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -58.68 -72.37 0.1 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 124.582 1.176 . . . . 0.0 111.903 167.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.82 2.03 7.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.657 -160.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 44.45 2.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.115 1.766 . . . . 0.0 109.068 173.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.5 -174.85 4.5 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 170.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -120.07 -25.78 5.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.27 0.941 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -142.2 139.91 32.17 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -123.44 100.87 7.03 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -80.98 120.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mt -110.55 112.16 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -99.41 123.29 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -87.55 114.29 24.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.281 2.232 . . . . 0.0 109.601 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -75.59 7.15 3.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.049 1.295 . . . . 0.0 113.643 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -96.31 -41.26 8.73 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 119.123 0.874 . . . . 0.0 113.208 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -130.03 37.1 3.95 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.185 160.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.7 29.4 7.81 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.884 1.23 . . . . 0.0 113.185 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -91.87 161.22 14.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.692 1.197 . . . . 0.0 107.914 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.57 155.83 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.236 0.541 . . . . 0.0 109.605 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -136.06 155.96 49.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 166.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.18 107.52 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.27 141.79 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 159.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -111.08 111.56 22.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 127.517 2.327 . . . . 0.0 105.269 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -136.79 102.89 5.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.237 0.926 . . . . 0.0 109.123 -167.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -108.91 60.15 0.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -157.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.67 126.16 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.83 38.84 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.675 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.15 168.52 26.84 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.993 0.917 . . . . 0.0 109.847 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.29 64.08 1.62 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.309 1.043 . . . . 0.0 109.177 174.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.36 170.33 22.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.983 0.913 . . . . 0.0 111.001 171.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.34 147.13 6.32 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 113.746 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -72.33 166.05 23.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.167 1.387 . . . . 0.0 109.61 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 123.91 4.71 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.21 -30.65 64.57 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 119.863 1.831 . . . . 0.0 112.176 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt 58.23 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.418 2.287 . . . . 0.0 110.787 -170.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -63.09 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 108.992 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.17 -53.08 38.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 115.612 -2.137 . . . . 0.0 109.184 -173.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -51.61 -46.14 63.49 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 120.658 1.572 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -38.89 85.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.5 mt -77.68 -38.21 48.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.965 0.802 . . . . 0.0 110.168 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -58.25 -32.42 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.372 1.869 . . . . 0.0 110.304 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -13.42 8.57 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 112.934 173.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -114.17 37.7 3.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.331 1.052 . . . . 0.0 110.091 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.58 25.2 8.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.579 1.085 . . . . 0.0 114.401 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.04 114.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.11 37.87 3.37 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.299 1.523 . . . . 0.0 110.48 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -176.48 172.07 2.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -165.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tp -177.6 130.41 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 108.459 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.32 104.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.98 6.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.622 0.646 . . . . 0.0 109.379 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 p -47.2 -33.46 5.36 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.692 1.197 . . . . 0.0 112.209 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.25 -176.44 5.88 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.296 1.5 p -104.78 176.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 165.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -104.82 25.84 24.26 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' A' ' 74' ' ' ASN . 6.2 ttt180 69.25 -169.53 0.18 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 128.659 2.784 . . . . 0.0 110.165 -164.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.41 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 22.0 t30 28.09 60.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.833 3.253 . . . . 0.0 114.77 170.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -174.73 -33.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.374 1.07 . . . . 0.0 113.328 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 48.1 t80 -54.13 -37.66 64.61 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.268 1.027 . . . . 0.0 112.178 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.5 -34.88 70.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.517 0.727 . . . . 0.0 110.189 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.8 -14.61 59.17 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.444 -0.785 . . . . 0.0 111.184 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.7 mt -70.25 -57.29 5.06 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.262 -0.899 . . . . 0.0 109.19 171.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.59 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -60.74 -28.89 69.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.352 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -53.28 51.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.062 0.846 . . . . 0.0 109.986 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.58 35.72 0.68 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.193 0.452 . . . . 0.0 111.556 176.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 36.19 0.4 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.214 2.34 . . . . 0.0 115.901 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 t -86.99 136.92 21.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.406 1.603 . . . . 0.0 109.925 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -79.23 162.33 25.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 172.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.39 139.02 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.74 155.88 26.99 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.307 1.843 . . . . 0.0 109.345 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -78.39 139.64 38.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 167.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.15 161.45 21.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 156.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -144.77 80.1 1.62 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.307 1.051 . . . . 0.0 110.686 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.75 139.65 1.31 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.52 166.24 13.07 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 121.784 0.658 . . . . 0.0 111.906 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.5 p -86.09 172.03 10.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.88 -0.66 . . . . 0.0 109.619 164.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -45.43 -40.9 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.199 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.13 -35.51 81.35 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.878 1.217 . . . . 0.0 114.277 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.37 -42.43 83.45 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.932 1.693 . . . . 0.0 108.617 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.46 -39.16 15.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.212 0.915 . . . . 0.0 111.916 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.33 -53.07 11.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -60.05 -27.23 66.77 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.829 2.051 . . . . 0.0 110.31 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -59.48 2.71 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -55.54 -49.77 71.78 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.204 0.911 . . . . 0.0 113.159 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.2 p -66.79 -25.88 66.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 110.414 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.19 37.23 3.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.278 1.431 . . . . 0.0 107.745 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.18 6.4 0.88 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.281 2.848 . . . . 0.0 116.715 168.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.449 ' HB3' HH11 ' A' ' 105' ' ' ARG . 0.0 OUTLIER -79.95 36.47 0.34 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 121.05 2.425 . . . . 0.0 111.445 -178.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.6 mt -141.84 173.49 11.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.381 -1.449 . . . . 0.0 108.863 173.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -127.6 148.54 50.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.444 1.898 . . . . 0.0 107.557 -166.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.36 99.0 11.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 120.374 1.443 . . . . 0.0 108.062 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 tp -82.8 57.89 4.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.974 1.309 . . . . 0.0 109.976 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.5 p -90.29 36.12 0.87 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.045 -1.66 . . . . 0.0 110.604 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 p -163.67 149.28 11.18 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.702 2.401 . . . . 0.0 107.074 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.38 147.71 50.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.143 1.777 . . . . 0.0 109.219 170.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.1 p -148.4 64.39 1.08 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.659 1.218 . . . . 0.0 109.444 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -140.96 96.92 3.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 120.894 -1.128 . . . . 0.0 108.388 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -84.87 75.66 10.33 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.69 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -175.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.54 166.8 31.27 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 151.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -77.91 135.99 37.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.43 158.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.95 145.52 50.24 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.67 118.29 21.23 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.86 102.54 0.77 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 1 C-N-CA 126.18 4.587 . . . . 0.0 107.995 176.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.0 t -96.31 173.45 7.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.185 1.394 . . . . 0.0 107.406 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.07 38.38 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 109.038 164.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.35 175.46 44.62 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 121.025 -1.047 . . . . 0.0 111.96 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 19.9 mtmt -97.15 39.34 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.974 1.31 . . . . 0.0 110.296 -164.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.56 152.18 49.16 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.04 -0.43 31.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.169 1.788 . . . . 0.0 110.236 174.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -133.51 37.34 3.32 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 119.96 -1.712 . . . . 0.0 109.607 166.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.6 m -82.76 173.36 11.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.321 156.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.97 139.03 39.15 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.812 -1.18 . . . . 0.0 109.216 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.502 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 62.1 t -69.57 153.65 8.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 164.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -118.64 153.64 33.99 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.56 1.144 . . . . 0.0 110.253 -169.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.29 35.79 2.46 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.687 0.756 . . . . 0.0 111.256 -164.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -162.03 106.65 1.22 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.549 -1.344 . . . . 0.0 108.332 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 79' ' ' LEU . 14.4 t80 -53.96 -56.23 19.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.96 -6.23 49.96 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 121.013 1.733 . . . . 0.0 112.48 -174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.47 39.0 4.07 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.254 1.021 . . . . 0.0 109.843 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.32 178.99 5.55 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.46 -18.04 7.98 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 89.8 m-85 -146.3 156.17 43.16 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -132.76 105.51 7.2 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.1 mm -80.05 119.34 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.63 109.44 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -98.45 108.87 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 102.28 8.39 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.924 1.69 . . . . 0.0 109.757 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -68.48 15.9 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -120.69 -18.85 7.6 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.572 0.749 . . . . 0.0 112.663 -165.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.82 38.77 0.53 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 123.502 0.501 . . . . 0.0 110.098 158.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.42 16.33 0.92 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 128.572 2.987 . . . . 0.0 116.005 173.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -76.63 144.46 39.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.744 1.272 . . . . 0.0 109.584 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.29 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.616 1.166 . . . . 0.0 109.288 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.51 149.33 36.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.314 1.845 . . . . 0.0 108.043 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.14 111.04 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 162.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.87 128.64 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 153.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -84.14 140.87 31.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 160.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.65 99.97 3.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.7 p -79.47 55.77 2.01 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 120.913 -1.117 . . . . 0.0 112.474 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.38 148.56 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 119.955 -1.716 . . . . 0.0 109.028 -166.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.38 159.57 25.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.222 1.409 . . . . 0.0 110.766 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.79 38.84 0.81 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.351 1.461 . . . . 0.0 110.439 -172.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.98 176.34 5.1 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.317 1.447 . . . . 0.0 110.075 -171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.86 167.52 7.51 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.239 -0.913 . . . . 0.0 109.708 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.93 166.35 19.5 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.684 -0.635 . . . . 0.0 112.075 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 p -94.99 155.42 16.74 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.538 1.535 . . . . 0.0 111.608 -170.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 -179.38 4.75 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.76 1.648 . . . . 0.0 114.268 168.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.46 -52.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.195 1.263 . . . . 0.0 109.639 167.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 63.34 -64.59 0.11 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 126.426 1.89 . . . . 0.0 111.266 -171.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -63.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.314 1.446 . . . . 0.0 108.752 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.46 -49.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 126.291 1.836 . . . . 0.0 108.894 177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.49 -37.96 12.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.017 1.281 . . . . 0.0 111.902 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -75.74 -58.74 3.1 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.792 0.837 . . . . 0.0 110.403 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.74 -44.33 85.97 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.26 1.024 . . . . 0.0 110.84 -171.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.76 -45.03 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.137 1.775 . . . . 0.0 110.108 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.4 m -77.18 7.42 5.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.622 1.169 . . . . 0.0 113.901 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.73 38.98 3.75 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.461 -1.399 . . . . 0.0 108.741 155.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.58 18.14 29.54 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.636 2.065 . . . . 0.0 116.759 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.74 89.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.511 1.924 . . . . 0.0 110.219 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -91.58 35.7 0.95 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.954 1.302 . . . . 0.0 111.066 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 177.89 166.56 0.71 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 120.03 -1.668 . . . . 0.0 107.317 -170.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 tp -165.96 150.51 8.22 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.1 mt -120.84 103.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.13 120.87 8.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.607 1.094 . . . . 0.0 108.16 -176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.4 p -54.35 -34.57 61.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.896 0.379 . . . . 0.0 111.981 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.26 170.33 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.37 147.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.15 33.72 2.67 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ttm105 61.14 -161.35 0.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.316 1.846 . . . . 0.0 108.64 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t30 25.28 69.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.842 2.857 . . . . 0.0 112.802 174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -177.89 -28.54 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.546 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 57.3 t80 -70.27 -36.92 74.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 121.317 1.871 . . . . 0.0 110.928 -158.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.24 -32.43 72.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.523 0.729 . . . . 0.0 109.598 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -13.85 59.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.627 1.171 . . . . 0.0 109.842 -177.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 21' ' ' PHE . 28.8 mt -80.81 -62.47 1.66 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.546 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -59.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.387 -0.815 . . . . 0.0 112.265 177.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -16.04 27.75 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.217 -0.897 . . . . 0.0 113.366 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.62 36.71 4.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.674 1.125 . . . . 0.0 111.071 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.03 31.01 1.14 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.121 2.296 . . . . 0.0 116.824 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.49 112.62 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.071 1.435 . . . . 0.0 109.841 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HZ3' ' CD ' ' A' ' 108' ' ' GLU . 12.0 mttt -79.31 102.75 8.8 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.05 126.05 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -96.69 157.1 16.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.17 1.788 . . . . 0.0 109.726 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.49 154.16 30.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.77 2.028 . . . . 0.0 105.794 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.43 168.52 19.48 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 152.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.56 38.75 1.38 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.035 1.289 . . . . 0.0 112.288 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 112.82 3.74 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.358 -1.463 . . . . 0.0 112.908 170.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.37 164.71 30.36 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.598 2.047 . . . . 0.0 109.697 -161.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -87.63 169.85 11.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.226 1.013 . . . . 0.0 109.211 166.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -43.1 -47.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.538 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -63.11 -30.32 71.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -69.6 -40.67 76.52 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 120.483 1.492 . . . . 0.0 110.119 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.88 -28.27 15.56 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -92.94 -56.78 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 C-N-CA 125.689 1.596 . . . . 0.0 107.351 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.93 -41.31 64.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.247 0.967 . . . . 0.0 108.68 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.39 -50.66 58.71 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -43.37 68.67 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 111.479 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.9 p -67.41 -35.65 79.7 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.175 1.79 . . . . 0.0 110.464 -171.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.64 36.76 2.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.031 0.932 . . . . 0.0 108.74 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.96 20.93 0.79 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.813 2.149 . . . . 0.0 115.953 172.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -93.63 38.92 1.06 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.58 1.69 . . . . 0.0 110.206 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.3 mt -140.37 169.67 17.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 109.02 165.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -121.61 143.18 49.46 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.609 -163.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.403 ' CD ' ' HZ3' ' A' ' 85' ' ' LYS . 23.2 tt0 -79.48 100.8 7.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.71 50.96 1.22 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.079 1.352 . . . . 0.0 108.517 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.346 13.5 t -79.8 38.64 0.4 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.934 1.294 . . . . 0.0 110.239 173.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.1 t 178.48 128.09 0.06 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.412 1.885 . . . . 0.0 108.047 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -104.88 127.72 52.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 161.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -80.31 47.14 0.89 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 110.698 172.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -105.1 94.93 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -82.35 45.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.128 0.971 . . . . 0.0 112.182 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.088 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -92.91 141.01 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.05 155.06 18.99 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.56 122.17 13.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.466 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 57.1 Cg_endo -70.45 102.62 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.618 4.212 . . . . 0.0 109.129 177.401 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -100.26 175.41 5.73 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.34 1.456 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.06 37.03 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.694 0.798 . . . . 0.0 109.968 166.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.94 -173.86 46.34 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 120.46 -1.4 . . . . 0.0 111.783 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -125.61 39.55 3.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.45 1.125 . . . . 0.0 111.602 -165.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.18 153.03 51.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.963 1.305 . . . . 0.0 107.626 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -75.39 -7.21 53.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.349 1.46 . . . . 0.0 113.02 -170.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -115.59 38.15 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.434 -1.416 . . . . 0.0 109.667 164.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.9 m -79.5 166.91 21.47 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.61 140.45 39.65 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.714 -1.242 . . . . 0.0 108.344 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.4 t -77.47 137.28 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -83.06 146.31 28.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.45 1.5 . . . . 0.0 108.203 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.67 38.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.786 -0.571 . . . . 0.0 110.293 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 179.77 108.91 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 119.923 -1.736 . . . . 0.0 108.889 -161.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 79' ' ' LEU . 19.5 t80 -53.95 -65.6 0.54 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.247 0.619 . . . . 0.0 111.392 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.96 12.19 3.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.711 -171.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -131.23 37.43 3.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.815 0.734 . . . . 0.0 109.481 164.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -86.81 -176.01 5.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -122.74 -14.27 7.74 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -144.72 154.69 43.01 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.487 ' CE2' HG23 ' A' ' 54' ' ' VAL . 71.2 m-85 -133.09 116.37 16.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 39' ' ' VAL . 12.4 mm -95.42 118.03 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.31 97.77 6.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.431 ' HB3' HG12 ' A' ' 4' ' ' VAL . 44.5 t80 -83.96 111.05 18.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.784 1.234 . . . . 0.0 108.637 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 101.36 7.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.813 2.845 . . . . 0.0 111.322 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 p -75.78 43.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.96 -1.088 . . . . 0.0 112.732 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.7 -37.72 1.17 Allowed 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 116.996 -1.478 . . . . 0.0 112.197 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -133.86 36.79 3.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 124.94 1.4 . . . . 0.0 111.972 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.89 1.3 Allowed Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.988 1.756 . . . . 0.0 113.003 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.01 150.85 21.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.3 149.12 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 122.218 1.008 . . . . 0.0 109.063 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.09 134.44 52.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 28' ' ' ILE . 40.9 t -101.32 108.63 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.24 152.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.34 103.25 7.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 CA-C-O 118.599 -0.667 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 0.4 OUTLIER 59.93 -62.06 0.06 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 127.038 2.135 . . . . 0.0 112.333 -168.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.487 HG23 ' CE2' ' A' ' 27' ' ' PHE . 2.7 p -52.5 -62.55 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -52.73 52.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-O 116.129 -1.891 . . . . 0.0 109.692 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -46.21 -48.42 17.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.96 1.254 . . . . 0.0 111.481 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 t -61.96 -62.65 1.64 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.388 0.675 . . . . 0.0 111.139 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.9 mt -53.75 -46.83 71.02 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.925 1.69 . . . . 0.0 111.281 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 t -56.75 -45.55 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.846 1.658 . . . . 0.0 110.232 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.8 m -71.95 8.07 1.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.013 0.925 . . . . 0.0 112.217 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.68 37.62 4.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 166.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.91 5.32 2.85 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 129.102 3.239 . . . . 0.0 117.344 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.7 t -53.46 108.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 121.107 2.453 . . . . 0.0 112.681 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -105.82 35.65 2.82 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.948 0.88 . . . . 0.0 111.711 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.726 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.5 m-85 -176.91 168.36 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.008 -2.308 . . . . 0.0 108.384 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 tp -166.55 152.19 8.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.787 HG21 ' HB1' ' A' ' 97' ' ' ALA . 44.1 mt -119.94 94.9 3.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.43 108.82 3.96 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.069 0.948 . . . . 0.0 111.202 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 p -48.74 -28.21 3.46 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.908 2.483 . . . . 0.0 115.565 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.75 178.52 4.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.662 1.985 . . . . 0.0 106.039 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.19 155.09 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.848 -1.158 . . . . 0.0 108.356 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -48.51 -58.93 6.94 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 167.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 151.6 -177.7 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 1 C-N-CA 133.82 4.848 . . . . 0.0 105.357 -166.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 25.62 58.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 129.426 3.091 . . . . 0.0 116.153 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.28 -29.3 0.12 Allowed 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.727 ' HA ' HD12 ' A' ' 79' ' ' LEU . 46.4 t80 -61.2 -33.8 74.05 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.632 0.651 . . . . 0.0 112.462 -169.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.89 -33.88 71.03 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.625 0.37 . . . . 0.0 110.833 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -16.54 41.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.307 0.643 . . . . 0.0 110.088 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 76' ' ' PHE . 27.8 mt -64.28 -66.69 0.51 Allowed 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.598 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -60.73 -27.0 67.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.47 -31.08 33.11 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.294 0.638 . . . . 0.0 112.368 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.25 37.42 2.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.279 1.032 . . . . 0.0 110.631 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.82 27.03 8.85 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.773 1.654 . . . . 0.0 116.653 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.64 114.02 19.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 118.639 1.219 . . . . 0.0 109.187 -168.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -79.59 103.32 9.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 79' ' ' LEU . 24.9 t -92.07 109.88 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.988 1.715 . . . . 0.0 108.695 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -79.72 162.25 25.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.015 1.326 . . . . 0.0 111.465 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -79.56 152.61 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.479 1.912 . . . . 0.0 106.567 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.55 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -131.92 163.93 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 155.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.33 92.72 1.72 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.658 1.572 . . . . 0.0 109.274 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.56 86.48 0.91 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.697 1.142 . . . . 0.0 115.695 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.63 159.95 28.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 121.387 -1.067 . . . . 0.0 112.302 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.7 p -82.8 172.51 12.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.347 0.659 . . . . 0.0 109.505 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.6 t -46.26 -42.55 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.298 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -35.24 76.93 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.548 1.522 . . . . 0.0 114.499 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.86 -45.64 85.19 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 125.106 1.362 . . . . 0.0 108.138 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.787 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -50.06 -29.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -89.58 -60.91 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 C-N-CA 125.141 1.376 . . . . 0.0 107.448 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -48.98 -41.23 33.59 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 127.51 2.324 . . . . 0.0 109.404 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.64 -54.99 15.1 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.731 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 106' ' ' LEU . 15.7 t80 -58.09 -47.44 83.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.932 1.293 . . . . 0.0 111.971 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.8 p -68.43 -33.44 74.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.086 1.754 . . . . 0.0 110.413 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.75 37.82 2.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.87 44.66 24.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.906 2.194 . . . . 0.0 115.115 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -118.28 38.25 3.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.49 1.145 . . . . 0.0 110.468 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 101' ' ' PHE . 25.4 mt -133.04 170.37 15.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.386 0.994 . . . . 0.0 108.686 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -112.74 147.29 37.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -79.94 121.97 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.234 0.241 0 C-N-CA 124.213 1.005 . . . . 0.0 109.903 -172.049 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -108.32 134.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.478 -2.415 . . . . 0.0 104.478 -177.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.43 146.19 27.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.25 123.41 20.62 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.606 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 87.9 Cg_endo -80.73 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 1 C-N-CA 126.404 4.736 . . . . 0.0 109.392 -174.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.2 t -83.48 169.34 15.6 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.307 1.043 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.1 m -120.56 38.77 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.701 1.2 . . . . 0.0 110.582 163.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 170.63 42.18 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 164.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -93.48 46.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.952 1.701 . . . . 0.0 110.27 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -138.41 153.43 48.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.041 0.936 . . . . 0.0 108.74 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.72 -15.49 59.76 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.246 1.418 . . . . 0.0 109.256 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.55 39.46 3.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.587 -1.321 . . . . 0.0 110.638 165.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -88.41 166.71 14.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 159.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.15 146.46 35.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.919 0.887 . . . . 0.0 109.887 -173.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 93' ' ' THR . 3.2 t -93.0 147.31 5.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 122.349 1.071 . . . . 0.0 109.859 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -105.8 132.74 51.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.222 1.809 . . . . 0.0 108.193 -165.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -79.45 38.44 0.37 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.767 0.794 . . . . 0.0 110.024 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -172.61 93.99 0.12 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 119.209 -2.182 . . . . 0.0 108.752 -160.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 79' ' ' LEU . 13.6 t80 -49.97 -61.42 2.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 112.047 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.5 -0.8 16.12 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -168.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -133.69 58.92 1.75 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.753 2.421 . . . . 0.0 107.066 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -101.98 179.71 4.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 163.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.91 -19.99 7.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.488 0.586 . . . . 0.0 112.145 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.41 144.23 33.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 42.6 m-85 -126.29 99.7 5.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.1 mm -80.79 121.53 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -108.82 117.11 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HB3' HG12 ' A' ' 4' ' ' VAL . 85.5 t80 -103.11 131.31 50.21 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.093 1.357 . . . . 0.0 109.014 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.12 122.78 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.849 1.66 . . . . 0.0 111.005 173.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 p -88.16 42.15 1.04 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 164.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.33 -96.85 0.36 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.72 37.92 1.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.919 -162.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.22 2.79 0.03 OUTLIER Glycine 0 CA--C 1.536 1.37 0 C-N-CA 128.708 3.052 . . . . 0.0 116.387 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -72.84 140.88 47.9 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.957 1.303 . . . . 0.0 109.745 -165.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.937 0.895 . . . . 0.0 109.745 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -141.92 128.76 20.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.646 1.578 . . . . 0.0 107.435 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.76 117.85 33.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.69 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 152.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.57 142.93 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.133 1.773 . . . . 0.0 106.382 158.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 O-C-N 121.025 -1.047 . . . . 0.0 109.929 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.45 -1.057 0 CA-C-O 118.268 -0.805 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 63.51 -63.56 0.13 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.403 1.481 . . . . 0.0 111.249 -166.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -65.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -49.05 -53.02 8.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 126.324 1.85 . . . . 0.0 108.97 175.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -53.57 7.06 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.378 1.049 . . . . 0.0 111.466 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -70.05 -46.79 64.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.19 -40.54 90.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.783 -1.198 . . . . 0.0 110.069 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.8 t -57.0 -41.95 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.998 1.719 . . . . 0.0 110.291 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -55.74 -29.85 60.23 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.597 0.635 . . . . 0.0 111.666 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -101.82 38.57 1.61 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.442 1.019 . . . . 0.0 109.045 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.47 18.35 29.56 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 126.324 1.916 . . . . 0.0 116.443 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.82 114.12 4.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' HA ' HG13 ' A' ' 84' ' ' VAL . 12.3 mt-10 -124.15 35.63 4.78 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.626 0.648 . . . . 0.0 111.443 167.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.645 ' HB3' HG23 ' A' ' 4' ' ' VAL . 8.0 m-30 -158.75 162.7 37.13 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 68' ' ' ALA . 6.7 tp -166.17 150.8 8.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.736 -1.853 . . . . 0.0 107.099 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 66' ' ' LEU . 59.0 mt -121.79 99.66 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -153.91 113.18 3.75 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.308 1.043 . . . . 0.0 109.21 -174.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -52.52 -30.45 30.46 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.433 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -160.53 169.81 22.2 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.541 1.937 . . . . 0.0 106.911 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.04 153.67 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.29 50.95 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.61 -160.82 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.834 3.254 . . . . 0.0 106.553 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -28.93 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 129.404 3.081 . . . . 0.0 112.766 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -175.98 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.38 1.872 . . . . 0.0 110.084 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' A' ' 79' ' ' LEU . 45.8 t80 -57.56 -38.97 75.67 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.195 1.398 . . . . 0.0 111.61 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.45 -24.89 63.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.457 0.571 . . . . 0.0 111.226 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.8 m -84.41 -18.2 36.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.964 -1.085 . . . . 0.0 112.065 170.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 76' ' ' PHE . 33.9 mt -66.85 -61.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.341 0.973 . . . . 0.0 108.696 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HE3' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -55.95 -32.67 64.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 171.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.28 67.66 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.388 0.994 . . . . 0.0 110.674 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.38 36.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.386 0.994 . . . . 0.0 111.914 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.16 28.68 3.18 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.453 1.502 . . . . 0.0 116.047 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 64' ' ' GLU . 12.4 t -86.61 123.63 39.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 118.772 1.286 . . . . 0.0 108.344 -170.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 159.65 28.3 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.14 148.0 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.642 1.577 . . . . 0.0 108.011 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -118.33 155.87 29.89 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.346 1.858 . . . . 0.0 109.994 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.78 146.45 33.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 164.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.406 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -122.85 166.91 14.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 154.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -154.31 60.11 0.7 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.816 1.189 . . . . 0.0 109.411 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.24 121.02 3.05 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.564 1.078 . . . . 0.0 111.89 168.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.97 167.58 18.32 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.359 1.079 . . . . 0.0 114.993 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.434 ' C ' HG23 ' A' ' 17' ' ' VAL . 81.1 p -87.88 174.79 8.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.231 1.012 . . . . 0.0 110.694 162.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.6 t -48.85 -38.29 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.002 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -65.99 -33.61 76.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 121.076 1.762 . . . . 0.0 113.928 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -69.58 -41.6 75.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.768 1.627 . . . . 0.0 108.801 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -42.88 -42.08 3.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.141 0.882 . . . . 0.0 111.902 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.19 -48.66 14.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.791 1.237 . . . . 0.0 108.227 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.13 -24.97 63.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.274 1.829 . . . . 0.0 110.153 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.67 -57.33 3.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.428 ' HB2' HD12 ' A' ' 106' ' ' LEU . 1.1 t80 -57.14 -44.7 83.65 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.211 1.004 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.0 p -61.97 -50.76 70.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.084 1.354 . . . . 0.0 108.765 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.92 35.62 0.64 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.857 . . . . 0.0 109.134 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.05 24.51 2.09 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.02 1.771 . . . . 0.0 114.978 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -98.34 37.76 1.42 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.076 1.438 . . . . 0.0 109.984 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 101' ' ' PHE . 19.7 mt -134.36 165.24 25.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -109.03 138.52 45.25 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.7 100.47 7.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.689 1.131 . . . . 0.0 108.59 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 CA--C 1.536 0.437 0 C-N-CA 123.751 0.821 . . . . 0.0 110.65 -166.41 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.812 HG23 ' HB3' ' A' ' 65' ' ' TYR . 9.8 p -82.88 156.02 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.96 146.4 39.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 163.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.49 HD11 HG13 ' A' ' 4' ' ' VAL . 4.2 mp -126.78 129.08 24.13 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.83 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.203 1 C-N-CA 125.307 4.005 . . . . 0.0 108.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 t -111.3 171.08 7.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.567 1.147 . . . . 0.0 109.876 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -129.82 39.39 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.73 2.012 . . . . 0.0 108.227 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.1 173.1 42.34 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -110.29 50.0 0.82 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.016 1.326 . . . . 0.0 108.268 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.71 157.13 45.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.983 1.313 . . . . 0.0 108.016 171.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 0.8 25.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.313 1.445 . . . . 0.0 110.339 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -127.25 37.63 4.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.021 -1.674 . . . . 0.0 108.755 168.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -81.07 165.07 21.98 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.419 -0.801 . . . . 0.0 109.381 163.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.41 135.35 37.41 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.664 1.12 . . . . 0.0 109.047 -175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 93.0 t -75.34 137.53 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.67 131.12 42.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 107.361 -172.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.67 38.59 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.634 1.207 . . . . 0.0 110.862 -173.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.46 93.5 0.76 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 118.401 -2.687 . . . . 0.0 107.132 -166.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 79' ' ' LEU . 20.2 t80 -55.12 -52.58 62.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.632 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.79 13.59 1.0 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.04 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.28 38.29 1.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.286 1.403 . . . . 0.0 110.082 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -103.91 127.85 51.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -172.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.43 -20.15 64.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.62 151.98 42.02 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 92.6 m-85 -131.3 119.61 22.0 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.31 112.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.492 HD11 HD23 ' A' ' 58' ' ' LEU . 83.2 mt -101.76 112.47 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.689 ' HB3' HG12 ' A' ' 4' ' ' VAL . 16.7 t80 -104.28 125.83 50.87 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.859 1.264 . . . . 0.0 110.582 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.84 112.11 19.82 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 108.676 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -77.43 54.57 1.16 Allowed 'General case' 0 C--O 1.239 0.518 0 O-C-N 120.832 -1.167 . . . . 0.0 108.838 163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -151.58 -34.67 0.14 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.46 38.03 0.43 Allowed 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 117.524 -1.67 . . . . 0.0 111.873 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.1 9.48 2.0 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.011 1.291 . . . . 0.0 115.01 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -61.91 146.36 50.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.893 1.346 . . . . 0.0 107.687 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.44 142.42 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.25 132.23 53.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.275 1.83 . . . . 0.0 106.629 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.27 110.53 25.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.22 150.57 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 158.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -124.02 106.76 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.966 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo . . . . . 0 N--CA 1.448 -1.158 0 N-CA-C 110.758 -0.516 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 58.61 -66.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.397 1.879 . . . . 0.0 111.094 -161.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -48.91 -63.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.427 1.491 . . . . 0.0 111.174 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.36 -49.66 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 116.028 -1.939 . . . . 0.0 109.266 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -49.69 -49.81 46.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.827 1.194 . . . . 0.0 110.652 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 t -61.83 -55.11 33.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.406 1.082 . . . . 0.0 112.073 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.492 HD23 HD11 ' A' ' 29' ' ' ILE . 96.0 mt -59.21 -43.15 92.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.28 0.632 . . . . 0.0 109.843 -174.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -60.66 -45.17 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.528 1.931 . . . . 0.0 110.861 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -58.02 -26.07 61.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.532 1.06 . . . . 0.0 111.808 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -104.0 36.78 2.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.053 0.941 . . . . 0.0 109.08 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.12 11.69 55.93 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 127.012 2.244 . . . . 0.0 117.162 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.57 105.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.96 1.38 . . . . 0.0 110.791 -170.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -104.88 36.43 2.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.338 1.055 . . . . 0.0 110.847 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.812 ' HB3' HG23 ' A' ' 4' ' ' VAL . 1.4 m-85 -171.62 173.05 4.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 119.804 -1.81 . . . . 0.0 109.888 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.496 HD23 HG13 ' A' ' 86' ' ' VAL . 16.4 tp -166.81 157.64 12.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.941 1.296 . . . . 0.0 108.716 170.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.792 HG21 ' HB1' ' A' ' 97' ' ' ALA . 48.2 mt -124.37 106.12 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 168.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.41 130.99 10.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 p -63.68 -26.04 68.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -170.02 -177.89 2.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -166.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.17 154.09 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.603 -1.311 . . . . 0.0 108.037 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.05 -51.37 25.31 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 164.52 -86.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 130.942 3.697 . . . . 0.0 104.937 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.73 119.88 15.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.7 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 130.572 3.549 . . . . 0.0 109.831 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.535 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 33.6 t80 -53.02 -43.92 66.92 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.163 1.385 . . . . 0.0 111.658 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.43 -31.2 72.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.339 1.455 . . . . 0.0 109.856 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -21.78 38.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.817 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.643 HD21 ' CE2' ' A' ' 21' ' ' PHE . 94.4 mt -69.86 -59.11 3.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.273 0.942 . . . . 0.0 108.653 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -58.9 -31.35 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.568 1.147 . . . . 0.0 112.999 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.13 -8.19 7.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.47 36.5 4.55 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.81 1.641 . . . . 0.0 110.211 165.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.79 19.46 3.39 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.681 2.086 . . . . 0.0 116.619 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.2 129.73 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.131 -1.217 . . . . 0.0 108.184 -163.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -78.56 165.18 24.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG13 HD23 ' A' ' 66' ' ' LEU . 29.6 t -151.71 114.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -89.03 157.51 18.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.768 0.827 . . . . 0.0 110.181 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.81 156.17 27.53 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.697 1.599 . . . . 0.0 107.101 162.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.04 175.73 9.33 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 158.182 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.45 38.72 0.71 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 122.191 2.269 . . . . 0.0 114.759 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.04 123.17 2.82 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 172.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.41 163.37 13.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -166.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.44 ' C ' HG23 ' A' ' 17' ' ' VAL . 25.5 p -81.97 172.31 13.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.305 0.553 . . . . 0.0 110.272 168.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -41.26 -47.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.698 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -35.22 77.89 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -67.88 -45.19 75.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 125.363 1.465 . . . . 0.0 108.573 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.792 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.25 -30.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 172.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.71 -52.6 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 116.359 -1.781 . . . . 0.0 108.684 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -33.69 69.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 124.38 1.05 . . . . 0.0 108.964 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -54.0 14.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.497 ' HB2' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -56.84 -45.53 82.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.515 1.126 . . . . 0.0 111.899 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.7 p -64.46 -42.15 96.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.526 1.13 . . . . 0.0 108.104 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.64 35.65 1.22 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.937 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.08 7.52 3.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.517 1.532 . . . . 0.0 116.39 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -85.66 36.82 0.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 120.067 1.933 . . . . 0.0 112.064 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 101' ' ' PHE . 17.5 mt -131.22 170.24 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 120.081 1.309 . . . . 0.0 108.614 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -111.69 142.07 44.49 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -81.34 106.68 13.5 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.905 1.23 . . . . 0.0 107.943 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.332 1.453 . . . . 0.0 109.48 178.589 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.93 HG23 ' HB3' ' A' ' 65' ' ' TYR . 9.3 p -129.35 125.79 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.878 1.271 . . . . 0.0 109.463 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.2 29.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.8 118.63 24.19 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 74.2 Cg_endo -71.55 99.58 0.95 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 1 C-N-CA 125.43 4.086 . . . . 0.0 107.551 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 t -94.3 175.47 6.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.911 1.285 . . . . 0.0 108.77 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.54 39.42 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.282 1.033 . . . . 0.0 109.891 161.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.17 172.13 45.2 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.774 -1.204 . . . . 0.0 111.441 167.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 29.4 mtmt -94.6 39.9 1.09 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.141 2.177 . . . . 0.0 108.871 -172.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.95 148.27 38.35 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -12.46 61.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.142 2.577 . . . . 0.0 110.81 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -116.02 38.8 3.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.607 -1.308 . . . . 0.0 109.014 170.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -89.88 168.03 12.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.182 -0.949 . . . . 0.0 109.026 163.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 142.39 38.32 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.283 -0.885 . . . . 0.0 109.007 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 59.2 t -81.83 150.81 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -109.03 138.46 45.33 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.805 1.642 . . . . 0.0 110.548 -167.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -83.45 37.31 0.56 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.422 1.106 . . . . 0.0 112.034 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -172.75 85.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 119.956 -1.715 . . . . 0.0 109.334 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CD2' HD11 ' A' ' 79' ' ' LEU . 14.4 t80 -50.39 -50.77 50.71 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -0.03 30.72 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.396 -0.815 . . . . 0.0 112.071 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.02 38.61 3.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.876 1.271 . . . . 0.0 109.839 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . . . -118.59 142.25 47.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -173.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -91.79 -20.64 21.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -158.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.554 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 96.5 m-85 -146.47 124.95 12.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.38 107.85 18.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.8 mm -81.88 114.96 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.554 HD11 ' CD2' ' A' ' 58' ' ' LEU . 78.6 mt -110.61 106.89 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.646 ' HB3' HG12 ' A' ' 4' ' ' VAL . 5.1 t80 -88.1 116.6 26.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.47 101.25 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.779 2.032 . . . . 0.0 108.079 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.555 HG22 ' CD2' ' A' ' 30' ' ' TYR . 5.3 p -86.6 22.51 1.88 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.559 1.171 . . . . 0.0 111.227 -171.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.47 -89.84 0.4 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 167.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.95 37.4 0.84 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.063 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.36 24.04 9.91 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.754 2.121 . . . . 0.0 114.437 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -82.66 154.3 24.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -138.92 136.88 42.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.443 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.8 pt-20 -122.96 163.2 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.312 1.045 . . . . 0.0 110.446 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.94 104.31 15.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.173 1.389 . . . . 0.0 108.209 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 t -79.25 151.75 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -120.17 123.56 43.61 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 129.597 3.159 . . . . 0.0 104.427 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 CA--C 1.513 -0.458 0 CA-C-N 118.991 0.814 . . . . 0.0 109.289 -177.976 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 CA-C-O 117.935 -0.944 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 63.66 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 126.597 1.959 . . . . 0.0 109.217 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -56.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 126.028 1.731 . . . . 0.0 111.675 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.11 -34.98 72.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.107 -171.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -16.38 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.535 1.516 . . . . 0.0 113.727 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -98.11 -46.2 5.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 120.283 1.401 . . . . 0.0 109.971 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.554 ' CD2' HD11 ' A' ' 29' ' ' ILE . 88.5 mt -68.88 -37.93 79.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.967 0.507 . . . . 0.0 112.012 -173.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.48 -50.52 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 123.85 0.86 . . . . 0.0 108.845 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.3 m -74.89 13.13 0.7 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 4.9 mttt -127.66 37.56 4.19 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.356 1.463 . . . . 0.0 108.707 163.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 38.57 39.3 0.79 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.831 1.682 . . . . 0.0 114.523 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 77.5 t -81.69 87.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.484 1.513 . . . . 0.0 108.402 -172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -91.09 35.62 0.91 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.555 1.071 . . . . 0.0 111.851 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.93 ' HB3' HG23 ' A' ' 4' ' ' VAL . 25.5 m-85 -164.63 162.45 21.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.797 -1.815 . . . . 0.0 108.595 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tp -160.15 153.22 21.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.742 HG21 ' HB1' ' A' ' 97' ' ' ALA . 79.1 mt -125.81 98.59 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.263 1.425 . . . . 0.0 107.707 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.62 133.33 16.84 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 120.205 1.366 . . . . 0.0 111.412 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.4 p -74.39 -18.4 60.67 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.42 -169.86 0.87 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.063 1.745 . . . . 0.0 108.292 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.66 140.37 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 120.376 -1.453 . . . . 0.0 108.764 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -46.29 -54.89 8.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.459 1.504 . . . . 0.0 110.526 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 172.12 152.92 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.541 2.736 . . . . 0.0 106.464 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 -144.91 0.5 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.378 1.871 . . . . 0.0 109.923 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.42 -30.9 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 129.565 3.146 . . . . 0.0 116.117 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.686 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 59.0 t80 -57.92 -40.94 81.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.245 2.218 . . . . 0.0 111.653 -169.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.75 -41.11 83.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.599 1.159 . . . . 0.0 110.099 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -69.06 -19.59 64.09 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.252 -0.905 . . . . 0.0 110.575 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 76' ' ' PHE . 71.0 mt -72.4 -61.33 1.84 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.351 0.978 . . . . 0.0 109.411 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.686 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -58.33 -35.89 72.57 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.769 -1.207 . . . . 0.0 112.473 176.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.12 -7.54 9.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.69 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.61 36.5 4.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 121.211 1.823 . . . . 0.0 110.733 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.16 5.91 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.111 1.815 . . . . 0.0 115.48 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.24 116.31 27.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 118.486 1.143 . . . . 0.0 109.626 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -79.8 94.62 5.82 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.12 128.78 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -103.78 160.65 14.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.415 1.886 . . . . 0.0 108.895 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -79.0 161.23 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 164.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.484 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -138.28 165.12 27.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 155.291 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -150.24 39.47 0.75 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 121.008 1.731 . . . . 0.0 113.189 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.25 102.69 1.71 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 121.231 -0.918 . . . . 0.0 112.207 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.07 163.14 26.99 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 111.68 -168.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.4 p -84.41 173.64 10.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.118 0.567 . . . . 0.0 109.95 165.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -48.61 -40.21 11.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.321 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -63.07 -33.53 75.64 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -71.77 -37.57 70.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.556 1.542 . . . . 0.0 109.897 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.742 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.03 -43.55 19.76 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.092 0.86 . . . . 0.0 110.548 168.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -81.14 -55.6 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 C-N-CA 125.329 1.452 . . . . 0.0 108.356 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.28 -31.23 65.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.109 1.764 . . . . 0.0 108.603 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.04 -52.54 7.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.939 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -51.77 -45.1 63.63 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.168 0.895 . . . . 0.0 111.14 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -65.95 -44.78 84.01 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.013 0.925 . . . . 0.0 110.16 -168.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.94 37.18 1.33 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.584 0.707 . . . . 0.0 109.18 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 41.89 44.16 4.46 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 127.93 2.681 . . . . 0.0 113.096 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -106.14 37.26 2.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.085 0.954 . . . . 0.0 110.485 169.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 89' ' ' PHE . 45.2 mt -138.75 172.73 12.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.198 0.908 . . . . 0.0 109.454 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.38 146.95 37.42 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.002 1.321 . . . . 0.0 108.498 -168.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -81.26 99.1 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.424 1.107 . . . . 0.0 108.474 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.5 -0.975 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.677 HG12 ' HB3' ' A' ' 30' ' ' TYR . 2.3 p -97.62 151.03 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.606 1.191 . . . . 0.0 108.235 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.67 136.79 52.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 166.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.55 HD11 HG13 ' A' ' 4' ' ' VAL . 3.5 mp -122.95 118.32 28.23 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.0 115.35 4.23 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 124.507 3.471 . . . . 0.0 107.573 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -118.16 151.87 36.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.233 1.413 . . . . 0.0 107.467 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.49 41.55 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.32 176.96 48.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -119.83 57.73 0.91 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.123 1.769 . . . . 0.0 108.202 -169.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.15 154.17 39.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.223 1.809 . . . . 0.0 106.431 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.717 1.207 . . . . 0.0 110.253 172.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -123.48 37.36 4.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 119.983 -1.698 . . . . 0.0 110.753 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.9 m -82.17 172.25 13.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.387 160.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.06 136.59 37.21 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.201 -0.937 . . . . 0.0 109.559 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 93' ' ' THR . 43.3 t -72.32 159.09 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -115.7 149.91 37.64 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.919 0.888 . . . . 0.0 111.447 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.3 37.81 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.453 1.101 . . . . 0.0 111.065 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.71 101.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.564 -1.335 . . . . 0.0 108.988 -162.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.488 ' HB3' HG23 ' A' ' 71' ' ' VAL . 31.4 t80 -53.39 -62.29 1.75 Allowed 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 123.36 0.412 . . . . 0.0 111.068 170.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 -3.5 29.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -118.78 38.94 3.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 109.495 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.38 115.31 28.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.188 -164.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -69.85 -23.8 63.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -166.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.08 156.9 47.31 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 106.855 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -132.19 112.72 12.52 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 124.107 0.963 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.448 HG13 HG11 ' A' ' 94' ' ' VAL . 8.4 mm -79.78 120.19 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 169.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.38 117.08 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.677 ' HB3' HG12 ' A' ' 4' ' ' VAL . 33.1 t80 -103.0 126.0 49.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.151 1.38 . . . . 0.0 110.182 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 115.03 27.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.842 2.057 . . . . 0.0 110.173 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -76.0 23.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.86 -6.02 2.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.25 36.46 0.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 158.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 34.88 34.54 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 C-N-CA 127.092 2.282 . . . . 0.0 113.327 -170.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -88.29 154.64 20.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -168.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.51 137.34 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 123.412 0.685 . . . . 0.0 110.872 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -109.86 154.28 23.25 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.174 2.19 . . . . 0.0 108.371 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.37 112.04 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 158.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.05 137.48 21.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 157.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.98 135.73 33.9 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 161.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.521 -0.143 0 CA-C-N 119.002 0.819 . . . . 0.0 110.159 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 CA-C-O 117.396 -1.168 . . . . 0.0 112.757 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.1 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.851 2.06 . . . . 0.0 111.231 -167.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.59 -54.44 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.928 1.691 . . . . 0.0 110.055 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.45 -52.83 42.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 116.521 -1.704 . . . . 0.0 109.624 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -53.47 -33.35 53.91 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.351 1.432 . . . . 0.0 111.418 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -68.04 -67.43 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 120.93 -1.106 . . . . 0.0 112.594 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.35 -38.58 80.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.794 0.838 . . . . 0.0 111.08 -166.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.8 t -54.77 -36.52 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.729 1.611 . . . . 0.0 111.518 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 t -67.66 -13.43 62.08 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.649 -1.282 . . . . 0.0 112.91 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.03 37.09 2.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.832 1.196 . . . . 0.0 109.957 172.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.8 26.76 41.35 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.964 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.7 t -73.05 97.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 118.256 1.028 . . . . 0.0 109.014 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -104.61 35.27 2.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.033 0.921 . . . . 0.0 111.597 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.551 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -174.74 151.5 1.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.447 -1.408 . . . . 0.0 108.363 -162.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 68' ' ' ALA . 13.1 tp -159.29 154.64 25.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.717 1.207 . . . . 0.0 108.706 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.764 HG21 ' HB1' ' A' ' 97' ' ' ALA . 48.3 mt -127.02 104.06 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -163.25 105.81 1.01 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.957 0.903 . . . . 0.0 109.203 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -13.46 25.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -156.34 -177.72 6.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 119.683 1.129 . . . . 0.0 108.806 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 21' ' ' PHE 0.256 4.1 p -133.16 166.14 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.18 60.2 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 168.37 -88.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 130.799 3.64 . . . . 0.0 106.52 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.75 139.32 58.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 153.31 -30.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 130.688 3.595 . . . . 0.0 109.838 160.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.592 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 60.7 t80 -52.74 -42.5 64.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.433 1.893 . . . . 0.0 111.434 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -69.45 -35.68 75.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.403 1.481 . . . . 0.0 109.408 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -22.36 58.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 110.276 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 21' ' ' PHE . 73.1 mt -68.85 -64.14 0.92 Allowed 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.95 -39.87 20.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.43 1.092 . . . . 0.0 111.892 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.64 37.16 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.979 0.912 . . . . 0.0 111.247 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.14 30.37 1.83 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.037 1.78 . . . . 0.0 116.742 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.49 126.53 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.68 1.24 . . . . 0.0 108.123 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.23 159.91 27.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.412 HG13 HD23 ' A' ' 66' ' ' LEU . 22.0 t -147.37 133.52 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -116.73 162.89 16.97 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.033 1.733 . . . . 0.0 110.14 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -79.74 153.42 29.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.264 2.226 . . . . 0.0 108.051 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.9 129.66 15.16 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.861 2.064 . . . . 0.0 106.303 164.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.68 39.38 3.94 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 123.472 2.851 . . . . 0.0 111.615 -165.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.74 131.91 4.03 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.322 1.915 . . . . 0.0 110.415 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.6 163.48 11.85 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.075 0.937 . . . . 0.0 113.035 -164.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.495 ' C ' HG23 ' A' ' 17' ' ' VAL . 23.4 p -87.89 170.02 11.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.489 1.516 . . . . 0.0 110.39 166.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 HG13 ' A' ' 28' ' ' ILE . 43.6 t -44.0 -47.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-N 119.338 0.972 . . . . 0.0 110.022 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -56.73 -38.01 71.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.47 -46.39 76.54 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.707 1.603 . . . . 0.0 108.722 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -50.76 -30.13 13.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.449 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.4 mm -93.5 -51.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 C-N-CA 124.596 1.158 . . . . 0.0 107.912 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.64 -42.46 78.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.32 -49.03 63.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.623 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.55 78.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 111.563 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.3 p -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.56 1.144 . . . . 0.0 109.499 -170.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.6 36.59 2.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.402 1.081 . . . . 0.0 108.617 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.72 11.92 0.19 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.642 2.068 . . . . 0.0 116.666 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -85.35 36.05 0.62 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.177 1.988 . . . . 0.0 111.061 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.8 mt -139.72 175.53 9.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -114.61 159.84 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -78.91 137.46 37.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 161.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 N--CA 1.453 -0.277 0 C-N-CA 125.013 1.325 . . . . 0.0 108.16 173.654 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm105 . . . . . 0 CA--C 1.507 -0.708 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.71 136.27 30.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.18 95.68 5.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 0.947 . . . . 0.0 108.81 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -83.96 132.07 49.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -170.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.63 136.5 23.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 1 C-N-CA 125.586 4.191 . . . . 0.0 109.676 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.0 t -138.05 166.08 25.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.261 1.424 . . . . 0.0 108.077 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.63 39.15 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.127 0.971 . . . . 0.0 109.532 163.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.14 167.17 40.31 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 164.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 8.7 mtmp? -92.95 42.42 1.1 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.543 1.537 . . . . 0.0 109.106 -175.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.83 149.94 32.17 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.522 0.729 . . . . 0.0 109.399 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -73.0 -12.0 60.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.216 1.807 . . . . 0.0 112.058 -174.041 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -114.12 35.8 3.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.828 -1.17 . . . . 0.0 111.625 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 m -86.26 169.63 12.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 171.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.48 134.22 37.35 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 65.5 t -78.86 130.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 122.452 1.12 . . . . 0.0 108.589 172.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -79.94 153.9 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.159 1.783 . . . . 0.0 109.499 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.94 37.14 1.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.645 1.112 . . . . 0.0 110.775 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -167.53 99.38 0.49 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 119.168 -2.208 . . . . 0.0 110.23 -166.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.474 ' CD2' HD11 ' A' ' 79' ' ' LEU . 3.1 t80 -49.27 -64.69 0.73 Allowed 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.253 0.933 . . . . 0.0 111.34 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.84 24.31 1.29 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.77 -170.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 39.42 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 167.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.71 132.8 56.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.29 -26.22 46.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -162.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' HG3' ' A' ' 11' ' ' LYS . 97.9 m-85 -135.36 148.21 49.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -125.92 125.37 42.66 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.535 HD12 HG22 ' A' ' 39' ' ' VAL . 19.3 mm -112.59 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -92.84 97.9 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 4' ' ' VAL . 38.8 t80 -81.77 117.95 22.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.89 118.35 22.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.711 2.004 . . . . 0.0 109.892 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.7 p -90.26 28.16 1.5 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.761 1.164 . . . . 0.0 111.802 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -99.67 -87.05 0.37 Allowed 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 155.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -94.78 35.42 1.25 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.339 -156.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 28.09 38.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.192 1.377 . . . . 0.0 113.933 -163.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -68.79 155.51 40.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.2 170.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.66 140.7 17.36 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG22 HD12 ' A' ' 28' ' ' ILE . 70.6 t -112.63 107.98 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.83 145.57 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -109.41 133.9 52.5 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 128.599 2.759 . . . . 0.0 104.446 166.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.462 0.153 0 C-N-CA 123.88 0.872 . . . . 0.0 109.009 -177.485 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 57.2 Cg_endo . . . . . 0 CA--C 1.503 -1.044 0 CA-C-O 117.29 -1.213 . . . . 0.0 113.852 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 66.15 -68.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -61.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.161 1.385 . . . . 0.0 108.566 170.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.2 t -57.54 -45.51 86.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-O 116.006 -1.949 . . . . 0.0 109.131 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -45.2 -53.56 8.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.247 1.385 . . . . 0.0 111.662 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -67.05 -44.85 79.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.78 -41.46 87.62 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.22 -0.925 . . . . 0.0 110.148 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.07 -34.03 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.84 1.656 . . . . 0.0 110.361 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -66.8 -16.24 64.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.371 0.987 . . . . 0.0 113.536 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -104.35 37.44 2.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.558 1.072 . . . . 0.0 109.634 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.13 34.12 3.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.006 1.289 . . . . 0.0 114.074 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.1 106.42 5.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 118.936 1.368 . . . . 0.0 107.525 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -108.27 35.23 3.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.587 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -168.58 151.83 5.45 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.326 -1.484 . . . . 0.0 108.406 -163.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 68' ' ' ALA . 22.3 tp -166.26 145.0 5.72 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.245 -1.534 . . . . 0.0 109.064 -169.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.775 HG21 ' HB1' ' A' ' 97' ' ' ALA . 41.9 mt -125.23 100.06 6.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -161.54 94.52 0.97 Allowed 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.315 0.961 . . . . 0.0 110.835 -167.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.5 p -29.6 -32.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.733 3.213 . . . . 0.0 119.462 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -162.63 -174.73 4.11 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.845 2.058 . . . . 0.0 105.816 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.38 156.62 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 120.735 -1.228 . . . . 0.0 109.304 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.02 66.15 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.697 1.142 . . . . 0.0 113.253 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 144.0 -105.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 1 C-N-CA 135.865 5.666 . . . . 0.0 107.019 169.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -57.13 119.01 5.61 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.881 -1.137 . . . . 0.0 109.846 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.88 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 130.89 3.676 . . . . 0.0 110.907 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.511 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 28.4 t80 -54.65 -36.1 64.22 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.231 0.923 . . . . 0.0 111.558 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.55 -30.74 71.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.61 1.964 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -92.96 -14.78 27.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.583 1.553 . . . . 0.0 111.002 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.474 HD11 ' CD2' ' A' ' 21' ' ' PHE . 60.0 mt -66.93 -68.05 0.4 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 167.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -52.25 -30.67 28.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.32 -30.62 12.46 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.05 36.9 3.15 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.927 1.291 . . . . 0.0 111.059 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.64 15.85 54.57 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.098 1.199 . . . . 0.0 116.098 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.93 123.35 36.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 118.314 1.057 . . . . 0.0 110.782 -158.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -78.9 156.79 28.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.456 HG13 HD23 ' A' ' 66' ' ' LEU . 18.5 t -149.29 138.31 15.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -122.25 155.45 35.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.76 0.824 . . . . 0.0 111.544 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -79.22 149.24 31.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 162.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.73 167.97 16.5 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.294 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -142.73 116.35 9.18 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.915 -1.115 . . . . 0.0 110.187 160.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.03 90.3 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 125.577 1.56 . . . . 0.0 113.654 162.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 165.72 37.98 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.2 p -81.81 178.39 8.34 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.977 -0.719 . . . . 0.0 110.698 167.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.03 -44.93 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.121 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -60.76 -37.27 81.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 120.972 1.715 . . . . 0.0 114.626 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.86 -40.7 83.61 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.592 1.557 . . . . 0.0 108.264 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.775 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.74 -35.53 14.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.397 0.544 . . . . 0.0 111.983 168.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.7 -53.25 9.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 125.131 1.372 . . . . 0.0 109.376 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -28.21 68.87 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.801 2.04 . . . . 0.0 108.69 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.68 -58.01 3.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.624 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.9 t80 -54.74 -50.74 67.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.569 0.747 . . . . 0.0 112.451 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 p -63.1 -44.72 94.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.896 0.879 . . . . 0.0 108.904 -168.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.63 37.4 0.91 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.875 0.845 . . . . 0.0 109.014 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.98 17.05 8.78 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 128.073 2.749 . . . . 0.0 116.501 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -89.65 36.62 0.85 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.72 2.26 . . . . 0.0 112.769 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 101' ' ' PHE . 19.1 mt -137.32 166.8 22.93 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.985 1.721 . . . . 0.0 110.339 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.21 147.7 24.34 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -93.24 82.4 4.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.986 0.898 . . . . 0.0 109.558 -169.588 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.873 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -121.29 124.81 72.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -169.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.9 137.97 39.48 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.498 HD11 HG13 ' A' ' 4' ' ' VAL . 4.8 mp -123.25 116.66 28.38 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 74.1 Cg_endo -67.57 112.53 2.65 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 125.074 3.849 . . . . 0.0 106.877 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -113.99 167.52 10.59 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.561 1.944 . . . . 0.0 107.447 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.13 38.36 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.569 -0.707 . . . . 0.0 109.654 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 166.94 39.84 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 120.99 -1.069 . . . . 0.0 110.958 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -89.22 39.44 0.94 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 122.151 -0.617 . . . . 0.0 110.712 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.02 153.42 50.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.609 1.164 . . . . 0.0 109.277 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.74 -15.89 55.3 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.486 1.914 . . . . 0.0 109.745 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 38.9 2.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.285 1.434 . . . . 0.0 108.229 170.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -83.88 173.17 11.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 119.822 -1.799 . . . . 0.0 107.991 164.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.39 140.65 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.582 -1.324 . . . . 0.0 109.553 166.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.7 t -73.37 149.93 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 167.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -102.57 136.52 42.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.82 1.648 . . . . 0.0 108.59 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -81.5 37.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.409 1.1 . . . . 0.0 111.082 -172.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 110.28 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -162.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -64.17 -56.45 14.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.677 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.34 0.02 9.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -134.93 76.61 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.487 1.915 . . . . 0.0 107.192 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.761 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -122.48 166.56 14.58 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 160.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 14.6 mt-10 -106.68 -16.89 14.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -144.76 153.86 42.12 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.761 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 70.4 m-85 -131.53 98.4 4.5 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.145 1.778 . . . . 0.0 107.51 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.406 HG22 ' CG1' ' A' ' 37' ' ' VAL . 2.2 mm -79.43 103.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -176.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 58' ' ' LEU . 55.9 mt -89.27 103.87 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.507 ' HB3' HG12 ' A' ' 4' ' ' VAL . 50.4 t80 -85.06 146.17 27.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.51 114.42 21.74 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 127.172 2.189 . . . . 0.0 111.09 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.9 p -78.86 13.82 1.58 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -99.89 -32.94 10.75 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.348 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.93 36.49 1.41 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.033 160.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.57 33.62 26.17 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.257 0.932 . . . . 0.0 111.784 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -81.88 157.79 24.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.128 1.771 . . . . 0.0 107.091 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.406 ' CG1' HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -138.48 150.33 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.867 0.842 . . . . 0.0 110.052 177.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.97 141.73 51.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.011 1.325 . . . . 0.0 108.845 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.87 110.26 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 163.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.37 150.31 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 160.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.88 117.01 27.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.213 -0.817 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -168.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.448 -1.153 0 CA-C-O 118.102 -0.874 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 -66.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.791 2.437 . . . . 0.0 114.99 -170.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -57.65 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.456 1.502 . . . . 0.0 107.99 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -41.93 79.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 115.747 -2.073 . . . . 0.0 110.922 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -40.56 61.76 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.879 1.672 . . . . 0.0 111.499 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -75.61 -50.78 14.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.084 1.354 . . . . 0.0 109.787 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' A' ' 29' ' ' ILE . 87.3 mt -58.5 -43.62 89.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.928 0.891 . . . . 0.0 110.102 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.74 -51.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.897 1.679 . . . . 0.0 110.756 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.3 t -62.15 -25.91 68.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -92.15 37.59 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.44 -1.412 . . . . 0.0 110.331 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.11 6.32 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 127.518 2.485 . . . . 0.0 115.779 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.68 137.81 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.189 1.495 . . . . 0.0 109.272 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.38 35.01 2.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 110.955 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.873 ' HB3' HG23 ' A' ' 4' ' ' VAL . 10.5 m-85 179.89 164.5 1.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 119.634 -1.916 . . . . 0.0 107.209 -170.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 68' ' ' ALA . 12.0 tp -171.2 147.42 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.72 HG21 ' HB1' ' A' ' 97' ' ' ALA . 62.9 mt -123.85 101.14 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -155.31 115.48 3.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.418 1.008 . . . . 0.0 110.639 -166.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.8 p -59.43 -23.89 63.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -171.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.01 174.09 9.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -170.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -120.06 157.66 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.492 -1.38 . . . . 0.0 108.428 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.7 67.62 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 169.75 -154.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 131.409 3.884 . . . . 0.0 105.657 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -24.75 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.18 2.992 . . . . 0.0 114.355 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -170.99 -29.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.412 1.485 . . . . 0.0 113.97 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.632 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 82.3 t80 -58.68 -36.08 73.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.49 1.116 . . . . 0.0 112.51 -169.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.16 -41.03 74.34 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -23.77 67.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.84 -0.537 . . . . 0.0 111.039 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.34 -68.16 0.41 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.857 0.863 . . . . 0.0 108.968 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.632 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -58.33 -31.38 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.82 24.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.096 0.558 . . . . 0.0 110.445 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.7 36.86 1.83 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.386 0.674 . . . . 0.0 111.828 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.25 8.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.416 1.484 . . . . 0.0 116.333 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.86 120.26 33.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.191 1.495 . . . . 0.0 108.98 -170.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -78.43 160.79 27.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.8 t -143.42 137.34 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.57 158.19 25.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.022 1.729 . . . . 0.0 110.112 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -78.95 148.24 32.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.525 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -138.12 161.12 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 156.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -148.94 85.38 1.48 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 120.268 1.395 . . . . 0.0 111.154 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.9 112.47 0.59 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.454 1.026 . . . . 0.0 111.063 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.92 158.3 10.76 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -83.08 171.76 13.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 110.397 170.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.15 -40.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-O 116.747 -1.597 . . . . 0.0 113.138 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -35.26 76.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 121.012 1.733 . . . . 0.0 113.626 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.83 -46.25 69.04 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.75 2.02 . . . . 0.0 108.355 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.72 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.41 -40.45 17.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 118.699 0.681 . . . . 0.0 111.144 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.65 -51.04 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.39 1.876 . . . . 0.0 108.886 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -40.05 85.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.382 1.473 . . . . 0.0 108.237 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.66 -49.48 25.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.79 0.836 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.78 -50.45 73.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.477 1.035 . . . . 0.0 111.787 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -64.18 -39.05 93.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.384 1.074 . . . . 0.0 110.163 -168.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -101.42 37.34 1.81 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.975 0.91 . . . . 0.0 109.435 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 40.22 46.06 3.3 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 127.497 2.475 . . . . 0.0 114.113 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -112.49 37.35 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.901 0.88 . . . . 0.0 109.854 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 89' ' ' PHE . 74.3 mt -143.39 170.09 16.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.994 -1.067 . . . . 0.0 108.547 165.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -119.11 147.64 43.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.641 1.576 . . . . 0.0 108.075 -165.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -78.99 116.84 19.55 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 C--O 1.232 0.147 0 C-N-CA 126.727 2.011 . . . . 0.0 108.362 -178.527 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 . . . . . 0 CA--C 1.51 -0.583 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -105.96 124.64 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.284 -172.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.45 111.38 23.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.98 124.55 51.68 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 60.8 Cg_endo -77.55 112.0 3.25 Favored 'Trans proline' 0 N--CA 1.443 -1.448 1 C-N-CA 125.464 4.109 . . . . 0.0 108.528 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 t -108.66 174.8 5.71 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.192 1.397 . . . . 0.0 108.498 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.82 38.49 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 109.655 167.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.78 -170.14 32.18 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -129.48 64.8 1.48 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.593 1.696 . . . . 0.0 110.195 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.62 153.99 29.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.082 1.753 . . . . 0.0 107.949 169.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -65.94 -12.07 52.14 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.737 1.215 . . . . 0.0 110.521 174.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -110.58 36.44 3.1 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.589 -1.319 . . . . 0.0 111.435 172.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 166.73 11.77 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.053 -1.03 . . . . 0.0 109.771 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 135.14 37.35 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.302 -1.499 . . . . 0.0 109.81 -172.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.599 HG21 ' HB2' ' A' ' 97' ' ' ALA . 45.7 t -78.02 131.11 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 t -81.07 144.16 31.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.614 1.566 . . . . 0.0 109.76 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -86.41 36.71 0.7 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.444 1.593 . . . . 0.0 110.739 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.61 121.54 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -166.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.65 -61.25 1.84 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . . . -66.41 -23.6 66.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.832 -168.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -105.04 75.56 1.19 Allowed 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 127.673 2.389 . . . . 0.0 107.753 166.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -133.19 160.26 37.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 157.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -105.96 -12.63 15.75 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -168.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -146.22 145.86 30.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.35 108.25 9.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 28' ' ' ILE . 1.4 mp -89.62 117.71 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -171.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.507 HD11 ' CD2' ' A' ' 58' ' ' LEU . 42.5 mt -105.24 97.29 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 -175.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HG12 ' A' ' 4' ' ' VAL . 71.9 t80 -91.25 109.08 20.34 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.77 110.22 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.463 1.505 . . . . 0.0 108.962 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -78.02 55.03 1.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.558 -0.714 . . . . 0.0 110.016 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -134.21 -39.86 0.83 Allowed 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 124.814 1.246 . . . . 0.0 111.374 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -144.37 37.33 1.23 Allowed 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.601 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 16.29 2.24 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.609 1.576 . . . . 0.0 115.294 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -82.22 134.03 35.28 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.305 1.053 . . . . 0.0 108.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.64 160.51 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 125.261 1.424 . . . . 0.0 108.817 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.17 132.86 27.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.87 110.55 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.12 152.07 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 160.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -124.44 96.04 4.76 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.96 2.504 . . . . 0.0 105.935 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.457 -0.635 0 CA-C-O 119.007 -0.497 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.46 -77.38 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.513 2.325 . . . . 0.0 110.87 -165.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -49.66 -60.52 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 C-N-CA 126.317 1.847 . . . . 0.0 109.334 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.3 t -60.04 -51.2 75.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 115.743 -2.075 . . . . 0.0 109.708 -173.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.82 -51.31 9.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.914 1.688 . . . . 0.0 110.949 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -62.41 -56.05 21.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 29' ' ' ILE . 93.0 mt -62.67 -41.9 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.301 0.64 . . . . 0.0 110.262 -172.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -57.44 -46.62 85.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -58.37 -27.64 64.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.146 0.884 . . . . 0.0 112.415 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -99.74 37.4 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.665 1.186 . . . . 0.0 109.471 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.11 23.42 7.75 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.292 2.377 . . . . 0.0 116.69 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.64 125.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.535 1.168 . . . . 0.0 108.053 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.19 36.59 4.61 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 164.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.559 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -165.74 157.46 14.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.485 -1.385 . . . . 0.0 109.112 -168.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 86' ' ' VAL . 12.1 tp -164.08 148.34 10.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -173.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.699 HG21 ' HB1' ' A' ' 97' ' ' ALA . 28.2 mt -124.58 106.77 17.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -156.77 134.44 10.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.999 2.182 . . . . 0.0 111.184 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -64.08 -21.16 66.41 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.602 -1.311 . . . . 0.0 113.641 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -163.21 177.45 9.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.07 1.748 . . . . 0.0 106.432 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 73' ' ' ARG 0.251 1.0 OUTLIER -107.35 161.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.055 -1.028 . . . . 0.0 108.561 174.847 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 22' ' ' ALA . . . -80.29 24.77 3.42 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.683 1.135 . . . . 0.0 111.63 171.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.486 ' H ' HG13 ' A' ' 71' ' ' VAL . 1.2 ttt-85 68.05 -71.09 0.11 Allowed 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 129.684 3.194 . . . . 0.0 113.257 -172.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.29 56.37 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.448 2.299 . . . . 0.0 113.833 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . . . -161.62 -28.64 0.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 113.95 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 79' ' ' LEU . 56.6 t80 -69.39 -32.59 71.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.897 1.68 . . . . 0.0 111.986 -169.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.21 -38.13 85.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 110.073 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -14.83 58.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.928 2.891 . . . . 0.0 109.366 -174.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 76' ' ' PHE . 31.9 mt -80.86 -58.13 3.23 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 108.221 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.642 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -62.6 -28.37 69.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.299 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.0 54.82 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.034 0.834 . . . . 0.0 111.876 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.9 37.31 4.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.617 1.099 . . . . 0.0 110.765 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.39 30.53 0.3 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.686 2.088 . . . . 0.0 117.041 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.78 125.2 38.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 118.87 1.335 . . . . 0.0 109.048 -169.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -78.96 155.99 28.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.453 HG13 HD23 ' A' ' 66' ' ' LEU . 43.6 t -145.69 129.47 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.24 170.6 7.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 110.655 171.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -107.58 152.02 24.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 126.898 2.079 . . . . 0.0 109.586 162.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.18 167.9 21.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.199 2.2 . . . . 0.0 106.425 176.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.93 129.17 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 167.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.04 90.5 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 128.04 2.733 . . . . 0.0 115.784 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.96 163.77 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -89.86 173.83 8.03 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.979 -0.719 . . . . 0.0 109.894 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.74 -42.83 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 117.731 -1.128 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -61.55 -36.9 81.9 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.55 -40.64 73.27 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.961 1.304 . . . . 0.0 109.08 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.75 -39.76 26.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.457 170.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -78.91 -60.43 2.27 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.91 -21.39 43.32 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 127.955 2.502 . . . . 0.0 110.919 -172.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.32 -52.69 6.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.585 ' HB2' HD12 ' A' ' 106' ' ' LEU . 19.4 t80 -59.51 -50.14 75.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.688 0.795 . . . . 0.0 112.732 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -64.07 -41.87 97.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 109.32 -168.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.38 36.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.293 1.037 . . . . 0.0 109.27 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.06 20.36 6.47 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 128.621 3.01 . . . . 0.0 117.244 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -97.1 37.41 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.538 1.669 . . . . 0.0 111.335 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 101' ' ' PHE . 27.0 mt -134.97 169.7 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.569 1.077 . . . . 0.0 109.062 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -108.64 138.74 44.46 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.354 1.462 . . . . 0.0 108.138 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.7 108.26 13.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--O 1.238 0.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -178.005 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 . . . . . 0 CA--C 1.503 -0.861 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.835 HG23 ' HB3' ' A' ' 65' ' ' TYR . 3.1 p -125.64 167.83 19.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 128.499 2.72 . . . . 0.0 103.756 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.42 149.45 52.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.52 120.01 19.59 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.57 123.67 11.07 Favored 'Trans proline' 0 N--CA 1.443 -1.492 1 C-N-CA 126.097 4.531 . . . . 0.0 107.135 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.3 t -127.44 169.16 13.93 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.825 1.65 . . . . 0.0 108.356 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.09 37.77 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 110.298 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.79 -177.85 41.03 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.224 -1.548 . . . . 0.0 111.008 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.4 mtpt -114.53 39.89 2.69 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.262 -1.14 . . . . 0.0 109.943 -172.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.33 148.44 36.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.919 1.288 . . . . 0.0 108.065 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -60.81 -10.5 5.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 112.574 173.711 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -112.69 36.6 3.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.277 -0.89 . . . . 0.0 111.396 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -90.2 167.97 12.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.041 -1.037 . . . . 0.0 108.967 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 139.8 39.16 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 120.865 1.666 . . . . 0.0 108.668 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 99.0 t -72.67 135.97 26.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -87.71 135.71 33.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.58 38.13 0.37 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.098 0.952 . . . . 0.0 110.903 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.93 99.05 0.07 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 119.86 -1.775 . . . . 0.0 110.174 -165.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 79' ' ' LEU . 18.9 t80 -53.49 -51.65 62.07 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.785 1.175 . . . . 0.0 112.957 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -3.66 33.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.002 -1.062 . . . . 0.0 112.401 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 38.79 3.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.549 0.74 . . . . 0.0 109.886 -171.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.77 108.94 16.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -165.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -52.64 -24.45 8.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.254 1.822 . . . . 0.0 115.272 -168.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 96.2 m-85 -139.19 151.26 46.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -129.61 112.79 14.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.1 mm -91.82 118.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.528 HD11 ' CD2' ' A' ' 58' ' ' LEU . 96.2 mt -111.97 100.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -172.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -82.77 141.7 32.15 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -117.87 110.82 18.23 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 127.197 2.199 . . . . 0.0 109.692 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.282 1.3 p -85.08 43.04 0.97 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.947 0.88 . . . . 0.0 110.699 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.94 -29.45 2.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 126.019 1.728 . . . . 0.0 112.604 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -147.58 35.25 0.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 117.728 -1.589 . . . . 0.0 111.069 157.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.2 24.12 14.59 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.804 -1.185 . . . . 0.0 112.31 -176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -64.75 156.24 31.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.74 162.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.533 1.158 . . . . 0.0 108.842 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -141.77 128.01 19.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.22 105.01 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.56 143.13 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 159.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.95 121.41 43.84 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 122.984 1.373 . . . . 0.0 110.221 -172.105 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.45 -1.034 0 CA-C-O 118.938 -0.526 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? 65.17 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.351 1.46 . . . . 0.0 108.674 -166.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -67.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 127.135 2.174 . . . . 0.0 108.985 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.2 t -55.81 -49.96 71.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 115.669 -2.11 . . . . 0.0 109.651 -173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.46 -50.37 23.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.306 1.412 . . . . 0.0 111.117 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -42.16 68.52 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.107 -0.996 . . . . 0.0 113.342 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 29' ' ' ILE . 78.3 mt -66.5 -44.32 82.88 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.751 0.705 . . . . 0.0 109.888 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.31 -32.17 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.407 1.483 . . . . 0.0 110.118 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.6 m -75.89 1.98 13.66 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.802 -1.186 . . . . 0.0 113.879 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -119.42 38.46 3.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.452 1.901 . . . . 0.0 108.289 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.89 19.98 12.24 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.64 1.114 . . . . 0.0 115.845 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.0 96.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.131 1.373 . . . . 0.0 107.864 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.47 36.31 2.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.324 1.05 . . . . 0.0 110.568 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.835 ' HB3' HG23 ' A' ' 4' ' ' VAL . 10.8 m-85 179.83 165.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.608 1.563 . . . . 0.0 107.024 -165.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 tp -166.14 152.65 9.31 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.271 1.429 . . . . 0.0 107.449 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.773 HG21 ' HB1' ' A' ' 97' ' ' ALA . 57.3 mt -123.06 103.04 12.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.95 130.03 13.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.698 1.136 . . . . 0.0 110.342 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.7 p -62.72 -28.19 69.79 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -169.14 -171.07 1.22 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.399 1.479 . . . . 0.0 107.15 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 p -136.24 136.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.45 96.54 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.85 177.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 129.486 3.114 . . . . 0.0 107.561 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.98 50.38 3.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 127.581 2.352 . . . . 0.0 115.616 154.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.4 -26.35 0.1 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 171.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.725 ' HA ' HD12 ' A' ' 79' ' ' LEU . 33.9 t80 -62.35 -35.62 79.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.377 0.989 . . . . 0.0 112.539 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.91 -34.59 73.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.7 m -73.09 -20.05 61.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.624 0.77 . . . . 0.0 111.072 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 76' ' ' PHE . 28.1 mt -69.46 -57.61 5.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -65.2 -29.74 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.94 -1.71 1.58 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.01 37.23 2.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.87 1.668 . . . . 0.0 110.181 162.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.6 30.99 1.58 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.868 . . . . 0.0 116.804 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.37 117.58 25.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 118.937 1.368 . . . . 0.0 108.524 -168.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -79.14 99.01 6.78 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.537 0.684 . . . . 0.0 109.959 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 79' ' ' LEU . 35.9 t -82.5 117.75 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.81 155.29 18.34 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.662 1.185 . . . . 0.0 109.558 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 157.56 26.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 164.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 163.15 30.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 160.245 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.52 68.21 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.801 1.182 . . . . 0.0 110.508 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.62 136.23 8.58 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.05 154.1 6.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.879 0.339 . . . . 0.0 112.519 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -80.05 171.08 15.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.07 0.548 . . . . 0.0 109.653 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -43.82 -42.15 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.769 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.37 -38.74 81.23 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -42.35 83.29 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 127.144 2.178 . . . . 0.0 108.849 -174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.773 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.81 -38.98 11.01 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.819 0.736 . . . . 0.0 111.167 171.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -86.0 -53.79 9.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 125.275 1.43 . . . . 0.0 109.121 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -26.69 65.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.044 1.738 . . . . 0.0 109.375 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.11 -62.6 1.41 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.415 ' HB2' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -51.75 -48.84 63.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.59 1.556 . . . . 0.0 112.626 -178.039 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -77.88 -13.27 59.94 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.664 2.786 . . . . 0.0 113.482 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -114.37 37.78 3.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.245 1.384 . . . . 0.0 109.836 159.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.51 12.73 4.91 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 127.626 2.536 . . . . 0.0 117.345 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -89.31 37.39 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.254 1.527 . . . . 0.0 111.413 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 101' ' ' PHE . 26.8 mt -136.29 167.33 21.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.013 1.279 . . . . 0.0 110.821 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -108.44 142.86 38.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.44 110.88 17.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 125.96 1.704 . . . . 0.0 108.608 -176.484 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -93.07 142.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.96 153.98 18.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 160.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.01 125.64 19.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 56.5 Cg_endo -74.27 106.63 2.27 Favored 'Trans proline' 0 N--CA 1.445 -1.35 1 C-N-CA 126.131 4.554 . . . . 0.0 109.576 177.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -104.12 172.07 7.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.364 1.466 . . . . 0.0 109.408 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.29 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 108.623 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.22 -169.36 42.36 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.794 -1.191 . . . . 0.0 111.259 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 7.5 mtmp? -129.96 52.71 1.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 111.842 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.64 167.48 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.917 1.687 . . . . 0.0 107.205 166.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -81.71 -6.31 58.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.501 -1.375 . . . . 0.0 111.0 174.142 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -116.26 39.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.579 -1.325 . . . . 0.0 108.922 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 m -78.66 169.39 18.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.25 -1.38 . . . . 0.0 107.303 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 145.08 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.441 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 69.5 t -86.05 137.77 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.404 1.097 . . . . 0.0 108.746 170.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -90.84 137.44 32.36 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.847 2.059 . . . . 0.0 108.74 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -81.25 36.16 0.41 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 122.895 1.331 . . . . 0.0 111.035 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 101.38 0.12 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -157.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 79' ' ' LEU . 8.5 t80 -55.04 -59.41 4.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.493 0.588 . . . . 0.0 110.571 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.08 -3.74 31.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.667 -170.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.71 74.1 1.24 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.312 1.415 . . . . 0.0 107.357 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -135.99 120.65 18.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.38 -22.13 66.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.259 1.424 . . . . 0.0 113.535 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 98.4 m-85 -137.25 148.67 46.61 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.01 1.724 . . . . 0.0 107.455 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -130.59 112.82 13.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.36 120.87 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.9 mt -109.77 101.49 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' HG12 ' A' ' 4' ' ' VAL . 38.9 t80 -89.63 110.89 21.73 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.86 108.88 13.78 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.076 2.15 . . . . 0.0 108.313 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -83.31 57.96 4.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -129.57 -48.51 1.16 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 124.649 1.18 . . . . 0.0 109.128 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 38.19 3.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.736 162.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.4 22.35 10.55 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.2 0.905 . . . . 0.0 113.68 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.86 148.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.14 148.88 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.1 0.96 . . . . 0.0 109.921 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -132.52 139.32 47.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.587 2.355 . . . . 0.0 105.793 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.9 t -108.9 103.57 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.48 151.71 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 167.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.54 129.96 56.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 CA--C 1.514 -0.414 0 O-C-N 120.697 -1.252 . . . . 0.0 110.124 -174.369 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 CA-C-O 117.932 -0.945 . . . . 0.0 112.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.322 1.7 ptpt 54.19 -65.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.821 2.448 . . . . 0.0 114.339 -164.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -65.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 127.156 2.182 . . . . 0.0 108.069 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.92 -48.09 78.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-O 116.863 -1.542 . . . . 0.0 109.151 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -46.95 21.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.171 0.896 . . . . 0.0 111.678 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -69.5 -56.22 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.305 0.642 . . . . 0.0 111.082 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -57.4 -46.01 83.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.418 0.554 . . . . 0.0 109.578 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 t -56.71 -36.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.373 1.869 . . . . 0.0 111.54 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -61.18 -38.93 88.26 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.575 1.079 . . . . 0.0 110.575 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.06 38.49 0.85 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.694 1.134 . . . . 0.0 110.029 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.17 26.4 42.76 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.019 1.771 . . . . 0.0 115.578 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.1 t -71.85 101.25 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.123 1.461 . . . . 0.0 109.231 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.28 34.88 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.618 0.645 . . . . 0.0 109.995 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.496 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -168.07 157.55 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 119.989 -1.694 . . . . 0.0 108.796 -169.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.9 tp -166.36 145.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 120.232 -1.542 . . . . 0.0 108.671 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.021 HG21 ' HB1' ' A' ' 97' ' ' ALA . 7.6 mt -111.18 107.02 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 126.404 1.882 . . . . 0.0 106.222 171.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.97 106.15 1.8 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 120.998 1.726 . . . . 0.0 110.623 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.7 p -34.46 -48.8 0.37 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.153 1.781 . . . . 0.0 113.195 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.39 -178.4 6.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -114.64 160.1 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.79 -23.54 38.6 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.392 -166.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -169.43 -132.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.363 3.465 . . . . 0.0 103.437 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -164.3 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.872 1.214 . . . . 0.0 110.872 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 97.58 -26.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.208 1 C-N-CA 133.427 4.691 . . . . 0.0 112.633 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 79' ' ' LEU . 60.6 t80 -60.85 -36.5 79.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.501 1.5 . . . . 0.0 112.247 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.75 -38.25 79.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.405 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -74.0 -24.44 59.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.914 0.886 . . . . 0.0 110.018 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 76' ' ' PHE . 27.6 mt -65.69 -72.01 0.17 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -57.05 -32.73 66.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.13 17.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.688 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.39 36.6 0.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.101 0.864 . . . . 0.0 112.071 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.26 33.89 0.56 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.232 1.872 . . . . 0.0 116.238 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 t -81.06 119.39 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 152.95 31.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.5 t -150.2 112.34 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.51 172.97 9.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.229 1.411 . . . . 0.0 111.311 166.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -112.02 148.46 33.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.452 2.701 . . . . 0.0 108.767 164.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -127.31 166.34 17.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.047 2.539 . . . . 0.0 105.086 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -148.4 56.68 1.05 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.122 1.328 . . . . 0.0 110.168 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.63 110.88 3.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 123.444 0.545 . . . . 0.0 112.395 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.56 166.49 31.94 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.6 p -87.39 173.68 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.748 0.819 . . . . 0.0 110.492 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.51 -38.42 12.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 CA-C-O 117.028 -1.463 . . . . 0.0 110.959 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.05 -45.33 93.19 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 120.45 1.477 . . . . 0.0 114.002 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -42.3 97.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.192 1.797 . . . . 0.0 109.283 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 1.021 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.75 -36.1 10.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -87.4 -57.13 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.71 -49.08 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.546 2.339 . . . . 0.0 106.53 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.81 76.7 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.354 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.57 ' HB2' HD12 ' A' ' 106' ' ' LEU . 6.3 t80 -62.34 -47.66 83.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.55 -0.719 . . . . 0.0 110.78 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.4 p -70.36 -29.97 66.78 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.059 1.344 . . . . 0.0 109.688 -166.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -99.96 35.98 1.93 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.238 1.015 . . . . 0.0 110.732 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.44 53.62 2.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.45 1.5 . . . . 0.0 113.289 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -127.27 38.28 4.1 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 126.641 1.977 . . . . 0.0 109.189 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 101' ' ' PHE . 28.7 mt -132.93 167.07 20.92 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 120.899 1.681 . . . . 0.0 111.071 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.68 134.96 40.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.914 1.686 . . . . 0.0 107.863 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -91.03 101.9 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.237 0.44 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -170.902 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.66 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -94.03 164.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 161.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 154.49 47.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 163.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.7 120.11 13.17 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.588 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 73.7 Cg_endo -70.45 108.57 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.75 3.634 . . . . 0.0 106.887 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 t -105.59 168.87 8.81 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.544 1.537 . . . . 0.0 108.16 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.03 37.47 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.531 -0.73 . . . . 0.0 110.317 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.57 165.93 39.26 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.5 39.64 1.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.051 1.34 . . . . 0.0 110.351 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.78 148.79 36.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -14.71 62.56 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.355 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 t -122.59 37.52 4.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -104.45 170.99 7.58 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.522 -0.736 . . . . 0.0 109.82 163.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.9 mmm -77.5 137.29 38.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.983 -1.073 . . . . 0.0 111.078 -166.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 41.6 t -71.51 131.17 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.623 167.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 t -79.51 144.67 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.46 1.904 . . . . 0.0 108.599 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -85.07 36.44 0.62 Allowed 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.29 116.23 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -156.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HB3' HG23 ' A' ' 71' ' ' VAL . 30.3 t80 -63.32 -69.33 0.28 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.575 0.75 . . . . 0.0 110.706 172.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.88 10.83 1.63 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -169.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -132.98 71.34 1.47 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 159.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -110.68 179.62 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 156.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -120.68 -16.89 8.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -140.01 155.2 47.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 93.1 m-85 -133.39 108.7 8.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -86.9 127.8 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.618 HD11 ' CD2' ' A' ' 58' ' ' LEU . 94.0 mt -125.22 97.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -165.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 4' ' ' VAL . 49.7 t80 -92.53 125.64 37.26 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.758 1.223 . . . . 0.0 109.153 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 125.79 30.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.043 1.737 . . . . 0.0 111.933 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.281 3.2 p -91.58 31.86 1.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.775 0.798 . . . . 0.0 109.967 174.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.88 -90.18 0.56 Allowed 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 154.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.55 35.59 1.21 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.359 -157.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 45.63 15.15 0.09 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.127 2.298 . . . . 0.0 115.617 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -69.35 154.58 41.81 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.34 144.09 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.679 1.228 . . . . 0.0 109.581 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.99 130.5 52.68 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.19 107.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.67 146.5 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 157.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.37 150.15 27.06 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.076 1.75 . . . . 0.0 106.533 161.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 109.879 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.326 0.7 OUTLIER 54.27 -67.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.895 2.078 . . . . 0.0 111.624 -158.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -50.59 -61.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.708 1.603 . . . . 0.0 109.876 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.41 -53.9 38.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-O 115.155 -2.355 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -49.03 -47.33 44.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 121.146 1.794 . . . . 0.0 110.194 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -50.35 60.03 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.185 1.394 . . . . 0.0 112.816 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.618 ' CD2' HD11 ' A' ' 29' ' ' ILE . 94.7 mt -65.69 -39.06 90.87 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.096 0.862 . . . . 0.0 110.088 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.73 -41.47 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.965 1.306 . . . . 0.0 109.791 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.39 1.41 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -126.43 37.46 4.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.367 1.467 . . . . 0.0 107.622 171.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.76 17.16 41.31 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.709 2.1 . . . . 0.0 116.503 166.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.05 102.43 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.777 1.288 . . . . 0.0 110.873 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.12 36.43 2.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.212 1.805 . . . . 0.0 111.658 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.623 ' HB3' HG23 ' A' ' 4' ' ' VAL . 8.4 m-85 177.11 173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.745 -1.847 . . . . 0.0 106.81 -168.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 68' ' ' ALA . 13.1 tp -174.62 146.17 0.98 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.807 HG21 ' HB1' ' A' ' 97' ' ' ALA . 30.5 mt -114.69 103.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -158.85 101.89 1.64 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.983 1.313 . . . . 0.0 109.412 -168.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 5.8 t -60.81 -17.55 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.664 1.585 . . . . 0.0 113.792 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.89 178.33 7.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.411 -1.431 . . . . 0.0 108.806 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.665 HG13 ' H ' ' A' ' 73' ' ' ARG . 1.7 p -126.47 156.51 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 120.313 -1.492 . . . . 0.0 110.216 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.4 20.5 0.13 Allowed Glycine 0 CA--C 1.546 2.009 0 C-N-CA 127.096 2.284 . . . . 0.0 114.219 166.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.665 ' H ' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER 62.7 0.76 0.7 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.874 2.469 . . . . 0.0 116.518 174.385 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.5 p30 -137.83 101.02 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' ASN . . . 162.31 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.502 1.521 . . . . 0.0 113.675 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.61 -44.73 81.45 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.806 1.185 . . . . 0.0 109.769 -160.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.73 -40.38 95.23 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.927 1.291 . . . . 0.0 110.384 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -67.1 -19.54 65.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.054 0.542 . . . . 0.0 111.271 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.71 -47.19 32.8 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -62.77 -35.23 79.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.195 0.998 . . . . 0.0 111.489 176.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.94 86.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.127 0.571 . . . . 0.0 110.073 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.18 36.27 1.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.361 0.528 . . . . 0.0 111.196 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.34 31.72 0.21 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 127.607 2.527 . . . . 0.0 117.083 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.42 125.16 38.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.016 1.326 . . . . 0.0 108.31 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -78.5 160.2 27.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.3 t -143.83 131.68 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -107.62 157.81 17.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.048 1.739 . . . . 0.0 109.762 172.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -80.0 160.73 25.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 160.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -132.77 159.08 40.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.512 1.525 . . . . 0.0 108.826 162.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 9.1 pt-20 -129.34 74.7 1.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.818 2.099 . . . . 0.0 111.632 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.47 159.86 3.01 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.942 1.258 . . . . 0.0 111.148 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.39 161.66 9.19 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.845 -0.797 . . . . 0.0 112.833 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -96.8 164.74 12.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.91 1.284 . . . . 0.0 107.555 167.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.87 -37.3 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 117.014 -1.469 . . . . 0.0 114.277 -166.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.54 -32.79 74.58 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 121.007 1.731 . . . . 0.0 114.184 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -66.53 -43.0 86.36 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.612 1.965 . . . . 0.0 108.898 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.807 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -51.81 -28.84 16.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.291 0.496 . . . . 0.0 112.166 174.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mm -95.04 -53.37 8.37 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -25.3 68.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 110.125 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -57.16 4.1 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.623 ' HB2' HD12 ' A' ' 106' ' ' LEU . 10.7 t80 -59.96 -44.29 94.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.499 1.52 . . . . 0.0 113.451 -177.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -67.71 -13.15 61.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.637 1.575 . . . . 0.0 111.498 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.37 35.15 4.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.261 1.024 . . . . 0.0 108.761 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.31 2.93 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.09 1.805 . . . . 0.0 117.016 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -81.12 39.69 0.52 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.747 2.274 . . . . 0.0 111.176 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 101' ' ' PHE . 28.5 mt -128.55 -166.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -128.24 154.75 45.52 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -78.48 132.2 37.17 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 164.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 108.833 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 31' ' ' ASP . 4.1 mtp180 . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -95.38 153.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.541 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.07 147.58 39.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.17 119.96 21.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.492 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 87.9 Cg_endo -72.54 95.13 0.78 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 1 C-N-CA 125.956 4.437 . . . . 0.0 107.308 177.29 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 t -89.57 172.58 8.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.3 1.04 . . . . 0.0 109.058 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.97 37.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.537 1.135 . . . . 0.0 111.107 166.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.23 173.16 45.19 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 167.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -107.78 38.12 2.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.393 0.596 . . . . 0.0 110.189 -166.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.93 151.69 47.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -5.3 39.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 111.649 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t -124.27 37.86 4.32 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.388 -1.445 . . . . 0.0 109.355 165.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.3 m -79.75 175.09 10.94 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 159.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.3 mmm -77.88 144.68 36.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 119.879 -1.763 . . . . 0.0 110.577 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 61.4 t -78.43 161.5 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 163.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -118.54 133.45 55.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 110.625 -167.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.19 39.03 0.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.392 1.477 . . . . 0.0 110.342 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -178.46 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.347 -1.471 . . . . 0.0 109.25 -164.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -50.98 -56.32 13.04 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.404 -0.81 . . . . 0.0 112.589 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.2 4.43 1.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -172.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -138.67 38.77 2.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.686 1.995 . . . . 0.0 108.166 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -90.31 179.59 5.85 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.7 -17.94 7.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -146.31 147.74 31.67 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 73.4 m-85 -128.94 96.09 4.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 mp -79.9 113.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.442 HD11 HD22 ' A' ' 58' ' ' LEU . 69.6 mt -100.37 107.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 4' ' ' VAL . 70.8 t80 -93.72 133.81 36.7 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.87 0.868 . . . . 0.0 108.783 175.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 16.4 t0 -97.76 115.15 27.43 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.034 1.734 . . . . 0.0 111.123 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.5 p -86.26 29.82 0.73 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.693 0.758 . . . . 0.0 110.758 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -113.35 -86.53 0.57 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 159.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -93.16 35.45 1.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 115.584 -2.446 . . . . 0.0 110.439 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.8 18.73 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.771 1.653 . . . . 0.0 113.827 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -69.92 160.77 31.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.548 1.139 . . . . 0.0 108.973 -175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.69 152.0 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.701 0.763 . . . . 0.0 109.081 172.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -131.97 123.92 28.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 173.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -88.91 104.89 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.96 141.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -98.07 141.4 31.06 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.842 1.657 . . . . 0.0 106.656 164.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.04 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.455 -0.744 0 CA-C-O 119.329 -0.363 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.341 2.1 ptpt 49.72 -73.59 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 129.142 2.977 . . . . 0.0 112.445 -163.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -54.35 -56.76 8.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 125.285 1.434 . . . . 0.0 109.182 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.6 t -57.03 -56.71 13.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.495 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -41.91 -54.59 3.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.972 0.909 . . . . 0.0 111.527 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.7 m -65.13 -53.6 42.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 113.598 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 29' ' ' ILE . 93.3 mt -63.1 -43.41 98.56 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.071 0.948 . . . . 0.0 109.755 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.24 -41.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.318 1.447 . . . . 0.0 110.346 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -68.59 0.89 3.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -110.02 38.39 2.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 109.972 165.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.55 32.41 16.07 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.069 1.318 . . . . 0.0 114.69 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.84 92.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 3.4 mm-40 -95.18 33.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.192 1.397 . . . . 0.0 111.109 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.74 ' HB3' HG23 ' A' ' 4' ' ' VAL . 3.4 m-85 171.65 160.13 0.09 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 119.184 -2.198 . . . . 0.0 107.748 -158.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 tp -168.8 147.01 3.99 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.301 1.04 . . . . 0.0 108.512 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.851 HG21 ' HB1' ' A' ' 97' ' ' ALA . 58.5 mt -118.25 105.97 18.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 125.6 1.56 . . . . 0.0 107.278 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.56 112.64 3.0 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.069 1.304 . . . . 0.0 111.85 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.32 -25.13 32.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.136 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.63 178.01 9.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.786 3.235 . . . . 0.0 104.562 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.09 165.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 151.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.02 -12.23 68.59 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.394 -1.225 . . . . 0.0 113.905 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 148.76 174.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 1 C-N-CA 132.942 4.497 . . . . 0.0 108.732 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 24.61 74.41 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 130.878 3.671 . . . . 0.0 113.21 168.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.06 -24.27 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.621 1.568 . . . . 0.0 112.484 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 79' ' ' LEU . 9.4 t80 -59.84 -45.05 93.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.893 -170.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -66.94 -34.11 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -15.69 62.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.739 1.216 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 76' ' ' PHE . 52.9 mt -79.63 -54.55 5.77 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.31 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.815 0.846 . . . . 0.0 112.303 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.82 -35.75 61.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.73 0.812 . . . . 0.0 112.2 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.79 37.07 2.89 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.962 0.801 . . . . 0.0 110.792 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.06 30.4 2.54 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.992 1.758 . . . . 0.0 115.865 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.34 97.24 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 118.529 1.165 . . . . 0.0 108.078 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -79.19 112.36 16.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.762 0.792 . . . . 0.0 108.978 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.11 131.12 40.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.745 1.618 . . . . 0.0 107.982 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.71 161.99 13.28 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 126.026 1.73 . . . . 0.0 109.979 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 160.51 26.83 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 163.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.18 151.94 49.35 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 127.701 2.4 . . . . 0.0 104.634 163.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -141.23 66.02 1.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 121.715 2.052 . . . . 0.0 111.191 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.8 128.08 1.75 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.67 160.03 8.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -161.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.8 p -89.77 174.51 7.67 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.583 1.153 . . . . 0.0 110.19 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 83.4 t -48.63 -40.23 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.761 -1.212 . . . . 0.0 112.17 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -64.32 -34.85 79.08 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.044 1.293 . . . . 0.0 113.483 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.72 -41.52 78.94 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 125.773 1.629 . . . . 0.0 109.15 -176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.851 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.63 -40.75 13.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.09 0.859 . . . . 0.0 111.301 170.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -84.89 -49.23 15.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 O-C-N 121.267 -0.896 . . . . 0.0 108.812 -171.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.05 -18.22 63.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 128.442 2.697 . . . . 0.0 109.618 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 -63.83 1.25 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 108.687 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.584 ' HB2' HD12 ' A' ' 106' ' ' LEU . 6.3 t80 -54.08 -51.28 64.65 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.95 0.795 . . . . 0.0 112.5 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -66.69 -41.52 87.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.5 36.8 0.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.42 0.629 . . . . 0.0 110.133 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.28 9.25 2.05 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 127.635 2.54 . . . . 0.0 117.101 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.89 36.75 0.73 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.851 1.825 . . . . 0.0 111.824 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 101' ' ' PHE . 27.9 mt -131.94 172.18 12.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.551 1.069 . . . . 0.0 110.066 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -107.36 149.73 27.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -82.97 127.34 33.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 162.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 C--O 1.24 0.562 0 C-N-CA 124.561 1.145 . . . . 0.0 109.677 -170.753 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 CA--C 1.504 -0.816 0 CA-C-O 121.97 0.89 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 65' ' ' TYR . 2.2 p -79.46 153.58 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.57 149.32 42.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 163.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.17 118.17 18.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.1 126.27 14.2 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 125.075 3.85 . . . . 0.0 108.227 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -125.16 173.98 8.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.113 2.165 . . . . 0.0 105.986 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.05 37.26 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 128.149 2.58 . . . . 0.0 107.626 170.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.72 177.38 46.49 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.474 1.988 . . . . 0.0 109.555 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -121.47 40.37 3.61 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.459 -157.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.77 155.27 48.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -15.77 63.11 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.129 2.172 . . . . 0.0 110.983 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 p -112.07 38.58 2.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.915 -1.115 . . . . 0.0 112.212 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -97.24 168.47 10.4 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 166.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.6 132.99 38.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.827 1.651 . . . . 0.0 111.11 -171.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.403 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 88.5 t -71.29 139.18 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.2 t -86.87 137.35 32.46 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -0.99 . . . . 0.0 109.355 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.31 37.43 0.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.59 1.186 . . . . 0.0 111.861 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 178.42 97.02 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.188 0 O-C-N 119.736 -1.853 . . . . 0.0 109.247 -156.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' VAL . 36.8 t80 -54.32 -50.38 67.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 119.424 1.011 . . . . 0.0 112.778 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.3 13.57 18.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.671 0.669 . . . . 0.0 111.173 -171.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.39 39.29 3.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.427 1.891 . . . . 0.0 106.856 168.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.28 139.51 51.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -89.82 -74.35 0.49 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.847 1.308 . . . . 0.0 108.792 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.48 156.63 22.77 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -135.52 124.56 24.3 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.5 mm -93.04 113.01 27.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -98.43 113.74 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' HG12 ' A' ' 4' ' ' VAL . 46.5 t80 -91.7 153.82 19.4 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.344 1.028 . . . . 0.0 108.643 170.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -124.45 106.17 9.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.54 1.936 . . . . 0.0 110.807 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.7 p -81.63 36.52 0.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.071 1.305 . . . . 0.0 112.228 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -105.54 -64.31 1.16 Allowed 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 124.743 1.217 . . . . 0.0 109.206 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -124.44 38.05 4.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 125.06 1.475 . . . . 0.0 110.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.79 15.24 18.62 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 126.08 1.8 . . . . 0.0 113.792 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.13 160.33 31.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.874 0.87 . . . . 0.0 109.032 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.29 147.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.689 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -130.36 140.34 50.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.208 1.803 . . . . 0.0 106.643 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.91 109.29 23.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 165.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.4 144.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.64 107.22 14.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.451 -1.001 0 CA-C-O 117.525 -1.115 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 60.67 -71.25 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.981 1.312 . . . . 0.0 110.701 -169.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.62 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.95 1.7 . . . . 0.0 110.049 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -54.79 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.349 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.32 -47.37 18.46 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.215 0.916 . . . . 0.0 111.42 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -67.29 0.42 Allowed 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 121.47 -0.769 . . . . 0.0 111.946 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 mt -51.79 -41.5 61.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.466 1.106 . . . . 0.0 110.744 -173.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.4 -41.52 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 126.486 1.914 . . . . 0.0 111.465 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.2 m -66.23 -3.8 6.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.848 -1.157 . . . . 0.0 111.716 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 37.26 4.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.445 1.021 . . . . 0.0 108.812 171.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.03 21.14 69.52 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.578 2.037 . . . . 0.0 116.115 161.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.95 122.81 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.23 1.012 . . . . 0.0 109.877 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -123.75 35.86 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.974 2.11 . . . . 0.0 109.923 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.569 ' HB3' HG23 ' A' ' 4' ' ' VAL . 5.9 m-85 -179.76 176.59 0.76 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.972 1.709 . . . . 0.0 107.358 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -176.63 151.04 0.89 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.339 1.856 . . . . 0.0 107.885 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.801 HG21 ' HB1' ' A' ' 97' ' ' ALA . 68.9 mt -123.07 105.61 16.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 126.444 1.898 . . . . 0.0 107.601 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.21 136.03 16.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.684 1.584 . . . . 0.0 110.339 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.5 p -64.4 -27.21 68.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.863 -1.148 . . . . 0.0 112.999 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -168.4 -175.29 2.49 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.921 1.688 . . . . 0.0 108.132 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -115.46 153.21 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.989 0.916 . . . . 0.0 109.953 177.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.77 28.92 2.1 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 126.682 2.087 . . . . 0.0 111.811 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 51.05 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.524 1.93 . . . . 0.0 111.488 -159.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 25.82 75.17 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.153 2.981 . . . . 0.0 112.07 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 179.89 -40.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.844 1.658 . . . . 0.0 112.301 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.4 -35.76 68.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.096 0.862 . . . . 0.0 112.095 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.9 -40.63 68.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.331 0.652 . . . . 0.0 110.012 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -15.46 63.53 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.542 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -75.78 -47.69 24.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -67.04 -26.14 66.61 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 120.944 -1.097 . . . . 0.0 113.114 174.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.99 -40.42 63.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.238 0.927 . . . . 0.0 110.699 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.74 36.5 2.62 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.958 0.503 . . . . 0.0 111.329 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.51 16.02 4.81 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 117.424 1.73 . . . . 0.0 117.424 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.19 126.76 39.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.97 1.885 . . . . 0.0 109.813 -159.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -79.83 132.16 36.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.5 t -113.1 141.55 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -111.69 160.4 17.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.84 1.656 . . . . 0.0 109.509 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -79.16 159.68 27.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 160.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -141.12 161.39 37.98 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 154.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -150.0 95.53 2.31 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.404 1.456 . . . . 0.0 111.992 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.1 109.27 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 125.69 1.614 . . . . 0.0 111.003 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 162.84 158.44 9.7 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 117.86 0.83 . . . . 0.0 113.682 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -85.29 168.5 14.64 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.148 0.579 . . . . 0.0 109.644 166.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -39.25 -44.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.394 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.97 -39.57 82.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.14 1.791 . . . . 0.0 114.729 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -64.91 -41.66 95.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.312 1.845 . . . . 0.0 108.76 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.801 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -49.69 -38.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.616 0.644 . . . . 0.0 111.53 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mm -82.42 -61.12 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 -33.01 43.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.22 1.808 . . . . 0.0 110.498 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.61 -50.57 20.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.642 ' HB2' HD12 ' A' ' 106' ' ' LEU . 14.9 t80 -61.89 -50.51 71.93 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.408 1.083 . . . . 0.0 112.027 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.5 p -64.51 -45.52 86.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.864 2.065 . . . . 0.0 108.656 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -91.84 36.45 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.06 45.54 14.82 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.926 2.203 . . . . 0.0 115.078 166.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -120.84 36.51 4.56 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 111.058 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.642 HD12 ' HB2' ' A' ' 101' ' ' PHE . 17.4 mt -124.7 -175.74 3.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.791 1.178 . . . . 0.0 109.446 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.49 138.42 53.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -79.72 111.08 15.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--O 1.239 0.551 0 C-N-CA 125.412 1.485 . . . . 0.0 109.762 -172.525 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 65' ' ' TYR . 10.0 p -115.2 134.28 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.774 1.63 . . . . 0.0 107.42 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' HD12 ' A' ' 66' ' ' LEU . . . -111.06 143.96 40.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.72 120.91 20.8 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.03 111.57 3.31 Favored 'Trans proline' 0 N--CA 1.446 -1.302 1 C-N-CA 125.687 4.258 . . . . 0.0 108.631 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -112.93 171.04 7.77 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.831 1.653 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.85 39.39 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.173 1.389 . . . . 0.0 109.899 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.69 -174.5 47.07 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.64 1.591 . . . . 0.0 109.984 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.2 mtmt -115.33 38.91 3.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.152 1.381 . . . . 0.0 109.457 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -124.48 149.37 46.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 2.23 3.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 122.309 1.052 . . . . 0.0 110.778 168.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 38.4 3.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.027 -1.671 . . . . 0.0 108.448 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.7 m -80.17 170.56 16.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 159.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 139.72 38.87 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.896 -1.128 . . . . 0.0 108.904 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 92.9 t -76.87 147.67 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -109.9 133.84 52.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -169.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.87 38.1 0.44 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.352 0.596 . . . . 0.0 110.833 -172.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -167.34 86.92 0.26 Allowed 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.427 -1.421 . . . . 0.0 107.839 -163.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 79' ' ' LEU . 9.1 t80 -48.23 -53.13 18.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.009 0.822 . . . . 0.0 112.787 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -74.72 -6.77 50.69 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -129.19 64.59 1.47 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.18 25.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.26 -16.77 61.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.36 1.064 . . . . 0.0 113.249 -163.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.478 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 92.1 m-85 -141.0 154.7 46.14 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -139.02 107.27 5.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.607 1.163 . . . . 0.0 107.885 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.74 116.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.85 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.6 ' HB3' HG12 ' A' ' 4' ' ' VAL . 18.3 t80 -88.84 116.51 27.16 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.99 1.716 . . . . 0.0 107.536 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.62 100.0 6.8 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.899 1.679 . . . . 0.0 108.501 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 p -74.04 70.3 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.445 1.117 . . . . 0.0 108.586 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -155.76 -53.01 0.09 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.91 2.484 . . . . 0.0 110.458 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 m -136.22 36.71 2.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.481 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.01 11.74 1.07 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.495 1.998 . . . . 0.0 114.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -71.59 141.97 50.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.676 1.238 . . . . 0.0 107.688 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.37 160.62 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.747 1.619 . . . . 0.0 107.066 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -137.42 141.91 41.65 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.8 116.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.79 132.52 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 160.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -85.85 136.6 33.24 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 155.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 CA--C 1.524 -0.046 0 CA-C-N 119.451 1.023 . . . . 0.0 111.288 167.487 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.457 -0.652 0 CA-C-O 118.382 -0.758 . . . . 0.0 112.992 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER 58.15 -64.65 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.041 1.291 . . . . 0.0 112.249 -157.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.13 -61.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.308 1.443 . . . . 0.0 108.582 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 55' ' ' VAL . 1.4 t -53.28 -47.62 56.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 126.101 1.76 . . . . 0.0 109.257 175.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -45.22 -52.47 9.44 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.365 1.439 . . . . 0.0 111.649 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 t -66.41 -51.95 51.61 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.374 0.669 . . . . 0.0 112.258 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.5 -41.33 97.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.632 -1.292 . . . . 0.0 110.113 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 t -59.99 -35.37 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.466 1.506 . . . . 0.0 111.241 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -65.45 -33.72 76.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.565 1.075 . . . . 0.0 109.489 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.33 38.07 0.65 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.766 1.226 . . . . 0.0 109.603 170.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.32 22.74 2.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.023 1.773 . . . . 0.0 116.092 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.66 118.86 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 119.831 1.816 . . . . 0.0 109.108 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.36 35.61 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.412 0.685 . . . . 0.0 110.982 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.897 ' HB3' HG23 ' A' ' 4' ' ' VAL . 23.3 m-85 -174.91 160.7 2.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 68' ' ' ALA . 18.2 tp -164.26 148.35 9.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.703 HG21 ' HB1' ' A' ' 97' ' ' ALA . 64.0 mt -119.43 97.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -152.69 103.67 2.81 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.281 0.632 . . . . 0.0 109.527 -171.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.5 p -45.92 -28.87 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.966 1.706 . . . . 0.0 115.58 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 -171.19 2.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -128.67 155.03 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -75.32 -41.65 30.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -171.52 -148.3 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.248 2.219 . . . . 0.0 107.761 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -52.49 104.58 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 111.561 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.79 -29.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.956 2.102 . . . . 0.0 109.141 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 79' ' ' LEU . 28.2 t80 -51.9 -39.49 59.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.088 1.755 . . . . 0.0 112.442 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.43 -37.35 86.66 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.618 0.767 . . . . 0.0 109.535 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.6 m -80.13 -13.84 58.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.726 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 76' ' ' PHE . 25.8 mt -71.14 -58.2 3.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.907 -1.12 . . . . 0.0 109.093 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.608 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -63.21 -29.27 70.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.27 37.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.22 171.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.94 35.88 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.069 0.849 . . . . 0.0 111.621 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.03 34.29 4.1 Favored Glycine 0 CA--C 1.538 1.521 0 O-C-N 120.387 -1.446 . . . . 0.0 115.696 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.79 127.92 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 119.258 1.529 . . . . 0.0 110.036 -166.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -79.35 112.54 16.69 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.651 -0.656 . . . . 0.0 110.748 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -97.61 121.04 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.05 157.89 15.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 109.954 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.46 151.5 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.6 172.79 10.86 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 156.07 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.38 52.21 0.53 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 121.288 1.858 . . . . 0.0 112.787 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.51 101.95 2.67 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.386 -0.822 . . . . 0.0 112.488 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.82 166.36 34.76 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -162.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.404 ' C ' HG23 ' A' ' 17' ' ' VAL . 26.6 p -88.39 174.11 8.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.373 1.069 . . . . 0.0 110.488 167.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.2 t -45.1 -42.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.588 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.15 -34.12 76.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 120.305 1.411 . . . . 0.0 114.369 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.36 -45.07 85.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.608 1.563 . . . . 0.0 107.209 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.69 -45.59 19.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.356 0.662 . . . . 0.0 111.254 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.38 -52.05 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.16 -33.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.758 2.023 . . . . 0.0 109.405 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -61.5 1.79 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.666 ' HB2' HD12 ' A' ' 106' ' ' LEU . 3.1 t80 -54.64 -41.17 69.75 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.452 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.1 p -69.41 -50.45 45.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.202 1.401 . . . . 0.0 108.119 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -86.12 36.63 0.69 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.597 0.713 . . . . 0.0 109.689 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.71 12.89 2.76 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.287 1.899 . . . . 0.0 116.658 172.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.6 mtp180 -85.74 35.91 0.64 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 121.027 2.413 . . . . 0.0 112.314 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 101' ' ' PHE . 20.1 mt -134.44 -178.89 5.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.586 -1.321 . . . . 0.0 109.414 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -127.81 153.34 46.71 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 125.769 1.628 . . . . 0.0 108.886 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.92 91.57 6.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.509 1.524 . . . . 0.0 107.065 -176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 124.521 1.128 . . . . 0.0 110.691 -175.646 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -115.37 151.14 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 127.706 2.403 . . . . 0.0 105.394 165.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.63 143.73 48.52 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.6 121.71 15.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.78 110.28 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.338 4.025 . . . . 0.0 108.363 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 t -111.23 169.18 8.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.189 1.795 . . . . 0.0 108.13 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.86 37.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.361 0.664 . . . . 0.0 111.051 165.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.62 177.04 42.19 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.472 1.51 . . . . 0.0 109.832 168.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -115.18 38.63 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.735 -166.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -139.29 159.26 42.58 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.471 1.908 . . . . 0.0 108.306 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -74.02 -5.05 39.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.612 1.965 . . . . 0.0 111.07 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -122.82 37.97 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.669 -1.269 . . . . 0.0 110.916 167.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 m -83.24 173.29 11.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.14 164.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.91 142.88 36.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.89 1.223 . . . . 0.0 109.766 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -71.57 165.07 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.047 0.927 . . . . 0.0 108.508 166.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 t -119.98 127.87 53.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.396 1.478 . . . . 0.0 109.26 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.22 37.11 0.37 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 122.13 0.967 . . . . 0.0 110.826 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.85 108.82 0.48 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 -166.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.62 ' CE2' HD11 ' A' ' 79' ' ' LEU . 13.3 t80 -63.65 -58.19 7.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.639 1.109 . . . . 0.0 110.622 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.76 -13.66 59.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.737 -170.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -123.82 77.39 1.52 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.201 1.8 . . . . 0.0 106.81 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.58 116.3 13.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.86 -16.34 11.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -173.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -142.97 157.76 44.24 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -135.19 107.52 7.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -79.88 126.79 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.447 HD11 ' CD2' ' A' ' 58' ' ' LEU . 62.6 mt -119.93 101.33 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.534 ' HB3' HG12 ' A' ' 4' ' ' VAL . 56.8 t80 -89.8 133.61 34.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.513 1.125 . . . . 0.0 108.191 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.64 121.65 27.95 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.338 1.455 . . . . 0.0 107.497 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 p -84.83 53.17 2.62 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.029 1.286 . . . . 0.0 108.454 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.08 -82.78 0.22 Allowed 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 p -104.88 36.97 2.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 117.99 -1.484 . . . . 0.0 110.347 -160.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.77 4.32 0.15 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.08 1.8 . . . . 0.0 116.489 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -75.26 158.32 33.09 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.221 1.008 . . . . 0.0 110.514 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.9 162.97 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.383 0.673 . . . . 0.0 109.349 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -131.69 138.2 48.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 168.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.73 110.05 22.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 155.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.08 135.79 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.454 -2.425 . . . . 0.0 104.454 156.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.25 128.67 47.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 CA--C 1.513 -0.456 0 CA-C-N 119.357 0.98 . . . . 0.0 111.766 -179.54 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' A' ' 78' ' ' THR . 59.2 Cg_endo . . . . . 0 N--CA 1.447 -1.234 0 CA-C-O 116.34 -1.608 . . . . 0.0 113.62 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 61.47 -72.82 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.544 1.152 . . . . 0.0 110.646 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.82 -56.53 12.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 119.702 1.137 . . . . 0.0 110.383 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.4 t -55.79 -51.25 61.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 C-N-CA 125.235 1.414 . . . . 0.0 107.893 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -12.91 1.08 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.504 1.521 . . . . 0.0 114.615 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.52 -48.72 3.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.377 1.471 . . . . 0.0 109.526 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD2' HD11 ' A' ' 29' ' ' ILE . 69.5 mt -58.08 -45.29 87.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.523 1.129 . . . . 0.0 110.504 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.27 -41.3 91.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.208 1.403 . . . . 0.0 109.652 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -67.1 3.33 1.17 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.299 -0.876 . . . . 0.0 113.223 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -124.61 38.84 4.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.488 2.315 . . . . 0.0 108.317 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.08 35.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 126.1 1.81 . . . . 0.0 116.745 165.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.99 120.59 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 118.456 1.128 . . . . 0.0 110.394 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -124.54 36.17 4.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.688 0.756 . . . . 0.0 110.984 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.677 ' HB3' HG23 ' A' ' 4' ' ' VAL . 11.0 m-85 170.74 170.8 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.317 1.847 . . . . 0.0 107.675 -168.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 68' ' ' ALA . 10.6 tp -172.51 146.34 1.72 Allowed 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.413 -1.429 . . . . 0.0 107.263 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.723 HG21 ' HB1' ' A' ' 97' ' ' ALA . 50.9 mt -114.91 103.25 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -156.07 102.36 2.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.538 1.063 . . . . 0.0 111.32 -171.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.472 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 22.7 t -59.74 -4.89 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.69 -179.43 3.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 123.612 2.915 . . . . 0.0 108.85 167.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.25 146.32 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 O-C-N 121.626 -0.671 . . . . 0.0 110.056 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.08 2.49 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.033 1.778 . . . . 0.0 110.461 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -171.54 173.61 4.66 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.066 2.546 . . . . 0.0 106.338 173.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -71.63 29.23 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.404 1.097 . . . . 0.0 112.373 162.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' ARG . . . -76.1 -27.64 57.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.209 -1.557 . . . . 0.0 111.677 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.2 t80 -61.54 -36.12 79.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.473 1.033 . . . . 0.0 110.951 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.97 -28.65 65.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.854 0.861 . . . . 0.0 110.639 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 52' ' ' PRO . 5.3 m -78.16 -20.79 51.3 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.862 -0.523 . . . . 0.0 110.432 173.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.817 HD12 ' HA ' ' A' ' 76' ' ' PHE . 14.1 mt -71.87 -54.83 8.85 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -56.2 -32.27 64.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 171.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.82 -2.58 7.46 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.68 37.33 4.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.643 1.177 . . . . 0.0 110.472 163.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.34 31.33 8.84 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.821 1.489 . . . . 0.0 116.821 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.42 115.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -78.73 107.77 11.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.83 114.69 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.9 163.24 19.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.983 1.713 . . . . 0.0 111.008 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -90.59 157.14 17.66 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.137 0.975 . . . . 0.0 108.54 161.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.472 ' H ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -121.42 171.36 8.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.264 2.626 . . . . 0.0 109.362 165.49 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.06 96.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.08 -1.637 . . . . 0.0 110.141 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.47 139.28 0.72 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.13 158.58 8.39 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.8 p -85.93 169.65 13.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.105 0.962 . . . . 0.0 108.73 160.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.5 t -42.17 -47.37 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.879 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -60.7 -32.65 71.88 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -64.32 -46.46 83.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.324 1.45 . . . . 0.0 109.274 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.84 -36.32 11.74 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 118.471 0.578 . . . . 0.0 111.582 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.68 -55.07 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 108.143 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -37.97 70.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 108.641 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.87 11.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 106' ' ' LEU . 9.3 t80 -58.54 -44.15 89.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.756 0.822 . . . . 0.0 112.272 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -69.51 -42.51 74.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 109.156 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -92.07 37.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.37 -1.54 0.1 OUTLIER Glycine 0 CA--C 1.526 0.77 0 C-N-CA 130.37 3.843 . . . . 0.0 118.277 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.6 mtt-85 -82.63 37.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.638 1.719 . . . . 0.0 111.692 -170.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 101' ' ' PHE . 21.7 mt -127.89 -171.24 2.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.588 -1.32 . . . . 0.0 108.532 169.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.79 145.15 37.84 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.337 1.455 . . . . 0.0 108.276 -169.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.7 108.46 13.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 109.501 -176.42 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.4 p -84.71 153.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.66 145.85 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.42 124.3 23.54 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 103.65 1.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 1 C-N-CA 125.768 4.312 . . . . 0.0 108.963 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -101.38 173.0 6.64 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.093 1.357 . . . . 0.0 109.249 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.27 38.58 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 109.172 169.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.14 177.84 48.45 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.734 1.635 . . . . 0.0 109.552 171.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 3.5 mttm -108.79 40.05 1.88 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.115 1.766 . . . . 0.0 109.698 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -128.27 154.89 45.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -14.77 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.703 1.201 . . . . 0.0 110.044 170.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -110.74 38.35 2.52 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.64 -1.287 . . . . 0.0 108.758 166.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -86.99 167.42 14.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.589 -1.319 . . . . 0.0 108.056 162.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.58 146.1 34.4 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.467 -1.396 . . . . 0.0 110.417 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 78.8 t -87.77 132.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.523 1.154 . . . . 0.0 108.521 170.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -91.81 135.65 33.75 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.354 2.262 . . . . 0.0 108.674 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.17 38.27 0.47 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.884 0.849 . . . . 0.0 112.147 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' CD ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -165.25 96.44 0.69 Allowed 'General case' 0 C--O 1.224 -0.266 0 O-C-N 119.905 -1.747 . . . . 0.0 107.996 -160.288 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' HD11 ' A' ' 79' ' ' LEU . 19.1 t80 -65.18 -32.62 74.4 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 119.979 -1.7 . . . . 0.0 113.927 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.69 -3.68 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.197 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HG3' ' CD ' ' A' ' 20' ' ' ARG . 7.0 ptp180 -135.37 79.3 1.78 Allowed 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 119.449 1.022 . . . . 0.0 109.885 164.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.27 127.52 33.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -72.19 -17.73 61.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.466 1.106 . . . . 0.0 112.744 -167.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.431 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.1 m-85 -143.98 154.88 43.74 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.804 1.241 . . . . 0.0 107.733 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -137.76 107.67 6.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.461 1.504 . . . . 0.0 107.633 -175.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.77 123.53 43.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -175.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.25 96.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.145 0.884 . . . . 0.0 108.679 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 4' ' ' VAL . 29.0 t80 -85.42 117.68 24.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.815 1.246 . . . . 0.0 107.869 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.77 119.91 28.57 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.263 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -89.91 60.05 4.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.862 1.21 . . . . 0.0 110.697 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -136.73 -43.29 0.59 Allowed 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 117.243 -1.361 . . . . 0.0 113.085 164.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.2 m -137.04 36.87 2.57 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 117.6 -1.64 . . . . 0.0 113.128 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.26 13.83 4.08 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.477 1.513 . . . . 0.0 114.192 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -82.24 135.08 35.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.785 1.634 . . . . 0.0 108.133 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.43 170.18 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 125.178 1.391 . . . . 0.0 107.938 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.04 145.03 39.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -106.69 109.08 26.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.9 129.37 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 159.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.89 133.87 33.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 127.145 2.178 . . . . 0.0 106.295 159.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 119.977 1.262 . . . . 0.0 111.159 178.288 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.433 ' HG3' HG21 ' A' ' 78' ' ' THR . 47.1 Cg_endo . . . . . 0 N--CA 1.449 -1.137 0 CA-C-O 118.231 -0.82 . . . . 0.0 113.162 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 58.82 -78.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.989 2.116 . . . . 0.0 111.395 -169.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -57.3 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 126.942 2.097 . . . . 0.0 109.963 -176.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -56.96 -42.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 CA-C-O 115.167 -2.349 . . . . 0.0 109.578 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -52.31 -44.43 65.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 121.074 1.761 . . . . 0.0 111.497 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -68.12 -51.9 40.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 111.191 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.17 -43.62 92.12 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.305 -0.872 . . . . 0.0 110.525 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.97 -34.65 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.604 1.962 . . . . 0.0 110.628 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -36.4 79.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.504 1.047 . . . . 0.0 109.973 175.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -81.39 38.3 0.48 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.383 0.992 . . . . 0.0 110.29 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.12 27.38 1.58 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.674 2.559 . . . . 0.0 116.279 171.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.66 120.58 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.839 1.319 . . . . 0.0 108.129 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -121.78 36.78 4.53 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.757 1.623 . . . . 0.0 109.953 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -179.6 169.45 1.36 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 120.06 -1.65 . . . . 0.0 108.044 -171.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 67' ' ' ILE . 16.6 tp -169.33 151.89 4.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.515 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.778 HG21 ' HB1' ' A' ' 97' ' ' ALA . 61.1 mt -126.63 102.88 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -159.44 111.02 2.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.78 0.832 . . . . 0.0 109.944 -171.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -46.54 -31.09 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.247 1.819 . . . . 0.0 114.998 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -165.55 -170.12 1.75 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 119.058 0.844 . . . . 0.0 109.102 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.83 133.54 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.347 -0.696 . . . . 0.0 111.388 -169.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -166.25 152.45 8.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.807 2.443 . . . . 0.0 105.44 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 45.36 -143.67 0.21 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.672 1.589 . . . . 0.0 109.228 168.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 72.77 -34.57 0.3 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 129.275 3.03 . . . . 0.0 114.767 162.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.625 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 56.5 t80 -56.39 -40.71 75.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.302 1.441 . . . . 0.0 110.109 174.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.19 -40.76 98.43 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.517 0.727 . . . . 0.0 110.612 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -67.53 -27.27 66.83 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.266 -0.896 . . . . 0.0 110.764 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.504 HD11 ' CD2' ' A' ' 21' ' ' PHE . 53.3 mt -69.12 -61.13 1.92 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -61.63 -27.55 68.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 176.72 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.05 67.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.224 0.92 . . . . 0.0 110.613 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.85 35.98 1.91 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.541 1.064 . . . . 0.0 111.484 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.88 19.28 1.34 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.238 1.875 . . . . 0.0 117.422 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.43 120.04 29.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 118.987 1.393 . . . . 0.0 108.769 -160.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HE3' ' CD ' ' A' ' 108' ' ' GLU . 44.1 tttt -80.42 116.39 20.46 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.929 0.892 . . . . 0.0 110.208 -171.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -99.3 129.23 50.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.26 158.13 16.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 0.0 110.306 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.407 ' O ' HD13 ' A' ' 106' ' ' LEU . 1.4 tpt180 -79.6 163.66 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.586 1.555 . . . . 0.0 106.891 162.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.36 169.92 16.89 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 157.42 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -153.41 67.41 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 121.931 2.15 . . . . 0.0 113.008 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.34 95.67 2.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.459 1.028 . . . . 0.0 111.783 159.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.8 168.84 40.55 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -165.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.414 ' C ' HG23 ' A' ' 17' ' ' VAL . 34.0 p -87.4 176.57 7.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.761 0.824 . . . . 0.0 110.559 167.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -46.33 -43.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.759 1.223 . . . . 0.0 109.887 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -32.43 73.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -72.57 -40.92 66.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.623 1.169 . . . . 0.0 109.072 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.778 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -45.88 -41.58 11.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 123.83 0.707 . . . . 0.0 111.083 168.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -81.69 -51.34 15.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 124.487 1.115 . . . . 0.0 108.313 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -21.0 65.49 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.95 1.3 . . . . 0.0 110.527 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.6 -62.31 1.71 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.643 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.1 t80 -56.03 -44.13 78.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.624 1.17 . . . . 0.0 112.657 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.7 p -63.61 -51.84 63.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.579 1.152 . . . . 0.0 108.451 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.37 36.36 0.69 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.593 0.711 . . . . 0.0 109.31 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.44 11.05 4.75 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.695 2.093 . . . . 0.0 116.747 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -85.03 35.34 0.57 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 121.508 2.654 . . . . 0.0 112.478 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 101' ' ' PHE . 26.9 mt -135.45 167.44 21.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 121.151 1.796 . . . . 0.0 110.033 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -110.27 139.95 44.92 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.624 1.57 . . . . 0.0 107.416 -167.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.403 ' CD ' ' HE3' ' A' ' 85' ' ' LYS . 73.5 tt0 -85.41 96.04 9.45 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.833 1.197 . . . . 0.0 107.883 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 111.676 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -97.65 129.22 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.51 133.1 46.69 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 4' ' ' VAL . 4.2 mp -113.64 121.29 37.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 57.2 Cg_endo -73.7 93.23 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 1 C-N-CA 126.043 4.495 . . . . 0.0 109.509 -176.602 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.2 t -87.71 171.02 10.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.753 2.821 . . . . 0.0 110.338 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 m -124.72 37.86 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.96 1.304 . . . . 0.0 109.487 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.93 -174.81 45.45 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.532 -1.355 . . . . 0.0 112.645 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 22.9 mtmt -111.06 39.6 2.23 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.05 1.34 . . . . 0.0 111.859 -162.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -143.35 157.58 44.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 108.784 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -78.95 -13.79 59.59 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.444 -0.785 . . . . 0.0 111.053 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -104.91 37.39 2.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.375 -1.453 . . . . 0.0 111.072 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' THR . 97.0 p -82.76 170.7 14.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.277 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.56 134.18 37.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.791 1.632 . . . . 0.0 109.133 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 47.8 t -78.14 132.42 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -79.7 152.23 30.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.402 2.681 . . . . 0.0 108.42 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -88.71 36.46 0.8 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.234 -0.916 . . . . 0.0 112.613 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.37 107.01 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.433 -1.417 . . . . 0.0 110.024 -153.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.478 ' HB3' HG23 ' A' ' 71' ' ' VAL . 21.5 t80 -58.0 -60.44 3.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.848 1.204 . . . . 0.0 112.058 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.06 1.19 28.75 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -167.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.8 63.91 1.29 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 162.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . . . -123.95 169.05 12.0 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 164.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -117.64 -30.48 5.46 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 119.034 0.834 . . . . 0.0 112.657 -165.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 95.7 m-85 -126.4 145.71 50.36 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HB3' HD21 ' A' ' 58' ' ' LEU . 94.1 m-85 -133.04 89.12 2.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 126.89 2.076 . . . . 0.0 106.009 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.449 HG22 ' CG1' ' A' ' 37' ' ' VAL . 3.0 mm -79.12 107.19 11.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 -176.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.448 HD11 HD23 ' A' ' 58' ' ' LEU . 81.1 mt -94.23 107.88 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.507 ' HB3' HG12 ' A' ' 4' ' ' VAL . 41.2 t80 -89.96 131.59 35.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -100.81 109.35 21.33 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.745 2.018 . . . . 0.0 111.211 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.2 p -82.14 53.86 2.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.372 0.987 . . . . 0.0 110.225 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -140.86 -20.53 0.81 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.563 1.545 . . . . 0.0 112.712 166.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.2 p -150.63 34.92 0.62 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.597 162.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.88 10.0 2.1 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.976 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.87 152.97 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.683 1.593 . . . . 0.0 107.2 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.449 ' CG1' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -135.43 160.72 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.175 172.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -149.9 136.88 19.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.226 -0.892 . . . . 0.0 109.232 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 11' ' ' LYS . 21.7 t -102.07 114.69 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.521 0.728 . . . . 0.0 109.508 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.73 158.12 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.692 1.197 . . . . 0.0 108.66 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -120.11 122.19 40.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 163.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 109.383 -1.045 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -152.64 -52.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.197 1.399 . . . . 0.0 107.486 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 10.1 p -87.56 -39.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.965 1.706 . . . . 0.0 110.473 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -61.3 -52.04 66.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 116.368 -1.777 . . . . 0.0 109.986 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -44.06 -49.86 8.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.849 1.204 . . . . 0.0 110.949 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -58.55 -64.59 0.87 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 112.657 173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 27' ' ' PHE . 69.3 mt -60.49 -39.39 87.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.337 -167.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.37 -33.87 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.643 1.977 . . . . 0.0 110.904 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -59.9 -30.87 69.32 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.66 37.86 1.63 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.163 0.985 . . . . 0.0 110.303 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.72 25.52 29.46 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.954 -0.914 . . . . 0.0 115.003 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 72.6 t -74.24 96.93 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -105.85 36.84 2.41 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -164.95 155.95 14.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.2 tp -164.56 146.06 8.24 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.26 -1.525 . . . . 0.0 107.15 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.824 HG21 ' HB1' ' A' ' 97' ' ' ALA . 28.3 mt -120.73 104.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.02 134.51 17.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.453 1.024 . . . . 0.0 111.831 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.3 p -68.43 -23.79 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.558 -0.714 . . . . 0.0 112.669 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -177.81 -176.19 0.56 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 107.433 -162.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 21' ' ' PHE . 4.3 p -138.07 141.16 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 119.75 -1.844 . . . . 0.0 112.872 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.87 11.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.911 2.672 . . . . 0.0 116.265 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.274 22.8 mtm180 143.27 -103.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 1 C-N-CA 131.716 4.006 . . . . 0.0 107.062 167.768 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -64.97 137.41 57.72 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.38 -35.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 130.354 3.462 . . . . 0.0 110.637 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.507 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 69.6 t80 -58.27 -41.86 85.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.718 0.807 . . . . 0.0 111.851 -162.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -62.34 -39.49 93.28 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.062 1.345 . . . . 0.0 109.357 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -74.69 -23.96 58.7 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.247 1.019 . . . . 0.0 110.652 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.67 -51.18 29.44 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 121.377 -0.827 . . . . 0.0 108.933 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.37 -30.44 70.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 117.125 -1.417 . . . . 0.0 113.575 175.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.31 -60.57 3.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.316 1.01 . . . . 0.0 108.961 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.53 36.83 0.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.693 0.679 . . . . 0.0 112.058 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.68 27.71 3.27 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.562 2.029 . . . . 0.0 115.636 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.36 121.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.197 0.999 . . . . 0.0 108.54 -166.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -77.65 153.51 33.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -144.16 116.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -172.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -95.37 157.99 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.526 0.731 . . . . 0.0 109.313 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 153.81 29.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 163.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.525 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -134.26 167.27 21.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 162.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.75 77.39 1.58 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.36 1.076 . . . . 0.0 112.266 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.53 88.33 0.11 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.832 1.206 . . . . 0.0 114.568 159.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.43 164.59 35.12 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.818 2.628 . . . . 0.0 109.781 -163.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 15' ' ' SER . 41.6 p -79.59 169.67 17.68 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.519 164.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -50.28 -41.78 19.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-N 121.135 1.788 . . . . 0.0 111.907 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -52.92 -39.5 62.85 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -65.69 -46.64 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.803 1.641 . . . . 0.0 108.575 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.824 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.28 -34.54 10.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.479 0.581 . . . . 0.0 112.464 171.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.96 -58.36 3.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.83 -29.06 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.992 2.517 . . . . 0.0 110.155 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 -60.55 2.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.595 ' HB2' HD12 ' A' ' 106' ' ' LEU . 9.7 t80 -56.01 -48.67 75.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.857 1.263 . . . . 0.0 113.217 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.1 p -72.25 -30.89 65.31 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.683 1.193 . . . . 0.0 109.992 -170.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -104.52 35.99 2.55 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 122.561 1.172 . . . . 0.0 108.494 170.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.46 -2.74 1.54 Allowed Glycine 0 CA--C 1.531 1.05 1 C-N-CA 131.334 4.302 . . . . 0.0 120.135 165.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -80.1 38.43 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.956 2.878 . . . . 0.0 113.59 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.595 HD12 ' HB2' ' A' ' 101' ' ' PHE . 16.9 mt -122.86 -166.6 1.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.129 -0.982 . . . . 0.0 108.684 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.21 148.23 46.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.233 1.413 . . . . 0.0 108.498 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.96 101.03 9.24 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.569 1.548 . . . . 0.0 107.856 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 N--CA 1.443 -0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 107.525 -177.47 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.9 p -99.4 149.6 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.03 147.56 44.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.152 1.342 . . . . 0.0 108.657 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 120.64 19.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 95.1 Cg_endo -73.03 101.31 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 127.147 5.231 . . . . 0.0 107.568 -178.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -100.1 164.37 12.01 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.77 1.228 . . . . 0.0 109.207 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 16' ' ' MET . 15.0 m -121.75 38.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 165.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 -178.68 41.83 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.594 1.092 . . . . 0.0 110.485 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 37.3 mtmt -108.91 39.95 1.92 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 109.536 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -143.02 148.66 37.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.376 1.07 . . . . 0.0 109.907 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 1.91 3.41 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.041 2.136 . . . . 0.0 112.957 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -130.74 38.18 3.73 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.25 -1.531 . . . . 0.0 107.98 167.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 p -81.76 165.2 21.15 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.466 167.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.429 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -78.13 131.77 37.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.324 1.42 . . . . 0.0 109.881 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 84.8 t -74.29 144.21 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.251 1.021 . . . . 0.0 108.763 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -94.92 132.22 39.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.286 2.234 . . . . 0.0 109.52 -169.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -81.3 39.01 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.054 0.93 . . . . 0.0 111.026 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.73 97.82 0.07 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.312 -1.492 . . . . 0.0 108.313 -162.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CD2' HD11 ' A' ' 79' ' ' LEU . 17.5 t80 -60.49 -51.04 71.16 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.755 1.161 . . . . 0.0 112.478 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.04 3.36 15.06 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -134.56 69.72 1.45 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 165.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 27' ' ' PHE . . . -100.67 -177.96 3.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 160.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.48 -21.42 9.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.894 0.378 . . . . 0.0 110.115 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.2 m-85 -145.42 156.34 43.7 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.567 2.347 . . . . 0.0 105.681 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 69.8 m-85 -132.92 110.77 10.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -86.35 129.58 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.9 mt -124.43 105.79 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.566 ' HB3' HG12 ' A' ' 4' ' ' VAL . 42.4 t80 -91.29 117.36 29.58 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.023 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.32 98.88 11.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.12 2.568 . . . . 0.0 112.055 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -78.13 58.11 1.95 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.652 -1.905 . . . . 0.0 109.3 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.88 -21.83 0.36 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.286 2.234 . . . . 0.0 112.105 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.78 35.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.072 1.305 . . . . 0.0 113.548 158.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.91 6.88 5.72 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.572 -1.33 . . . . 0.0 114.593 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.68 158.04 34.99 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.177 0.989 . . . . 0.0 109.254 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.35 173.54 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 125.736 1.614 . . . . 0.0 107.945 171.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.77 139.91 28.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.58 104.37 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.58 145.45 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 162.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -105.42 144.09 32.68 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 O-C-N 120.74 -1.225 . . . . 0.0 110.491 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.453 -0.873 0 CA-C-O 119.102 -0.458 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 60.31 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.907 2.083 . . . . 0.0 111.16 -169.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.274 1.43 . . . . 0.0 110.627 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -45.46 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.822 0 CA-C-O 115.859 -2.02 . . . . 0.0 109.072 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -51.97 -42.73 63.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.054 1.752 . . . . 0.0 112.138 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -68.46 -55.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.361 0.664 . . . . 0.0 110.111 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -45.61 80.45 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.015 -1.053 . . . . 0.0 110.923 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 t -56.67 -33.87 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.412 1.885 . . . . 0.0 111.484 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 m -66.75 -39.24 87.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.336 0.971 . . . . 0.0 109.806 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.74 37.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.027 0.931 . . . . 0.0 110.21 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.27 30.25 0.77 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.812 2.149 . . . . 0.0 116.353 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.64 119.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.74 1.27 . . . . 0.0 108.211 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -120.0 36.06 4.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.943 0.897 . . . . 0.0 111.089 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.773 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.0 m-85 -177.39 168.52 2.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.093 -2.255 . . . . 0.0 107.286 -167.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 68' ' ' ALA . 17.6 tp -169.85 153.84 5.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.953 0.901 . . . . 0.0 108.614 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.808 HG21 ' HB1' ' A' ' 97' ' ' ALA . 37.0 mt -127.21 106.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.183 1.793 . . . . 0.0 106.594 171.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -157.98 125.49 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.585 0.754 . . . . 0.0 109.823 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.8 p -60.49 -27.97 67.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -165.38 -179.61 5.63 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 126.424 1.89 . . . . 0.0 105.989 -168.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.43 166.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -10.3 84.33 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 116.114 -2.492 . . . . 0.0 113.545 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 73' ' ' ARG 0.408 0.2 OUTLIER 143.99 -59.36 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 131.782 4.033 . . . . 0.0 112.614 161.334 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -76.51 -159.07 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.665 1.186 . . . . 0.0 109.139 165.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 77.42 -35.99 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.317 2.647 . . . . 0.0 113.244 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HA ' HD12 ' A' ' 79' ' ' LEU . 60.9 t80 -55.35 -43.43 75.03 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.776 1.23 . . . . 0.0 111.544 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -66.43 -32.14 73.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.127 0.971 . . . . 0.0 110.445 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -18.47 54.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.926 1.29 . . . . 0.0 110.756 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' CD2' ' A' ' 21' ' ' PHE . 36.9 mt -76.57 -62.85 1.49 Allowed 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.406 -0.809 . . . . 0.0 108.944 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -55.97 -35.45 66.74 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 120.973 -1.08 . . . . 0.0 113.74 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.31 69.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.14 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.74 36.35 0.54 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.245 0.929 . . . . 0.0 111.651 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.48 33.22 3.07 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.309 1.433 . . . . 0.0 115.259 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.97 111.38 23.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 118.858 1.329 . . . . 0.0 108.581 -169.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -80.33 113.23 18.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.101 -0.999 . . . . 0.0 110.355 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.25 133.73 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -172.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -105.15 155.56 18.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.355 1.062 . . . . 0.0 110.073 165.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 162.59 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 163.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -140.39 172.6 12.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 160.128 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.68 75.06 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.995 1.725 . . . . 0.0 112.46 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.76 124.82 2.38 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.748 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.84 162.72 12.88 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.404 ' C ' HG23 ' A' ' 17' ' ' VAL . 20.4 p -82.31 174.29 11.28 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.751 167.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.3 t -42.29 -47.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-O 117.429 -1.272 . . . . 0.0 110.597 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -60.82 -36.23 78.55 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.817 1.19 . . . . 0.0 113.85 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -66.08 -44.02 85.67 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.995 1.318 . . . . 0.0 108.632 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.808 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.7 -36.81 11.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.61 0.641 . . . . 0.0 111.298 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.5 mm -87.16 -52.06 12.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 108.849 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.47 -13.73 43.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.508 2.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -62.31 1.52 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 167.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.644 ' HB2' HD12 ' A' ' 106' ' ' LEU . 3.5 t80 -55.73 -43.78 76.91 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.449 -1.407 . . . . 0.0 113.163 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 p -60.16 -51.24 70.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.098 1.359 . . . . 0.0 108.794 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.49 37.87 0.71 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.169 0.988 . . . . 0.0 109.753 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 44.17 33.9 3.04 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.672 2.558 . . . . 0.0 114.549 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -106.63 36.58 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.422 1.111 . . . . 0.0 110.684 -168.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 101' ' ' PHE . 18.9 mt -137.82 172.05 13.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.3 -0.875 . . . . 0.0 108.922 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -111.33 139.13 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -170.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.23 91.89 6.82 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 124.745 1.218 . . . . 0.0 110.214 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.1 p -114.68 166.96 7.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.31 154.41 41.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 163.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.06 129.87 16.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.65 1.98 . . . . 0.0 106.947 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.79 99.19 0.81 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 1 C-N-CA 127.97 5.78 . . . . 0.0 108.765 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -96.04 170.32 9.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.842 1.257 . . . . 0.0 109.455 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 18' ' ' SER . 25.8 m -121.06 38.27 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.506 1.123 . . . . 0.0 110.739 163.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.23 171.62 44.69 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 120.807 -1.183 . . . . 0.0 112.623 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 26' ' ' TYR . 12.9 mttt -90.57 38.19 0.94 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.891 0.876 . . . . 0.0 111.212 -172.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.48 160.57 41.93 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 120.939 -1.101 . . . . 0.0 111.301 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -12.53 59.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.427 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 t -121.05 37.22 4.38 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 120.575 -1.328 . . . . 0.0 108.499 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 m -80.0 168.91 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 159.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mtp -79.26 145.62 33.45 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.572 -1.33 . . . . 0.0 110.099 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 57.3 t -80.2 158.68 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -126.99 149.49 49.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.206 . . . . 0.0 111.32 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER -86.21 33.02 0.61 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.436 1.016 . . . . 0.0 113.297 -166.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -165.13 120.93 1.38 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 118.717 -2.489 . . . . 0.0 106.657 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CE2' HD21 ' A' ' 79' ' ' LEU . 6.3 t80 -58.68 -72.37 0.1 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 124.582 1.176 . . . . 0.0 111.903 167.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -72.82 2.03 7.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.657 -160.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.478 HH11 ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -134.02 44.45 2.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.115 1.766 . . . . 0.0 109.068 173.133 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' CE1' ' A' ' 27' ' ' PHE . . . -89.5 -174.85 4.5 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -120.07 -25.78 5.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.27 0.941 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 81.0 m-85 -142.2 139.91 32.17 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 25.1 m-85 -123.44 100.87 7.03 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -80.98 120.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 58' ' ' LEU . 39.1 mt -110.55 112.16 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 4' ' ' VAL . 65.8 t80 -99.41 123.29 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -87.55 114.29 24.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.281 2.232 . . . . 0.0 109.601 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -75.59 7.15 3.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.049 1.295 . . . . 0.0 113.643 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -96.31 -41.26 8.73 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 119.123 0.874 . . . . 0.0 113.208 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -130.03 37.1 3.95 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.185 160.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.7 29.4 7.81 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.884 1.23 . . . . 0.0 113.185 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -91.87 161.22 14.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.692 1.197 . . . . 0.0 107.914 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.57 155.83 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.236 0.541 . . . . 0.0 109.605 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.2 pt-20 -136.06 155.96 49.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 166.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.18 107.52 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.27 141.79 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 159.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -111.08 111.56 22.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 127.517 2.327 . . . . 0.0 105.269 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 . . . . . 0 CA--C 1.519 -0.232 0 CA-C-N 119.237 0.926 . . . . 0.0 109.123 -167.159 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 CA-C-O 118.213 -0.828 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt 58.23 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.418 2.287 . . . . 0.0 110.787 -170.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -63.09 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 108.992 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.17 -53.08 38.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 115.612 -2.137 . . . . 0.0 109.184 -173.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -51.61 -46.14 63.49 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 120.658 1.572 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -38.89 85.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 29' ' ' ILE . 81.5 mt -77.68 -38.21 48.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.965 0.802 . . . . 0.0 110.168 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -58.25 -32.42 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.372 1.869 . . . . 0.0 110.304 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -13.42 8.57 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 112.934 173.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 8.2 mptt -114.17 37.7 3.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.331 1.052 . . . . 0.0 110.091 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.58 25.2 8.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.579 1.085 . . . . 0.0 114.401 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.04 114.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.11 37.87 3.37 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.299 1.523 . . . . 0.0 110.48 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.743 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.3 m-85 -176.48 172.07 2.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -165.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 67' ' ' ILE . 8.2 tp -177.6 130.41 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 108.459 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.754 HG21 ' HB1' ' A' ' 97' ' ' ALA . 55.0 mt -101.32 104.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.98 6.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.622 0.646 . . . . 0.0 109.379 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 p -47.2 -33.46 5.36 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.692 1.197 . . . . 0.0 112.209 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.25 -176.44 5.88 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 73' ' ' ARG 0.296 1.5 p -104.78 176.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 165.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -104.82 25.84 24.26 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.59 ' H ' HG13 ' A' ' 71' ' ' VAL . 6.2 ttt180 69.25 -169.53 0.18 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 128.659 2.784 . . . . 0.0 110.165 -164.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.4 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 22.0 t30 28.09 60.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.833 3.253 . . . . 0.0 114.77 170.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -174.73 -33.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.374 1.07 . . . . 0.0 113.328 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.613 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 48.1 t80 -54.13 -37.66 64.61 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.268 1.027 . . . . 0.0 112.178 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.5 -34.88 70.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.517 0.727 . . . . 0.0 110.189 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.8 -14.61 59.17 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.444 -0.785 . . . . 0.0 111.184 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' A' ' 21' ' ' PHE . 79.7 mt -70.25 -57.29 5.06 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.262 -0.899 . . . . 0.0 109.19 171.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.613 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -60.74 -28.89 69.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.352 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -53.28 51.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.062 0.846 . . . . 0.0 109.986 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.58 35.72 0.68 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.193 0.452 . . . . 0.0 111.556 176.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 36.19 0.4 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.214 2.34 . . . . 0.0 115.901 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 t -86.99 136.92 21.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.406 1.603 . . . . 0.0 109.925 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -79.23 162.33 25.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 172.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.39 139.02 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.74 155.88 26.99 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.307 1.843 . . . . 0.0 109.345 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -78.39 139.64 38.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 167.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.459 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -120.15 161.45 21.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 156.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -144.77 80.1 1.62 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.307 1.051 . . . . 0.0 110.686 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.75 139.65 1.31 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.52 166.24 13.07 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 121.784 0.658 . . . . 0.0 111.906 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.5 p -86.09 172.03 10.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.88 -0.66 . . . . 0.0 109.619 164.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -45.43 -40.9 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.199 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.13 -35.51 81.35 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.878 1.217 . . . . 0.0 114.277 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.37 -42.43 83.45 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.932 1.693 . . . . 0.0 108.617 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.754 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.46 -39.16 15.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.212 0.915 . . . . 0.0 111.916 171.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.33 -53.07 11.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -60.05 -27.23 66.77 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.829 2.051 . . . . 0.0 110.31 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -59.48 2.71 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.458 ' HB2' HD12 ' A' ' 106' ' ' LEU . 10.0 t80 -55.54 -49.77 71.78 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.204 0.911 . . . . 0.0 113.159 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.2 p -66.79 -25.88 66.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 110.414 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.19 37.23 3.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.278 1.431 . . . . 0.0 107.745 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.18 6.4 0.88 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.281 2.848 . . . . 0.0 116.715 168.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.503 ' HB3' HH11 ' A' ' 105' ' ' ARG . 0.0 OUTLIER -79.95 36.47 0.34 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 121.05 2.425 . . . . 0.0 111.445 -178.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 89' ' ' PHE . 38.6 mt -141.84 173.49 11.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.381 -1.449 . . . . 0.0 108.863 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -127.6 148.54 50.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.444 1.898 . . . . 0.0 107.557 -166.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.36 99.0 11.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 120.374 1.443 . . . . 0.0 108.062 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 tp . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.974 1.309 . . . . 0.0 109.976 -178.294 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.81 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -114.43 158.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.95 145.52 50.24 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.67 118.29 21.23 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.86 102.54 0.77 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 1 C-N-CA 126.18 4.587 . . . . 0.0 107.995 176.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.0 t -96.31 173.45 7.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.185 1.394 . . . . 0.0 107.406 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.07 38.38 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 109.038 164.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.35 175.46 44.62 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 121.025 -1.047 . . . . 0.0 111.96 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 19.9 mtmt -97.15 39.34 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.974 1.31 . . . . 0.0 110.296 -164.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.56 152.18 49.16 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -79.04 -0.43 31.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.169 1.788 . . . . 0.0 110.236 174.617 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -133.51 37.34 3.32 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 119.96 -1.712 . . . . 0.0 109.607 166.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 94' ' ' VAL . 36.6 m -82.76 173.36 11.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.321 156.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.97 139.03 39.15 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.812 -1.18 . . . . 0.0 109.216 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 97' ' ' ALA . 62.1 t -69.57 153.65 8.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 164.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -118.64 153.64 33.99 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.56 1.144 . . . . 0.0 110.253 -169.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.29 35.79 2.46 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.687 0.756 . . . . 0.0 111.256 -164.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -162.03 106.65 1.22 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.549 -1.344 . . . . 0.0 108.332 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CD2' HD11 ' A' ' 79' ' ' LEU . 14.4 t80 -53.96 -56.23 19.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -75.96 -6.23 49.96 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 121.013 1.733 . . . . 0.0 112.48 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.47 39.0 4.07 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.254 1.021 . . . . 0.0 109.843 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.32 178.99 5.55 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.46 -18.04 7.98 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 89.8 m-85 -146.3 156.17 43.16 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -132.76 105.51 7.2 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.1 mm -80.05 119.34 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.63 109.44 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -98.45 108.87 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 102.28 8.39 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.924 1.69 . . . . 0.0 109.757 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -68.48 15.9 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -120.69 -18.85 7.6 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.572 0.749 . . . . 0.0 112.663 -165.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.82 38.77 0.53 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 123.502 0.501 . . . . 0.0 110.098 158.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.42 16.33 0.92 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 128.572 2.987 . . . . 0.0 116.005 173.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -76.63 144.46 39.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.744 1.272 . . . . 0.0 109.584 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.29 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.616 1.166 . . . . 0.0 109.288 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.51 149.33 36.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.314 1.845 . . . . 0.0 108.043 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.14 111.04 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 162.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.87 128.64 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 153.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -84.14 140.87 31.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 160.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.885 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.436 -1.862 0 N-CA-C 109.639 -0.947 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 63.34 -64.59 0.11 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 126.426 1.89 . . . . 0.0 111.266 -171.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -63.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.314 1.446 . . . . 0.0 108.752 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -53.46 -49.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 126.291 1.836 . . . . 0.0 108.894 177.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.49 -37.96 12.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.017 1.281 . . . . 0.0 111.902 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -75.74 -58.74 3.1 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.792 0.837 . . . . 0.0 110.403 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.74 -44.33 85.97 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.26 1.024 . . . . 0.0 110.84 -171.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.76 -45.03 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.137 1.775 . . . . 0.0 110.108 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.4 m -77.18 7.42 5.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.622 1.169 . . . . 0.0 113.901 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.73 38.98 3.75 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.461 -1.399 . . . . 0.0 108.741 155.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.58 18.14 29.54 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.636 2.065 . . . . 0.0 116.759 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.74 89.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.511 1.924 . . . . 0.0 110.219 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -91.58 35.7 0.95 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.954 1.302 . . . . 0.0 111.066 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.81 ' HB3' HG23 ' A' ' 4' ' ' VAL . 15.3 m-85 177.89 166.56 0.71 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 120.03 -1.668 . . . . 0.0 107.317 -170.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 68' ' ' ALA . 9.2 tp -165.96 150.51 8.22 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.733 HG21 ' HB1' ' A' ' 97' ' ' ALA . 67.1 mt -120.84 103.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -149.13 120.87 8.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.607 1.094 . . . . 0.0 108.16 -176.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' A' ' 89' ' ' PHE . 79.4 p -54.35 -34.57 61.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.896 0.379 . . . . 0.0 111.981 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.26 170.33 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -97.37 147.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -82.15 33.72 2.67 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ttm105 61.14 -161.35 0.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.316 1.846 . . . . 0.0 108.64 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t30 25.28 69.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.842 2.857 . . . . 0.0 112.802 174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -177.89 -28.54 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 57.3 t80 -70.27 -36.92 74.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 121.317 1.871 . . . . 0.0 110.928 -158.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.24 -32.43 72.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.523 0.729 . . . . 0.0 109.598 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -13.85 59.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.627 1.171 . . . . 0.0 109.842 -177.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' CD2' ' A' ' 21' ' ' PHE . 28.8 mt -80.81 -62.47 1.66 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -59.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.387 -0.815 . . . . 0.0 112.265 177.602 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -16.04 27.75 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.217 -0.897 . . . . 0.0 113.366 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.62 36.71 4.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.674 1.125 . . . . 0.0 111.071 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.03 31.01 1.14 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.121 2.296 . . . . 0.0 116.824 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.49 112.62 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.071 1.435 . . . . 0.0 109.841 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -79.31 102.75 8.8 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 79' ' ' LEU . 61.8 t -84.05 126.05 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -96.69 157.1 16.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.17 1.788 . . . . 0.0 109.726 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.49 154.16 30.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.77 2.028 . . . . 0.0 105.794 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.43 168.52 19.48 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 152.353 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.56 38.75 1.38 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.035 1.289 . . . . 0.0 112.288 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 112.82 3.74 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.358 -1.463 . . . . 0.0 112.908 170.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.37 164.71 30.36 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.598 2.047 . . . . 0.0 109.697 -161.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.42 ' C ' HG23 ' A' ' 17' ' ' VAL . 69.6 p -87.63 169.85 11.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.226 1.013 . . . . 0.0 109.211 166.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 15' ' ' SER . 27.0 t -43.1 -47.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.538 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -63.11 -30.32 71.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -69.6 -40.67 76.52 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 120.483 1.492 . . . . 0.0 110.119 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.733 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -51.88 -28.27 15.56 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -92.94 -56.78 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 C-N-CA 125.689 1.596 . . . . 0.0 107.351 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.93 -41.31 64.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.247 0.967 . . . . 0.0 108.68 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.39 -50.66 58.71 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -43.37 68.67 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 111.479 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.9 p -67.41 -35.65 79.7 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.175 1.79 . . . . 0.0 110.464 -171.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.64 36.76 2.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.031 0.932 . . . . 0.0 108.74 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.96 20.93 0.79 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.813 2.149 . . . . 0.0 115.953 172.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -93.63 38.92 1.06 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.58 1.69 . . . . 0.0 110.206 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.3 mt -140.37 169.67 17.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 109.02 165.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -121.61 143.18 49.46 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.609 -163.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -79.48 100.8 7.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 125.079 1.352 . . . . 0.0 108.517 174.055 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 -173.85 3.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.531 1.132 . . . . 0.0 112.029 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.23 116.74 27.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 128.371 2.669 . . . . 0.0 107.636 165.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -92.91 141.01 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.05 155.06 18.99 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.56 122.17 13.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.466 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 57.1 Cg_endo -70.45 102.62 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.618 4.212 . . . . 0.0 109.129 177.401 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -100.26 175.41 5.73 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.34 1.456 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.06 37.03 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.694 0.798 . . . . 0.0 109.968 166.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.94 -173.86 46.34 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 120.46 -1.4 . . . . 0.0 111.783 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -125.61 39.55 3.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.45 1.125 . . . . 0.0 111.602 -165.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.18 153.03 51.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.963 1.305 . . . . 0.0 107.626 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -75.39 -7.21 53.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.349 1.46 . . . . 0.0 113.02 -170.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -115.59 38.15 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.434 -1.416 . . . . 0.0 109.667 164.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.9 m -79.5 166.91 21.47 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.61 140.45 39.65 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.714 -1.242 . . . . 0.0 108.344 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.4 t -77.47 137.28 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -83.06 146.31 28.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.45 1.5 . . . . 0.0 108.203 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.67 38.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.786 -0.571 . . . . 0.0 110.293 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 179.77 108.91 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 119.923 -1.736 . . . . 0.0 108.889 -161.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 79' ' ' LEU . 19.5 t80 -53.95 -65.6 0.54 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.247 0.619 . . . . 0.0 111.392 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.96 12.19 3.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.711 -171.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -131.23 37.43 3.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.815 0.734 . . . . 0.0 109.481 164.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -86.81 -176.01 5.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -122.74 -14.27 7.74 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -144.72 154.69 43.01 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.487 ' CE2' HG23 ' A' ' 54' ' ' VAL . 71.2 m-85 -133.09 116.37 16.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 39' ' ' VAL . 12.4 mm -95.42 118.03 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.31 97.77 6.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.431 ' HB3' HG12 ' A' ' 4' ' ' VAL . 44.5 t80 -83.96 111.05 18.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.784 1.234 . . . . 0.0 108.637 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 101.36 7.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.813 2.845 . . . . 0.0 111.322 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 p -75.78 43.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.96 -1.088 . . . . 0.0 112.732 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.7 -37.72 1.17 Allowed 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 116.996 -1.478 . . . . 0.0 112.197 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -133.86 36.79 3.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 124.94 1.4 . . . . 0.0 111.972 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.89 1.3 Allowed Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.988 1.756 . . . . 0.0 113.003 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.01 150.85 21.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.3 149.12 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 122.218 1.008 . . . . 0.0 109.063 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.09 134.44 52.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 28' ' ' ILE . 40.9 t -101.32 108.63 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.24 152.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.34 103.25 7.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.95 111.96 14.72 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -168.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.3 p -96.75 71.13 2.56 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -166.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' CG2' ' HE3' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -112.34 96.83 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 126.608 1.963 . . . . 0.0 108.4 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.75 50.3 2.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.033 0.933 . . . . 0.0 109.303 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -160.61 -171.46 3.14 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.278 -0.889 . . . . 0.0 108.823 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.94 176.11 7.85 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.21 1.804 . . . . 0.0 110.126 170.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 61.59 -174.72 0.13 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.271 2.228 . . . . 0.0 112.167 -164.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.06 179.34 18.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.307 1.432 . . . . 0.0 110.061 -166.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.7 t -135.06 134.07 39.97 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.682 1.193 . . . . 0.0 108.325 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.34 157.36 24.0 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.011 1.291 . . . . 0.0 110.356 -171.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.11 -55.12 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.303 2.002 . . . . 0.0 111.523 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HE3' ' CG2' ' A' ' 44' ' ' ILE . 0.4 OUTLIER 59.93 -62.06 0.06 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 127.038 2.135 . . . . 0.0 112.333 -168.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG23 ' CE2' ' A' ' 27' ' ' PHE . 2.7 p -52.5 -62.55 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -52.73 52.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-O 116.129 -1.891 . . . . 0.0 109.692 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -46.21 -48.42 17.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.96 1.254 . . . . 0.0 111.481 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 t -61.96 -62.65 1.64 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.388 0.675 . . . . 0.0 111.139 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.9 mt -53.75 -46.83 71.02 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.925 1.69 . . . . 0.0 111.281 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 t -56.75 -45.55 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.846 1.658 . . . . 0.0 110.232 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.8 m -71.95 8.07 1.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.013 0.925 . . . . 0.0 112.217 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.68 37.62 4.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 166.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.91 5.32 2.85 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 129.102 3.239 . . . . 0.0 117.344 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.7 t -53.46 108.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 121.107 2.453 . . . . 0.0 112.681 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -105.82 35.65 2.82 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.948 0.88 . . . . 0.0 111.711 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.726 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.5 m-85 -176.91 168.36 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.008 -2.308 . . . . 0.0 108.384 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 tp -166.55 152.19 8.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.787 HG21 ' HB1' ' A' ' 97' ' ' ALA . 44.1 mt -119.94 94.9 3.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.43 108.82 3.96 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.069 0.948 . . . . 0.0 111.202 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 p -48.74 -28.21 3.46 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.908 2.483 . . . . 0.0 115.565 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.75 178.52 4.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.662 1.985 . . . . 0.0 106.039 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.19 155.09 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.848 -1.158 . . . . 0.0 108.356 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -48.51 -58.93 6.94 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 167.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 151.6 -177.7 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 1 C-N-CA 133.82 4.848 . . . . 0.0 105.357 -166.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 25.62 58.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 129.426 3.091 . . . . 0.0 116.153 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.28 -29.3 0.12 Allowed 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.727 ' HA ' HD12 ' A' ' 79' ' ' LEU . 46.4 t80 -61.2 -33.8 74.05 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.632 0.651 . . . . 0.0 112.462 -169.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.89 -33.88 71.03 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.625 0.37 . . . . 0.0 110.833 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -16.54 41.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.307 0.643 . . . . 0.0 110.088 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 76' ' ' PHE . 27.8 mt -64.28 -66.69 0.51 Allowed 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.598 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -60.73 -27.0 67.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.47 -31.08 33.11 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.294 0.638 . . . . 0.0 112.368 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.25 37.42 2.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.279 1.032 . . . . 0.0 110.631 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.82 27.03 8.85 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.773 1.654 . . . . 0.0 116.653 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.64 114.02 19.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 118.639 1.219 . . . . 0.0 109.187 -168.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -79.59 103.32 9.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 79' ' ' LEU . 24.9 t -92.07 109.88 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.988 1.715 . . . . 0.0 108.695 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -79.72 162.25 25.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.015 1.326 . . . . 0.0 111.465 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -79.56 152.61 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.479 1.912 . . . . 0.0 106.567 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.55 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -131.92 163.93 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 155.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.33 92.72 1.72 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.658 1.572 . . . . 0.0 109.274 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.56 86.48 0.91 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.697 1.142 . . . . 0.0 115.695 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.63 159.95 28.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 121.387 -1.067 . . . . 0.0 112.302 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.7 p -82.8 172.51 12.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.347 0.659 . . . . 0.0 109.505 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.6 t -46.26 -42.55 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.298 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -35.24 76.93 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.548 1.522 . . . . 0.0 114.499 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.86 -45.64 85.19 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 125.106 1.362 . . . . 0.0 108.138 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.787 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -50.06 -29.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -89.58 -60.91 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 C-N-CA 125.141 1.376 . . . . 0.0 107.448 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -48.98 -41.23 33.59 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 127.51 2.324 . . . . 0.0 109.404 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.64 -54.99 15.1 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.731 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 106' ' ' LEU . 15.7 t80 -58.09 -47.44 83.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.932 1.293 . . . . 0.0 111.971 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.8 p -68.43 -33.44 74.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.086 1.754 . . . . 0.0 110.413 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.75 37.82 2.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.87 44.66 24.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.906 2.194 . . . . 0.0 115.115 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -118.28 38.25 3.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.49 1.145 . . . . 0.0 110.468 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 101' ' ' PHE . 25.4 mt -133.04 170.37 15.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.386 0.994 . . . . 0.0 108.686 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -112.74 147.29 37.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -79.94 121.97 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.51 66.93 0.89 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.213 1.005 . . . . 0.0 109.903 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -96.03 37.7 1.22 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.295 1.038 . . . . 0.0 111.913 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.1 t 157.93 164.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 1 C-N-CA 133.112 4.565 . . . . 0.0 104.929 172.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.77 169.21 17.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.8 1.64 . . . . 0.0 107.567 173.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -94.76 161.94 13.97 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.242 1.017 . . . . 0.0 109.348 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -164.17 107.82 0.95 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.99 38.38 0.65 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 117.01 -1.994 . . . . 0.0 109.072 -178.269 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 178.86 158.4 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.533 2.733 . . . . 0.0 107.879 162.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -79.35 140.7 37.42 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -108.32 134.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.478 -2.415 . . . . 0.0 104.478 -177.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.43 146.19 27.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.25 123.41 20.62 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.606 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 87.9 Cg_endo -80.73 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 1 C-N-CA 126.404 4.736 . . . . 0.0 109.392 -174.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.2 t -83.48 169.34 15.6 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.307 1.043 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.1 m -120.56 38.77 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.701 1.2 . . . . 0.0 110.582 163.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 170.63 42.18 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 164.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -93.48 46.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.952 1.701 . . . . 0.0 110.27 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -138.41 153.43 48.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.041 0.936 . . . . 0.0 108.74 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.72 -15.49 59.76 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.246 1.418 . . . . 0.0 109.256 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.55 39.46 3.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.587 -1.321 . . . . 0.0 110.638 165.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -88.41 166.71 14.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 159.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.15 146.46 35.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.919 0.887 . . . . 0.0 109.887 -173.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 93' ' ' THR . 3.2 t -93.0 147.31 5.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 122.349 1.071 . . . . 0.0 109.859 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -105.8 132.74 51.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.222 1.809 . . . . 0.0 108.193 -165.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -79.45 38.44 0.37 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.767 0.794 . . . . 0.0 110.024 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -172.61 93.99 0.12 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 119.209 -2.182 . . . . 0.0 108.752 -160.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 79' ' ' LEU . 13.6 t80 -49.97 -61.42 2.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 112.047 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.5 -0.8 16.12 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -168.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -133.69 58.92 1.75 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.753 2.421 . . . . 0.0 107.066 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -101.98 179.71 4.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 163.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.91 -19.99 7.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.488 0.586 . . . . 0.0 112.145 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.41 144.23 33.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 42.6 m-85 -126.29 99.7 5.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.1 mm -80.79 121.53 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -108.82 117.11 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HB3' HG12 ' A' ' 4' ' ' VAL . 85.5 t80 -103.11 131.31 50.21 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.093 1.357 . . . . 0.0 109.014 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.12 122.78 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.849 1.66 . . . . 0.0 111.005 173.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 p -88.16 42.15 1.04 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 164.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.33 -96.85 0.36 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.72 37.92 1.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.919 -162.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.22 2.79 0.03 OUTLIER Glycine 0 CA--C 1.536 1.37 0 C-N-CA 128.708 3.052 . . . . 0.0 116.387 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -72.84 140.88 47.9 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.957 1.303 . . . . 0.0 109.745 -165.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.937 0.895 . . . . 0.0 109.745 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -141.92 128.76 20.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.646 1.578 . . . . 0.0 107.435 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.76 117.85 33.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.69 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 152.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.57 142.93 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.133 1.773 . . . . 0.0 106.382 158.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.2 114.33 4.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.025 -1.047 . . . . 0.0 109.929 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.2 p -101.65 52.1 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.308 0.643 . . . . 0.0 110.116 -155.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 107.35 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.829 0.824 . . . . 0.0 110.361 -172.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.66 60.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.761 2.025 . . . . 0.0 107.298 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -147.79 152.55 37.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.241 1.816 . . . . 0.0 106.252 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.01 39.67 1.48 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.292 1.037 . . . . 0.0 110.768 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -4.87 56.0 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.1 15.8 80.92 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.953 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.7 m -102.52 102.78 13.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.381 1.591 . . . . 0.0 109.923 -170.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.31 171.56 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.423 1.487 . . . . 0.0 114.867 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.23 -59.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.833 1.688 . . . . 0.0 111.008 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 63.51 -63.56 0.13 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.403 1.481 . . . . 0.0 111.249 -166.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -65.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -49.05 -53.02 8.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 126.324 1.85 . . . . 0.0 108.97 175.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -53.57 7.06 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.378 1.049 . . . . 0.0 111.466 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -70.05 -46.79 64.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.19 -40.54 90.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.783 -1.198 . . . . 0.0 110.069 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.8 t -57.0 -41.95 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.998 1.719 . . . . 0.0 110.291 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -55.74 -29.85 60.23 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.597 0.635 . . . . 0.0 111.666 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -101.82 38.57 1.61 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.442 1.019 . . . . 0.0 109.045 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.47 18.35 29.56 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 126.324 1.916 . . . . 0.0 116.443 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.82 114.12 4.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' HA ' HG13 ' A' ' 84' ' ' VAL . 12.3 mt-10 -124.15 35.63 4.78 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.626 0.648 . . . . 0.0 111.443 167.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.645 ' HB3' HG23 ' A' ' 4' ' ' VAL . 8.0 m-30 -158.75 162.7 37.13 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 68' ' ' ALA . 6.7 tp -166.17 150.8 8.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.736 -1.853 . . . . 0.0 107.099 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 66' ' ' LEU . 59.0 mt -121.79 99.66 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -153.91 113.18 3.75 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.308 1.043 . . . . 0.0 109.21 -174.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -52.52 -30.45 30.46 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.433 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -160.53 169.81 22.2 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.541 1.937 . . . . 0.0 106.911 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.04 153.67 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.29 50.95 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.61 -160.82 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.834 3.254 . . . . 0.0 106.553 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -28.93 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 129.404 3.081 . . . . 0.0 112.766 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -175.98 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.38 1.872 . . . . 0.0 110.084 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' A' ' 79' ' ' LEU . 45.8 t80 -57.56 -38.97 75.67 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.195 1.398 . . . . 0.0 111.61 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.45 -24.89 63.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.457 0.571 . . . . 0.0 111.226 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.8 m -84.41 -18.2 36.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.964 -1.085 . . . . 0.0 112.065 170.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 76' ' ' PHE . 33.9 mt -66.85 -61.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.341 0.973 . . . . 0.0 108.696 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HE3' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -55.95 -32.67 64.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 171.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.28 67.66 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.388 0.994 . . . . 0.0 110.674 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.38 36.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.386 0.994 . . . . 0.0 111.914 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.16 28.68 3.18 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.453 1.502 . . . . 0.0 116.047 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 64' ' ' GLU . 12.4 t -86.61 123.63 39.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 118.772 1.286 . . . . 0.0 108.344 -170.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 159.65 28.3 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.14 148.0 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.642 1.577 . . . . 0.0 108.011 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -118.33 155.87 29.89 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.346 1.858 . . . . 0.0 109.994 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.78 146.45 33.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 164.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.406 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -122.85 166.91 14.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 154.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -154.31 60.11 0.7 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.816 1.189 . . . . 0.0 109.411 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.24 121.02 3.05 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.564 1.078 . . . . 0.0 111.89 168.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.97 167.58 18.32 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.359 1.079 . . . . 0.0 114.993 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.434 ' C ' HG23 ' A' ' 17' ' ' VAL . 81.1 p -87.88 174.79 8.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.231 1.012 . . . . 0.0 110.694 162.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.6 t -48.85 -38.29 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.002 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -65.99 -33.61 76.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 121.076 1.762 . . . . 0.0 113.928 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -69.58 -41.6 75.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.768 1.627 . . . . 0.0 108.801 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -42.88 -42.08 3.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.141 0.882 . . . . 0.0 111.902 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.19 -48.66 14.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.791 1.237 . . . . 0.0 108.227 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.13 -24.97 63.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.274 1.829 . . . . 0.0 110.153 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.67 -57.33 3.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.428 ' HB2' HD12 ' A' ' 106' ' ' LEU . 1.1 t80 -57.14 -44.7 83.65 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.211 1.004 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.0 p -61.97 -50.76 70.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.084 1.354 . . . . 0.0 108.765 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.92 35.62 0.64 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.857 . . . . 0.0 109.134 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.05 24.51 2.09 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.02 1.771 . . . . 0.0 114.978 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -98.34 37.76 1.42 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.076 1.438 . . . . 0.0 109.984 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 101' ' ' PHE . 19.7 mt -134.36 165.24 25.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -109.03 138.52 45.25 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.7 100.47 7.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.689 1.131 . . . . 0.0 108.59 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -84.61 71.72 10.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.751 0.821 . . . . 0.0 110.65 -166.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 p -91.25 35.29 0.93 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.955 -1.09 . . . . 0.0 112.306 -170.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.7 t 158.82 164.63 0.01 OUTLIER 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.328 2.251 . . . . 0.0 106.495 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -167.82 -169.65 1.21 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.979 2.511 . . . . 0.0 106.097 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.1 m -128.44 145.85 50.97 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -162.67 91.47 0.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -85.82 59.13 5.44 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 -170.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 126.227 1.87 . . . . 0.0 110.331 176.512 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptp . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 65' ' ' TYR . . . -154.04 128.99 9.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 161.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -98.18 103.59 15.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.112 1.365 . . . . 0.0 109.719 164.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.812 HG23 ' HB3' ' A' ' 65' ' ' TYR . 9.8 p -82.88 156.02 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.96 146.4 39.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 163.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.49 HD11 HG13 ' A' ' 4' ' ' VAL . 4.2 mp -126.78 129.08 24.13 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.83 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.203 1 C-N-CA 125.307 4.005 . . . . 0.0 108.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 t -111.3 171.08 7.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.567 1.147 . . . . 0.0 109.876 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -129.82 39.39 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.73 2.012 . . . . 0.0 108.227 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.1 173.1 42.34 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -110.29 50.0 0.82 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.016 1.326 . . . . 0.0 108.268 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.71 157.13 45.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.983 1.313 . . . . 0.0 108.016 171.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 0.8 25.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.313 1.445 . . . . 0.0 110.339 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -127.25 37.63 4.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.021 -1.674 . . . . 0.0 108.755 168.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -81.07 165.07 21.98 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.419 -0.801 . . . . 0.0 109.381 163.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.41 135.35 37.41 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.664 1.12 . . . . 0.0 109.047 -175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 93.0 t -75.34 137.53 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.67 131.12 42.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 107.361 -172.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.67 38.59 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.634 1.207 . . . . 0.0 110.862 -173.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.46 93.5 0.76 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 118.401 -2.687 . . . . 0.0 107.132 -166.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 79' ' ' LEU . 20.2 t80 -55.12 -52.58 62.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.632 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.79 13.59 1.0 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.04 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.28 38.29 1.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.286 1.403 . . . . 0.0 110.082 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -103.91 127.85 51.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -172.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.43 -20.15 64.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.62 151.98 42.02 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 92.6 m-85 -131.3 119.61 22.0 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.31 112.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.492 HD11 HD23 ' A' ' 58' ' ' LEU . 83.2 mt -101.76 112.47 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.689 ' HB3' HG12 ' A' ' 4' ' ' VAL . 16.7 t80 -104.28 125.83 50.87 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.859 1.264 . . . . 0.0 110.582 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.84 112.11 19.82 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 108.676 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -77.43 54.57 1.16 Allowed 'General case' 0 C--O 1.239 0.518 0 O-C-N 120.832 -1.167 . . . . 0.0 108.838 163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -151.58 -34.67 0.14 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.46 38.03 0.43 Allowed 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 117.524 -1.67 . . . . 0.0 111.873 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.1 9.48 2.0 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.011 1.291 . . . . 0.0 115.01 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -61.91 146.36 50.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.893 1.346 . . . . 0.0 107.687 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.44 142.42 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.25 132.23 53.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.275 1.83 . . . . 0.0 106.629 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.27 110.53 25.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.22 150.57 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 158.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -124.02 106.76 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -122.89 124.56 43.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.1 p -110.02 62.22 0.6 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -165.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.39 76.74 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.092 -1.005 . . . . 0.0 110.485 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -105.5 37.69 2.15 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.885 -0.509 . . . . 0.0 111.337 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -144.7 159.62 42.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 110.006 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.6 103.55 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -145.72 -47.28 0.21 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.314 -168.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.24 174.37 18.53 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.496 1.044 . . . . 0.0 113.84 163.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m 52.1 87.76 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.804 2.041 . . . . 0.0 111.1 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.8 126.24 2.56 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 117.91 -1.495 . . . . 0.0 110.61 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -74.94 -51.22 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.029 1.819 . . . . 0.0 110.758 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 58.61 -66.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.397 1.879 . . . . 0.0 111.094 -161.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -48.91 -63.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.427 1.491 . . . . 0.0 111.174 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.36 -49.66 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 116.028 -1.939 . . . . 0.0 109.266 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -49.69 -49.81 46.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.827 1.194 . . . . 0.0 110.652 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 t -61.83 -55.11 33.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.406 1.082 . . . . 0.0 112.073 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.492 HD23 HD11 ' A' ' 29' ' ' ILE . 96.0 mt -59.21 -43.15 92.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.28 0.632 . . . . 0.0 109.843 -174.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -60.66 -45.17 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.528 1.931 . . . . 0.0 110.861 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -58.02 -26.07 61.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.532 1.06 . . . . 0.0 111.808 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -104.0 36.78 2.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.053 0.941 . . . . 0.0 109.08 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.12 11.69 55.93 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 127.012 2.244 . . . . 0.0 117.162 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.57 105.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.96 1.38 . . . . 0.0 110.791 -170.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -104.88 36.43 2.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.338 1.055 . . . . 0.0 110.847 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.812 ' HB3' HG23 ' A' ' 4' ' ' VAL . 1.4 m-85 -171.62 173.05 4.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 119.804 -1.81 . . . . 0.0 109.888 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.496 HD23 HG13 ' A' ' 86' ' ' VAL . 16.4 tp -166.81 157.64 12.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.941 1.296 . . . . 0.0 108.716 170.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.792 HG21 ' HB1' ' A' ' 97' ' ' ALA . 48.2 mt -124.37 106.12 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 168.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.41 130.99 10.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 p -63.68 -26.04 68.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -170.02 -177.89 2.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -166.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.17 154.09 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.603 -1.311 . . . . 0.0 108.037 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.05 -51.37 25.31 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 164.52 -86.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 130.942 3.697 . . . . 0.0 104.937 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.73 119.88 15.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.7 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 130.572 3.549 . . . . 0.0 109.831 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.535 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 33.6 t80 -53.02 -43.92 66.92 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.163 1.385 . . . . 0.0 111.658 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.43 -31.2 72.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.339 1.455 . . . . 0.0 109.856 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -21.78 38.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.817 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.643 HD21 ' CE2' ' A' ' 21' ' ' PHE . 94.4 mt -69.86 -59.11 3.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.273 0.942 . . . . 0.0 108.653 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -58.9 -31.35 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.568 1.147 . . . . 0.0 112.999 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.13 -8.19 7.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.47 36.5 4.55 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.81 1.641 . . . . 0.0 110.211 165.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.79 19.46 3.39 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.681 2.086 . . . . 0.0 116.619 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.2 129.73 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.131 -1.217 . . . . 0.0 108.184 -163.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -78.56 165.18 24.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG13 HD23 ' A' ' 66' ' ' LEU . 29.6 t -151.71 114.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -89.03 157.51 18.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.768 0.827 . . . . 0.0 110.181 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.81 156.17 27.53 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.697 1.599 . . . . 0.0 107.101 162.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.04 175.73 9.33 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 158.182 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.45 38.72 0.71 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 122.191 2.269 . . . . 0.0 114.759 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.04 123.17 2.82 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 172.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.41 163.37 13.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -166.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.44 ' C ' HG23 ' A' ' 17' ' ' VAL . 25.5 p -81.97 172.31 13.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.305 0.553 . . . . 0.0 110.272 168.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -41.26 -47.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.698 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -35.22 77.89 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -67.88 -45.19 75.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 125.363 1.465 . . . . 0.0 108.573 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.792 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.25 -30.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 172.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.71 -52.6 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 116.359 -1.781 . . . . 0.0 108.684 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -33.69 69.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 124.38 1.05 . . . . 0.0 108.964 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -54.0 14.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.497 ' HB2' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -56.84 -45.53 82.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.515 1.126 . . . . 0.0 111.899 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.7 p -64.46 -42.15 96.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.526 1.13 . . . . 0.0 108.104 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.64 35.65 1.22 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.937 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.08 7.52 3.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.517 1.532 . . . . 0.0 116.39 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -85.66 36.82 0.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 120.067 1.933 . . . . 0.0 112.064 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 101' ' ' PHE . 17.5 mt -131.22 170.24 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 120.081 1.309 . . . . 0.0 108.614 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -111.69 142.07 44.49 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -81.34 106.68 13.5 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.905 1.23 . . . . 0.0 107.943 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -85.08 54.74 3.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.332 1.453 . . . . 0.0 109.48 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.286 8.2 t -88.48 35.88 0.78 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.446 -1.409 . . . . 0.0 111.555 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t 169.61 84.75 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.35 -1.469 . . . . 0.0 107.847 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -156.9 170.32 22.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 107.302 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.65 168.67 26.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.726 1.61 . . . . 0.0 107.675 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -146.17 171.89 14.25 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 161.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.37 47.34 0.59 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.575 -0.703 . . . . 0.0 110.807 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 157.087 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.47 -173.65 4.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.725 1.21 . . . . 0.0 110.906 -173.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -110.27 147.97 32.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.179 150.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.93 HG23 ' HB3' ' A' ' 65' ' ' TYR . 9.3 p -129.35 125.79 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.878 1.271 . . . . 0.0 109.463 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.2 29.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.8 118.63 24.19 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 74.2 Cg_endo -71.55 99.58 0.95 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 1 C-N-CA 125.43 4.086 . . . . 0.0 107.551 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 t -94.3 175.47 6.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.911 1.285 . . . . 0.0 108.77 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.54 39.42 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.282 1.033 . . . . 0.0 109.891 161.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.17 172.13 45.2 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.774 -1.204 . . . . 0.0 111.441 167.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 29.4 mtmt -94.6 39.9 1.09 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.141 2.177 . . . . 0.0 108.871 -172.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.95 148.27 38.35 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -12.46 61.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.142 2.577 . . . . 0.0 110.81 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -116.02 38.8 3.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.607 -1.308 . . . . 0.0 109.014 170.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -89.88 168.03 12.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.182 -0.949 . . . . 0.0 109.026 163.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 142.39 38.32 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.283 -0.885 . . . . 0.0 109.007 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 59.2 t -81.83 150.81 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -109.03 138.46 45.33 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.805 1.642 . . . . 0.0 110.548 -167.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -83.45 37.31 0.56 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.422 1.106 . . . . 0.0 112.034 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -172.75 85.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 119.956 -1.715 . . . . 0.0 109.334 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CD2' HD11 ' A' ' 79' ' ' LEU . 14.4 t80 -50.39 -50.77 50.71 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -0.03 30.72 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.396 -0.815 . . . . 0.0 112.071 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.02 38.61 3.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.876 1.271 . . . . 0.0 109.839 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . . . -118.59 142.25 47.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -173.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -91.79 -20.64 21.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -158.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.554 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 96.5 m-85 -146.47 124.95 12.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.38 107.85 18.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.8 mm -81.88 114.96 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.554 HD11 ' CD2' ' A' ' 58' ' ' LEU . 78.6 mt -110.61 106.89 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.646 ' HB3' HG12 ' A' ' 4' ' ' VAL . 5.1 t80 -88.1 116.6 26.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.47 101.25 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.779 2.032 . . . . 0.0 108.079 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.555 HG22 ' CD2' ' A' ' 30' ' ' TYR . 5.3 p -86.6 22.51 1.88 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.559 1.171 . . . . 0.0 111.227 -171.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.47 -89.84 0.4 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 167.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.95 37.4 0.84 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.063 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.36 24.04 9.91 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.754 2.121 . . . . 0.0 114.437 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -82.66 154.3 24.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -138.92 136.88 42.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.443 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.8 pt-20 -122.96 163.2 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.312 1.045 . . . . 0.0 110.446 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.94 104.31 15.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.173 1.389 . . . . 0.0 108.209 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 t -79.25 151.75 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -120.17 123.56 43.61 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 129.597 3.159 . . . . 0.0 104.427 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -144.96 113.04 6.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.991 0.814 . . . . 0.0 109.289 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.3 p -94.79 65.17 3.0 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -161.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.69 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 122.987 1.375 . . . . 0.0 112.198 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.22 -139.27 0.09 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.733 1.613 . . . . 0.0 109.15 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.57 38.84 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.499 1.52 . . . . 0.0 109.465 -165.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.76 -175.36 3.55 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.926 1.691 . . . . 0.0 109.833 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 157.13 8.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 169.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.07 -62.25 6.51 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.266 8.7 p 64.85 -137.18 0.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.366 1.466 . . . . 0.0 109.203 -173.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.18 170.51 20.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.93 -27.35 84.72 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 63.66 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 126.597 1.959 . . . . 0.0 109.217 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -56.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 126.028 1.731 . . . . 0.0 111.675 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.11 -34.98 72.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.107 -171.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -16.38 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.535 1.516 . . . . 0.0 113.727 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -98.11 -46.2 5.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 120.283 1.401 . . . . 0.0 109.971 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.554 ' CD2' HD11 ' A' ' 29' ' ' ILE . 88.5 mt -68.88 -37.93 79.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.967 0.507 . . . . 0.0 112.012 -173.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.48 -50.52 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 123.85 0.86 . . . . 0.0 108.845 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.3 m -74.89 13.13 0.7 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 4.9 mttt -127.66 37.56 4.19 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.356 1.463 . . . . 0.0 108.707 163.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 38.57 39.3 0.79 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.831 1.682 . . . . 0.0 114.523 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 77.5 t -81.69 87.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.484 1.513 . . . . 0.0 108.402 -172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -91.09 35.62 0.91 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.555 1.071 . . . . 0.0 111.851 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.93 ' HB3' HG23 ' A' ' 4' ' ' VAL . 25.5 m-85 -164.63 162.45 21.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.797 -1.815 . . . . 0.0 108.595 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tp -160.15 153.22 21.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.742 HG21 ' HB1' ' A' ' 97' ' ' ALA . 79.1 mt -125.81 98.59 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.263 1.425 . . . . 0.0 107.707 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.62 133.33 16.84 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 120.205 1.366 . . . . 0.0 111.412 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.4 p -74.39 -18.4 60.67 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.42 -169.86 0.87 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.063 1.745 . . . . 0.0 108.292 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.66 140.37 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 120.376 -1.453 . . . . 0.0 108.764 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -46.29 -54.89 8.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.459 1.504 . . . . 0.0 110.526 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 172.12 152.92 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.541 2.736 . . . . 0.0 106.464 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 -144.91 0.5 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.378 1.871 . . . . 0.0 109.923 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.42 -30.9 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 129.565 3.146 . . . . 0.0 116.117 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.686 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 59.0 t80 -57.92 -40.94 81.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.245 2.218 . . . . 0.0 111.653 -169.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.75 -41.11 83.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.599 1.159 . . . . 0.0 110.099 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -69.06 -19.59 64.09 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.252 -0.905 . . . . 0.0 110.575 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 76' ' ' PHE . 71.0 mt -72.4 -61.33 1.84 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.351 0.978 . . . . 0.0 109.411 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.686 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -58.33 -35.89 72.57 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.769 -1.207 . . . . 0.0 112.473 176.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.12 -7.54 9.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.69 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.61 36.5 4.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 121.211 1.823 . . . . 0.0 110.733 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.16 5.91 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.111 1.815 . . . . 0.0 115.48 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.24 116.31 27.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 118.486 1.143 . . . . 0.0 109.626 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -79.8 94.62 5.82 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.678 HG11 ' CZ ' ' A' ' 112' ' ' PHE . 38.8 t -80.12 128.78 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -103.78 160.65 14.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.415 1.886 . . . . 0.0 108.895 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -79.0 161.23 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 164.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.484 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -138.28 165.12 27.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 155.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -150.24 39.47 0.75 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 121.008 1.731 . . . . 0.0 113.189 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.25 102.69 1.71 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 121.231 -0.918 . . . . 0.0 112.207 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.07 163.14 26.99 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 111.68 -168.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.4 p -84.41 173.64 10.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.118 0.567 . . . . 0.0 109.95 165.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -48.61 -40.21 11.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.321 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -63.07 -33.53 75.64 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -71.77 -37.57 70.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.556 1.542 . . . . 0.0 109.897 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.742 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.03 -43.55 19.76 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.092 0.86 . . . . 0.0 110.548 168.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -81.14 -55.6 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 C-N-CA 125.329 1.452 . . . . 0.0 108.356 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.28 -31.23 65.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.109 1.764 . . . . 0.0 108.603 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.04 -52.54 7.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.939 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -51.77 -45.1 63.63 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.168 0.895 . . . . 0.0 111.14 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -65.95 -44.78 84.01 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.013 0.925 . . . . 0.0 110.16 -168.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.94 37.18 1.33 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.584 0.707 . . . . 0.0 109.18 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 41.89 44.16 4.46 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 127.93 2.681 . . . . 0.0 113.096 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -106.14 37.26 2.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.085 0.954 . . . . 0.0 110.485 169.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 89' ' ' PHE . 45.2 mt -138.75 172.73 12.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.198 0.908 . . . . 0.0 109.454 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.38 146.95 37.42 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.002 1.321 . . . . 0.0 108.498 -168.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -81.26 99.1 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.424 1.107 . . . . 0.0 108.474 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp -87.83 87.41 7.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.3 p -122.46 35.81 4.79 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.696 1.589 . . . . 0.0 110.662 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -159.63 38.38 0.19 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.269 -163.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.678 ' CZ ' HG11 ' A' ' 86' ' ' VAL . 24.7 p90 -125.24 128.32 48.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.822 -1.174 . . . . 0.0 108.299 -167.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.85 143.64 33.47 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -154.19 140.84 18.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -148.37 78.59 1.43 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 103.775 -3.73 . . . . 0.0 103.775 158.549 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 91.3 mtp . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.51 -172.41 1.92 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.698 1.599 . . . . 0.0 109.845 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.75 125.66 42.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.471 156.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.677 HG12 ' HB3' ' A' ' 30' ' ' TYR . 2.3 p -97.62 151.03 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.606 1.191 . . . . 0.0 108.235 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.67 136.79 52.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 166.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.55 HD11 HG13 ' A' ' 4' ' ' VAL . 3.5 mp -122.95 118.32 28.23 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.0 115.35 4.23 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 124.507 3.471 . . . . 0.0 107.573 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -118.16 151.87 36.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.233 1.413 . . . . 0.0 107.467 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.49 41.55 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.32 176.96 48.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -119.83 57.73 0.91 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.123 1.769 . . . . 0.0 108.202 -169.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.15 154.17 39.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.223 1.809 . . . . 0.0 106.431 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.717 1.207 . . . . 0.0 110.253 172.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -123.48 37.36 4.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 119.983 -1.698 . . . . 0.0 110.753 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.9 m -82.17 172.25 13.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.387 160.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.06 136.59 37.21 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.201 -0.937 . . . . 0.0 109.559 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 93' ' ' THR . 43.3 t -72.32 159.09 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -115.7 149.91 37.64 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.919 0.888 . . . . 0.0 111.447 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.3 37.81 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.453 1.101 . . . . 0.0 111.065 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.71 101.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.564 -1.335 . . . . 0.0 108.988 -162.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.488 ' HB3' HG23 ' A' ' 71' ' ' VAL . 31.4 t80 -53.39 -62.29 1.75 Allowed 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 123.36 0.412 . . . . 0.0 111.068 170.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 -3.5 29.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -118.78 38.94 3.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 109.495 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.38 115.31 28.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.188 -164.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -69.85 -23.8 63.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -166.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.08 156.9 47.31 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 106.855 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -132.19 112.72 12.52 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 124.107 0.963 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.448 HG13 HG11 ' A' ' 94' ' ' VAL . 8.4 mm -79.78 120.19 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 169.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.38 117.08 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.677 ' HB3' HG12 ' A' ' 4' ' ' VAL . 33.1 t80 -103.0 126.0 49.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.151 1.38 . . . . 0.0 110.182 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 115.03 27.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.842 2.057 . . . . 0.0 110.173 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 80.9 p -76.0 23.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.86 -6.02 2.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.25 36.46 0.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 158.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 34.88 34.54 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 C-N-CA 127.092 2.282 . . . . 0.0 113.327 -170.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -88.29 154.64 20.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -168.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.51 137.34 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 123.412 0.685 . . . . 0.0 110.872 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -109.86 154.28 23.25 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.174 2.19 . . . . 0.0 108.371 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.37 112.04 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 158.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.05 137.48 21.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 157.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.98 135.73 33.9 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 161.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.05 95.04 3.13 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.002 0.819 . . . . 0.0 110.159 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.1 p -93.3 76.91 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.41 163.29 3.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 162.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -131.84 133.26 44.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 153.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -79.07 77.35 5.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.04 114.85 1.51 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.905 2.082 . . . . 0.0 107.658 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.4 m170 67.57 -64.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.762 2.425 . . . . 0.0 111.688 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.44 83.09 0.07 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.86 1.219 . . . . 0.0 112.219 168.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -69.35 -10.21 56.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -172.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -169.76 -173.31 37.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.373 1.94 . . . . 0.0 108.812 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.59 -33.86 3.74 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 120.383 2.092 . . . . 0.0 112.757 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.1 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.851 2.06 . . . . 0.0 111.231 -167.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.59 -54.44 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.928 1.691 . . . . 0.0 110.055 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.45 -52.83 42.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 116.521 -1.704 . . . . 0.0 109.624 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -53.47 -33.35 53.91 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.351 1.432 . . . . 0.0 111.418 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -68.04 -67.43 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 120.93 -1.106 . . . . 0.0 112.594 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.35 -38.58 80.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.794 0.838 . . . . 0.0 111.08 -166.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.8 t -54.77 -36.52 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.729 1.611 . . . . 0.0 111.518 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 t -67.66 -13.43 62.08 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.649 -1.282 . . . . 0.0 112.91 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.03 37.09 2.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.832 1.196 . . . . 0.0 109.957 172.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.8 26.76 41.35 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.964 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.7 t -73.05 97.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 118.256 1.028 . . . . 0.0 109.014 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -104.61 35.27 2.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.033 0.921 . . . . 0.0 111.597 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.551 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -174.74 151.5 1.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.447 -1.408 . . . . 0.0 108.363 -162.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 68' ' ' ALA . 13.1 tp -159.29 154.64 25.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.717 1.207 . . . . 0.0 108.706 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.764 HG21 ' HB1' ' A' ' 97' ' ' ALA . 48.3 mt -127.02 104.06 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -163.25 105.81 1.01 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.957 0.903 . . . . 0.0 109.203 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -13.46 25.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -156.34 -177.72 6.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 119.683 1.129 . . . . 0.0 108.806 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 21' ' ' PHE 0.256 4.1 p -133.16 166.14 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.18 60.2 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 168.37 -88.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 130.799 3.64 . . . . 0.0 106.52 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.75 139.32 58.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 153.31 -30.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 130.688 3.595 . . . . 0.0 109.838 160.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.592 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 60.7 t80 -52.74 -42.5 64.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.433 1.893 . . . . 0.0 111.434 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -69.45 -35.68 75.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.403 1.481 . . . . 0.0 109.408 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -22.36 58.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 110.276 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 21' ' ' PHE . 73.1 mt -68.85 -64.14 0.92 Allowed 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.95 -39.87 20.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.43 1.092 . . . . 0.0 111.892 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.64 37.16 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.979 0.912 . . . . 0.0 111.247 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.14 30.37 1.83 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.037 1.78 . . . . 0.0 116.742 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.49 126.53 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.68 1.24 . . . . 0.0 108.123 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.23 159.91 27.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.412 HG13 HD23 ' A' ' 66' ' ' LEU . 22.0 t -147.37 133.52 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -116.73 162.89 16.97 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.033 1.733 . . . . 0.0 110.14 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -79.74 153.42 29.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.264 2.226 . . . . 0.0 108.051 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.9 129.66 15.16 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.861 2.064 . . . . 0.0 106.303 164.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.68 39.38 3.94 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 123.472 2.851 . . . . 0.0 111.615 -165.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.74 131.91 4.03 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.322 1.915 . . . . 0.0 110.415 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.6 163.48 11.85 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.075 0.937 . . . . 0.0 113.035 -164.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.495 ' C ' HG23 ' A' ' 17' ' ' VAL . 23.4 p -87.89 170.02 11.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.489 1.516 . . . . 0.0 110.39 166.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 HG13 ' A' ' 28' ' ' ILE . 43.6 t -44.0 -47.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-N 119.338 0.972 . . . . 0.0 110.022 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -56.73 -38.01 71.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.47 -46.39 76.54 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.707 1.603 . . . . 0.0 108.722 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -50.76 -30.13 13.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.449 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.4 mm -93.5 -51.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 C-N-CA 124.596 1.158 . . . . 0.0 107.912 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.64 -42.46 78.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.32 -49.03 63.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.623 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.55 78.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 111.563 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.3 p -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.56 1.144 . . . . 0.0 109.499 -170.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.6 36.59 2.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.402 1.081 . . . . 0.0 108.617 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.72 11.92 0.19 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.642 2.068 . . . . 0.0 116.666 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -85.35 36.05 0.62 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.177 1.988 . . . . 0.0 111.061 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.8 mt -139.72 175.53 9.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -114.61 159.84 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -78.91 137.46 37.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 161.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp -120.64 59.05 0.92 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.013 1.325 . . . . 0.0 108.16 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.345 7.2 t -104.33 36.58 2.34 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.557 1.17 . . . . 0.0 109.611 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.43 89.02 0.11 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -171.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.465 ' CE2' HG12 ' A' ' 71' ' ' VAL . 6.8 m-85 -79.12 158.84 27.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.24 45.74 2.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.198 1.799 . . . . 0.0 107.959 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -114.0 97.66 6.51 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 125.789 1.636 . . . . 0.0 108.525 -171.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.72 94.85 5.81 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.416 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -177.532 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.07 93.53 2.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.596 1.089 . . . . 0.0 113.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm105 -78.62 114.44 17.54 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.923 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.71 136.27 30.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.18 95.68 5.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 0.947 . . . . 0.0 108.81 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -83.96 132.07 49.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -170.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.63 136.5 23.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 1 C-N-CA 125.586 4.191 . . . . 0.0 109.676 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.0 t -138.05 166.08 25.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.261 1.424 . . . . 0.0 108.077 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.63 39.15 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.127 0.971 . . . . 0.0 109.532 163.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.14 167.17 40.31 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 164.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 8.7 mtmp? -92.95 42.42 1.1 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.543 1.537 . . . . 0.0 109.106 -175.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.83 149.94 32.17 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.522 0.729 . . . . 0.0 109.399 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -73.0 -12.0 60.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.216 1.807 . . . . 0.0 112.058 -174.041 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -114.12 35.8 3.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.828 -1.17 . . . . 0.0 111.625 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 m -86.26 169.63 12.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 171.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.48 134.22 37.35 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 65.5 t -78.86 130.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 122.452 1.12 . . . . 0.0 108.589 172.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -79.94 153.9 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.159 1.783 . . . . 0.0 109.499 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.94 37.14 1.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.645 1.112 . . . . 0.0 110.775 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -167.53 99.38 0.49 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 119.168 -2.208 . . . . 0.0 110.23 -166.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.474 ' CD2' HD11 ' A' ' 79' ' ' LEU . 3.1 t80 -49.27 -64.69 0.73 Allowed 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.253 0.933 . . . . 0.0 111.34 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.84 24.31 1.29 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.77 -170.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 39.42 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 167.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.71 132.8 56.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.29 -26.22 46.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -162.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' HG3' ' A' ' 11' ' ' LYS . 97.9 m-85 -135.36 148.21 49.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -125.92 125.37 42.66 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.535 HD12 HG22 ' A' ' 39' ' ' VAL . 19.3 mm -112.59 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -92.84 97.9 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 4' ' ' VAL . 38.8 t80 -81.77 117.95 22.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.89 118.35 22.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.711 2.004 . . . . 0.0 109.892 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.7 p -90.26 28.16 1.5 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.761 1.164 . . . . 0.0 111.802 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -99.67 -87.05 0.37 Allowed 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 155.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -94.78 35.42 1.25 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.339 -156.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 28.09 38.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.192 1.377 . . . . 0.0 113.933 -163.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -68.79 155.51 40.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.2 170.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.66 140.7 17.36 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG22 HD12 ' A' ' 28' ' ' ILE . 70.6 t -112.63 107.98 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.83 145.57 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -109.41 133.9 52.5 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 128.599 2.759 . . . . 0.0 104.446 166.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -153.89 112.29 3.61 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.88 0.872 . . . . 0.0 109.009 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.0 p -117.05 55.58 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.68 0.752 . . . . 0.0 110.255 -155.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.81 99.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.1 0.96 . . . . 0.0 111.037 -170.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.91 39.65 3.9 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.946 -1.096 . . . . 0.0 111.786 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.96 146.78 16.18 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.242 1.417 . . . . 0.0 108.278 -175.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.08 38.22 2.35 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.544 0.738 . . . . 0.0 112.835 -166.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -130.96 77.84 1.81 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -126.89 103.43 0.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.363 1.935 . . . . 0.0 110.988 -170.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -80.42 -11.34 59.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.966 1.306 . . . . 0.0 112.423 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.54 168.06 27.4 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 57.2 Cg_endo -73.5 -35.69 4.57 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 C-N-CA 123.014 2.476 . . . . 0.0 113.852 -161.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 66.15 -68.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -61.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.161 1.385 . . . . 0.0 108.566 170.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.2 t -57.54 -45.51 86.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-O 116.006 -1.949 . . . . 0.0 109.131 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -45.2 -53.56 8.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.247 1.385 . . . . 0.0 111.662 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -67.05 -44.85 79.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.78 -41.46 87.62 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.22 -0.925 . . . . 0.0 110.148 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.07 -34.03 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.84 1.656 . . . . 0.0 110.361 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -66.8 -16.24 64.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.371 0.987 . . . . 0.0 113.536 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -104.35 37.44 2.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.558 1.072 . . . . 0.0 109.634 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.13 34.12 3.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.006 1.289 . . . . 0.0 114.074 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.1 106.42 5.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 118.936 1.368 . . . . 0.0 107.525 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -108.27 35.23 3.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.587 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -168.58 151.83 5.45 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.326 -1.484 . . . . 0.0 108.406 -163.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 68' ' ' ALA . 22.3 tp -166.26 145.0 5.72 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.245 -1.534 . . . . 0.0 109.064 -169.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.775 HG21 ' HB1' ' A' ' 97' ' ' ALA . 41.9 mt -125.23 100.06 6.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -161.54 94.52 0.97 Allowed 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.315 0.961 . . . . 0.0 110.835 -167.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.5 p -29.6 -32.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.733 3.213 . . . . 0.0 119.462 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -162.63 -174.73 4.11 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.845 2.058 . . . . 0.0 105.816 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.38 156.62 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 120.735 -1.228 . . . . 0.0 109.304 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.02 66.15 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.697 1.142 . . . . 0.0 113.253 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 144.0 -105.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 1 C-N-CA 135.865 5.666 . . . . 0.0 107.019 169.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -57.13 119.01 5.61 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.881 -1.137 . . . . 0.0 109.846 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.88 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 130.89 3.676 . . . . 0.0 110.907 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.511 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 28.4 t80 -54.65 -36.1 64.22 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.231 0.923 . . . . 0.0 111.558 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.55 -30.74 71.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.61 1.964 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -92.96 -14.78 27.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.583 1.553 . . . . 0.0 111.002 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.474 HD11 ' CD2' ' A' ' 21' ' ' PHE . 60.0 mt -66.93 -68.05 0.4 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 167.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -52.25 -30.67 28.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.32 -30.62 12.46 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.05 36.9 3.15 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.927 1.291 . . . . 0.0 111.059 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.64 15.85 54.57 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.098 1.199 . . . . 0.0 116.098 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.93 123.35 36.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 118.314 1.057 . . . . 0.0 110.782 -158.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -78.9 156.79 28.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG13 HD23 ' A' ' 66' ' ' LEU . 18.5 t -149.29 138.31 15.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -122.25 155.45 35.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.76 0.824 . . . . 0.0 111.544 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -79.22 149.24 31.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 162.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.73 167.97 16.5 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -142.73 116.35 9.18 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.915 -1.115 . . . . 0.0 110.187 160.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.03 90.3 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 125.577 1.56 . . . . 0.0 113.654 162.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 165.72 37.98 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.2 p -81.81 178.39 8.34 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.977 -0.719 . . . . 0.0 110.698 167.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.03 -44.93 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.121 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -60.76 -37.27 81.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 120.972 1.715 . . . . 0.0 114.626 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.86 -40.7 83.61 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.592 1.557 . . . . 0.0 108.264 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.775 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.74 -35.53 14.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.397 0.544 . . . . 0.0 111.983 168.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.7 -53.25 9.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 125.131 1.372 . . . . 0.0 109.376 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -28.21 68.87 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.801 2.04 . . . . 0.0 108.69 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.68 -58.01 3.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.624 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.9 t80 -54.74 -50.74 67.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.569 0.747 . . . . 0.0 112.451 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 p -63.1 -44.72 94.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.896 0.879 . . . . 0.0 108.904 -168.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.63 37.4 0.91 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.875 0.845 . . . . 0.0 109.014 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.98 17.05 8.78 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 128.073 2.749 . . . . 0.0 116.501 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -89.65 36.62 0.85 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.72 2.26 . . . . 0.0 112.769 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 101' ' ' PHE . 19.1 mt -137.32 166.8 22.93 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.985 1.721 . . . . 0.0 110.339 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.21 147.7 24.34 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -93.24 82.4 4.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 tp -79.53 74.01 6.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.986 0.898 . . . . 0.0 109.558 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p -115.43 37.42 3.57 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 120.442 -1.411 . . . . 0.0 110.125 -167.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t 168.7 90.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.705 2.002 . . . . 0.0 105.596 -166.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.75 165.97 33.06 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.1 m -143.26 -155.01 0.56 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.963 2.105 . . . . 0.0 105.662 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.509 ' CD ' ' H ' ' A' ' 116' ' ' GLY . 2.5 tmm_? -141.59 141.57 33.48 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.54 36.5 2.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.509 ' H ' ' CD ' ' A' ' 114' ' ' ARG . . . . . . . . 0 C--O 1.256 1.511 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 9.9 ttt . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 119.94 -0.076 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 65' ' ' TYR . . . 161.93 140.67 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 128.137 2.575 . . . . 0.0 109.083 169.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 -116.8 131.62 56.9 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 124.003 0.814 . . . . 0.0 110.111 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.873 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -121.29 124.81 72.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -169.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.9 137.97 39.48 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.498 HD11 HG13 ' A' ' 4' ' ' VAL . 4.8 mp -123.25 116.66 28.38 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 74.1 Cg_endo -67.57 112.53 2.65 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 125.074 3.849 . . . . 0.0 106.877 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -113.99 167.52 10.59 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.561 1.944 . . . . 0.0 107.447 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.13 38.36 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.569 -0.707 . . . . 0.0 109.654 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 166.94 39.84 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 120.99 -1.069 . . . . 0.0 110.958 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -89.22 39.44 0.94 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 122.151 -0.617 . . . . 0.0 110.712 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.02 153.42 50.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.609 1.164 . . . . 0.0 109.277 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.74 -15.89 55.3 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.486 1.914 . . . . 0.0 109.745 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 38.9 2.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.285 1.434 . . . . 0.0 108.229 170.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -83.88 173.17 11.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 119.822 -1.799 . . . . 0.0 107.991 164.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.39 140.65 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.582 -1.324 . . . . 0.0 109.553 166.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.7 t -73.37 149.93 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 167.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -102.57 136.52 42.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.82 1.648 . . . . 0.0 108.59 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -81.5 37.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.409 1.1 . . . . 0.0 111.082 -172.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 110.28 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -162.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -64.17 -56.45 14.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.677 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.34 0.02 9.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -134.93 76.61 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.487 1.915 . . . . 0.0 107.192 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.761 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -122.48 166.56 14.58 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 160.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 14.6 mt-10 -106.68 -16.89 14.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -144.76 153.86 42.12 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.761 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 70.4 m-85 -131.53 98.4 4.5 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.145 1.778 . . . . 0.0 107.51 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.406 HG22 ' CG1' ' A' ' 37' ' ' VAL . 2.2 mm -79.43 103.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -176.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 58' ' ' LEU . 55.9 mt -89.27 103.87 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.507 ' HB3' HG12 ' A' ' 4' ' ' VAL . 50.4 t80 -85.06 146.17 27.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.51 114.42 21.74 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 127.172 2.189 . . . . 0.0 111.09 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.9 p -78.86 13.82 1.58 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 1' ' ' MET . 17.5 mm-40 -99.89 -32.94 10.75 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.348 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.93 36.49 1.41 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.033 160.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.57 33.62 26.17 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.257 0.932 . . . . 0.0 111.784 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -81.88 157.79 24.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.128 1.771 . . . . 0.0 107.091 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.406 ' CG1' HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -138.48 150.33 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.867 0.842 . . . . 0.0 110.052 177.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.97 141.73 51.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.011 1.325 . . . . 0.0 108.845 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.87 110.26 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 163.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.37 150.31 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 160.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.88 117.01 27.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -134.65 87.75 2.38 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -168.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.1 p -79.63 60.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 -174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mm -91.23 152.65 3.32 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.18 172.22 13.15 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.205 1.002 . . . . 0.0 110.533 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.43 76.07 6.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.801 1.64 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.11 163.71 23.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.966 1.706 . . . . 0.0 106.805 168.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.437 ' CE1' HH21 ' A' ' 73' ' ' ARG . 31.2 m-70 -56.95 -56.38 22.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.94 74.55 0.5 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 166.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.9 p -60.03 146.56 42.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.566 0.746 . . . . 0.0 112.663 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.42 171.57 41.6 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -168.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.53 -33.77 2.25 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.17 1.247 . . . . 0.0 113.149 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 -66.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.791 2.437 . . . . 0.0 114.99 -170.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -57.65 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.456 1.502 . . . . 0.0 107.99 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -41.93 79.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 115.747 -2.073 . . . . 0.0 110.922 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -40.56 61.76 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.879 1.672 . . . . 0.0 111.499 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -75.61 -50.78 14.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.084 1.354 . . . . 0.0 109.787 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' A' ' 29' ' ' ILE . 87.3 mt -58.5 -43.62 89.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.928 0.891 . . . . 0.0 110.102 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.74 -51.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.897 1.679 . . . . 0.0 110.756 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.3 t -62.15 -25.91 68.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -92.15 37.59 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.44 -1.412 . . . . 0.0 110.331 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.11 6.32 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 127.518 2.485 . . . . 0.0 115.779 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.68 137.81 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.189 1.495 . . . . 0.0 109.272 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.38 35.01 2.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 110.955 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.873 ' HB3' HG23 ' A' ' 4' ' ' VAL . 10.5 m-85 179.89 164.5 1.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 119.634 -1.916 . . . . 0.0 107.209 -170.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 68' ' ' ALA . 12.0 tp -171.2 147.42 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.72 HG21 ' HB1' ' A' ' 97' ' ' ALA . 62.9 mt -123.85 101.14 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -155.31 115.48 3.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.418 1.008 . . . . 0.0 110.639 -166.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.8 p -59.43 -23.89 63.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -171.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.01 174.09 9.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -170.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -120.06 157.66 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.492 -1.38 . . . . 0.0 108.428 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.7 67.62 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.437 HH21 ' CE1' ' A' ' 48' ' ' HIS . 9.6 ttp-105 169.75 -154.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 131.409 3.884 . . . . 0.0 105.657 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -24.75 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.18 2.992 . . . . 0.0 114.355 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -170.99 -29.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.412 1.485 . . . . 0.0 113.97 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.632 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 82.3 t80 -58.68 -36.08 73.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.49 1.116 . . . . 0.0 112.51 -169.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.16 -41.03 74.34 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -23.77 67.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.84 -0.537 . . . . 0.0 111.039 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.34 -68.16 0.41 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.857 0.863 . . . . 0.0 108.968 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.632 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -58.33 -31.38 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.82 24.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.096 0.558 . . . . 0.0 110.445 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.7 36.86 1.83 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.386 0.674 . . . . 0.0 111.828 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.25 8.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.416 1.484 . . . . 0.0 116.333 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.86 120.26 33.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.191 1.495 . . . . 0.0 108.98 -170.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -78.43 160.79 27.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.8 t -143.42 137.34 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.57 158.19 25.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.022 1.729 . . . . 0.0 110.112 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -78.95 148.24 32.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.525 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -138.12 161.12 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 156.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -148.94 85.38 1.48 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 120.268 1.395 . . . . 0.0 111.154 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.9 112.47 0.59 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.454 1.026 . . . . 0.0 111.063 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.92 158.3 10.76 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -83.08 171.76 13.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 110.397 170.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.15 -40.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-O 116.747 -1.597 . . . . 0.0 113.138 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -35.26 76.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 121.012 1.733 . . . . 0.0 113.626 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.83 -46.25 69.04 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.75 2.02 . . . . 0.0 108.355 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.72 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.41 -40.45 17.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 118.699 0.681 . . . . 0.0 111.144 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.65 -51.04 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.39 1.876 . . . . 0.0 108.886 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -40.05 85.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.382 1.473 . . . . 0.0 108.237 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.66 -49.48 25.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.79 0.836 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.78 -50.45 73.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.477 1.035 . . . . 0.0 111.787 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -64.18 -39.05 93.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.384 1.074 . . . . 0.0 110.163 -168.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -101.42 37.34 1.81 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.975 0.91 . . . . 0.0 109.435 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 40.22 46.06 3.3 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 127.497 2.475 . . . . 0.0 114.113 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -112.49 37.35 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.901 0.88 . . . . 0.0 109.854 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 89' ' ' PHE . 74.3 mt -143.39 170.09 16.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.994 -1.067 . . . . 0.0 108.547 165.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -119.11 147.64 43.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.641 1.576 . . . . 0.0 108.075 -165.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -78.99 116.84 19.55 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.1 59.63 2.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.727 2.011 . . . . 0.0 108.362 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 p -88.97 38.95 0.91 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.456 1.102 . . . . 0.0 111.396 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t 159.57 159.96 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 131.222 3.809 . . . . 0.0 104.645 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -165.0 163.05 20.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.4 m -108.49 142.55 38.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -146.89 125.54 12.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.48 96.27 5.36 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 175.822 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 153.94 22.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.235 1.414 . . . . 0.0 108.566 170.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -78.52 119.57 22.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -105.96 124.64 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.284 -172.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.45 111.38 23.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.98 124.55 51.68 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 60.8 Cg_endo -77.55 112.0 3.25 Favored 'Trans proline' 0 N--CA 1.443 -1.448 1 C-N-CA 125.464 4.109 . . . . 0.0 108.528 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 t -108.66 174.8 5.71 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.192 1.397 . . . . 0.0 108.498 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.82 38.49 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 109.655 167.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.78 -170.14 32.18 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -129.48 64.8 1.48 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.593 1.696 . . . . 0.0 110.195 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.62 153.99 29.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.082 1.753 . . . . 0.0 107.949 169.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -65.94 -12.07 52.14 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.737 1.215 . . . . 0.0 110.521 174.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -110.58 36.44 3.1 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.589 -1.319 . . . . 0.0 111.435 172.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 166.73 11.77 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.053 -1.03 . . . . 0.0 109.771 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 135.14 37.35 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.302 -1.499 . . . . 0.0 109.81 -172.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.599 HG21 ' HB2' ' A' ' 97' ' ' ALA . 45.7 t -78.02 131.11 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 t -81.07 144.16 31.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.614 1.566 . . . . 0.0 109.76 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -86.41 36.71 0.7 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.444 1.593 . . . . 0.0 110.739 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.61 121.54 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -166.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.65 -61.25 1.84 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . . . -66.41 -23.6 66.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.832 -168.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -105.04 75.56 1.19 Allowed 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 127.673 2.389 . . . . 0.0 107.753 166.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -133.19 160.26 37.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 157.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -105.96 -12.63 15.75 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -168.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -146.22 145.86 30.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.35 108.25 9.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 28' ' ' ILE . 1.4 mp -89.62 117.71 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -171.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.507 HD11 ' CD2' ' A' ' 58' ' ' LEU . 42.5 mt -105.24 97.29 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 -175.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HG12 ' A' ' 4' ' ' VAL . 71.9 t80 -91.25 109.08 20.34 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.77 110.22 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.463 1.505 . . . . 0.0 108.962 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -78.02 55.03 1.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.558 -0.714 . . . . 0.0 110.016 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -134.21 -39.86 0.83 Allowed 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 124.814 1.246 . . . . 0.0 111.374 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -144.37 37.33 1.23 Allowed 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.601 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 16.29 2.24 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.609 1.576 . . . . 0.0 115.294 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -82.22 134.03 35.28 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.305 1.053 . . . . 0.0 108.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.64 160.51 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 125.261 1.424 . . . . 0.0 108.817 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.17 132.86 27.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.87 110.55 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.12 152.07 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 160.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -124.44 96.04 4.76 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.96 2.504 . . . . 0.0 105.935 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.483 ' HB3' HD11 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -114.46 106.7 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -170.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.8 p -84.27 62.09 6.95 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.268 -0.895 . . . . 0.0 110.642 -167.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 42' ' ' ASN . 3.8 mm -82.3 156.38 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.216 -0.927 . . . . 0.0 109.171 -166.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.07 178.61 10.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.167 1.787 . . . . 0.0 110.046 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.94 40.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.149 2.18 . . . . 0.0 114.665 -156.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.82 -179.32 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 120.545 -1.347 . . . . 0.0 110.194 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -175.22 5.02 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.512 1.525 . . . . 0.0 109.013 161.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.92 56.26 0.01 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p 50.34 29.56 3.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.95 2.1 . . . . 0.0 115.729 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.49 129.02 7.37 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 161.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 -30.35 50.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 CA-C-N 121.106 2.453 . . . . 0.0 112.033 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.46 -77.38 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.513 2.325 . . . . 0.0 110.87 -165.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -49.66 -60.52 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 C-N-CA 126.317 1.847 . . . . 0.0 109.334 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.3 t -60.04 -51.2 75.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 115.743 -2.075 . . . . 0.0 109.708 -173.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.82 -51.31 9.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.914 1.688 . . . . 0.0 110.949 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -62.41 -56.05 21.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 29' ' ' ILE . 93.0 mt -62.67 -41.9 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.301 0.64 . . . . 0.0 110.262 -172.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -57.44 -46.62 85.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -58.37 -27.64 64.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.146 0.884 . . . . 0.0 112.415 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -99.74 37.4 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.665 1.186 . . . . 0.0 109.471 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.11 23.42 7.75 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.292 2.377 . . . . 0.0 116.69 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.64 125.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.535 1.168 . . . . 0.0 108.053 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.19 36.59 4.61 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 164.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.559 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -165.74 157.46 14.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.485 -1.385 . . . . 0.0 109.112 -168.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 86' ' ' VAL . 12.1 tp -164.08 148.34 10.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -173.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.699 HG21 ' HB1' ' A' ' 97' ' ' ALA . 28.2 mt -124.58 106.77 17.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -156.77 134.44 10.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.999 2.182 . . . . 0.0 111.184 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -64.08 -21.16 66.41 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.602 -1.311 . . . . 0.0 113.641 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -163.21 177.45 9.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.07 1.748 . . . . 0.0 106.432 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 73' ' ' ARG 0.251 1.0 OUTLIER -107.35 161.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.055 -1.028 . . . . 0.0 108.561 174.847 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 22' ' ' ALA . . . -80.29 24.77 3.42 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.683 1.135 . . . . 0.0 111.63 171.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.486 ' H ' HG13 ' A' ' 71' ' ' VAL . 1.2 ttt-85 68.05 -71.09 0.11 Allowed 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 129.684 3.194 . . . . 0.0 113.257 -172.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.29 56.37 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.448 2.299 . . . . 0.0 113.833 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . . . -161.62 -28.64 0.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 113.95 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 79' ' ' LEU . 56.6 t80 -69.39 -32.59 71.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.897 1.68 . . . . 0.0 111.986 -169.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.21 -38.13 85.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 110.073 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -14.83 58.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.928 2.891 . . . . 0.0 109.366 -174.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 76' ' ' PHE . 31.9 mt -80.86 -58.13 3.23 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 108.221 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.642 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -62.6 -28.37 69.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.299 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.0 54.82 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.034 0.834 . . . . 0.0 111.876 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.9 37.31 4.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.617 1.099 . . . . 0.0 110.765 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.39 30.53 0.3 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.686 2.088 . . . . 0.0 117.041 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.78 125.2 38.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 118.87 1.335 . . . . 0.0 109.048 -169.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -78.96 155.99 28.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.453 HG13 HD23 ' A' ' 66' ' ' LEU . 43.6 t -145.69 129.47 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.24 170.6 7.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 110.655 171.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -107.58 152.02 24.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 126.898 2.079 . . . . 0.0 109.586 162.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.18 167.9 21.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.199 2.2 . . . . 0.0 106.425 176.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.93 129.17 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 167.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.04 90.5 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 128.04 2.733 . . . . 0.0 115.784 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.96 163.77 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -89.86 173.83 8.03 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.979 -0.719 . . . . 0.0 109.894 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.74 -42.83 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 117.731 -1.128 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -61.55 -36.9 81.9 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.55 -40.64 73.27 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.961 1.304 . . . . 0.0 109.08 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.75 -39.76 26.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.457 170.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -78.91 -60.43 2.27 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.91 -21.39 43.32 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 127.955 2.502 . . . . 0.0 110.919 -172.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.32 -52.69 6.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.585 ' HB2' HD12 ' A' ' 106' ' ' LEU . 19.4 t80 -59.51 -50.14 75.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.688 0.795 . . . . 0.0 112.732 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -64.07 -41.87 97.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 109.32 -168.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.38 36.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.293 1.037 . . . . 0.0 109.27 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.06 20.36 6.47 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 128.621 3.01 . . . . 0.0 117.244 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -97.1 37.41 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.538 1.669 . . . . 0.0 111.335 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 101' ' ' PHE . 27.0 mt -134.97 169.7 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.569 1.077 . . . . 0.0 109.062 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -108.64 138.74 44.46 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.354 1.462 . . . . 0.0 108.138 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.7 108.26 13.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp -95.62 50.41 1.22 Allowed 'General case' 0 C--O 1.238 0.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.4 p -86.52 37.36 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 120.732 -1.23 . . . . 0.0 110.24 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 t 159.8 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.7 2.8 . . . . 0.0 103.714 -161.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.11 161.74 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.643 1.977 . . . . 0.0 106.064 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.3 m -83.95 133.06 34.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -154.82 102.86 2.39 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.498 1.044 . . . . 0.0 109.996 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -78.14 105.12 9.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 147.978 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttm . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.77 165.71 26.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 119.558 1.072 . . . . 0.0 110.95 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -103.02 152.8 20.92 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.596 155.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.835 HG23 ' HB3' ' A' ' 65' ' ' TYR . 3.1 p -125.64 167.83 19.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 128.499 2.72 . . . . 0.0 103.756 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.42 149.45 52.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.52 120.01 19.59 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.57 123.67 11.07 Favored 'Trans proline' 0 N--CA 1.443 -1.492 1 C-N-CA 126.097 4.531 . . . . 0.0 107.135 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.3 t -127.44 169.16 13.93 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.825 1.65 . . . . 0.0 108.356 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.09 37.77 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 110.298 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.79 -177.85 41.03 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.224 -1.548 . . . . 0.0 111.008 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.4 mtpt -114.53 39.89 2.69 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.262 -1.14 . . . . 0.0 109.943 -172.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.33 148.44 36.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.919 1.288 . . . . 0.0 108.065 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -60.81 -10.5 5.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 112.574 173.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -112.69 36.6 3.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.277 -0.89 . . . . 0.0 111.396 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -90.2 167.97 12.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.041 -1.037 . . . . 0.0 108.967 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 139.8 39.16 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 120.865 1.666 . . . . 0.0 108.668 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 99.0 t -72.67 135.97 26.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -87.71 135.71 33.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.58 38.13 0.37 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.098 0.952 . . . . 0.0 110.903 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.93 99.05 0.07 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 119.86 -1.775 . . . . 0.0 110.174 -165.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 79' ' ' LEU . 18.9 t80 -53.49 -51.65 62.07 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.785 1.175 . . . . 0.0 112.957 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -3.66 33.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.002 -1.062 . . . . 0.0 112.401 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 38.79 3.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.549 0.74 . . . . 0.0 109.886 -171.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.77 108.94 16.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -165.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -52.64 -24.45 8.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.254 1.822 . . . . 0.0 115.272 -168.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 96.2 m-85 -139.19 151.26 46.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -129.61 112.79 14.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.1 mm -91.82 118.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.528 HD11 ' CD2' ' A' ' 58' ' ' LEU . 96.2 mt -111.97 100.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -172.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -82.77 141.7 32.15 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -117.87 110.82 18.23 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 127.197 2.199 . . . . 0.0 109.692 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.282 1.3 p -85.08 43.04 0.97 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.947 0.88 . . . . 0.0 110.699 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.94 -29.45 2.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 126.019 1.728 . . . . 0.0 112.604 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -147.58 35.25 0.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 117.728 -1.589 . . . . 0.0 111.069 157.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.2 24.12 14.59 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.804 -1.185 . . . . 0.0 112.31 -176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -64.75 156.24 31.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.74 162.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.533 1.158 . . . . 0.0 108.842 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -141.77 128.01 19.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.22 105.01 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.56 143.13 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 159.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.95 121.41 43.84 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -138.72 116.77 11.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.984 1.373 . . . . 0.0 110.221 -172.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.9 p -92.3 51.99 1.86 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.925 1.69 . . . . 0.0 110.67 -164.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.73 38.89 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.815 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.44 39.18 1.02 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.057 1.343 . . . . 0.0 110.61 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -147.54 168.18 22.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.01 173.84 12.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.994 1.718 . . . . 0.0 109.837 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 55.43 -174.18 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.45 1.5 . . . . 0.0 112.645 175.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.9 153.5 5.92 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 120.812 -1.18 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -88.96 -12.85 40.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.197 0.999 . . . . 0.0 112.539 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.38 -152.86 22.85 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -64.38 -43.67 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.289 1.992 . . . . 0.0 111.127 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? 65.17 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.351 1.46 . . . . 0.0 108.674 -166.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -67.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 127.135 2.174 . . . . 0.0 108.985 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.2 t -55.81 -49.96 71.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 115.669 -2.11 . . . . 0.0 109.651 -173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.46 -50.37 23.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.306 1.412 . . . . 0.0 111.117 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -42.16 68.52 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.107 -0.996 . . . . 0.0 113.342 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 29' ' ' ILE . 78.3 mt -66.5 -44.32 82.88 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.751 0.705 . . . . 0.0 109.888 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.31 -32.17 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.407 1.483 . . . . 0.0 110.118 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.6 m -75.89 1.98 13.66 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.802 -1.186 . . . . 0.0 113.879 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -119.42 38.46 3.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.452 1.901 . . . . 0.0 108.289 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.89 19.98 12.24 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.64 1.114 . . . . 0.0 115.845 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.0 96.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.131 1.373 . . . . 0.0 107.864 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.47 36.31 2.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.324 1.05 . . . . 0.0 110.568 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.835 ' HB3' HG23 ' A' ' 4' ' ' VAL . 10.8 m-85 179.83 165.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.608 1.563 . . . . 0.0 107.024 -165.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 tp -166.14 152.65 9.31 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.271 1.429 . . . . 0.0 107.449 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.773 HG21 ' HB1' ' A' ' 97' ' ' ALA . 57.3 mt -123.06 103.04 12.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.95 130.03 13.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.698 1.136 . . . . 0.0 110.342 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.7 p -62.72 -28.19 69.79 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -169.14 -171.07 1.22 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.399 1.479 . . . . 0.0 107.15 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 p -136.24 136.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.45 96.54 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.85 177.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 129.486 3.114 . . . . 0.0 107.561 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.98 50.38 3.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 127.581 2.352 . . . . 0.0 115.616 154.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.4 -26.35 0.1 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 171.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.725 ' HA ' HD12 ' A' ' 79' ' ' LEU . 33.9 t80 -62.35 -35.62 79.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.377 0.989 . . . . 0.0 112.539 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.91 -34.59 73.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.7 m -73.09 -20.05 61.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.624 0.77 . . . . 0.0 111.072 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 76' ' ' PHE . 28.1 mt -69.46 -57.61 5.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -65.2 -29.74 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.94 -1.71 1.58 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.01 37.23 2.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.87 1.668 . . . . 0.0 110.181 162.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.6 30.99 1.58 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.868 . . . . 0.0 116.804 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.37 117.58 25.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 118.937 1.368 . . . . 0.0 108.524 -168.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -79.14 99.01 6.78 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.537 0.684 . . . . 0.0 109.959 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 79' ' ' LEU . 35.9 t -82.5 117.75 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.81 155.29 18.34 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.662 1.185 . . . . 0.0 109.558 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 157.56 26.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 164.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 163.15 30.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 160.245 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.52 68.21 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.801 1.182 . . . . 0.0 110.508 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.62 136.23 8.58 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.05 154.1 6.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.879 0.339 . . . . 0.0 112.519 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -80.05 171.08 15.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.07 0.548 . . . . 0.0 109.653 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -43.82 -42.15 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.769 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.37 -38.74 81.23 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -42.35 83.29 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 127.144 2.178 . . . . 0.0 108.849 -174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.773 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.81 -38.98 11.01 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.819 0.736 . . . . 0.0 111.167 171.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -86.0 -53.79 9.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 125.275 1.43 . . . . 0.0 109.121 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -26.69 65.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.044 1.738 . . . . 0.0 109.375 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.11 -62.6 1.41 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.415 ' HB2' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -51.75 -48.84 63.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.59 1.556 . . . . 0.0 112.626 -178.039 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -77.88 -13.27 59.94 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.664 2.786 . . . . 0.0 113.482 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -114.37 37.78 3.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.245 1.384 . . . . 0.0 109.836 159.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.51 12.73 4.91 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 127.626 2.536 . . . . 0.0 117.345 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -89.31 37.39 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.254 1.527 . . . . 0.0 111.413 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 101' ' ' PHE . 26.8 mt -136.29 167.33 21.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.013 1.279 . . . . 0.0 110.821 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -108.44 142.86 38.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.436 ' HG2' HG23 ' A' ' 110' ' ' THR . 34.8 tt0 -81.44 110.88 17.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.2 tp -99.48 58.04 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.96 1.704 . . . . 0.0 108.608 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 108' ' ' GLU . 24.9 p -101.7 35.91 2.2 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.154 -1.591 . . . . 0.0 110.181 -169.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.3 t -175.45 37.59 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.086 -1.009 . . . . 0.0 112.137 -173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -88.96 174.36 7.96 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.532 -1.355 . . . . 0.0 110.257 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.8 p -106.12 172.42 6.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.345 0.52 . . . . 0.0 110.255 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -142.72 122.15 13.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -152.36 88.18 1.35 Allowed 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 124.157 0.91 . . . . 0.0 109.241 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 176.247 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.25 153.9 14.12 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.451 1.9 . . . . 0.0 108.777 156.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -80.76 117.97 21.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.795 -0.566 . . . . 0.0 109.595 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -93.07 142.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.96 153.98 18.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 160.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.01 125.64 19.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 56.5 Cg_endo -74.27 106.63 2.27 Favored 'Trans proline' 0 N--CA 1.445 -1.35 1 C-N-CA 126.131 4.554 . . . . 0.0 109.576 177.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -104.12 172.07 7.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.364 1.466 . . . . 0.0 109.408 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.29 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 108.623 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.22 -169.36 42.36 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.794 -1.191 . . . . 0.0 111.259 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 7.5 mtmp? -129.96 52.71 1.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 111.842 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.64 167.48 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.917 1.687 . . . . 0.0 107.205 166.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -81.71 -6.31 58.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.501 -1.375 . . . . 0.0 111.0 174.142 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -116.26 39.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.579 -1.325 . . . . 0.0 108.922 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 m -78.66 169.39 18.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.25 -1.38 . . . . 0.0 107.303 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 145.08 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.441 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 69.5 t -86.05 137.77 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.404 1.097 . . . . 0.0 108.746 170.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -90.84 137.44 32.36 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.847 2.059 . . . . 0.0 108.74 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -81.25 36.16 0.41 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 122.895 1.331 . . . . 0.0 111.035 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 101.38 0.12 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -157.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 79' ' ' LEU . 8.5 t80 -55.04 -59.41 4.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.493 0.588 . . . . 0.0 110.571 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.08 -3.74 31.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.667 -170.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.71 74.1 1.24 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.312 1.415 . . . . 0.0 107.357 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -135.99 120.65 18.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.38 -22.13 66.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.259 1.424 . . . . 0.0 113.535 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 98.4 m-85 -137.25 148.67 46.61 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.01 1.724 . . . . 0.0 107.455 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -130.59 112.82 13.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.36 120.87 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.9 mt -109.77 101.49 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' HG12 ' A' ' 4' ' ' VAL . 38.9 t80 -89.63 110.89 21.73 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.86 108.88 13.78 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.076 2.15 . . . . 0.0 108.313 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -83.31 57.96 4.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -129.57 -48.51 1.16 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 124.649 1.18 . . . . 0.0 109.128 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 38.19 3.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.736 162.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.4 22.35 10.55 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.2 0.905 . . . . 0.0 113.68 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.86 148.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.14 148.88 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.1 0.96 . . . . 0.0 109.921 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -132.52 139.32 47.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.587 2.355 . . . . 0.0 105.793 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.9 t -108.9 103.57 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.48 151.71 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 167.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.54 129.96 56.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.78 132.31 23.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 120.697 -1.252 . . . . 0.0 110.124 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.2 p -115.3 57.24 0.73 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.314 1.054 . . . . 0.0 110.31 -152.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.51 40.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 128.178 2.591 . . . . 0.0 112.317 -174.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.55 38.42 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.294 -1.503 . . . . 0.0 112.243 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 160.26 25.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.066 2.147 . . . . 0.0 108.426 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.93 -152.31 0.07 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.371 2.268 . . . . 0.0 113.728 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -77.76 131.68 37.74 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.351 1.46 . . . . 0.0 112.958 -162.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.71 -175.77 45.7 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.767 1.651 . . . . 0.0 109.567 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.314 1.5 t 48.82 -153.21 0.11 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.193 1.797 . . . . 0.0 110.862 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.13 -163.69 38.41 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.307 -1.496 . . . . 0.0 109.749 165.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.5 -27.43 54.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.153 1.902 . . . . 0.0 112.968 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.322 1.7 ptpt 54.19 -65.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.821 2.448 . . . . 0.0 114.339 -164.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -65.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 127.156 2.182 . . . . 0.0 108.069 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.92 -48.09 78.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-O 116.863 -1.542 . . . . 0.0 109.151 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -46.95 21.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.171 0.896 . . . . 0.0 111.678 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -69.5 -56.22 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.305 0.642 . . . . 0.0 111.082 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -57.4 -46.01 83.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.418 0.554 . . . . 0.0 109.578 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 t -56.71 -36.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.373 1.869 . . . . 0.0 111.54 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -61.18 -38.93 88.26 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.575 1.079 . . . . 0.0 110.575 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.06 38.49 0.85 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.694 1.134 . . . . 0.0 110.029 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.17 26.4 42.76 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.019 1.771 . . . . 0.0 115.578 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.1 t -71.85 101.25 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.123 1.461 . . . . 0.0 109.231 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.28 34.88 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.618 0.645 . . . . 0.0 109.995 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.496 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -168.07 157.55 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 119.989 -1.694 . . . . 0.0 108.796 -169.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.9 tp -166.36 145.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 120.232 -1.542 . . . . 0.0 108.671 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.021 HG21 ' HB1' ' A' ' 97' ' ' ALA . 7.6 mt -111.18 107.02 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 126.404 1.882 . . . . 0.0 106.222 171.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.97 106.15 1.8 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 120.998 1.726 . . . . 0.0 110.623 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.7 p -34.46 -48.8 0.37 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.153 1.781 . . . . 0.0 113.195 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.39 -178.4 6.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -114.64 160.1 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.79 -23.54 38.6 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.392 -166.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -169.43 -132.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.363 3.465 . . . . 0.0 103.437 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -164.3 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.872 1.214 . . . . 0.0 110.872 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 97.58 -26.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.208 1 C-N-CA 133.427 4.691 . . . . 0.0 112.633 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 79' ' ' LEU . 60.6 t80 -60.85 -36.5 79.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.501 1.5 . . . . 0.0 112.247 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.75 -38.25 79.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.405 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -74.0 -24.44 59.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.914 0.886 . . . . 0.0 110.018 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 76' ' ' PHE . 27.6 mt -65.69 -72.01 0.17 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -57.05 -32.73 66.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.13 17.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.688 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.39 36.6 0.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.101 0.864 . . . . 0.0 112.071 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.26 33.89 0.56 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.232 1.872 . . . . 0.0 116.238 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 t -81.06 119.39 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 152.95 31.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.5 t -150.2 112.34 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.51 172.97 9.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.229 1.411 . . . . 0.0 111.311 166.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -112.02 148.46 33.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.452 2.701 . . . . 0.0 108.767 164.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -127.31 166.34 17.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.047 2.539 . . . . 0.0 105.086 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -148.4 56.68 1.05 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.122 1.328 . . . . 0.0 110.168 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.63 110.88 3.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 123.444 0.545 . . . . 0.0 112.395 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.56 166.49 31.94 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.6 p -87.39 173.68 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.748 0.819 . . . . 0.0 110.492 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.51 -38.42 12.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 CA-C-O 117.028 -1.463 . . . . 0.0 110.959 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.05 -45.33 93.19 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 120.45 1.477 . . . . 0.0 114.002 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -42.3 97.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.192 1.797 . . . . 0.0 109.283 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 1.021 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.75 -36.1 10.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -87.4 -57.13 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.71 -49.08 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.546 2.339 . . . . 0.0 106.53 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.81 76.7 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.354 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.57 ' HB2' HD12 ' A' ' 106' ' ' LEU . 6.3 t80 -62.34 -47.66 83.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.55 -0.719 . . . . 0.0 110.78 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.4 p -70.36 -29.97 66.78 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.059 1.344 . . . . 0.0 109.688 -166.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -99.96 35.98 1.93 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.238 1.015 . . . . 0.0 110.732 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.44 53.62 2.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.45 1.5 . . . . 0.0 113.289 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -127.27 38.28 4.1 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 126.641 1.977 . . . . 0.0 109.189 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 101' ' ' PHE . 28.7 mt -132.93 167.07 20.92 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 120.899 1.681 . . . . 0.0 111.071 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.68 134.96 40.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.914 1.686 . . . . 0.0 107.863 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -91.03 101.9 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.4 tp -82.3 72.91 9.36 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -170.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -91.44 37.67 0.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.904 -1.122 . . . . 0.0 110.323 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -177.4 168.25 2.27 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.855 -1.153 . . . . 0.0 109.039 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -136.48 177.85 7.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.703 2.401 . . . . 0.0 112.293 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.25 168.88 8.92 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 124.768 1.293 . . . . 0.0 107.559 158.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -130.72 125.53 34.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.998 1.719 . . . . 0.0 109.396 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -95.88 90.11 5.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 115.407 -2.885 . . . . 0.0 113.601 171.246 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.71 155.87 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.153 -0.967 . . . . 0.0 108.68 168.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.76 140.76 29.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 151.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -94.03 164.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 161.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 154.49 47.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 163.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.7 120.11 13.17 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.588 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 73.7 Cg_endo -70.45 108.57 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.75 3.634 . . . . 0.0 106.887 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 t -105.59 168.87 8.81 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.544 1.537 . . . . 0.0 108.16 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.03 37.47 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.531 -0.73 . . . . 0.0 110.317 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.57 165.93 39.26 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.5 39.64 1.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.051 1.34 . . . . 0.0 110.351 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.78 148.79 36.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -14.71 62.56 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.355 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 t -122.59 37.52 4.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -104.45 170.99 7.58 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.522 -0.736 . . . . 0.0 109.82 163.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.9 mmm -77.5 137.29 38.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.983 -1.073 . . . . 0.0 111.078 -166.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 41.6 t -71.51 131.17 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.623 167.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 t -79.51 144.67 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.46 1.904 . . . . 0.0 108.599 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -85.07 36.44 0.62 Allowed 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.29 116.23 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -156.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HB3' HG23 ' A' ' 71' ' ' VAL . 30.3 t80 -63.32 -69.33 0.28 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.575 0.75 . . . . 0.0 110.706 172.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.88 10.83 1.63 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -169.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -132.98 71.34 1.47 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 159.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -110.68 179.62 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 156.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -120.68 -16.89 8.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -140.01 155.2 47.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 93.1 m-85 -133.39 108.7 8.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -86.9 127.8 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.618 HD11 ' CD2' ' A' ' 58' ' ' LEU . 94.0 mt -125.22 97.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -165.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 4' ' ' VAL . 49.7 t80 -92.53 125.64 37.26 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.758 1.223 . . . . 0.0 109.153 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 125.79 30.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.043 1.737 . . . . 0.0 111.933 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.281 3.2 p -91.58 31.86 1.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.775 0.798 . . . . 0.0 109.967 174.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.88 -90.18 0.56 Allowed 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 154.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.55 35.59 1.21 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.359 -157.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 45.63 15.15 0.09 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.127 2.298 . . . . 0.0 115.617 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -69.35 154.58 41.81 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.34 144.09 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.679 1.228 . . . . 0.0 109.581 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.99 130.5 52.68 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.19 107.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.67 146.5 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 157.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.37 150.15 27.06 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.076 1.75 . . . . 0.0 106.533 161.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.58 133.69 7.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 109.879 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 p -119.58 61.42 0.83 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 123.628 1.68 . . . . 0.0 109.789 -163.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 75.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.656 1.982 . . . . 0.0 111.265 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.1 38.37 2.22 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.248 1.419 . . . . 0.0 112.497 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.92 -177.12 5.37 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.408 -1.432 . . . . 0.0 110.516 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.34 39.0 2.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.202 1.801 . . . . 0.0 111.975 -168.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -56.99 150.02 17.72 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.777 0.831 . . . . 0.0 111.218 -174.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.51 -30.75 6.07 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.556 -1.135 . . . . 0.0 112.269 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -146.25 165.33 29.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.023 1.912 . . . . 0.0 109.936 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.15 99.31 0.18 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -166.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -62.9 -38.13 49.81 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 CA-C-N 120.383 2.091 . . . . 0.0 110.687 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.326 0.7 OUTLIER 54.27 -67.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.895 2.078 . . . . 0.0 111.624 -158.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -50.59 -61.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.708 1.603 . . . . 0.0 109.876 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.41 -53.9 38.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-O 115.155 -2.355 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -49.03 -47.33 44.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 121.146 1.794 . . . . 0.0 110.194 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -50.35 60.03 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.185 1.394 . . . . 0.0 112.816 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.618 ' CD2' HD11 ' A' ' 29' ' ' ILE . 94.7 mt -65.69 -39.06 90.87 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.096 0.862 . . . . 0.0 110.088 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.73 -41.47 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.965 1.306 . . . . 0.0 109.791 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.39 1.41 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -126.43 37.46 4.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.367 1.467 . . . . 0.0 107.622 171.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.76 17.16 41.31 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.709 2.1 . . . . 0.0 116.503 166.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.05 102.43 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.777 1.288 . . . . 0.0 110.873 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.12 36.43 2.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.212 1.805 . . . . 0.0 111.658 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.623 ' HB3' HG23 ' A' ' 4' ' ' VAL . 8.4 m-85 177.11 173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.745 -1.847 . . . . 0.0 106.81 -168.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 68' ' ' ALA . 13.1 tp -174.62 146.17 0.98 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.807 HG21 ' HB1' ' A' ' 97' ' ' ALA . 30.5 mt -114.69 103.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -158.85 101.89 1.64 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.983 1.313 . . . . 0.0 109.412 -168.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 5.8 t -60.81 -17.55 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.664 1.585 . . . . 0.0 113.792 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.89 178.33 7.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.411 -1.431 . . . . 0.0 108.806 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.665 HG13 ' H ' ' A' ' 73' ' ' ARG . 1.7 p -126.47 156.51 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 120.313 -1.492 . . . . 0.0 110.216 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.4 20.5 0.13 Allowed Glycine 0 CA--C 1.546 2.009 0 C-N-CA 127.096 2.284 . . . . 0.0 114.219 166.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.665 ' H ' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER 62.7 0.76 0.7 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.874 2.469 . . . . 0.0 116.518 174.385 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.5 p30 -137.83 101.02 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' ASN . . . 162.31 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.502 1.521 . . . . 0.0 113.675 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.61 -44.73 81.45 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.806 1.185 . . . . 0.0 109.769 -160.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.73 -40.38 95.23 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.927 1.291 . . . . 0.0 110.384 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -67.1 -19.54 65.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.054 0.542 . . . . 0.0 111.271 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.71 -47.19 32.8 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -62.77 -35.23 79.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.195 0.998 . . . . 0.0 111.489 176.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.94 86.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.127 0.571 . . . . 0.0 110.073 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.18 36.27 1.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.361 0.528 . . . . 0.0 111.196 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.34 31.72 0.21 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 127.607 2.527 . . . . 0.0 117.083 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.42 125.16 38.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.016 1.326 . . . . 0.0 108.31 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -78.5 160.2 27.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.3 t -143.83 131.68 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -107.62 157.81 17.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.048 1.739 . . . . 0.0 109.762 172.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -80.0 160.73 25.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 160.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -132.77 159.08 40.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.512 1.525 . . . . 0.0 108.826 162.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 9.1 pt-20 -129.34 74.7 1.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.818 2.099 . . . . 0.0 111.632 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.47 159.86 3.01 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.942 1.258 . . . . 0.0 111.148 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.39 161.66 9.19 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.845 -0.797 . . . . 0.0 112.833 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -96.8 164.74 12.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.91 1.284 . . . . 0.0 107.555 167.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.87 -37.3 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 117.014 -1.469 . . . . 0.0 114.277 -166.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.54 -32.79 74.58 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 121.007 1.731 . . . . 0.0 114.184 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -66.53 -43.0 86.36 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.612 1.965 . . . . 0.0 108.898 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.807 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -51.81 -28.84 16.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.291 0.496 . . . . 0.0 112.166 174.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mm -95.04 -53.37 8.37 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -25.3 68.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 110.125 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -57.16 4.1 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.623 ' HB2' HD12 ' A' ' 106' ' ' LEU . 10.7 t80 -59.96 -44.29 94.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.499 1.52 . . . . 0.0 113.451 -177.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -67.71 -13.15 61.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.637 1.575 . . . . 0.0 111.498 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.37 35.15 4.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.261 1.024 . . . . 0.0 108.761 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.31 2.93 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.09 1.805 . . . . 0.0 117.016 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -81.12 39.69 0.52 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.747 2.274 . . . . 0.0 111.176 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 101' ' ' PHE . 28.5 mt -128.55 -166.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -128.24 154.75 45.52 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -78.48 132.2 37.17 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 164.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp -117.22 71.49 0.8 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 108.833 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.2 p -112.5 37.37 3.07 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.925 -1.11 . . . . 0.0 110.453 -167.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 t 173.88 106.35 0.01 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 128.43 2.692 . . . . 0.0 103.854 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -161.46 166.24 27.51 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.981 1.712 . . . . 0.0 106.463 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 p -145.77 173.12 12.38 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.126 1.371 . . . . 0.0 107.805 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -145.74 131.47 18.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 164.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.94 88.94 2.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 176.542 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 11.2 ptt? . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 159.13 148.36 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 130.617 3.567 . . . . 0.0 107.31 166.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 31' ' ' ASP . 4.1 mtp180 -105.35 131.74 52.42 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 165.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -95.38 153.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.07 147.58 39.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.17 119.96 21.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.492 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 87.9 Cg_endo -72.54 95.13 0.78 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 1 C-N-CA 125.956 4.437 . . . . 0.0 107.308 177.29 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 t -89.57 172.58 8.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.3 1.04 . . . . 0.0 109.058 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.97 37.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.537 1.135 . . . . 0.0 111.107 166.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.23 173.16 45.19 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 167.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -107.78 38.12 2.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.393 0.596 . . . . 0.0 110.189 -166.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.93 151.69 47.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -5.3 39.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 111.649 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t -124.27 37.86 4.32 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.388 -1.445 . . . . 0.0 109.355 165.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.3 m -79.75 175.09 10.94 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 159.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.3 mmm -77.88 144.68 36.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 119.879 -1.763 . . . . 0.0 110.577 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 61.4 t -78.43 161.5 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 163.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -118.54 133.45 55.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 110.625 -167.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.19 39.03 0.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.392 1.477 . . . . 0.0 110.342 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -178.46 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.347 -1.471 . . . . 0.0 109.25 -164.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -50.98 -56.32 13.04 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.404 -0.81 . . . . 0.0 112.589 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.2 4.43 1.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -172.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -138.67 38.77 2.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.686 1.995 . . . . 0.0 108.166 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -90.31 179.59 5.85 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.7 -17.94 7.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -146.31 147.74 31.67 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 73.4 m-85 -128.94 96.09 4.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 mp -79.9 113.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.442 HD11 HD22 ' A' ' 58' ' ' LEU . 69.6 mt -100.37 107.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 4' ' ' VAL . 70.8 t80 -93.72 133.81 36.7 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.87 0.868 . . . . 0.0 108.783 175.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 16.4 t0 -97.76 115.15 27.43 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.034 1.734 . . . . 0.0 111.123 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.5 p -86.26 29.82 0.73 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.693 0.758 . . . . 0.0 110.758 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 22.8 mt-10 -113.35 -86.53 0.57 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 159.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -93.16 35.45 1.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 115.584 -2.446 . . . . 0.0 110.439 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.8 18.73 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.771 1.653 . . . . 0.0 113.827 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -69.92 160.77 31.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.548 1.139 . . . . 0.0 108.973 -175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.69 152.0 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.701 0.763 . . . . 0.0 109.081 172.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -131.97 123.92 28.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 173.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -88.91 104.89 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.96 141.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -98.07 141.4 31.06 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.842 1.657 . . . . 0.0 106.656 164.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -146.42 146.95 30.78 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 p -129.02 44.38 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.14 -0.975 . . . . 0.0 110.122 -163.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.94 93.94 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 122.514 1.149 . . . . 0.0 111.235 -165.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.57 38.99 2.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.632 1.973 . . . . 0.0 108.866 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -158.05 179.81 8.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.375 2.27 . . . . 0.0 108.902 -164.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 159.78 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.796 3.239 . . . . 0.0 108.996 166.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -83.63 46.68 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.329 1.052 . . . . 0.0 110.5 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.14 82.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.579 1.085 . . . . 0.0 114.404 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 p -86.52 178.39 7.1 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.105 1.362 . . . . 0.0 113.893 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.22 -179.7 8.1 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.908 2.194 . . . . 0.0 112.775 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.51 -32.73 58.9 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.851 1.701 . . . . 0.0 112.615 -165.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.341 2.1 ptpt 49.72 -73.59 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 129.142 2.977 . . . . 0.0 112.445 -163.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -54.35 -56.76 8.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 125.285 1.434 . . . . 0.0 109.182 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.6 t -57.03 -56.71 13.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.495 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -41.91 -54.59 3.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.972 0.909 . . . . 0.0 111.527 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.7 m -65.13 -53.6 42.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 113.598 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 29' ' ' ILE . 93.3 mt -63.1 -43.41 98.56 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.071 0.948 . . . . 0.0 109.755 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.24 -41.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.318 1.447 . . . . 0.0 110.346 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -68.59 0.89 3.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -110.02 38.39 2.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 109.972 165.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.55 32.41 16.07 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.069 1.318 . . . . 0.0 114.69 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.84 92.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 3.4 mm-40 -95.18 33.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.192 1.397 . . . . 0.0 111.109 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.74 ' HB3' HG23 ' A' ' 4' ' ' VAL . 3.4 m-85 171.65 160.13 0.09 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 119.184 -2.198 . . . . 0.0 107.748 -158.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 tp -168.8 147.01 3.99 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.301 1.04 . . . . 0.0 108.512 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.851 HG21 ' HB1' ' A' ' 97' ' ' ALA . 58.5 mt -118.25 105.97 18.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 125.6 1.56 . . . . 0.0 107.278 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.56 112.64 3.0 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.069 1.304 . . . . 0.0 111.85 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.32 -25.13 32.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.63 178.01 9.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.786 3.235 . . . . 0.0 104.562 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.09 165.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 151.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.02 -12.23 68.59 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.394 -1.225 . . . . 0.0 113.905 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 148.76 174.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 1 C-N-CA 132.942 4.497 . . . . 0.0 108.732 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 24.61 74.41 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 130.878 3.671 . . . . 0.0 113.21 168.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.06 -24.27 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.621 1.568 . . . . 0.0 112.484 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 79' ' ' LEU . 9.4 t80 -59.84 -45.05 93.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.893 -170.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -66.94 -34.11 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -15.69 62.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.739 1.216 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 76' ' ' PHE . 52.9 mt -79.63 -54.55 5.77 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.31 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.815 0.846 . . . . 0.0 112.303 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.82 -35.75 61.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.73 0.812 . . . . 0.0 112.2 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.79 37.07 2.89 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.962 0.801 . . . . 0.0 110.792 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.06 30.4 2.54 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.992 1.758 . . . . 0.0 115.865 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.34 97.24 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 118.529 1.165 . . . . 0.0 108.078 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -79.19 112.36 16.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.762 0.792 . . . . 0.0 108.978 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.11 131.12 40.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.745 1.618 . . . . 0.0 107.982 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.71 161.99 13.28 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 126.026 1.73 . . . . 0.0 109.979 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 160.51 26.83 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 163.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.18 151.94 49.35 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 127.701 2.4 . . . . 0.0 104.634 163.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -141.23 66.02 1.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 121.715 2.052 . . . . 0.0 111.191 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.8 128.08 1.75 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.67 160.03 8.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -161.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.8 p -89.77 174.51 7.67 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.583 1.153 . . . . 0.0 110.19 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 83.4 t -48.63 -40.23 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.761 -1.212 . . . . 0.0 112.17 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -64.32 -34.85 79.08 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.044 1.293 . . . . 0.0 113.483 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.72 -41.52 78.94 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 125.773 1.629 . . . . 0.0 109.15 -176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.851 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.63 -40.75 13.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.09 0.859 . . . . 0.0 111.301 170.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -84.89 -49.23 15.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 O-C-N 121.267 -0.896 . . . . 0.0 108.812 -171.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.05 -18.22 63.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 128.442 2.697 . . . . 0.0 109.618 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 -63.83 1.25 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 108.687 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.584 ' HB2' HD12 ' A' ' 106' ' ' LEU . 6.3 t80 -54.08 -51.28 64.65 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.95 0.795 . . . . 0.0 112.5 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -66.69 -41.52 87.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.5 36.8 0.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.42 0.629 . . . . 0.0 110.133 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.28 9.25 2.05 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 127.635 2.54 . . . . 0.0 117.101 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.89 36.75 0.73 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.851 1.825 . . . . 0.0 111.824 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 101' ' ' PHE . 27.9 mt -131.94 172.18 12.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.551 1.069 . . . . 0.0 110.066 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -107.36 149.73 27.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -82.97 127.34 33.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 162.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp -112.83 64.46 0.64 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.561 1.145 . . . . 0.0 109.677 -170.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 111' ' ' THR . 16.3 p -107.85 37.98 2.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -164.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 110' ' ' THR . 7.0 t 165.44 57.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.255 1.422 . . . . 0.0 109.311 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -79.99 164.79 23.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.597 -1.315 . . . . 0.0 108.909 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.2 p -111.35 165.16 12.19 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.379 1.071 . . . . 0.0 109.628 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -153.04 142.24 21.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.319 -0.863 . . . . 0.0 110.644 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -155.45 88.56 1.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 117.96 -1.467 . . . . 0.0 112.144 -171.62 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 161.84 165.77 0.02 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 131.082 3.753 . . . . 0.0 108.083 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -112.85 112.24 23.58 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.97 0.89 . . . . 0.0 109.92 167.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 65' ' ' TYR . 2.2 p -79.46 153.58 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.57 149.32 42.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 163.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.17 118.17 18.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.1 126.27 14.2 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 125.075 3.85 . . . . 0.0 108.227 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -125.16 173.98 8.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.113 2.165 . . . . 0.0 105.986 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.05 37.26 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 128.149 2.58 . . . . 0.0 107.626 170.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.72 177.38 46.49 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.474 1.988 . . . . 0.0 109.555 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -121.47 40.37 3.61 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.459 -157.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.77 155.27 48.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -15.77 63.11 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.129 2.172 . . . . 0.0 110.983 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 p -112.07 38.58 2.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.915 -1.115 . . . . 0.0 112.212 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -97.24 168.47 10.4 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 166.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.6 132.99 38.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.827 1.651 . . . . 0.0 111.11 -171.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.403 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 88.5 t -71.29 139.18 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.2 t -86.87 137.35 32.46 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -0.99 . . . . 0.0 109.355 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.31 37.43 0.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.59 1.186 . . . . 0.0 111.861 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 178.42 97.02 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.188 0 O-C-N 119.736 -1.853 . . . . 0.0 109.247 -156.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' VAL . 36.8 t80 -54.32 -50.38 67.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 119.424 1.011 . . . . 0.0 112.778 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.3 13.57 18.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.671 0.669 . . . . 0.0 111.173 -171.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.39 39.29 3.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.427 1.891 . . . . 0.0 106.856 168.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.28 139.51 51.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -89.82 -74.35 0.49 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.847 1.308 . . . . 0.0 108.792 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.48 156.63 22.77 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -135.52 124.56 24.3 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.5 mm -93.04 113.01 27.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -98.43 113.74 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' HG12 ' A' ' 4' ' ' VAL . 46.5 t80 -91.7 153.82 19.4 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.344 1.028 . . . . 0.0 108.643 170.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -124.45 106.17 9.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.54 1.936 . . . . 0.0 110.807 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.7 p -81.63 36.52 0.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.071 1.305 . . . . 0.0 112.228 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -105.54 -64.31 1.16 Allowed 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 124.743 1.217 . . . . 0.0 109.206 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -124.44 38.05 4.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 125.06 1.475 . . . . 0.0 110.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.79 15.24 18.62 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 126.08 1.8 . . . . 0.0 113.792 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.13 160.33 31.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.874 0.87 . . . . 0.0 109.032 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.29 147.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.689 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -130.36 140.34 50.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.208 1.803 . . . . 0.0 106.643 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.91 109.29 23.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 165.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.4 144.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.64 107.22 14.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.687 ' OD1' HD11 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -118.09 109.38 16.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 -177.011 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.9 p -82.01 71.93 9.06 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.076 -1.64 . . . . 0.0 109.409 -172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.799 HD12 ' HE3' ' A' ' 53' ' ' LYS . 3.6 mm -106.0 110.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 122.409 1.1 . . . . 0.0 109.527 -166.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.34 165.74 12.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.938 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 69.02 6.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 123.006 1.384 . . . . 0.0 109.401 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.74 142.63 34.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 150.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -74.58 163.0 28.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.306 0.957 . . . . 0.0 108.424 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.02 -164.75 24.24 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.214 0.911 . . . . 0.0 111.059 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.91 156.98 41.75 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.881 1.672 . . . . 0.0 107.467 168.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.42 159.65 6.78 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.562 1.553 . . . . 0.0 111.304 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.62 -45.88 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.353 2.035 . . . . 0.0 113.366 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.799 ' HE3' HD12 ' A' ' 44' ' ' ILE . 11.3 ttpt 60.67 -71.25 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.981 1.312 . . . . 0.0 110.701 -169.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.62 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.95 1.7 . . . . 0.0 110.049 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -54.79 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.349 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.32 -47.37 18.46 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.215 0.916 . . . . 0.0 111.42 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -67.29 0.42 Allowed 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 121.47 -0.769 . . . . 0.0 111.946 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 mt -51.79 -41.5 61.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.466 1.106 . . . . 0.0 110.744 -173.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.4 -41.52 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 126.486 1.914 . . . . 0.0 111.465 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.2 m -66.23 -3.8 6.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.848 -1.157 . . . . 0.0 111.716 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 37.26 4.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.445 1.021 . . . . 0.0 108.812 171.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.03 21.14 69.52 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.578 2.037 . . . . 0.0 116.115 161.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.95 122.81 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.23 1.012 . . . . 0.0 109.877 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -123.75 35.86 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.974 2.11 . . . . 0.0 109.923 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.569 ' HB3' HG23 ' A' ' 4' ' ' VAL . 5.9 m-85 -179.76 176.59 0.76 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.972 1.709 . . . . 0.0 107.358 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -176.63 151.04 0.89 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.339 1.856 . . . . 0.0 107.885 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.801 HG21 ' HB1' ' A' ' 97' ' ' ALA . 68.9 mt -123.07 105.61 16.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 126.444 1.898 . . . . 0.0 107.601 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.21 136.03 16.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.684 1.584 . . . . 0.0 110.339 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.5 p -64.4 -27.21 68.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.863 -1.148 . . . . 0.0 112.999 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -168.4 -175.29 2.49 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.921 1.688 . . . . 0.0 108.132 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -115.46 153.21 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.989 0.916 . . . . 0.0 109.953 177.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.77 28.92 2.1 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 126.682 2.087 . . . . 0.0 111.811 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 51.05 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.524 1.93 . . . . 0.0 111.488 -159.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 25.82 75.17 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.153 2.981 . . . . 0.0 112.07 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 179.89 -40.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.844 1.658 . . . . 0.0 112.301 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.4 -35.76 68.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.096 0.862 . . . . 0.0 112.095 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.9 -40.63 68.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.331 0.652 . . . . 0.0 110.012 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -15.46 63.53 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.542 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -75.78 -47.69 24.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -67.04 -26.14 66.61 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 120.944 -1.097 . . . . 0.0 113.114 174.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.99 -40.42 63.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.238 0.927 . . . . 0.0 110.699 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.74 36.5 2.62 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.958 0.503 . . . . 0.0 111.329 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.51 16.02 4.81 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 117.424 1.73 . . . . 0.0 117.424 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.19 126.76 39.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.97 1.885 . . . . 0.0 109.813 -159.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -79.83 132.16 36.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.5 t -113.1 141.55 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -111.69 160.4 17.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.84 1.656 . . . . 0.0 109.509 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -79.16 159.68 27.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 160.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -141.12 161.39 37.98 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 154.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -150.0 95.53 2.31 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.404 1.456 . . . . 0.0 111.992 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.1 109.27 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 125.69 1.614 . . . . 0.0 111.003 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 162.84 158.44 9.7 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 117.86 0.83 . . . . 0.0 113.682 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -85.29 168.5 14.64 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.148 0.579 . . . . 0.0 109.644 166.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -39.25 -44.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.394 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.97 -39.57 82.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.14 1.791 . . . . 0.0 114.729 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -64.91 -41.66 95.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.312 1.845 . . . . 0.0 108.76 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.801 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -49.69 -38.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.616 0.644 . . . . 0.0 111.53 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mm -82.42 -61.12 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 -33.01 43.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.22 1.808 . . . . 0.0 110.498 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.61 -50.57 20.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.642 ' HB2' HD12 ' A' ' 106' ' ' LEU . 14.9 t80 -61.89 -50.51 71.93 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.408 1.083 . . . . 0.0 112.027 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.5 p -64.51 -45.52 86.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.864 2.065 . . . . 0.0 108.656 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -91.84 36.45 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.06 45.54 14.82 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.926 2.203 . . . . 0.0 115.078 166.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -120.84 36.51 4.56 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 111.058 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.642 HD12 ' HB2' ' A' ' 101' ' ' PHE . 17.4 mt -124.7 -175.74 3.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.791 1.178 . . . . 0.0 109.446 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.49 138.42 53.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -79.72 111.08 15.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.27 61.62 2.86 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.412 1.485 . . . . 0.0 109.762 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.8 p -95.93 35.03 1.45 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.921 -1.112 . . . . 0.0 112.759 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.1 t 167.91 93.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.3 -1.5 . . . . 0.0 107.864 -169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -82.5 158.14 23.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.8 p -140.38 68.19 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.632 1.206 . . . . 0.0 109.472 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -147.27 102.22 3.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.68 109.04 13.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 147.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 115.336 -2.925 . . . . 0.0 113.634 162.298 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.83 177.33 11.47 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 140.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -114.32 130.18 56.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 156.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 65' ' ' TYR . 10.0 p -115.2 134.28 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.774 1.63 . . . . 0.0 107.42 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' HD12 ' A' ' 66' ' ' LEU . . . -111.06 143.96 40.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.72 120.91 20.8 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.03 111.57 3.31 Favored 'Trans proline' 0 N--CA 1.446 -1.302 1 C-N-CA 125.687 4.258 . . . . 0.0 108.631 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -112.93 171.04 7.77 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.831 1.653 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.85 39.39 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.173 1.389 . . . . 0.0 109.899 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.69 -174.5 47.07 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.64 1.591 . . . . 0.0 109.984 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.2 mtmt -115.33 38.91 3.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.152 1.381 . . . . 0.0 109.457 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -124.48 149.37 46.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 2.23 3.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 122.309 1.052 . . . . 0.0 110.778 168.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 38.4 3.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.027 -1.671 . . . . 0.0 108.448 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.7 m -80.17 170.56 16.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 159.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 139.72 38.87 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.896 -1.128 . . . . 0.0 108.904 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 92.9 t -76.87 147.67 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -109.9 133.84 52.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -169.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.87 38.1 0.44 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.352 0.596 . . . . 0.0 110.833 -172.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -167.34 86.92 0.26 Allowed 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.427 -1.421 . . . . 0.0 107.839 -163.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 79' ' ' LEU . 9.1 t80 -48.23 -53.13 18.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.009 0.822 . . . . 0.0 112.787 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -74.72 -6.77 50.69 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -129.19 64.59 1.47 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.18 25.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.26 -16.77 61.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.36 1.064 . . . . 0.0 113.249 -163.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.478 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 92.1 m-85 -141.0 154.7 46.14 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -139.02 107.27 5.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.607 1.163 . . . . 0.0 107.885 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.74 116.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.85 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.6 ' HB3' HG12 ' A' ' 4' ' ' VAL . 18.3 t80 -88.84 116.51 27.16 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.99 1.716 . . . . 0.0 107.536 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.62 100.0 6.8 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.899 1.679 . . . . 0.0 108.501 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 p -74.04 70.3 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.445 1.117 . . . . 0.0 108.586 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -155.76 -53.01 0.09 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.91 2.484 . . . . 0.0 110.458 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 m -136.22 36.71 2.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.481 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.01 11.74 1.07 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.495 1.998 . . . . 0.0 114.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -71.59 141.97 50.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.676 1.238 . . . . 0.0 107.688 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.37 160.62 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.747 1.619 . . . . 0.0 107.066 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -137.42 141.91 41.65 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.8 116.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.79 132.52 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 160.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -85.85 136.6 33.24 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 155.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.73 132.11 20.77 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-N 119.451 1.023 . . . . 0.0 111.288 167.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -103.22 50.2 0.81 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.382 0.673 . . . . 0.0 111.516 -159.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.42 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 120.445 -1.409 . . . . 0.0 111.74 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.66 39.67 0.75 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.662 1.585 . . . . 0.0 111.241 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.94 179.43 9.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.976 2.11 . . . . 0.0 107.046 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 76.06 1.57 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.223 1.809 . . . . 0.0 110.232 -172.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -159.12 176.85 11.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.088 0.955 . . . . 0.0 110.816 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.51 104.12 1.66 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.9 p -74.21 -16.44 60.97 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.921 0.86 . . . . 0.0 111.53 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.6 178.46 16.48 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 126.523 2.011 . . . . 0.0 108.877 165.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.32 -48.09 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.352 2.702 . . . . 0.0 112.992 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER 58.15 -64.65 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.041 1.291 . . . . 0.0 112.249 -157.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.13 -61.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.308 1.443 . . . . 0.0 108.582 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 55' ' ' VAL . 1.4 t -53.28 -47.62 56.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 126.101 1.76 . . . . 0.0 109.257 175.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -45.22 -52.47 9.44 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.365 1.439 . . . . 0.0 111.649 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 t -66.41 -51.95 51.61 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.374 0.669 . . . . 0.0 112.258 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.5 -41.33 97.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.632 -1.292 . . . . 0.0 110.113 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 t -59.99 -35.37 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.466 1.506 . . . . 0.0 111.241 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -65.45 -33.72 76.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.565 1.075 . . . . 0.0 109.489 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.33 38.07 0.65 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.766 1.226 . . . . 0.0 109.603 170.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.32 22.74 2.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.023 1.773 . . . . 0.0 116.092 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.66 118.86 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 119.831 1.816 . . . . 0.0 109.108 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.36 35.61 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.412 0.685 . . . . 0.0 110.982 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.897 ' HB3' HG23 ' A' ' 4' ' ' VAL . 23.3 m-85 -174.91 160.7 2.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 68' ' ' ALA . 18.2 tp -164.26 148.35 9.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.703 HG21 ' HB1' ' A' ' 97' ' ' ALA . 64.0 mt -119.43 97.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -152.69 103.67 2.81 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.281 0.632 . . . . 0.0 109.527 -171.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.5 p -45.92 -28.87 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.966 1.706 . . . . 0.0 115.58 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 -171.19 2.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -128.67 155.03 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -75.32 -41.65 30.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -171.52 -148.3 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.248 2.219 . . . . 0.0 107.761 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -52.49 104.58 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 111.561 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.79 -29.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.956 2.102 . . . . 0.0 109.141 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 79' ' ' LEU . 28.2 t80 -51.9 -39.49 59.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.088 1.755 . . . . 0.0 112.442 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.43 -37.35 86.66 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.618 0.767 . . . . 0.0 109.535 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.6 m -80.13 -13.84 58.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.726 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 76' ' ' PHE . 25.8 mt -71.14 -58.2 3.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.907 -1.12 . . . . 0.0 109.093 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.608 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -63.21 -29.27 70.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.27 37.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.22 171.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.94 35.88 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.069 0.849 . . . . 0.0 111.621 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.03 34.29 4.1 Favored Glycine 0 CA--C 1.538 1.521 0 O-C-N 120.387 -1.446 . . . . 0.0 115.696 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.79 127.92 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 119.258 1.529 . . . . 0.0 110.036 -166.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -79.35 112.54 16.69 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.651 -0.656 . . . . 0.0 110.748 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -97.61 121.04 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.05 157.89 15.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 109.954 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.46 151.5 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.6 172.79 10.86 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 156.07 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.38 52.21 0.53 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 121.288 1.858 . . . . 0.0 112.787 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.51 101.95 2.67 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.386 -0.822 . . . . 0.0 112.488 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.82 166.36 34.76 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -162.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.404 ' C ' HG23 ' A' ' 17' ' ' VAL . 26.6 p -88.39 174.11 8.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.373 1.069 . . . . 0.0 110.488 167.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.2 t -45.1 -42.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.588 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.15 -34.12 76.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 120.305 1.411 . . . . 0.0 114.369 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.36 -45.07 85.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.608 1.563 . . . . 0.0 107.209 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.69 -45.59 19.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.356 0.662 . . . . 0.0 111.254 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.38 -52.05 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.16 -33.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.758 2.023 . . . . 0.0 109.405 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -61.5 1.79 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.666 ' HB2' HD12 ' A' ' 106' ' ' LEU . 3.1 t80 -54.64 -41.17 69.75 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.452 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.1 p -69.41 -50.45 45.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.202 1.401 . . . . 0.0 108.119 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -86.12 36.63 0.69 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.597 0.713 . . . . 0.0 109.689 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.71 12.89 2.76 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.287 1.899 . . . . 0.0 116.658 172.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.6 mtp180 -85.74 35.91 0.64 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 121.027 2.413 . . . . 0.0 112.314 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 101' ' ' PHE . 20.1 mt -134.44 -178.89 5.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.586 -1.321 . . . . 0.0 109.414 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -127.81 153.34 46.71 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 125.769 1.628 . . . . 0.0 108.886 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.92 91.57 6.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.509 1.524 . . . . 0.0 107.065 -176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -85.33 49.04 1.67 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.521 1.128 . . . . 0.0 110.691 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.0 p -85.73 36.54 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 119.904 -1.747 . . . . 0.0 110.351 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t 169.78 106.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -160.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -170.09 168.18 8.52 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.035 2.934 . . . . 0.0 106.165 170.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.6 p -142.12 164.71 29.43 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.291 0.637 . . . . 0.0 110.043 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -165.83 140.79 4.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 124.939 1.296 . . . . 0.0 110.871 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.33 105.67 3.22 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.561 165.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 153.374 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 64' ' ' GLU . . . -162.47 159.0 24.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.697 1.599 . . . . 0.0 108.377 -174.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -79.68 149.42 31.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.007 157.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -115.37 151.14 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 127.706 2.403 . . . . 0.0 105.394 165.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.63 143.73 48.52 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.6 121.71 15.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.78 110.28 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.338 4.025 . . . . 0.0 108.363 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 t -111.23 169.18 8.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.189 1.795 . . . . 0.0 108.13 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.86 37.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.361 0.664 . . . . 0.0 111.051 165.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.62 177.04 42.19 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.472 1.51 . . . . 0.0 109.832 168.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -115.18 38.63 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.735 -166.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -139.29 159.26 42.58 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.471 1.908 . . . . 0.0 108.306 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -74.02 -5.05 39.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.612 1.965 . . . . 0.0 111.07 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -122.82 37.97 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.669 -1.269 . . . . 0.0 110.916 167.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 m -83.24 173.29 11.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.14 164.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.91 142.88 36.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.89 1.223 . . . . 0.0 109.766 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -71.57 165.07 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.047 0.927 . . . . 0.0 108.508 166.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 t -119.98 127.87 53.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.396 1.478 . . . . 0.0 109.26 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.22 37.11 0.37 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 122.13 0.967 . . . . 0.0 110.826 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.85 108.82 0.48 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 -166.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.62 ' CE2' HD11 ' A' ' 79' ' ' LEU . 13.3 t80 -63.65 -58.19 7.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.639 1.109 . . . . 0.0 110.622 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.76 -13.66 59.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.737 -170.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -123.82 77.39 1.52 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.201 1.8 . . . . 0.0 106.81 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.58 116.3 13.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.86 -16.34 11.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -173.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -142.97 157.76 44.24 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -135.19 107.52 7.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -79.88 126.79 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.447 HD11 ' CD2' ' A' ' 58' ' ' LEU . 62.6 mt -119.93 101.33 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.534 ' HB3' HG12 ' A' ' 4' ' ' VAL . 56.8 t80 -89.8 133.61 34.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.513 1.125 . . . . 0.0 108.191 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.64 121.65 27.95 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.338 1.455 . . . . 0.0 107.497 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 p -84.83 53.17 2.62 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.029 1.286 . . . . 0.0 108.454 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.08 -82.78 0.22 Allowed 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 p -104.88 36.97 2.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 117.99 -1.484 . . . . 0.0 110.347 -160.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.77 4.32 0.15 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.08 1.8 . . . . 0.0 116.489 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -75.26 158.32 33.09 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.221 1.008 . . . . 0.0 110.514 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.9 162.97 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.383 0.673 . . . . 0.0 109.349 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -131.69 138.2 48.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 168.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.73 110.05 22.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 155.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.08 135.79 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.454 -2.425 . . . . 0.0 104.454 156.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.25 128.67 47.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -140.12 132.51 28.44 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.357 0.98 . . . . 0.0 111.766 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -110.58 54.32 0.67 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.61 1.195 . . . . 0.0 108.303 -155.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.47 89.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.914 1.286 . . . . 0.0 109.263 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.3 60.23 1.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.439 1.896 . . . . 0.0 107.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.1 p30 -162.79 170.32 18.49 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.727 0.811 . . . . 0.0 111.846 -165.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.15 38.31 0.97 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.532 1.933 . . . . 0.0 109.93 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 178.84 3.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 109.695 167.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.14 -114.94 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.535 1.064 . . . . 0.0 112.451 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.265 53.8 m 52.05 -171.54 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.956 0.903 . . . . 0.0 109.497 -164.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.42 -119.53 4.41 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' A' ' 78' ' ' THR . 59.2 Cg_endo -71.0 -43.54 1.58 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 119.552 1.676 . . . . 0.0 113.62 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 61.47 -72.82 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.544 1.152 . . . . 0.0 110.646 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.82 -56.53 12.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 119.702 1.137 . . . . 0.0 110.383 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.4 t -55.79 -51.25 61.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 C-N-CA 125.235 1.414 . . . . 0.0 107.893 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -12.91 1.08 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.504 1.521 . . . . 0.0 114.615 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.52 -48.72 3.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.377 1.471 . . . . 0.0 109.526 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD2' HD11 ' A' ' 29' ' ' ILE . 69.5 mt -58.08 -45.29 87.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.523 1.129 . . . . 0.0 110.504 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.27 -41.3 91.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.208 1.403 . . . . 0.0 109.652 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -67.1 3.33 1.17 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.299 -0.876 . . . . 0.0 113.223 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -124.61 38.84 4.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.488 2.315 . . . . 0.0 108.317 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.08 35.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 126.1 1.81 . . . . 0.0 116.745 165.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.99 120.59 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 118.456 1.128 . . . . 0.0 110.394 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 5.7 mm-40 -124.54 36.17 4.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.688 0.756 . . . . 0.0 110.984 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.677 ' HB3' HG23 ' A' ' 4' ' ' VAL . 11.0 m-85 170.74 170.8 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.317 1.847 . . . . 0.0 107.675 -168.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 68' ' ' ALA . 10.6 tp -172.51 146.34 1.72 Allowed 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.413 -1.429 . . . . 0.0 107.263 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.723 HG21 ' HB1' ' A' ' 97' ' ' ALA . 50.9 mt -114.91 103.25 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -156.07 102.36 2.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.538 1.063 . . . . 0.0 111.32 -171.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.472 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 22.7 t -59.74 -4.89 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.69 -179.43 3.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 123.612 2.915 . . . . 0.0 108.85 167.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.25 146.32 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 O-C-N 121.626 -0.671 . . . . 0.0 110.056 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.08 2.49 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.033 1.778 . . . . 0.0 110.461 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -171.54 173.61 4.66 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.066 2.546 . . . . 0.0 106.338 173.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -71.63 29.23 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.404 1.097 . . . . 0.0 112.373 162.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' ARG . . . -76.1 -27.64 57.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.209 -1.557 . . . . 0.0 111.677 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.2 t80 -61.54 -36.12 79.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.473 1.033 . . . . 0.0 110.951 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.97 -28.65 65.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.854 0.861 . . . . 0.0 110.639 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 52' ' ' PRO . 5.3 m -78.16 -20.79 51.3 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.862 -0.523 . . . . 0.0 110.432 173.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.817 HD12 ' HA ' ' A' ' 76' ' ' PHE . 14.1 mt -71.87 -54.83 8.85 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -56.2 -32.27 64.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 171.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.82 -2.58 7.46 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.68 37.33 4.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.643 1.177 . . . . 0.0 110.472 163.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.34 31.33 8.84 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.821 1.489 . . . . 0.0 116.821 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.42 115.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -78.73 107.77 11.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.83 114.69 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.9 163.24 19.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.983 1.713 . . . . 0.0 111.008 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -90.59 157.14 17.66 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.137 0.975 . . . . 0.0 108.54 161.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.472 ' H ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -121.42 171.36 8.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.264 2.626 . . . . 0.0 109.362 165.49 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.06 96.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.08 -1.637 . . . . 0.0 110.141 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.47 139.28 0.72 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.13 158.58 8.39 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.8 p -85.93 169.65 13.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.105 0.962 . . . . 0.0 108.73 160.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.5 t -42.17 -47.37 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.879 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -60.7 -32.65 71.88 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -64.32 -46.46 83.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.324 1.45 . . . . 0.0 109.274 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.84 -36.32 11.74 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 118.471 0.578 . . . . 0.0 111.582 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.68 -55.07 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 108.143 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -37.97 70.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 108.641 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.87 11.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 106' ' ' LEU . 9.3 t80 -58.54 -44.15 89.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.756 0.822 . . . . 0.0 112.272 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -69.51 -42.51 74.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 109.156 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -92.07 37.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.37 -1.54 0.1 OUTLIER Glycine 0 CA--C 1.526 0.77 0 C-N-CA 130.37 3.843 . . . . 0.0 118.277 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.6 mtt-85 -82.63 37.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.638 1.719 . . . . 0.0 111.692 -170.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 101' ' ' PHE . 21.7 mt -127.89 -171.24 2.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.588 -1.32 . . . . 0.0 108.532 169.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.79 145.15 37.84 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.337 1.455 . . . . 0.0 108.276 -169.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.7 108.46 13.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -87.91 44.22 1.18 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 109.501 -176.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 p -89.55 36.58 0.84 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 119.332 -2.105 . . . . 0.0 112.034 -163.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.1 t -172.56 38.48 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.536 -1.352 . . . . 0.0 111.84 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -137.53 124.29 21.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.165 -1.585 . . . . 0.0 110.087 -171.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.99 37.78 0.5 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.431 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -110.63 103.26 11.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -100.34 84.78 2.86 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.835 2.054 . . . . 0.0 106.704 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 CA-C-O 115.685 -2.73 . . . . 0.0 114.11 174.171 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' CD2' ' A' ' 65' ' ' TYR . . . -140.03 112.03 7.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.313 0.96 . . . . 0.0 112.129 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -80.91 107.74 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.4 p -84.71 153.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.66 145.85 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.42 124.3 23.54 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 103.65 1.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 1 C-N-CA 125.768 4.312 . . . . 0.0 108.963 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -101.38 173.0 6.64 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.093 1.357 . . . . 0.0 109.249 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.27 38.58 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 109.172 169.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.14 177.84 48.45 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.734 1.635 . . . . 0.0 109.552 171.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 3.5 mttm -108.79 40.05 1.88 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.115 1.766 . . . . 0.0 109.698 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -128.27 154.89 45.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -14.77 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.703 1.201 . . . . 0.0 110.044 170.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -110.74 38.35 2.52 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.64 -1.287 . . . . 0.0 108.758 166.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -86.99 167.42 14.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.589 -1.319 . . . . 0.0 108.056 162.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.58 146.1 34.4 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.467 -1.396 . . . . 0.0 110.417 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 78.8 t -87.77 132.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.523 1.154 . . . . 0.0 108.521 170.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -91.81 135.65 33.75 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.354 2.262 . . . . 0.0 108.674 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.17 38.27 0.47 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.884 0.849 . . . . 0.0 112.147 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' CD ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -165.25 96.44 0.69 Allowed 'General case' 0 C--O 1.224 -0.266 0 O-C-N 119.905 -1.747 . . . . 0.0 107.996 -160.288 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' HD11 ' A' ' 79' ' ' LEU . 19.1 t80 -65.18 -32.62 74.4 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 119.979 -1.7 . . . . 0.0 113.927 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.69 -3.68 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.197 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HG3' ' CD ' ' A' ' 20' ' ' ARG . 7.0 ptp180 -135.37 79.3 1.78 Allowed 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 119.449 1.022 . . . . 0.0 109.885 164.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.27 127.52 33.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -72.19 -17.73 61.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.466 1.106 . . . . 0.0 112.744 -167.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.431 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.1 m-85 -143.98 154.88 43.74 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.804 1.241 . . . . 0.0 107.733 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -137.76 107.67 6.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.461 1.504 . . . . 0.0 107.633 -175.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.77 123.53 43.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -175.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.25 96.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.145 0.884 . . . . 0.0 108.679 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 4' ' ' VAL . 29.0 t80 -85.42 117.68 24.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.815 1.246 . . . . 0.0 107.869 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.77 119.91 28.57 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.263 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -89.91 60.05 4.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.862 1.21 . . . . 0.0 110.697 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -136.73 -43.29 0.59 Allowed 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 117.243 -1.361 . . . . 0.0 113.085 164.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.2 m -137.04 36.87 2.57 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 117.6 -1.64 . . . . 0.0 113.128 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.26 13.83 4.08 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.477 1.513 . . . . 0.0 114.192 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -82.24 135.08 35.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.785 1.634 . . . . 0.0 108.133 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.43 170.18 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 125.178 1.391 . . . . 0.0 107.938 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.04 145.03 39.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -106.69 109.08 26.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.9 129.37 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 159.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.89 133.87 33.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 127.145 2.178 . . . . 0.0 106.295 159.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -145.57 122.51 11.33 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.977 1.262 . . . . 0.0 111.159 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.4 p -103.73 46.31 0.92 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.429 0.692 . . . . 0.0 111.944 -155.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.84 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 120.252 -1.53 . . . . 0.0 110.653 -165.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.09 83.9 1.33 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.214 1.406 . . . . 0.0 108.435 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -157.37 163.53 38.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.034 1.334 . . . . 0.0 108.339 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 39.05 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.778 -1.202 . . . . 0.0 111.144 167.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -72.64 -74.18 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 108.972 161.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.81 94.47 0.89 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.5 m -140.65 61.36 1.51 Allowed 'General case' 0 C--O 1.238 0.473 0 O-C-N 120.39 -1.653 . . . . 0.0 109.944 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.54 -174.94 26.92 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.433 ' HG3' HG21 ' A' ' 78' ' ' THR . 47.1 Cg_endo -69.91 -31.76 19.25 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.032 1.821 . . . . 0.0 113.162 -171.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 58.82 -78.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.989 2.116 . . . . 0.0 111.395 -169.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -57.3 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 126.942 2.097 . . . . 0.0 109.963 -176.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -56.96 -42.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 CA-C-O 115.167 -2.349 . . . . 0.0 109.578 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -52.31 -44.43 65.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 121.074 1.761 . . . . 0.0 111.497 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -68.12 -51.9 40.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 111.191 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.17 -43.62 92.12 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.305 -0.872 . . . . 0.0 110.525 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.97 -34.65 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.604 1.962 . . . . 0.0 110.628 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -36.4 79.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.504 1.047 . . . . 0.0 109.973 175.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -81.39 38.3 0.48 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.383 0.992 . . . . 0.0 110.29 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.12 27.38 1.58 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.674 2.559 . . . . 0.0 116.279 171.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.66 120.58 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.839 1.319 . . . . 0.0 108.129 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -121.78 36.78 4.53 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.757 1.623 . . . . 0.0 109.953 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -179.6 169.45 1.36 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 120.06 -1.65 . . . . 0.0 108.044 -171.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 67' ' ' ILE . 16.6 tp -169.33 151.89 4.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.515 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.778 HG21 ' HB1' ' A' ' 97' ' ' ALA . 61.1 mt -126.63 102.88 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -159.44 111.02 2.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.78 0.832 . . . . 0.0 109.944 -171.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -46.54 -31.09 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.247 1.819 . . . . 0.0 114.998 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -165.55 -170.12 1.75 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 119.058 0.844 . . . . 0.0 109.102 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.83 133.54 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.347 -0.696 . . . . 0.0 111.388 -169.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -166.25 152.45 8.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.807 2.443 . . . . 0.0 105.44 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 45.36 -143.67 0.21 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.672 1.589 . . . . 0.0 109.228 168.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 72.77 -34.57 0.3 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 129.275 3.03 . . . . 0.0 114.767 162.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.625 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 56.5 t80 -56.39 -40.71 75.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.302 1.441 . . . . 0.0 110.109 174.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.19 -40.76 98.43 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.517 0.727 . . . . 0.0 110.612 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -67.53 -27.27 66.83 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.266 -0.896 . . . . 0.0 110.764 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.504 HD11 ' CD2' ' A' ' 21' ' ' PHE . 53.3 mt -69.12 -61.13 1.92 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -61.63 -27.55 68.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 176.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.05 67.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.224 0.92 . . . . 0.0 110.613 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.85 35.98 1.91 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.541 1.064 . . . . 0.0 111.484 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.88 19.28 1.34 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.238 1.875 . . . . 0.0 117.422 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.43 120.04 29.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 118.987 1.393 . . . . 0.0 108.769 -160.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HE3' ' CD ' ' A' ' 108' ' ' GLU . 44.1 tttt -80.42 116.39 20.46 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.929 0.892 . . . . 0.0 110.208 -171.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -99.3 129.23 50.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.26 158.13 16.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 0.0 110.306 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.407 ' O ' HD13 ' A' ' 106' ' ' LEU . 1.4 tpt180 -79.6 163.66 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.586 1.555 . . . . 0.0 106.891 162.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.36 169.92 16.89 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 157.42 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -153.41 67.41 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 121.931 2.15 . . . . 0.0 113.008 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.34 95.67 2.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.459 1.028 . . . . 0.0 111.783 159.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.8 168.84 40.55 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -165.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.414 ' C ' HG23 ' A' ' 17' ' ' VAL . 34.0 p -87.4 176.57 7.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.761 0.824 . . . . 0.0 110.559 167.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -46.33 -43.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.759 1.223 . . . . 0.0 109.887 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -32.43 73.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -72.57 -40.92 66.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.623 1.169 . . . . 0.0 109.072 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.778 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -45.88 -41.58 11.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 123.83 0.707 . . . . 0.0 111.083 168.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -81.69 -51.34 15.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 124.487 1.115 . . . . 0.0 108.313 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -21.0 65.49 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.95 1.3 . . . . 0.0 110.527 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.6 -62.31 1.71 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.643 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.1 t80 -56.03 -44.13 78.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.624 1.17 . . . . 0.0 112.657 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.7 p -63.61 -51.84 63.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.579 1.152 . . . . 0.0 108.451 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.37 36.36 0.69 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.593 0.711 . . . . 0.0 109.31 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.44 11.05 4.75 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.695 2.093 . . . . 0.0 116.747 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -85.03 35.34 0.57 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 121.508 2.654 . . . . 0.0 112.478 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 101' ' ' PHE . 26.9 mt -135.45 167.44 21.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 121.151 1.796 . . . . 0.0 110.033 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -110.27 139.95 44.92 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.624 1.57 . . . . 0.0 107.416 -167.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.403 ' CD ' ' HE3' ' A' ' 85' ' ' LYS . 73.5 tt0 -85.41 96.04 9.45 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.833 1.197 . . . . 0.0 107.883 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.81 38.76 0.46 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 111.676 -169.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 p -91.88 37.51 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 118.656 -2.527 . . . . 0.0 109.505 -167.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 t -176.1 40.87 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -159.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -136.76 143.1 43.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.323 -1.485 . . . . 0.0 108.129 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 12.6 p -155.81 94.51 1.56 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.897 1.279 . . . . 0.0 108.626 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -155.16 114.5 3.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.62 -1.3 . . . . 0.0 109.718 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -79.76 90.55 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.696 0 C-N-CA 125.778 1.656 . . . . 0.0 110.805 -175.377 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.41 133.62 34.06 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 120.933 1.697 . . . . 0.0 113.308 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -104.74 111.76 24.6 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 170.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -97.65 129.22 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.51 133.1 46.69 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 4' ' ' VAL . 4.2 mp -113.64 121.29 37.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 57.2 Cg_endo -73.7 93.23 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 1 C-N-CA 126.043 4.495 . . . . 0.0 109.509 -176.602 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.2 t -87.71 171.02 10.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.753 2.821 . . . . 0.0 110.338 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 m -124.72 37.86 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.96 1.304 . . . . 0.0 109.487 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.93 -174.81 45.45 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.532 -1.355 . . . . 0.0 112.645 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 22.9 mtmt -111.06 39.6 2.23 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.05 1.34 . . . . 0.0 111.859 -162.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -143.35 157.58 44.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 108.784 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -78.95 -13.79 59.59 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.444 -0.785 . . . . 0.0 111.053 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -104.91 37.39 2.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.375 -1.453 . . . . 0.0 111.072 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' THR . 97.0 p -82.76 170.7 14.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.277 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.56 134.18 37.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.791 1.632 . . . . 0.0 109.133 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 47.8 t -78.14 132.42 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -79.7 152.23 30.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.402 2.681 . . . . 0.0 108.42 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -88.71 36.46 0.8 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.234 -0.916 . . . . 0.0 112.613 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.37 107.01 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.433 -1.417 . . . . 0.0 110.024 -153.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.478 ' HB3' HG23 ' A' ' 71' ' ' VAL . 21.5 t80 -58.0 -60.44 3.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.848 1.204 . . . . 0.0 112.058 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.06 1.19 28.75 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -167.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.8 63.91 1.29 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 162.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . . . -123.95 169.05 12.0 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 164.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -117.64 -30.48 5.46 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 119.034 0.834 . . . . 0.0 112.657 -165.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 95.7 m-85 -126.4 145.71 50.36 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HB3' HD21 ' A' ' 58' ' ' LEU . 94.1 m-85 -133.04 89.12 2.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 126.89 2.076 . . . . 0.0 106.009 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.449 HG22 ' CG1' ' A' ' 37' ' ' VAL . 3.0 mm -79.12 107.19 11.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 -176.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.448 HD11 HD23 ' A' ' 58' ' ' LEU . 81.1 mt -94.23 107.88 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.507 ' HB3' HG12 ' A' ' 4' ' ' VAL . 41.2 t80 -89.96 131.59 35.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -100.81 109.35 21.33 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.745 2.018 . . . . 0.0 111.211 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.2 p -82.14 53.86 2.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.372 0.987 . . . . 0.0 110.225 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -140.86 -20.53 0.81 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.563 1.545 . . . . 0.0 112.712 166.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.2 p -150.63 34.92 0.62 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.597 162.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.88 10.0 2.1 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.976 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.87 152.97 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.683 1.593 . . . . 0.0 107.2 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.449 ' CG1' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -135.43 160.72 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.175 172.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -149.9 136.88 19.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.226 -0.892 . . . . 0.0 109.232 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 11' ' ' LYS . 21.7 t -102.07 114.69 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.521 0.728 . . . . 0.0 109.508 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.73 158.12 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.692 1.197 . . . . 0.0 108.66 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -120.11 122.19 40.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 163.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.604 ' CG ' HD11 ' A' ' 44' ' ' ILE . 1.7 t-20 -133.87 111.7 10.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -174.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 p -83.58 74.97 10.07 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 42' ' ' ASN . 4.6 mm -98.33 113.03 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 C-N-CA 123.9 0.88 . . . . 0.0 109.933 -170.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.5 -165.79 1.09 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.664 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -78.68 108.39 12.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.23 2.212 . . . . 0.0 106.52 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 157.23 28.81 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.784 2.034 . . . . 0.0 108.282 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -73.07 -48.99 31.19 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.762 -0.586 . . . . 0.0 110.039 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.68 -134.26 3.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m 62.73 99.66 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.039 1.736 . . . . 0.0 110.72 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.57 -173.63 33.25 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.456 0.55 . . . . 0.0 111.914 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.53 -167.08 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.406 2.737 . . . . 0.0 109.383 163.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -152.64 -52.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.197 1.399 . . . . 0.0 107.486 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 10.1 p -87.56 -39.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.965 1.706 . . . . 0.0 110.473 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -61.3 -52.04 66.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 116.368 -1.777 . . . . 0.0 109.986 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -44.06 -49.86 8.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.849 1.204 . . . . 0.0 110.949 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -58.55 -64.59 0.87 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 112.657 173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 27' ' ' PHE . 69.3 mt -60.49 -39.39 87.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.337 -167.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.37 -33.87 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.643 1.977 . . . . 0.0 110.904 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -59.9 -30.87 69.32 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.66 37.86 1.63 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.163 0.985 . . . . 0.0 110.303 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.72 25.52 29.46 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.954 -0.914 . . . . 0.0 115.003 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 72.6 t -74.24 96.93 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -105.85 36.84 2.41 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -164.95 155.95 14.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.2 tp -164.56 146.06 8.24 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.26 -1.525 . . . . 0.0 107.15 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.824 HG21 ' HB1' ' A' ' 97' ' ' ALA . 28.3 mt -120.73 104.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.02 134.51 17.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.453 1.024 . . . . 0.0 111.831 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.3 p -68.43 -23.79 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.558 -0.714 . . . . 0.0 112.669 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -177.81 -176.19 0.56 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 107.433 -162.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 21' ' ' PHE . 4.3 p -138.07 141.16 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 119.75 -1.844 . . . . 0.0 112.872 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.87 11.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.911 2.672 . . . . 0.0 116.265 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.274 22.8 mtm180 143.27 -103.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 1 C-N-CA 131.716 4.006 . . . . 0.0 107.062 167.768 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -64.97 137.41 57.72 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.38 -35.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 130.354 3.462 . . . . 0.0 110.637 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.507 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 69.6 t80 -58.27 -41.86 85.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.718 0.807 . . . . 0.0 111.851 -162.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -62.34 -39.49 93.28 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.062 1.345 . . . . 0.0 109.357 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -74.69 -23.96 58.7 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.247 1.019 . . . . 0.0 110.652 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.67 -51.18 29.44 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 121.377 -0.827 . . . . 0.0 108.933 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.37 -30.44 70.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 117.125 -1.417 . . . . 0.0 113.575 175.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.31 -60.57 3.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.316 1.01 . . . . 0.0 108.961 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.53 36.83 0.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.693 0.679 . . . . 0.0 112.058 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.68 27.71 3.27 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.562 2.029 . . . . 0.0 115.636 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.36 121.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.197 0.999 . . . . 0.0 108.54 -166.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -77.65 153.51 33.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -144.16 116.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -172.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -95.37 157.99 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.526 0.731 . . . . 0.0 109.313 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 153.81 29.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 163.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.525 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -134.26 167.27 21.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 162.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.75 77.39 1.58 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.36 1.076 . . . . 0.0 112.266 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.53 88.33 0.11 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.832 1.206 . . . . 0.0 114.568 159.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.43 164.59 35.12 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.818 2.628 . . . . 0.0 109.781 -163.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 15' ' ' SER . 41.6 p -79.59 169.67 17.68 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.519 164.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -50.28 -41.78 19.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-N 121.135 1.788 . . . . 0.0 111.907 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -52.92 -39.5 62.85 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -65.69 -46.64 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.803 1.641 . . . . 0.0 108.575 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.824 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.28 -34.54 10.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.479 0.581 . . . . 0.0 112.464 171.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.96 -58.36 3.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.83 -29.06 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.992 2.517 . . . . 0.0 110.155 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 -60.55 2.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.595 ' HB2' HD12 ' A' ' 106' ' ' LEU . 9.7 t80 -56.01 -48.67 75.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.857 1.263 . . . . 0.0 113.217 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.1 p -72.25 -30.89 65.31 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.683 1.193 . . . . 0.0 109.992 -170.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -104.52 35.99 2.55 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 122.561 1.172 . . . . 0.0 108.494 170.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.46 -2.74 1.54 Allowed Glycine 0 CA--C 1.531 1.05 1 C-N-CA 131.334 4.302 . . . . 0.0 120.135 165.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -80.1 38.43 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.956 2.878 . . . . 0.0 113.59 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.595 HD12 ' HB2' ' A' ' 101' ' ' PHE . 16.9 mt -122.86 -166.6 1.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.129 -0.982 . . . . 0.0 108.684 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.21 148.23 46.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.233 1.413 . . . . 0.0 108.498 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.96 101.03 9.24 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.569 1.548 . . . . 0.0 107.856 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.42 67.49 1.81 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 107.525 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.8 p -105.72 36.78 2.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.298 1.408 . . . . 0.0 110.08 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -168.17 37.96 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.336 1.065 . . . . 0.0 110.537 -148.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -125.23 167.72 14.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 125.664 1.586 . . . . 0.0 107.83 -169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.69 -169.27 3.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 123.006 1.384 . . . . 0.0 108.467 -171.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.99 155.72 37.73 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 156.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -113.35 86.84 2.47 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.191 1.853 . . . . 0.0 108.918 -174.538 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' THR . 3.4 ptt? . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 159.35 148.68 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 130.526 3.53 . . . . 0.0 108.753 164.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 -109.83 126.27 53.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 165.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.9 p -99.4 149.6 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.03 147.56 44.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.152 1.342 . . . . 0.0 108.657 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 120.64 19.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 95.1 Cg_endo -73.03 101.31 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 127.147 5.231 . . . . 0.0 107.568 -178.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -100.1 164.37 12.01 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.77 1.228 . . . . 0.0 109.207 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 16' ' ' MET . 15.0 m -121.75 38.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 165.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 -178.68 41.83 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.594 1.092 . . . . 0.0 110.485 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 37.3 mtmt -108.91 39.95 1.92 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 109.536 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -143.02 148.66 37.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.376 1.07 . . . . 0.0 109.907 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 1.91 3.41 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.041 2.136 . . . . 0.0 112.957 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -130.74 38.18 3.73 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.25 -1.531 . . . . 0.0 107.98 167.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 p -81.76 165.2 21.15 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.466 167.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.429 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -78.13 131.77 37.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.324 1.42 . . . . 0.0 109.881 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 84.8 t -74.29 144.21 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.251 1.021 . . . . 0.0 108.763 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -94.92 132.22 39.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.286 2.234 . . . . 0.0 109.52 -169.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -81.3 39.01 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.054 0.93 . . . . 0.0 111.026 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.73 97.82 0.07 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.312 -1.492 . . . . 0.0 108.313 -162.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CD2' HD11 ' A' ' 79' ' ' LEU . 17.5 t80 -60.49 -51.04 71.16 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.755 1.161 . . . . 0.0 112.478 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.04 3.36 15.06 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -134.56 69.72 1.45 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 165.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 27' ' ' PHE . . . -100.67 -177.96 3.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 160.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.48 -21.42 9.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.894 0.378 . . . . 0.0 110.115 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.2 m-85 -145.42 156.34 43.7 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.567 2.347 . . . . 0.0 105.681 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 69.8 m-85 -132.92 110.77 10.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -86.35 129.58 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.9 mt -124.43 105.79 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.566 ' HB3' HG12 ' A' ' 4' ' ' VAL . 42.4 t80 -91.29 117.36 29.58 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.023 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.32 98.88 11.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.12 2.568 . . . . 0.0 112.055 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 1' ' ' MET . 76.1 p -78.13 58.11 1.95 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.652 -1.905 . . . . 0.0 109.3 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.88 -21.83 0.36 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.286 2.234 . . . . 0.0 112.105 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.78 35.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.072 1.305 . . . . 0.0 113.548 158.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.91 6.88 5.72 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.572 -1.33 . . . . 0.0 114.593 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.68 158.04 34.99 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.177 0.989 . . . . 0.0 109.254 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.35 173.54 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 125.736 1.614 . . . . 0.0 107.945 171.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.77 139.91 28.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.58 104.37 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.58 145.45 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 162.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -105.42 144.09 32.68 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.04 129.63 9.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 120.74 -1.225 . . . . 0.0 110.491 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.2 p -116.02 43.75 2.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.441 0.296 . . . . 0.0 110.685 -158.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.33 48.53 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 120.91 -1.119 . . . . 0.0 113.477 -163.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 98.47 6.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 152.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.14 -175.53 4.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.006 2.122 . . . . 0.0 106.867 163.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.5 67.72 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.563 1.529 . . . . 0.0 111.154 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -131.92 100.8 5.19 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 108.145 171.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.8 45.24 1.88 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.731 1.158 . . . . 0.0 111.434 169.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -116.96 68.3 0.74 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.856 1.262 . . . . 0.0 107.638 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.6 142.28 9.52 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.908 1.718 . . . . 0.0 109.313 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.84 -33.21 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.629 2.886 . . . . 0.0 112.4 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 60.31 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.907 2.083 . . . . 0.0 111.16 -169.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.274 1.43 . . . . 0.0 110.627 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -45.46 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.822 0 CA-C-O 115.859 -2.02 . . . . 0.0 109.072 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -51.97 -42.73 63.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.054 1.752 . . . . 0.0 112.138 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -68.46 -55.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.361 0.664 . . . . 0.0 110.111 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -45.61 80.45 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.015 -1.053 . . . . 0.0 110.923 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 t -56.67 -33.87 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.412 1.885 . . . . 0.0 111.484 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 m -66.75 -39.24 87.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.336 0.971 . . . . 0.0 109.806 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.74 37.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.027 0.931 . . . . 0.0 110.21 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.27 30.25 0.77 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.812 2.149 . . . . 0.0 116.353 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.64 119.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.74 1.27 . . . . 0.0 108.211 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -120.0 36.06 4.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.943 0.897 . . . . 0.0 111.089 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.773 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.0 m-85 -177.39 168.52 2.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.093 -2.255 . . . . 0.0 107.286 -167.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 68' ' ' ALA . 17.6 tp -169.85 153.84 5.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.953 0.901 . . . . 0.0 108.614 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.808 HG21 ' HB1' ' A' ' 97' ' ' ALA . 37.0 mt -127.21 106.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.183 1.793 . . . . 0.0 106.594 171.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -157.98 125.49 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.585 0.754 . . . . 0.0 109.823 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.8 p -60.49 -27.97 67.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -165.38 -179.61 5.63 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 126.424 1.89 . . . . 0.0 105.989 -168.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.43 166.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -10.3 84.33 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 116.114 -2.492 . . . . 0.0 113.545 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 73' ' ' ARG 0.408 0.2 OUTLIER 143.99 -59.36 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 131.782 4.033 . . . . 0.0 112.614 161.334 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -76.51 -159.07 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.665 1.186 . . . . 0.0 109.139 165.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 77.42 -35.99 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.317 2.647 . . . . 0.0 113.244 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HA ' HD12 ' A' ' 79' ' ' LEU . 60.9 t80 -55.35 -43.43 75.03 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.776 1.23 . . . . 0.0 111.544 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -66.43 -32.14 73.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.127 0.971 . . . . 0.0 110.445 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -18.47 54.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.926 1.29 . . . . 0.0 110.756 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' CD2' ' A' ' 21' ' ' PHE . 36.9 mt -76.57 -62.85 1.49 Allowed 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.406 -0.809 . . . . 0.0 108.944 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -55.97 -35.45 66.74 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 120.973 -1.08 . . . . 0.0 113.74 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.31 69.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.14 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.74 36.35 0.54 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.245 0.929 . . . . 0.0 111.651 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.48 33.22 3.07 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.309 1.433 . . . . 0.0 115.259 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.97 111.38 23.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 118.858 1.329 . . . . 0.0 108.581 -169.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -80.33 113.23 18.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.101 -0.999 . . . . 0.0 110.355 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.25 133.73 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -172.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -105.15 155.56 18.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.355 1.062 . . . . 0.0 110.073 165.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 162.59 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 163.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -140.39 172.6 12.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 160.128 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.68 75.06 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.995 1.725 . . . . 0.0 112.46 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.76 124.82 2.38 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.748 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.84 162.72 12.88 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.404 ' C ' HG23 ' A' ' 17' ' ' VAL . 20.4 p -82.31 174.29 11.28 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.751 167.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.3 t -42.29 -47.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-O 117.429 -1.272 . . . . 0.0 110.597 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -60.82 -36.23 78.55 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.817 1.19 . . . . 0.0 113.85 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -66.08 -44.02 85.67 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.995 1.318 . . . . 0.0 108.632 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.808 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.7 -36.81 11.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.61 0.641 . . . . 0.0 111.298 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.5 mm -87.16 -52.06 12.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 108.849 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.47 -13.73 43.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.508 2.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -62.31 1.52 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 167.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.644 ' HB2' HD12 ' A' ' 106' ' ' LEU . 3.5 t80 -55.73 -43.78 76.91 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.449 -1.407 . . . . 0.0 113.163 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 p -60.16 -51.24 70.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.098 1.359 . . . . 0.0 108.794 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.49 37.87 0.71 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.169 0.988 . . . . 0.0 109.753 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 44.17 33.9 3.04 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.672 2.558 . . . . 0.0 114.549 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -106.63 36.58 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.422 1.111 . . . . 0.0 110.684 -168.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 101' ' ' PHE . 18.9 mt -137.82 172.05 13.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.3 -0.875 . . . . 0.0 108.922 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -111.33 139.13 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -170.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.23 91.89 6.82 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 38.47 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.745 1.218 . . . . 0.0 110.214 -176.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.323 5.7 t -93.7 36.03 1.11 Allowed 'General case' 0 CA--C 1.542 0.654 0 O-C-N 119.36 -2.087 . . . . 0.0 110.262 -167.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.3 t 171.57 56.89 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.547 -1.346 . . . . 0.0 107.539 -163.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.35 138.42 34.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 120.629 -1.294 . . . . 0.0 108.058 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -145.86 110.62 5.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 171.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -147.1 147.43 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.08 39.64 3.35 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 O-C-N 120.463 -1.398 . . . . 0.0 110.851 177.511 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 64' ' ' GLU . . . -168.9 172.58 7.59 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.721 1.209 . . . . 0.0 111.279 -169.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -89.01 148.43 23.76 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 159.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.1 p -114.68 166.96 7.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.31 154.41 41.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 163.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.06 129.87 16.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.65 1.98 . . . . 0.0 106.947 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.79 99.19 0.81 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 1 C-N-CA 127.97 5.78 . . . . 0.0 108.765 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -96.04 170.32 9.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.842 1.257 . . . . 0.0 109.455 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 18' ' ' SER . 25.8 m -121.06 38.27 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.506 1.123 . . . . 0.0 110.739 163.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.23 171.62 44.69 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 120.807 -1.183 . . . . 0.0 112.623 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 26' ' ' TYR . 12.9 mttt -90.57 38.19 0.94 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.891 0.876 . . . . 0.0 111.212 -172.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.48 160.57 41.93 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 120.939 -1.101 . . . . 0.0 111.301 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -12.53 59.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.427 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 t -121.05 37.22 4.38 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 120.575 -1.328 . . . . 0.0 108.499 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 m -80.0 168.91 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 159.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mtp -79.26 145.62 33.45 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.572 -1.33 . . . . 0.0 110.099 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 57.3 t -80.2 158.68 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -126.99 149.49 49.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.206 . . . . 0.0 111.32 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER -86.21 33.02 0.61 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.436 1.016 . . . . 0.0 113.297 -166.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -165.13 120.93 1.38 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 118.717 -2.489 . . . . 0.0 106.657 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CE2' HD21 ' A' ' 79' ' ' LEU . 6.3 t80 -58.68 -72.37 0.1 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 124.582 1.176 . . . . 0.0 111.903 167.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -72.82 2.03 7.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.657 -160.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.478 HH11 ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -134.02 44.45 2.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.115 1.766 . . . . 0.0 109.068 173.133 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' CE1' ' A' ' 27' ' ' PHE . . . -89.5 -174.85 4.5 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -120.07 -25.78 5.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.27 0.941 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 81.0 m-85 -142.2 139.91 32.17 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 25.1 m-85 -123.44 100.87 7.03 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -80.98 120.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 58' ' ' LEU . 39.1 mt -110.55 112.16 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 4' ' ' VAL . 65.8 t80 -99.41 123.29 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -87.55 114.29 24.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.281 2.232 . . . . 0.0 109.601 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -75.59 7.15 3.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.049 1.295 . . . . 0.0 113.643 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -96.31 -41.26 8.73 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 119.123 0.874 . . . . 0.0 113.208 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -130.03 37.1 3.95 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.185 160.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.7 29.4 7.81 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.884 1.23 . . . . 0.0 113.185 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -91.87 161.22 14.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.692 1.197 . . . . 0.0 107.914 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.57 155.83 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.236 0.541 . . . . 0.0 109.605 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.2 pt-20 -136.06 155.96 49.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 166.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.18 107.52 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.27 141.79 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 159.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -111.08 111.56 22.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 127.517 2.327 . . . . 0.0 105.269 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -136.79 102.89 5.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.237 0.926 . . . . 0.0 109.123 -167.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -108.91 60.15 0.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -157.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.67 126.16 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.83 38.84 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.675 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.15 168.52 26.84 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.993 0.917 . . . . 0.0 109.847 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.29 64.08 1.62 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.309 1.043 . . . . 0.0 109.177 174.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.36 170.33 22.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.983 0.913 . . . . 0.0 111.001 171.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.34 147.13 6.32 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 113.746 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -72.33 166.05 23.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.167 1.387 . . . . 0.0 109.61 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 123.91 4.71 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.21 -30.65 64.57 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 119.863 1.831 . . . . 0.0 112.176 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt 58.23 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.418 2.287 . . . . 0.0 110.787 -170.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -63.09 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 108.992 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.17 -53.08 38.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 115.612 -2.137 . . . . 0.0 109.184 -173.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -51.61 -46.14 63.49 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 120.658 1.572 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -38.89 85.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 29' ' ' ILE . 81.5 mt -77.68 -38.21 48.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.965 0.802 . . . . 0.0 110.168 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -58.25 -32.42 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.372 1.869 . . . . 0.0 110.304 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -13.42 8.57 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 112.934 173.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 8.2 mptt -114.17 37.7 3.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.331 1.052 . . . . 0.0 110.091 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.58 25.2 8.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.579 1.085 . . . . 0.0 114.401 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.04 114.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 0.7 OUTLIER -115.11 37.87 3.37 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.299 1.523 . . . . 0.0 110.48 -178.154 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.743 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.3 m-85 -176.48 172.07 2.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -165.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 67' ' ' ILE . 8.2 tp -177.6 130.41 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 108.459 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.754 HG21 ' HB1' ' A' ' 97' ' ' ALA . 55.0 mt -101.32 104.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.98 6.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.622 0.646 . . . . 0.0 109.379 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 p -47.2 -33.46 5.36 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.692 1.197 . . . . 0.0 112.209 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.25 -176.44 5.88 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 73' ' ' ARG 0.296 1.5 p -104.78 176.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 165.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -104.82 25.84 24.26 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.59 ' H ' HG13 ' A' ' 71' ' ' VAL . 6.2 ttt180 69.25 -169.53 0.18 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 128.659 2.784 . . . . 0.0 110.165 -164.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.4 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 22.0 t30 28.09 60.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.833 3.253 . . . . 0.0 114.77 170.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -174.73 -33.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.374 1.07 . . . . 0.0 113.328 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.613 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 48.1 t80 -54.13 -37.66 64.61 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.268 1.027 . . . . 0.0 112.178 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.5 -34.88 70.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.517 0.727 . . . . 0.0 110.189 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.8 -14.61 59.17 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.444 -0.785 . . . . 0.0 111.184 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' A' ' 21' ' ' PHE . 79.7 mt -70.25 -57.29 5.06 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.262 -0.899 . . . . 0.0 109.19 171.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.613 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -60.74 -28.89 69.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.352 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -53.28 51.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.062 0.846 . . . . 0.0 109.986 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.58 35.72 0.68 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.193 0.452 . . . . 0.0 111.556 176.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 36.19 0.4 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.214 2.34 . . . . 0.0 115.901 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 t -86.99 136.92 21.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.406 1.603 . . . . 0.0 109.925 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -79.23 162.33 25.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 172.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.39 139.02 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.74 155.88 26.99 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.307 1.843 . . . . 0.0 109.345 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -78.39 139.64 38.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 167.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.459 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -120.15 161.45 21.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 156.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -144.77 80.1 1.62 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.307 1.051 . . . . 0.0 110.686 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.75 139.65 1.31 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.52 166.24 13.07 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 121.784 0.658 . . . . 0.0 111.906 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.5 p -86.09 172.03 10.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.88 -0.66 . . . . 0.0 109.619 164.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -45.43 -40.9 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.199 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.13 -35.51 81.35 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.878 1.217 . . . . 0.0 114.277 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.37 -42.43 83.45 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.932 1.693 . . . . 0.0 108.617 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.754 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.46 -39.16 15.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.212 0.915 . . . . 0.0 111.916 171.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.33 -53.07 11.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -60.05 -27.23 66.77 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.829 2.051 . . . . 0.0 110.31 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -59.48 2.71 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.458 ' HB2' HD12 ' A' ' 106' ' ' LEU . 10.0 t80 -55.54 -49.77 71.78 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.204 0.911 . . . . 0.0 113.159 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.2 p -66.79 -25.88 66.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 110.414 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.19 37.23 3.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.278 1.431 . . . . 0.0 107.745 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.18 6.4 0.88 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.281 2.848 . . . . 0.0 116.715 168.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.503 ' HB3' HH11 ' A' ' 105' ' ' ARG . 0.0 OUTLIER -79.95 36.47 0.34 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 121.05 2.425 . . . . 0.0 111.445 -178.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 89' ' ' PHE . 38.6 mt -141.84 173.49 11.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.381 -1.449 . . . . 0.0 108.863 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -127.6 148.54 50.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.444 1.898 . . . . 0.0 107.557 -166.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.36 99.0 11.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 120.374 1.443 . . . . 0.0 108.062 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 tp -82.8 57.89 4.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.974 1.309 . . . . 0.0 109.976 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.5 p -90.29 36.12 0.87 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.045 -1.66 . . . . 0.0 110.604 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 p -163.67 149.28 11.18 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.702 2.401 . . . . 0.0 107.074 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.38 147.71 50.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.143 1.777 . . . . 0.0 109.219 170.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.1 p -148.4 64.39 1.08 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.659 1.218 . . . . 0.0 109.444 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -140.96 96.92 3.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 120.894 -1.128 . . . . 0.0 108.388 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -84.87 75.66 10.33 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.69 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -175.865 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.719 ' HB3' ' CD2' ' A' ' 65' ' ' TYR . . . -158.54 166.8 31.27 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 151.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -77.91 135.99 37.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.81 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -114.43 158.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.95 145.52 50.24 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.67 118.29 21.23 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.86 102.54 0.77 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 1 C-N-CA 126.18 4.587 . . . . 0.0 107.995 176.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.0 t -96.31 173.45 7.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.185 1.394 . . . . 0.0 107.406 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.07 38.38 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 109.038 164.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.35 175.46 44.62 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 121.025 -1.047 . . . . 0.0 111.96 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 19.9 mtmt -97.15 39.34 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.974 1.31 . . . . 0.0 110.296 -164.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.56 152.18 49.16 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -79.04 -0.43 31.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.169 1.788 . . . . 0.0 110.236 174.617 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -133.51 37.34 3.32 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 119.96 -1.712 . . . . 0.0 109.607 166.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 94' ' ' VAL . 36.6 m -82.76 173.36 11.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.321 156.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.97 139.03 39.15 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.812 -1.18 . . . . 0.0 109.216 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 97' ' ' ALA . 62.1 t -69.57 153.65 8.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 164.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -118.64 153.64 33.99 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.56 1.144 . . . . 0.0 110.253 -169.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.29 35.79 2.46 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.687 0.756 . . . . 0.0 111.256 -164.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -162.03 106.65 1.22 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.549 -1.344 . . . . 0.0 108.332 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CD2' HD11 ' A' ' 79' ' ' LEU . 14.4 t80 -53.96 -56.23 19.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -75.96 -6.23 49.96 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 121.013 1.733 . . . . 0.0 112.48 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.47 39.0 4.07 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.254 1.021 . . . . 0.0 109.843 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.32 178.99 5.55 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.46 -18.04 7.98 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 89.8 m-85 -146.3 156.17 43.16 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -132.76 105.51 7.2 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.1 mm -80.05 119.34 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.63 109.44 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -98.45 108.87 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 102.28 8.39 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.924 1.69 . . . . 0.0 109.757 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -68.48 15.9 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -120.69 -18.85 7.6 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.572 0.749 . . . . 0.0 112.663 -165.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.82 38.77 0.53 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 123.502 0.501 . . . . 0.0 110.098 158.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.42 16.33 0.92 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 128.572 2.987 . . . . 0.0 116.005 173.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -76.63 144.46 39.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.744 1.272 . . . . 0.0 109.584 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.29 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.616 1.166 . . . . 0.0 109.288 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.51 149.33 36.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.314 1.845 . . . . 0.0 108.043 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.14 111.04 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 162.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.87 128.64 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 153.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -84.14 140.87 31.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 160.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB3' HD11 ' A' ' 44' ' ' ILE . 2.2 m-20 -142.65 99.97 3.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.7 p -79.47 55.77 2.01 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 120.913 -1.117 . . . . 0.0 112.474 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.65 HG23 ' HE3' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -86.38 148.56 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 119.955 -1.716 . . . . 0.0 109.028 -166.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.38 159.57 25.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.222 1.409 . . . . 0.0 110.766 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.79 38.84 0.81 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.351 1.461 . . . . 0.0 110.439 -172.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.98 176.34 5.1 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.317 1.447 . . . . 0.0 110.075 -171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.86 167.52 7.51 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.239 -0.913 . . . . 0.0 109.708 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.93 166.35 19.5 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.684 -0.635 . . . . 0.0 112.075 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 p -94.99 155.42 16.74 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.538 1.535 . . . . 0.0 111.608 -170.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 -179.38 4.75 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.76 1.648 . . . . 0.0 114.268 168.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.46 -52.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.195 1.263 . . . . 0.0 109.639 167.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.65 ' HE3' HG23 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 63.34 -64.59 0.11 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 126.426 1.89 . . . . 0.0 111.266 -171.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -63.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.314 1.446 . . . . 0.0 108.752 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -53.46 -49.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 126.291 1.836 . . . . 0.0 108.894 177.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.49 -37.96 12.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.017 1.281 . . . . 0.0 111.902 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -75.74 -58.74 3.1 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.792 0.837 . . . . 0.0 110.403 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.74 -44.33 85.97 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.26 1.024 . . . . 0.0 110.84 -171.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.76 -45.03 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.137 1.775 . . . . 0.0 110.108 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.4 m -77.18 7.42 5.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.622 1.169 . . . . 0.0 113.901 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.73 38.98 3.75 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.461 -1.399 . . . . 0.0 108.741 155.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.58 18.14 29.54 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.636 2.065 . . . . 0.0 116.759 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.74 89.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.511 1.924 . . . . 0.0 110.219 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.674 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 3.3 mm-40 -91.58 35.7 0.95 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.954 1.302 . . . . 0.0 111.066 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.81 ' HB3' HG23 ' A' ' 4' ' ' VAL . 15.3 m-85 177.89 166.56 0.71 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 120.03 -1.668 . . . . 0.0 107.317 -170.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 68' ' ' ALA . 9.2 tp -165.96 150.51 8.22 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.733 HG21 ' HB1' ' A' ' 97' ' ' ALA . 67.1 mt -120.84 103.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -149.13 120.87 8.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.607 1.094 . . . . 0.0 108.16 -176.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' A' ' 89' ' ' PHE . 79.4 p -54.35 -34.57 61.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.896 0.379 . . . . 0.0 111.981 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.26 170.33 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -97.37 147.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -82.15 33.72 2.67 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ttm105 61.14 -161.35 0.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.316 1.846 . . . . 0.0 108.64 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t30 25.28 69.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.842 2.857 . . . . 0.0 112.802 174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -177.89 -28.54 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 57.3 t80 -70.27 -36.92 74.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 121.317 1.871 . . . . 0.0 110.928 -158.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.24 -32.43 72.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.523 0.729 . . . . 0.0 109.598 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -13.85 59.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.627 1.171 . . . . 0.0 109.842 -177.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' CD2' ' A' ' 21' ' ' PHE . 28.8 mt -80.81 -62.47 1.66 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -59.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.387 -0.815 . . . . 0.0 112.265 177.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -16.04 27.75 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.217 -0.897 . . . . 0.0 113.366 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.62 36.71 4.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.674 1.125 . . . . 0.0 111.071 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.03 31.01 1.14 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.121 2.296 . . . . 0.0 116.824 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.49 112.62 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.071 1.435 . . . . 0.0 109.841 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -79.31 102.75 8.8 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 79' ' ' LEU . 61.8 t -84.05 126.05 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -96.69 157.1 16.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.17 1.788 . . . . 0.0 109.726 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.49 154.16 30.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.77 2.028 . . . . 0.0 105.794 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.43 168.52 19.48 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 152.353 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.56 38.75 1.38 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.035 1.289 . . . . 0.0 112.288 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 112.82 3.74 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.358 -1.463 . . . . 0.0 112.908 170.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.37 164.71 30.36 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.598 2.047 . . . . 0.0 109.697 -161.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.42 ' C ' HG23 ' A' ' 17' ' ' VAL . 69.6 p -87.63 169.85 11.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.226 1.013 . . . . 0.0 109.211 166.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 15' ' ' SER . 27.0 t -43.1 -47.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.538 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -63.11 -30.32 71.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -69.6 -40.67 76.52 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 120.483 1.492 . . . . 0.0 110.119 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.733 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -51.88 -28.27 15.56 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -92.94 -56.78 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 C-N-CA 125.689 1.596 . . . . 0.0 107.351 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.93 -41.31 64.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.247 0.967 . . . . 0.0 108.68 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.39 -50.66 58.71 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -43.37 68.67 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 111.479 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.9 p -67.41 -35.65 79.7 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.175 1.79 . . . . 0.0 110.464 -171.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.64 36.76 2.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.031 0.932 . . . . 0.0 108.74 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.96 20.93 0.79 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.813 2.149 . . . . 0.0 115.953 172.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -93.63 38.92 1.06 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.58 1.69 . . . . 0.0 110.206 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.3 mt -140.37 169.67 17.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 109.02 165.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -121.61 143.18 49.46 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.609 -163.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -79.48 100.8 7.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.71 50.96 1.22 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.079 1.352 . . . . 0.0 108.517 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.346 13.5 t -79.8 38.64 0.4 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.934 1.294 . . . . 0.0 110.239 173.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.1 t 178.48 128.09 0.06 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.412 1.885 . . . . 0.0 108.047 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -104.88 127.72 52.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 161.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -80.31 47.14 0.89 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 110.698 172.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -105.1 94.93 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -82.35 45.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.128 0.971 . . . . 0.0 112.182 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.088 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -92.91 141.01 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.05 155.06 18.99 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.56 122.17 13.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.466 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 57.1 Cg_endo -70.45 102.62 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.618 4.212 . . . . 0.0 109.129 177.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -100.26 175.41 5.73 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.34 1.456 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.06 37.03 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.694 0.798 . . . . 0.0 109.968 166.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.94 -173.86 46.34 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 120.46 -1.4 . . . . 0.0 111.783 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -125.61 39.55 3.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.45 1.125 . . . . 0.0 111.602 -165.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.18 153.03 51.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.963 1.305 . . . . 0.0 107.626 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -75.39 -7.21 53.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.349 1.46 . . . . 0.0 113.02 -170.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -115.59 38.15 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.434 -1.416 . . . . 0.0 109.667 164.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.9 m -79.5 166.91 21.47 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.61 140.45 39.65 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.714 -1.242 . . . . 0.0 108.344 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.4 t -77.47 137.28 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -83.06 146.31 28.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.45 1.5 . . . . 0.0 108.203 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.67 38.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.786 -0.571 . . . . 0.0 110.293 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 179.77 108.91 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 119.923 -1.736 . . . . 0.0 108.889 -161.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 79' ' ' LEU . 19.5 t80 -53.95 -65.6 0.54 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.247 0.619 . . . . 0.0 111.392 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.96 12.19 3.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.711 -171.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -131.23 37.43 3.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.815 0.734 . . . . 0.0 109.481 164.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -86.81 -176.01 5.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -122.74 -14.27 7.74 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -144.72 154.69 43.01 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.487 ' CE2' HG23 ' A' ' 54' ' ' VAL . 71.2 m-85 -133.09 116.37 16.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 39' ' ' VAL . 12.4 mm -95.42 118.03 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.31 97.77 6.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.431 ' HB3' HG12 ' A' ' 4' ' ' VAL . 44.5 t80 -83.96 111.05 18.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.784 1.234 . . . . 0.0 108.637 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 101.36 7.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.813 2.845 . . . . 0.0 111.322 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 p -75.78 43.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.96 -1.088 . . . . 0.0 112.732 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.7 -37.72 1.17 Allowed 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 116.996 -1.478 . . . . 0.0 112.197 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -133.86 36.79 3.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 124.94 1.4 . . . . 0.0 111.972 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.89 1.3 Allowed Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.988 1.756 . . . . 0.0 113.003 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.01 150.85 21.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.3 149.12 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 122.218 1.008 . . . . 0.0 109.063 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.09 134.44 52.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 28' ' ' ILE . 40.9 t -101.32 108.63 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.24 152.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.34 103.25 7.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 CA-C-O 118.599 -0.667 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 0.4 OUTLIER 59.93 -62.06 0.06 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 127.038 2.135 . . . . 0.0 112.333 -168.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.487 HG23 ' CE2' ' A' ' 27' ' ' PHE . 2.7 p -52.5 -62.55 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -52.73 52.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-O 116.129 -1.891 . . . . 0.0 109.692 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -46.21 -48.42 17.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.96 1.254 . . . . 0.0 111.481 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 t -61.96 -62.65 1.64 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.388 0.675 . . . . 0.0 111.139 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.9 mt -53.75 -46.83 71.02 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.925 1.69 . . . . 0.0 111.281 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 t -56.75 -45.55 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.846 1.658 . . . . 0.0 110.232 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.8 m -71.95 8.07 1.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.013 0.925 . . . . 0.0 112.217 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.68 37.62 4.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 166.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.91 5.32 2.85 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 129.102 3.239 . . . . 0.0 117.344 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.7 t -53.46 108.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 121.107 2.453 . . . . 0.0 112.681 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -105.82 35.65 2.82 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.948 0.88 . . . . 0.0 111.711 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.726 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.5 m-85 -176.91 168.36 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.008 -2.308 . . . . 0.0 108.384 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 tp -166.55 152.19 8.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.787 HG21 ' HB1' ' A' ' 97' ' ' ALA . 44.1 mt -119.94 94.9 3.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.43 108.82 3.96 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.069 0.948 . . . . 0.0 111.202 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 p -48.74 -28.21 3.46 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.908 2.483 . . . . 0.0 115.565 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.75 178.52 4.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.662 1.985 . . . . 0.0 106.039 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.19 155.09 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.848 -1.158 . . . . 0.0 108.356 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -48.51 -58.93 6.94 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 167.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 151.6 -177.7 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 1 C-N-CA 133.82 4.848 . . . . 0.0 105.357 -166.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 25.62 58.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 129.426 3.091 . . . . 0.0 116.153 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.28 -29.3 0.12 Allowed 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.727 ' HA ' HD12 ' A' ' 79' ' ' LEU . 46.4 t80 -61.2 -33.8 74.05 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.632 0.651 . . . . 0.0 112.462 -169.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.89 -33.88 71.03 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.625 0.37 . . . . 0.0 110.833 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -16.54 41.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.307 0.643 . . . . 0.0 110.088 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 76' ' ' PHE . 27.8 mt -64.28 -66.69 0.51 Allowed 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.598 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -60.73 -27.0 67.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.47 -31.08 33.11 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.294 0.638 . . . . 0.0 112.368 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.25 37.42 2.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.279 1.032 . . . . 0.0 110.631 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.82 27.03 8.85 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.773 1.654 . . . . 0.0 116.653 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.64 114.02 19.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 118.639 1.219 . . . . 0.0 109.187 -168.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -79.59 103.32 9.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 79' ' ' LEU . 24.9 t -92.07 109.88 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.988 1.715 . . . . 0.0 108.695 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -79.72 162.25 25.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.015 1.326 . . . . 0.0 111.465 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -79.56 152.61 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.479 1.912 . . . . 0.0 106.567 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.55 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -131.92 163.93 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 155.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.33 92.72 1.72 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.658 1.572 . . . . 0.0 109.274 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.56 86.48 0.91 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.697 1.142 . . . . 0.0 115.695 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.63 159.95 28.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 121.387 -1.067 . . . . 0.0 112.302 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.7 p -82.8 172.51 12.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.347 0.659 . . . . 0.0 109.505 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.6 t -46.26 -42.55 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.298 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -35.24 76.93 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.548 1.522 . . . . 0.0 114.499 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.86 -45.64 85.19 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 125.106 1.362 . . . . 0.0 108.138 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.787 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -50.06 -29.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -89.58 -60.91 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 C-N-CA 125.141 1.376 . . . . 0.0 107.448 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -48.98 -41.23 33.59 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 127.51 2.324 . . . . 0.0 109.404 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.64 -54.99 15.1 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.731 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 106' ' ' LEU . 15.7 t80 -58.09 -47.44 83.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.932 1.293 . . . . 0.0 111.971 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.8 p -68.43 -33.44 74.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.086 1.754 . . . . 0.0 110.413 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.75 37.82 2.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.87 44.66 24.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.906 2.194 . . . . 0.0 115.115 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -118.28 38.25 3.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.49 1.145 . . . . 0.0 110.468 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 101' ' ' PHE . 25.4 mt -133.04 170.37 15.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.386 0.994 . . . . 0.0 108.686 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -112.74 147.29 37.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -79.94 121.97 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.234 0.241 0 C-N-CA 124.213 1.005 . . . . 0.0 109.903 -172.049 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -108.32 134.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.478 -2.415 . . . . 0.0 104.478 -177.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.43 146.19 27.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.25 123.41 20.62 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.606 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 87.9 Cg_endo -80.73 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 1 C-N-CA 126.404 4.736 . . . . 0.0 109.392 -174.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.2 t -83.48 169.34 15.6 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.307 1.043 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.1 m -120.56 38.77 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.701 1.2 . . . . 0.0 110.582 163.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 170.63 42.18 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 164.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -93.48 46.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.952 1.701 . . . . 0.0 110.27 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -138.41 153.43 48.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.041 0.936 . . . . 0.0 108.74 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.72 -15.49 59.76 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.246 1.418 . . . . 0.0 109.256 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.55 39.46 3.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.587 -1.321 . . . . 0.0 110.638 165.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -88.41 166.71 14.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 159.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.15 146.46 35.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.919 0.887 . . . . 0.0 109.887 -173.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 93' ' ' THR . 3.2 t -93.0 147.31 5.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 122.349 1.071 . . . . 0.0 109.859 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -105.8 132.74 51.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.222 1.809 . . . . 0.0 108.193 -165.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -79.45 38.44 0.37 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.767 0.794 . . . . 0.0 110.024 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -172.61 93.99 0.12 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 119.209 -2.182 . . . . 0.0 108.752 -160.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 79' ' ' LEU . 13.6 t80 -49.97 -61.42 2.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 112.047 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.5 -0.8 16.12 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -168.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -133.69 58.92 1.75 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.753 2.421 . . . . 0.0 107.066 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -101.98 179.71 4.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 163.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.91 -19.99 7.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.488 0.586 . . . . 0.0 112.145 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.41 144.23 33.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 42.6 m-85 -126.29 99.7 5.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.1 mm -80.79 121.53 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -108.82 117.11 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HB3' HG12 ' A' ' 4' ' ' VAL . 85.5 t80 -103.11 131.31 50.21 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.093 1.357 . . . . 0.0 109.014 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.12 122.78 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.849 1.66 . . . . 0.0 111.005 173.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 p -88.16 42.15 1.04 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 164.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.33 -96.85 0.36 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.72 37.92 1.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.919 -162.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.22 2.79 0.03 OUTLIER Glycine 0 CA--C 1.536 1.37 0 C-N-CA 128.708 3.052 . . . . 0.0 116.387 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -72.84 140.88 47.9 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.957 1.303 . . . . 0.0 109.745 -165.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.937 0.895 . . . . 0.0 109.745 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -141.92 128.76 20.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.646 1.578 . . . . 0.0 107.435 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.76 117.85 33.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.69 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 152.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.57 142.93 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.133 1.773 . . . . 0.0 106.382 158.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 O-C-N 121.025 -1.047 . . . . 0.0 109.929 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.45 -1.057 0 CA-C-O 118.268 -0.805 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 63.51 -63.56 0.13 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.403 1.481 . . . . 0.0 111.249 -166.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -65.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -49.05 -53.02 8.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 126.324 1.85 . . . . 0.0 108.97 175.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -53.57 7.06 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.378 1.049 . . . . 0.0 111.466 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -70.05 -46.79 64.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.19 -40.54 90.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.783 -1.198 . . . . 0.0 110.069 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.8 t -57.0 -41.95 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.998 1.719 . . . . 0.0 110.291 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -55.74 -29.85 60.23 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.597 0.635 . . . . 0.0 111.666 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -101.82 38.57 1.61 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.442 1.019 . . . . 0.0 109.045 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.47 18.35 29.56 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 126.324 1.916 . . . . 0.0 116.443 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.82 114.12 4.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' HA ' HG13 ' A' ' 84' ' ' VAL . 12.3 mt-10 -124.15 35.63 4.78 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.626 0.648 . . . . 0.0 111.443 167.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.645 ' HB3' HG23 ' A' ' 4' ' ' VAL . 8.0 m-30 -158.75 162.7 37.13 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 68' ' ' ALA . 6.7 tp -166.17 150.8 8.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.736 -1.853 . . . . 0.0 107.099 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 66' ' ' LEU . 59.0 mt -121.79 99.66 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -153.91 113.18 3.75 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.308 1.043 . . . . 0.0 109.21 -174.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -52.52 -30.45 30.46 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.433 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -160.53 169.81 22.2 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.541 1.937 . . . . 0.0 106.911 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.04 153.67 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.29 50.95 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.61 -160.82 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.834 3.254 . . . . 0.0 106.553 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -28.93 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 129.404 3.081 . . . . 0.0 112.766 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -175.98 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.38 1.872 . . . . 0.0 110.084 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' A' ' 79' ' ' LEU . 45.8 t80 -57.56 -38.97 75.67 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.195 1.398 . . . . 0.0 111.61 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.45 -24.89 63.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.457 0.571 . . . . 0.0 111.226 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.8 m -84.41 -18.2 36.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.964 -1.085 . . . . 0.0 112.065 170.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 76' ' ' PHE . 33.9 mt -66.85 -61.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.341 0.973 . . . . 0.0 108.696 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HE3' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -55.95 -32.67 64.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 171.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.28 67.66 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.388 0.994 . . . . 0.0 110.674 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.38 36.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.386 0.994 . . . . 0.0 111.914 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.16 28.68 3.18 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.453 1.502 . . . . 0.0 116.047 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 64' ' ' GLU . 12.4 t -86.61 123.63 39.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 118.772 1.286 . . . . 0.0 108.344 -170.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 159.65 28.3 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.14 148.0 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.642 1.577 . . . . 0.0 108.011 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -118.33 155.87 29.89 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.346 1.858 . . . . 0.0 109.994 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.78 146.45 33.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 164.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.406 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -122.85 166.91 14.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 154.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -154.31 60.11 0.7 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.816 1.189 . . . . 0.0 109.411 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.24 121.02 3.05 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.564 1.078 . . . . 0.0 111.89 168.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.97 167.58 18.32 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.359 1.079 . . . . 0.0 114.993 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.434 ' C ' HG23 ' A' ' 17' ' ' VAL . 81.1 p -87.88 174.79 8.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.231 1.012 . . . . 0.0 110.694 162.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.6 t -48.85 -38.29 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.002 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -65.99 -33.61 76.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 121.076 1.762 . . . . 0.0 113.928 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -69.58 -41.6 75.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.768 1.627 . . . . 0.0 108.801 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -42.88 -42.08 3.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.141 0.882 . . . . 0.0 111.902 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.19 -48.66 14.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.791 1.237 . . . . 0.0 108.227 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.13 -24.97 63.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.274 1.829 . . . . 0.0 110.153 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.67 -57.33 3.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.428 ' HB2' HD12 ' A' ' 106' ' ' LEU . 1.1 t80 -57.14 -44.7 83.65 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.211 1.004 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.0 p -61.97 -50.76 70.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.084 1.354 . . . . 0.0 108.765 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.92 35.62 0.64 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.857 . . . . 0.0 109.134 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.05 24.51 2.09 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.02 1.771 . . . . 0.0 114.978 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -98.34 37.76 1.42 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.076 1.438 . . . . 0.0 109.984 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 101' ' ' PHE . 19.7 mt -134.36 165.24 25.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -109.03 138.52 45.25 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.7 100.47 7.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.689 1.131 . . . . 0.0 108.59 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 CA--C 1.536 0.437 0 C-N-CA 123.751 0.821 . . . . 0.0 110.65 -166.41 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.812 HG23 ' HB3' ' A' ' 65' ' ' TYR . 9.8 p -82.88 156.02 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.96 146.4 39.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 163.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.49 HD11 HG13 ' A' ' 4' ' ' VAL . 4.2 mp -126.78 129.08 24.13 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.83 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.203 1 C-N-CA 125.307 4.005 . . . . 0.0 108.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 t -111.3 171.08 7.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.567 1.147 . . . . 0.0 109.876 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -129.82 39.39 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.73 2.012 . . . . 0.0 108.227 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.1 173.1 42.34 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -110.29 50.0 0.82 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.016 1.326 . . . . 0.0 108.268 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.71 157.13 45.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.983 1.313 . . . . 0.0 108.016 171.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 0.8 25.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.313 1.445 . . . . 0.0 110.339 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -127.25 37.63 4.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.021 -1.674 . . . . 0.0 108.755 168.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -81.07 165.07 21.98 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.419 -0.801 . . . . 0.0 109.381 163.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.41 135.35 37.41 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.664 1.12 . . . . 0.0 109.047 -175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 93.0 t -75.34 137.53 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.67 131.12 42.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 107.361 -172.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.67 38.59 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.634 1.207 . . . . 0.0 110.862 -173.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.46 93.5 0.76 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 118.401 -2.687 . . . . 0.0 107.132 -166.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 79' ' ' LEU . 20.2 t80 -55.12 -52.58 62.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.632 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.79 13.59 1.0 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.04 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.28 38.29 1.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.286 1.403 . . . . 0.0 110.082 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -103.91 127.85 51.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -172.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.43 -20.15 64.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.62 151.98 42.02 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 92.6 m-85 -131.3 119.61 22.0 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.31 112.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.492 HD11 HD23 ' A' ' 58' ' ' LEU . 83.2 mt -101.76 112.47 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.689 ' HB3' HG12 ' A' ' 4' ' ' VAL . 16.7 t80 -104.28 125.83 50.87 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.859 1.264 . . . . 0.0 110.582 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.84 112.11 19.82 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 108.676 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -77.43 54.57 1.16 Allowed 'General case' 0 C--O 1.239 0.518 0 O-C-N 120.832 -1.167 . . . . 0.0 108.838 163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -151.58 -34.67 0.14 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.46 38.03 0.43 Allowed 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 117.524 -1.67 . . . . 0.0 111.873 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.1 9.48 2.0 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.011 1.291 . . . . 0.0 115.01 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -61.91 146.36 50.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.893 1.346 . . . . 0.0 107.687 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.44 142.42 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.25 132.23 53.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.275 1.83 . . . . 0.0 106.629 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.27 110.53 25.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.22 150.57 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 158.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -124.02 106.76 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo . . . . . 0 N--CA 1.448 -1.158 0 N-CA-C 110.758 -0.516 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 58.61 -66.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.397 1.879 . . . . 0.0 111.094 -161.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -48.91 -63.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.427 1.491 . . . . 0.0 111.174 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.36 -49.66 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 116.028 -1.939 . . . . 0.0 109.266 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -49.69 -49.81 46.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.827 1.194 . . . . 0.0 110.652 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 t -61.83 -55.11 33.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.406 1.082 . . . . 0.0 112.073 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.492 HD23 HD11 ' A' ' 29' ' ' ILE . 96.0 mt -59.21 -43.15 92.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.28 0.632 . . . . 0.0 109.843 -174.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -60.66 -45.17 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.528 1.931 . . . . 0.0 110.861 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -58.02 -26.07 61.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.532 1.06 . . . . 0.0 111.808 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -104.0 36.78 2.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.053 0.941 . . . . 0.0 109.08 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.12 11.69 55.93 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 127.012 2.244 . . . . 0.0 117.162 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.57 105.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.96 1.38 . . . . 0.0 110.791 -170.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -104.88 36.43 2.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.338 1.055 . . . . 0.0 110.847 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.812 ' HB3' HG23 ' A' ' 4' ' ' VAL . 1.4 m-85 -171.62 173.05 4.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 119.804 -1.81 . . . . 0.0 109.888 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.496 HD23 HG13 ' A' ' 86' ' ' VAL . 16.4 tp -166.81 157.64 12.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.941 1.296 . . . . 0.0 108.716 170.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.792 HG21 ' HB1' ' A' ' 97' ' ' ALA . 48.2 mt -124.37 106.12 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 168.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.41 130.99 10.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 p -63.68 -26.04 68.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -170.02 -177.89 2.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -166.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.17 154.09 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.603 -1.311 . . . . 0.0 108.037 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.05 -51.37 25.31 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 164.52 -86.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 130.942 3.697 . . . . 0.0 104.937 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.73 119.88 15.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.7 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 130.572 3.549 . . . . 0.0 109.831 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.535 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 33.6 t80 -53.02 -43.92 66.92 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.163 1.385 . . . . 0.0 111.658 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.43 -31.2 72.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.339 1.455 . . . . 0.0 109.856 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -21.78 38.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.817 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.643 HD21 ' CE2' ' A' ' 21' ' ' PHE . 94.4 mt -69.86 -59.11 3.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.273 0.942 . . . . 0.0 108.653 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -58.9 -31.35 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.568 1.147 . . . . 0.0 112.999 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.13 -8.19 7.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.47 36.5 4.55 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.81 1.641 . . . . 0.0 110.211 165.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.79 19.46 3.39 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.681 2.086 . . . . 0.0 116.619 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.2 129.73 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.131 -1.217 . . . . 0.0 108.184 -163.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -78.56 165.18 24.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG13 HD23 ' A' ' 66' ' ' LEU . 29.6 t -151.71 114.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -89.03 157.51 18.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.768 0.827 . . . . 0.0 110.181 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.81 156.17 27.53 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.697 1.599 . . . . 0.0 107.101 162.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.04 175.73 9.33 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 158.182 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.45 38.72 0.71 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 122.191 2.269 . . . . 0.0 114.759 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.04 123.17 2.82 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 172.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.41 163.37 13.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -166.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.44 ' C ' HG23 ' A' ' 17' ' ' VAL . 25.5 p -81.97 172.31 13.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.305 0.553 . . . . 0.0 110.272 168.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -41.26 -47.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.698 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -35.22 77.89 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -67.88 -45.19 75.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 125.363 1.465 . . . . 0.0 108.573 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.792 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.25 -30.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 172.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.71 -52.6 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 116.359 -1.781 . . . . 0.0 108.684 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -33.69 69.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 124.38 1.05 . . . . 0.0 108.964 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -54.0 14.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.497 ' HB2' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -56.84 -45.53 82.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.515 1.126 . . . . 0.0 111.899 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.7 p -64.46 -42.15 96.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.526 1.13 . . . . 0.0 108.104 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.64 35.65 1.22 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.937 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.08 7.52 3.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.517 1.532 . . . . 0.0 116.39 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -85.66 36.82 0.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 120.067 1.933 . . . . 0.0 112.064 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 101' ' ' PHE . 17.5 mt -131.22 170.24 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 120.081 1.309 . . . . 0.0 108.614 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -111.69 142.07 44.49 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -81.34 106.68 13.5 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.905 1.23 . . . . 0.0 107.943 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 125.332 1.453 . . . . 0.0 109.48 178.589 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.93 HG23 ' HB3' ' A' ' 65' ' ' TYR . 9.3 p -129.35 125.79 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.878 1.271 . . . . 0.0 109.463 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.2 29.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.8 118.63 24.19 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 74.2 Cg_endo -71.55 99.58 0.95 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 1 C-N-CA 125.43 4.086 . . . . 0.0 107.551 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 t -94.3 175.47 6.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.911 1.285 . . . . 0.0 108.77 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.54 39.42 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.282 1.033 . . . . 0.0 109.891 161.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.17 172.13 45.2 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.774 -1.204 . . . . 0.0 111.441 167.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 29.4 mtmt -94.6 39.9 1.09 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.141 2.177 . . . . 0.0 108.871 -172.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.95 148.27 38.35 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -12.46 61.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.142 2.577 . . . . 0.0 110.81 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -116.02 38.8 3.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.607 -1.308 . . . . 0.0 109.014 170.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -89.88 168.03 12.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.182 -0.949 . . . . 0.0 109.026 163.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 142.39 38.32 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.283 -0.885 . . . . 0.0 109.007 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 59.2 t -81.83 150.81 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -109.03 138.46 45.33 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.805 1.642 . . . . 0.0 110.548 -167.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -83.45 37.31 0.56 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.422 1.106 . . . . 0.0 112.034 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -172.75 85.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 119.956 -1.715 . . . . 0.0 109.334 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CD2' HD11 ' A' ' 79' ' ' LEU . 14.4 t80 -50.39 -50.77 50.71 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -0.03 30.72 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.396 -0.815 . . . . 0.0 112.071 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.02 38.61 3.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.876 1.271 . . . . 0.0 109.839 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . . . -118.59 142.25 47.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -173.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -91.79 -20.64 21.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -158.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.554 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 96.5 m-85 -146.47 124.95 12.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.38 107.85 18.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.8 mm -81.88 114.96 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.554 HD11 ' CD2' ' A' ' 58' ' ' LEU . 78.6 mt -110.61 106.89 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.646 ' HB3' HG12 ' A' ' 4' ' ' VAL . 5.1 t80 -88.1 116.6 26.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.47 101.25 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.779 2.032 . . . . 0.0 108.079 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.555 HG22 ' CD2' ' A' ' 30' ' ' TYR . 5.3 p -86.6 22.51 1.88 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.559 1.171 . . . . 0.0 111.227 -171.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.47 -89.84 0.4 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 167.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.95 37.4 0.84 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.063 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.36 24.04 9.91 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.754 2.121 . . . . 0.0 114.437 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -82.66 154.3 24.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -138.92 136.88 42.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.443 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.8 pt-20 -122.96 163.2 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.312 1.045 . . . . 0.0 110.446 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.94 104.31 15.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.173 1.389 . . . . 0.0 108.209 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 t -79.25 151.75 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -120.17 123.56 43.61 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 129.597 3.159 . . . . 0.0 104.427 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 CA--C 1.513 -0.458 0 CA-C-N 118.991 0.814 . . . . 0.0 109.289 -177.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 CA-C-O 117.935 -0.944 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 63.66 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 126.597 1.959 . . . . 0.0 109.217 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -56.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 126.028 1.731 . . . . 0.0 111.675 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.11 -34.98 72.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.107 -171.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -16.38 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.535 1.516 . . . . 0.0 113.727 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -98.11 -46.2 5.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 120.283 1.401 . . . . 0.0 109.971 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.554 ' CD2' HD11 ' A' ' 29' ' ' ILE . 88.5 mt -68.88 -37.93 79.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.967 0.507 . . . . 0.0 112.012 -173.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.48 -50.52 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 123.85 0.86 . . . . 0.0 108.845 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.3 m -74.89 13.13 0.7 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 4.9 mttt -127.66 37.56 4.19 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.356 1.463 . . . . 0.0 108.707 163.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 38.57 39.3 0.79 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.831 1.682 . . . . 0.0 114.523 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 77.5 t -81.69 87.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.484 1.513 . . . . 0.0 108.402 -172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -91.09 35.62 0.91 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.555 1.071 . . . . 0.0 111.851 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.93 ' HB3' HG23 ' A' ' 4' ' ' VAL . 25.5 m-85 -164.63 162.45 21.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.797 -1.815 . . . . 0.0 108.595 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tp -160.15 153.22 21.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.742 HG21 ' HB1' ' A' ' 97' ' ' ALA . 79.1 mt -125.81 98.59 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.263 1.425 . . . . 0.0 107.707 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.62 133.33 16.84 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 120.205 1.366 . . . . 0.0 111.412 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.4 p -74.39 -18.4 60.67 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.42 -169.86 0.87 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.063 1.745 . . . . 0.0 108.292 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.66 140.37 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 120.376 -1.453 . . . . 0.0 108.764 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -46.29 -54.89 8.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.459 1.504 . . . . 0.0 110.526 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 172.12 152.92 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.541 2.736 . . . . 0.0 106.464 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 -144.91 0.5 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.378 1.871 . . . . 0.0 109.923 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.42 -30.9 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 129.565 3.146 . . . . 0.0 116.117 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.686 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 59.0 t80 -57.92 -40.94 81.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.245 2.218 . . . . 0.0 111.653 -169.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.75 -41.11 83.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.599 1.159 . . . . 0.0 110.099 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -69.06 -19.59 64.09 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.252 -0.905 . . . . 0.0 110.575 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 76' ' ' PHE . 71.0 mt -72.4 -61.33 1.84 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.351 0.978 . . . . 0.0 109.411 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.686 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -58.33 -35.89 72.57 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.769 -1.207 . . . . 0.0 112.473 176.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.12 -7.54 9.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.69 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.61 36.5 4.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 121.211 1.823 . . . . 0.0 110.733 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.16 5.91 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.111 1.815 . . . . 0.0 115.48 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.24 116.31 27.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 118.486 1.143 . . . . 0.0 109.626 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -79.8 94.62 5.82 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.12 128.78 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -103.78 160.65 14.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.415 1.886 . . . . 0.0 108.895 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -79.0 161.23 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 164.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.484 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -138.28 165.12 27.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 155.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -150.24 39.47 0.75 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 121.008 1.731 . . . . 0.0 113.189 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.25 102.69 1.71 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 121.231 -0.918 . . . . 0.0 112.207 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.07 163.14 26.99 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 111.68 -168.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.4 p -84.41 173.64 10.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.118 0.567 . . . . 0.0 109.95 165.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -48.61 -40.21 11.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.321 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -63.07 -33.53 75.64 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -71.77 -37.57 70.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.556 1.542 . . . . 0.0 109.897 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.742 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.03 -43.55 19.76 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.092 0.86 . . . . 0.0 110.548 168.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -81.14 -55.6 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 C-N-CA 125.329 1.452 . . . . 0.0 108.356 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.28 -31.23 65.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.109 1.764 . . . . 0.0 108.603 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.04 -52.54 7.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.939 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -51.77 -45.1 63.63 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.168 0.895 . . . . 0.0 111.14 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -65.95 -44.78 84.01 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.013 0.925 . . . . 0.0 110.16 -168.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.94 37.18 1.33 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.584 0.707 . . . . 0.0 109.18 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 41.89 44.16 4.46 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 127.93 2.681 . . . . 0.0 113.096 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -106.14 37.26 2.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.085 0.954 . . . . 0.0 110.485 169.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 89' ' ' PHE . 45.2 mt -138.75 172.73 12.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.198 0.908 . . . . 0.0 109.454 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.38 146.95 37.42 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.002 1.321 . . . . 0.0 108.498 -168.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -81.26 99.1 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.424 1.107 . . . . 0.0 108.474 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.5 -0.975 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.677 HG12 ' HB3' ' A' ' 30' ' ' TYR . 2.3 p -97.62 151.03 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.606 1.191 . . . . 0.0 108.235 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.67 136.79 52.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 166.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.55 HD11 HG13 ' A' ' 4' ' ' VAL . 3.5 mp -122.95 118.32 28.23 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.0 115.35 4.23 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 124.507 3.471 . . . . 0.0 107.573 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -118.16 151.87 36.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.233 1.413 . . . . 0.0 107.467 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.49 41.55 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.32 176.96 48.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -119.83 57.73 0.91 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.123 1.769 . . . . 0.0 108.202 -169.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.15 154.17 39.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.223 1.809 . . . . 0.0 106.431 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.717 1.207 . . . . 0.0 110.253 172.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -123.48 37.36 4.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 119.983 -1.698 . . . . 0.0 110.753 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.9 m -82.17 172.25 13.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.387 160.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.06 136.59 37.21 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.201 -0.937 . . . . 0.0 109.559 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 93' ' ' THR . 43.3 t -72.32 159.09 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -115.7 149.91 37.64 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.919 0.888 . . . . 0.0 111.447 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.3 37.81 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.453 1.101 . . . . 0.0 111.065 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.71 101.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.564 -1.335 . . . . 0.0 108.988 -162.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.488 ' HB3' HG23 ' A' ' 71' ' ' VAL . 31.4 t80 -53.39 -62.29 1.75 Allowed 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 123.36 0.412 . . . . 0.0 111.068 170.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 -3.5 29.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -118.78 38.94 3.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 109.495 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.38 115.31 28.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.188 -164.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -69.85 -23.8 63.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -166.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.08 156.9 47.31 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 106.855 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -132.19 112.72 12.52 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 124.107 0.963 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.448 HG13 HG11 ' A' ' 94' ' ' VAL . 8.4 mm -79.78 120.19 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 169.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.38 117.08 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.677 ' HB3' HG12 ' A' ' 4' ' ' VAL . 33.1 t80 -103.0 126.0 49.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.151 1.38 . . . . 0.0 110.182 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 115.03 27.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.842 2.057 . . . . 0.0 110.173 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -76.0 23.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.86 -6.02 2.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.25 36.46 0.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 158.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 34.88 34.54 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 C-N-CA 127.092 2.282 . . . . 0.0 113.327 -170.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -88.29 154.64 20.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -168.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.51 137.34 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 123.412 0.685 . . . . 0.0 110.872 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -109.86 154.28 23.25 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.174 2.19 . . . . 0.0 108.371 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.37 112.04 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 158.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.05 137.48 21.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 157.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.98 135.73 33.9 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 161.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.521 -0.143 0 CA-C-N 119.002 0.819 . . . . 0.0 110.159 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 CA-C-O 117.396 -1.168 . . . . 0.0 112.757 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.1 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.851 2.06 . . . . 0.0 111.231 -167.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.59 -54.44 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.928 1.691 . . . . 0.0 110.055 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.45 -52.83 42.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 116.521 -1.704 . . . . 0.0 109.624 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -53.47 -33.35 53.91 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.351 1.432 . . . . 0.0 111.418 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -68.04 -67.43 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 120.93 -1.106 . . . . 0.0 112.594 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.35 -38.58 80.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.794 0.838 . . . . 0.0 111.08 -166.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.8 t -54.77 -36.52 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.729 1.611 . . . . 0.0 111.518 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 t -67.66 -13.43 62.08 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.649 -1.282 . . . . 0.0 112.91 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.03 37.09 2.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.832 1.196 . . . . 0.0 109.957 172.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.8 26.76 41.35 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.964 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.7 t -73.05 97.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 118.256 1.028 . . . . 0.0 109.014 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -104.61 35.27 2.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.033 0.921 . . . . 0.0 111.597 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.551 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -174.74 151.5 1.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.447 -1.408 . . . . 0.0 108.363 -162.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 68' ' ' ALA . 13.1 tp -159.29 154.64 25.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.717 1.207 . . . . 0.0 108.706 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.764 HG21 ' HB1' ' A' ' 97' ' ' ALA . 48.3 mt -127.02 104.06 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -163.25 105.81 1.01 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.957 0.903 . . . . 0.0 109.203 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -13.46 25.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -156.34 -177.72 6.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 119.683 1.129 . . . . 0.0 108.806 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 21' ' ' PHE 0.256 4.1 p -133.16 166.14 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.18 60.2 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 168.37 -88.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 130.799 3.64 . . . . 0.0 106.52 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.75 139.32 58.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 153.31 -30.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 130.688 3.595 . . . . 0.0 109.838 160.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.592 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 60.7 t80 -52.74 -42.5 64.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.433 1.893 . . . . 0.0 111.434 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -69.45 -35.68 75.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.403 1.481 . . . . 0.0 109.408 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -22.36 58.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 110.276 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 21' ' ' PHE . 73.1 mt -68.85 -64.14 0.92 Allowed 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.95 -39.87 20.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.43 1.092 . . . . 0.0 111.892 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.64 37.16 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.979 0.912 . . . . 0.0 111.247 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.14 30.37 1.83 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.037 1.78 . . . . 0.0 116.742 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.49 126.53 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.68 1.24 . . . . 0.0 108.123 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.23 159.91 27.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.412 HG13 HD23 ' A' ' 66' ' ' LEU . 22.0 t -147.37 133.52 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -116.73 162.89 16.97 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.033 1.733 . . . . 0.0 110.14 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -79.74 153.42 29.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.264 2.226 . . . . 0.0 108.051 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.9 129.66 15.16 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.861 2.064 . . . . 0.0 106.303 164.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.68 39.38 3.94 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 123.472 2.851 . . . . 0.0 111.615 -165.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.74 131.91 4.03 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.322 1.915 . . . . 0.0 110.415 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.6 163.48 11.85 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.075 0.937 . . . . 0.0 113.035 -164.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.495 ' C ' HG23 ' A' ' 17' ' ' VAL . 23.4 p -87.89 170.02 11.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.489 1.516 . . . . 0.0 110.39 166.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 HG13 ' A' ' 28' ' ' ILE . 43.6 t -44.0 -47.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-N 119.338 0.972 . . . . 0.0 110.022 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -56.73 -38.01 71.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.47 -46.39 76.54 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.707 1.603 . . . . 0.0 108.722 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -50.76 -30.13 13.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.449 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.4 mm -93.5 -51.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 C-N-CA 124.596 1.158 . . . . 0.0 107.912 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.64 -42.46 78.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.32 -49.03 63.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.623 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.55 78.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 111.563 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.3 p -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.56 1.144 . . . . 0.0 109.499 -170.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.6 36.59 2.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.402 1.081 . . . . 0.0 108.617 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.72 11.92 0.19 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.642 2.068 . . . . 0.0 116.666 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -85.35 36.05 0.62 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.177 1.988 . . . . 0.0 111.061 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.8 mt -139.72 175.53 9.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -114.61 159.84 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -78.91 137.46 37.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 161.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 N--CA 1.453 -0.277 0 C-N-CA 125.013 1.325 . . . . 0.0 108.16 173.654 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm105 . . . . . 0 CA--C 1.507 -0.708 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.71 136.27 30.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.18 95.68 5.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 0.947 . . . . 0.0 108.81 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -83.96 132.07 49.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -170.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.63 136.5 23.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 1 C-N-CA 125.586 4.191 . . . . 0.0 109.676 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.0 t -138.05 166.08 25.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.261 1.424 . . . . 0.0 108.077 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.63 39.15 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.127 0.971 . . . . 0.0 109.532 163.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.14 167.17 40.31 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 164.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 8.7 mtmp? -92.95 42.42 1.1 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.543 1.537 . . . . 0.0 109.106 -175.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.83 149.94 32.17 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.522 0.729 . . . . 0.0 109.399 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -73.0 -12.0 60.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.216 1.807 . . . . 0.0 112.058 -174.041 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -114.12 35.8 3.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.828 -1.17 . . . . 0.0 111.625 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 m -86.26 169.63 12.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 171.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.48 134.22 37.35 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 65.5 t -78.86 130.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 122.452 1.12 . . . . 0.0 108.589 172.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -79.94 153.9 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.159 1.783 . . . . 0.0 109.499 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.94 37.14 1.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.645 1.112 . . . . 0.0 110.775 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -167.53 99.38 0.49 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 119.168 -2.208 . . . . 0.0 110.23 -166.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.474 ' CD2' HD11 ' A' ' 79' ' ' LEU . 3.1 t80 -49.27 -64.69 0.73 Allowed 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.253 0.933 . . . . 0.0 111.34 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.84 24.31 1.29 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.77 -170.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 39.42 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 167.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.71 132.8 56.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.29 -26.22 46.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -162.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' HG3' ' A' ' 11' ' ' LYS . 97.9 m-85 -135.36 148.21 49.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -125.92 125.37 42.66 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.535 HD12 HG22 ' A' ' 39' ' ' VAL . 19.3 mm -112.59 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -92.84 97.9 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 4' ' ' VAL . 38.8 t80 -81.77 117.95 22.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.89 118.35 22.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.711 2.004 . . . . 0.0 109.892 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.7 p -90.26 28.16 1.5 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.761 1.164 . . . . 0.0 111.802 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -99.67 -87.05 0.37 Allowed 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 155.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -94.78 35.42 1.25 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.339 -156.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 28.09 38.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.192 1.377 . . . . 0.0 113.933 -163.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -68.79 155.51 40.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.2 170.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.66 140.7 17.36 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG22 HD12 ' A' ' 28' ' ' ILE . 70.6 t -112.63 107.98 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.83 145.57 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -109.41 133.9 52.5 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 128.599 2.759 . . . . 0.0 104.446 166.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.462 0.153 0 C-N-CA 123.88 0.872 . . . . 0.0 109.009 -177.485 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 57.2 Cg_endo . . . . . 0 CA--C 1.503 -1.044 0 CA-C-O 117.29 -1.213 . . . . 0.0 113.852 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 66.15 -68.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -61.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.161 1.385 . . . . 0.0 108.566 170.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.2 t -57.54 -45.51 86.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-O 116.006 -1.949 . . . . 0.0 109.131 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -45.2 -53.56 8.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.247 1.385 . . . . 0.0 111.662 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -67.05 -44.85 79.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.78 -41.46 87.62 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.22 -0.925 . . . . 0.0 110.148 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.07 -34.03 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.84 1.656 . . . . 0.0 110.361 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -66.8 -16.24 64.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.371 0.987 . . . . 0.0 113.536 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -104.35 37.44 2.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.558 1.072 . . . . 0.0 109.634 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.13 34.12 3.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.006 1.289 . . . . 0.0 114.074 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.1 106.42 5.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 118.936 1.368 . . . . 0.0 107.525 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -108.27 35.23 3.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.587 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -168.58 151.83 5.45 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.326 -1.484 . . . . 0.0 108.406 -163.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 68' ' ' ALA . 22.3 tp -166.26 145.0 5.72 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.245 -1.534 . . . . 0.0 109.064 -169.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.775 HG21 ' HB1' ' A' ' 97' ' ' ALA . 41.9 mt -125.23 100.06 6.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -161.54 94.52 0.97 Allowed 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.315 0.961 . . . . 0.0 110.835 -167.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.5 p -29.6 -32.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.733 3.213 . . . . 0.0 119.462 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -162.63 -174.73 4.11 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.845 2.058 . . . . 0.0 105.816 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.38 156.62 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 120.735 -1.228 . . . . 0.0 109.304 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.02 66.15 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.697 1.142 . . . . 0.0 113.253 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 144.0 -105.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 1 C-N-CA 135.865 5.666 . . . . 0.0 107.019 169.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -57.13 119.01 5.61 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.881 -1.137 . . . . 0.0 109.846 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.88 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 130.89 3.676 . . . . 0.0 110.907 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.511 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 28.4 t80 -54.65 -36.1 64.22 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.231 0.923 . . . . 0.0 111.558 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.55 -30.74 71.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.61 1.964 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -92.96 -14.78 27.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.583 1.553 . . . . 0.0 111.002 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.474 HD11 ' CD2' ' A' ' 21' ' ' PHE . 60.0 mt -66.93 -68.05 0.4 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 167.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -52.25 -30.67 28.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.32 -30.62 12.46 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.05 36.9 3.15 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.927 1.291 . . . . 0.0 111.059 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.64 15.85 54.57 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.098 1.199 . . . . 0.0 116.098 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.93 123.35 36.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 118.314 1.057 . . . . 0.0 110.782 -158.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -78.9 156.79 28.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.456 HG13 HD23 ' A' ' 66' ' ' LEU . 18.5 t -149.29 138.31 15.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -122.25 155.45 35.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.76 0.824 . . . . 0.0 111.544 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -79.22 149.24 31.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 162.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.73 167.97 16.5 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -142.73 116.35 9.18 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.915 -1.115 . . . . 0.0 110.187 160.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.03 90.3 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 125.577 1.56 . . . . 0.0 113.654 162.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 165.72 37.98 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.2 p -81.81 178.39 8.34 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.977 -0.719 . . . . 0.0 110.698 167.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.03 -44.93 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.121 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -60.76 -37.27 81.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 120.972 1.715 . . . . 0.0 114.626 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.86 -40.7 83.61 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.592 1.557 . . . . 0.0 108.264 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.775 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.74 -35.53 14.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.397 0.544 . . . . 0.0 111.983 168.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.7 -53.25 9.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 125.131 1.372 . . . . 0.0 109.376 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -28.21 68.87 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.801 2.04 . . . . 0.0 108.69 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.68 -58.01 3.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.624 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.9 t80 -54.74 -50.74 67.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.569 0.747 . . . . 0.0 112.451 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 p -63.1 -44.72 94.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.896 0.879 . . . . 0.0 108.904 -168.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.63 37.4 0.91 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.875 0.845 . . . . 0.0 109.014 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.98 17.05 8.78 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 128.073 2.749 . . . . 0.0 116.501 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -89.65 36.62 0.85 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.72 2.26 . . . . 0.0 112.769 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 101' ' ' PHE . 19.1 mt -137.32 166.8 22.93 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.985 1.721 . . . . 0.0 110.339 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.21 147.7 24.34 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -93.24 82.4 4.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.986 0.898 . . . . 0.0 109.558 -169.588 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.873 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -121.29 124.81 72.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -169.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.9 137.97 39.48 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.498 HD11 HG13 ' A' ' 4' ' ' VAL . 4.8 mp -123.25 116.66 28.38 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 74.1 Cg_endo -67.57 112.53 2.65 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 125.074 3.849 . . . . 0.0 106.877 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -113.99 167.52 10.59 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.561 1.944 . . . . 0.0 107.447 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.13 38.36 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.569 -0.707 . . . . 0.0 109.654 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 166.94 39.84 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 120.99 -1.069 . . . . 0.0 110.958 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -89.22 39.44 0.94 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 122.151 -0.617 . . . . 0.0 110.712 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.02 153.42 50.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.609 1.164 . . . . 0.0 109.277 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.74 -15.89 55.3 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.486 1.914 . . . . 0.0 109.745 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 38.9 2.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.285 1.434 . . . . 0.0 108.229 170.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -83.88 173.17 11.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 119.822 -1.799 . . . . 0.0 107.991 164.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.39 140.65 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.582 -1.324 . . . . 0.0 109.553 166.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.7 t -73.37 149.93 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 167.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -102.57 136.52 42.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.82 1.648 . . . . 0.0 108.59 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -81.5 37.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.409 1.1 . . . . 0.0 111.082 -172.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 110.28 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -162.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -64.17 -56.45 14.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.677 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.34 0.02 9.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -134.93 76.61 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.487 1.915 . . . . 0.0 107.192 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.761 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -122.48 166.56 14.58 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 160.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 14.6 mt-10 -106.68 -16.89 14.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -144.76 153.86 42.12 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.761 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 70.4 m-85 -131.53 98.4 4.5 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.145 1.778 . . . . 0.0 107.51 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.406 HG22 ' CG1' ' A' ' 37' ' ' VAL . 2.2 mm -79.43 103.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -176.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 58' ' ' LEU . 55.9 mt -89.27 103.87 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.507 ' HB3' HG12 ' A' ' 4' ' ' VAL . 50.4 t80 -85.06 146.17 27.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.51 114.42 21.74 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 127.172 2.189 . . . . 0.0 111.09 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.9 p -78.86 13.82 1.58 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -99.89 -32.94 10.75 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.348 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.93 36.49 1.41 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.033 160.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.57 33.62 26.17 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.257 0.932 . . . . 0.0 111.784 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -81.88 157.79 24.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.128 1.771 . . . . 0.0 107.091 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.406 ' CG1' HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -138.48 150.33 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.867 0.842 . . . . 0.0 110.052 177.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.97 141.73 51.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.011 1.325 . . . . 0.0 108.845 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.87 110.26 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 163.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.37 150.31 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 160.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.88 117.01 27.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.213 -0.817 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -168.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.448 -1.153 0 CA-C-O 118.102 -0.874 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 -66.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.791 2.437 . . . . 0.0 114.99 -170.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -57.65 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.456 1.502 . . . . 0.0 107.99 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -41.93 79.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 115.747 -2.073 . . . . 0.0 110.922 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -40.56 61.76 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.879 1.672 . . . . 0.0 111.499 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -75.61 -50.78 14.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.084 1.354 . . . . 0.0 109.787 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' A' ' 29' ' ' ILE . 87.3 mt -58.5 -43.62 89.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.928 0.891 . . . . 0.0 110.102 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.74 -51.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.897 1.679 . . . . 0.0 110.756 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.3 t -62.15 -25.91 68.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -92.15 37.59 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.44 -1.412 . . . . 0.0 110.331 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.11 6.32 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 127.518 2.485 . . . . 0.0 115.779 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.68 137.81 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.189 1.495 . . . . 0.0 109.272 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.38 35.01 2.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 110.955 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.873 ' HB3' HG23 ' A' ' 4' ' ' VAL . 10.5 m-85 179.89 164.5 1.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 119.634 -1.916 . . . . 0.0 107.209 -170.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 68' ' ' ALA . 12.0 tp -171.2 147.42 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.72 HG21 ' HB1' ' A' ' 97' ' ' ALA . 62.9 mt -123.85 101.14 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -155.31 115.48 3.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.418 1.008 . . . . 0.0 110.639 -166.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.8 p -59.43 -23.89 63.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -171.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.01 174.09 9.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -170.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -120.06 157.66 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.492 -1.38 . . . . 0.0 108.428 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.7 67.62 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 169.75 -154.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 131.409 3.884 . . . . 0.0 105.657 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -24.75 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.18 2.992 . . . . 0.0 114.355 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -170.99 -29.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.412 1.485 . . . . 0.0 113.97 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.632 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 82.3 t80 -58.68 -36.08 73.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.49 1.116 . . . . 0.0 112.51 -169.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.16 -41.03 74.34 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -23.77 67.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.84 -0.537 . . . . 0.0 111.039 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.34 -68.16 0.41 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.857 0.863 . . . . 0.0 108.968 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.632 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -58.33 -31.38 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.82 24.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.096 0.558 . . . . 0.0 110.445 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.7 36.86 1.83 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.386 0.674 . . . . 0.0 111.828 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.25 8.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.416 1.484 . . . . 0.0 116.333 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.86 120.26 33.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.191 1.495 . . . . 0.0 108.98 -170.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -78.43 160.79 27.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.8 t -143.42 137.34 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.57 158.19 25.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.022 1.729 . . . . 0.0 110.112 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -78.95 148.24 32.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.525 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -138.12 161.12 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 156.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -148.94 85.38 1.48 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 120.268 1.395 . . . . 0.0 111.154 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.9 112.47 0.59 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.454 1.026 . . . . 0.0 111.063 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.92 158.3 10.76 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -83.08 171.76 13.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 110.397 170.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.15 -40.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-O 116.747 -1.597 . . . . 0.0 113.138 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -35.26 76.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 121.012 1.733 . . . . 0.0 113.626 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.83 -46.25 69.04 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.75 2.02 . . . . 0.0 108.355 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.72 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.41 -40.45 17.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 118.699 0.681 . . . . 0.0 111.144 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.65 -51.04 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.39 1.876 . . . . 0.0 108.886 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -40.05 85.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.382 1.473 . . . . 0.0 108.237 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.66 -49.48 25.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.79 0.836 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.78 -50.45 73.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.477 1.035 . . . . 0.0 111.787 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -64.18 -39.05 93.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.384 1.074 . . . . 0.0 110.163 -168.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -101.42 37.34 1.81 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.975 0.91 . . . . 0.0 109.435 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 40.22 46.06 3.3 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 127.497 2.475 . . . . 0.0 114.113 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -112.49 37.35 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.901 0.88 . . . . 0.0 109.854 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 89' ' ' PHE . 74.3 mt -143.39 170.09 16.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.994 -1.067 . . . . 0.0 108.547 165.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -119.11 147.64 43.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.641 1.576 . . . . 0.0 108.075 -165.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -78.99 116.84 19.55 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 C--O 1.232 0.147 0 C-N-CA 126.727 2.011 . . . . 0.0 108.362 -178.527 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 . . . . . 0 CA--C 1.51 -0.583 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -105.96 124.64 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.284 -172.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.45 111.38 23.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.98 124.55 51.68 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 60.8 Cg_endo -77.55 112.0 3.25 Favored 'Trans proline' 0 N--CA 1.443 -1.448 1 C-N-CA 125.464 4.109 . . . . 0.0 108.528 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 t -108.66 174.8 5.71 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.192 1.397 . . . . 0.0 108.498 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.82 38.49 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 109.655 167.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.78 -170.14 32.18 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -129.48 64.8 1.48 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.593 1.696 . . . . 0.0 110.195 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.62 153.99 29.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.082 1.753 . . . . 0.0 107.949 169.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -65.94 -12.07 52.14 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.737 1.215 . . . . 0.0 110.521 174.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -110.58 36.44 3.1 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.589 -1.319 . . . . 0.0 111.435 172.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 166.73 11.77 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.053 -1.03 . . . . 0.0 109.771 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 135.14 37.35 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.302 -1.499 . . . . 0.0 109.81 -172.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.599 HG21 ' HB2' ' A' ' 97' ' ' ALA . 45.7 t -78.02 131.11 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 t -81.07 144.16 31.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.614 1.566 . . . . 0.0 109.76 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -86.41 36.71 0.7 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.444 1.593 . . . . 0.0 110.739 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.61 121.54 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -166.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.65 -61.25 1.84 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . . . -66.41 -23.6 66.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.832 -168.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -105.04 75.56 1.19 Allowed 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 127.673 2.389 . . . . 0.0 107.753 166.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -133.19 160.26 37.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 157.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -105.96 -12.63 15.75 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -168.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -146.22 145.86 30.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.35 108.25 9.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.4 mp -89.62 117.71 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -171.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.507 HD11 ' CD2' ' A' ' 58' ' ' LEU . 42.5 mt -105.24 97.29 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 -175.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HG12 ' A' ' 4' ' ' VAL . 71.9 t80 -91.25 109.08 20.34 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.77 110.22 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.463 1.505 . . . . 0.0 108.962 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -78.02 55.03 1.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.558 -0.714 . . . . 0.0 110.016 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -134.21 -39.86 0.83 Allowed 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 124.814 1.246 . . . . 0.0 111.374 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -144.37 37.33 1.23 Allowed 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.601 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 16.29 2.24 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.609 1.576 . . . . 0.0 115.294 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -82.22 134.03 35.28 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.305 1.053 . . . . 0.0 108.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.64 160.51 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 125.261 1.424 . . . . 0.0 108.817 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.17 132.86 27.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.87 110.55 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.12 152.07 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 160.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -124.44 96.04 4.76 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.96 2.504 . . . . 0.0 105.935 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.457 -0.635 0 CA-C-O 119.007 -0.497 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.46 -77.38 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.513 2.325 . . . . 0.0 110.87 -165.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -49.66 -60.52 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 C-N-CA 126.317 1.847 . . . . 0.0 109.334 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.3 t -60.04 -51.2 75.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 115.743 -2.075 . . . . 0.0 109.708 -173.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.82 -51.31 9.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.914 1.688 . . . . 0.0 110.949 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -62.41 -56.05 21.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 29' ' ' ILE . 93.0 mt -62.67 -41.9 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.301 0.64 . . . . 0.0 110.262 -172.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -57.44 -46.62 85.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -58.37 -27.64 64.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.146 0.884 . . . . 0.0 112.415 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -99.74 37.4 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.665 1.186 . . . . 0.0 109.471 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.11 23.42 7.75 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.292 2.377 . . . . 0.0 116.69 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.64 125.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.535 1.168 . . . . 0.0 108.053 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.19 36.59 4.61 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 164.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.559 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -165.74 157.46 14.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.485 -1.385 . . . . 0.0 109.112 -168.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 86' ' ' VAL . 12.1 tp -164.08 148.34 10.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -173.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.699 HG21 ' HB1' ' A' ' 97' ' ' ALA . 28.2 mt -124.58 106.77 17.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -156.77 134.44 10.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.999 2.182 . . . . 0.0 111.184 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -64.08 -21.16 66.41 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.602 -1.311 . . . . 0.0 113.641 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -163.21 177.45 9.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.07 1.748 . . . . 0.0 106.432 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 73' ' ' ARG 0.251 1.0 OUTLIER -107.35 161.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.055 -1.028 . . . . 0.0 108.561 174.847 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 22' ' ' ALA . . . -80.29 24.77 3.42 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.683 1.135 . . . . 0.0 111.63 171.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.486 ' H ' HG13 ' A' ' 71' ' ' VAL . 1.2 ttt-85 68.05 -71.09 0.11 Allowed 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 129.684 3.194 . . . . 0.0 113.257 -172.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.29 56.37 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.448 2.299 . . . . 0.0 113.833 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . . . -161.62 -28.64 0.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 113.95 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 79' ' ' LEU . 56.6 t80 -69.39 -32.59 71.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.897 1.68 . . . . 0.0 111.986 -169.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.21 -38.13 85.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 110.073 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -14.83 58.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.928 2.891 . . . . 0.0 109.366 -174.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 76' ' ' PHE . 31.9 mt -80.86 -58.13 3.23 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 108.221 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.642 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -62.6 -28.37 69.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.299 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.0 54.82 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.034 0.834 . . . . 0.0 111.876 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.9 37.31 4.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.617 1.099 . . . . 0.0 110.765 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.39 30.53 0.3 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.686 2.088 . . . . 0.0 117.041 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.78 125.2 38.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 118.87 1.335 . . . . 0.0 109.048 -169.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -78.96 155.99 28.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.453 HG13 HD23 ' A' ' 66' ' ' LEU . 43.6 t -145.69 129.47 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.24 170.6 7.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 110.655 171.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -107.58 152.02 24.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 126.898 2.079 . . . . 0.0 109.586 162.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.18 167.9 21.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.199 2.2 . . . . 0.0 106.425 176.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.93 129.17 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 167.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.04 90.5 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 128.04 2.733 . . . . 0.0 115.784 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.96 163.77 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -89.86 173.83 8.03 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.979 -0.719 . . . . 0.0 109.894 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.74 -42.83 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 117.731 -1.128 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -61.55 -36.9 81.9 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.55 -40.64 73.27 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.961 1.304 . . . . 0.0 109.08 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.75 -39.76 26.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.457 170.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -78.91 -60.43 2.27 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.91 -21.39 43.32 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 127.955 2.502 . . . . 0.0 110.919 -172.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.32 -52.69 6.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.585 ' HB2' HD12 ' A' ' 106' ' ' LEU . 19.4 t80 -59.51 -50.14 75.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.688 0.795 . . . . 0.0 112.732 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -64.07 -41.87 97.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 109.32 -168.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.38 36.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.293 1.037 . . . . 0.0 109.27 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.06 20.36 6.47 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 128.621 3.01 . . . . 0.0 117.244 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -97.1 37.41 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.538 1.669 . . . . 0.0 111.335 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 101' ' ' PHE . 27.0 mt -134.97 169.7 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.569 1.077 . . . . 0.0 109.062 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -108.64 138.74 44.46 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.354 1.462 . . . . 0.0 108.138 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.7 108.26 13.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--O 1.238 0.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -178.005 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 . . . . . 0 CA--C 1.503 -0.861 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.835 HG23 ' HB3' ' A' ' 65' ' ' TYR . 3.1 p -125.64 167.83 19.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 128.499 2.72 . . . . 0.0 103.756 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.42 149.45 52.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.52 120.01 19.59 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.57 123.67 11.07 Favored 'Trans proline' 0 N--CA 1.443 -1.492 1 C-N-CA 126.097 4.531 . . . . 0.0 107.135 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.3 t -127.44 169.16 13.93 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.825 1.65 . . . . 0.0 108.356 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.09 37.77 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 110.298 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.79 -177.85 41.03 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.224 -1.548 . . . . 0.0 111.008 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.4 mtpt -114.53 39.89 2.69 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.262 -1.14 . . . . 0.0 109.943 -172.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.33 148.44 36.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.919 1.288 . . . . 0.0 108.065 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -60.81 -10.5 5.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 112.574 173.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -112.69 36.6 3.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.277 -0.89 . . . . 0.0 111.396 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -90.2 167.97 12.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.041 -1.037 . . . . 0.0 108.967 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 139.8 39.16 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 120.865 1.666 . . . . 0.0 108.668 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 99.0 t -72.67 135.97 26.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -87.71 135.71 33.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.58 38.13 0.37 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.098 0.952 . . . . 0.0 110.903 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.93 99.05 0.07 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 119.86 -1.775 . . . . 0.0 110.174 -165.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 79' ' ' LEU . 18.9 t80 -53.49 -51.65 62.07 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.785 1.175 . . . . 0.0 112.957 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -3.66 33.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.002 -1.062 . . . . 0.0 112.401 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 38.79 3.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.549 0.74 . . . . 0.0 109.886 -171.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.77 108.94 16.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -165.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -52.64 -24.45 8.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.254 1.822 . . . . 0.0 115.272 -168.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 96.2 m-85 -139.19 151.26 46.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -129.61 112.79 14.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.1 mm -91.82 118.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.528 HD11 ' CD2' ' A' ' 58' ' ' LEU . 96.2 mt -111.97 100.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -172.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -82.77 141.7 32.15 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -117.87 110.82 18.23 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 127.197 2.199 . . . . 0.0 109.692 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.282 1.3 p -85.08 43.04 0.97 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.947 0.88 . . . . 0.0 110.699 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.94 -29.45 2.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 126.019 1.728 . . . . 0.0 112.604 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -147.58 35.25 0.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 117.728 -1.589 . . . . 0.0 111.069 157.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.2 24.12 14.59 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.804 -1.185 . . . . 0.0 112.31 -176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -64.75 156.24 31.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.74 162.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.533 1.158 . . . . 0.0 108.842 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -141.77 128.01 19.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.22 105.01 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.56 143.13 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 159.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.95 121.41 43.84 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 122.984 1.373 . . . . 0.0 110.221 -172.105 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.45 -1.034 0 CA-C-O 118.938 -0.526 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? 65.17 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.351 1.46 . . . . 0.0 108.674 -166.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -67.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 127.135 2.174 . . . . 0.0 108.985 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.2 t -55.81 -49.96 71.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 115.669 -2.11 . . . . 0.0 109.651 -173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.46 -50.37 23.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.306 1.412 . . . . 0.0 111.117 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -42.16 68.52 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.107 -0.996 . . . . 0.0 113.342 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 29' ' ' ILE . 78.3 mt -66.5 -44.32 82.88 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.751 0.705 . . . . 0.0 109.888 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.31 -32.17 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.407 1.483 . . . . 0.0 110.118 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.6 m -75.89 1.98 13.66 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.802 -1.186 . . . . 0.0 113.879 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -119.42 38.46 3.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.452 1.901 . . . . 0.0 108.289 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.89 19.98 12.24 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.64 1.114 . . . . 0.0 115.845 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.0 96.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.131 1.373 . . . . 0.0 107.864 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.47 36.31 2.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.324 1.05 . . . . 0.0 110.568 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.835 ' HB3' HG23 ' A' ' 4' ' ' VAL . 10.8 m-85 179.83 165.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.608 1.563 . . . . 0.0 107.024 -165.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 tp -166.14 152.65 9.31 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.271 1.429 . . . . 0.0 107.449 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.773 HG21 ' HB1' ' A' ' 97' ' ' ALA . 57.3 mt -123.06 103.04 12.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.95 130.03 13.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.698 1.136 . . . . 0.0 110.342 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.7 p -62.72 -28.19 69.79 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -169.14 -171.07 1.22 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.399 1.479 . . . . 0.0 107.15 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 p -136.24 136.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.45 96.54 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.85 177.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 129.486 3.114 . . . . 0.0 107.561 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.98 50.38 3.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 127.581 2.352 . . . . 0.0 115.616 154.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.4 -26.35 0.1 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 171.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.725 ' HA ' HD12 ' A' ' 79' ' ' LEU . 33.9 t80 -62.35 -35.62 79.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.377 0.989 . . . . 0.0 112.539 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.91 -34.59 73.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.7 m -73.09 -20.05 61.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.624 0.77 . . . . 0.0 111.072 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 76' ' ' PHE . 28.1 mt -69.46 -57.61 5.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -65.2 -29.74 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.94 -1.71 1.58 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.01 37.23 2.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.87 1.668 . . . . 0.0 110.181 162.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.6 30.99 1.58 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.868 . . . . 0.0 116.804 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.37 117.58 25.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 118.937 1.368 . . . . 0.0 108.524 -168.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -79.14 99.01 6.78 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.537 0.684 . . . . 0.0 109.959 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 79' ' ' LEU . 35.9 t -82.5 117.75 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.81 155.29 18.34 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.662 1.185 . . . . 0.0 109.558 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 157.56 26.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 164.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 163.15 30.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 160.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.52 68.21 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.801 1.182 . . . . 0.0 110.508 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.62 136.23 8.58 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.05 154.1 6.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.879 0.339 . . . . 0.0 112.519 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -80.05 171.08 15.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.07 0.548 . . . . 0.0 109.653 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -43.82 -42.15 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.769 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.37 -38.74 81.23 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -42.35 83.29 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 127.144 2.178 . . . . 0.0 108.849 -174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.773 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.81 -38.98 11.01 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.819 0.736 . . . . 0.0 111.167 171.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -86.0 -53.79 9.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 125.275 1.43 . . . . 0.0 109.121 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -26.69 65.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.044 1.738 . . . . 0.0 109.375 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.11 -62.6 1.41 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.415 ' HB2' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -51.75 -48.84 63.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.59 1.556 . . . . 0.0 112.626 -178.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -77.88 -13.27 59.94 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.664 2.786 . . . . 0.0 113.482 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -114.37 37.78 3.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.245 1.384 . . . . 0.0 109.836 159.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.51 12.73 4.91 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 127.626 2.536 . . . . 0.0 117.345 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -89.31 37.39 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.254 1.527 . . . . 0.0 111.413 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 101' ' ' PHE . 26.8 mt -136.29 167.33 21.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.013 1.279 . . . . 0.0 110.821 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -108.44 142.86 38.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.44 110.88 17.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 125.96 1.704 . . . . 0.0 108.608 -176.484 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -93.07 142.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.96 153.98 18.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 160.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.01 125.64 19.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 56.5 Cg_endo -74.27 106.63 2.27 Favored 'Trans proline' 0 N--CA 1.445 -1.35 1 C-N-CA 126.131 4.554 . . . . 0.0 109.576 177.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -104.12 172.07 7.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.364 1.466 . . . . 0.0 109.408 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.29 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 108.623 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.22 -169.36 42.36 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.794 -1.191 . . . . 0.0 111.259 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 7.5 mtmp? -129.96 52.71 1.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 111.842 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.64 167.48 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.917 1.687 . . . . 0.0 107.205 166.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -81.71 -6.31 58.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.501 -1.375 . . . . 0.0 111.0 174.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -116.26 39.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.579 -1.325 . . . . 0.0 108.922 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 m -78.66 169.39 18.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.25 -1.38 . . . . 0.0 107.303 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 145.08 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.441 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 69.5 t -86.05 137.77 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.404 1.097 . . . . 0.0 108.746 170.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -90.84 137.44 32.36 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.847 2.059 . . . . 0.0 108.74 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -81.25 36.16 0.41 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 122.895 1.331 . . . . 0.0 111.035 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 101.38 0.12 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -157.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 79' ' ' LEU . 8.5 t80 -55.04 -59.41 4.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.493 0.588 . . . . 0.0 110.571 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.08 -3.74 31.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.667 -170.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.71 74.1 1.24 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.312 1.415 . . . . 0.0 107.357 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -135.99 120.65 18.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.38 -22.13 66.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.259 1.424 . . . . 0.0 113.535 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 98.4 m-85 -137.25 148.67 46.61 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.01 1.724 . . . . 0.0 107.455 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -130.59 112.82 13.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.36 120.87 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.9 mt -109.77 101.49 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' HG12 ' A' ' 4' ' ' VAL . 38.9 t80 -89.63 110.89 21.73 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.86 108.88 13.78 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.076 2.15 . . . . 0.0 108.313 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -83.31 57.96 4.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -129.57 -48.51 1.16 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 124.649 1.18 . . . . 0.0 109.128 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 38.19 3.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.736 162.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.4 22.35 10.55 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.2 0.905 . . . . 0.0 113.68 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.86 148.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.14 148.88 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.1 0.96 . . . . 0.0 109.921 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -132.52 139.32 47.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.587 2.355 . . . . 0.0 105.793 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.9 t -108.9 103.57 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.48 151.71 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 167.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.54 129.96 56.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 CA--C 1.514 -0.414 0 O-C-N 120.697 -1.252 . . . . 0.0 110.124 -174.369 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 CA-C-O 117.932 -0.945 . . . . 0.0 112.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.322 1.7 ptpt 54.19 -65.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.821 2.448 . . . . 0.0 114.339 -164.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -65.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 127.156 2.182 . . . . 0.0 108.069 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.92 -48.09 78.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-O 116.863 -1.542 . . . . 0.0 109.151 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -46.95 21.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.171 0.896 . . . . 0.0 111.678 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -69.5 -56.22 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.305 0.642 . . . . 0.0 111.082 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -57.4 -46.01 83.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.418 0.554 . . . . 0.0 109.578 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 t -56.71 -36.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.373 1.869 . . . . 0.0 111.54 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -61.18 -38.93 88.26 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.575 1.079 . . . . 0.0 110.575 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.06 38.49 0.85 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.694 1.134 . . . . 0.0 110.029 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.17 26.4 42.76 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.019 1.771 . . . . 0.0 115.578 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.1 t -71.85 101.25 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.123 1.461 . . . . 0.0 109.231 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.28 34.88 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.618 0.645 . . . . 0.0 109.995 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.496 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -168.07 157.55 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 119.989 -1.694 . . . . 0.0 108.796 -169.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.9 tp -166.36 145.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 120.232 -1.542 . . . . 0.0 108.671 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.021 HG21 ' HB1' ' A' ' 97' ' ' ALA . 7.6 mt -111.18 107.02 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 126.404 1.882 . . . . 0.0 106.222 171.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.97 106.15 1.8 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 120.998 1.726 . . . . 0.0 110.623 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.7 p -34.46 -48.8 0.37 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.153 1.781 . . . . 0.0 113.195 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.39 -178.4 6.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -114.64 160.1 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.79 -23.54 38.6 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.392 -166.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -169.43 -132.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.363 3.465 . . . . 0.0 103.437 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -164.3 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.872 1.214 . . . . 0.0 110.872 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 97.58 -26.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.208 1 C-N-CA 133.427 4.691 . . . . 0.0 112.633 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 79' ' ' LEU . 60.6 t80 -60.85 -36.5 79.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.501 1.5 . . . . 0.0 112.247 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.75 -38.25 79.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.405 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -74.0 -24.44 59.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.914 0.886 . . . . 0.0 110.018 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 76' ' ' PHE . 27.6 mt -65.69 -72.01 0.17 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -57.05 -32.73 66.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.13 17.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.688 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.39 36.6 0.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.101 0.864 . . . . 0.0 112.071 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.26 33.89 0.56 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.232 1.872 . . . . 0.0 116.238 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 t -81.06 119.39 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 152.95 31.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.5 t -150.2 112.34 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.51 172.97 9.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.229 1.411 . . . . 0.0 111.311 166.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -112.02 148.46 33.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.452 2.701 . . . . 0.0 108.767 164.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -127.31 166.34 17.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.047 2.539 . . . . 0.0 105.086 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -148.4 56.68 1.05 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.122 1.328 . . . . 0.0 110.168 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.63 110.88 3.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 123.444 0.545 . . . . 0.0 112.395 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.56 166.49 31.94 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.6 p -87.39 173.68 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.748 0.819 . . . . 0.0 110.492 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.51 -38.42 12.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 CA-C-O 117.028 -1.463 . . . . 0.0 110.959 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.05 -45.33 93.19 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 120.45 1.477 . . . . 0.0 114.002 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -42.3 97.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.192 1.797 . . . . 0.0 109.283 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 1.021 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.75 -36.1 10.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -87.4 -57.13 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.71 -49.08 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.546 2.339 . . . . 0.0 106.53 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.81 76.7 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.354 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.57 ' HB2' HD12 ' A' ' 106' ' ' LEU . 6.3 t80 -62.34 -47.66 83.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.55 -0.719 . . . . 0.0 110.78 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.4 p -70.36 -29.97 66.78 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.059 1.344 . . . . 0.0 109.688 -166.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -99.96 35.98 1.93 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.238 1.015 . . . . 0.0 110.732 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.44 53.62 2.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.45 1.5 . . . . 0.0 113.289 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -127.27 38.28 4.1 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 126.641 1.977 . . . . 0.0 109.189 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 101' ' ' PHE . 28.7 mt -132.93 167.07 20.92 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 120.899 1.681 . . . . 0.0 111.071 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.68 134.96 40.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.914 1.686 . . . . 0.0 107.863 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -91.03 101.9 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.237 0.44 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -170.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.66 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -94.03 164.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 161.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 154.49 47.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 163.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.7 120.11 13.17 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.588 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 73.7 Cg_endo -70.45 108.57 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.75 3.634 . . . . 0.0 106.887 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 t -105.59 168.87 8.81 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.544 1.537 . . . . 0.0 108.16 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.03 37.47 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.531 -0.73 . . . . 0.0 110.317 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.57 165.93 39.26 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.5 39.64 1.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.051 1.34 . . . . 0.0 110.351 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.78 148.79 36.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -14.71 62.56 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.355 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 t -122.59 37.52 4.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -104.45 170.99 7.58 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.522 -0.736 . . . . 0.0 109.82 163.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.9 mmm -77.5 137.29 38.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.983 -1.073 . . . . 0.0 111.078 -166.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 41.6 t -71.51 131.17 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.623 167.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 t -79.51 144.67 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.46 1.904 . . . . 0.0 108.599 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -85.07 36.44 0.62 Allowed 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.29 116.23 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -156.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HB3' HG23 ' A' ' 71' ' ' VAL . 30.3 t80 -63.32 -69.33 0.28 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.575 0.75 . . . . 0.0 110.706 172.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.88 10.83 1.63 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -169.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -132.98 71.34 1.47 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 159.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -110.68 179.62 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 156.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -120.68 -16.89 8.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -140.01 155.2 47.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 93.1 m-85 -133.39 108.7 8.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -86.9 127.8 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.618 HD11 ' CD2' ' A' ' 58' ' ' LEU . 94.0 mt -125.22 97.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -165.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 4' ' ' VAL . 49.7 t80 -92.53 125.64 37.26 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.758 1.223 . . . . 0.0 109.153 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 125.79 30.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.043 1.737 . . . . 0.0 111.933 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.281 3.2 p -91.58 31.86 1.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.775 0.798 . . . . 0.0 109.967 174.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.88 -90.18 0.56 Allowed 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 154.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.55 35.59 1.21 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.359 -157.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 45.63 15.15 0.09 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.127 2.298 . . . . 0.0 115.617 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -69.35 154.58 41.81 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.34 144.09 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.679 1.228 . . . . 0.0 109.581 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.99 130.5 52.68 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.19 107.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.67 146.5 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 157.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.37 150.15 27.06 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.076 1.75 . . . . 0.0 106.533 161.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 109.879 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.326 0.7 OUTLIER 54.27 -67.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.895 2.078 . . . . 0.0 111.624 -158.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -50.59 -61.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.708 1.603 . . . . 0.0 109.876 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.41 -53.9 38.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-O 115.155 -2.355 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -49.03 -47.33 44.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 121.146 1.794 . . . . 0.0 110.194 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -50.35 60.03 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.185 1.394 . . . . 0.0 112.816 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.618 ' CD2' HD11 ' A' ' 29' ' ' ILE . 94.7 mt -65.69 -39.06 90.87 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.096 0.862 . . . . 0.0 110.088 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.73 -41.47 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.965 1.306 . . . . 0.0 109.791 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.39 1.41 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -126.43 37.46 4.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.367 1.467 . . . . 0.0 107.622 171.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.76 17.16 41.31 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.709 2.1 . . . . 0.0 116.503 166.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.05 102.43 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.777 1.288 . . . . 0.0 110.873 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.12 36.43 2.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.212 1.805 . . . . 0.0 111.658 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.623 ' HB3' HG23 ' A' ' 4' ' ' VAL . 8.4 m-85 177.11 173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.745 -1.847 . . . . 0.0 106.81 -168.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 68' ' ' ALA . 13.1 tp -174.62 146.17 0.98 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.807 HG21 ' HB1' ' A' ' 97' ' ' ALA . 30.5 mt -114.69 103.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -158.85 101.89 1.64 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.983 1.313 . . . . 0.0 109.412 -168.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 5.8 t -60.81 -17.55 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.664 1.585 . . . . 0.0 113.792 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.89 178.33 7.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.411 -1.431 . . . . 0.0 108.806 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.665 HG13 ' H ' ' A' ' 73' ' ' ARG . 1.7 p -126.47 156.51 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 120.313 -1.492 . . . . 0.0 110.216 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.4 20.5 0.13 Allowed Glycine 0 CA--C 1.546 2.009 0 C-N-CA 127.096 2.284 . . . . 0.0 114.219 166.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.665 ' H ' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER 62.7 0.76 0.7 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.874 2.469 . . . . 0.0 116.518 174.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.5 p30 -137.83 101.02 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' ASN . . . 162.31 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.502 1.521 . . . . 0.0 113.675 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.61 -44.73 81.45 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.806 1.185 . . . . 0.0 109.769 -160.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.73 -40.38 95.23 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.927 1.291 . . . . 0.0 110.384 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -67.1 -19.54 65.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.054 0.542 . . . . 0.0 111.271 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.71 -47.19 32.8 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -62.77 -35.23 79.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.195 0.998 . . . . 0.0 111.489 176.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.94 86.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.127 0.571 . . . . 0.0 110.073 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.18 36.27 1.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.361 0.528 . . . . 0.0 111.196 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.34 31.72 0.21 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 127.607 2.527 . . . . 0.0 117.083 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.42 125.16 38.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.016 1.326 . . . . 0.0 108.31 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -78.5 160.2 27.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.3 t -143.83 131.68 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -107.62 157.81 17.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.048 1.739 . . . . 0.0 109.762 172.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -80.0 160.73 25.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 160.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -132.77 159.08 40.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.512 1.525 . . . . 0.0 108.826 162.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 9.1 pt-20 -129.34 74.7 1.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.818 2.099 . . . . 0.0 111.632 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.47 159.86 3.01 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.942 1.258 . . . . 0.0 111.148 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.39 161.66 9.19 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.845 -0.797 . . . . 0.0 112.833 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -96.8 164.74 12.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.91 1.284 . . . . 0.0 107.555 167.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.87 -37.3 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 117.014 -1.469 . . . . 0.0 114.277 -166.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.54 -32.79 74.58 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 121.007 1.731 . . . . 0.0 114.184 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -66.53 -43.0 86.36 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.612 1.965 . . . . 0.0 108.898 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.807 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -51.81 -28.84 16.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.291 0.496 . . . . 0.0 112.166 174.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mm -95.04 -53.37 8.37 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -25.3 68.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 110.125 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -57.16 4.1 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.623 ' HB2' HD12 ' A' ' 106' ' ' LEU . 10.7 t80 -59.96 -44.29 94.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.499 1.52 . . . . 0.0 113.451 -177.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -67.71 -13.15 61.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.637 1.575 . . . . 0.0 111.498 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.37 35.15 4.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.261 1.024 . . . . 0.0 108.761 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.31 2.93 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.09 1.805 . . . . 0.0 117.016 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -81.12 39.69 0.52 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.747 2.274 . . . . 0.0 111.176 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 101' ' ' PHE . 28.5 mt -128.55 -166.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -128.24 154.75 45.52 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -78.48 132.2 37.17 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 164.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 108.833 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 31' ' ' ASP . 4.1 mtp180 . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -95.38 153.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.07 147.58 39.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.17 119.96 21.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.492 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 87.9 Cg_endo -72.54 95.13 0.78 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 1 C-N-CA 125.956 4.437 . . . . 0.0 107.308 177.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 t -89.57 172.58 8.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.3 1.04 . . . . 0.0 109.058 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.97 37.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.537 1.135 . . . . 0.0 111.107 166.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.23 173.16 45.19 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 167.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -107.78 38.12 2.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.393 0.596 . . . . 0.0 110.189 -166.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.93 151.69 47.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -5.3 39.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 111.649 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t -124.27 37.86 4.32 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.388 -1.445 . . . . 0.0 109.355 165.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.3 m -79.75 175.09 10.94 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 159.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.3 mmm -77.88 144.68 36.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 119.879 -1.763 . . . . 0.0 110.577 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 61.4 t -78.43 161.5 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 163.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -118.54 133.45 55.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 110.625 -167.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.19 39.03 0.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.392 1.477 . . . . 0.0 110.342 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -178.46 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.347 -1.471 . . . . 0.0 109.25 -164.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -50.98 -56.32 13.04 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.404 -0.81 . . . . 0.0 112.589 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.2 4.43 1.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -172.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -138.67 38.77 2.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.686 1.995 . . . . 0.0 108.166 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -90.31 179.59 5.85 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.7 -17.94 7.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -146.31 147.74 31.67 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 73.4 m-85 -128.94 96.09 4.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 mp -79.9 113.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.442 HD11 HD22 ' A' ' 58' ' ' LEU . 69.6 mt -100.37 107.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 4' ' ' VAL . 70.8 t80 -93.72 133.81 36.7 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.87 0.868 . . . . 0.0 108.783 175.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 16.4 t0 -97.76 115.15 27.43 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.034 1.734 . . . . 0.0 111.123 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.5 p -86.26 29.82 0.73 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.693 0.758 . . . . 0.0 110.758 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -113.35 -86.53 0.57 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 159.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -93.16 35.45 1.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 115.584 -2.446 . . . . 0.0 110.439 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.8 18.73 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.771 1.653 . . . . 0.0 113.827 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -69.92 160.77 31.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.548 1.139 . . . . 0.0 108.973 -175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.69 152.0 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.701 0.763 . . . . 0.0 109.081 172.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -131.97 123.92 28.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 173.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -88.91 104.89 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.96 141.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -98.07 141.4 31.06 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.842 1.657 . . . . 0.0 106.656 164.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.04 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.455 -0.744 0 CA-C-O 119.329 -0.363 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.341 2.1 ptpt 49.72 -73.59 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 129.142 2.977 . . . . 0.0 112.445 -163.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -54.35 -56.76 8.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 125.285 1.434 . . . . 0.0 109.182 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.6 t -57.03 -56.71 13.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.495 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -41.91 -54.59 3.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.972 0.909 . . . . 0.0 111.527 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.7 m -65.13 -53.6 42.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 113.598 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 29' ' ' ILE . 93.3 mt -63.1 -43.41 98.56 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.071 0.948 . . . . 0.0 109.755 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.24 -41.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.318 1.447 . . . . 0.0 110.346 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -68.59 0.89 3.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -110.02 38.39 2.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 109.972 165.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.55 32.41 16.07 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.069 1.318 . . . . 0.0 114.69 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.84 92.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 3.4 mm-40 -95.18 33.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.192 1.397 . . . . 0.0 111.109 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.74 ' HB3' HG23 ' A' ' 4' ' ' VAL . 3.4 m-85 171.65 160.13 0.09 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 119.184 -2.198 . . . . 0.0 107.748 -158.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 tp -168.8 147.01 3.99 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.301 1.04 . . . . 0.0 108.512 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.851 HG21 ' HB1' ' A' ' 97' ' ' ALA . 58.5 mt -118.25 105.97 18.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 125.6 1.56 . . . . 0.0 107.278 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.56 112.64 3.0 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.069 1.304 . . . . 0.0 111.85 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.32 -25.13 32.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.63 178.01 9.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.786 3.235 . . . . 0.0 104.562 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.09 165.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 151.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.02 -12.23 68.59 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.394 -1.225 . . . . 0.0 113.905 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 148.76 174.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 1 C-N-CA 132.942 4.497 . . . . 0.0 108.732 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 24.61 74.41 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 130.878 3.671 . . . . 0.0 113.21 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.06 -24.27 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.621 1.568 . . . . 0.0 112.484 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 79' ' ' LEU . 9.4 t80 -59.84 -45.05 93.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.893 -170.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -66.94 -34.11 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -15.69 62.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.739 1.216 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 76' ' ' PHE . 52.9 mt -79.63 -54.55 5.77 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.31 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.815 0.846 . . . . 0.0 112.303 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.82 -35.75 61.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.73 0.812 . . . . 0.0 112.2 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.79 37.07 2.89 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.962 0.801 . . . . 0.0 110.792 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.06 30.4 2.54 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.992 1.758 . . . . 0.0 115.865 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.34 97.24 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 118.529 1.165 . . . . 0.0 108.078 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -79.19 112.36 16.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.762 0.792 . . . . 0.0 108.978 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.11 131.12 40.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.745 1.618 . . . . 0.0 107.982 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.71 161.99 13.28 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 126.026 1.73 . . . . 0.0 109.979 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 160.51 26.83 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 163.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.18 151.94 49.35 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 127.701 2.4 . . . . 0.0 104.634 163.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -141.23 66.02 1.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 121.715 2.052 . . . . 0.0 111.191 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.8 128.08 1.75 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.67 160.03 8.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -161.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.8 p -89.77 174.51 7.67 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.583 1.153 . . . . 0.0 110.19 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 83.4 t -48.63 -40.23 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.761 -1.212 . . . . 0.0 112.17 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -64.32 -34.85 79.08 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.044 1.293 . . . . 0.0 113.483 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.72 -41.52 78.94 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 125.773 1.629 . . . . 0.0 109.15 -176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.851 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.63 -40.75 13.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.09 0.859 . . . . 0.0 111.301 170.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -84.89 -49.23 15.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 O-C-N 121.267 -0.896 . . . . 0.0 108.812 -171.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.05 -18.22 63.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 128.442 2.697 . . . . 0.0 109.618 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 -63.83 1.25 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 108.687 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.584 ' HB2' HD12 ' A' ' 106' ' ' LEU . 6.3 t80 -54.08 -51.28 64.65 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.95 0.795 . . . . 0.0 112.5 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -66.69 -41.52 87.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.5 36.8 0.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.42 0.629 . . . . 0.0 110.133 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.28 9.25 2.05 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 127.635 2.54 . . . . 0.0 117.101 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.89 36.75 0.73 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.851 1.825 . . . . 0.0 111.824 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 101' ' ' PHE . 27.9 mt -131.94 172.18 12.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.551 1.069 . . . . 0.0 110.066 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -107.36 149.73 27.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -82.97 127.34 33.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 162.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 C--O 1.24 0.562 0 C-N-CA 124.561 1.145 . . . . 0.0 109.677 -170.753 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 CA--C 1.504 -0.816 0 CA-C-O 121.97 0.89 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 65' ' ' TYR . 2.2 p -79.46 153.58 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.57 149.32 42.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 163.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.17 118.17 18.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.1 126.27 14.2 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 125.075 3.85 . . . . 0.0 108.227 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -125.16 173.98 8.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.113 2.165 . . . . 0.0 105.986 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.05 37.26 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 128.149 2.58 . . . . 0.0 107.626 170.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.72 177.38 46.49 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.474 1.988 . . . . 0.0 109.555 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -121.47 40.37 3.61 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.459 -157.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.77 155.27 48.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -15.77 63.11 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.129 2.172 . . . . 0.0 110.983 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 p -112.07 38.58 2.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.915 -1.115 . . . . 0.0 112.212 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -97.24 168.47 10.4 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 166.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.6 132.99 38.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.827 1.651 . . . . 0.0 111.11 -171.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.403 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 88.5 t -71.29 139.18 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.2 t -86.87 137.35 32.46 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -0.99 . . . . 0.0 109.355 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.31 37.43 0.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.59 1.186 . . . . 0.0 111.861 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 178.42 97.02 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.188 0 O-C-N 119.736 -1.853 . . . . 0.0 109.247 -156.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' VAL . 36.8 t80 -54.32 -50.38 67.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 119.424 1.011 . . . . 0.0 112.778 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.3 13.57 18.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.671 0.669 . . . . 0.0 111.173 -171.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.39 39.29 3.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.427 1.891 . . . . 0.0 106.856 168.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.28 139.51 51.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -89.82 -74.35 0.49 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.847 1.308 . . . . 0.0 108.792 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.48 156.63 22.77 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -135.52 124.56 24.3 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.5 mm -93.04 113.01 27.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -98.43 113.74 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' HG12 ' A' ' 4' ' ' VAL . 46.5 t80 -91.7 153.82 19.4 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.344 1.028 . . . . 0.0 108.643 170.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -124.45 106.17 9.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.54 1.936 . . . . 0.0 110.807 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.7 p -81.63 36.52 0.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.071 1.305 . . . . 0.0 112.228 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -105.54 -64.31 1.16 Allowed 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 124.743 1.217 . . . . 0.0 109.206 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -124.44 38.05 4.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 125.06 1.475 . . . . 0.0 110.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.79 15.24 18.62 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 126.08 1.8 . . . . 0.0 113.792 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.13 160.33 31.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.874 0.87 . . . . 0.0 109.032 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.29 147.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.689 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -130.36 140.34 50.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.208 1.803 . . . . 0.0 106.643 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.91 109.29 23.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 165.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.4 144.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.64 107.22 14.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.451 -1.001 0 CA-C-O 117.525 -1.115 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 60.67 -71.25 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.981 1.312 . . . . 0.0 110.701 -169.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.62 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.95 1.7 . . . . 0.0 110.049 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -54.79 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.349 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.32 -47.37 18.46 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.215 0.916 . . . . 0.0 111.42 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -67.29 0.42 Allowed 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 121.47 -0.769 . . . . 0.0 111.946 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 mt -51.79 -41.5 61.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.466 1.106 . . . . 0.0 110.744 -173.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.4 -41.52 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 126.486 1.914 . . . . 0.0 111.465 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.2 m -66.23 -3.8 6.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.848 -1.157 . . . . 0.0 111.716 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 37.26 4.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.445 1.021 . . . . 0.0 108.812 171.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.03 21.14 69.52 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.578 2.037 . . . . 0.0 116.115 161.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.95 122.81 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.23 1.012 . . . . 0.0 109.877 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -123.75 35.86 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.974 2.11 . . . . 0.0 109.923 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.569 ' HB3' HG23 ' A' ' 4' ' ' VAL . 5.9 m-85 -179.76 176.59 0.76 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.972 1.709 . . . . 0.0 107.358 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -176.63 151.04 0.89 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.339 1.856 . . . . 0.0 107.885 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.801 HG21 ' HB1' ' A' ' 97' ' ' ALA . 68.9 mt -123.07 105.61 16.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 126.444 1.898 . . . . 0.0 107.601 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.21 136.03 16.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.684 1.584 . . . . 0.0 110.339 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.5 p -64.4 -27.21 68.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.863 -1.148 . . . . 0.0 112.999 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -168.4 -175.29 2.49 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.921 1.688 . . . . 0.0 108.132 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -115.46 153.21 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.989 0.916 . . . . 0.0 109.953 177.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.77 28.92 2.1 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 126.682 2.087 . . . . 0.0 111.811 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 51.05 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.524 1.93 . . . . 0.0 111.488 -159.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 25.82 75.17 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.153 2.981 . . . . 0.0 112.07 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 179.89 -40.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.844 1.658 . . . . 0.0 112.301 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.4 -35.76 68.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.096 0.862 . . . . 0.0 112.095 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.9 -40.63 68.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.331 0.652 . . . . 0.0 110.012 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -15.46 63.53 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.542 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -75.78 -47.69 24.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -67.04 -26.14 66.61 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 120.944 -1.097 . . . . 0.0 113.114 174.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.99 -40.42 63.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.238 0.927 . . . . 0.0 110.699 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.74 36.5 2.62 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.958 0.503 . . . . 0.0 111.329 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.51 16.02 4.81 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 117.424 1.73 . . . . 0.0 117.424 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.19 126.76 39.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.97 1.885 . . . . 0.0 109.813 -159.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -79.83 132.16 36.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.5 t -113.1 141.55 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -111.69 160.4 17.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.84 1.656 . . . . 0.0 109.509 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -79.16 159.68 27.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 160.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -141.12 161.39 37.98 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 154.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -150.0 95.53 2.31 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.404 1.456 . . . . 0.0 111.992 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.1 109.27 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 125.69 1.614 . . . . 0.0 111.003 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 162.84 158.44 9.7 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 117.86 0.83 . . . . 0.0 113.682 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -85.29 168.5 14.64 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.148 0.579 . . . . 0.0 109.644 166.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -39.25 -44.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.394 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.97 -39.57 82.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.14 1.791 . . . . 0.0 114.729 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -64.91 -41.66 95.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.312 1.845 . . . . 0.0 108.76 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.801 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -49.69 -38.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.616 0.644 . . . . 0.0 111.53 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mm -82.42 -61.12 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 -33.01 43.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.22 1.808 . . . . 0.0 110.498 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.61 -50.57 20.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.642 ' HB2' HD12 ' A' ' 106' ' ' LEU . 14.9 t80 -61.89 -50.51 71.93 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.408 1.083 . . . . 0.0 112.027 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.5 p -64.51 -45.52 86.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.864 2.065 . . . . 0.0 108.656 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -91.84 36.45 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.06 45.54 14.82 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.926 2.203 . . . . 0.0 115.078 166.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -120.84 36.51 4.56 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 111.058 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.642 HD12 ' HB2' ' A' ' 101' ' ' PHE . 17.4 mt -124.7 -175.74 3.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.791 1.178 . . . . 0.0 109.446 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.49 138.42 53.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -79.72 111.08 15.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--O 1.239 0.551 0 C-N-CA 125.412 1.485 . . . . 0.0 109.762 -172.525 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 65' ' ' TYR . 10.0 p -115.2 134.28 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.774 1.63 . . . . 0.0 107.42 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' HD12 ' A' ' 66' ' ' LEU . . . -111.06 143.96 40.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.72 120.91 20.8 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.03 111.57 3.31 Favored 'Trans proline' 0 N--CA 1.446 -1.302 1 C-N-CA 125.687 4.258 . . . . 0.0 108.631 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -112.93 171.04 7.77 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.831 1.653 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.85 39.39 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.173 1.389 . . . . 0.0 109.899 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.69 -174.5 47.07 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.64 1.591 . . . . 0.0 109.984 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.2 mtmt -115.33 38.91 3.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.152 1.381 . . . . 0.0 109.457 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -124.48 149.37 46.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 2.23 3.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 122.309 1.052 . . . . 0.0 110.778 168.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 38.4 3.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.027 -1.671 . . . . 0.0 108.448 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.7 m -80.17 170.56 16.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 159.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 139.72 38.87 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.896 -1.128 . . . . 0.0 108.904 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 92.9 t -76.87 147.67 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -109.9 133.84 52.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -169.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.87 38.1 0.44 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.352 0.596 . . . . 0.0 110.833 -172.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -167.34 86.92 0.26 Allowed 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.427 -1.421 . . . . 0.0 107.839 -163.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 79' ' ' LEU . 9.1 t80 -48.23 -53.13 18.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.009 0.822 . . . . 0.0 112.787 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -74.72 -6.77 50.69 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -129.19 64.59 1.47 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.18 25.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.26 -16.77 61.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.36 1.064 . . . . 0.0 113.249 -163.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.478 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 92.1 m-85 -141.0 154.7 46.14 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -139.02 107.27 5.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.607 1.163 . . . . 0.0 107.885 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.74 116.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.85 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.6 ' HB3' HG12 ' A' ' 4' ' ' VAL . 18.3 t80 -88.84 116.51 27.16 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.99 1.716 . . . . 0.0 107.536 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.62 100.0 6.8 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.899 1.679 . . . . 0.0 108.501 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 p -74.04 70.3 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.445 1.117 . . . . 0.0 108.586 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -155.76 -53.01 0.09 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.91 2.484 . . . . 0.0 110.458 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 m -136.22 36.71 2.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.481 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.01 11.74 1.07 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.495 1.998 . . . . 0.0 114.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -71.59 141.97 50.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.676 1.238 . . . . 0.0 107.688 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.37 160.62 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.747 1.619 . . . . 0.0 107.066 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -137.42 141.91 41.65 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.8 116.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.79 132.52 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 160.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -85.85 136.6 33.24 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 155.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 CA--C 1.524 -0.046 0 CA-C-N 119.451 1.023 . . . . 0.0 111.288 167.487 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.457 -0.652 0 CA-C-O 118.382 -0.758 . . . . 0.0 112.992 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER 58.15 -64.65 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.041 1.291 . . . . 0.0 112.249 -157.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.13 -61.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.308 1.443 . . . . 0.0 108.582 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 55' ' ' VAL . 1.4 t -53.28 -47.62 56.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 126.101 1.76 . . . . 0.0 109.257 175.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -45.22 -52.47 9.44 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.365 1.439 . . . . 0.0 111.649 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 t -66.41 -51.95 51.61 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.374 0.669 . . . . 0.0 112.258 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.5 -41.33 97.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.632 -1.292 . . . . 0.0 110.113 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 t -59.99 -35.37 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.466 1.506 . . . . 0.0 111.241 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -65.45 -33.72 76.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.565 1.075 . . . . 0.0 109.489 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.33 38.07 0.65 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.766 1.226 . . . . 0.0 109.603 170.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.32 22.74 2.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.023 1.773 . . . . 0.0 116.092 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.66 118.86 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 119.831 1.816 . . . . 0.0 109.108 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.36 35.61 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.412 0.685 . . . . 0.0 110.982 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.897 ' HB3' HG23 ' A' ' 4' ' ' VAL . 23.3 m-85 -174.91 160.7 2.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 68' ' ' ALA . 18.2 tp -164.26 148.35 9.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.703 HG21 ' HB1' ' A' ' 97' ' ' ALA . 64.0 mt -119.43 97.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -152.69 103.67 2.81 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.281 0.632 . . . . 0.0 109.527 -171.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.5 p -45.92 -28.87 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.966 1.706 . . . . 0.0 115.58 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 -171.19 2.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -128.67 155.03 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -75.32 -41.65 30.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -171.52 -148.3 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.248 2.219 . . . . 0.0 107.761 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -52.49 104.58 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 111.561 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.79 -29.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.956 2.102 . . . . 0.0 109.141 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 79' ' ' LEU . 28.2 t80 -51.9 -39.49 59.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.088 1.755 . . . . 0.0 112.442 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.43 -37.35 86.66 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.618 0.767 . . . . 0.0 109.535 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.6 m -80.13 -13.84 58.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.726 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 76' ' ' PHE . 25.8 mt -71.14 -58.2 3.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.907 -1.12 . . . . 0.0 109.093 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.608 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -63.21 -29.27 70.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.27 37.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.22 171.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.94 35.88 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.069 0.849 . . . . 0.0 111.621 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.03 34.29 4.1 Favored Glycine 0 CA--C 1.538 1.521 0 O-C-N 120.387 -1.446 . . . . 0.0 115.696 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.79 127.92 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 119.258 1.529 . . . . 0.0 110.036 -166.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -79.35 112.54 16.69 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.651 -0.656 . . . . 0.0 110.748 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -97.61 121.04 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.05 157.89 15.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 109.954 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.46 151.5 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.6 172.79 10.86 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 156.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.38 52.21 0.53 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 121.288 1.858 . . . . 0.0 112.787 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.51 101.95 2.67 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.386 -0.822 . . . . 0.0 112.488 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.82 166.36 34.76 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -162.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.404 ' C ' HG23 ' A' ' 17' ' ' VAL . 26.6 p -88.39 174.11 8.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.373 1.069 . . . . 0.0 110.488 167.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.2 t -45.1 -42.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.588 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.15 -34.12 76.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 120.305 1.411 . . . . 0.0 114.369 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.36 -45.07 85.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.608 1.563 . . . . 0.0 107.209 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.69 -45.59 19.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.356 0.662 . . . . 0.0 111.254 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.38 -52.05 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.16 -33.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.758 2.023 . . . . 0.0 109.405 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -61.5 1.79 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.666 ' HB2' HD12 ' A' ' 106' ' ' LEU . 3.1 t80 -54.64 -41.17 69.75 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.452 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.1 p -69.41 -50.45 45.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.202 1.401 . . . . 0.0 108.119 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -86.12 36.63 0.69 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.597 0.713 . . . . 0.0 109.689 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.71 12.89 2.76 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.287 1.899 . . . . 0.0 116.658 172.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.6 mtp180 -85.74 35.91 0.64 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 121.027 2.413 . . . . 0.0 112.314 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 101' ' ' PHE . 20.1 mt -134.44 -178.89 5.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.586 -1.321 . . . . 0.0 109.414 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -127.81 153.34 46.71 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 125.769 1.628 . . . . 0.0 108.886 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.92 91.57 6.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.509 1.524 . . . . 0.0 107.065 -176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 124.521 1.128 . . . . 0.0 110.691 -175.646 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -115.37 151.14 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 127.706 2.403 . . . . 0.0 105.394 165.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.63 143.73 48.52 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.6 121.71 15.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.78 110.28 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.338 4.025 . . . . 0.0 108.363 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 t -111.23 169.18 8.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.189 1.795 . . . . 0.0 108.13 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.86 37.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.361 0.664 . . . . 0.0 111.051 165.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.62 177.04 42.19 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.472 1.51 . . . . 0.0 109.832 168.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -115.18 38.63 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.735 -166.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -139.29 159.26 42.58 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.471 1.908 . . . . 0.0 108.306 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -74.02 -5.05 39.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.612 1.965 . . . . 0.0 111.07 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -122.82 37.97 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.669 -1.269 . . . . 0.0 110.916 167.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 m -83.24 173.29 11.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.14 164.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.91 142.88 36.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.89 1.223 . . . . 0.0 109.766 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -71.57 165.07 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.047 0.927 . . . . 0.0 108.508 166.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 t -119.98 127.87 53.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.396 1.478 . . . . 0.0 109.26 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.22 37.11 0.37 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 122.13 0.967 . . . . 0.0 110.826 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.85 108.82 0.48 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 -166.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.62 ' CE2' HD11 ' A' ' 79' ' ' LEU . 13.3 t80 -63.65 -58.19 7.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.639 1.109 . . . . 0.0 110.622 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.76 -13.66 59.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.737 -170.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -123.82 77.39 1.52 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.201 1.8 . . . . 0.0 106.81 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.58 116.3 13.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.86 -16.34 11.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -173.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -142.97 157.76 44.24 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -135.19 107.52 7.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -79.88 126.79 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.447 HD11 ' CD2' ' A' ' 58' ' ' LEU . 62.6 mt -119.93 101.33 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.534 ' HB3' HG12 ' A' ' 4' ' ' VAL . 56.8 t80 -89.8 133.61 34.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.513 1.125 . . . . 0.0 108.191 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.64 121.65 27.95 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.338 1.455 . . . . 0.0 107.497 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 p -84.83 53.17 2.62 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.029 1.286 . . . . 0.0 108.454 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.08 -82.78 0.22 Allowed 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 p -104.88 36.97 2.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 117.99 -1.484 . . . . 0.0 110.347 -160.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.77 4.32 0.15 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.08 1.8 . . . . 0.0 116.489 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -75.26 158.32 33.09 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.221 1.008 . . . . 0.0 110.514 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.9 162.97 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.383 0.673 . . . . 0.0 109.349 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -131.69 138.2 48.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 168.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.73 110.05 22.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 155.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.08 135.79 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.454 -2.425 . . . . 0.0 104.454 156.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.25 128.67 47.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 CA--C 1.513 -0.456 0 CA-C-N 119.357 0.98 . . . . 0.0 111.766 -179.54 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' A' ' 78' ' ' THR . 59.2 Cg_endo . . . . . 0 N--CA 1.447 -1.234 0 CA-C-O 116.34 -1.608 . . . . 0.0 113.62 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 61.47 -72.82 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.544 1.152 . . . . 0.0 110.646 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.82 -56.53 12.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 119.702 1.137 . . . . 0.0 110.383 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.4 t -55.79 -51.25 61.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 C-N-CA 125.235 1.414 . . . . 0.0 107.893 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -12.91 1.08 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.504 1.521 . . . . 0.0 114.615 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.52 -48.72 3.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.377 1.471 . . . . 0.0 109.526 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD2' HD11 ' A' ' 29' ' ' ILE . 69.5 mt -58.08 -45.29 87.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.523 1.129 . . . . 0.0 110.504 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.27 -41.3 91.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.208 1.403 . . . . 0.0 109.652 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -67.1 3.33 1.17 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.299 -0.876 . . . . 0.0 113.223 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -124.61 38.84 4.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.488 2.315 . . . . 0.0 108.317 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.08 35.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 126.1 1.81 . . . . 0.0 116.745 165.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.99 120.59 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 118.456 1.128 . . . . 0.0 110.394 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -124.54 36.17 4.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.688 0.756 . . . . 0.0 110.984 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.677 ' HB3' HG23 ' A' ' 4' ' ' VAL . 11.0 m-85 170.74 170.8 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.317 1.847 . . . . 0.0 107.675 -168.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 68' ' ' ALA . 10.6 tp -172.51 146.34 1.72 Allowed 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.413 -1.429 . . . . 0.0 107.263 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.723 HG21 ' HB1' ' A' ' 97' ' ' ALA . 50.9 mt -114.91 103.25 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -156.07 102.36 2.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.538 1.063 . . . . 0.0 111.32 -171.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.472 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 22.7 t -59.74 -4.89 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.69 -179.43 3.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 123.612 2.915 . . . . 0.0 108.85 167.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.25 146.32 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 O-C-N 121.626 -0.671 . . . . 0.0 110.056 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.08 2.49 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.033 1.778 . . . . 0.0 110.461 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -171.54 173.61 4.66 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.066 2.546 . . . . 0.0 106.338 173.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -71.63 29.23 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.404 1.097 . . . . 0.0 112.373 162.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' ARG . . . -76.1 -27.64 57.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.209 -1.557 . . . . 0.0 111.677 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.2 t80 -61.54 -36.12 79.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.473 1.033 . . . . 0.0 110.951 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.97 -28.65 65.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.854 0.861 . . . . 0.0 110.639 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 52' ' ' PRO . 5.3 m -78.16 -20.79 51.3 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.862 -0.523 . . . . 0.0 110.432 173.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.817 HD12 ' HA ' ' A' ' 76' ' ' PHE . 14.1 mt -71.87 -54.83 8.85 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -56.2 -32.27 64.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 171.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.82 -2.58 7.46 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.68 37.33 4.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.643 1.177 . . . . 0.0 110.472 163.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.34 31.33 8.84 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.821 1.489 . . . . 0.0 116.821 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.42 115.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -78.73 107.77 11.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.83 114.69 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.9 163.24 19.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.983 1.713 . . . . 0.0 111.008 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -90.59 157.14 17.66 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.137 0.975 . . . . 0.0 108.54 161.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.472 ' H ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -121.42 171.36 8.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.264 2.626 . . . . 0.0 109.362 165.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.06 96.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.08 -1.637 . . . . 0.0 110.141 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.47 139.28 0.72 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.13 158.58 8.39 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.8 p -85.93 169.65 13.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.105 0.962 . . . . 0.0 108.73 160.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.5 t -42.17 -47.37 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.879 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -60.7 -32.65 71.88 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -64.32 -46.46 83.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.324 1.45 . . . . 0.0 109.274 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.84 -36.32 11.74 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 118.471 0.578 . . . . 0.0 111.582 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.68 -55.07 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 108.143 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -37.97 70.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 108.641 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.87 11.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 106' ' ' LEU . 9.3 t80 -58.54 -44.15 89.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.756 0.822 . . . . 0.0 112.272 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -69.51 -42.51 74.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 109.156 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -92.07 37.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.37 -1.54 0.1 OUTLIER Glycine 0 CA--C 1.526 0.77 0 C-N-CA 130.37 3.843 . . . . 0.0 118.277 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.6 mtt-85 -82.63 37.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.638 1.719 . . . . 0.0 111.692 -170.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 101' ' ' PHE . 21.7 mt -127.89 -171.24 2.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.588 -1.32 . . . . 0.0 108.532 169.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.79 145.15 37.84 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.337 1.455 . . . . 0.0 108.276 -169.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.7 108.46 13.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 109.501 -176.42 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.4 p -84.71 153.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.66 145.85 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.42 124.3 23.54 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 103.65 1.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 1 C-N-CA 125.768 4.312 . . . . 0.0 108.963 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -101.38 173.0 6.64 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.093 1.357 . . . . 0.0 109.249 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.27 38.58 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 109.172 169.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.14 177.84 48.45 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.734 1.635 . . . . 0.0 109.552 171.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 3.5 mttm -108.79 40.05 1.88 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.115 1.766 . . . . 0.0 109.698 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -128.27 154.89 45.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -14.77 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.703 1.201 . . . . 0.0 110.044 170.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -110.74 38.35 2.52 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.64 -1.287 . . . . 0.0 108.758 166.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -86.99 167.42 14.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.589 -1.319 . . . . 0.0 108.056 162.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.58 146.1 34.4 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.467 -1.396 . . . . 0.0 110.417 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 78.8 t -87.77 132.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.523 1.154 . . . . 0.0 108.521 170.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -91.81 135.65 33.75 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.354 2.262 . . . . 0.0 108.674 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.17 38.27 0.47 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.884 0.849 . . . . 0.0 112.147 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' CD ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -165.25 96.44 0.69 Allowed 'General case' 0 C--O 1.224 -0.266 0 O-C-N 119.905 -1.747 . . . . 0.0 107.996 -160.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' HD11 ' A' ' 79' ' ' LEU . 19.1 t80 -65.18 -32.62 74.4 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 119.979 -1.7 . . . . 0.0 113.927 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.69 -3.68 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.197 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HG3' ' CD ' ' A' ' 20' ' ' ARG . 7.0 ptp180 -135.37 79.3 1.78 Allowed 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 119.449 1.022 . . . . 0.0 109.885 164.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.27 127.52 33.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -72.19 -17.73 61.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.466 1.106 . . . . 0.0 112.744 -167.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.431 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.1 m-85 -143.98 154.88 43.74 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.804 1.241 . . . . 0.0 107.733 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -137.76 107.67 6.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.461 1.504 . . . . 0.0 107.633 -175.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.77 123.53 43.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -175.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.25 96.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.145 0.884 . . . . 0.0 108.679 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 4' ' ' VAL . 29.0 t80 -85.42 117.68 24.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.815 1.246 . . . . 0.0 107.869 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.77 119.91 28.57 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.263 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -89.91 60.05 4.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.862 1.21 . . . . 0.0 110.697 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -136.73 -43.29 0.59 Allowed 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 117.243 -1.361 . . . . 0.0 113.085 164.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.2 m -137.04 36.87 2.57 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 117.6 -1.64 . . . . 0.0 113.128 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.26 13.83 4.08 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.477 1.513 . . . . 0.0 114.192 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -82.24 135.08 35.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.785 1.634 . . . . 0.0 108.133 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.43 170.18 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 125.178 1.391 . . . . 0.0 107.938 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.04 145.03 39.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -106.69 109.08 26.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.9 129.37 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 159.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.89 133.87 33.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 127.145 2.178 . . . . 0.0 106.295 159.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 119.977 1.262 . . . . 0.0 111.159 178.288 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.433 ' HG3' HG21 ' A' ' 78' ' ' THR . 47.1 Cg_endo . . . . . 0 N--CA 1.449 -1.137 0 CA-C-O 118.231 -0.82 . . . . 0.0 113.162 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 58.82 -78.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.989 2.116 . . . . 0.0 111.395 -169.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -57.3 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 126.942 2.097 . . . . 0.0 109.963 -176.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -56.96 -42.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 CA-C-O 115.167 -2.349 . . . . 0.0 109.578 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -52.31 -44.43 65.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 121.074 1.761 . . . . 0.0 111.497 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -68.12 -51.9 40.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 111.191 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.17 -43.62 92.12 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.305 -0.872 . . . . 0.0 110.525 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.97 -34.65 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.604 1.962 . . . . 0.0 110.628 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -36.4 79.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.504 1.047 . . . . 0.0 109.973 175.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -81.39 38.3 0.48 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.383 0.992 . . . . 0.0 110.29 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.12 27.38 1.58 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.674 2.559 . . . . 0.0 116.279 171.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.66 120.58 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.839 1.319 . . . . 0.0 108.129 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -121.78 36.78 4.53 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.757 1.623 . . . . 0.0 109.953 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -179.6 169.45 1.36 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 120.06 -1.65 . . . . 0.0 108.044 -171.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 67' ' ' ILE . 16.6 tp -169.33 151.89 4.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.515 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.778 HG21 ' HB1' ' A' ' 97' ' ' ALA . 61.1 mt -126.63 102.88 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -159.44 111.02 2.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.78 0.832 . . . . 0.0 109.944 -171.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -46.54 -31.09 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.247 1.819 . . . . 0.0 114.998 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -165.55 -170.12 1.75 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 119.058 0.844 . . . . 0.0 109.102 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.83 133.54 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.347 -0.696 . . . . 0.0 111.388 -169.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -166.25 152.45 8.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.807 2.443 . . . . 0.0 105.44 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 45.36 -143.67 0.21 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.672 1.589 . . . . 0.0 109.228 168.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 72.77 -34.57 0.3 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 129.275 3.03 . . . . 0.0 114.767 162.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.625 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 56.5 t80 -56.39 -40.71 75.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.302 1.441 . . . . 0.0 110.109 174.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.19 -40.76 98.43 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.517 0.727 . . . . 0.0 110.612 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -67.53 -27.27 66.83 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.266 -0.896 . . . . 0.0 110.764 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.504 HD11 ' CD2' ' A' ' 21' ' ' PHE . 53.3 mt -69.12 -61.13 1.92 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -61.63 -27.55 68.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 176.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.05 67.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.224 0.92 . . . . 0.0 110.613 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.85 35.98 1.91 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.541 1.064 . . . . 0.0 111.484 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.88 19.28 1.34 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.238 1.875 . . . . 0.0 117.422 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.43 120.04 29.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 118.987 1.393 . . . . 0.0 108.769 -160.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HE3' ' CD ' ' A' ' 108' ' ' GLU . 44.1 tttt -80.42 116.39 20.46 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.929 0.892 . . . . 0.0 110.208 -171.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -99.3 129.23 50.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.26 158.13 16.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 0.0 110.306 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.407 ' O ' HD13 ' A' ' 106' ' ' LEU . 1.4 tpt180 -79.6 163.66 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.586 1.555 . . . . 0.0 106.891 162.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.36 169.92 16.89 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 157.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -153.41 67.41 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 121.931 2.15 . . . . 0.0 113.008 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.34 95.67 2.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.459 1.028 . . . . 0.0 111.783 159.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.8 168.84 40.55 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -165.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.414 ' C ' HG23 ' A' ' 17' ' ' VAL . 34.0 p -87.4 176.57 7.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.761 0.824 . . . . 0.0 110.559 167.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -46.33 -43.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.759 1.223 . . . . 0.0 109.887 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -32.43 73.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -72.57 -40.92 66.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.623 1.169 . . . . 0.0 109.072 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.778 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -45.88 -41.58 11.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 123.83 0.707 . . . . 0.0 111.083 168.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -81.69 -51.34 15.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 124.487 1.115 . . . . 0.0 108.313 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -21.0 65.49 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.95 1.3 . . . . 0.0 110.527 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.6 -62.31 1.71 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.643 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.1 t80 -56.03 -44.13 78.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.624 1.17 . . . . 0.0 112.657 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.7 p -63.61 -51.84 63.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.579 1.152 . . . . 0.0 108.451 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.37 36.36 0.69 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.593 0.711 . . . . 0.0 109.31 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.44 11.05 4.75 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.695 2.093 . . . . 0.0 116.747 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -85.03 35.34 0.57 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 121.508 2.654 . . . . 0.0 112.478 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 101' ' ' PHE . 26.9 mt -135.45 167.44 21.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 121.151 1.796 . . . . 0.0 110.033 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -110.27 139.95 44.92 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.624 1.57 . . . . 0.0 107.416 -167.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.403 ' CD ' ' HE3' ' A' ' 85' ' ' LYS . 73.5 tt0 -85.41 96.04 9.45 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.833 1.197 . . . . 0.0 107.883 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 111.676 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -97.65 129.22 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.51 133.1 46.69 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 4' ' ' VAL . 4.2 mp -113.64 121.29 37.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 57.2 Cg_endo -73.7 93.23 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 1 C-N-CA 126.043 4.495 . . . . 0.0 109.509 -176.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.2 t -87.71 171.02 10.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.753 2.821 . . . . 0.0 110.338 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 m -124.72 37.86 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.96 1.304 . . . . 0.0 109.487 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.93 -174.81 45.45 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.532 -1.355 . . . . 0.0 112.645 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 22.9 mtmt -111.06 39.6 2.23 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.05 1.34 . . . . 0.0 111.859 -162.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -143.35 157.58 44.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 108.784 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -78.95 -13.79 59.59 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.444 -0.785 . . . . 0.0 111.053 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -104.91 37.39 2.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.375 -1.453 . . . . 0.0 111.072 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' THR . 97.0 p -82.76 170.7 14.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.277 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.56 134.18 37.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.791 1.632 . . . . 0.0 109.133 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 47.8 t -78.14 132.42 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -79.7 152.23 30.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.402 2.681 . . . . 0.0 108.42 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -88.71 36.46 0.8 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.234 -0.916 . . . . 0.0 112.613 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.37 107.01 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.433 -1.417 . . . . 0.0 110.024 -153.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.478 ' HB3' HG23 ' A' ' 71' ' ' VAL . 21.5 t80 -58.0 -60.44 3.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.848 1.204 . . . . 0.0 112.058 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.06 1.19 28.75 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -167.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.8 63.91 1.29 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 162.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . . . -123.95 169.05 12.0 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 164.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -117.64 -30.48 5.46 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 119.034 0.834 . . . . 0.0 112.657 -165.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 95.7 m-85 -126.4 145.71 50.36 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HB3' HD21 ' A' ' 58' ' ' LEU . 94.1 m-85 -133.04 89.12 2.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 126.89 2.076 . . . . 0.0 106.009 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.449 HG22 ' CG1' ' A' ' 37' ' ' VAL . 3.0 mm -79.12 107.19 11.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 -176.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.448 HD11 HD23 ' A' ' 58' ' ' LEU . 81.1 mt -94.23 107.88 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.507 ' HB3' HG12 ' A' ' 4' ' ' VAL . 41.2 t80 -89.96 131.59 35.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -100.81 109.35 21.33 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.745 2.018 . . . . 0.0 111.211 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.2 p -82.14 53.86 2.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.372 0.987 . . . . 0.0 110.225 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -140.86 -20.53 0.81 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.563 1.545 . . . . 0.0 112.712 166.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.2 p -150.63 34.92 0.62 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.597 162.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.88 10.0 2.1 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.976 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.87 152.97 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.683 1.593 . . . . 0.0 107.2 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.449 ' CG1' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -135.43 160.72 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.175 172.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -149.9 136.88 19.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.226 -0.892 . . . . 0.0 109.232 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 11' ' ' LYS . 21.7 t -102.07 114.69 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.521 0.728 . . . . 0.0 109.508 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.73 158.12 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.692 1.197 . . . . 0.0 108.66 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -120.11 122.19 40.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 163.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 109.383 -1.045 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -152.64 -52.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.197 1.399 . . . . 0.0 107.486 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 10.1 p -87.56 -39.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.965 1.706 . . . . 0.0 110.473 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -61.3 -52.04 66.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 116.368 -1.777 . . . . 0.0 109.986 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -44.06 -49.86 8.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.849 1.204 . . . . 0.0 110.949 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -58.55 -64.59 0.87 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 112.657 173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 27' ' ' PHE . 69.3 mt -60.49 -39.39 87.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.337 -167.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.37 -33.87 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.643 1.977 . . . . 0.0 110.904 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -59.9 -30.87 69.32 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.66 37.86 1.63 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.163 0.985 . . . . 0.0 110.303 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.72 25.52 29.46 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.954 -0.914 . . . . 0.0 115.003 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 72.6 t -74.24 96.93 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -105.85 36.84 2.41 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -164.95 155.95 14.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.2 tp -164.56 146.06 8.24 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.26 -1.525 . . . . 0.0 107.15 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.824 HG21 ' HB1' ' A' ' 97' ' ' ALA . 28.3 mt -120.73 104.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.02 134.51 17.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.453 1.024 . . . . 0.0 111.831 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.3 p -68.43 -23.79 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.558 -0.714 . . . . 0.0 112.669 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -177.81 -176.19 0.56 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 107.433 -162.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 21' ' ' PHE . 4.3 p -138.07 141.16 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 119.75 -1.844 . . . . 0.0 112.872 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.87 11.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.911 2.672 . . . . 0.0 116.265 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.274 22.8 mtm180 143.27 -103.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 1 C-N-CA 131.716 4.006 . . . . 0.0 107.062 167.768 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -64.97 137.41 57.72 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.38 -35.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 130.354 3.462 . . . . 0.0 110.637 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.507 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 69.6 t80 -58.27 -41.86 85.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.718 0.807 . . . . 0.0 111.851 -162.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -62.34 -39.49 93.28 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.062 1.345 . . . . 0.0 109.357 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -74.69 -23.96 58.7 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.247 1.019 . . . . 0.0 110.652 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.67 -51.18 29.44 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 121.377 -0.827 . . . . 0.0 108.933 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.37 -30.44 70.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 117.125 -1.417 . . . . 0.0 113.575 175.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.31 -60.57 3.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.316 1.01 . . . . 0.0 108.961 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.53 36.83 0.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.693 0.679 . . . . 0.0 112.058 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.68 27.71 3.27 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.562 2.029 . . . . 0.0 115.636 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.36 121.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.197 0.999 . . . . 0.0 108.54 -166.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -77.65 153.51 33.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -144.16 116.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -172.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -95.37 157.99 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.526 0.731 . . . . 0.0 109.313 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 153.81 29.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 163.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.525 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -134.26 167.27 21.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 162.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.75 77.39 1.58 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.36 1.076 . . . . 0.0 112.266 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.53 88.33 0.11 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.832 1.206 . . . . 0.0 114.568 159.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.43 164.59 35.12 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.818 2.628 . . . . 0.0 109.781 -163.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 15' ' ' SER . 41.6 p -79.59 169.67 17.68 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.519 164.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -50.28 -41.78 19.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-N 121.135 1.788 . . . . 0.0 111.907 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -52.92 -39.5 62.85 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -65.69 -46.64 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.803 1.641 . . . . 0.0 108.575 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.824 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.28 -34.54 10.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.479 0.581 . . . . 0.0 112.464 171.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.96 -58.36 3.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.83 -29.06 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.992 2.517 . . . . 0.0 110.155 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 -60.55 2.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.595 ' HB2' HD12 ' A' ' 106' ' ' LEU . 9.7 t80 -56.01 -48.67 75.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.857 1.263 . . . . 0.0 113.217 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.1 p -72.25 -30.89 65.31 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.683 1.193 . . . . 0.0 109.992 -170.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -104.52 35.99 2.55 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 122.561 1.172 . . . . 0.0 108.494 170.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.46 -2.74 1.54 Allowed Glycine 0 CA--C 1.531 1.05 1 C-N-CA 131.334 4.302 . . . . 0.0 120.135 165.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -80.1 38.43 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.956 2.878 . . . . 0.0 113.59 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.595 HD12 ' HB2' ' A' ' 101' ' ' PHE . 16.9 mt -122.86 -166.6 1.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.129 -0.982 . . . . 0.0 108.684 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.21 148.23 46.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.233 1.413 . . . . 0.0 108.498 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.96 101.03 9.24 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.569 1.548 . . . . 0.0 107.856 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 N--CA 1.443 -0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 107.525 -177.47 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.9 p -99.4 149.6 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.03 147.56 44.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.152 1.342 . . . . 0.0 108.657 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 120.64 19.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 95.1 Cg_endo -73.03 101.31 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 127.147 5.231 . . . . 0.0 107.568 -178.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -100.1 164.37 12.01 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.77 1.228 . . . . 0.0 109.207 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 16' ' ' MET . 15.0 m -121.75 38.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 165.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 -178.68 41.83 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.594 1.092 . . . . 0.0 110.485 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 37.3 mtmt -108.91 39.95 1.92 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 109.536 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -143.02 148.66 37.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.376 1.07 . . . . 0.0 109.907 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 1.91 3.41 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.041 2.136 . . . . 0.0 112.957 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -130.74 38.18 3.73 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.25 -1.531 . . . . 0.0 107.98 167.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 p -81.76 165.2 21.15 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.466 167.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.429 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -78.13 131.77 37.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.324 1.42 . . . . 0.0 109.881 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 84.8 t -74.29 144.21 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.251 1.021 . . . . 0.0 108.763 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -94.92 132.22 39.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.286 2.234 . . . . 0.0 109.52 -169.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -81.3 39.01 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.054 0.93 . . . . 0.0 111.026 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.73 97.82 0.07 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.312 -1.492 . . . . 0.0 108.313 -162.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CD2' HD11 ' A' ' 79' ' ' LEU . 17.5 t80 -60.49 -51.04 71.16 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.755 1.161 . . . . 0.0 112.478 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.04 3.36 15.06 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -134.56 69.72 1.45 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 165.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 27' ' ' PHE . . . -100.67 -177.96 3.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 160.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.48 -21.42 9.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.894 0.378 . . . . 0.0 110.115 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.2 m-85 -145.42 156.34 43.7 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.567 2.347 . . . . 0.0 105.681 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 69.8 m-85 -132.92 110.77 10.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -86.35 129.58 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.9 mt -124.43 105.79 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.566 ' HB3' HG12 ' A' ' 4' ' ' VAL . 42.4 t80 -91.29 117.36 29.58 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.023 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.32 98.88 11.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.12 2.568 . . . . 0.0 112.055 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -78.13 58.11 1.95 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.652 -1.905 . . . . 0.0 109.3 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.88 -21.83 0.36 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.286 2.234 . . . . 0.0 112.105 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.78 35.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.072 1.305 . . . . 0.0 113.548 158.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.91 6.88 5.72 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.572 -1.33 . . . . 0.0 114.593 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.68 158.04 34.99 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.177 0.989 . . . . 0.0 109.254 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.35 173.54 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 125.736 1.614 . . . . 0.0 107.945 171.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.77 139.91 28.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.58 104.37 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.58 145.45 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 162.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -105.42 144.09 32.68 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 O-C-N 120.74 -1.225 . . . . 0.0 110.491 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.453 -0.873 0 CA-C-O 119.102 -0.458 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 60.31 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.907 2.083 . . . . 0.0 111.16 -169.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.274 1.43 . . . . 0.0 110.627 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -45.46 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.822 0 CA-C-O 115.859 -2.02 . . . . 0.0 109.072 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -51.97 -42.73 63.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.054 1.752 . . . . 0.0 112.138 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -68.46 -55.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.361 0.664 . . . . 0.0 110.111 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -45.61 80.45 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.015 -1.053 . . . . 0.0 110.923 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 t -56.67 -33.87 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.412 1.885 . . . . 0.0 111.484 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 m -66.75 -39.24 87.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.336 0.971 . . . . 0.0 109.806 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.74 37.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.027 0.931 . . . . 0.0 110.21 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.27 30.25 0.77 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.812 2.149 . . . . 0.0 116.353 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.64 119.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.74 1.27 . . . . 0.0 108.211 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -120.0 36.06 4.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.943 0.897 . . . . 0.0 111.089 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.773 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.0 m-85 -177.39 168.52 2.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.093 -2.255 . . . . 0.0 107.286 -167.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 68' ' ' ALA . 17.6 tp -169.85 153.84 5.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.953 0.901 . . . . 0.0 108.614 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.808 HG21 ' HB1' ' A' ' 97' ' ' ALA . 37.0 mt -127.21 106.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.183 1.793 . . . . 0.0 106.594 171.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -157.98 125.49 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.585 0.754 . . . . 0.0 109.823 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.8 p -60.49 -27.97 67.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -165.38 -179.61 5.63 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 126.424 1.89 . . . . 0.0 105.989 -168.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.43 166.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -10.3 84.33 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 116.114 -2.492 . . . . 0.0 113.545 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 73' ' ' ARG 0.408 0.2 OUTLIER 143.99 -59.36 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 131.782 4.033 . . . . 0.0 112.614 161.334 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -76.51 -159.07 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.665 1.186 . . . . 0.0 109.139 165.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 77.42 -35.99 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.317 2.647 . . . . 0.0 113.244 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HA ' HD12 ' A' ' 79' ' ' LEU . 60.9 t80 -55.35 -43.43 75.03 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.776 1.23 . . . . 0.0 111.544 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -66.43 -32.14 73.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.127 0.971 . . . . 0.0 110.445 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -18.47 54.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.926 1.29 . . . . 0.0 110.756 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' CD2' ' A' ' 21' ' ' PHE . 36.9 mt -76.57 -62.85 1.49 Allowed 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.406 -0.809 . . . . 0.0 108.944 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -55.97 -35.45 66.74 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 120.973 -1.08 . . . . 0.0 113.74 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.31 69.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.14 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.74 36.35 0.54 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.245 0.929 . . . . 0.0 111.651 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.48 33.22 3.07 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.309 1.433 . . . . 0.0 115.259 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.97 111.38 23.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 118.858 1.329 . . . . 0.0 108.581 -169.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -80.33 113.23 18.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.101 -0.999 . . . . 0.0 110.355 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.25 133.73 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -172.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -105.15 155.56 18.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.355 1.062 . . . . 0.0 110.073 165.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 162.59 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 163.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -140.39 172.6 12.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 160.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.68 75.06 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.995 1.725 . . . . 0.0 112.46 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.76 124.82 2.38 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.748 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.84 162.72 12.88 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.404 ' C ' HG23 ' A' ' 17' ' ' VAL . 20.4 p -82.31 174.29 11.28 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.751 167.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.3 t -42.29 -47.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-O 117.429 -1.272 . . . . 0.0 110.597 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -60.82 -36.23 78.55 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.817 1.19 . . . . 0.0 113.85 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -66.08 -44.02 85.67 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.995 1.318 . . . . 0.0 108.632 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.808 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.7 -36.81 11.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.61 0.641 . . . . 0.0 111.298 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.5 mm -87.16 -52.06 12.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 108.849 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.47 -13.73 43.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.508 2.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -62.31 1.52 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 167.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.644 ' HB2' HD12 ' A' ' 106' ' ' LEU . 3.5 t80 -55.73 -43.78 76.91 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.449 -1.407 . . . . 0.0 113.163 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 p -60.16 -51.24 70.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.098 1.359 . . . . 0.0 108.794 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.49 37.87 0.71 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.169 0.988 . . . . 0.0 109.753 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 44.17 33.9 3.04 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.672 2.558 . . . . 0.0 114.549 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -106.63 36.58 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.422 1.111 . . . . 0.0 110.684 -168.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 101' ' ' PHE . 18.9 mt -137.82 172.05 13.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.3 -0.875 . . . . 0.0 108.922 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -111.33 139.13 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -170.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.23 91.89 6.82 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 124.745 1.218 . . . . 0.0 110.214 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.1 p -114.68 166.96 7.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.31 154.41 41.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 163.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.06 129.87 16.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.65 1.98 . . . . 0.0 106.947 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.79 99.19 0.81 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 1 C-N-CA 127.97 5.78 . . . . 0.0 108.765 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -96.04 170.32 9.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.842 1.257 . . . . 0.0 109.455 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 18' ' ' SER . 25.8 m -121.06 38.27 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.506 1.123 . . . . 0.0 110.739 163.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.23 171.62 44.69 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 120.807 -1.183 . . . . 0.0 112.623 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 26' ' ' TYR . 12.9 mttt -90.57 38.19 0.94 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.891 0.876 . . . . 0.0 111.212 -172.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.48 160.57 41.93 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 120.939 -1.101 . . . . 0.0 111.301 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -12.53 59.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.427 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 t -121.05 37.22 4.38 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 120.575 -1.328 . . . . 0.0 108.499 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 m -80.0 168.91 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 159.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mtp -79.26 145.62 33.45 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.572 -1.33 . . . . 0.0 110.099 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 57.3 t -80.2 158.68 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -126.99 149.49 49.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.206 . . . . 0.0 111.32 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER -86.21 33.02 0.61 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.436 1.016 . . . . 0.0 113.297 -166.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -165.13 120.93 1.38 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 118.717 -2.489 . . . . 0.0 106.657 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CE2' HD21 ' A' ' 79' ' ' LEU . 6.3 t80 -58.68 -72.37 0.1 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 124.582 1.176 . . . . 0.0 111.903 167.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -72.82 2.03 7.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.657 -160.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.478 HH11 ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -134.02 44.45 2.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.115 1.766 . . . . 0.0 109.068 173.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' CE1' ' A' ' 27' ' ' PHE . . . -89.5 -174.85 4.5 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -120.07 -25.78 5.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.27 0.941 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 81.0 m-85 -142.2 139.91 32.17 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 25.1 m-85 -123.44 100.87 7.03 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -80.98 120.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 58' ' ' LEU . 39.1 mt -110.55 112.16 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 4' ' ' VAL . 65.8 t80 -99.41 123.29 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -87.55 114.29 24.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.281 2.232 . . . . 0.0 109.601 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -75.59 7.15 3.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.049 1.295 . . . . 0.0 113.643 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -96.31 -41.26 8.73 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 119.123 0.874 . . . . 0.0 113.208 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -130.03 37.1 3.95 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.185 160.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.7 29.4 7.81 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.884 1.23 . . . . 0.0 113.185 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -91.87 161.22 14.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.692 1.197 . . . . 0.0 107.914 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.57 155.83 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.236 0.541 . . . . 0.0 109.605 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.2 pt-20 -136.06 155.96 49.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 166.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.18 107.52 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.27 141.79 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 159.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -111.08 111.56 22.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 127.517 2.327 . . . . 0.0 105.269 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 . . . . . 0 CA--C 1.519 -0.232 0 CA-C-N 119.237 0.926 . . . . 0.0 109.123 -167.159 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 CA-C-O 118.213 -0.828 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt 58.23 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.418 2.287 . . . . 0.0 110.787 -170.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -63.09 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 108.992 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.17 -53.08 38.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 115.612 -2.137 . . . . 0.0 109.184 -173.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -51.61 -46.14 63.49 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 120.658 1.572 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -38.89 85.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 29' ' ' ILE . 81.5 mt -77.68 -38.21 48.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.965 0.802 . . . . 0.0 110.168 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -58.25 -32.42 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.372 1.869 . . . . 0.0 110.304 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -13.42 8.57 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 112.934 173.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 8.2 mptt -114.17 37.7 3.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.331 1.052 . . . . 0.0 110.091 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.58 25.2 8.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.579 1.085 . . . . 0.0 114.401 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.04 114.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.11 37.87 3.37 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.299 1.523 . . . . 0.0 110.48 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.743 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.3 m-85 -176.48 172.07 2.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -165.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 67' ' ' ILE . 8.2 tp -177.6 130.41 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 108.459 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.754 HG21 ' HB1' ' A' ' 97' ' ' ALA . 55.0 mt -101.32 104.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.98 6.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.622 0.646 . . . . 0.0 109.379 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 p -47.2 -33.46 5.36 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.692 1.197 . . . . 0.0 112.209 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.25 -176.44 5.88 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 73' ' ' ARG 0.296 1.5 p -104.78 176.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 165.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -104.82 25.84 24.26 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.59 ' H ' HG13 ' A' ' 71' ' ' VAL . 6.2 ttt180 69.25 -169.53 0.18 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 128.659 2.784 . . . . 0.0 110.165 -164.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.4 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 22.0 t30 28.09 60.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.833 3.253 . . . . 0.0 114.77 170.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -174.73 -33.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.374 1.07 . . . . 0.0 113.328 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.613 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 48.1 t80 -54.13 -37.66 64.61 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.268 1.027 . . . . 0.0 112.178 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.5 -34.88 70.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.517 0.727 . . . . 0.0 110.189 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.8 -14.61 59.17 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.444 -0.785 . . . . 0.0 111.184 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' A' ' 21' ' ' PHE . 79.7 mt -70.25 -57.29 5.06 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.262 -0.899 . . . . 0.0 109.19 171.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.613 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -60.74 -28.89 69.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.352 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -53.28 51.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.062 0.846 . . . . 0.0 109.986 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.58 35.72 0.68 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.193 0.452 . . . . 0.0 111.556 176.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 36.19 0.4 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.214 2.34 . . . . 0.0 115.901 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 t -86.99 136.92 21.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.406 1.603 . . . . 0.0 109.925 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -79.23 162.33 25.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 172.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.39 139.02 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.74 155.88 26.99 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.307 1.843 . . . . 0.0 109.345 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -78.39 139.64 38.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 167.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.459 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -120.15 161.45 21.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 156.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -144.77 80.1 1.62 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.307 1.051 . . . . 0.0 110.686 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.75 139.65 1.31 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.52 166.24 13.07 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 121.784 0.658 . . . . 0.0 111.906 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.5 p -86.09 172.03 10.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.88 -0.66 . . . . 0.0 109.619 164.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -45.43 -40.9 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.199 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.13 -35.51 81.35 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.878 1.217 . . . . 0.0 114.277 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.37 -42.43 83.45 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.932 1.693 . . . . 0.0 108.617 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.754 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.46 -39.16 15.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.212 0.915 . . . . 0.0 111.916 171.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.33 -53.07 11.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -60.05 -27.23 66.77 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.829 2.051 . . . . 0.0 110.31 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -59.48 2.71 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.458 ' HB2' HD12 ' A' ' 106' ' ' LEU . 10.0 t80 -55.54 -49.77 71.78 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.204 0.911 . . . . 0.0 113.159 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.2 p -66.79 -25.88 66.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 110.414 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.19 37.23 3.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.278 1.431 . . . . 0.0 107.745 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.18 6.4 0.88 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.281 2.848 . . . . 0.0 116.715 168.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.503 HH11 ' HB3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -79.95 36.47 0.34 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 121.05 2.425 . . . . 0.0 111.445 -178.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 89' ' ' PHE . 38.6 mt -141.84 173.49 11.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.381 -1.449 . . . . 0.0 108.863 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -127.6 148.54 50.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.444 1.898 . . . . 0.0 107.557 -166.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.36 99.0 11.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 120.374 1.443 . . . . 0.0 108.062 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 tp . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.974 1.309 . . . . 0.0 109.976 -178.294 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.81 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -114.43 158.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.95 145.52 50.24 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.67 118.29 21.23 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.86 102.54 0.77 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 1 C-N-CA 126.18 4.587 . . . . 0.0 107.995 176.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.0 t -96.31 173.45 7.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.185 1.394 . . . . 0.0 107.406 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.07 38.38 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 109.038 164.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.35 175.46 44.62 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 121.025 -1.047 . . . . 0.0 111.96 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 19.9 mtmt -97.15 39.34 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.974 1.31 . . . . 0.0 110.296 -164.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.56 152.18 49.16 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -79.04 -0.43 31.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.169 1.788 . . . . 0.0 110.236 174.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -133.51 37.34 3.32 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 119.96 -1.712 . . . . 0.0 109.607 166.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 94' ' ' VAL . 36.6 m -82.76 173.36 11.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.321 156.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.97 139.03 39.15 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.812 -1.18 . . . . 0.0 109.216 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 97' ' ' ALA . 62.1 t -69.57 153.65 8.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 164.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -118.64 153.64 33.99 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.56 1.144 . . . . 0.0 110.253 -169.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.29 35.79 2.46 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.687 0.756 . . . . 0.0 111.256 -164.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -162.03 106.65 1.22 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.549 -1.344 . . . . 0.0 108.332 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CD2' HD11 ' A' ' 79' ' ' LEU . 14.4 t80 -53.96 -56.23 19.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -75.96 -6.23 49.96 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 121.013 1.733 . . . . 0.0 112.48 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.47 39.0 4.07 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.254 1.021 . . . . 0.0 109.843 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.32 178.99 5.55 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.46 -18.04 7.98 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 89.8 m-85 -146.3 156.17 43.16 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -132.76 105.51 7.2 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.1 mm -80.05 119.34 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.63 109.44 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -98.45 108.87 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 102.28 8.39 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.924 1.69 . . . . 0.0 109.757 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -68.48 15.9 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -120.69 -18.85 7.6 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.572 0.749 . . . . 0.0 112.663 -165.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.82 38.77 0.53 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 123.502 0.501 . . . . 0.0 110.098 158.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.42 16.33 0.92 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 128.572 2.987 . . . . 0.0 116.005 173.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -76.63 144.46 39.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.744 1.272 . . . . 0.0 109.584 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.29 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.616 1.166 . . . . 0.0 109.288 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.51 149.33 36.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.314 1.845 . . . . 0.0 108.043 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.14 111.04 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 162.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.87 128.64 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 153.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -84.14 140.87 31.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 160.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.436 -1.862 0 N-CA-C 109.639 -0.947 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 63.34 -64.59 0.11 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 126.426 1.89 . . . . 0.0 111.266 -171.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -63.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.314 1.446 . . . . 0.0 108.752 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -53.46 -49.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 126.291 1.836 . . . . 0.0 108.894 177.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.49 -37.96 12.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.017 1.281 . . . . 0.0 111.902 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -75.74 -58.74 3.1 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.792 0.837 . . . . 0.0 110.403 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.74 -44.33 85.97 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.26 1.024 . . . . 0.0 110.84 -171.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.76 -45.03 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.137 1.775 . . . . 0.0 110.108 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.4 m -77.18 7.42 5.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.622 1.169 . . . . 0.0 113.901 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.73 38.98 3.75 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.461 -1.399 . . . . 0.0 108.741 155.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.58 18.14 29.54 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.636 2.065 . . . . 0.0 116.759 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.74 89.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.511 1.924 . . . . 0.0 110.219 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -91.58 35.7 0.95 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.954 1.302 . . . . 0.0 111.066 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.81 ' HB3' HG23 ' A' ' 4' ' ' VAL . 15.3 m-85 177.89 166.56 0.71 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 120.03 -1.668 . . . . 0.0 107.317 -170.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 68' ' ' ALA . 9.2 tp -165.96 150.51 8.22 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.733 HG21 ' HB1' ' A' ' 97' ' ' ALA . 67.1 mt -120.84 103.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -149.13 120.87 8.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.607 1.094 . . . . 0.0 108.16 -176.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' A' ' 89' ' ' PHE . 79.4 p -54.35 -34.57 61.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.896 0.379 . . . . 0.0 111.981 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.26 170.33 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -97.37 147.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -82.15 33.72 2.67 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ttm105 61.14 -161.35 0.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.316 1.846 . . . . 0.0 108.64 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t30 25.28 69.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.842 2.857 . . . . 0.0 112.802 174.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -177.89 -28.54 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 57.3 t80 -70.27 -36.92 74.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 121.317 1.871 . . . . 0.0 110.928 -158.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.24 -32.43 72.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.523 0.729 . . . . 0.0 109.598 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -13.85 59.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.627 1.171 . . . . 0.0 109.842 -177.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' CD2' ' A' ' 21' ' ' PHE . 28.8 mt -80.81 -62.47 1.66 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -59.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.387 -0.815 . . . . 0.0 112.265 177.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -16.04 27.75 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.217 -0.897 . . . . 0.0 113.366 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.62 36.71 4.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.674 1.125 . . . . 0.0 111.071 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.03 31.01 1.14 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.121 2.296 . . . . 0.0 116.824 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.49 112.62 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.071 1.435 . . . . 0.0 109.841 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -79.31 102.75 8.8 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 79' ' ' LEU . 61.8 t -84.05 126.05 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -96.69 157.1 16.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.17 1.788 . . . . 0.0 109.726 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.49 154.16 30.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.77 2.028 . . . . 0.0 105.794 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.43 168.52 19.48 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 152.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.56 38.75 1.38 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.035 1.289 . . . . 0.0 112.288 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 112.82 3.74 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.358 -1.463 . . . . 0.0 112.908 170.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.37 164.71 30.36 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.598 2.047 . . . . 0.0 109.697 -161.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.42 ' C ' HG23 ' A' ' 17' ' ' VAL . 69.6 p -87.63 169.85 11.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.226 1.013 . . . . 0.0 109.211 166.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 15' ' ' SER . 27.0 t -43.1 -47.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.538 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -63.11 -30.32 71.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -69.6 -40.67 76.52 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 120.483 1.492 . . . . 0.0 110.119 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.733 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -51.88 -28.27 15.56 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -92.94 -56.78 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 C-N-CA 125.689 1.596 . . . . 0.0 107.351 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.93 -41.31 64.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.247 0.967 . . . . 0.0 108.68 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.39 -50.66 58.71 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -43.37 68.67 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 111.479 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.9 p -67.41 -35.65 79.7 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.175 1.79 . . . . 0.0 110.464 -171.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.64 36.76 2.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.031 0.932 . . . . 0.0 108.74 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.96 20.93 0.79 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.813 2.149 . . . . 0.0 115.953 172.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -93.63 38.92 1.06 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.58 1.69 . . . . 0.0 110.206 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.3 mt -140.37 169.67 17.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 109.02 165.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -121.61 143.18 49.46 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.609 -163.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -79.48 100.8 7.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.448 -0.567 0 C-N-CA 125.079 1.352 . . . . 0.0 108.517 174.055 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 -173.85 3.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.531 1.132 . . . . 0.0 112.029 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.23 116.74 27.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 128.371 2.669 . . . . 0.0 107.636 165.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -92.91 141.01 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.05 155.06 18.99 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.56 122.17 13.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.466 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 57.1 Cg_endo -70.45 102.62 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.618 4.212 . . . . 0.0 109.129 177.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -100.26 175.41 5.73 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.34 1.456 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.06 37.03 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.694 0.798 . . . . 0.0 109.968 166.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.94 -173.86 46.34 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 120.46 -1.4 . . . . 0.0 111.783 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -125.61 39.55 3.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.45 1.125 . . . . 0.0 111.602 -165.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.18 153.03 51.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.963 1.305 . . . . 0.0 107.626 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -75.39 -7.21 53.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.349 1.46 . . . . 0.0 113.02 -170.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -115.59 38.15 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.434 -1.416 . . . . 0.0 109.667 164.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.9 m -79.5 166.91 21.47 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.61 140.45 39.65 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.714 -1.242 . . . . 0.0 108.344 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.4 t -77.47 137.28 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -83.06 146.31 28.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.45 1.5 . . . . 0.0 108.203 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.67 38.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.786 -0.571 . . . . 0.0 110.293 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 179.77 108.91 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 119.923 -1.736 . . . . 0.0 108.889 -161.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 79' ' ' LEU . 19.5 t80 -53.95 -65.6 0.54 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.247 0.619 . . . . 0.0 111.392 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.96 12.19 3.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.711 -171.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -131.23 37.43 3.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.815 0.734 . . . . 0.0 109.481 164.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -86.81 -176.01 5.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -122.74 -14.27 7.74 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -144.72 154.69 43.01 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.487 ' CE2' HG23 ' A' ' 54' ' ' VAL . 71.2 m-85 -133.09 116.37 16.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 39' ' ' VAL . 12.4 mm -95.42 118.03 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.31 97.77 6.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.431 ' HB3' HG12 ' A' ' 4' ' ' VAL . 44.5 t80 -83.96 111.05 18.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.784 1.234 . . . . 0.0 108.637 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 101.36 7.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.813 2.845 . . . . 0.0 111.322 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 p -75.78 43.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.96 -1.088 . . . . 0.0 112.732 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.7 -37.72 1.17 Allowed 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 116.996 -1.478 . . . . 0.0 112.197 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -133.86 36.79 3.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 124.94 1.4 . . . . 0.0 111.972 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.89 1.3 Allowed Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.988 1.756 . . . . 0.0 113.003 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.01 150.85 21.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.3 149.12 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 122.218 1.008 . . . . 0.0 109.063 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.09 134.44 52.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 28' ' ' ILE . 40.9 t -101.32 108.63 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.24 152.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.34 103.25 7.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.95 111.96 14.72 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -168.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.3 p -96.75 71.13 2.56 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -166.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' CG2' ' HE3' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -112.34 96.83 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 126.608 1.963 . . . . 0.0 108.4 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.75 50.3 2.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.033 0.933 . . . . 0.0 109.303 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -160.61 -171.46 3.14 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.278 -0.889 . . . . 0.0 108.823 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.94 176.11 7.85 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.21 1.804 . . . . 0.0 110.126 170.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 61.59 -174.72 0.13 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.271 2.228 . . . . 0.0 112.167 -164.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.06 179.34 18.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.307 1.432 . . . . 0.0 110.061 -166.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.7 t -135.06 134.07 39.97 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.682 1.193 . . . . 0.0 108.325 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.34 157.36 24.0 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.011 1.291 . . . . 0.0 110.356 -171.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.11 -55.12 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.303 2.002 . . . . 0.0 111.523 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HE3' ' CG2' ' A' ' 44' ' ' ILE . 0.4 OUTLIER 59.93 -62.06 0.06 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 127.038 2.135 . . . . 0.0 112.333 -168.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG23 ' CE2' ' A' ' 27' ' ' PHE . 2.7 p -52.5 -62.55 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -52.73 52.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-O 116.129 -1.891 . . . . 0.0 109.692 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -46.21 -48.42 17.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.96 1.254 . . . . 0.0 111.481 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 t -61.96 -62.65 1.64 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.388 0.675 . . . . 0.0 111.139 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.9 mt -53.75 -46.83 71.02 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.925 1.69 . . . . 0.0 111.281 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 t -56.75 -45.55 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.846 1.658 . . . . 0.0 110.232 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.8 m -71.95 8.07 1.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.013 0.925 . . . . 0.0 112.217 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.68 37.62 4.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 166.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.91 5.32 2.85 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 129.102 3.239 . . . . 0.0 117.344 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.7 t -53.46 108.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 121.107 2.453 . . . . 0.0 112.681 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -105.82 35.65 2.82 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.948 0.88 . . . . 0.0 111.711 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.726 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.5 m-85 -176.91 168.36 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.008 -2.308 . . . . 0.0 108.384 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 tp -166.55 152.19 8.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.787 HG21 ' HB1' ' A' ' 97' ' ' ALA . 44.1 mt -119.94 94.9 3.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.43 108.82 3.96 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.069 0.948 . . . . 0.0 111.202 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 p -48.74 -28.21 3.46 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.908 2.483 . . . . 0.0 115.565 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.75 178.52 4.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.662 1.985 . . . . 0.0 106.039 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.19 155.09 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 120.848 -1.158 . . . . 0.0 108.356 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -48.51 -58.93 6.94 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 167.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 151.6 -177.7 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 1 C-N-CA 133.82 4.848 . . . . 0.0 105.357 -166.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 25.62 58.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 129.426 3.091 . . . . 0.0 116.153 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.28 -29.3 0.12 Allowed 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.727 ' HA ' HD12 ' A' ' 79' ' ' LEU . 46.4 t80 -61.2 -33.8 74.05 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.632 0.651 . . . . 0.0 112.462 -169.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.89 -33.88 71.03 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.625 0.37 . . . . 0.0 110.833 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 -16.54 41.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.307 0.643 . . . . 0.0 110.088 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 76' ' ' PHE . 27.8 mt -64.28 -66.69 0.51 Allowed 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.598 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -60.73 -27.0 67.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.47 -31.08 33.11 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.294 0.638 . . . . 0.0 112.368 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.25 37.42 2.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.279 1.032 . . . . 0.0 110.631 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.82 27.03 8.85 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.773 1.654 . . . . 0.0 116.653 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.64 114.02 19.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 118.639 1.219 . . . . 0.0 109.187 -168.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -79.59 103.32 9.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 79' ' ' LEU . 24.9 t -92.07 109.88 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.988 1.715 . . . . 0.0 108.695 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -79.72 162.25 25.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.015 1.326 . . . . 0.0 111.465 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -79.56 152.61 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.479 1.912 . . . . 0.0 106.567 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.55 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -131.92 163.93 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 155.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.33 92.72 1.72 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.658 1.572 . . . . 0.0 109.274 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.56 86.48 0.91 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.697 1.142 . . . . 0.0 115.695 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.63 159.95 28.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 121.387 -1.067 . . . . 0.0 112.302 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.7 p -82.8 172.51 12.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.347 0.659 . . . . 0.0 109.505 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.6 t -46.26 -42.55 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.298 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -35.24 76.93 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.548 1.522 . . . . 0.0 114.499 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.86 -45.64 85.19 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 125.106 1.362 . . . . 0.0 108.138 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.787 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -50.06 -29.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -89.58 -60.91 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 C-N-CA 125.141 1.376 . . . . 0.0 107.448 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -48.98 -41.23 33.59 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 127.51 2.324 . . . . 0.0 109.404 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.64 -54.99 15.1 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.731 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 106' ' ' LEU . 15.7 t80 -58.09 -47.44 83.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.932 1.293 . . . . 0.0 111.971 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.8 p -68.43 -33.44 74.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.086 1.754 . . . . 0.0 110.413 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.75 37.82 2.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.87 44.66 24.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.906 2.194 . . . . 0.0 115.115 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -118.28 38.25 3.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.49 1.145 . . . . 0.0 110.468 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 101' ' ' PHE . 25.4 mt -133.04 170.37 15.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.386 0.994 . . . . 0.0 108.686 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -112.74 147.29 37.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -79.94 121.97 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.51 66.93 0.89 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.213 1.005 . . . . 0.0 109.903 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -96.03 37.7 1.22 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.295 1.038 . . . . 0.0 111.913 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.1 t 157.93 164.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 1 C-N-CA 133.112 4.565 . . . . 0.0 104.929 172.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.77 169.21 17.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.8 1.64 . . . . 0.0 107.567 173.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 m -94.76 161.94 13.97 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.242 1.017 . . . . 0.0 109.348 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -164.17 107.82 0.95 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.99 38.38 0.65 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 117.01 -1.994 . . . . 0.0 109.072 -178.269 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 178.86 158.4 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.533 2.733 . . . . 0.0 107.879 162.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -79.35 140.7 37.42 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -108.32 134.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.478 -2.415 . . . . 0.0 104.478 -177.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.43 146.19 27.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.25 123.41 20.62 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.606 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 87.9 Cg_endo -80.73 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 1 C-N-CA 126.404 4.736 . . . . 0.0 109.392 -174.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.2 t -83.48 169.34 15.6 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.307 1.043 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.1 m -120.56 38.77 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.701 1.2 . . . . 0.0 110.582 163.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.49 170.63 42.18 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 164.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -93.48 46.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.952 1.701 . . . . 0.0 110.27 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -138.41 153.43 48.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.041 0.936 . . . . 0.0 108.74 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.72 -15.49 59.76 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.246 1.418 . . . . 0.0 109.256 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.55 39.46 3.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.587 -1.321 . . . . 0.0 110.638 165.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -88.41 166.71 14.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 159.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.15 146.46 35.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.919 0.887 . . . . 0.0 109.887 -173.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 93' ' ' THR . 3.2 t -93.0 147.31 5.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 122.349 1.071 . . . . 0.0 109.859 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -105.8 132.74 51.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.222 1.809 . . . . 0.0 108.193 -165.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -79.45 38.44 0.37 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.767 0.794 . . . . 0.0 110.024 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -172.61 93.99 0.12 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 119.209 -2.182 . . . . 0.0 108.752 -160.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 79' ' ' LEU . 13.6 t80 -49.97 -61.42 2.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 112.047 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.5 -0.8 16.12 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -168.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -133.69 58.92 1.75 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.753 2.421 . . . . 0.0 107.066 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -101.98 179.71 4.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 163.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.91 -19.99 7.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.488 0.586 . . . . 0.0 112.145 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.41 144.23 33.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 42.6 m-85 -126.29 99.7 5.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.1 mm -80.79 121.53 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -108.82 117.11 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HB3' HG12 ' A' ' 4' ' ' VAL . 85.5 t80 -103.11 131.31 50.21 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.093 1.357 . . . . 0.0 109.014 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.12 122.78 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.849 1.66 . . . . 0.0 111.005 173.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 p -88.16 42.15 1.04 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 164.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.33 -96.85 0.36 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.72 37.92 1.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.919 -162.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.22 2.79 0.03 OUTLIER Glycine 0 CA--C 1.536 1.37 0 C-N-CA 128.708 3.052 . . . . 0.0 116.387 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -72.84 140.88 47.9 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.957 1.303 . . . . 0.0 109.745 -165.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.937 0.895 . . . . 0.0 109.745 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -141.92 128.76 20.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.646 1.578 . . . . 0.0 107.435 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.76 117.85 33.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.69 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 152.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.57 142.93 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.133 1.773 . . . . 0.0 106.382 158.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.2 114.33 4.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.025 -1.047 . . . . 0.0 109.929 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.2 p -101.65 52.1 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.308 0.643 . . . . 0.0 110.116 -155.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 107.35 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.829 0.824 . . . . 0.0 110.361 -172.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.66 60.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.761 2.025 . . . . 0.0 107.298 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -147.79 152.55 37.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.241 1.816 . . . . 0.0 106.252 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.01 39.67 1.48 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.292 1.037 . . . . 0.0 110.768 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -4.87 56.0 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.1 15.8 80.92 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.953 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.7 m -102.52 102.78 13.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.381 1.591 . . . . 0.0 109.923 -170.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.31 171.56 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.423 1.487 . . . . 0.0 114.867 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.23 -59.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.833 1.688 . . . . 0.0 111.008 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 63.51 -63.56 0.13 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.403 1.481 . . . . 0.0 111.249 -166.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -65.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -49.05 -53.02 8.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 126.324 1.85 . . . . 0.0 108.97 175.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -53.57 7.06 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 124.378 1.049 . . . . 0.0 111.466 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -70.05 -46.79 64.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.19 -40.54 90.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.783 -1.198 . . . . 0.0 110.069 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.8 t -57.0 -41.95 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.998 1.719 . . . . 0.0 110.291 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -55.74 -29.85 60.23 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.597 0.635 . . . . 0.0 111.666 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -101.82 38.57 1.61 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.442 1.019 . . . . 0.0 109.045 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.47 18.35 29.56 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 126.324 1.916 . . . . 0.0 116.443 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.82 114.12 4.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' HA ' HG13 ' A' ' 84' ' ' VAL . 12.3 mt-10 -124.15 35.63 4.78 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 118.626 0.648 . . . . 0.0 111.443 167.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.645 ' HB3' HG23 ' A' ' 4' ' ' VAL . 8.0 m-30 -158.75 162.7 37.13 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 68' ' ' ALA . 6.7 tp -166.17 150.8 8.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.736 -1.853 . . . . 0.0 107.099 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 66' ' ' LEU . 59.0 mt -121.79 99.66 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -153.91 113.18 3.75 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.308 1.043 . . . . 0.0 109.21 -174.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -52.52 -30.45 30.46 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.433 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -160.53 169.81 22.2 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.541 1.937 . . . . 0.0 106.911 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.04 153.67 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.29 50.95 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.61 -160.82 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.834 3.254 . . . . 0.0 106.553 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -28.93 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 129.404 3.081 . . . . 0.0 112.766 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -175.98 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.38 1.872 . . . . 0.0 110.084 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' A' ' 79' ' ' LEU . 45.8 t80 -57.56 -38.97 75.67 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.195 1.398 . . . . 0.0 111.61 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.45 -24.89 63.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.457 0.571 . . . . 0.0 111.226 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.8 m -84.41 -18.2 36.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.964 -1.085 . . . . 0.0 112.065 170.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 76' ' ' PHE . 33.9 mt -66.85 -61.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.341 0.973 . . . . 0.0 108.696 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HE3' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -55.95 -32.67 64.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 171.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.28 67.66 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.388 0.994 . . . . 0.0 110.674 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.38 36.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.386 0.994 . . . . 0.0 111.914 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.16 28.68 3.18 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.453 1.502 . . . . 0.0 116.047 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 64' ' ' GLU . 12.4 t -86.61 123.63 39.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 118.772 1.286 . . . . 0.0 108.344 -170.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 159.65 28.3 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.14 148.0 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.642 1.577 . . . . 0.0 108.011 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -118.33 155.87 29.89 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.346 1.858 . . . . 0.0 109.994 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.78 146.45 33.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 164.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.406 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -122.85 166.91 14.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 154.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -154.31 60.11 0.7 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.816 1.189 . . . . 0.0 109.411 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.24 121.02 3.05 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.564 1.078 . . . . 0.0 111.89 168.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.97 167.58 18.32 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.359 1.079 . . . . 0.0 114.993 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.434 ' C ' HG23 ' A' ' 17' ' ' VAL . 81.1 p -87.88 174.79 8.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.231 1.012 . . . . 0.0 110.694 162.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.6 t -48.85 -38.29 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.002 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -65.99 -33.61 76.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 121.076 1.762 . . . . 0.0 113.928 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -69.58 -41.6 75.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.768 1.627 . . . . 0.0 108.801 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -42.88 -42.08 3.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.141 0.882 . . . . 0.0 111.902 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.19 -48.66 14.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.791 1.237 . . . . 0.0 108.227 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.13 -24.97 63.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.274 1.829 . . . . 0.0 110.153 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.67 -57.33 3.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.428 ' HB2' HD12 ' A' ' 106' ' ' LEU . 1.1 t80 -57.14 -44.7 83.65 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.211 1.004 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.0 p -61.97 -50.76 70.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.084 1.354 . . . . 0.0 108.765 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.92 35.62 0.64 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.841 0.857 . . . . 0.0 109.134 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.05 24.51 2.09 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.02 1.771 . . . . 0.0 114.978 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -98.34 37.76 1.42 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.076 1.438 . . . . 0.0 109.984 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 101' ' ' PHE . 19.7 mt -134.36 165.24 25.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -109.03 138.52 45.25 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.7 100.47 7.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.689 1.131 . . . . 0.0 108.59 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -84.61 71.72 10.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.751 0.821 . . . . 0.0 110.65 -166.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 p -91.25 35.29 0.93 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.955 -1.09 . . . . 0.0 112.306 -170.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.7 t 158.82 164.63 0.01 OUTLIER 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.328 2.251 . . . . 0.0 106.495 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -167.82 -169.65 1.21 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.979 2.511 . . . . 0.0 106.097 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.1 m -128.44 145.85 50.97 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -162.67 91.47 0.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -85.82 59.13 5.44 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 -170.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 126.227 1.87 . . . . 0.0 110.331 176.512 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptp . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 65' ' ' TYR . . . -154.04 128.99 9.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 161.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -98.18 103.59 15.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.112 1.365 . . . . 0.0 109.719 164.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.812 HG23 ' HB3' ' A' ' 65' ' ' TYR . 9.8 p -82.88 156.02 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.96 146.4 39.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 163.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.49 HD11 HG13 ' A' ' 4' ' ' VAL . 4.2 mp -126.78 129.08 24.13 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.83 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.448 -1.203 1 C-N-CA 125.307 4.005 . . . . 0.0 108.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 t -111.3 171.08 7.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.567 1.147 . . . . 0.0 109.876 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -129.82 39.39 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.73 2.012 . . . . 0.0 108.227 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.1 173.1 42.34 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -110.29 50.0 0.82 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.016 1.326 . . . . 0.0 108.268 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.71 157.13 45.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.983 1.313 . . . . 0.0 108.016 171.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 0.8 25.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.313 1.445 . . . . 0.0 110.339 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -127.25 37.63 4.22 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.021 -1.674 . . . . 0.0 108.755 168.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -81.07 165.07 21.98 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.419 -0.801 . . . . 0.0 109.381 163.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.41 135.35 37.41 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.664 1.12 . . . . 0.0 109.047 -175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 93.0 t -75.34 137.53 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.67 131.12 42.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 107.361 -172.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.67 38.59 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.634 1.207 . . . . 0.0 110.862 -173.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.46 93.5 0.76 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 118.401 -2.687 . . . . 0.0 107.132 -166.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 79' ' ' LEU . 20.2 t80 -55.12 -52.58 62.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.632 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.79 13.59 1.0 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.04 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.28 38.29 1.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.286 1.403 . . . . 0.0 110.082 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -103.91 127.85 51.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -172.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.43 -20.15 64.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.62 151.98 42.02 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 92.6 m-85 -131.3 119.61 22.0 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.31 112.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.492 HD11 HD23 ' A' ' 58' ' ' LEU . 83.2 mt -101.76 112.47 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.689 ' HB3' HG12 ' A' ' 4' ' ' VAL . 16.7 t80 -104.28 125.83 50.87 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.859 1.264 . . . . 0.0 110.582 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.84 112.11 19.82 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.188 0.995 . . . . 0.0 108.676 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -77.43 54.57 1.16 Allowed 'General case' 0 C--O 1.239 0.518 0 O-C-N 120.832 -1.167 . . . . 0.0 108.838 163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -151.58 -34.67 0.14 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.46 38.03 0.43 Allowed 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 117.524 -1.67 . . . . 0.0 111.873 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.1 9.48 2.0 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.011 1.291 . . . . 0.0 115.01 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -61.91 146.36 50.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.893 1.346 . . . . 0.0 107.687 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.44 142.42 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.25 132.23 53.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.275 1.83 . . . . 0.0 106.629 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.27 110.53 25.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.22 150.57 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 158.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -124.02 106.76 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -122.89 124.56 43.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.1 p -110.02 62.22 0.6 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -165.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.39 76.74 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.092 -1.005 . . . . 0.0 110.485 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -105.5 37.69 2.15 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.885 -0.509 . . . . 0.0 111.337 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -144.7 159.62 42.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.218 1.007 . . . . 0.0 110.006 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.6 103.55 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -145.72 -47.28 0.21 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.314 -168.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.24 174.37 18.53 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.496 1.044 . . . . 0.0 113.84 163.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m 52.1 87.76 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.804 2.041 . . . . 0.0 111.1 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.8 126.24 2.56 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 117.91 -1.495 . . . . 0.0 110.61 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -74.94 -51.22 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.029 1.819 . . . . 0.0 110.758 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 58.61 -66.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.397 1.879 . . . . 0.0 111.094 -161.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -48.91 -63.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.427 1.491 . . . . 0.0 111.174 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.36 -49.66 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 116.028 -1.939 . . . . 0.0 109.266 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -49.69 -49.81 46.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.827 1.194 . . . . 0.0 110.652 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 t -61.83 -55.11 33.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.406 1.082 . . . . 0.0 112.073 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.492 HD23 HD11 ' A' ' 29' ' ' ILE . 96.0 mt -59.21 -43.15 92.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.28 0.632 . . . . 0.0 109.843 -174.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 t -60.66 -45.17 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.528 1.931 . . . . 0.0 110.861 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -58.02 -26.07 61.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.532 1.06 . . . . 0.0 111.808 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -104.0 36.78 2.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.053 0.941 . . . . 0.0 109.08 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.12 11.69 55.93 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 127.012 2.244 . . . . 0.0 117.162 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.57 105.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.96 1.38 . . . . 0.0 110.791 -170.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -104.88 36.43 2.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.338 1.055 . . . . 0.0 110.847 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.812 ' HB3' HG23 ' A' ' 4' ' ' VAL . 1.4 m-85 -171.62 173.05 4.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 119.804 -1.81 . . . . 0.0 109.888 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.496 HD23 HG13 ' A' ' 86' ' ' VAL . 16.4 tp -166.81 157.64 12.14 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.941 1.296 . . . . 0.0 108.716 170.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.792 HG21 ' HB1' ' A' ' 97' ' ' ALA . 48.2 mt -124.37 106.12 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 168.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.41 130.99 10.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 p -63.68 -26.04 68.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -170.02 -177.89 2.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -166.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.17 154.09 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.603 -1.311 . . . . 0.0 108.037 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.05 -51.37 25.31 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 164.52 -86.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 130.942 3.697 . . . . 0.0 104.937 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.73 119.88 15.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.7 -35.84 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 130.572 3.549 . . . . 0.0 109.831 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.535 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 33.6 t80 -53.02 -43.92 66.92 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.163 1.385 . . . . 0.0 111.658 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.43 -31.2 72.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.339 1.455 . . . . 0.0 109.856 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -21.78 38.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.817 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.643 HD21 ' CE2' ' A' ' 21' ' ' PHE . 94.4 mt -69.86 -59.11 3.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.273 0.942 . . . . 0.0 108.653 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -58.9 -31.35 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.568 1.147 . . . . 0.0 112.999 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.13 -8.19 7.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.47 36.5 4.55 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.81 1.641 . . . . 0.0 110.211 165.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.79 19.46 3.39 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.681 2.086 . . . . 0.0 116.619 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.2 129.73 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 O-C-N 121.131 -1.217 . . . . 0.0 108.184 -163.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -78.56 165.18 24.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG13 HD23 ' A' ' 66' ' ' LEU . 29.6 t -151.71 114.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -89.03 157.51 18.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.768 0.827 . . . . 0.0 110.181 167.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.81 156.17 27.53 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.697 1.599 . . . . 0.0 107.101 162.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -138.04 175.73 9.33 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 158.182 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.45 38.72 0.71 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 122.191 2.269 . . . . 0.0 114.759 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.04 123.17 2.82 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 172.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.41 163.37 13.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -166.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.44 ' C ' HG23 ' A' ' 17' ' ' VAL . 25.5 p -81.97 172.31 13.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.305 0.553 . . . . 0.0 110.272 168.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -41.26 -47.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.698 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -35.22 77.89 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -67.88 -45.19 75.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 125.363 1.465 . . . . 0.0 108.573 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.792 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.25 -30.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 172.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.71 -52.6 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 116.359 -1.781 . . . . 0.0 108.684 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -33.69 69.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 124.38 1.05 . . . . 0.0 108.964 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.24 -54.0 14.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.497 ' HB2' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -56.84 -45.53 82.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.515 1.126 . . . . 0.0 111.899 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.7 p -64.46 -42.15 96.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.526 1.13 . . . . 0.0 108.104 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.64 35.65 1.22 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.937 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.08 7.52 3.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.517 1.532 . . . . 0.0 116.39 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -85.66 36.82 0.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 120.067 1.933 . . . . 0.0 112.064 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 101' ' ' PHE . 17.5 mt -131.22 170.24 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 120.081 1.309 . . . . 0.0 108.614 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -111.69 142.07 44.49 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -81.34 106.68 13.5 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.905 1.23 . . . . 0.0 107.943 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -85.08 54.74 3.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.332 1.453 . . . . 0.0 109.48 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.286 8.2 t -88.48 35.88 0.78 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.446 -1.409 . . . . 0.0 111.555 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t 169.61 84.75 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.35 -1.469 . . . . 0.0 107.847 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -156.9 170.32 22.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 107.302 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.65 168.67 26.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.726 1.61 . . . . 0.0 107.675 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -146.17 171.89 14.25 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 161.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.37 47.34 0.59 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.575 -0.703 . . . . 0.0 110.807 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 157.087 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.47 -173.65 4.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.725 1.21 . . . . 0.0 110.906 -173.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -110.27 147.97 32.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.179 150.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.93 HG23 ' HB3' ' A' ' 65' ' ' TYR . 9.3 p -129.35 125.79 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.878 1.271 . . . . 0.0 109.463 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.2 29.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.8 118.63 24.19 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 74.2 Cg_endo -71.55 99.58 0.95 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 1 C-N-CA 125.43 4.086 . . . . 0.0 107.551 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 t -94.3 175.47 6.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.911 1.285 . . . . 0.0 108.77 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.54 39.42 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.282 1.033 . . . . 0.0 109.891 161.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.17 172.13 45.2 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.774 -1.204 . . . . 0.0 111.441 167.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 29.4 mtmt -94.6 39.9 1.09 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.141 2.177 . . . . 0.0 108.871 -172.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.95 148.27 38.35 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -12.46 61.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.142 2.577 . . . . 0.0 110.81 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -116.02 38.8 3.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.607 -1.308 . . . . 0.0 109.014 170.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -89.88 168.03 12.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.182 -0.949 . . . . 0.0 109.026 163.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 142.39 38.32 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.283 -0.885 . . . . 0.0 109.007 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 59.2 t -81.83 150.81 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -109.03 138.46 45.33 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.805 1.642 . . . . 0.0 110.548 -167.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -83.45 37.31 0.56 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.422 1.106 . . . . 0.0 112.034 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -172.75 85.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 119.956 -1.715 . . . . 0.0 109.334 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CD2' HD11 ' A' ' 79' ' ' LEU . 14.4 t80 -50.39 -50.77 50.71 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -0.03 30.72 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.396 -0.815 . . . . 0.0 112.071 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.02 38.61 3.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.876 1.271 . . . . 0.0 109.839 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . . . -118.59 142.25 47.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -173.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -91.79 -20.64 21.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -158.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.554 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 96.5 m-85 -146.47 124.95 12.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.38 107.85 18.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.8 mm -81.88 114.96 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.554 HD11 ' CD2' ' A' ' 58' ' ' LEU . 78.6 mt -110.61 106.89 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.646 ' HB3' HG12 ' A' ' 4' ' ' VAL . 5.1 t80 -88.1 116.6 26.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.47 101.25 8.1 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.779 2.032 . . . . 0.0 108.079 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.555 HG22 ' CD2' ' A' ' 30' ' ' TYR . 5.3 p -86.6 22.51 1.88 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.559 1.171 . . . . 0.0 111.227 -171.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.47 -89.84 0.4 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 167.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.95 37.4 0.84 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.063 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.36 24.04 9.91 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.754 2.121 . . . . 0.0 114.437 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -82.66 154.3 24.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -138.92 136.88 42.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.443 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.8 pt-20 -122.96 163.2 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.312 1.045 . . . . 0.0 110.446 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.94 104.31 15.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.173 1.389 . . . . 0.0 108.209 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 t -79.25 151.75 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -120.17 123.56 43.61 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 129.597 3.159 . . . . 0.0 104.427 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -144.96 113.04 6.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.991 0.814 . . . . 0.0 109.289 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.3 p -94.79 65.17 3.0 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -161.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.69 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 122.987 1.375 . . . . 0.0 112.198 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.22 -139.27 0.09 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.733 1.613 . . . . 0.0 109.15 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.57 38.84 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.499 1.52 . . . . 0.0 109.465 -165.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.76 -175.36 3.55 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.926 1.691 . . . . 0.0 109.833 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 157.13 8.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 169.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.07 -62.25 6.51 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.266 8.7 p 64.85 -137.18 0.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.366 1.466 . . . . 0.0 109.203 -173.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.18 170.51 20.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.93 -27.35 84.72 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 63.66 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 126.597 1.959 . . . . 0.0 109.217 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -56.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 126.028 1.731 . . . . 0.0 111.675 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.11 -34.98 72.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.107 -171.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -16.38 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.535 1.516 . . . . 0.0 113.727 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -98.11 -46.2 5.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 120.283 1.401 . . . . 0.0 109.971 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.554 ' CD2' HD11 ' A' ' 29' ' ' ILE . 88.5 mt -68.88 -37.93 79.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.967 0.507 . . . . 0.0 112.012 -173.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.48 -50.52 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 123.85 0.86 . . . . 0.0 108.845 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.3 m -74.89 13.13 0.7 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 4.9 mttt -127.66 37.56 4.19 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.356 1.463 . . . . 0.0 108.707 163.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 38.57 39.3 0.79 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.831 1.682 . . . . 0.0 114.523 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 77.5 t -81.69 87.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.484 1.513 . . . . 0.0 108.402 -172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -91.09 35.62 0.91 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.555 1.071 . . . . 0.0 111.851 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.93 ' HB3' HG23 ' A' ' 4' ' ' VAL . 25.5 m-85 -164.63 162.45 21.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.797 -1.815 . . . . 0.0 108.595 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tp -160.15 153.22 21.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.742 HG21 ' HB1' ' A' ' 97' ' ' ALA . 79.1 mt -125.81 98.59 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.263 1.425 . . . . 0.0 107.707 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.62 133.33 16.84 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 120.205 1.366 . . . . 0.0 111.412 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.4 p -74.39 -18.4 60.67 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.42 -169.86 0.87 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.063 1.745 . . . . 0.0 108.292 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.66 140.37 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 120.376 -1.453 . . . . 0.0 108.764 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -46.29 -54.89 8.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.459 1.504 . . . . 0.0 110.526 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 172.12 152.92 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.541 2.736 . . . . 0.0 106.464 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 -144.91 0.5 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.378 1.871 . . . . 0.0 109.923 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.42 -30.9 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 129.565 3.146 . . . . 0.0 116.117 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.686 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 59.0 t80 -57.92 -40.94 81.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.245 2.218 . . . . 0.0 111.653 -169.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.75 -41.11 83.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.599 1.159 . . . . 0.0 110.099 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -69.06 -19.59 64.09 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.252 -0.905 . . . . 0.0 110.575 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 76' ' ' PHE . 71.0 mt -72.4 -61.33 1.84 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.351 0.978 . . . . 0.0 109.411 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.686 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -58.33 -35.89 72.57 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.769 -1.207 . . . . 0.0 112.473 176.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.12 -7.54 9.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.69 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.61 36.5 4.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 121.211 1.823 . . . . 0.0 110.733 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.16 5.91 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.111 1.815 . . . . 0.0 115.48 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.24 116.31 27.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 118.486 1.143 . . . . 0.0 109.626 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -79.8 94.62 5.82 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.678 HG11 ' CZ ' ' A' ' 112' ' ' PHE . 38.8 t -80.12 128.78 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -103.78 160.65 14.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.415 1.886 . . . . 0.0 108.895 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -79.0 161.23 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 164.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.484 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -138.28 165.12 27.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 155.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -150.24 39.47 0.75 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 121.008 1.731 . . . . 0.0 113.189 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.25 102.69 1.71 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 121.231 -0.918 . . . . 0.0 112.207 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.07 163.14 26.99 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 111.68 -168.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.4 p -84.41 173.64 10.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.118 0.567 . . . . 0.0 109.95 165.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -48.61 -40.21 11.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.321 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -63.07 -33.53 75.64 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -71.77 -37.57 70.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.556 1.542 . . . . 0.0 109.897 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.742 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.03 -43.55 19.76 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.092 0.86 . . . . 0.0 110.548 168.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -81.14 -55.6 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 C-N-CA 125.329 1.452 . . . . 0.0 108.356 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.28 -31.23 65.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.109 1.764 . . . . 0.0 108.603 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.04 -52.54 7.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.939 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -51.77 -45.1 63.63 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.168 0.895 . . . . 0.0 111.14 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -65.95 -44.78 84.01 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.013 0.925 . . . . 0.0 110.16 -168.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.94 37.18 1.33 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.584 0.707 . . . . 0.0 109.18 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 41.89 44.16 4.46 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 127.93 2.681 . . . . 0.0 113.096 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -106.14 37.26 2.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.085 0.954 . . . . 0.0 110.485 169.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 89' ' ' PHE . 45.2 mt -138.75 172.73 12.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.198 0.908 . . . . 0.0 109.454 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.38 146.95 37.42 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.002 1.321 . . . . 0.0 108.498 -168.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -81.26 99.1 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.424 1.107 . . . . 0.0 108.474 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp -87.83 87.41 7.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.3 p -122.46 35.81 4.79 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.696 1.589 . . . . 0.0 110.662 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -159.63 38.38 0.19 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.269 -163.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.678 ' CZ ' HG11 ' A' ' 86' ' ' VAL . 24.7 p90 -125.24 128.32 48.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.822 -1.174 . . . . 0.0 108.299 -167.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.85 143.64 33.47 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -154.19 140.84 18.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -148.37 78.59 1.43 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 103.775 -3.73 . . . . 0.0 103.775 158.549 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 91.3 mtp . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.51 -172.41 1.92 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.698 1.599 . . . . 0.0 109.845 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.75 125.66 42.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.471 156.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.677 HG12 ' HB3' ' A' ' 30' ' ' TYR . 2.3 p -97.62 151.03 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.606 1.191 . . . . 0.0 108.235 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.67 136.79 52.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 166.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.55 HD11 HG13 ' A' ' 4' ' ' VAL . 3.5 mp -122.95 118.32 28.23 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.0 115.35 4.23 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 124.507 3.471 . . . . 0.0 107.573 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -118.16 151.87 36.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.233 1.413 . . . . 0.0 107.467 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.49 41.55 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.32 176.96 48.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -119.83 57.73 0.91 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.123 1.769 . . . . 0.0 108.202 -169.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.15 154.17 39.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.223 1.809 . . . . 0.0 106.431 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.717 1.207 . . . . 0.0 110.253 172.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -123.48 37.36 4.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 119.983 -1.698 . . . . 0.0 110.753 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.9 m -82.17 172.25 13.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.387 160.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.06 136.59 37.21 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.201 -0.937 . . . . 0.0 109.559 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 93' ' ' THR . 43.3 t -72.32 159.09 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -115.7 149.91 37.64 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.919 0.888 . . . . 0.0 111.447 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.3 37.81 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.453 1.101 . . . . 0.0 111.065 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.71 101.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.564 -1.335 . . . . 0.0 108.988 -162.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.488 ' HB3' HG23 ' A' ' 71' ' ' VAL . 31.4 t80 -53.39 -62.29 1.75 Allowed 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 123.36 0.412 . . . . 0.0 111.068 170.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 -3.5 29.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -118.78 38.94 3.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 109.495 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.38 115.31 28.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.188 -164.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -69.85 -23.8 63.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -166.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.08 156.9 47.31 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 106.855 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -132.19 112.72 12.52 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 124.107 0.963 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.448 HG13 HG11 ' A' ' 94' ' ' VAL . 8.4 mm -79.78 120.19 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 169.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.38 117.08 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.677 ' HB3' HG12 ' A' ' 4' ' ' VAL . 33.1 t80 -103.0 126.0 49.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.151 1.38 . . . . 0.0 110.182 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 115.03 27.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.842 2.057 . . . . 0.0 110.173 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 80.9 p -76.0 23.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.86 -6.02 2.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.25 36.46 0.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 158.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 34.88 34.54 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 C-N-CA 127.092 2.282 . . . . 0.0 113.327 -170.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -88.29 154.64 20.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -168.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.51 137.34 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 123.412 0.685 . . . . 0.0 110.872 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -109.86 154.28 23.25 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.174 2.19 . . . . 0.0 108.371 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.37 112.04 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 158.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.05 137.48 21.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 157.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.98 135.73 33.9 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 161.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.05 95.04 3.13 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.002 0.819 . . . . 0.0 110.159 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.1 p -93.3 76.91 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.41 163.29 3.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 162.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -131.84 133.26 44.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 153.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -79.07 77.35 5.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.04 114.85 1.51 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.905 2.082 . . . . 0.0 107.658 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.4 m170 67.57 -64.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.762 2.425 . . . . 0.0 111.688 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.44 83.09 0.07 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.86 1.219 . . . . 0.0 112.219 168.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -69.35 -10.21 56.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -172.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -169.76 -173.31 37.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.373 1.94 . . . . 0.0 108.812 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.59 -33.86 3.74 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 120.383 2.092 . . . . 0.0 112.757 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.1 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.851 2.06 . . . . 0.0 111.231 -167.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.59 -54.44 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.928 1.691 . . . . 0.0 110.055 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.45 -52.83 42.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 116.521 -1.704 . . . . 0.0 109.624 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -53.47 -33.35 53.91 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.351 1.432 . . . . 0.0 111.418 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -68.04 -67.43 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 120.93 -1.106 . . . . 0.0 112.594 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.35 -38.58 80.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.794 0.838 . . . . 0.0 111.08 -166.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.8 t -54.77 -36.52 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.729 1.611 . . . . 0.0 111.518 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 t -67.66 -13.43 62.08 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.649 -1.282 . . . . 0.0 112.91 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.03 37.09 2.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.832 1.196 . . . . 0.0 109.957 172.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.8 26.76 41.35 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.964 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.7 t -73.05 97.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 118.256 1.028 . . . . 0.0 109.014 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -104.61 35.27 2.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 122.033 0.921 . . . . 0.0 111.597 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.551 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -174.74 151.5 1.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.447 -1.408 . . . . 0.0 108.363 -162.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 68' ' ' ALA . 13.1 tp -159.29 154.64 25.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.717 1.207 . . . . 0.0 108.706 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.764 HG21 ' HB1' ' A' ' 97' ' ' ALA . 48.3 mt -127.02 104.06 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -163.25 105.81 1.01 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.957 0.903 . . . . 0.0 109.203 -173.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -13.46 25.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -156.34 -177.72 6.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 119.683 1.129 . . . . 0.0 108.806 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 21' ' ' PHE 0.256 4.1 p -133.16 166.14 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.18 60.2 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 168.37 -88.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 130.799 3.64 . . . . 0.0 106.52 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.75 139.32 58.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 153.31 -30.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 130.688 3.595 . . . . 0.0 109.838 160.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.592 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 60.7 t80 -52.74 -42.5 64.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.433 1.893 . . . . 0.0 111.434 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -69.45 -35.68 75.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.403 1.481 . . . . 0.0 109.408 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -22.36 58.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 110.276 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 21' ' ' PHE . 73.1 mt -68.85 -64.14 0.92 Allowed 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.95 -39.87 20.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.43 1.092 . . . . 0.0 111.892 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.64 37.16 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.979 0.912 . . . . 0.0 111.247 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.14 30.37 1.83 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.037 1.78 . . . . 0.0 116.742 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.49 126.53 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.68 1.24 . . . . 0.0 108.123 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.23 159.91 27.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.412 HG13 HD23 ' A' ' 66' ' ' LEU . 22.0 t -147.37 133.52 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -116.73 162.89 16.97 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.033 1.733 . . . . 0.0 110.14 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -79.74 153.42 29.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.264 2.226 . . . . 0.0 108.051 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.9 129.66 15.16 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 126.861 2.064 . . . . 0.0 106.303 164.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.68 39.38 3.94 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 123.472 2.851 . . . . 0.0 111.615 -165.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.74 131.91 4.03 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.322 1.915 . . . . 0.0 110.415 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.6 163.48 11.85 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.075 0.937 . . . . 0.0 113.035 -164.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.495 ' C ' HG23 ' A' ' 17' ' ' VAL . 23.4 p -87.89 170.02 11.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.489 1.516 . . . . 0.0 110.39 166.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 HG13 ' A' ' 28' ' ' ILE . 43.6 t -44.0 -47.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-N 119.338 0.972 . . . . 0.0 110.022 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -56.73 -38.01 71.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.47 -46.39 76.54 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.707 1.603 . . . . 0.0 108.722 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -50.76 -30.13 13.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.449 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.4 mm -93.5 -51.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 C-N-CA 124.596 1.158 . . . . 0.0 107.912 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.64 -42.46 78.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.32 -49.03 63.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.623 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.55 78.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 111.563 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.3 p -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.56 1.144 . . . . 0.0 109.499 -170.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.6 36.59 2.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.402 1.081 . . . . 0.0 108.617 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.72 11.92 0.19 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.642 2.068 . . . . 0.0 116.666 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -85.35 36.05 0.62 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.177 1.988 . . . . 0.0 111.061 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.8 mt -139.72 175.53 9.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -114.61 159.84 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -78.91 137.46 37.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 161.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp -120.64 59.05 0.92 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.013 1.325 . . . . 0.0 108.16 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.345 7.2 t -104.33 36.58 2.34 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.557 1.17 . . . . 0.0 109.611 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.43 89.02 0.11 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -171.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.465 ' CE2' HG12 ' A' ' 71' ' ' VAL . 6.8 m-85 -79.12 158.84 27.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.24 45.74 2.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.198 1.799 . . . . 0.0 107.959 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -114.0 97.66 6.51 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 125.789 1.636 . . . . 0.0 108.525 -171.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.72 94.85 5.81 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.416 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -177.532 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.07 93.53 2.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.596 1.089 . . . . 0.0 113.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.2 mtm105 -78.62 114.44 17.54 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.923 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.71 136.27 30.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.18 95.68 5.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 0.947 . . . . 0.0 108.81 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -83.96 132.07 49.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -170.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.63 136.5 23.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 1 C-N-CA 125.586 4.191 . . . . 0.0 109.676 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.0 t -138.05 166.08 25.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.261 1.424 . . . . 0.0 108.077 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.63 39.15 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.127 0.971 . . . . 0.0 109.532 163.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.14 167.17 40.31 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 164.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 8.7 mtmp? -92.95 42.42 1.1 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.543 1.537 . . . . 0.0 109.106 -175.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.83 149.94 32.17 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.522 0.729 . . . . 0.0 109.399 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -73.0 -12.0 60.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.216 1.807 . . . . 0.0 112.058 -174.041 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -114.12 35.8 3.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.828 -1.17 . . . . 0.0 111.625 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 m -86.26 169.63 12.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 171.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.48 134.22 37.35 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 65.5 t -78.86 130.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 122.452 1.12 . . . . 0.0 108.589 172.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -79.94 153.9 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.159 1.783 . . . . 0.0 109.499 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.94 37.14 1.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.645 1.112 . . . . 0.0 110.775 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -167.53 99.38 0.49 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 119.168 -2.208 . . . . 0.0 110.23 -166.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.474 ' CD2' HD11 ' A' ' 79' ' ' LEU . 3.1 t80 -49.27 -64.69 0.73 Allowed 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.253 0.933 . . . . 0.0 111.34 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.84 24.31 1.29 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.77 -170.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 39.42 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 167.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.71 132.8 56.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.29 -26.22 46.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -162.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' HG3' ' A' ' 11' ' ' LYS . 97.9 m-85 -135.36 148.21 49.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -125.92 125.37 42.66 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.535 HD12 HG22 ' A' ' 39' ' ' VAL . 19.3 mm -112.59 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 -169.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -92.84 97.9 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 4' ' ' VAL . 38.8 t80 -81.77 117.95 22.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.89 118.35 22.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.711 2.004 . . . . 0.0 109.892 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.7 p -90.26 28.16 1.5 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.761 1.164 . . . . 0.0 111.802 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -99.67 -87.05 0.37 Allowed 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 155.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -94.78 35.42 1.25 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.339 -156.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 28.09 38.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.192 1.377 . . . . 0.0 113.933 -163.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -68.79 155.51 40.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.2 170.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.66 140.7 17.36 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG22 HD12 ' A' ' 28' ' ' ILE . 70.6 t -112.63 107.98 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.83 145.57 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -109.41 133.9 52.5 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 128.599 2.759 . . . . 0.0 104.446 166.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -153.89 112.29 3.61 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.88 0.872 . . . . 0.0 109.009 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.0 p -117.05 55.58 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.68 0.752 . . . . 0.0 110.255 -155.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.81 99.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.1 0.96 . . . . 0.0 111.037 -170.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.91 39.65 3.9 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.946 -1.096 . . . . 0.0 111.786 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.96 146.78 16.18 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.242 1.417 . . . . 0.0 108.278 -175.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.08 38.22 2.35 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.544 0.738 . . . . 0.0 112.835 -166.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -130.96 77.84 1.81 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -126.89 103.43 0.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.363 1.935 . . . . 0.0 110.988 -170.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -80.42 -11.34 59.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.966 1.306 . . . . 0.0 112.423 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.54 168.06 27.4 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 57.2 Cg_endo -73.5 -35.69 4.57 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 C-N-CA 123.014 2.476 . . . . 0.0 113.852 -161.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 66.15 -68.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -61.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.161 1.385 . . . . 0.0 108.566 170.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.2 t -57.54 -45.51 86.09 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-O 116.006 -1.949 . . . . 0.0 109.131 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -45.2 -53.56 8.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.247 1.385 . . . . 0.0 111.662 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -67.05 -44.85 79.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.78 -41.46 87.62 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.22 -0.925 . . . . 0.0 110.148 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.07 -34.03 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.84 1.656 . . . . 0.0 110.361 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -66.8 -16.24 64.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.371 0.987 . . . . 0.0 113.536 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -104.35 37.44 2.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.558 1.072 . . . . 0.0 109.634 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.13 34.12 3.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.006 1.289 . . . . 0.0 114.074 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.1 106.42 5.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 118.936 1.368 . . . . 0.0 107.525 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -108.27 35.23 3.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.587 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -168.58 151.83 5.45 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.326 -1.484 . . . . 0.0 108.406 -163.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 68' ' ' ALA . 22.3 tp -166.26 145.0 5.72 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.245 -1.534 . . . . 0.0 109.064 -169.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.775 HG21 ' HB1' ' A' ' 97' ' ' ALA . 41.9 mt -125.23 100.06 6.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -161.54 94.52 0.97 Allowed 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.315 0.961 . . . . 0.0 110.835 -167.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.5 p -29.6 -32.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.733 3.213 . . . . 0.0 119.462 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -162.63 -174.73 4.11 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.845 2.058 . . . . 0.0 105.816 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.38 156.62 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 120.735 -1.228 . . . . 0.0 109.304 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.02 66.15 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.697 1.142 . . . . 0.0 113.253 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 144.0 -105.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 1 C-N-CA 135.865 5.666 . . . . 0.0 107.019 169.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -57.13 119.01 5.61 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.881 -1.137 . . . . 0.0 109.846 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.88 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 130.89 3.676 . . . . 0.0 110.907 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.511 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 28.4 t80 -54.65 -36.1 64.22 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.231 0.923 . . . . 0.0 111.558 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.55 -30.74 71.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.61 1.964 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -92.96 -14.78 27.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.583 1.553 . . . . 0.0 111.002 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.474 HD11 ' CD2' ' A' ' 21' ' ' PHE . 60.0 mt -66.93 -68.05 0.4 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 167.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -52.25 -30.67 28.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.32 -30.62 12.46 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.05 36.9 3.15 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.927 1.291 . . . . 0.0 111.059 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.64 15.85 54.57 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 116.098 1.199 . . . . 0.0 116.098 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.93 123.35 36.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 118.314 1.057 . . . . 0.0 110.782 -158.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -78.9 156.79 28.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG13 HD23 ' A' ' 66' ' ' LEU . 18.5 t -149.29 138.31 15.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -122.25 155.45 35.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.76 0.824 . . . . 0.0 111.544 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -79.22 149.24 31.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 162.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.73 167.97 16.5 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -142.73 116.35 9.18 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 120.915 -1.115 . . . . 0.0 110.187 160.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.03 90.3 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 125.577 1.56 . . . . 0.0 113.654 162.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 165.72 37.98 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.2 p -81.81 178.39 8.34 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.977 -0.719 . . . . 0.0 110.698 167.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.03 -44.93 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.121 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -60.76 -37.27 81.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 120.972 1.715 . . . . 0.0 114.626 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.86 -40.7 83.61 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.592 1.557 . . . . 0.0 108.264 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.775 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.74 -35.53 14.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.397 0.544 . . . . 0.0 111.983 168.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.7 -53.25 9.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 125.131 1.372 . . . . 0.0 109.376 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -28.21 68.87 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.801 2.04 . . . . 0.0 108.69 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.68 -58.01 3.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.624 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.9 t80 -54.74 -50.74 67.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.569 0.747 . . . . 0.0 112.451 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 p -63.1 -44.72 94.87 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.896 0.879 . . . . 0.0 108.904 -168.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.63 37.4 0.91 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.875 0.845 . . . . 0.0 109.014 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.98 17.05 8.78 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 128.073 2.749 . . . . 0.0 116.501 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -89.65 36.62 0.85 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.72 2.26 . . . . 0.0 112.769 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 101' ' ' PHE . 19.1 mt -137.32 166.8 22.93 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.985 1.721 . . . . 0.0 110.339 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.21 147.7 24.34 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -93.24 82.4 4.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 tp -79.53 74.01 6.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.986 0.898 . . . . 0.0 109.558 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p -115.43 37.42 3.57 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 120.442 -1.411 . . . . 0.0 110.125 -167.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t 168.7 90.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.705 2.002 . . . . 0.0 105.596 -166.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.75 165.97 33.06 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.1 m -143.26 -155.01 0.56 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.963 2.105 . . . . 0.0 105.662 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.509 ' CD ' ' H ' ' A' ' 116' ' ' GLY . 2.5 tmm_? -141.59 141.57 33.48 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.54 36.5 2.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.509 ' H ' ' CD ' ' A' ' 114' ' ' ARG . . . . . . . . 0 C--O 1.256 1.511 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 9.9 ttt . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 119.94 -0.076 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 65' ' ' TYR . . . 161.93 140.67 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 128.137 2.575 . . . . 0.0 109.083 169.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 -116.8 131.62 56.9 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 124.003 0.814 . . . . 0.0 110.111 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.873 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -121.29 124.81 72.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -169.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.9 137.97 39.48 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.498 HD11 HG13 ' A' ' 4' ' ' VAL . 4.8 mp -123.25 116.66 28.38 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 74.1 Cg_endo -67.57 112.53 2.65 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 125.074 3.849 . . . . 0.0 106.877 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -113.99 167.52 10.59 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.561 1.944 . . . . 0.0 107.447 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.13 38.36 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.569 -0.707 . . . . 0.0 109.654 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 166.94 39.84 Favored Glycine 0 CA--C 1.523 0.562 0 O-C-N 120.99 -1.069 . . . . 0.0 110.958 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -89.22 39.44 0.94 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 122.151 -0.617 . . . . 0.0 110.712 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.02 153.42 50.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.609 1.164 . . . . 0.0 109.277 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.74 -15.89 55.3 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.486 1.914 . . . . 0.0 109.745 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 38.9 2.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.285 1.434 . . . . 0.0 108.229 170.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -83.88 173.17 11.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 119.822 -1.799 . . . . 0.0 107.991 164.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.39 140.65 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.582 -1.324 . . . . 0.0 109.553 166.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 58.7 t -73.37 149.93 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 167.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -102.57 136.52 42.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.82 1.648 . . . . 0.0 108.59 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -81.5 37.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.409 1.1 . . . . 0.0 111.082 -172.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 110.28 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -162.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -64.17 -56.45 14.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.677 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.34 0.02 9.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -134.93 76.61 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.487 1.915 . . . . 0.0 107.192 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.761 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -122.48 166.56 14.58 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 160.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 14.6 mt-10 -106.68 -16.89 14.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -144.76 153.86 42.12 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.761 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 70.4 m-85 -131.53 98.4 4.5 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.145 1.778 . . . . 0.0 107.51 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.406 HG22 ' CG1' ' A' ' 37' ' ' VAL . 2.2 mm -79.43 103.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -176.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 58' ' ' LEU . 55.9 mt -89.27 103.87 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.507 ' HB3' HG12 ' A' ' 4' ' ' VAL . 50.4 t80 -85.06 146.17 27.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.51 114.42 21.74 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 127.172 2.189 . . . . 0.0 111.09 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.9 p -78.86 13.82 1.58 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 1' ' ' MET . 17.5 mm-40 -99.89 -32.94 10.75 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.348 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.93 36.49 1.41 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.033 160.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.57 33.62 26.17 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.257 0.932 . . . . 0.0 111.784 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -81.88 157.79 24.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.128 1.771 . . . . 0.0 107.091 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.406 ' CG1' HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -138.48 150.33 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.867 0.842 . . . . 0.0 110.052 177.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.97 141.73 51.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.011 1.325 . . . . 0.0 108.845 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.87 110.26 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 163.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.37 150.31 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 160.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.88 117.01 27.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -134.65 87.75 2.38 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -168.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.1 p -79.63 60.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 -174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mm -91.23 152.65 3.32 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.18 172.22 13.15 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.205 1.002 . . . . 0.0 110.533 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.43 76.07 6.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.801 1.64 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.11 163.71 23.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.966 1.706 . . . . 0.0 106.805 168.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.437 ' CE1' HH21 ' A' ' 73' ' ' ARG . 31.2 m-70 -56.95 -56.38 22.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.94 74.55 0.5 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 166.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.9 p -60.03 146.56 42.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.566 0.746 . . . . 0.0 112.663 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.42 171.57 41.6 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -168.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.53 -33.77 2.25 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.17 1.247 . . . . 0.0 113.149 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 -66.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.791 2.437 . . . . 0.0 114.99 -170.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -57.65 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.456 1.502 . . . . 0.0 107.99 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -41.93 79.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 115.747 -2.073 . . . . 0.0 110.922 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -40.56 61.76 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.879 1.672 . . . . 0.0 111.499 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -75.61 -50.78 14.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.084 1.354 . . . . 0.0 109.787 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' A' ' 29' ' ' ILE . 87.3 mt -58.5 -43.62 89.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.928 0.891 . . . . 0.0 110.102 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.74 -51.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.897 1.679 . . . . 0.0 110.756 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.3 t -62.15 -25.91 68.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -92.15 37.59 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.44 -1.412 . . . . 0.0 110.331 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.11 6.32 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 127.518 2.485 . . . . 0.0 115.779 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.68 137.81 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.189 1.495 . . . . 0.0 109.272 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.38 35.01 2.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 110.955 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.873 ' HB3' HG23 ' A' ' 4' ' ' VAL . 10.5 m-85 179.89 164.5 1.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 119.634 -1.916 . . . . 0.0 107.209 -170.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 68' ' ' ALA . 12.0 tp -171.2 147.42 2.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.72 HG21 ' HB1' ' A' ' 97' ' ' ALA . 62.9 mt -123.85 101.14 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -155.31 115.48 3.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.418 1.008 . . . . 0.0 110.639 -166.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.8 p -59.43 -23.89 63.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -171.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.01 174.09 9.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -170.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -120.06 157.66 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.492 -1.38 . . . . 0.0 108.428 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.7 67.62 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.437 HH21 ' CE1' ' A' ' 48' ' ' HIS . 9.6 ttp-105 169.75 -154.89 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 131.409 3.884 . . . . 0.0 105.657 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -24.75 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.18 2.992 . . . . 0.0 114.355 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -170.99 -29.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.412 1.485 . . . . 0.0 113.97 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.632 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 82.3 t80 -58.68 -36.08 73.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.49 1.116 . . . . 0.0 112.51 -169.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.16 -41.03 74.34 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -23.77 67.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.84 -0.537 . . . . 0.0 111.039 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.34 -68.16 0.41 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.857 0.863 . . . . 0.0 108.968 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.632 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -58.33 -31.38 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.82 24.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.096 0.558 . . . . 0.0 110.445 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.7 36.86 1.83 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.386 0.674 . . . . 0.0 111.828 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.25 8.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.416 1.484 . . . . 0.0 116.333 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.86 120.26 33.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.191 1.495 . . . . 0.0 108.98 -170.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -78.43 160.79 27.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.8 t -143.42 137.34 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.57 158.19 25.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.022 1.729 . . . . 0.0 110.112 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -78.95 148.24 32.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.525 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -138.12 161.12 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 156.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -148.94 85.38 1.48 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 120.268 1.395 . . . . 0.0 111.154 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.9 112.47 0.59 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.454 1.026 . . . . 0.0 111.063 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.92 158.3 10.76 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -83.08 171.76 13.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 110.397 170.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.15 -40.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-O 116.747 -1.597 . . . . 0.0 113.138 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -35.26 76.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 121.012 1.733 . . . . 0.0 113.626 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.83 -46.25 69.04 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.75 2.02 . . . . 0.0 108.355 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.72 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.41 -40.45 17.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 118.699 0.681 . . . . 0.0 111.144 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mm -81.65 -51.04 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.39 1.876 . . . . 0.0 108.886 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -40.05 85.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.382 1.473 . . . . 0.0 108.237 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.66 -49.48 25.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.79 0.836 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.78 -50.45 73.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.477 1.035 . . . . 0.0 111.787 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -64.18 -39.05 93.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.384 1.074 . . . . 0.0 110.163 -168.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -101.42 37.34 1.81 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.975 0.91 . . . . 0.0 109.435 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 40.22 46.06 3.3 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 127.497 2.475 . . . . 0.0 114.113 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -112.49 37.35 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.901 0.88 . . . . 0.0 109.854 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 89' ' ' PHE . 74.3 mt -143.39 170.09 16.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.994 -1.067 . . . . 0.0 108.547 165.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -119.11 147.64 43.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.641 1.576 . . . . 0.0 108.075 -165.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -78.99 116.84 19.55 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.1 59.63 2.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.727 2.011 . . . . 0.0 108.362 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 p -88.97 38.95 0.91 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.456 1.102 . . . . 0.0 111.396 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t 159.57 159.96 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 131.222 3.809 . . . . 0.0 104.645 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -165.0 163.05 20.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.4 m -108.49 142.55 38.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -146.89 125.54 12.54 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.48 96.27 5.36 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 175.822 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 153.94 22.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.235 1.414 . . . . 0.0 108.566 170.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -78.52 119.57 22.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -105.96 124.64 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.284 -172.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.45 111.38 23.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.98 124.55 51.68 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 60.8 Cg_endo -77.55 112.0 3.25 Favored 'Trans proline' 0 N--CA 1.443 -1.448 1 C-N-CA 125.464 4.109 . . . . 0.0 108.528 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 t -108.66 174.8 5.71 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.192 1.397 . . . . 0.0 108.498 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.82 38.49 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.46 1.104 . . . . 0.0 109.655 167.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.78 -170.14 32.18 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -129.48 64.8 1.48 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.593 1.696 . . . . 0.0 110.195 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.62 153.99 29.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.082 1.753 . . . . 0.0 107.949 169.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -65.94 -12.07 52.14 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.737 1.215 . . . . 0.0 110.521 174.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -110.58 36.44 3.1 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.589 -1.319 . . . . 0.0 111.435 172.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 166.73 11.77 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.053 -1.03 . . . . 0.0 109.771 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 135.14 37.35 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.302 -1.499 . . . . 0.0 109.81 -172.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.599 HG21 ' HB2' ' A' ' 97' ' ' ALA . 45.7 t -78.02 131.11 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 t -81.07 144.16 31.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.614 1.566 . . . . 0.0 109.76 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -86.41 36.71 0.7 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.444 1.593 . . . . 0.0 110.739 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.61 121.54 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -166.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.65 -61.25 1.84 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . . . -66.41 -23.6 66.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.832 -168.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -105.04 75.56 1.19 Allowed 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 127.673 2.389 . . . . 0.0 107.753 166.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -133.19 160.26 37.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 157.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -105.96 -12.63 15.75 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -168.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -146.22 145.86 30.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -131.35 108.25 9.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.4 mp -89.62 117.71 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -171.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.507 HD11 ' CD2' ' A' ' 58' ' ' LEU . 42.5 mt -105.24 97.29 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 -175.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HG12 ' A' ' 4' ' ' VAL . 71.9 t80 -91.25 109.08 20.34 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.77 110.22 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.463 1.505 . . . . 0.0 108.962 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.9 p -78.02 55.03 1.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.558 -0.714 . . . . 0.0 110.016 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -134.21 -39.86 0.83 Allowed 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 124.814 1.246 . . . . 0.0 111.374 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -144.37 37.33 1.23 Allowed 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.601 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 16.29 2.24 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.609 1.576 . . . . 0.0 115.294 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -82.22 134.03 35.28 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.305 1.053 . . . . 0.0 108.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.64 160.51 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 125.261 1.424 . . . . 0.0 108.817 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.17 132.86 27.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.87 110.55 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.12 152.07 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 160.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -124.44 96.04 4.76 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.96 2.504 . . . . 0.0 105.935 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.483 ' HB3' HD11 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -114.46 106.7 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -170.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.8 p -84.27 62.09 6.95 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.268 -0.895 . . . . 0.0 110.642 -167.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 42' ' ' ASN . 3.8 mm -82.3 156.38 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.216 -0.927 . . . . 0.0 109.171 -166.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.07 178.61 10.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.167 1.787 . . . . 0.0 110.046 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.94 40.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.149 2.18 . . . . 0.0 114.665 -156.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.82 -179.32 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 120.545 -1.347 . . . . 0.0 110.194 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -175.22 5.02 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.512 1.525 . . . . 0.0 109.013 161.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.92 56.26 0.01 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p 50.34 29.56 3.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.95 2.1 . . . . 0.0 115.729 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.49 129.02 7.37 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 106.551 -2.62 . . . . 0.0 106.551 161.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 -30.35 50.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 CA-C-N 121.106 2.453 . . . . 0.0 112.033 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.46 -77.38 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.513 2.325 . . . . 0.0 110.87 -165.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -49.66 -60.52 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 C-N-CA 126.317 1.847 . . . . 0.0 109.334 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.3 t -60.04 -51.2 75.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 115.743 -2.075 . . . . 0.0 109.708 -173.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.82 -51.31 9.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.914 1.688 . . . . 0.0 110.949 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -62.41 -56.05 21.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 29' ' ' ILE . 93.0 mt -62.67 -41.9 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.301 0.64 . . . . 0.0 110.262 -172.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -57.44 -46.62 85.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -58.37 -27.64 64.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.146 0.884 . . . . 0.0 112.415 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -99.74 37.4 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.665 1.186 . . . . 0.0 109.471 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.11 23.42 7.75 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.292 2.377 . . . . 0.0 116.69 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.64 125.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.535 1.168 . . . . 0.0 108.053 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.19 36.59 4.61 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 164.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.559 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -165.74 157.46 14.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.485 -1.385 . . . . 0.0 109.112 -168.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 86' ' ' VAL . 12.1 tp -164.08 148.34 10.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -173.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.699 HG21 ' HB1' ' A' ' 97' ' ' ALA . 28.2 mt -124.58 106.77 17.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -156.77 134.44 10.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.999 2.182 . . . . 0.0 111.184 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -64.08 -21.16 66.41 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.602 -1.311 . . . . 0.0 113.641 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -163.21 177.45 9.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.07 1.748 . . . . 0.0 106.432 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 73' ' ' ARG 0.251 1.0 OUTLIER -107.35 161.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 O-C-N 121.055 -1.028 . . . . 0.0 108.561 174.847 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 22' ' ' ALA . . . -80.29 24.77 3.42 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.683 1.135 . . . . 0.0 111.63 171.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.486 ' H ' HG13 ' A' ' 71' ' ' VAL . 1.2 ttt-85 68.05 -71.09 0.11 Allowed 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 129.684 3.194 . . . . 0.0 113.257 -172.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.29 56.37 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.448 2.299 . . . . 0.0 113.833 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . . . -161.62 -28.64 0.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 113.95 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 79' ' ' LEU . 56.6 t80 -69.39 -32.59 71.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.897 1.68 . . . . 0.0 111.986 -169.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.21 -38.13 85.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 110.073 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -14.83 58.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.928 2.891 . . . . 0.0 109.366 -174.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 76' ' ' PHE . 31.9 mt -80.86 -58.13 3.23 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 108.221 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.642 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -62.6 -28.37 69.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.299 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.0 54.82 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.034 0.834 . . . . 0.0 111.876 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.9 37.31 4.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.617 1.099 . . . . 0.0 110.765 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.39 30.53 0.3 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.686 2.088 . . . . 0.0 117.041 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.78 125.2 38.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 118.87 1.335 . . . . 0.0 109.048 -169.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -78.96 155.99 28.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.453 HG13 HD23 ' A' ' 66' ' ' LEU . 43.6 t -145.69 129.47 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.24 170.6 7.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 110.655 171.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -107.58 152.02 24.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 126.898 2.079 . . . . 0.0 109.586 162.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.18 167.9 21.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.199 2.2 . . . . 0.0 106.425 176.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.93 129.17 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 167.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.04 90.5 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 128.04 2.733 . . . . 0.0 115.784 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.96 163.77 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -89.86 173.83 8.03 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.979 -0.719 . . . . 0.0 109.894 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.74 -42.83 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 117.731 -1.128 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -61.55 -36.9 81.9 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.55 -40.64 73.27 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.961 1.304 . . . . 0.0 109.08 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.75 -39.76 26.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.457 170.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mm -78.91 -60.43 2.27 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.91 -21.39 43.32 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 127.955 2.502 . . . . 0.0 110.919 -172.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.32 -52.69 6.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.585 ' HB2' HD12 ' A' ' 106' ' ' LEU . 19.4 t80 -59.51 -50.14 75.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.688 0.795 . . . . 0.0 112.732 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -64.07 -41.87 97.19 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 109.32 -168.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.38 36.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.293 1.037 . . . . 0.0 109.27 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.06 20.36 6.47 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 128.621 3.01 . . . . 0.0 117.244 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -97.1 37.41 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.538 1.669 . . . . 0.0 111.335 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 101' ' ' PHE . 27.0 mt -134.97 169.7 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.569 1.077 . . . . 0.0 109.062 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -108.64 138.74 44.46 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.354 1.462 . . . . 0.0 108.138 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.7 108.26 13.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp -95.62 50.41 1.22 Allowed 'General case' 0 C--O 1.238 0.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.4 p -86.52 37.36 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 120.732 -1.23 . . . . 0.0 110.24 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 t 159.8 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.7 2.8 . . . . 0.0 103.714 -161.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.11 161.74 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.643 1.977 . . . . 0.0 106.064 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.3 m -83.95 133.06 34.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -154.82 102.86 2.39 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.498 1.044 . . . . 0.0 109.996 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -78.14 105.12 9.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 147.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttm . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.77 165.71 26.75 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 119.558 1.072 . . . . 0.0 110.95 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -103.02 152.8 20.92 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.596 155.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.835 HG23 ' HB3' ' A' ' 65' ' ' TYR . 3.1 p -125.64 167.83 19.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 128.499 2.72 . . . . 0.0 103.756 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.42 149.45 52.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.52 120.01 19.59 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.57 123.67 11.07 Favored 'Trans proline' 0 N--CA 1.443 -1.492 1 C-N-CA 126.097 4.531 . . . . 0.0 107.135 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.3 t -127.44 169.16 13.93 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.825 1.65 . . . . 0.0 108.356 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.09 37.77 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.623 0.769 . . . . 0.0 110.298 167.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.79 -177.85 41.03 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.224 -1.548 . . . . 0.0 111.008 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.4 mtpt -114.53 39.89 2.69 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.262 -1.14 . . . . 0.0 109.943 -172.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.33 148.44 36.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.919 1.288 . . . . 0.0 108.065 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -60.81 -10.5 5.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 112.574 173.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -112.69 36.6 3.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.277 -0.89 . . . . 0.0 111.396 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -90.2 167.97 12.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.041 -1.037 . . . . 0.0 108.967 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.99 139.8 39.16 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 120.865 1.666 . . . . 0.0 108.668 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 99.0 t -72.67 135.97 26.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -87.71 135.71 33.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.58 38.13 0.37 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 122.098 0.952 . . . . 0.0 110.903 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.93 99.05 0.07 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 119.86 -1.775 . . . . 0.0 110.174 -165.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 79' ' ' LEU . 18.9 t80 -53.49 -51.65 62.07 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.785 1.175 . . . . 0.0 112.957 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -3.66 33.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.002 -1.062 . . . . 0.0 112.401 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 38.79 3.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.549 0.74 . . . . 0.0 109.886 -171.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.77 108.94 16.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -165.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -52.64 -24.45 8.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.254 1.822 . . . . 0.0 115.272 -168.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 96.2 m-85 -139.19 151.26 46.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -129.61 112.79 14.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.1 mm -91.82 118.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.528 HD11 ' CD2' ' A' ' 58' ' ' LEU . 96.2 mt -111.97 100.41 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -172.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -82.77 141.7 32.15 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -117.87 110.82 18.23 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 127.197 2.199 . . . . 0.0 109.692 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.282 1.3 p -85.08 43.04 0.97 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.947 0.88 . . . . 0.0 110.699 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.94 -29.45 2.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 126.019 1.728 . . . . 0.0 112.604 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -147.58 35.25 0.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 117.728 -1.589 . . . . 0.0 111.069 157.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.2 24.12 14.59 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.804 -1.185 . . . . 0.0 112.31 -176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -64.75 156.24 31.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.74 162.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.533 1.158 . . . . 0.0 108.842 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -141.77 128.01 19.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.22 105.01 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.56 143.13 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 159.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.95 121.41 43.84 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -138.72 116.77 11.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.984 1.373 . . . . 0.0 110.221 -172.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.9 p -92.3 51.99 1.86 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.925 1.69 . . . . 0.0 110.67 -164.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.73 38.89 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.815 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.44 39.18 1.02 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.057 1.343 . . . . 0.0 110.61 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -147.54 168.18 22.59 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.01 173.84 12.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.994 1.718 . . . . 0.0 109.837 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 55.43 -174.18 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.45 1.5 . . . . 0.0 112.645 175.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.9 153.5 5.92 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 120.812 -1.18 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -88.96 -12.85 40.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.197 0.999 . . . . 0.0 112.539 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.38 -152.86 22.85 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -64.38 -43.67 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.289 1.992 . . . . 0.0 111.127 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? 65.17 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.351 1.46 . . . . 0.0 108.674 -166.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -67.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 127.135 2.174 . . . . 0.0 108.985 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.2 t -55.81 -49.96 71.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 115.669 -2.11 . . . . 0.0 109.651 -173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.46 -50.37 23.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.306 1.412 . . . . 0.0 111.117 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -42.16 68.52 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.107 -0.996 . . . . 0.0 113.342 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 29' ' ' ILE . 78.3 mt -66.5 -44.32 82.88 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.751 0.705 . . . . 0.0 109.888 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.31 -32.17 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.407 1.483 . . . . 0.0 110.118 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.6 m -75.89 1.98 13.66 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.802 -1.186 . . . . 0.0 113.879 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -119.42 38.46 3.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.452 1.901 . . . . 0.0 108.289 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.89 19.98 12.24 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.64 1.114 . . . . 0.0 115.845 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.0 96.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.131 1.373 . . . . 0.0 107.864 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.47 36.31 2.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.324 1.05 . . . . 0.0 110.568 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.835 ' HB3' HG23 ' A' ' 4' ' ' VAL . 10.8 m-85 179.83 165.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.608 1.563 . . . . 0.0 107.024 -165.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 tp -166.14 152.65 9.31 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.271 1.429 . . . . 0.0 107.449 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.773 HG21 ' HB1' ' A' ' 97' ' ' ALA . 57.3 mt -123.06 103.04 12.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.95 130.03 13.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.698 1.136 . . . . 0.0 110.342 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.7 p -62.72 -28.19 69.79 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -169.14 -171.07 1.22 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.399 1.479 . . . . 0.0 107.15 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 p -136.24 136.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.45 96.54 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.85 177.05 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 129.486 3.114 . . . . 0.0 107.561 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.98 50.38 3.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 127.581 2.352 . . . . 0.0 115.616 154.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.4 -26.35 0.1 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 171.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.725 ' HA ' HD12 ' A' ' 79' ' ' LEU . 33.9 t80 -62.35 -35.62 79.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.377 0.989 . . . . 0.0 112.539 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.91 -34.59 73.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.7 m -73.09 -20.05 61.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.624 0.77 . . . . 0.0 111.072 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 76' ' ' PHE . 28.1 mt -69.46 -57.61 5.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -65.2 -29.74 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.94 -1.71 1.58 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.01 37.23 2.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.87 1.668 . . . . 0.0 110.181 162.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.6 30.99 1.58 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.222 1.868 . . . . 0.0 116.804 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.37 117.58 25.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 118.937 1.368 . . . . 0.0 108.524 -168.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -79.14 99.01 6.78 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.537 0.684 . . . . 0.0 109.959 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 79' ' ' LEU . 35.9 t -82.5 117.75 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.81 155.29 18.34 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.662 1.185 . . . . 0.0 109.558 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 157.56 26.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 164.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 163.15 30.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 160.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.52 68.21 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.801 1.182 . . . . 0.0 110.508 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.62 136.23 8.58 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.05 154.1 6.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.879 0.339 . . . . 0.0 112.519 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -80.05 171.08 15.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.07 0.548 . . . . 0.0 109.653 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -43.82 -42.15 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.769 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.37 -38.74 81.23 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -42.35 83.29 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 127.144 2.178 . . . . 0.0 108.849 -174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.773 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.81 -38.98 11.01 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.819 0.736 . . . . 0.0 111.167 171.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 mm -86.0 -53.79 9.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 125.275 1.43 . . . . 0.0 109.121 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -26.69 65.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.044 1.738 . . . . 0.0 109.375 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.11 -62.6 1.41 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.415 ' HB2' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -51.75 -48.84 63.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.59 1.556 . . . . 0.0 112.626 -178.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -77.88 -13.27 59.94 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.664 2.786 . . . . 0.0 113.482 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -114.37 37.78 3.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.245 1.384 . . . . 0.0 109.836 159.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.51 12.73 4.91 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 127.626 2.536 . . . . 0.0 117.345 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -89.31 37.39 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.254 1.527 . . . . 0.0 111.413 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 101' ' ' PHE . 26.8 mt -136.29 167.33 21.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.013 1.279 . . . . 0.0 110.821 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -108.44 142.86 38.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.436 ' HG2' HG23 ' A' ' 110' ' ' THR . 34.8 tt0 -81.44 110.88 17.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.2 tp -99.48 58.04 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.96 1.704 . . . . 0.0 108.608 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 108' ' ' GLU . 24.9 p -101.7 35.91 2.2 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.154 -1.591 . . . . 0.0 110.181 -169.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.3 t -175.45 37.59 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.086 -1.009 . . . . 0.0 112.137 -173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -88.96 174.36 7.96 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.532 -1.355 . . . . 0.0 110.257 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.8 p -106.12 172.42 6.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.345 0.52 . . . . 0.0 110.255 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -142.72 122.15 13.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -152.36 88.18 1.35 Allowed 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 124.157 0.91 . . . . 0.0 109.241 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 176.247 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.25 153.9 14.12 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.451 1.9 . . . . 0.0 108.777 156.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -80.76 117.97 21.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.795 -0.566 . . . . 0.0 109.595 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -93.07 142.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.96 153.98 18.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 160.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.01 125.64 19.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 56.5 Cg_endo -74.27 106.63 2.27 Favored 'Trans proline' 0 N--CA 1.445 -1.35 1 C-N-CA 126.131 4.554 . . . . 0.0 109.576 177.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -104.12 172.07 7.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.364 1.466 . . . . 0.0 109.408 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.29 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 108.623 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.22 -169.36 42.36 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.794 -1.191 . . . . 0.0 111.259 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 7.5 mtmp? -129.96 52.71 1.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 111.842 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.64 167.48 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.917 1.687 . . . . 0.0 107.205 166.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -81.71 -6.31 58.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.501 -1.375 . . . . 0.0 111.0 174.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -116.26 39.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.579 -1.325 . . . . 0.0 108.922 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 m -78.66 169.39 18.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.25 -1.38 . . . . 0.0 107.303 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 145.08 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.441 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 69.5 t -86.05 137.77 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.404 1.097 . . . . 0.0 108.746 170.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -90.84 137.44 32.36 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.847 2.059 . . . . 0.0 108.74 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -81.25 36.16 0.41 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 122.895 1.331 . . . . 0.0 111.035 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 101.38 0.12 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -157.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 79' ' ' LEU . 8.5 t80 -55.04 -59.41 4.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.493 0.588 . . . . 0.0 110.571 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.08 -3.74 31.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.667 -170.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.71 74.1 1.24 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.312 1.415 . . . . 0.0 107.357 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -135.99 120.65 18.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.38 -22.13 66.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.259 1.424 . . . . 0.0 113.535 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 98.4 m-85 -137.25 148.67 46.61 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.01 1.724 . . . . 0.0 107.455 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -130.59 112.82 13.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.36 120.87 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.9 mt -109.77 101.49 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' HG12 ' A' ' 4' ' ' VAL . 38.9 t80 -89.63 110.89 21.73 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.86 108.88 13.78 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.076 2.15 . . . . 0.0 108.313 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -83.31 57.96 4.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -129.57 -48.51 1.16 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 124.649 1.18 . . . . 0.0 109.128 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 38.19 3.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.736 162.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.4 22.35 10.55 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.2 0.905 . . . . 0.0 113.68 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.86 148.81 48.57 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.14 148.88 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.1 0.96 . . . . 0.0 109.921 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -132.52 139.32 47.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.587 2.355 . . . . 0.0 105.793 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.9 t -108.9 103.57 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.48 151.71 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 167.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.54 129.96 56.71 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.78 132.31 23.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 120.697 -1.252 . . . . 0.0 110.124 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.2 p -115.3 57.24 0.73 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.314 1.054 . . . . 0.0 110.31 -152.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.51 40.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 128.178 2.591 . . . . 0.0 112.317 -174.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.55 38.42 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.294 -1.503 . . . . 0.0 112.243 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 160.26 25.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.066 2.147 . . . . 0.0 108.426 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.93 -152.31 0.07 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.371 2.268 . . . . 0.0 113.728 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -77.76 131.68 37.74 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.351 1.46 . . . . 0.0 112.958 -162.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.71 -175.77 45.7 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.767 1.651 . . . . 0.0 109.567 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.314 1.5 t 48.82 -153.21 0.11 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.193 1.797 . . . . 0.0 110.862 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.13 -163.69 38.41 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.307 -1.496 . . . . 0.0 109.749 165.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.5 -27.43 54.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.153 1.902 . . . . 0.0 112.968 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.322 1.7 ptpt 54.19 -65.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.821 2.448 . . . . 0.0 114.339 -164.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -65.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 127.156 2.182 . . . . 0.0 108.069 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.92 -48.09 78.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-O 116.863 -1.542 . . . . 0.0 109.151 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -46.95 21.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.171 0.896 . . . . 0.0 111.678 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -69.5 -56.22 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.305 0.642 . . . . 0.0 111.082 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -57.4 -46.01 83.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.418 0.554 . . . . 0.0 109.578 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 t -56.71 -36.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.373 1.869 . . . . 0.0 111.54 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -61.18 -38.93 88.26 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.575 1.079 . . . . 0.0 110.575 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.06 38.49 0.85 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.694 1.134 . . . . 0.0 110.029 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.17 26.4 42.76 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.019 1.771 . . . . 0.0 115.578 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.1 t -71.85 101.25 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.123 1.461 . . . . 0.0 109.231 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.28 34.88 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.618 0.645 . . . . 0.0 109.995 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.496 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -168.07 157.55 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 119.989 -1.694 . . . . 0.0 108.796 -169.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.9 tp -166.36 145.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 120.232 -1.542 . . . . 0.0 108.671 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.021 HG21 ' HB1' ' A' ' 97' ' ' ALA . 7.6 mt -111.18 107.02 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 126.404 1.882 . . . . 0.0 106.222 171.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.97 106.15 1.8 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 120.998 1.726 . . . . 0.0 110.623 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.7 p -34.46 -48.8 0.37 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.153 1.781 . . . . 0.0 113.195 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.39 -178.4 6.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -114.64 160.1 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.79 -23.54 38.6 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.392 -166.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -169.43 -132.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.363 3.465 . . . . 0.0 103.437 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -164.3 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.872 1.214 . . . . 0.0 110.872 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 97.58 -26.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.208 1 C-N-CA 133.427 4.691 . . . . 0.0 112.633 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 79' ' ' LEU . 60.6 t80 -60.85 -36.5 79.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.501 1.5 . . . . 0.0 112.247 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.75 -38.25 79.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.405 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -74.0 -24.44 59.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.914 0.886 . . . . 0.0 110.018 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 76' ' ' PHE . 27.6 mt -65.69 -72.01 0.17 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -57.05 -32.73 66.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.13 17.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.688 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.39 36.6 0.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.101 0.864 . . . . 0.0 112.071 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 40.26 33.89 0.56 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.232 1.872 . . . . 0.0 116.238 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 t -81.06 119.39 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 152.95 31.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.5 t -150.2 112.34 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.51 172.97 9.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.229 1.411 . . . . 0.0 111.311 166.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -112.02 148.46 33.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.452 2.701 . . . . 0.0 108.767 164.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -127.31 166.34 17.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.047 2.539 . . . . 0.0 105.086 177.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -148.4 56.68 1.05 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.122 1.328 . . . . 0.0 110.168 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.63 110.88 3.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 123.444 0.545 . . . . 0.0 112.395 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.56 166.49 31.94 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.6 p -87.39 173.68 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.748 0.819 . . . . 0.0 110.492 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.51 -38.42 12.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 CA-C-O 117.028 -1.463 . . . . 0.0 110.959 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.05 -45.33 93.19 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 120.45 1.477 . . . . 0.0 114.002 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -42.3 97.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.192 1.797 . . . . 0.0 109.283 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 1.021 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.75 -36.1 10.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -87.4 -57.13 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.71 -49.08 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.546 2.339 . . . . 0.0 106.53 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.81 76.7 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.354 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.57 ' HB2' HD12 ' A' ' 106' ' ' LEU . 6.3 t80 -62.34 -47.66 83.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.55 -0.719 . . . . 0.0 110.78 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.4 p -70.36 -29.97 66.78 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.059 1.344 . . . . 0.0 109.688 -166.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -99.96 35.98 1.93 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.238 1.015 . . . . 0.0 110.732 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.44 53.62 2.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.45 1.5 . . . . 0.0 113.289 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -127.27 38.28 4.1 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 126.641 1.977 . . . . 0.0 109.189 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 101' ' ' PHE . 28.7 mt -132.93 167.07 20.92 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 120.899 1.681 . . . . 0.0 111.071 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.68 134.96 40.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.914 1.686 . . . . 0.0 107.863 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -91.03 101.9 14.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.4 tp -82.3 72.91 9.36 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -170.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -91.44 37.67 0.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.904 -1.122 . . . . 0.0 110.323 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -177.4 168.25 2.27 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.855 -1.153 . . . . 0.0 109.039 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -136.48 177.85 7.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.703 2.401 . . . . 0.0 112.293 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.25 168.88 8.92 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 124.768 1.293 . . . . 0.0 107.559 158.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -130.72 125.53 34.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.998 1.719 . . . . 0.0 109.396 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -95.88 90.11 5.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 115.407 -2.885 . . . . 0.0 113.601 171.246 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.71 155.87 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.153 -0.967 . . . . 0.0 108.68 168.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.76 140.76 29.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 151.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -94.03 164.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 161.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 154.49 47.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 163.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.7 120.11 13.17 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.588 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 73.7 Cg_endo -70.45 108.57 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.75 3.634 . . . . 0.0 106.887 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 t -105.59 168.87 8.81 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.544 1.537 . . . . 0.0 108.16 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.03 37.47 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.531 -0.73 . . . . 0.0 110.317 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.57 165.93 39.26 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.5 39.64 1.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.051 1.34 . . . . 0.0 110.351 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.78 148.79 36.1 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -14.71 62.56 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.355 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 t -122.59 37.52 4.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -104.45 170.99 7.58 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.522 -0.736 . . . . 0.0 109.82 163.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.9 mmm -77.5 137.29 38.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.983 -1.073 . . . . 0.0 111.078 -166.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 41.6 t -71.51 131.17 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.623 167.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 t -79.51 144.67 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.46 1.904 . . . . 0.0 108.599 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -85.07 36.44 0.62 Allowed 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.29 116.23 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -156.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HB3' HG23 ' A' ' 71' ' ' VAL . 30.3 t80 -63.32 -69.33 0.28 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.575 0.75 . . . . 0.0 110.706 172.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.88 10.83 1.63 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -169.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -132.98 71.34 1.47 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 159.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -110.68 179.62 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 156.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -120.68 -16.89 8.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -140.01 155.2 47.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 93.1 m-85 -133.39 108.7 8.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -86.9 127.8 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.618 HD11 ' CD2' ' A' ' 58' ' ' LEU . 94.0 mt -125.22 97.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -165.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 4' ' ' VAL . 49.7 t80 -92.53 125.64 37.26 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.758 1.223 . . . . 0.0 109.153 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 125.79 30.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.043 1.737 . . . . 0.0 111.933 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.281 3.2 p -91.58 31.86 1.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.775 0.798 . . . . 0.0 109.967 174.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.88 -90.18 0.56 Allowed 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 154.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.55 35.59 1.21 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.359 -157.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 45.63 15.15 0.09 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.127 2.298 . . . . 0.0 115.617 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -69.35 154.58 41.81 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.34 144.09 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.679 1.228 . . . . 0.0 109.581 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.99 130.5 52.68 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.19 107.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.67 146.5 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 157.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.37 150.15 27.06 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.076 1.75 . . . . 0.0 106.533 161.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.58 133.69 7.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 109.879 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 p -119.58 61.42 0.83 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 123.628 1.68 . . . . 0.0 109.789 -163.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 75.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.656 1.982 . . . . 0.0 111.265 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.1 38.37 2.22 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.248 1.419 . . . . 0.0 112.497 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.92 -177.12 5.37 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.408 -1.432 . . . . 0.0 110.516 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.34 39.0 2.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.202 1.801 . . . . 0.0 111.975 -168.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -56.99 150.02 17.72 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.777 0.831 . . . . 0.0 111.218 -174.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.51 -30.75 6.07 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.556 -1.135 . . . . 0.0 112.269 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -146.25 165.33 29.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.023 1.912 . . . . 0.0 109.936 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.15 99.31 0.18 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -166.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -62.9 -38.13 49.81 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 CA-C-N 120.383 2.091 . . . . 0.0 110.687 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.326 0.7 OUTLIER 54.27 -67.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.895 2.078 . . . . 0.0 111.624 -158.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 p -50.59 -61.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.708 1.603 . . . . 0.0 109.876 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.41 -53.9 38.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-O 115.155 -2.355 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -49.03 -47.33 44.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 121.146 1.794 . . . . 0.0 110.194 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -50.35 60.03 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.185 1.394 . . . . 0.0 112.816 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.618 ' CD2' HD11 ' A' ' 29' ' ' ILE . 94.7 mt -65.69 -39.06 90.87 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.096 0.862 . . . . 0.0 110.088 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.73 -41.47 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.965 1.306 . . . . 0.0 109.791 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.39 1.41 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -126.43 37.46 4.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.367 1.467 . . . . 0.0 107.622 171.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.76 17.16 41.31 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.709 2.1 . . . . 0.0 116.503 166.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.05 102.43 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.777 1.288 . . . . 0.0 110.873 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.12 36.43 2.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.212 1.805 . . . . 0.0 111.658 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.623 ' HB3' HG23 ' A' ' 4' ' ' VAL . 8.4 m-85 177.11 173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.745 -1.847 . . . . 0.0 106.81 -168.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 68' ' ' ALA . 13.1 tp -174.62 146.17 0.98 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.807 HG21 ' HB1' ' A' ' 97' ' ' ALA . 30.5 mt -114.69 103.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -158.85 101.89 1.64 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.983 1.313 . . . . 0.0 109.412 -168.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 5.8 t -60.81 -17.55 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.664 1.585 . . . . 0.0 113.792 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.89 178.33 7.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.411 -1.431 . . . . 0.0 108.806 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.665 HG13 ' H ' ' A' ' 73' ' ' ARG . 1.7 p -126.47 156.51 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 120.313 -1.492 . . . . 0.0 110.216 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.4 20.5 0.13 Allowed Glycine 0 CA--C 1.546 2.009 0 C-N-CA 127.096 2.284 . . . . 0.0 114.219 166.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.665 ' H ' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER 62.7 0.76 0.7 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.874 2.469 . . . . 0.0 116.518 174.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.5 p30 -137.83 101.02 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' ASN . . . 162.31 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.502 1.521 . . . . 0.0 113.675 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.61 -44.73 81.45 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.806 1.185 . . . . 0.0 109.769 -160.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.73 -40.38 95.23 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.927 1.291 . . . . 0.0 110.384 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -67.1 -19.54 65.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.054 0.542 . . . . 0.0 111.271 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.71 -47.19 32.8 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -62.77 -35.23 79.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.195 0.998 . . . . 0.0 111.489 176.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.94 86.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.127 0.571 . . . . 0.0 110.073 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.18 36.27 1.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.361 0.528 . . . . 0.0 111.196 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.34 31.72 0.21 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 127.607 2.527 . . . . 0.0 117.083 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.42 125.16 38.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.016 1.326 . . . . 0.0 108.31 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -78.5 160.2 27.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.3 t -143.83 131.68 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -107.62 157.81 17.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.048 1.739 . . . . 0.0 109.762 172.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -80.0 160.73 25.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 160.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -132.77 159.08 40.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.512 1.525 . . . . 0.0 108.826 162.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 9.1 pt-20 -129.34 74.7 1.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.818 2.099 . . . . 0.0 111.632 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.47 159.86 3.01 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.942 1.258 . . . . 0.0 111.148 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.39 161.66 9.19 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.845 -0.797 . . . . 0.0 112.833 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -96.8 164.74 12.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.91 1.284 . . . . 0.0 107.555 167.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.87 -37.3 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 117.014 -1.469 . . . . 0.0 114.277 -166.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.54 -32.79 74.58 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 121.007 1.731 . . . . 0.0 114.184 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -66.53 -43.0 86.36 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.612 1.965 . . . . 0.0 108.898 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.807 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -51.81 -28.84 16.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.291 0.496 . . . . 0.0 112.166 174.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mm -95.04 -53.37 8.37 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -25.3 68.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 110.125 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -57.16 4.1 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.623 ' HB2' HD12 ' A' ' 106' ' ' LEU . 10.7 t80 -59.96 -44.29 94.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.499 1.52 . . . . 0.0 113.451 -177.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -67.71 -13.15 61.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.637 1.575 . . . . 0.0 111.498 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.37 35.15 4.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.261 1.024 . . . . 0.0 108.761 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.31 2.93 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.09 1.805 . . . . 0.0 117.016 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -81.12 39.69 0.52 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.747 2.274 . . . . 0.0 111.176 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 101' ' ' PHE . 28.5 mt -128.55 -166.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -128.24 154.75 45.52 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -78.48 132.2 37.17 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 164.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp -117.22 71.49 0.8 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 108.833 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.2 p -112.5 37.37 3.07 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.925 -1.11 . . . . 0.0 110.453 -167.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 t 173.88 106.35 0.01 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 128.43 2.692 . . . . 0.0 103.854 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -161.46 166.24 27.51 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.981 1.712 . . . . 0.0 106.463 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 p -145.77 173.12 12.38 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.126 1.371 . . . . 0.0 107.805 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -145.74 131.47 18.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 164.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.94 88.94 2.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 176.542 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 11.2 ptt? . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 159.13 148.36 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 130.617 3.567 . . . . 0.0 107.31 166.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 31' ' ' ASP . 4.1 mtp180 -105.35 131.74 52.42 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 165.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -95.38 153.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.07 147.58 39.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.17 119.96 21.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.492 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 87.9 Cg_endo -72.54 95.13 0.78 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 1 C-N-CA 125.956 4.437 . . . . 0.0 107.308 177.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 t -89.57 172.58 8.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.3 1.04 . . . . 0.0 109.058 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.97 37.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.537 1.135 . . . . 0.0 111.107 166.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.23 173.16 45.19 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 167.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -107.78 38.12 2.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.393 0.596 . . . . 0.0 110.189 -166.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -138.93 151.69 47.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -5.3 39.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 111.649 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t -124.27 37.86 4.32 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.388 -1.445 . . . . 0.0 109.355 165.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.3 m -79.75 175.09 10.94 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 159.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.3 mmm -77.88 144.68 36.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 119.879 -1.763 . . . . 0.0 110.577 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 61.4 t -78.43 161.5 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 163.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -118.54 133.45 55.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 110.625 -167.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.19 39.03 0.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.392 1.477 . . . . 0.0 110.342 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -178.46 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.347 -1.471 . . . . 0.0 109.25 -164.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -50.98 -56.32 13.04 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.404 -0.81 . . . . 0.0 112.589 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.2 4.43 1.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -172.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -138.67 38.77 2.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.686 1.995 . . . . 0.0 108.166 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . . . -90.31 179.59 5.85 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.7 -17.94 7.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -146.31 147.74 31.67 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 24' ' ' ALA . 73.4 m-85 -128.94 96.09 4.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 mp -79.9 113.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.442 HD11 HD22 ' A' ' 58' ' ' LEU . 69.6 mt -100.37 107.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 4' ' ' VAL . 70.8 t80 -93.72 133.81 36.7 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.87 0.868 . . . . 0.0 108.783 175.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 16.4 t0 -97.76 115.15 27.43 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.034 1.734 . . . . 0.0 111.123 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.5 p -86.26 29.82 0.73 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.693 0.758 . . . . 0.0 110.758 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 22.8 mt-10 -113.35 -86.53 0.57 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 159.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -93.16 35.45 1.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 115.584 -2.446 . . . . 0.0 110.439 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.8 18.73 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.771 1.653 . . . . 0.0 113.827 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -69.92 160.77 31.25 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.548 1.139 . . . . 0.0 108.973 -175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.69 152.0 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.701 0.763 . . . . 0.0 109.081 172.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -131.97 123.92 28.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 173.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -88.91 104.89 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.96 141.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -98.07 141.4 31.06 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.842 1.657 . . . . 0.0 106.656 164.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -146.42 146.95 30.78 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 p -129.02 44.38 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.14 -0.975 . . . . 0.0 110.122 -163.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.94 93.94 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 122.514 1.149 . . . . 0.0 111.235 -165.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.57 38.99 2.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.632 1.973 . . . . 0.0 108.866 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -158.05 179.81 8.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.375 2.27 . . . . 0.0 108.902 -164.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 159.78 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.796 3.239 . . . . 0.0 108.996 166.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -83.63 46.68 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.329 1.052 . . . . 0.0 110.5 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.14 82.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.579 1.085 . . . . 0.0 114.404 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 p -86.52 178.39 7.1 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.105 1.362 . . . . 0.0 113.893 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.22 -179.7 8.1 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.908 2.194 . . . . 0.0 112.775 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.51 -32.73 58.9 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.851 1.701 . . . . 0.0 112.615 -165.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.341 2.1 ptpt 49.72 -73.59 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 129.142 2.977 . . . . 0.0 112.445 -163.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -54.35 -56.76 8.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 125.285 1.434 . . . . 0.0 109.182 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.6 t -57.03 -56.71 13.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.495 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -41.91 -54.59 3.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.972 0.909 . . . . 0.0 111.527 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.7 m -65.13 -53.6 42.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 113.598 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 29' ' ' ILE . 93.3 mt -63.1 -43.41 98.56 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.071 0.948 . . . . 0.0 109.755 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.24 -41.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.318 1.447 . . . . 0.0 110.346 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -68.59 0.89 3.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -110.02 38.39 2.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 109.972 165.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.55 32.41 16.07 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.069 1.318 . . . . 0.0 114.69 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.84 92.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 3.4 mm-40 -95.18 33.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.192 1.397 . . . . 0.0 111.109 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.74 ' HB3' HG23 ' A' ' 4' ' ' VAL . 3.4 m-85 171.65 160.13 0.09 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 119.184 -2.198 . . . . 0.0 107.748 -158.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.2 tp -168.8 147.01 3.99 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.301 1.04 . . . . 0.0 108.512 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.851 HG21 ' HB1' ' A' ' 97' ' ' ALA . 58.5 mt -118.25 105.97 18.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 125.6 1.56 . . . . 0.0 107.278 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.56 112.64 3.0 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.069 1.304 . . . . 0.0 111.85 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.32 -25.13 32.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -175.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.63 178.01 9.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.786 3.235 . . . . 0.0 104.562 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.09 165.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 151.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.02 -12.23 68.59 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.394 -1.225 . . . . 0.0 113.905 -171.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 148.76 174.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 1 C-N-CA 132.942 4.497 . . . . 0.0 108.732 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 24.61 74.41 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 130.878 3.671 . . . . 0.0 113.21 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.06 -24.27 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.621 1.568 . . . . 0.0 112.484 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 79' ' ' LEU . 9.4 t80 -59.84 -45.05 93.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.893 -170.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -66.94 -34.11 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -15.69 62.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.739 1.216 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 76' ' ' PHE . 52.9 mt -79.63 -54.55 5.77 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.31 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.815 0.846 . . . . 0.0 112.303 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.82 -35.75 61.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.73 0.812 . . . . 0.0 112.2 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.79 37.07 2.89 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.962 0.801 . . . . 0.0 110.792 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.06 30.4 2.54 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.992 1.758 . . . . 0.0 115.865 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.34 97.24 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 118.529 1.165 . . . . 0.0 108.078 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -79.19 112.36 16.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.762 0.792 . . . . 0.0 108.978 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.11 131.12 40.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.745 1.618 . . . . 0.0 107.982 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.71 161.99 13.28 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 126.026 1.73 . . . . 0.0 109.979 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 160.51 26.83 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 163.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.18 151.94 49.35 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 127.701 2.4 . . . . 0.0 104.634 163.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -141.23 66.02 1.37 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 121.715 2.052 . . . . 0.0 111.191 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.8 128.08 1.75 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.67 160.03 8.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -161.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.8 p -89.77 174.51 7.67 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.583 1.153 . . . . 0.0 110.19 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 83.4 t -48.63 -40.23 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 120.761 -1.212 . . . . 0.0 112.17 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -64.32 -34.85 79.08 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.044 1.293 . . . . 0.0 113.483 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.72 -41.52 78.94 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 125.773 1.629 . . . . 0.0 109.15 -176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.851 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.63 -40.75 13.59 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.09 0.859 . . . . 0.0 111.301 170.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mm -84.89 -49.23 15.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 O-C-N 121.267 -0.896 . . . . 0.0 108.812 -171.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -63.05 -18.22 63.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 128.442 2.697 . . . . 0.0 109.618 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 -63.83 1.25 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 108.687 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.584 ' HB2' HD12 ' A' ' 106' ' ' LEU . 6.3 t80 -54.08 -51.28 64.65 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.95 0.795 . . . . 0.0 112.5 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -66.69 -41.52 87.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.5 36.8 0.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.42 0.629 . . . . 0.0 110.133 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.28 9.25 2.05 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 127.635 2.54 . . . . 0.0 117.101 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -86.89 36.75 0.73 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.851 1.825 . . . . 0.0 111.824 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 101' ' ' PHE . 27.9 mt -131.94 172.18 12.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.551 1.069 . . . . 0.0 110.066 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -107.36 149.73 27.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -82.97 127.34 33.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 162.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp -112.83 64.46 0.64 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.561 1.145 . . . . 0.0 109.677 -170.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 111' ' ' THR . 16.3 p -107.85 37.98 2.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -164.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 110' ' ' THR . 7.0 t 165.44 57.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.255 1.422 . . . . 0.0 109.311 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -79.99 164.79 23.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.597 -1.315 . . . . 0.0 108.909 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.2 p -111.35 165.16 12.19 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.379 1.071 . . . . 0.0 109.628 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -153.04 142.24 21.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.319 -0.863 . . . . 0.0 110.644 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -155.45 88.56 1.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.928 -2.989 . . . . 0.0 102.928 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 117.96 -1.467 . . . . 0.0 112.144 -171.62 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 161.84 165.77 0.02 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 131.082 3.753 . . . . 0.0 108.083 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -112.85 112.24 23.58 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.97 0.89 . . . . 0.0 109.92 167.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 65' ' ' TYR . 2.2 p -79.46 153.58 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.57 149.32 42.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 163.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.17 118.17 18.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.1 126.27 14.2 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 125.075 3.85 . . . . 0.0 108.227 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -125.16 173.98 8.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.113 2.165 . . . . 0.0 105.986 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.05 37.26 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 128.149 2.58 . . . . 0.0 107.626 170.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.72 177.38 46.49 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.474 1.988 . . . . 0.0 109.555 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -121.47 40.37 3.61 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.459 -157.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.77 155.27 48.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -15.77 63.11 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.129 2.172 . . . . 0.0 110.983 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 p -112.07 38.58 2.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.915 -1.115 . . . . 0.0 112.212 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -97.24 168.47 10.4 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 166.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.6 132.99 38.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.827 1.651 . . . . 0.0 111.11 -171.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.403 ' HB ' ' CZ ' ' A' ' 89' ' ' PHE . 88.5 t -71.29 139.18 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.2 t -86.87 137.35 32.46 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -0.99 . . . . 0.0 109.355 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.31 37.43 0.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.59 1.186 . . . . 0.0 111.861 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 178.42 97.02 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.188 0 O-C-N 119.736 -1.853 . . . . 0.0 109.247 -156.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' VAL . 36.8 t80 -54.32 -50.38 67.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 119.424 1.011 . . . . 0.0 112.778 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.3 13.57 18.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.671 0.669 . . . . 0.0 111.173 -171.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.39 39.29 3.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.427 1.891 . . . . 0.0 106.856 168.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.28 139.51 51.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -89.82 -74.35 0.49 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.847 1.308 . . . . 0.0 108.792 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.48 156.63 22.77 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -135.52 124.56 24.3 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.5 mm -93.04 113.01 27.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -98.43 113.74 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' HG12 ' A' ' 4' ' ' VAL . 46.5 t80 -91.7 153.82 19.4 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.344 1.028 . . . . 0.0 108.643 170.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -124.45 106.17 9.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.54 1.936 . . . . 0.0 110.807 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.7 p -81.63 36.52 0.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.071 1.305 . . . . 0.0 112.228 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -105.54 -64.31 1.16 Allowed 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 124.743 1.217 . . . . 0.0 109.206 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -124.44 38.05 4.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 125.06 1.475 . . . . 0.0 110.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.79 15.24 18.62 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 126.08 1.8 . . . . 0.0 113.792 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.13 160.33 31.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.874 0.87 . . . . 0.0 109.032 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.29 147.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.689 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -130.36 140.34 50.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.208 1.803 . . . . 0.0 106.643 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.91 109.29 23.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 165.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.4 144.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.64 107.22 14.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.687 ' OD1' HD11 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -118.09 109.38 16.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 -177.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.9 p -82.01 71.93 9.06 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.076 -1.64 . . . . 0.0 109.409 -172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.799 HD12 ' HE3' ' A' ' 53' ' ' LYS . 3.6 mm -106.0 110.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 122.409 1.1 . . . . 0.0 109.527 -166.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.34 165.74 12.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.938 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 69.02 6.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 123.006 1.384 . . . . 0.0 109.401 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.74 142.63 34.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 150.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -74.58 163.0 28.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.306 0.957 . . . . 0.0 108.424 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.02 -164.75 24.24 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.214 0.911 . . . . 0.0 111.059 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.91 156.98 41.75 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.881 1.672 . . . . 0.0 107.467 168.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.42 159.65 6.78 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.562 1.553 . . . . 0.0 111.304 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.62 -45.88 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.353 2.035 . . . . 0.0 113.366 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.799 ' HE3' HD12 ' A' ' 44' ' ' ILE . 11.3 ttpt 60.67 -71.25 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.981 1.312 . . . . 0.0 110.701 -169.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.62 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.95 1.7 . . . . 0.0 110.049 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -54.79 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.349 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.32 -47.37 18.46 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.215 0.916 . . . . 0.0 111.42 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -67.29 0.42 Allowed 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 121.47 -0.769 . . . . 0.0 111.946 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 mt -51.79 -41.5 61.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.466 1.106 . . . . 0.0 110.744 -173.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.4 -41.52 91.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 126.486 1.914 . . . . 0.0 111.465 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.2 m -66.23 -3.8 6.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.848 -1.157 . . . . 0.0 111.716 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 37.26 4.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.445 1.021 . . . . 0.0 108.812 171.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.03 21.14 69.52 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.578 2.037 . . . . 0.0 116.115 161.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.95 122.81 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.23 1.012 . . . . 0.0 109.877 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -123.75 35.86 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.974 2.11 . . . . 0.0 109.923 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.569 ' HB3' HG23 ' A' ' 4' ' ' VAL . 5.9 m-85 -179.76 176.59 0.76 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.972 1.709 . . . . 0.0 107.358 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -176.63 151.04 0.89 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.339 1.856 . . . . 0.0 107.885 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.801 HG21 ' HB1' ' A' ' 97' ' ' ALA . 68.9 mt -123.07 105.61 16.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 C-N-CA 126.444 1.898 . . . . 0.0 107.601 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.21 136.03 16.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.684 1.584 . . . . 0.0 110.339 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.5 p -64.4 -27.21 68.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.863 -1.148 . . . . 0.0 112.999 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -168.4 -175.29 2.49 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.921 1.688 . . . . 0.0 108.132 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -115.46 153.21 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.989 0.916 . . . . 0.0 109.953 177.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.77 28.92 2.1 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 126.682 2.087 . . . . 0.0 111.811 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 51.05 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.524 1.93 . . . . 0.0 111.488 -159.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 25.82 75.17 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.153 2.981 . . . . 0.0 112.07 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 179.89 -40.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.844 1.658 . . . . 0.0 112.301 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -56.4 -35.76 68.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.096 0.862 . . . . 0.0 112.095 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.9 -40.63 68.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.331 0.652 . . . . 0.0 110.012 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -15.46 63.53 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.542 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -75.78 -47.69 24.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -67.04 -26.14 66.61 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 120.944 -1.097 . . . . 0.0 113.114 174.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.99 -40.42 63.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.238 0.927 . . . . 0.0 110.699 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.74 36.5 2.62 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.958 0.503 . . . . 0.0 111.329 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.51 16.02 4.81 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 117.424 1.73 . . . . 0.0 117.424 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.19 126.76 39.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.97 1.885 . . . . 0.0 109.813 -159.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -79.83 132.16 36.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.5 t -113.1 141.55 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -111.69 160.4 17.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.84 1.656 . . . . 0.0 109.509 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -79.16 159.68 27.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 160.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -141.12 161.39 37.98 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 154.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -150.0 95.53 2.31 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.404 1.456 . . . . 0.0 111.992 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.1 109.27 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 125.69 1.614 . . . . 0.0 111.003 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 162.84 158.44 9.7 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 117.86 0.83 . . . . 0.0 113.682 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -85.29 168.5 14.64 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.148 0.579 . . . . 0.0 109.644 166.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -39.25 -44.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.394 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.97 -39.57 82.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.14 1.791 . . . . 0.0 114.729 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -64.91 -41.66 95.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.312 1.845 . . . . 0.0 108.76 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.801 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -49.69 -38.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.616 0.644 . . . . 0.0 111.53 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mm -82.42 -61.12 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 -33.01 43.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.22 1.808 . . . . 0.0 110.498 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.61 -50.57 20.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.642 ' HB2' HD12 ' A' ' 106' ' ' LEU . 14.9 t80 -61.89 -50.51 71.93 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.408 1.083 . . . . 0.0 112.027 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.5 p -64.51 -45.52 86.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.864 2.065 . . . . 0.0 108.656 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -91.84 36.45 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.06 45.54 14.82 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.926 2.203 . . . . 0.0 115.078 166.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -120.84 36.51 4.56 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 111.058 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.642 HD12 ' HB2' ' A' ' 101' ' ' PHE . 17.4 mt -124.7 -175.74 3.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.791 1.178 . . . . 0.0 109.446 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.49 138.42 53.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -79.72 111.08 15.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.27 61.62 2.86 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.412 1.485 . . . . 0.0 109.762 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.8 p -95.93 35.03 1.45 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.921 -1.112 . . . . 0.0 112.759 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.1 t 167.91 93.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.3 -1.5 . . . . 0.0 107.864 -169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -82.5 158.14 23.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.8 p -140.38 68.19 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.632 1.206 . . . . 0.0 109.472 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -147.27 102.22 3.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.68 109.04 13.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 147.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 115.336 -2.925 . . . . 0.0 113.634 162.298 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.83 177.33 11.47 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 140.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -114.32 130.18 56.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 156.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 65' ' ' TYR . 10.0 p -115.2 134.28 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.774 1.63 . . . . 0.0 107.42 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' HD12 ' A' ' 66' ' ' LEU . . . -111.06 143.96 40.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.72 120.91 20.8 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.03 111.57 3.31 Favored 'Trans proline' 0 N--CA 1.446 -1.302 1 C-N-CA 125.687 4.258 . . . . 0.0 108.631 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -112.93 171.04 7.77 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.831 1.653 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.85 39.39 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.173 1.389 . . . . 0.0 109.899 168.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.69 -174.5 47.07 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.64 1.591 . . . . 0.0 109.984 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 39.2 mtmt -115.33 38.91 3.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.152 1.381 . . . . 0.0 109.457 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -124.48 149.37 46.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 2.23 3.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 122.309 1.052 . . . . 0.0 110.778 168.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 38.4 3.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.027 -1.671 . . . . 0.0 108.448 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.7 m -80.17 170.56 16.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 159.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 139.72 38.87 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.896 -1.128 . . . . 0.0 108.904 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 92.9 t -76.87 147.67 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 t -109.9 133.84 52.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -169.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.87 38.1 0.44 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.352 0.596 . . . . 0.0 110.833 -172.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -167.34 86.92 0.26 Allowed 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.427 -1.421 . . . . 0.0 107.839 -163.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 79' ' ' LEU . 9.1 t80 -48.23 -53.13 18.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.009 0.822 . . . . 0.0 112.787 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -74.72 -6.77 50.69 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -129.19 64.59 1.47 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 171.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.18 25.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.26 -16.77 61.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.36 1.064 . . . . 0.0 113.249 -163.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.478 ' CE1' ' CG ' ' A' ' 11' ' ' LYS . 92.1 m-85 -141.0 154.7 46.14 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -139.02 107.27 5.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.607 1.163 . . . . 0.0 107.885 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.74 116.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.85 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.6 ' HB3' HG12 ' A' ' 4' ' ' VAL . 18.3 t80 -88.84 116.51 27.16 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.99 1.716 . . . . 0.0 107.536 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.62 100.0 6.8 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.899 1.679 . . . . 0.0 108.501 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 p -74.04 70.3 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.445 1.117 . . . . 0.0 108.586 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -155.76 -53.01 0.09 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.91 2.484 . . . . 0.0 110.458 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 m -136.22 36.71 2.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.481 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.01 11.74 1.07 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.495 1.998 . . . . 0.0 114.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -71.59 141.97 50.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.676 1.238 . . . . 0.0 107.688 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.37 160.62 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.747 1.619 . . . . 0.0 107.066 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -137.42 141.91 41.65 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.8 116.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.79 132.52 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 160.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -85.85 136.6 33.24 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 155.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.73 132.11 20.77 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-N 119.451 1.023 . . . . 0.0 111.288 167.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.0 p -103.22 50.2 0.81 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.382 0.673 . . . . 0.0 111.516 -159.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.42 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 120.445 -1.409 . . . . 0.0 111.74 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.66 39.67 0.75 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.662 1.585 . . . . 0.0 111.241 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.94 179.43 9.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.976 2.11 . . . . 0.0 107.046 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 76.06 1.57 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.223 1.809 . . . . 0.0 110.232 -172.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -159.12 176.85 11.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.088 0.955 . . . . 0.0 110.816 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.51 104.12 1.66 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.9 p -74.21 -16.44 60.97 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.921 0.86 . . . . 0.0 111.53 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.6 178.46 16.48 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 126.523 2.011 . . . . 0.0 108.877 165.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.32 -48.09 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.352 2.702 . . . . 0.0 112.992 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER 58.15 -64.65 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.041 1.291 . . . . 0.0 112.249 -157.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.13 -61.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.308 1.443 . . . . 0.0 108.582 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 55' ' ' VAL . 1.4 t -53.28 -47.62 56.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 126.101 1.76 . . . . 0.0 109.257 175.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -45.22 -52.47 9.44 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.365 1.439 . . . . 0.0 111.649 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 t -66.41 -51.95 51.61 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.374 0.669 . . . . 0.0 112.258 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.5 -41.33 97.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.632 -1.292 . . . . 0.0 110.113 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 t -59.99 -35.37 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.466 1.506 . . . . 0.0 111.241 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -65.45 -33.72 76.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.565 1.075 . . . . 0.0 109.489 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.33 38.07 0.65 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.766 1.226 . . . . 0.0 109.603 170.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.32 22.74 2.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.023 1.773 . . . . 0.0 116.092 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.66 118.86 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 119.831 1.816 . . . . 0.0 109.108 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.36 35.61 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.412 0.685 . . . . 0.0 110.982 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.897 ' HB3' HG23 ' A' ' 4' ' ' VAL . 23.3 m-85 -174.91 160.7 2.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 68' ' ' ALA . 18.2 tp -164.26 148.35 9.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.703 HG21 ' HB1' ' A' ' 97' ' ' ALA . 64.0 mt -119.43 97.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -152.69 103.67 2.81 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.281 0.632 . . . . 0.0 109.527 -171.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.5 p -45.92 -28.87 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.966 1.706 . . . . 0.0 115.58 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 -171.19 2.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -128.67 155.03 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -75.32 -41.65 30.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -171.52 -148.3 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.248 2.219 . . . . 0.0 107.761 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -52.49 104.58 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 111.561 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.79 -29.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.956 2.102 . . . . 0.0 109.141 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 79' ' ' LEU . 28.2 t80 -51.9 -39.49 59.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.088 1.755 . . . . 0.0 112.442 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.43 -37.35 86.66 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.618 0.767 . . . . 0.0 109.535 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.6 m -80.13 -13.84 58.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.726 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 76' ' ' PHE . 25.8 mt -71.14 -58.2 3.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.907 -1.12 . . . . 0.0 109.093 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.608 ' HE3' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -63.21 -29.27 70.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.27 37.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.22 171.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.94 35.88 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.069 0.849 . . . . 0.0 111.621 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 45.03 34.29 4.1 Favored Glycine 0 CA--C 1.538 1.521 0 O-C-N 120.387 -1.446 . . . . 0.0 115.696 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.79 127.92 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 119.258 1.529 . . . . 0.0 110.036 -166.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -79.35 112.54 16.69 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.651 -0.656 . . . . 0.0 110.748 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -97.61 121.04 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.05 157.89 15.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 109.954 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.46 151.5 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -128.6 172.79 10.86 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 156.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.38 52.21 0.53 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 121.288 1.858 . . . . 0.0 112.787 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.51 101.95 2.67 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.386 -0.822 . . . . 0.0 112.488 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.82 166.36 34.76 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -162.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.404 ' C ' HG23 ' A' ' 17' ' ' VAL . 26.6 p -88.39 174.11 8.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.373 1.069 . . . . 0.0 110.488 167.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.2 t -45.1 -42.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.588 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.15 -34.12 76.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 120.305 1.411 . . . . 0.0 114.369 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.36 -45.07 85.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.608 1.563 . . . . 0.0 107.209 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -46.69 -45.59 19.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.356 0.662 . . . . 0.0 111.254 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.38 -52.05 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.16 -33.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.758 2.023 . . . . 0.0 109.405 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -61.5 1.79 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.666 ' HB2' HD12 ' A' ' 106' ' ' LEU . 3.1 t80 -54.64 -41.17 69.75 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.445 1.498 . . . . 0.0 112.452 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.1 p -69.41 -50.45 45.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.202 1.401 . . . . 0.0 108.119 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -86.12 36.63 0.69 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.597 0.713 . . . . 0.0 109.689 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.71 12.89 2.76 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.287 1.899 . . . . 0.0 116.658 172.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.6 mtp180 -85.74 35.91 0.64 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 121.027 2.413 . . . . 0.0 112.314 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 101' ' ' PHE . 20.1 mt -134.44 -178.89 5.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.586 -1.321 . . . . 0.0 109.414 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -127.81 153.34 46.71 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 125.769 1.628 . . . . 0.0 108.886 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.92 91.57 6.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.509 1.524 . . . . 0.0 107.065 -176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -85.33 49.04 1.67 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.521 1.128 . . . . 0.0 110.691 -175.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.0 p -85.73 36.54 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 119.904 -1.747 . . . . 0.0 110.351 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t 169.78 106.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -160.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -170.09 168.18 8.52 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.035 2.934 . . . . 0.0 106.165 170.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.6 p -142.12 164.71 29.43 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.291 0.637 . . . . 0.0 110.043 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -165.83 140.79 4.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 124.939 1.296 . . . . 0.0 110.871 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.33 105.67 3.22 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.561 165.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 153.374 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 64' ' ' GLU . . . -162.47 159.0 24.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.697 1.599 . . . . 0.0 108.377 -174.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -79.68 149.42 31.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.007 157.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -115.37 151.14 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 127.706 2.403 . . . . 0.0 105.394 165.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.63 143.73 48.52 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.6 121.71 15.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.78 110.28 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.455 1 C-N-CA 125.338 4.025 . . . . 0.0 108.363 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 t -111.23 169.18 8.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.189 1.795 . . . . 0.0 108.13 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.86 37.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.361 0.664 . . . . 0.0 111.051 165.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.62 177.04 42.19 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.472 1.51 . . . . 0.0 109.832 168.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -115.18 38.63 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.735 -166.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -139.29 159.26 42.58 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.471 1.908 . . . . 0.0 108.306 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -74.02 -5.05 39.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.612 1.965 . . . . 0.0 111.07 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -122.82 37.97 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.669 -1.269 . . . . 0.0 110.916 167.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 m -83.24 173.29 11.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.14 164.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.91 142.88 36.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.89 1.223 . . . . 0.0 109.766 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -71.57 165.07 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.047 0.927 . . . . 0.0 108.508 166.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 t -119.98 127.87 53.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.396 1.478 . . . . 0.0 109.26 -175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.22 37.11 0.37 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 122.13 0.967 . . . . 0.0 110.826 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.85 108.82 0.48 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 -166.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.62 ' CE2' HD11 ' A' ' 79' ' ' LEU . 13.3 t80 -63.65 -58.19 7.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.639 1.109 . . . . 0.0 110.622 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.76 -13.66 59.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.737 -170.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -123.82 77.39 1.52 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.201 1.8 . . . . 0.0 106.81 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.58 116.3 13.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.86 -16.34 11.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -173.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -142.97 157.76 44.24 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -135.19 107.52 7.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -79.88 126.79 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.447 HD11 ' CD2' ' A' ' 58' ' ' LEU . 62.6 mt -119.93 101.33 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.534 ' HB3' HG12 ' A' ' 4' ' ' VAL . 56.8 t80 -89.8 133.61 34.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.513 1.125 . . . . 0.0 108.191 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.64 121.65 27.95 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.338 1.455 . . . . 0.0 107.497 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 p -84.83 53.17 2.62 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.029 1.286 . . . . 0.0 108.454 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.08 -82.78 0.22 Allowed 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 p -104.88 36.97 2.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 117.99 -1.484 . . . . 0.0 110.347 -160.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.77 4.32 0.15 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.08 1.8 . . . . 0.0 116.489 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -75.26 158.32 33.09 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.221 1.008 . . . . 0.0 110.514 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.9 162.97 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.383 0.673 . . . . 0.0 109.349 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -131.69 138.2 48.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 168.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.73 110.05 22.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 155.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.08 135.79 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.454 -2.425 . . . . 0.0 104.454 156.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.25 128.67 47.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -140.12 132.51 28.44 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.357 0.98 . . . . 0.0 111.766 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -110.58 54.32 0.67 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.61 1.195 . . . . 0.0 108.303 -155.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.47 89.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.914 1.286 . . . . 0.0 109.263 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.3 60.23 1.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.439 1.896 . . . . 0.0 107.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.1 p30 -162.79 170.32 18.49 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.727 0.811 . . . . 0.0 111.846 -165.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.15 38.31 0.97 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.532 1.933 . . . . 0.0 109.93 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 178.84 3.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 109.695 167.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.14 -114.94 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.535 1.064 . . . . 0.0 112.451 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.265 53.8 m 52.05 -171.54 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.956 0.903 . . . . 0.0 109.497 -164.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.42 -119.53 4.41 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' A' ' 78' ' ' THR . 59.2 Cg_endo -71.0 -43.54 1.58 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 119.552 1.676 . . . . 0.0 113.62 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 61.47 -72.82 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.544 1.152 . . . . 0.0 110.646 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.82 -56.53 12.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 119.702 1.137 . . . . 0.0 110.383 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG23 ' H ' ' A' ' 55' ' ' VAL . 1.4 t -55.79 -51.25 61.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 C-N-CA 125.235 1.414 . . . . 0.0 107.893 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -12.91 1.08 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.504 1.521 . . . . 0.0 114.615 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.52 -48.72 3.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.377 1.471 . . . . 0.0 109.526 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD2' HD11 ' A' ' 29' ' ' ILE . 69.5 mt -58.08 -45.29 87.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.523 1.129 . . . . 0.0 110.504 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.27 -41.3 91.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.208 1.403 . . . . 0.0 109.652 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -67.1 3.33 1.17 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.299 -0.876 . . . . 0.0 113.223 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -124.61 38.84 4.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.488 2.315 . . . . 0.0 108.317 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.08 35.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 126.1 1.81 . . . . 0.0 116.745 165.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.99 120.59 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 118.456 1.128 . . . . 0.0 110.394 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 5.7 mm-40 -124.54 36.17 4.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.688 0.756 . . . . 0.0 110.984 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.677 ' HB3' HG23 ' A' ' 4' ' ' VAL . 11.0 m-85 170.74 170.8 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.317 1.847 . . . . 0.0 107.675 -168.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 68' ' ' ALA . 10.6 tp -172.51 146.34 1.72 Allowed 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.413 -1.429 . . . . 0.0 107.263 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.723 HG21 ' HB1' ' A' ' 97' ' ' ALA . 50.9 mt -114.91 103.25 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -156.07 102.36 2.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.538 1.063 . . . . 0.0 111.32 -171.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.472 ' HB2' ' H ' ' A' ' 89' ' ' PHE . 22.7 t -59.74 -4.89 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.69 -179.43 3.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 123.612 2.915 . . . . 0.0 108.85 167.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.25 146.32 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 O-C-N 121.626 -0.671 . . . . 0.0 110.056 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.08 2.49 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.033 1.778 . . . . 0.0 110.461 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -171.54 173.61 4.66 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.066 2.546 . . . . 0.0 106.338 173.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -71.63 29.23 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.404 1.097 . . . . 0.0 112.373 162.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' ARG . . . -76.1 -27.64 57.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.209 -1.557 . . . . 0.0 111.677 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.2 t80 -61.54 -36.12 79.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.473 1.033 . . . . 0.0 110.951 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.97 -28.65 65.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.854 0.861 . . . . 0.0 110.639 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 52' ' ' PRO . 5.3 m -78.16 -20.79 51.3 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.862 -0.523 . . . . 0.0 110.432 173.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.817 HD12 ' HA ' ' A' ' 76' ' ' PHE . 14.1 mt -71.87 -54.83 8.85 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -56.2 -32.27 64.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 171.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.82 -2.58 7.46 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.68 37.33 4.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.643 1.177 . . . . 0.0 110.472 163.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.34 31.33 8.84 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.821 1.489 . . . . 0.0 116.821 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.42 115.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -78.73 107.77 11.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.83 114.69 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -84.9 163.24 19.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.983 1.713 . . . . 0.0 111.008 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -90.59 157.14 17.66 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.137 0.975 . . . . 0.0 108.54 161.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.472 ' H ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -121.42 171.36 8.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.264 2.626 . . . . 0.0 109.362 165.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.06 96.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.08 -1.637 . . . . 0.0 110.141 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.47 139.28 0.72 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.13 158.58 8.39 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 115.695 1.038 . . . . 0.0 115.695 172.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.8 p -85.93 169.65 13.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.105 0.962 . . . . 0.0 108.73 160.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.5 t -42.17 -47.37 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.879 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -60.7 -32.65 71.88 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -64.32 -46.46 83.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.324 1.45 . . . . 0.0 109.274 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.84 -36.32 11.74 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 118.471 0.578 . . . . 0.0 111.582 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.68 -55.07 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 108.143 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -37.97 70.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 108.641 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.87 11.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 106' ' ' LEU . 9.3 t80 -58.54 -44.15 89.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.756 0.822 . . . . 0.0 112.272 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -69.51 -42.51 74.63 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 109.156 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -92.07 37.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.37 -1.54 0.1 OUTLIER Glycine 0 CA--C 1.526 0.77 0 C-N-CA 130.37 3.843 . . . . 0.0 118.277 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.6 mtt-85 -82.63 37.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.638 1.719 . . . . 0.0 111.692 -170.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 101' ' ' PHE . 21.7 mt -127.89 -171.24 2.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.588 -1.32 . . . . 0.0 108.532 169.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.79 145.15 37.84 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.337 1.455 . . . . 0.0 108.276 -169.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.7 108.46 13.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -87.91 44.22 1.18 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.851 1.261 . . . . 0.0 109.501 -176.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 p -89.55 36.58 0.84 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 119.332 -2.105 . . . . 0.0 112.034 -163.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.1 t -172.56 38.48 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.536 -1.352 . . . . 0.0 111.84 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -137.53 124.29 21.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.165 -1.585 . . . . 0.0 110.087 -171.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.99 37.78 0.5 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.431 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -110.63 103.26 11.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -100.34 84.78 2.86 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.835 2.054 . . . . 0.0 106.704 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 CA-C-O 115.685 -2.73 . . . . 0.0 114.11 174.171 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' CD2' ' A' ' 65' ' ' TYR . . . -140.03 112.03 7.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.313 0.96 . . . . 0.0 112.129 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -80.91 107.74 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.4 p -84.71 153.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.66 145.85 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.42 124.3 23.54 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 103.65 1.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 1 C-N-CA 125.768 4.312 . . . . 0.0 108.963 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -101.38 173.0 6.64 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.093 1.357 . . . . 0.0 109.249 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.27 38.58 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 109.172 169.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.14 177.84 48.45 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.734 1.635 . . . . 0.0 109.552 171.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 3.5 mttm -108.79 40.05 1.88 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.115 1.766 . . . . 0.0 109.698 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -128.27 154.89 45.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -14.77 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.703 1.201 . . . . 0.0 110.044 170.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -110.74 38.35 2.52 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.64 -1.287 . . . . 0.0 108.758 166.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -86.99 167.42 14.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.589 -1.319 . . . . 0.0 108.056 162.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.58 146.1 34.4 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.467 -1.396 . . . . 0.0 110.417 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 78.8 t -87.77 132.1 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.523 1.154 . . . . 0.0 108.521 170.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -91.81 135.65 33.75 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.354 2.262 . . . . 0.0 108.674 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.17 38.27 0.47 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.884 0.849 . . . . 0.0 112.147 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' CD ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -165.25 96.44 0.69 Allowed 'General case' 0 C--O 1.224 -0.266 0 O-C-N 119.905 -1.747 . . . . 0.0 107.996 -160.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' HD11 ' A' ' 79' ' ' LEU . 19.1 t80 -65.18 -32.62 74.4 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 119.979 -1.7 . . . . 0.0 113.927 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.69 -3.68 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.197 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HG3' ' CD ' ' A' ' 20' ' ' ARG . 7.0 ptp180 -135.37 79.3 1.78 Allowed 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 119.449 1.022 . . . . 0.0 109.885 164.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.27 127.52 33.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -72.19 -17.73 61.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.466 1.106 . . . . 0.0 112.744 -167.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.431 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.1 m-85 -143.98 154.88 43.74 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.804 1.241 . . . . 0.0 107.733 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -137.76 107.67 6.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.461 1.504 . . . . 0.0 107.633 -175.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.77 123.53 43.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -175.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.25 96.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.145 0.884 . . . . 0.0 108.679 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 4' ' ' VAL . 29.0 t80 -85.42 117.68 24.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.815 1.246 . . . . 0.0 107.869 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.77 119.91 28.57 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.263 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -89.91 60.05 4.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.862 1.21 . . . . 0.0 110.697 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -136.73 -43.29 0.59 Allowed 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 117.243 -1.361 . . . . 0.0 113.085 164.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.2 m -137.04 36.87 2.57 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 117.6 -1.64 . . . . 0.0 113.128 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.26 13.83 4.08 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.477 1.513 . . . . 0.0 114.192 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -82.24 135.08 35.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.785 1.634 . . . . 0.0 108.133 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.43 170.18 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 125.178 1.391 . . . . 0.0 107.938 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.04 145.03 39.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -106.69 109.08 26.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.9 129.37 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 159.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.89 133.87 33.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 127.145 2.178 . . . . 0.0 106.295 159.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -145.57 122.51 11.33 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.977 1.262 . . . . 0.0 111.159 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.4 p -103.73 46.31 0.92 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.429 0.692 . . . . 0.0 111.944 -155.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.84 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 120.252 -1.53 . . . . 0.0 110.653 -165.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.09 83.9 1.33 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.214 1.406 . . . . 0.0 108.435 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -157.37 163.53 38.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.034 1.334 . . . . 0.0 108.339 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 39.05 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.778 -1.202 . . . . 0.0 111.144 167.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -72.64 -74.18 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 108.972 161.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.81 94.47 0.89 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.5 m -140.65 61.36 1.51 Allowed 'General case' 0 C--O 1.238 0.473 0 O-C-N 120.39 -1.653 . . . . 0.0 109.944 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.54 -174.94 26.92 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.433 ' HG3' HG21 ' A' ' 78' ' ' THR . 47.1 Cg_endo -69.91 -31.76 19.25 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.032 1.821 . . . . 0.0 113.162 -171.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 58.82 -78.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.989 2.116 . . . . 0.0 111.395 -169.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -57.3 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 126.942 2.097 . . . . 0.0 109.963 -176.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -56.96 -42.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 CA-C-O 115.167 -2.349 . . . . 0.0 109.578 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -52.31 -44.43 65.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 121.074 1.761 . . . . 0.0 111.497 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -68.12 -51.9 40.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.31 1.044 . . . . 0.0 111.191 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.17 -43.62 92.12 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.305 -0.872 . . . . 0.0 110.525 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.97 -34.65 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.604 1.962 . . . . 0.0 110.628 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -36.4 79.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.504 1.047 . . . . 0.0 109.973 175.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -81.39 38.3 0.48 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.383 0.992 . . . . 0.0 110.29 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.12 27.38 1.58 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.674 2.559 . . . . 0.0 116.279 171.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.66 120.58 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.839 1.319 . . . . 0.0 108.129 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -121.78 36.78 4.53 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.757 1.623 . . . . 0.0 109.953 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -179.6 169.45 1.36 Allowed 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 120.06 -1.65 . . . . 0.0 108.044 -171.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 67' ' ' ILE . 16.6 tp -169.33 151.89 4.71 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.515 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.778 HG21 ' HB1' ' A' ' 97' ' ' ALA . 61.1 mt -126.63 102.88 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -159.44 111.02 2.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.78 0.832 . . . . 0.0 109.944 -171.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -46.54 -31.09 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.247 1.819 . . . . 0.0 114.998 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -165.55 -170.12 1.75 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 119.058 0.844 . . . . 0.0 109.102 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.83 133.54 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.347 -0.696 . . . . 0.0 111.388 -169.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -166.25 152.45 8.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.807 2.443 . . . . 0.0 105.44 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 45.36 -143.67 0.21 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.672 1.589 . . . . 0.0 109.228 168.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 72.77 -34.57 0.3 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 129.275 3.03 . . . . 0.0 114.767 162.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.625 ' CE2' ' HE3' ' A' ' 80' ' ' LYS . 56.5 t80 -56.39 -40.71 75.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.302 1.441 . . . . 0.0 110.109 174.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.19 -40.76 98.43 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.517 0.727 . . . . 0.0 110.612 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -67.53 -27.27 66.83 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.266 -0.896 . . . . 0.0 110.764 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.504 HD11 ' CD2' ' A' ' 21' ' ' PHE . 53.3 mt -69.12 -61.13 1.92 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -61.63 -27.55 68.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 176.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.05 67.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.224 0.92 . . . . 0.0 110.613 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.85 35.98 1.91 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.541 1.064 . . . . 0.0 111.484 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.88 19.28 1.34 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.238 1.875 . . . . 0.0 117.422 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.43 120.04 29.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 118.987 1.393 . . . . 0.0 108.769 -160.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HE3' ' CD ' ' A' ' 108' ' ' GLU . 44.1 tttt -80.42 116.39 20.46 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.929 0.892 . . . . 0.0 110.208 -171.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -99.3 129.23 50.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.26 158.13 16.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 0.0 110.306 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.407 ' O ' HD13 ' A' ' 106' ' ' LEU . 1.4 tpt180 -79.6 163.66 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.586 1.555 . . . . 0.0 106.891 162.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.36 169.92 16.89 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 157.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -153.41 67.41 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 121.931 2.15 . . . . 0.0 113.008 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.34 95.67 2.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.459 1.028 . . . . 0.0 111.783 159.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.8 168.84 40.55 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -165.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.414 ' C ' HG23 ' A' ' 17' ' ' VAL . 34.0 p -87.4 176.57 7.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.761 0.824 . . . . 0.0 110.559 167.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -46.33 -43.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.759 1.223 . . . . 0.0 109.887 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -32.43 73.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -72.57 -40.92 66.24 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.623 1.169 . . . . 0.0 109.072 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.778 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -45.88 -41.58 11.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 123.83 0.707 . . . . 0.0 111.083 168.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -81.69 -51.34 15.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 124.487 1.115 . . . . 0.0 108.313 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -21.0 65.49 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.95 1.3 . . . . 0.0 110.527 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.6 -62.31 1.71 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.643 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.1 t80 -56.03 -44.13 78.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.624 1.17 . . . . 0.0 112.657 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.7 p -63.61 -51.84 63.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.579 1.152 . . . . 0.0 108.451 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.37 36.36 0.69 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.593 0.711 . . . . 0.0 109.31 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.44 11.05 4.75 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.695 2.093 . . . . 0.0 116.747 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -85.03 35.34 0.57 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 121.508 2.654 . . . . 0.0 112.478 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 101' ' ' PHE . 26.9 mt -135.45 167.44 21.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 121.151 1.796 . . . . 0.0 110.033 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -110.27 139.95 44.92 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.624 1.57 . . . . 0.0 107.416 -167.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.403 ' CD ' ' HE3' ' A' ' 85' ' ' LYS . 73.5 tt0 -85.41 96.04 9.45 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.833 1.197 . . . . 0.0 107.883 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.81 38.76 0.46 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 111.676 -169.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 p -91.88 37.51 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 118.656 -2.527 . . . . 0.0 109.505 -167.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 t -176.1 40.87 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -159.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -136.76 143.1 43.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.323 -1.485 . . . . 0.0 108.129 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 12.6 p -155.81 94.51 1.56 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.897 1.279 . . . . 0.0 108.626 -175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -155.16 114.5 3.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.62 -1.3 . . . . 0.0 109.718 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -79.76 90.55 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.696 0 C-N-CA 125.778 1.656 . . . . 0.0 110.805 -175.377 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.41 133.62 34.06 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 120.933 1.697 . . . . 0.0 113.308 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -104.74 111.76 24.6 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 170.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -97.65 129.22 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.51 133.1 46.69 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 4' ' ' VAL . 4.2 mp -113.64 121.29 37.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 57.2 Cg_endo -73.7 93.23 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 1 C-N-CA 126.043 4.495 . . . . 0.0 109.509 -176.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.2 t -87.71 171.02 10.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.753 2.821 . . . . 0.0 110.338 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 m -124.72 37.86 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.96 1.304 . . . . 0.0 109.487 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.93 -174.81 45.45 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.532 -1.355 . . . . 0.0 112.645 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 22.9 mtmt -111.06 39.6 2.23 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.05 1.34 . . . . 0.0 111.859 -162.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -143.35 157.58 44.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 108.784 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -78.95 -13.79 59.59 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.444 -0.785 . . . . 0.0 111.053 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -104.91 37.39 2.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.375 -1.453 . . . . 0.0 111.072 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' THR . 97.0 p -82.76 170.7 14.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.277 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.56 134.18 37.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.791 1.632 . . . . 0.0 109.133 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 47.8 t -78.14 132.42 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -79.7 152.23 30.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.402 2.681 . . . . 0.0 108.42 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -88.71 36.46 0.8 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.234 -0.916 . . . . 0.0 112.613 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.37 107.01 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.433 -1.417 . . . . 0.0 110.024 -153.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.478 ' HB3' HG23 ' A' ' 71' ' ' VAL . 21.5 t80 -58.0 -60.44 3.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.848 1.204 . . . . 0.0 112.058 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.06 1.19 28.75 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -167.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.8 63.91 1.29 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 162.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . . . -123.95 169.05 12.0 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 164.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -117.64 -30.48 5.46 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 119.034 0.834 . . . . 0.0 112.657 -165.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 95.7 m-85 -126.4 145.71 50.36 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HB3' HD21 ' A' ' 58' ' ' LEU . 94.1 m-85 -133.04 89.12 2.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 126.89 2.076 . . . . 0.0 106.009 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.449 HG22 ' CG1' ' A' ' 37' ' ' VAL . 3.0 mm -79.12 107.19 11.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 -176.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.448 HD11 HD23 ' A' ' 58' ' ' LEU . 81.1 mt -94.23 107.88 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.507 ' HB3' HG12 ' A' ' 4' ' ' VAL . 41.2 t80 -89.96 131.59 35.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -100.81 109.35 21.33 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.745 2.018 . . . . 0.0 111.211 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.2 p -82.14 53.86 2.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.372 0.987 . . . . 0.0 110.225 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -140.86 -20.53 0.81 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.563 1.545 . . . . 0.0 112.712 166.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.2 p -150.63 34.92 0.62 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.597 162.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.88 10.0 2.1 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.976 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -62.87 152.97 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.683 1.593 . . . . 0.0 107.2 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.449 ' CG1' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -135.43 160.72 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.175 172.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -149.9 136.88 19.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.226 -0.892 . . . . 0.0 109.232 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 11' ' ' LYS . 21.7 t -102.07 114.69 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.521 0.728 . . . . 0.0 109.508 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.73 158.12 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.692 1.197 . . . . 0.0 108.66 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -120.11 122.19 40.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 163.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.604 ' CG ' HD11 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -133.87 111.7 10.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -174.207 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 p -83.58 74.97 10.07 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 42' ' ' ASN . 4.6 mm -98.33 113.03 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 C-N-CA 123.9 0.88 . . . . 0.0 109.933 -170.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.5 -165.79 1.09 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.664 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -78.68 108.39 12.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.23 2.212 . . . . 0.0 106.52 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 157.23 28.81 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.784 2.034 . . . . 0.0 108.282 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -73.07 -48.99 31.19 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.762 -0.586 . . . . 0.0 110.039 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.68 -134.26 3.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m 62.73 99.66 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.039 1.736 . . . . 0.0 110.72 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.57 -173.63 33.25 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.456 0.55 . . . . 0.0 111.914 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.53 -167.08 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.406 2.737 . . . . 0.0 109.383 163.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -152.64 -52.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.197 1.399 . . . . 0.0 107.486 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 10.1 p -87.56 -39.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.965 1.706 . . . . 0.0 110.473 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -61.3 -52.04 66.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 116.368 -1.777 . . . . 0.0 109.986 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -44.06 -49.86 8.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.849 1.204 . . . . 0.0 110.949 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -58.55 -64.59 0.87 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 112.657 173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 27' ' ' PHE . 69.3 mt -60.49 -39.39 87.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.337 -167.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.37 -33.87 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.643 1.977 . . . . 0.0 110.904 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -59.9 -30.87 69.32 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.66 37.86 1.63 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.163 0.985 . . . . 0.0 110.303 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.72 25.52 29.46 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.954 -0.914 . . . . 0.0 115.003 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 72.6 t -74.24 96.93 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -105.85 36.84 2.41 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -164.95 155.95 14.54 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.2 tp -164.56 146.06 8.24 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.26 -1.525 . . . . 0.0 107.15 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.824 HG21 ' HB1' ' A' ' 97' ' ' ALA . 28.3 mt -120.73 104.97 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.02 134.51 17.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 119.453 1.024 . . . . 0.0 111.831 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.3 p -68.43 -23.79 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.558 -0.714 . . . . 0.0 112.669 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -177.81 -176.19 0.56 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.095 2.158 . . . . 0.0 107.433 -162.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 21' ' ' PHE . 4.3 p -138.07 141.16 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 119.75 -1.844 . . . . 0.0 112.872 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.87 11.09 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 127.911 2.672 . . . . 0.0 116.265 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.274 22.8 mtm180 143.27 -103.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 1 C-N-CA 131.716 4.006 . . . . 0.0 107.062 167.768 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -64.97 137.41 57.72 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 154.38 -35.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 130.354 3.462 . . . . 0.0 110.637 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.507 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 69.6 t80 -58.27 -41.86 85.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.718 0.807 . . . . 0.0 111.851 -162.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -62.34 -39.49 93.28 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.062 1.345 . . . . 0.0 109.357 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -74.69 -23.96 58.7 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.247 1.019 . . . . 0.0 110.652 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.67 -51.18 29.44 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 121.377 -0.827 . . . . 0.0 108.933 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.37 -30.44 70.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 117.125 -1.417 . . . . 0.0 113.575 175.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.31 -60.57 3.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.316 1.01 . . . . 0.0 108.961 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.53 36.83 0.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.693 0.679 . . . . 0.0 112.058 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.68 27.71 3.27 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.562 2.029 . . . . 0.0 115.636 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.36 121.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.197 0.999 . . . . 0.0 108.54 -166.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -77.65 153.51 33.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -144.16 116.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -172.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -95.37 157.99 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.526 0.731 . . . . 0.0 109.313 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 153.81 29.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 163.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.525 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -134.26 167.27 21.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 162.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.75 77.39 1.58 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.36 1.076 . . . . 0.0 112.266 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.53 88.33 0.11 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.832 1.206 . . . . 0.0 114.568 159.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.43 164.59 35.12 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.818 2.628 . . . . 0.0 109.781 -163.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 15' ' ' SER . 41.6 p -79.59 169.67 17.68 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.519 164.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -50.28 -41.78 19.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-N 121.135 1.788 . . . . 0.0 111.907 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -52.92 -39.5 62.85 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -65.69 -46.64 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.803 1.641 . . . . 0.0 108.575 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.824 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -48.28 -34.54 10.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.479 0.581 . . . . 0.0 112.464 171.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.96 -58.36 3.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.83 -29.06 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.992 2.517 . . . . 0.0 110.155 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.02 -60.55 2.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.595 ' HB2' HD12 ' A' ' 106' ' ' LEU . 9.7 t80 -56.01 -48.67 75.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.857 1.263 . . . . 0.0 113.217 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.1 p -72.25 -30.89 65.31 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.683 1.193 . . . . 0.0 109.992 -170.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -104.52 35.99 2.55 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 122.561 1.172 . . . . 0.0 108.494 170.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.46 -2.74 1.54 Allowed Glycine 0 CA--C 1.531 1.05 1 C-N-CA 131.334 4.302 . . . . 0.0 120.135 165.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -80.1 38.43 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.956 2.878 . . . . 0.0 113.59 -169.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.595 HD12 ' HB2' ' A' ' 101' ' ' PHE . 16.9 mt -122.86 -166.6 1.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.129 -0.982 . . . . 0.0 108.684 175.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.21 148.23 46.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.233 1.413 . . . . 0.0 108.498 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.96 101.03 9.24 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.569 1.548 . . . . 0.0 107.856 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 tp -98.42 67.49 1.81 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 107.525 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.8 p -105.72 36.78 2.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.298 1.408 . . . . 0.0 110.08 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -168.17 37.96 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.336 1.065 . . . . 0.0 110.537 -148.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -125.23 167.72 14.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 125.664 1.586 . . . . 0.0 107.83 -169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.69 -169.27 3.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 123.006 1.384 . . . . 0.0 108.467 -171.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.99 155.72 37.73 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 156.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -113.35 86.84 2.47 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.191 1.853 . . . . 0.0 108.918 -174.538 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' THR . 3.4 ptt? . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 159.35 148.68 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 130.526 3.53 . . . . 0.0 108.753 164.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 -109.83 126.27 53.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 165.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.9 p -99.4 149.6 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.03 147.56 44.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.152 1.342 . . . . 0.0 108.657 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 120.64 19.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 95.1 Cg_endo -73.03 101.31 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 127.147 5.231 . . . . 0.0 107.568 -178.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -100.1 164.37 12.01 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.77 1.228 . . . . 0.0 109.207 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 16' ' ' MET . 15.0 m -121.75 38.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 165.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 -178.68 41.83 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.594 1.092 . . . . 0.0 110.485 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' CG ' ' CE2' ' A' ' 26' ' ' TYR . 37.3 mtmt -108.91 39.95 1.92 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 109.536 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -143.02 148.66 37.12 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.376 1.07 . . . . 0.0 109.907 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 1.91 3.41 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.041 2.136 . . . . 0.0 112.957 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -130.74 38.18 3.73 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.25 -1.531 . . . . 0.0 107.98 167.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 p -81.76 165.2 21.15 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.466 167.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.429 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -78.13 131.77 37.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.324 1.42 . . . . 0.0 109.881 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 84.8 t -74.29 144.21 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.251 1.021 . . . . 0.0 108.763 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -94.92 132.22 39.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.286 2.234 . . . . 0.0 109.52 -169.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -81.3 39.01 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.054 0.93 . . . . 0.0 111.026 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -175.73 97.82 0.07 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.312 -1.492 . . . . 0.0 108.313 -162.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CD2' HD11 ' A' ' 79' ' ' LEU . 17.5 t80 -60.49 -51.04 71.16 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.755 1.161 . . . . 0.0 112.478 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.04 3.36 15.06 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -134.56 69.72 1.45 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 165.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 27' ' ' PHE . . . -100.67 -177.96 3.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 160.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.48 -21.42 9.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.894 0.378 . . . . 0.0 110.115 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 86.2 m-85 -145.42 156.34 43.7 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.567 2.347 . . . . 0.0 105.681 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 69.8 m-85 -132.92 110.77 10.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -86.35 129.58 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.9 mt -124.43 105.79 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.566 ' HB3' HG12 ' A' ' 4' ' ' VAL . 42.4 t80 -91.29 117.36 29.58 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.023 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.32 98.88 11.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.12 2.568 . . . . 0.0 112.055 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 1' ' ' MET . 76.1 p -78.13 58.11 1.95 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 119.652 -1.905 . . . . 0.0 109.3 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.88 -21.83 0.36 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.286 2.234 . . . . 0.0 112.105 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.78 35.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.072 1.305 . . . . 0.0 113.548 158.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.91 6.88 5.72 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.572 -1.33 . . . . 0.0 114.593 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.68 158.04 34.99 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.177 0.989 . . . . 0.0 109.254 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.35 173.54 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 125.736 1.614 . . . . 0.0 107.945 171.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.77 139.91 28.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.58 104.37 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.58 145.45 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 162.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -105.42 144.09 32.68 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.04 129.63 9.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 120.74 -1.225 . . . . 0.0 110.491 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.2 p -116.02 43.75 2.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.441 0.296 . . . . 0.0 110.685 -158.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.33 48.53 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 120.91 -1.119 . . . . 0.0 113.477 -163.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 98.47 6.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 152.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -162.14 -175.53 4.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.006 2.122 . . . . 0.0 106.867 163.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.5 67.72 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.563 1.529 . . . . 0.0 111.154 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -131.92 100.8 5.19 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 108.145 171.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.8 45.24 1.88 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.731 1.158 . . . . 0.0 111.434 169.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -116.96 68.3 0.74 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.856 1.262 . . . . 0.0 107.638 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.6 142.28 9.52 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.908 1.718 . . . . 0.0 109.313 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.84 -33.21 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.629 2.886 . . . . 0.0 112.4 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 60.31 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.907 2.083 . . . . 0.0 111.16 -169.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.274 1.43 . . . . 0.0 110.627 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -45.46 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.822 0 CA-C-O 115.859 -2.02 . . . . 0.0 109.072 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -51.97 -42.73 63.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.054 1.752 . . . . 0.0 112.138 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -68.46 -55.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.361 0.664 . . . . 0.0 110.111 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -45.61 80.45 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.015 -1.053 . . . . 0.0 110.923 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 t -56.67 -33.87 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.412 1.885 . . . . 0.0 111.484 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 m -66.75 -39.24 87.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.336 0.971 . . . . 0.0 109.806 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.74 37.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.027 0.931 . . . . 0.0 110.21 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.27 30.25 0.77 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.812 2.149 . . . . 0.0 116.353 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.64 119.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.74 1.27 . . . . 0.0 108.211 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -120.0 36.06 4.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.943 0.897 . . . . 0.0 111.089 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.773 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.0 m-85 -177.39 168.52 2.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.093 -2.255 . . . . 0.0 107.286 -167.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 68' ' ' ALA . 17.6 tp -169.85 153.84 5.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.953 0.901 . . . . 0.0 108.614 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.808 HG21 ' HB1' ' A' ' 97' ' ' ALA . 37.0 mt -127.21 106.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 126.183 1.793 . . . . 0.0 106.594 171.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -157.98 125.49 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.585 0.754 . . . . 0.0 109.823 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.8 p -60.49 -27.97 67.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -165.38 -179.61 5.63 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 126.424 1.89 . . . . 0.0 105.989 -168.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.43 166.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -10.3 84.33 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 116.114 -2.492 . . . . 0.0 113.545 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 73' ' ' ARG 0.408 0.2 OUTLIER 143.99 -59.36 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 131.782 4.033 . . . . 0.0 112.614 161.334 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -76.51 -159.07 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.665 1.186 . . . . 0.0 109.139 165.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 77.42 -35.99 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.317 2.647 . . . . 0.0 113.244 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HA ' HD12 ' A' ' 79' ' ' LEU . 60.9 t80 -55.35 -43.43 75.03 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.776 1.23 . . . . 0.0 111.544 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -66.43 -32.14 73.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.127 0.971 . . . . 0.0 110.445 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -18.47 54.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.926 1.29 . . . . 0.0 110.756 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' CD2' ' A' ' 21' ' ' PHE . 36.9 mt -76.57 -62.85 1.49 Allowed 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.406 -0.809 . . . . 0.0 108.944 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HE3' ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -55.97 -35.45 66.74 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 120.973 -1.08 . . . . 0.0 113.74 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.31 69.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.14 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.74 36.35 0.54 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.245 0.929 . . . . 0.0 111.651 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.48 33.22 3.07 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.309 1.433 . . . . 0.0 115.259 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.97 111.38 23.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 118.858 1.329 . . . . 0.0 108.581 -169.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -80.33 113.23 18.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.101 -0.999 . . . . 0.0 110.355 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.25 133.73 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -172.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -105.15 155.56 18.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.355 1.062 . . . . 0.0 110.073 165.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 162.59 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 163.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -140.39 172.6 12.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 160.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.68 75.06 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.995 1.725 . . . . 0.0 112.46 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.76 124.82 2.38 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.748 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.84 162.72 12.88 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.404 ' C ' HG23 ' A' ' 17' ' ' VAL . 20.4 p -82.31 174.29 11.28 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.751 167.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.3 t -42.29 -47.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-O 117.429 -1.272 . . . . 0.0 110.597 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -60.82 -36.23 78.55 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.817 1.19 . . . . 0.0 113.85 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -66.08 -44.02 85.67 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 124.995 1.318 . . . . 0.0 108.632 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.808 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.7 -36.81 11.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.61 0.641 . . . . 0.0 111.298 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.5 mm -87.16 -52.06 12.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 108.849 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.47 -13.73 43.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.508 2.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -62.31 1.52 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 167.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.644 ' HB2' HD12 ' A' ' 106' ' ' LEU . 3.5 t80 -55.73 -43.78 76.91 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.449 -1.407 . . . . 0.0 113.163 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 p -60.16 -51.24 70.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.098 1.359 . . . . 0.0 108.794 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.49 37.87 0.71 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.169 0.988 . . . . 0.0 109.753 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 44.17 33.9 3.04 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.672 2.558 . . . . 0.0 114.549 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -106.63 36.58 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.422 1.111 . . . . 0.0 110.684 -168.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 101' ' ' PHE . 18.9 mt -137.82 172.05 13.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.3 -0.875 . . . . 0.0 108.922 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -111.33 139.13 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -170.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.23 91.89 6.82 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 38.47 0.35 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.745 1.218 . . . . 0.0 110.214 -176.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.323 5.7 t -93.7 36.03 1.11 Allowed 'General case' 0 CA--C 1.542 0.654 0 O-C-N 119.36 -2.087 . . . . 0.0 110.262 -167.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.3 t 171.57 56.89 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.547 -1.346 . . . . 0.0 107.539 -163.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.35 138.42 34.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 120.629 -1.294 . . . . 0.0 108.058 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -145.86 110.62 5.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 171.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -147.1 147.43 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -118.08 39.64 3.35 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 O-C-N 120.463 -1.398 . . . . 0.0 110.851 177.511 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 64' ' ' GLU . . . -168.9 172.58 7.59 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.721 1.209 . . . . 0.0 111.279 -169.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -89.01 148.43 23.76 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 159.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 65' ' ' TYR . 1.1 p -114.68 166.96 7.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.31 154.41 41.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 163.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -138.06 129.87 16.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.65 1.98 . . . . 0.0 106.947 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.79 99.19 0.81 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 1 C-N-CA 127.97 5.78 . . . . 0.0 108.765 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -96.04 170.32 9.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.842 1.257 . . . . 0.0 109.455 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 18' ' ' SER . 25.8 m -121.06 38.27 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.506 1.123 . . . . 0.0 110.739 163.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.23 171.62 44.69 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 120.807 -1.183 . . . . 0.0 112.623 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 26' ' ' TYR . 12.9 mttt -90.57 38.19 0.94 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.891 0.876 . . . . 0.0 111.212 -172.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.48 160.57 41.93 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 120.939 -1.101 . . . . 0.0 111.301 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -12.53 59.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.427 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 t -121.05 37.22 4.38 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 120.575 -1.328 . . . . 0.0 108.499 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 m -80.0 168.91 18.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 159.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mtp -79.26 145.62 33.45 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.572 -1.33 . . . . 0.0 110.099 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 89' ' ' PHE . 57.3 t -80.2 158.68 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -126.99 149.49 49.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.206 . . . . 0.0 111.32 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER -86.21 33.02 0.61 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.436 1.016 . . . . 0.0 113.297 -166.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -165.13 120.93 1.38 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 118.717 -2.489 . . . . 0.0 106.657 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CE2' HD21 ' A' ' 79' ' ' LEU . 6.3 t80 -58.68 -72.37 0.1 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 124.582 1.176 . . . . 0.0 111.903 167.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -72.82 2.03 7.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.657 -160.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.478 HH11 ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -134.02 44.45 2.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.115 1.766 . . . . 0.0 109.068 173.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' CE1' ' A' ' 27' ' ' PHE . . . -89.5 -174.85 4.5 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -120.07 -25.78 5.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.27 0.941 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 81.0 m-85 -142.2 139.91 32.17 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 25.1 m-85 -123.44 100.87 7.03 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -80.98 120.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 58' ' ' LEU . 39.1 mt -110.55 112.16 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 4' ' ' VAL . 65.8 t80 -99.41 123.29 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -87.55 114.29 24.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.281 2.232 . . . . 0.0 109.601 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -75.59 7.15 3.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.049 1.295 . . . . 0.0 113.643 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -96.31 -41.26 8.73 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 119.123 0.874 . . . . 0.0 113.208 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -130.03 37.1 3.95 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.185 160.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 48.7 29.4 7.81 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.884 1.23 . . . . 0.0 113.185 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -91.87 161.22 14.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.692 1.197 . . . . 0.0 107.914 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.57 155.83 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.236 0.541 . . . . 0.0 109.605 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 13.2 pt-20 -136.06 155.96 49.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 166.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.18 107.52 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.27 141.79 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 159.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -111.08 111.56 22.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 127.517 2.327 . . . . 0.0 105.269 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -136.79 102.89 5.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.237 0.926 . . . . 0.0 109.123 -167.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -108.91 60.15 0.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -157.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.67 126.16 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.83 38.84 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.675 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.15 168.52 26.84 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.993 0.917 . . . . 0.0 109.847 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.29 64.08 1.62 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.309 1.043 . . . . 0.0 109.177 174.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.36 170.33 22.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.983 0.913 . . . . 0.0 111.001 171.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.34 147.13 6.32 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 113.746 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -72.33 166.05 23.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.167 1.387 . . . . 0.0 109.61 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 123.91 4.71 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.21 -30.65 64.57 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 119.863 1.831 . . . . 0.0 112.176 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt 58.23 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.418 2.287 . . . . 0.0 110.787 -170.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -63.09 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 108.992 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.17 -53.08 38.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 CA-C-O 115.612 -2.137 . . . . 0.0 109.184 -173.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -51.61 -46.14 63.49 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 120.658 1.572 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -38.89 85.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 29' ' ' ILE . 81.5 mt -77.68 -38.21 48.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.965 0.802 . . . . 0.0 110.168 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -58.25 -32.42 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.372 1.869 . . . . 0.0 110.304 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -13.42 8.57 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.209 -0.932 . . . . 0.0 112.934 173.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 8.2 mptt -114.17 37.7 3.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.331 1.052 . . . . 0.0 110.091 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.58 25.2 8.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.579 1.085 . . . . 0.0 114.401 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.04 114.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 0.7 OUTLIER -115.11 37.87 3.37 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.299 1.523 . . . . 0.0 110.48 -178.154 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.743 ' HB3' HG23 ' A' ' 4' ' ' VAL . 7.3 m-85 -176.48 172.07 2.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -165.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 67' ' ' ILE . 8.2 tp -177.6 130.41 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 108.459 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.754 HG21 ' HB1' ' A' ' 97' ' ' ALA . 55.0 mt -101.32 104.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.98 6.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.622 0.646 . . . . 0.0 109.379 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 p -47.2 -33.46 5.36 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.692 1.197 . . . . 0.0 112.209 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.25 -176.44 5.88 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 73' ' ' ARG 0.296 1.5 p -104.78 176.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 165.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -104.82 25.84 24.26 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.59 ' H ' HG13 ' A' ' 71' ' ' VAL . 6.2 ttt180 69.25 -169.53 0.18 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 128.659 2.784 . . . . 0.0 110.165 -164.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.4 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 22.0 t30 28.09 60.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.833 3.253 . . . . 0.0 114.77 170.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -174.73 -33.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.374 1.07 . . . . 0.0 113.328 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.613 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 48.1 t80 -54.13 -37.66 64.61 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.268 1.027 . . . . 0.0 112.178 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.5 -34.88 70.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.517 0.727 . . . . 0.0 110.189 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.8 -14.61 59.17 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.444 -0.785 . . . . 0.0 111.184 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' A' ' 21' ' ' PHE . 79.7 mt -70.25 -57.29 5.06 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.262 -0.899 . . . . 0.0 109.19 171.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.613 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -60.74 -28.89 69.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.352 174.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -53.28 51.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.062 0.846 . . . . 0.0 109.986 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.58 35.72 0.68 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.193 0.452 . . . . 0.0 111.556 176.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 36.19 0.4 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 127.214 2.34 . . . . 0.0 115.901 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 t -86.99 136.92 21.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.406 1.603 . . . . 0.0 109.925 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -79.23 162.33 25.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 172.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.39 139.02 36.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.74 155.88 26.99 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.307 1.843 . . . . 0.0 109.345 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -78.39 139.64 38.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 167.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.459 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -120.15 161.45 21.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 156.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -144.77 80.1 1.62 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.307 1.051 . . . . 0.0 110.686 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.75 139.65 1.31 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 149.52 166.24 13.07 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 121.784 0.658 . . . . 0.0 111.906 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.5 p -86.09 172.03 10.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.88 -0.66 . . . . 0.0 109.619 164.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -45.43 -40.9 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.199 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.13 -35.51 81.35 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.878 1.217 . . . . 0.0 114.277 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.37 -42.43 83.45 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.932 1.693 . . . . 0.0 108.617 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.754 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -47.46 -39.16 15.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.212 0.915 . . . . 0.0 111.916 171.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.33 -53.07 11.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -60.05 -27.23 66.77 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.829 2.051 . . . . 0.0 110.31 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.68 -59.48 2.71 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.458 ' HB2' HD12 ' A' ' 106' ' ' LEU . 10.0 t80 -55.54 -49.77 71.78 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.204 0.911 . . . . 0.0 113.159 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.2 p -66.79 -25.88 66.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 110.414 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.19 37.23 3.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.278 1.431 . . . . 0.0 107.745 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.18 6.4 0.88 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.281 2.848 . . . . 0.0 116.715 168.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.503 HH11 ' HB3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -79.95 36.47 0.34 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 121.05 2.425 . . . . 0.0 111.445 -178.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 89' ' ' PHE . 38.6 mt -141.84 173.49 11.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.381 -1.449 . . . . 0.0 108.863 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -127.6 148.54 50.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.444 1.898 . . . . 0.0 107.557 -166.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.36 99.0 11.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 120.374 1.443 . . . . 0.0 108.062 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 tp -82.8 57.89 4.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.974 1.309 . . . . 0.0 109.976 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.5 p -90.29 36.12 0.87 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.045 -1.66 . . . . 0.0 110.604 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 p -163.67 149.28 11.18 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.702 2.401 . . . . 0.0 107.074 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.38 147.71 50.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.143 1.777 . . . . 0.0 109.219 170.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.1 p -148.4 64.39 1.08 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.659 1.218 . . . . 0.0 109.444 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -140.96 96.92 3.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 120.894 -1.128 . . . . 0.0 108.388 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -84.87 75.66 10.33 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.69 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -175.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.719 ' HB3' ' CD2' ' A' ' 65' ' ' TYR . . . -158.54 166.8 31.27 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 151.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -77.91 135.99 37.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.81 HG23 ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -114.43 158.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.95 145.52 50.24 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.67 118.29 21.23 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.86 102.54 0.77 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 1 C-N-CA 126.18 4.587 . . . . 0.0 107.995 176.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.0 t -96.31 173.45 7.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.185 1.394 . . . . 0.0 107.406 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.07 38.38 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.655 1.182 . . . . 0.0 109.038 164.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.35 175.46 44.62 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 121.025 -1.047 . . . . 0.0 111.96 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 19.9 mtmt -97.15 39.34 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.974 1.31 . . . . 0.0 110.296 -164.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.56 152.18 49.16 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -79.04 -0.43 31.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.169 1.788 . . . . 0.0 110.236 174.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 p -133.51 37.34 3.32 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 119.96 -1.712 . . . . 0.0 109.607 166.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 94' ' ' VAL . 36.6 m -82.76 173.36 11.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.321 156.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.97 139.03 39.15 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.812 -1.18 . . . . 0.0 109.216 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 97' ' ' ALA . 62.1 t -69.57 153.65 8.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 164.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -118.64 153.64 33.99 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.56 1.144 . . . . 0.0 110.253 -169.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.29 35.79 2.46 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.687 0.756 . . . . 0.0 111.256 -164.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -162.03 106.65 1.22 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.549 -1.344 . . . . 0.0 108.332 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CD2' HD11 ' A' ' 79' ' ' LEU . 14.4 t80 -53.96 -56.23 19.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 72' ' ' GLY . . . -75.96 -6.23 49.96 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 121.013 1.733 . . . . 0.0 112.48 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.47 39.0 4.07 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.254 1.021 . . . . 0.0 109.843 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.32 178.99 5.55 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.46 -18.04 7.98 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' A' ' 11' ' ' LYS . 89.8 m-85 -146.3 156.17 43.16 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -132.76 105.51 7.2 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.1 mm -80.05 119.34 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.63 109.44 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -98.45 108.87 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 102.28 8.39 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.924 1.69 . . . . 0.0 109.757 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -68.48 15.9 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -120.69 -18.85 7.6 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.572 0.749 . . . . 0.0 112.663 -165.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.82 38.77 0.53 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 123.502 0.501 . . . . 0.0 110.098 158.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.42 16.33 0.92 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 128.572 2.987 . . . . 0.0 116.005 173.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -76.63 144.46 39.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.744 1.272 . . . . 0.0 109.584 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.29 138.08 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.616 1.166 . . . . 0.0 109.288 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.51 149.33 36.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.314 1.845 . . . . 0.0 108.043 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.14 111.04 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 162.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.87 128.64 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 153.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -84.14 140.87 31.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 160.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB3' HD11 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -142.65 99.97 3.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.7 p -79.47 55.77 2.01 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 120.913 -1.117 . . . . 0.0 112.474 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.65 HG23 ' HE3' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -86.38 148.56 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 119.955 -1.716 . . . . 0.0 109.028 -166.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.38 159.57 25.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.222 1.409 . . . . 0.0 110.766 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.79 38.84 0.81 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.351 1.461 . . . . 0.0 110.439 -172.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.98 176.34 5.1 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.317 1.447 . . . . 0.0 110.075 -171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.86 167.52 7.51 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.239 -0.913 . . . . 0.0 109.708 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.93 166.35 19.5 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.684 -0.635 . . . . 0.0 112.075 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 p -94.99 155.42 16.74 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.538 1.535 . . . . 0.0 111.608 -170.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 -179.38 4.75 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.76 1.648 . . . . 0.0 114.268 168.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.46 -52.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.195 1.263 . . . . 0.0 109.639 167.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.65 ' HE3' HG23 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 63.34 -64.59 0.11 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 126.426 1.89 . . . . 0.0 111.266 -171.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -63.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.314 1.446 . . . . 0.0 108.752 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -53.46 -49.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 126.291 1.836 . . . . 0.0 108.894 177.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.49 -37.96 12.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.017 1.281 . . . . 0.0 111.902 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -75.74 -58.74 3.1 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.792 0.837 . . . . 0.0 110.403 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.74 -44.33 85.97 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.26 1.024 . . . . 0.0 110.84 -171.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.76 -45.03 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.137 1.775 . . . . 0.0 110.108 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.4 m -77.18 7.42 5.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.622 1.169 . . . . 0.0 113.901 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.73 38.98 3.75 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.461 -1.399 . . . . 0.0 108.741 155.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.58 18.14 29.54 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.636 2.065 . . . . 0.0 116.759 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.74 89.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.511 1.924 . . . . 0.0 110.219 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.674 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 3.3 mm-40 -91.58 35.7 0.95 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.954 1.302 . . . . 0.0 111.066 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.81 ' HB3' HG23 ' A' ' 4' ' ' VAL . 15.3 m-85 177.89 166.56 0.71 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 120.03 -1.668 . . . . 0.0 107.317 -170.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 68' ' ' ALA . 9.2 tp -165.96 150.51 8.22 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.733 HG21 ' HB1' ' A' ' 97' ' ' ALA . 67.1 mt -120.84 103.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -149.13 120.87 8.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.607 1.094 . . . . 0.0 108.16 -176.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' A' ' 89' ' ' PHE . 79.4 p -54.35 -34.57 61.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.896 0.379 . . . . 0.0 111.981 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.26 170.33 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -97.37 147.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 22' ' ' ALA . . . -82.15 33.72 2.67 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ttm105 61.14 -161.35 0.29 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.316 1.846 . . . . 0.0 108.64 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t30 25.28 69.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.842 2.857 . . . . 0.0 112.802 174.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -177.89 -28.54 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CE1' ' HE3' ' A' ' 80' ' ' LYS . 57.3 t80 -70.27 -36.92 74.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 121.317 1.871 . . . . 0.0 110.928 -158.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.24 -32.43 72.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.523 0.729 . . . . 0.0 109.598 175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -13.85 59.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.627 1.171 . . . . 0.0 109.842 -177.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' CD2' ' A' ' 21' ' ' PHE . 28.8 mt -80.81 -62.47 1.66 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.987 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -59.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.387 -0.815 . . . . 0.0 112.265 177.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -16.04 27.75 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.217 -0.897 . . . . 0.0 113.366 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.62 36.71 4.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.674 1.125 . . . . 0.0 111.071 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.03 31.01 1.14 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.121 2.296 . . . . 0.0 116.824 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.49 112.62 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.071 1.435 . . . . 0.0 109.841 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -79.31 102.75 8.8 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 79' ' ' LEU . 61.8 t -84.05 126.05 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -96.69 157.1 16.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.17 1.788 . . . . 0.0 109.726 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.49 154.16 30.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.77 2.028 . . . . 0.0 105.794 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.43 168.52 19.48 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 152.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.56 38.75 1.38 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.035 1.289 . . . . 0.0 112.288 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 112.82 3.74 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.358 -1.463 . . . . 0.0 112.908 170.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.37 164.71 30.36 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.598 2.047 . . . . 0.0 109.697 -161.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.42 ' C ' HG23 ' A' ' 17' ' ' VAL . 69.6 p -87.63 169.85 11.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.226 1.013 . . . . 0.0 109.211 166.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 15' ' ' SER . 27.0 t -43.1 -47.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.538 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -63.11 -30.32 71.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -69.6 -40.67 76.52 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 120.483 1.492 . . . . 0.0 110.119 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.733 ' HB1' HG21 ' A' ' 67' ' ' ILE . . . -51.88 -28.27 15.56 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mm -92.94 -56.78 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 C-N-CA 125.689 1.596 . . . . 0.0 107.351 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.93 -41.31 64.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.247 0.967 . . . . 0.0 108.68 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.39 -50.66 58.71 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -43.37 68.67 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 111.479 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.9 p -67.41 -35.65 79.7 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.175 1.79 . . . . 0.0 110.464 -171.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.64 36.76 2.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.031 0.932 . . . . 0.0 108.74 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 46.96 20.93 0.79 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.813 2.149 . . . . 0.0 115.953 172.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -93.63 38.92 1.06 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.58 1.69 . . . . 0.0 110.206 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.3 mt -140.37 169.67 17.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 109.02 165.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -121.61 143.18 49.46 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.609 -163.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -79.48 100.8 7.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.71 50.96 1.22 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.079 1.352 . . . . 0.0 108.517 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.346 13.5 t -79.8 38.64 0.4 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.934 1.294 . . . . 0.0 110.239 173.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.1 t 178.48 128.09 0.06 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.412 1.885 . . . . 0.0 108.047 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -104.88 127.72 52.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 161.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -80.31 47.14 0.89 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 110.698 172.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -105.1 94.93 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -82.35 45.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.128 0.971 . . . . 0.0 112.182 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.088 -179.965 . . . . . . . . 0 0 . 1 stop_ save_